Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5984242797396009,-2.7350589501253246,0.0,0.0,0.0,59/87,21.25%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC61B;RPLP2;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26
prerank,protein targeting to ER (GO:0045047),-0.5683890862607436,-2.6214307112476085,0.0,0.0,0.0,69/99,24.74%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;EDEM1;RPS14;RPSA;SPCS2;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;SGTA;RPS4X;RPS27;RPL27A;RPS9;RPL30;SGTB;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC62;RPLP2;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26;ZFAND2A;RPS27A;RPS3;RPL4;SEC63;SPCS1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.5687965203955773,-2.55411787828928,0.0,0.0,0.0,61/91,21.25%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;SIL1;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC62;RPLP2;RPL29;RPLP0;RPL10A;SSR2;RPS10;RPL35;RPS26
prerank,cytoplasmic translation (GO:0002181),-0.5583296114488692,-2.4546670090774203,0.0,0.0,0.0,61/91,23.10%,RPL13;RPS8;EIF3M;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RWDD1;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26;TMA7;RPS27A;RPS3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.494076185296543,-2.1936803935237696,0.0,0.004771911056773898,0.012,72/110,26.41%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;EIF4A3;RPL31;RBM8A;SMG1;RPL13A;RPL36A;RPLP2;RPL29;RPLP0;DCP1A;RPL10A;RPS10;NCBP1;RPL35;RPS26;RPS27A;CASC3;RPS3;RPL4;MAGOH;EIF3E;UPF1;GSPT1;RPS25
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.9082481613095686,2.164452262753865,0.0,0.0,0.0,50/125,2.94%,KNL1;KIF11;CENPF;KIF4A;CENPE;NUF2;CDCA8;SPC25;NSL1;CENPM;KIF2C;NUSAP1;CENPH;CENPP;ZWILCH;CCNB1;KNTC1;NDC80;STIL;CENPK;CENPA;DLGAP5;INCENP;TTK;BUB1B;SGO1;SKA1;PLK1;BIRC5;BUB1;ESPL1;CENPI;SPDL1;KIF18A;CDC20;WDR62;CENPN;AURKB;CENPQ;CKAP5;CENPU;SKA2;STMN1;XPO1;DSN1;ITGB3BP;PMF1;GPSM2;AURKA;NUP160
prerank,mitotic spindle organization (GO:0007052),0.9008249861373486,2.162832888091543,0.0,0.0,0.0,56/153,3.25%,KNL1;KIF11;PRC1;CENPF;TPX2;KIF4A;CENPE;NUF2;CDCA8;SPC25;NSL1;CENPM;KIF23;KIF2C;CENPH;CENPP;ZWILCH;CCNB1;KNTC1;NDC80;STIL;CENPK;CENPA;DLGAP5;KIFC1;INCENP;TTK;BUB1B;SGO1;SKA1;PLK1;BIRC5;BUB1;CENPI;SPDL1;KIF18A;CDC20;WDR62;CENPN;AURKB;CEP192;CENPQ;CKAP5;CENPU;SKA2;STMN1;XPO1;DSN1;ITGB3BP;SMC1A;PMF1;GPSM2;CCDC61;AURKA;NUP160;RHOA
prerank,mitotic sister chromatid segregation (GO:0000070),0.9084635797089631,2.143617160988586,0.0,0.0,0.0,41/98,2.82%,PRC1;KIF18B;CENPE;KIF14;CDCA8;NSL1;KIF23;CEP55;KIF2C;NUSAP1;NCAPG;CCNB1;NDC80;CDK1;CENPK;DLGAP5;KIFC1;SGO1;NCAPG2;PLK1;CDCA5;SPAG5;ESPL1;KNSTRN;SPDL1;NCAPH;SMC2;KIF18A;SMC4;KIF22;NCAPD3;NCAPD2;NCAPH2;HASPIN;PDS5A;DSN1;PSRC1;KMT5A;SMC1A;RB1;PDS5B
prerank,sister chromatid segregation (GO:0000819),0.950185985246619,2.1253420949118937,0.0,0.0,0.0,19/31,2.56%,TOP2A;KIF18B;CDCA8;NSL1;NUSAP1;NDC80;CENPK;KIFC1;SGO1;NCAPG2;PLK1;SPAG5;ESPL1;KNSTRN;KIF18A;SMC4;DSN1;SMC1A;RB1
prerank,mitotic nuclear division (GO:0140014),0.8926641498353666,2.1195668785278214,0.0,0.0,0.0,23/71,2.40%,KIF11;KIF18B;TPX2;CDCA8;NSL1;NUSAP1;NDC80;CENPK;KIFC1;SGO1;NCAPG2;PLK1;SPAG5;ESPL1;KNSTRN;KIF18A;SMC4;UBE2C;CEP192;DSN1;UBE2S;SMC1A;CCDC61
prerank,centromere complex assembly (GO:0034508),0.9366916677896946,2.0847399494335095,0.0,0.0,0.0,18/36,2.05%,KNL1;CENPF;MIS18BP1;CENPE;CENPM;CENPH;CENPP;CENPK;CENPA;DLGAP5;CENPI;HJURP;CENPN;CENPQ;CENPU;HELLS;OIP5;ITGB3BP
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.9141103901423314,2.0641709211905286,0.0,0.0,0.0,16/38,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;ASF1B;CENPI;HJURP;CENPN;ATRX;CENPQ;CENPU;OIP5;ITGB3BP
prerank,positive regulation of cell cycle process (GO:0090068),0.8545398502980143,2.060084583208413,0.0,0.0,0.0,26/91,3.48%,KIF20B;KIF14;KIF23;ECT2;NUSAP1;E2F7;CCNB1;NDC80;E2F8;SPAG5;RACGAP1;CEP295;ATRX;AURKB;DBF4;GEN1;CIT;DDX11;PLK4;GPSM2;AURKA;PHIP;CSPP1;RHOA;RAD21;CDC6
prerank,chromatin remodeling at centromere (GO:0031055),0.9298548247518107,2.056176540987523,0.0,0.0,0.0,15/31,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;HELLS;OIP5;ITGB3BP
prerank,histone exchange (GO:0043486),0.9103734141069628,2.0466096428523217,0.0,0.0,0.0,14/37,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,chromosome condensation (GO:0030261),0.9243634229479983,2.0459668821765837,0.0,0.0,0.0,17/36,2.56%,TOP2A;NUSAP1;NCAPG;CCNB1;CDK1;INCENP;NCAPG2;PLK1;CDCA5;NCAPH;SMC2;SMC4;NCAPD3;NCAPD2;NCAPH2;KMT5A;RB1
prerank,mitotic spindle assembly (GO:0090307),0.8989733628949901,2.043587595393841,0.0,0.0,0.0,14/42,4.72%,KIF11;PRC1;TPX2;KIF4A;KIF23;KIFC1;RACGAP1;AURKB;CEP192;SMC1A;CCDC61;RHOA;CHEK2;SMC3
prerank,mitotic cytokinesis (GO:0000281),0.8868902926919263,2.036329498955103,0.0,0.0,0.0,15/47,1.85%,KIF4A;KIF23;CEP55;ECT2;NUSAP1;CKAP2;CENPA;INCENP;PLK1;RACGAP1;ESPL1;KIF20A;ANLN;CIT;STMN1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.932940587898957,2.035085198113822,0.0,0.0,0.0,14/29,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,CENP-A containing chromatin organization (GO:0061641),0.932940587898957,2.035085198113822,0.0,0.0,0.0,14/29,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.8805082670204861,2.0300427585208727,0.0,0.0,0.0,18/56,3.25%,KIF4A;KIF23;CEP55;ECT2;NUSAP1;CKAP2;CENPA;INCENP;PLK1;RACGAP1;ESPL1;KIF20A;AURKB;ANLN;CIT;STMN1;ROCK2;RHOA
prerank,mitotic metaphase plate congression (GO:0007080),0.8946948787367813,2.0250029193585037,0.0,0.0,0.0,14/51,2.10%,CENPE;KIF14;NUF2;CDCA8;CEP55;KIF2C;CCNB1;NDC80;KIFC1;CDCA5;SPDL1;KIF18A;KIF22;PSRC1
prerank,positive regulation of cytokinesis (GO:0032467),0.8890487726617806,1.9977860817579274,0.0,0.00027651847389982635,0.006,10/32,3.48%,KIF20B;KIF14;KIF23;ECT2;RACGAP1;AURKB;CIT;CSPP1;RHOA;CDC6
prerank,DNA replication (GO:0006260),0.832224178765751,1.9954771985538327,0.0,0.0003056256816787554,0.007,49/105,7.95%,BRCA1;EXO1;TICRR;CDK1;BRIP1;POLE;CLSPN;PIF1;BARD1;RMI2;DBF4;MCM5;POLA1;WDHD1;ORC1;PCLAF;TIPIN;POLA2;MCM8;CDC45;RFC4;NAP1L1;TIMELESS;FAM111A;MCM10;MCM6;MCM7;MCM2;RPAIN;TOPBP1;RBBP8;CDC6;RPA1;RAD1;DNA2;RFC2;BLM;MRE11;MCM3;POLD1;RPA2;MCM4;RFC1;RFC3;ORC2;CHEK1;RNASEH2A;ORC3;CDK2
prerank,positive regulation of cell division (GO:0051781),0.87207973606358,1.981077465142354,0.0,0.000746599879529531,0.016,11/38,3.52%,KIF20B;KIF14;KIF23;ECT2;RACGAP1;AURKB;CIT;CSPP1;RHOA;CDC6;FGFR2
prerank,negative regulation of cell cycle process (GO:0010948),0.8290742601761973,1.9808176057178555,0.0,0.0007110475043138392,0.016,22/61,7.14%,BRCA1;NEK2;E2F7;E2F8;RRM2;EZH2;ESPL1;RAD51;AURKB;E2F1;CBX5;TERF1;FBXO5;SUZ12;RBBP8;TFDP1;EED;WAPL;YAF2;RBBP4;RBBP7;CHEK1
prerank,regulation of cation channel activity (GO:2001257),-0.46863793206442694,-1.9700862822948648,0.0,0.11901373409453947,0.319,36/89,18.60%,CAMK2D;AHNAK;FGF14;LRRC7;MEF2C;GRIN2A;KCNAB1;CALM1;FKBP1A;GRIN2B;HOMER1;FGF13;SHISA6;CACNG7;NETO1;NEFL;CACNG4;MINK1;RELN;OPRM1;GRIA1;APP;SELENON;SHANK1;CACNG2;CACNB2;DLG4;PRRT1;GRIN1;CACNG3;CACNG8;CACNB1;GRIA2;STAC;NLGN1;PDE4D
prerank,mitotic chromosome condensation (GO:0007076),0.9206524699869432,1.9675850944007995,0.0,0.0013574543264173293,0.031,15/26,2.56%,NUSAP1;NCAPG;CCNB1;CDK1;NCAPG2;PLK1;CDCA5;NCAPH;SMC2;SMC4;NCAPD3;NCAPD2;NCAPH2;KMT5A;RB1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.8374138873177425,1.9657502840317083,0.0,0.0014427050812164852,0.035,21/82,3.29%,CENPF;TPX2;HMMR;KIF14;NEK2;CDK1;PLK1;ATAD5;GTSE1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;HAUS4;HAUS6;AURKA;ACTR1A;CEP43
prerank,response to cadmium ion (GO:0046686),-0.604173465696027,-1.9581502188984996,0.0,0.11881084671967665,0.365,15/26,20.87%,MAPK8;MAPK9;JUN;MAPK3;MAPK1;CHUK;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.888391803180167,1.9548101626003693,0.0,0.0018319348895863498,0.046,12/26,3.64%,CENPE;CCNB1;DLGAP5;PLK1;ESPL1;UBE2C;CDK5RAP2;FBXO5;ANAPC7;RB1;CDC6;CDC27
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.8285123526312711,1.9529907574038126,0.0,0.0019245685783427916,0.05,21/57,8.18%,DTL;BRCA1;EME1;TICRR;CDK1;CLSPN;PLK1;FANCD2;TIPIN;RFWD3;TOPBP1;CHEK2;PRKDC;BLM;MRE11;RPA2;MDC1;CHEK1;CDK2;UIMC1;MRNIP
prerank,dendrite morphogenesis (GO:0048813),-0.5340561505355722,-1.950641219227355,0.0,0.11290682411116813,0.385,17/35,15.33%,CTNND2;DOCK10;SHANK3;PAK3;KLF7;TAOK2;DIP2A;EPHB2;BTBD3;TMEM106B;MINK1;CTNNA2;CHRNA7;MEF2A;SHANK1;DLG4;DVL1
prerank,cellular response to cadmium ion (GO:0071276),-0.6175926398101995,-1.9479789987876857,0.0,0.1026339600306132,0.392,15/24,20.87%,MAPK8;MAPK9;JUN;MAPK3;MAPK1;CHUK;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,regulation of cytokinesis (GO:0032465),0.8300400298792666,1.9440957272707864,0.0,0.0028396320204328324,0.072,17/78,3.48%,PRC1;KIF20B;KIF14;KIF23;ECT2;E2F7;E2F8;PLK1;RACGAP1;KIF20A;AURKB;CIT;PLK4;AURKA;CSPP1;RHOA;CDC6
prerank,dendritic spine morphogenesis (GO:0060997),-0.6861055730134179,-1.9406162524060655,0.0,0.10361864008994749,0.426,8/15,13.64%,CTNND2;DOCK10;SHANK3;PAK3;DIP2A;EPHB2;SHANK1;DLG4
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.928845760049962,1.9398888309091153,0.0,0.003410394511431192,0.088,11/17,3.49%,KNL1;ZWILCH;CDK1;CENPA;TTK;SPDL1;AURKB;HASPIN;MTBP;RB1;CTCF
prerank,negative regulation of protein transport (GO:0051224),-0.5958090069571182,-1.93887817044808,0.0,0.09574808548981392,0.431,12/25,23.23%,APOE;SNX3;SERGEF;CYP51A1;PPM1F;RHBDF1;PKDCC;WWP2;RHBDF2;DRD2;DPH3;NDFIP1
prerank,protein depolymerization (GO:0051261),0.8862774035619008,1.9344478746131915,0.0,0.003970015232418935,0.103,7/27,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,DNA replication initiation (GO:0006270),0.8699712965723687,1.9293776349328284,0.0,0.004548252139662661,0.123,23/37,7.95%,POLE;DBF4;MCM5;POLA1;ORC1;PRIM2;POLA2;MCM8;CDC45;PRIM1;MCM10;MCM6;MCM7;MCM2;TOPBP1;CDC6;RPA1;MCM3;RPA2;MCM4;ORC2;ORC3;CDK2
prerank,embryonic heart tube development (GO:0035050),-0.6988457760098706,-1.9280865663910178,0.0,0.09813662322115367,0.469,7/14,17.86%,ACVR1;RYR2;MEGF8;SOX17;NDRG4;CITED2;TBX2
prerank,regulation of cell cycle process (GO:0010564),0.8186371054766809,1.92586247809929,0.0,0.004894376988026926,0.137,20/104,2.75%,KIF11;PRC1;KIF20B;MKI67;NEK2;ECT2;PLK1;SPAG5;RACGAP1;BUB1;KNSTRN;BORA;RMI2;KIF20A;AURKB;DBF4;TIPIN;PLK4;FBXO5;AURKA
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.8199335745656267,1.923309740195645,0.0,0.0053252106102643975,0.148,11/79,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6384021839684759,-1.9223897557498648,0.0,0.09753576445713683,0.493,11/18,27.90%,ELOVL7;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;ACSL1;ELOVL1;ACSBG1;TECR
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.8205553226793154,1.9222837812990792,0.0,0.005228712961014898,0.154,11/78,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.8205553226793154,1.9222837812990792,0.0,0.005228712961014898,0.154,11/78,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8594814255721385,1.9219727448121249,0.0,0.005148123352311472,0.157,20/40,7.37%,EME1;POLE;RAD51;ATRX;GEN1;DDX11;ZRANB3;TIPIN;MMS22L;RFWD3;TIMELESS;FAM111A;RTEL1;MSH3;PRIMPOL;TONSL;BLM;POLD1;ETAA1;NUCKS1
prerank,kinetochore organization (GO:0051383),0.9686209183078872,1.9189831062582152,0.0,0.005640976867556458,0.174,7/13,0.52%,CENPF;CENPE;NUF2;CENPH;NDC80;CENPA;DLGAP5
prerank,microtubule depolymerization (GO:0007019),0.9289180528219986,1.9187193198124959,0.0,0.005507326271838208,0.175,7/17,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,spindle assembly (GO:0051225),0.8058000603422067,1.9170476370912526,0.0,0.005829308368699042,0.192,19/67,8.31%,KIF11;TPX2;NEK2;KIFC1;CEP192;HAUS8;SMC1A;CCDC61;HAUS4;HAUS6;RHOA;CHEK2;TUBGCP5;SMC3;NUMA1;HAUS7;STAG1;HAUS1;GOLGA8B
prerank,regulation of mitotic nuclear division (GO:0007088),0.8245991289399022,1.9166299839472463,0.0,0.0057195663285595656,0.193,11/55,3.97%,KIF20B;MKI67;NEK2;NUSAP1;CCNB1;BORA;CDK5RAP2;FBXO5;AURKA;PHIP;OBSL1
prerank,replication fork processing (GO:0031297),0.8592128469448369,1.9144245605866153,0.0,0.006040865122119284,0.208,19/38,7.37%,EME1;RAD51;ATRX;ZGRF1;GEN1;DDX11;BRCA2;ZRANB3;MMS22L;RFWD3;FAM111A;RTEL1;PRIMPOL;DNA2;TONSL;BLM;MRE11;ETAA1;NUCKS1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5903270116641249,-1.912753122667151,0.0,0.10359429360496396,0.535,13/23,28.01%,ELOVL7;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;ACOT7;ACSL1;ELOVL1;ACSBG1;TECR;FAR2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.902096771369154,1.9111491399728626,0.0,0.0063006709410031855,0.229,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,spindle assembly checkpoint signaling (GO:0071173),0.902096771369154,1.9111491399728626,0.0,0.0063006709410031855,0.229,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.902096771369154,1.9111491399728626,0.0,0.0063006709410031855,0.229,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,regulation of chromosome segregation (GO:0051983),0.9048509774440359,1.9086957836964877,0.0012953367875647669,0.006694319333249284,0.242,10/16,4.91%,MKI67;KIF2C;BUB1;RMI2;AURKB;RAD18;SMC6;CDC6;SMC5;NUMA1
prerank,DNA recombination (GO:0006310),0.840539693851786,1.905253856646541,0.0,0.007334024069115848,0.262,16/37,5.38%,EXO1;RAD51B;RAD54B;RAD51;RAD54L;GEN1;DMC1;XRCC2;RPAIN;RTEL1;RAD21;RPA1;MSH3;BLM;MRE11;RECQL
prerank,establishment of mitotic spindle localization (GO:0040001),0.8688536221577025,1.9012666327232026,0.0,0.008092774002801584,0.29,12/28,6.66%,NUSAP1;NDC80;CENPA;PLK1;ESPL1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6896262990774825,-1.8986560227702576,0.0,0.1167982039610373,0.599,6/14,6.74%,PTK2;STAT3;STAT6;SOCS2;PIK3R1;LYN
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.49215538346115956,-1.8984810623725836,0.0,0.11024392731609339,0.603,22/46,18.42%,GRM7;GRIK1;MEF2C;CDH2;GRM3;SHANK3;OPHN1;SYT1;HOMER1;CACNG7;NRXN1;TSHZ3;CACNG4;DGKI;RELN;GRM5;CACNG2;ATP1A2;GRM1;CACNG3;CACNG8;NLGN1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.795425338759343,1.89547080037279,0.0,0.009521853536028803,0.332,39/95,8.71%,BRCA1;RAD51AP1;POLQ;RAD51B;RAD54B;RAD51;RAD54L;MCM5;GEN1;RAD51AP2;BRCA2;MMS22L;MCM8;CDC45;AUNIP;RFWD3;XRCC2;SMC6;MCM6;MCM7;MCM2;RAD21;RBBP8;RPA1;SMC5;ERCC4;TONSL;BLM;MRE11;RECQL;MCM3;RPA2;MCM4;SPIDR;UBE2N;NUCKS1;NIPBL;RAD51C;PSMD14
prerank,DNA replication checkpoint signaling (GO:0000076),0.9111892639975989,1.893132874082572,0.0,0.01013116621394683,0.359,9/16,4.70%,TICRR;CLSPN;ORC1;TIPIN;CDC45;TIMELESS;TOPBP1;CDC6;DNA2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.8878554759629127,1.8919099103535244,0.0,0.010490419603574662,0.371,7/24,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.804625619034364,1.891305594760103,0.0,0.01037790762248532,0.375,9/80,1.09%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.8475349748873477,1.8911786046697543,0.0,0.010220122795337582,0.376,17/42,6.48%,DTL;POLK;POLE;POLA1;PCLAF;USP43;RFC4;CDKN2D;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4167061311824994,-1.8906689337745364,0.0,0.11428526480508916,0.646,36/107,16.25%,NRG3;GRM7;GRIK1;DLGAP1;DLGAP4;MCTP1;SYN3;RIMS1;IQSEC2;MEF2C;CDH2;SLC8A3;GRM3;OPHN1;TMEM108;GRID2;CNTNAP4;SYT1;LGI1;HOMER1;BCR;GRIK4;CACNA1B;DGKI;RELN;CHRNA7;APP;GRM5;PSMC5;ATP1A2;DLG4;GRM1;LRP8;CPLX1;SLC4A8;SLC12A2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.7154996961967611,-1.8901071408453065,0.003194888178913738,0.10888289117638852,0.649,7/12,17.83%,PARP8;PARP12;TIPARP;PARP6;PARP1;PARP16;PARP10
prerank,DNA metabolic process (GO:0006259),0.7856040769226202,1.8886279758547757,0.0,0.0108492836524226,0.395,88/270,7.65%,TOP2A;NEIL3;BRCA1;EXO1;TICRR;RAD51AP1;POLQ;POLK;UHRF1;CDK1;FANCA;POLE;RAD51B;BARD1;UBE2T;KPNA2;RMI2;RAD51;RAD54L;DBF4;MCM5;GEN1;POLA1;WDHD1;ORC1;RAD18;HELLS;HMGB2;PRIM2;TYMS;ZRANB3;POLA2;MCM8;TERF1;CDC45;RFC4;PRIM1;PDS5A;DMC1;SMC1A;TIMELESS;XRCC2;MCM10;MCM6;MCM7;MCM2;PDS5B;RPAIN;TOPBP1;RTEL1;EID3;POLH;RAD21;RBBP8;CDC6;RPA1;STN1;CHD1L;MSH3;PRIMPOL;UHRF2;SMARCAD1;ERCC4;RAD1;POLD3;DNA2;RFC2;PRKDC;BLM;MRE11;RECQL;MCM3;NSMCE4A;POLD1;RPA2;MCM4;ERCC3;RFC1;TCF7L2;FANCL;RFC3;ORC2;UBE2N;DNASE2;CHEK1;RIF1;RNASEH2A;ORC3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8920565292458231,1.8883725821599968,0.0,0.010784220482093227,0.396,9/21,2.18%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20;FBXO5
prerank,interstrand cross-link repair (GO:0036297),0.8209889895070311,1.885562665017487,0.0,0.01151986396926069,0.42,18/53,7.37%,NEIL3;EME1;RAD51AP1;FANCA;UBE2T;FANCD2;RAD51;RAD51AP2;MCM8;RFWD3;RNF168;FANCI;USP1;RPA1;ERCC4;RPA2;FANCL;NUCKS1
prerank,protein localization to kinetochore (GO:0034501),0.9248313586523643,1.8824157143923637,0.0,0.012443331325492187,0.45,7/14,2.47%,KNL1;ZWILCH;CDK1;TTK;SPDL1;AURKB;MTBP
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.8376570422244968,1.8819395198593556,0.0011904761904761906,0.012398082847944941,0.455,12/32,8.18%,DTL;BRCA1;TICRR;CDK1;CLSPN;PLK1;TOPBP1;BLM;MRE11;CHEK1;UIMC1;MRNIP
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.8159129919460341,1.8690199769712479,0.0,0.018739064436604305,0.587,17/36,10.07%,BRCA1;RRM2;EZH2;RAD51;E2F1;CBX5;SUZ12;RBBP8;TFDP1;EED;YAF2;RBBP4;RBBP7;CHEK1;UXT;EPC1;APAF1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.9120787152588993,1.8645537020254421,0.0,0.021088172035834126,0.632,4/16,4.47%,TOP2A;EME1;HFM1;ERCC4
prerank,protein localization to condensed chromosome (GO:1903083),0.9341451553687588,1.8613276915056673,0.0,0.022998708932633834,0.658,7/12,2.47%,KNL1;ZWILCH;CDK1;TTK;SPDL1;AURKB;MTBP
prerank,negative regulation of centrosome duplication (GO:0010826),0.9338121151952284,1.86072012601578,0.0015037593984962407,0.023030708148199096,0.667,4/11,2.31%,BRCA1;CCNF;CDK5RAP2;TRIM37
prerank,apoptotic nuclear changes (GO:0030262),0.8590540059310758,1.8605326358012866,0.003821656050955414,0.02278512224934569,0.671,2/24,1.44%,TOP2A;HMGB2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.8090516938386036,1.8600121035350226,0.001148105625717566,0.02271077957767426,0.674,14/43,8.18%,DTL;BRCA1;TICRR;CDK1;CLSPN;PLK1;ORC1;TOPBP1;CDC6;BLM;MRE11;CHEK1;UIMC1;MRNIP
prerank,postreplication repair (GO:0006301),0.8210745525841012,1.8584054859407666,0.0011061946902654867,0.02338811092146273,0.693,17/45,6.78%,DTL;BRCA1;POLK;RAD18;PCLAF;USP43;RFC4;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3;UBE2N
prerank,recombinational repair (GO:0000725),0.7865961032838696,1.8561676425229996,0.0,0.024373128342313262,0.717,29/77,8.71%,BRCA1;RAD51AP1;POLQ;RAD51B;RAD54B;RAD51;GEN1;RAD51AP2;BRCA2;MMS22L;MCM8;AUNIP;RFWD3;XRCC2;SMC6;RBBP8;RPA1;SMC5;ERCC4;TONSL;BLM;MRE11;RECQL;RPA2;SPIDR;UBE2N;NUCKS1;RAD51C;PSMD14
prerank,regulation of nuclear division (GO:0051783),0.8939450617339655,1.854048012367277,0.0,0.025171822327193567,0.733,6/20,3.97%,KIF20B;MKI67;NEK2;BORA;FBXO5;OBSL1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.7780450993835883,1.8539074108109725,0.0,0.024835613086572093,0.733,44/145,10.32%,CENPF;TPX2;HMMR;DTL;KIF14;NEK2;CCNB1;CDK1;PLK1;RAD51B;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;FBXO5;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;PSMC2;PSMD5;PCM1;FBXL7;HAUS7;NDE1;CDC25B;CNTRL;HAUS1;CDK2;CEP76;PSMB1;RAD51C;PSMD14;ALMS1;CDC25C;ODF2;PSMD1;SDCCAG8;CDC25A;NINL
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.9166706468229234,1.8534602346195688,0.0030211480362537764,0.024710696349411754,0.737,6/12,4.19%,TICRR;CLSPN;ORC1;TOPBP1;CDC6;CHEK2
prerank,double-strand break repair (GO:0006302),0.7674513355251231,1.8534004500081622,0.0,0.024391405682805577,0.737,50/158,7.37%,BRCA1;EME1;RAD51AP1;POLQ;BRIP1;CDCA5;RAD51B;RAD54B;BARD1;TRIP13;KPNA2;RAD51;GEN1;POLA1;NSD2;RAD51AP2;HMGB2;BRCA2;MMS22L;MCM8;AUNIP;RFWD3;RNF168;XRCC2;SMC6;PAXIP1;BAZ1B;SETX;RAD21;RBBP8;RPA1;SMC5;CHEK2;SMARCAD1;ERCC4;DNA2;TDP2;TONSL;PRKDC;BLM;MRE11;RECQL;RPA2;SPIDR;MDC1;UBE2N;TENT4A;PRPF19;RIF1;NUCKS1
prerank,regulation of G0 to G1 transition (GO:0070316),0.8129297249698351,1.8533423835853433,0.0011792452830188679,0.024057107229284887,0.739,17/38,10.07%,BRCA1;RRM2;EZH2;RAD51;E2F1;CBX5;SUZ12;RBBP8;TFDP1;EED;YAF2;RBBP4;RBBP7;CHEK1;UXT;EPC1;APAF1
prerank,regulation of DNA recombination (GO:0000018),0.83291592756541,1.8514687593472645,0.0,0.02509104587082337,0.75,14/32,7.49%,RAD51AP1;FIGNL1;KPNA2;RAD51;ZRANB3;RTEL1;MSH3;SMARCAD1;BLM;MRE11;RPA2;SPIDR;CHEK1;SETD2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.8317427763735363,1.8501860624421778,0.0,0.02565696411399103,0.764,18/42,8.37%,RAD51AP1;POLQ;PARPBP;FIGNL1;RMI2;RAD51;TIMELESS;RTEL1;ARID2;KLHL15;RPA2;SPIDR;CHEK1;RIF1;SETD2;FUS;MRNIP;SMCHD1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.8305908860537187,1.8470127097665763,0.0,0.027492167707871464,0.781,14/32,6.37%,E2F7;RRM2;POLA1;ORC1;E2F1;TYMS;CDC45;FBXO5;RB1;CDK14;CDC6;TFDP1;CCNA1;CCNE1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.7108120418383628,-1.8456527586789317,0.0,0.17266783429116075,0.806,4/13,4.62%,PLA2G4A;ABHD6;ABHD12;ABHD16A
prerank,regulation of exit from mitosis (GO:0007096),0.8213225704296879,1.8453992438190319,0.0,0.028435316399365473,0.796,12/38,6.46%,NEK2;KNTC1;BUB1B;CDCA5;CDC20;UBE2C;ANLN;UBE2S;ANAPC7;CDC27;ZW10;BUB3
prerank,glycerolipid catabolic process (GO:0046503),-0.6069990764835123,-1.843841662259462,0.00398406374501992,0.16786901396151035,0.811,9/19,14.75%,GPCPD1;PLA2G4A;ABHD6;ABHD12;PNPLA6;ENPP6;ABHD2;GDPD3;GDPD1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.9533305492937629,1.8431551473812702,0.0,0.02996626913728118,0.818,4/12,0.39%,CENPE;NUF2;KIF2C;NDC80
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.7684927560302754,1.8425105449388535,0.0,0.030076989140806785,0.824,51/184,9.81%,CENPF;TPX2;HMMR;CENPE;KIF14;NEK2;CCNB1;KNTC1;CDK1;BUB1B;PLK1;CDC20;UBE2C;CEP192;CEP152;CDK5RAP2;CKAP5;ANLN;E2F1;HAUS8;PLK4;CEP57;UBE2S;FBXO5;ANAPC7;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;CDC6;PSMC2;CDC27;PSMD5;PCM1;ZW10;HAUS7;ERCC3;BUB3;NDE1;CNTRL;HAUS1;CDK2;CEP76;PSMB1;CUL3;PSMD14;ALMS1;ODF2;PSMD1;SDCCAG8
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.699557581418665,-1.8398077250074776,0.009523809523809525,0.1679095914364829,0.828,8/13,13.93%,SHANK3;SQSTM1;EPHB2;LGMN;RELN;CHRNA7;APP;ADCY8
prerank,regulation of spindle organization (GO:0090224),0.8814215996386142,1.8358281276946846,0.002717391304347826,0.035925280129065436,0.873,6/18,4.91%,TPX2;BORA;PSRC1;GPSM2;TACC3;NUMA1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.8560776051683257,1.832390035078066,0.001287001287001287,0.03902185042862681,0.894,10/23,6.66%,NDC80;CENPA;PLK1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.9713029146055084,1.826224366569946,0.0,0.04507610239468338,0.933,6/10,0.77%,NEK2;ECT2;CCNB1;SPAG5;RACGAP1;KNSTRN
prerank,mitotic sister chromatid cohesion (GO:0007064),0.8871683736556768,1.823824514169619,0.0013869625520110957,0.04708258784440505,0.944,9/16,3.39%,SGO1;CDCA5;DSCC1;HASPIN;PDS5A;SMC1A;RB1;PDS5B;RAD21
prerank,regulation of DNA replication (GO:0006275),0.8026859584949458,1.8236738314070065,0.0,0.04667561834752132,0.944,19/49,7.65%,ESCO2;ATAD5;GLI2;DSCC1;TERF1;PDS5A;FBXO5;CDC6;STN1;WAPL;CCNA2;DNA2;SMC3;DHX9;BLM;FAF1;USP37;NUCKS1;ORC3
prerank,DNA repair (GO:0006281),0.7570885256141229,1.815039167675962,0.0,0.05679343805810058,0.968,81/284,7.56%,NEIL3;BRCA1;EME1;EXO1;TICRR;RAD51AP1;POLQ;POLK;CDK1;FANCA;BRIP1;POLE;CDCA5;RAD51B;BARD1;TRIP13;UBE2T;FANCD2;KPNA2;RMI2;RAD51;RAD54L;POLA1;NSD2;WDHD1;RAD18;RAD51AP2;BRCA2;ZRANB3;RFC4;PDS5A;CDKN2D;SMC1A;RFWD3;RNF168;TIMELESS;XRCC2;FAM111A;BAZ1B;SETX;PDS5B;FANCI;USP1;RPAIN;MGME1;TOPBP1;EID3;POLH;RAD21;RBBP8;RPA1;FTO;CHD1L;APEX2;MSH3;PRIMPOL;CHEK2;ERCC4;RAD1;POLD3;DNA2;TDP2;RFC2;PRKDC;BLM;MRE11;RECQL;NSMCE4A;POLD1;RPA2;ERCC3;FANCL;RFC3;MDC1;UBE2N;TENT4A;CHEK1;MLH1;NUCKS1;SETD2;RNASEH2A
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.7654741691413959,1.813213071592457,0.0,0.05835563941782261,0.972,33/94,11.82%,NEK2;CDK1;KIF24;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;CEP89;HAUS4;HAUS6;SCLT1;ACTR1A;CEP43;CEP97;PCM1;C2CD3;HAUS7;NDE1;CEP83;CNTRL;HAUS1;CEP76;ALMS1;ODF2;SDCCAG8;NINL;NPHP1;AKAP9;CC2D2A
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.742298439743208,-1.813170961539419,0.0,0.2120246844543857,0.898,5/10,12.77%,LYN;FAS;MAPK3;MAPK1;MAP2K1
prerank,regulation of centriole replication (GO:0046599),0.870685420336089,1.8086964926987366,0.0053475935828877,0.0640275154138537,0.979,6/17,2.31%,BRCA1;STIL;CEP295;CDK5RAP2;PLK4;TRIM37
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8446043415109252,1.8066689779923888,0.0038119440914866584,0.06614455157598978,0.983,6/21,2.18%,DTL;CCNB1;CDK1;RAD51B;ATAD5;FBXO5
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.7584508615263157,1.8041547468488528,0.0,0.06868521378476045,0.987,46/128,10.32%,NEK2;MELK;CCNB1;CDK1;PLK1;MASTL;BORA;CEP192;CCNB2;CEP152;CDK5RAP2;CKAP5;WEE1;HAUS8;PLK4;CEP57;HAUS4;HAUS6;CDK14;AURKA;ACTR1A;CEP43;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;HAUS7;NDE1;CDC25B;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CEP76;DNM2;ALMS1;CDC25C;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,DNA biosynthetic process (GO:0071897),0.8785888881243238,1.8036913088380808,0.004092769440654843,0.06846272097908053,0.987,8/16,6.48%,POLE;POLA1;TYMS;CDKN2D;POLH;POLD3;POLD1;RFC3
prerank,DNA double-strand break processing (GO:0000729),0.8413595023834914,1.8012977093215268,0.007989347536617843,0.07119707636702156,0.989,8/18,6.78%,BRCA1;BARD1;RBBP8;SMARCAD1;DNA2;BLM;MRE11;UBE2N
prerank,translesion synthesis (GO:0019985),0.7979182919834046,1.7982856642722975,0.0011123470522803114,0.07502232250495978,0.991,14/42,6.48%,DTL;POLK;PCLAF;USP43;RFC4;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.7772802235474467,1.7965653505292685,0.001081081081081081,0.07710152038727316,0.995,14/56,3.71%,DTL;CCNB1;CDK1;DLGAP5;CDCA5;RAD51B;ESPL1;UBE2C;FBXO5;ANAPC7;RB1;HYAL1;CDC27;TFDP1
prerank,homologous chromosome segregation (GO:0045143),0.8204968300943936,1.7963729212138295,0.01015228426395939,0.07650551574504859,0.995,2/20,0.88%,SGO1;FANCD2
prerank,cell cycle G2/M phase transition (GO:0044839),0.7528282585743122,1.7952253525207114,0.0,0.07748047638673135,0.995,46/129,10.32%,NEK2;MELK;CCNB1;CDK1;PLK1;MASTL;BORA;CEP192;CCNB2;CEP152;CDK5RAP2;CKAP5;WEE1;HAUS8;PLK4;CEP57;HAUS4;HAUS6;CDK14;AURKA;ACTR1A;CEP43;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;HAUS7;NDE1;CDC25B;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CEP76;DNM2;ALMS1;CDC25C;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,keratan sulfate catabolic process (GO:0042340),-0.71003092184621,-1.7951222645491927,0.003076923076923077,0.24304143270525438,0.926,8/11,16.97%,GNS;FMOD;HEXB;PRELP;HEXA;OGN;LUM;GALNS
prerank,DNA integrity checkpoint signaling (GO:0031570),0.7903296636276115,1.7944010275030668,0.00461361014994233,0.07820610948087726,0.996,14/36,7.16%,BRIP1;CLSPN;E2F1;TIPIN;CDC45;TIMELESS;CDC6;CHEK2;INTS7;RAD1;DNA2;MAP3K20;CHEK1;PRPF19
prerank,mitotic cell cycle phase transition (GO:0044772),0.7510939110580872,1.7941546104350294,0.0,0.07780688841135656,0.996,69/203,10.32%,CCNF;NEK2;MELK;CCNB1;CDKN3;CDK1;POLE;PLK1;CCNE2;MASTL;BORA;UBE2C;CEP192;CCNB2;CEP152;DBF4;CDK5RAP2;CKAP5;WEE1;E2F1;HAUS8;PLK4;SPDYA;CEP57;UBE2S;CDKN2D;ANAPC7;CDKN2C;HAUS4;HAUS6;RB1;CDK14;AURKA;ACTR1A;CEP43;E2F3;CDC27;TACC3;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;EIF4E;HAUS7;CCNA1;CCNE1;USP37;NDE1;CDC25B;CUL5;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CEP76;CUL3;DNM2;ALMS1;CDC25C;CUL4B;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8955079275948988,1.7939451260154247,0.0014367816091954023,0.07722001382421925,0.996,4/13,1.20%,CCNB1;NDC80;GEN1;CDK5RAP2
prerank,meiosis I (GO:0007127),0.8382410653140422,1.7931405217012781,0.0037128712871287127,0.07784583377458622,0.996,3/23,1.03%,SGO1;MEIOC;MYBL1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.9033111208558187,1.7928177571253203,0.007473841554559043,0.0774542798997303,0.996,2/10,0.99%,BRCA1;ATRX
prerank,cellular response to radiation (GO:0071478),0.7853908620403884,1.7919006864286324,0.0022701475595913734,0.07796092723513229,0.996,9/40,6.29%,ECT2;RAD51AP1;FIGNL1;RAD51;INTS7;RAD1;BLM;NET1;SPIDR
prerank,intracellular protein transmembrane transport (GO:0065002),-0.4685008206848154,-1.7875632238630386,0.0,0.25237160559188143,0.948,32/42,38.87%,PEX1;DNAJC19;AKT2;HSPD1;AIFM1;HSPA5;PEX5;TIMM44;PEX6;TOMM70;SEC61B;SEC62;DNAJC15;PAM16;TIMM17A;PEX26;TIMM17B;SEC63;CHCHD4;SEC61A2;C2CD5;PEX10;ROMO1;GRPEL1;ZFAND2B;SEC61A1;PEX16;DNLZ;TOMM40L;PEX2;PEX14;TIMM50
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6869907097096244,-1.786779097104238,0.0032258064516129032,0.24384465500114616,0.95,6/12,18.03%,PTK2;LYN;MAPK3;MAPK1;BST2;IL34
prerank,regulation of sister chromatid cohesion (GO:0007063),0.8901993315839358,1.7847895156247087,0.007407407407407408,0.08904465000757708,0.997,8/12,4.39%,CDCA5;BUB1;ESPL1;DDX11;RB1;RAD21;CTCF;WAPL
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.8764011267603111,1.783458578254999,0.004166666666666667,0.09027763849413208,0.998,8/15,6.58%,CENPE;PLK1;UBE2C;ANAPC7;CDC6;CDC27;TACC3;TPR
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6641116282274432,-1.782924342622673,0.0031847133757961785,0.24403605582924753,0.954,6/13,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.5568892950859816,-1.7828598163344602,0.004347826086956522,0.23512392442437524,0.954,12/23,29.47%,GPX4;PTGS2;ASAH2;GSTM1;EPHX2;ELOVL6;ACOT7;HPGD;FADS1;GSTM2;ACSBG1;ALOX12
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.8514419669978585,1.780294610001134,0.008032128514056224,0.09503856154460093,0.998,5/18,2.18%,DTL;CCNB1;CDK1;RAD51B;FBXO5
prerank,establishment of spindle orientation (GO:0051294),0.8214421693833882,1.7798063677195488,0.003708281829419036,0.0949011402424204,0.998,12/28,9.49%,NDC80;CENPA;PLK1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1;LLGL2;MAP4
prerank,chromosome organization (GO:0051276),0.7485382951849718,1.774633540905104,0.0,0.10316055541134116,0.999,10/99,2.16%,TOP2A;NUF2;CDCA8;CENPH;NDC80;PHF19;EZH2;HMGB2;NUP155;RFWD3
prerank,nuclear membrane disassembly (GO:0051081),0.8702282666291098,1.7721576059813244,0.002805049088359046,0.10724850339167676,0.999,4/14,1.04%,CCNB1;CDK1;PLK1;CCNB2
prerank,negative regulation of cell division (GO:0051782),0.8777314690904372,1.769389834692482,0.007587253414264037,0.11194165831263164,0.999,4/11,5.21%,E2F7;E2F8;AURKB;BLM
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.8965479312077207,1.7661482338976433,0.0014619883040935672,0.11783675235352312,0.999,4/12,1.04%,CCNB1;CDK1;PLK1;CCNB2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.854303872085073,1.7637112853096844,0.008391608391608392,0.121928845934172,0.999,6/15,6.74%,EME1;FANCD2;TIPIN;CHEK2;MRE11;MDC1
prerank,negative regulation of secretion by cell (GO:1903531),-0.48463640003586483,-1.7579952815352935,0.0,0.2897840375165884,0.984,19/38,30.81%,GRM7;APOE;STXBP6;IL1RAPL1;SERGEF;CYP51A1;TNFRSF1B;SYT11;RHBDF1;SLC30A1;VAMP8;VAMP3;RHBDF2;DRD2;DPH3;TNFRSF1A;RSAD2;CHGA;HTR1B
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.7530924544275898,1.7564071105731285,0.0,0.13639925891320964,1.0,20/63,9.33%,E2F7;CCNB1;E2F8;CDK1;GTSE1;E2F1;RFWD3;AURKA;TFDP1;CNOT1;CHEK2;MDM4;PRKDC;CNOT6L;RPA2;PML;CDK2;CNOT6;CDC25C;PLAGL1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.6201164948896175,-1.7539483850021262,0.014652014652014652,0.2907222167224196,0.985,8/14,28.44%,ECE1;NOS3;ACE;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,DNA conformation change (GO:0071103),0.838991382237766,1.7522334544816642,0.018276762402088774,0.1447690503681717,1.0,4/17,6.09%,TOP2A;HMGB2;HAT1;ERCC3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.8195145294567441,1.7482757922986363,0.010139416983523447,0.1523924033936821,1.0,10/24,6.48%,POLK;POLE;RFC4;RPA1;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,double-strand break repair via break-induced replication (GO:0000727),0.8753604161885867,1.7474173854358779,0.010144927536231883,0.15312527600544512,1.0,7/12,6.01%,MCM5;CDC45;MCM6;MCM7;MCM2;MCM3;MCM4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.7542159446916987,1.7445687224178308,0.002183406113537118,0.15831688152488332,1.0,16/54,9.33%,E2F7;CCNB1;E2F8;CDK1;GTSE1;E2F1;AURKA;TFDP1;CNOT1;CHEK2;MDM4;CNOT6L;PML;CNOT6;CDC25C;PLAGL1
prerank,ganglion development (GO:0061548),-0.6978909625642917,-1.7419477249634943,0.0,0.3143780450974613,0.992,6/11,19.33%,NRP2;SEMA3A;CTNNB1;UNC5C;TUBB3;NRP1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.8016323865294811,1.7401227317333883,0.015727391874180863,0.16819796685377006,1.0,5/23,1.42%,ZWILCH;BUB1B;BUB1;AURKB;WEE1
prerank,protein localization to chromosome (GO:0034502),0.772264451234283,1.7395674780774275,0.008284023668639054,0.16830346292211842,1.0,12/34,6.03%,CENPA;PLK1;ATRX;MCM8;HASPIN;RB1;RAD21;CTCF;RPA1;WAPL;RPA2;SLF1
prerank,base-excision repair (GO:0006284),0.7662990464798453,1.7393013402787583,0.0022002200220022,0.16745273600854085,1.0,13/48,6.48%,NEIL3;POLQ;POLE;RFC4;RPA1;APEX2;POLD3;DNA2;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,regulation of mitotic spindle organization (GO:0060236),0.7702024125746159,1.7387527911103757,0.017361111111111112,0.167482873559958,1.0,12/35,10.90%,TPX2;PLK1;BORA;PSRC1;GPSM2;CEP97;TACC3;NUMA1;TPR;CCSAP;HNRNPU;DRG1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.7401789766168213,1.7365502635870576,0.0,0.17159534235988877,1.0,37/83,14.14%,CDKN3;RRM2;POLE;CCNE2;DBF4;POLA1;ORC1;E2F1;TYMS;SPDYA;CDC45;CDKN2D;FBXO5;CDKN2C;RB1;CDK14;CDC6;E2F3;TFDP1;KHDRBS1;EIF4E;CCNA1;CCNE1;USP37;CUL5;CDK2;CUL3;KLF11;CUL4B;CDC25A;CRLF3;PCNA;NASP;BRD4;DHFR;PLK2;CDKN1B
prerank,chloride transmembrane transport (GO:1902476),-0.4662960228438877,-1.7353965137901397,0.0,0.3222689241337395,0.994,20/48,16.25%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;GABRA5;GABRB2;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;SLC1A1;SLC12A2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.8341166205488325,1.7347995819939945,0.012178619756427604,0.1747715944044273,1.0,11/18,11.29%,POLE;POLA1;RFC4;MCM7;GINS3;POLD3;MCM3;MCM4;RFC3;GINS1;PCNA
prerank,response to ionizing radiation (GO:0010212),0.7404919087448673,1.7337538217849073,0.0021164021164021165,0.17580902766205372,1.0,16/70,6.29%,BRCA1;ECT2;TICRR;RAD51AP1;FIGNL1;FANCD2;RAD51;RFWD3;RNF168;PAXIP1;TOPBP1;INTS7;RAD1;BLM;NET1;SPIDR
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.7731702278178391,1.730374626184311,0.005847953216374269,0.18309975388273667,1.0,8/34,3.64%,NUSAP1;DLGAP5;ESPL1;ANAPC7;RB1;AURKA;PHIP;CDC27
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.8907032025574063,1.7303372953025842,0.015698587127158554,0.18165172419029432,1.0,6/10,7.36%,E2F7;E2F8;ATRX;DBF4;WIZ;STOML2
prerank,regulation of double-strand break repair (GO:2000779),0.7732059378916067,1.728819431854505,0.0011574074074074073,0.18414747769358936,1.0,16/39,9.20%,RAD51AP1;FIGNL1;RAD51;DDX11;TIMELESS;DEK;RTEL1;RPA2;SLF1;SPIDR;PML;CHEK1;SETD2;UBR5;MRNIP;MGMT
prerank,negative regulation of JNK cascade (GO:0046329),-0.48216844601793374,-1.7279816637791308,0.011363636363636364,0.3350989326922027,0.996,12/31,14.06%,MECOM;PRKN;ZMYND11;PDCD4;DUSP3;CYLD;DNAJA1;DACT1;PTPN22;HDAC3;PINK1;SH3RF2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.7871607546063588,1.7273226243724904,0.01182033096926714,0.18639630417492095,1.0,6/33,4.05%,KIF14;EZH2;FAM83D;E2F1;ATP2B4;DDRGK1
prerank,mitotic recombination (GO:0006312),0.844840970848481,1.7257887878136662,0.021917808219178082,0.18896864528237883,1.0,7/15,4.06%,RAD54B;RAD51;GEN1;DMC1;SMC6;SMC5;MSH3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.7423841551089994,1.723938671049022,0.003293084522502744,0.19236243689197188,1.0,20/58,10.40%,BRCA1;POLQ;BARD1;POLA1;NSD2;HMGB2;RNF168;PAXIP1;SMC5;ERCC4;PRKDC;MRE11;MDC1;UBE2N;PRPF19;RIF1;UIMC1;PSMD14;HMGB1;HERC2
prerank,positive regulation of viral genome replication (GO:0045070),0.776942172082922,1.7165302238265678,0.019253910950661854,0.2116169120903058,1.0,1/29,0.01%,TOP2A
prerank,cellular response to nitrogen compound (GO:1901699),0.8154586866215449,1.713013574951869,0.01310615989515072,0.22021710046603046,1.0,9/20,8.98%,ATRX;DDX11;ATP2B4;TIMELESS;ROCK2;BLM;SPIDR;FMR1;RIOK3
prerank,proton transmembrane transport (GO:1902600),-0.4852246790210367,-1.711533399403742,0.007194244604316547,0.3752973771599125,0.998,10/36,15.04%,ATP6V0D1;ATP6V0A4;ATP1A1;ATP1A3;ATP5PO;ATP5MF;ATP6V0C;ATP1A2;ATP6V1H;ATP5F1B
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5390786080204183,-1.7096671434279909,0.004608294930875576,0.37112635991968423,0.998,14/22,20.99%,AEBP1;APOE;CAMSAP2;MAP1B;PRUNE1;MAP1A;CHRNA7;ABL1;CAMSAP1;GPX1;PIK3CA;ARL2;PARK7;GBA2
prerank,DNA damage checkpoint signaling (GO:0000077),0.7633791691949545,1.7084970452903807,0.009615384615384616,0.2319924158287662,1.0,9/28,7.16%,BRIP1;CLSPN;E2F1;CHEK2;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,regulation of cell division (GO:0051302),0.73782467718547,1.7078347702476462,0.0010504201680672268,0.23223632648112816,1.0,15/72,7.86%,PRC1;KIF18B;PLK1;KIF20A;AURKB;PLK4;AURKA;CSPP1;FGFR2;BLM;AHCTF1;PRPF40A;SFRP2;SETD2;SH3GLB1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.7509223726597454,1.7077187697829415,0.006593406593406593,0.23076546797229178,1.0,12/50,6.37%,CCNF;CCNB1;CDKN3;CCNE2;CCNB2;CDKN2D;CDKN2C;CDC6;CCNA2;BLM;CCNA1;CCNE1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6444416676098353,-1.7069426158743553,0.01607717041800643,0.36923879126037207,0.998,5/13,13.14%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4977391832972935,-1.7058716374620102,0.011834319526627219,0.3621539641301619,0.998,17/29,30.35%,ELOVL7;ACLY;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;PPT1;CBR4;ACSL1;SCD;ELOVL1;FASN;ACSBG1;TECR;HSD17B8
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.4621888440613438,-1.7050968481892526,0.0,0.3550836132883202,0.998,25/57,18.42%,DLGAP1;DLGAP4;LRRC7;MEF2C;GRIN2A;GRIN2B;SHISA6;CACNG7;NETO1;NEFL;CACNG4;MINK1;RELN;OPRM1;GRIA1;APP;SHANK1;CACNG2;DLG4;PRRT1;GRIN1;CACNG3;CACNG8;GRIA2;NLGN1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.6367389349251573,-1.7050082043852282,0.014184397163120567,0.34600840040423514,0.998,6/14,18.03%,PTK2;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.7820472449779451,1.7045735378111173,0.02192448233861145,0.23857756701589666,1.0,10/24,9.69%,PHF19;EZH2;PPM1D;SUZ12;MPHOSPH8;EED;RBBP4;RBBP7;PHF1;EPC1
prerank,cell cycle checkpoint signaling (GO:0000075),0.8529262939283653,1.703694680554878,0.022321428571428572,0.2393139767691966,1.0,4/12,1.42%,ZWILCH;BUB1B;BUB1;WEE1
prerank,negative regulation of histone methylation (GO:0031061),0.8613993410544736,1.7007197285637388,0.025222551928783383,0.24685922903901364,1.0,3/10,7.90%,BRCA1;BCOR;PHF1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.711347716432468,1.6990058225163558,0.0,0.25050059931016083,1.0,94/336,11.15%,TOP2A;DTL;BRCA1;EXO1;TICRR;RAD51AP1;POLQ;POLK;CDK1;FANCA;RAD51B;BARD1;UBE2T;MASTL;RMI2;RAD51;RAD54L;POLA1;WDHD1;RAD18;WDR76;PCLAF;DDX11;E2F1;CBX5;ZRANB3;MCM8;SPDYA;RFC4;PDS5A;SMC1A;RFWD3;RNF168;TIMELESS;XRCC2;SMC6;FAM111A;MCM10;BAZ1B;SETX;MCM7;PDS5B;RPAIN;TOPBP1;RTEL1;EID3;POLH;RBBP8;RPA1;SMC5;CHD1L;MSH3;CHEK2;ERCC4;RAD1;RFC2;PRKDC;BLM;MRE11;RECQL;NSMCE4A;POLD1;SLF1;ERCC3;NRDE2;SPIDR;FANCL;RFC3;PML;FMR1;ETAA1;CHEK1;RIF1;NIPBL;PHF1;UBR5;TRIM28;MRNIP;HTRA2;RAD51C;USP16;YAP1;MGMT;CUL4B;IKBKG;CBX1;MBD4;SUSD6;HERC2;MMS19;FBXO45;BOK;USP28;XPA
prerank,intracellular pH reduction (GO:0051452),-0.49242556504276724,-1.6984158576855208,0.013245033112582781,0.35527140010596875,0.998,18/33,32.34%,ATP6V0A1;DMXL2;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;GPR89B;GPR89A;ATP6V0C;ATP6V1H;TMEM9;RAB38;ATP6V1G2;ATP6V1B2;RAB39A;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5059766104157224,-1.6982353919185458,0.01020408163265306,0.34681567859053153,0.998,10/27,16.10%,GPCPD1;PLA2G4A;ABHD12;ABHD16A;PNPLA6;PNPLA8;ENPP6;GDPD3;GDPD1;PLA2G7
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5075503955278904,-1.6978999935990742,0.0,0.33898026714277996,0.998,14/32,18.42%,LRRC7;MEF2C;GRIN2A;GRIN2B;EPHB2;NEFL;RELN;OPRM1;GRIA1;APP;DLG4;GRIN1;GRIA2;NLGN1
prerank,placenta development (GO:0001890),0.8580217533933188,1.6962617575208623,0.016200294550810016,0.25721831605612644,1.0,2/12,0.44%,E2F7;E2F8
prerank,protein localization to centrosome (GO:0071539),0.8440101832911421,1.6953496944811315,0.013280212483399735,0.2585365188135346,1.0,8/17,7.18%,STIL;SPAG5;CEP192;PCM1;CCDC14;C2CD3;CEP83;NUDCD3
prerank,male meiosis I (GO:0007141),0.8320807938244151,1.695153195179528,0.018617021276595744,0.25723591898654513,1.0,3/16,6.03%,MEIOC;MYBL1;CCNA1
prerank,neuron maturation (GO:0042551),-0.5788505567957135,-1.6947540715471054,0.017391304347826087,0.33975519794530484,0.998,13/18,22.35%,B4GALT5;B4GALT6;APP;SCARF1;CX3CL1;FARP2;ADGRB3;EPHA8;MTCH1;PICK1;LGI4;CLN5;ANKS1A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.8341777386853333,1.6947389237381765,0.013458950201884253,0.2567047053104601,1.0,6/16,8.37%,POLQ;PARPBP;RMI2;KLHL15;RIF1;SMCHD1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8446924238755302,1.693957345449538,0.036827195467422094,0.257228787366537,1.0,4/12,2.03%,PLK1;CDC20;UBE2C;UBE2S
prerank,response to ethanol (GO:0045471),-0.6215517429751402,-1.6938561244903632,0.010416666666666666,0.3341526754124646,0.998,5/14,4.69%,GRIN3A;GRIN2A;GLRA1;GRIN2B;GOT2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.8643445268741062,1.6938270517563268,0.020618556701030927,0.2558577348825719,1.0,6/11,5.21%,ZRANB3;TIPIN;FBXO5;TIMELESS;MSH3;BLM
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.843513154815737,1.6936936057071517,0.009681881051175657,0.25444076150169487,1.0,8/16,6.01%,RAD51;MCM6;MCM7;MCM2;RPA1;BLM;RECQL;MCM4
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6120569412552082,-1.6935300564639,0.01893939393939394,0.32744915644453354,0.998,3/15,6.91%,PLTP;APOE;ABCA5
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5511190216682551,-1.6934945274595758,0.02252252252252252,0.3202482531434927,0.998,7/21,18.03%,PTK2;MTUS1;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,regulation of chromosome organization (GO:0033044),0.8007356148273269,1.6916183273381475,0.02574002574002574,0.2590938597802244,1.0,11/22,11.99%,PIF1;BUB1;RMI2;RB1;HNRNPD;WAPL;MAPT;YLPM1;HDAC8;TERF2;CENPV
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.7622369226990533,1.6898894165029223,0.021660649819494584,0.26297495205051996,1.0,3/29,3.39%,TRIP13;FANCD2;RAD21
prerank,regulation of DNA repair (GO:0006282),0.7412308885195186,1.6886681928547393,0.011337868480725623,0.26504879917257296,1.0,17/44,12.36%,BRCA1;RNF168;DEK;EYA4;USP1;POLH;DHX9;PML;UBE2N;UIMC1;UBR5;TRIM28;SMCHD1;AXIN2;EYA2;PCNA;TRIP12
prerank,signal transduction in response to DNA damage (GO:0042770),0.7238989573036309,1.6882081673796472,0.005500550055005501,0.2646513838695939,1.0,13/49,7.16%,E2F7;BRIP1;CLSPN;ATRX;E2F1;PAXIP1;CHEK2;MDM4;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,microtubule nucleation (GO:0007020),0.7903109327092485,1.6881224803122796,0.035526315789473684,0.2630670023049077,1.0,6/19,11.55%,TPX2;TUBGCP5;NDE1;CCDC57;TPPP;AKAP9
prerank,negative regulation of histone acetylation (GO:0035067),0.8467460656471544,1.6874386217023145,0.024242424242424242,0.2632665644161719,1.0,2/11,5.16%,BRCA1;CTBP1
prerank,regulation of catecholamine secretion (GO:0050433),-0.49095346262013473,-1.6861869611818832,0.012578616352201259,0.33358918598751686,0.999,12/29,22.19%,PRKN;KCNB1;SYT1;SYT7;DTNBP1;KCNA2;SYT11;SYT12;SYT10;SYT6;SYT2;DRD2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6988081325066255,-1.6861297844306509,0.01977401129943503,0.3267453687886747,0.999,7/10,25.25%,WDFY1;IFI35;LBP;PTPN22;NR1H3;TIRAP;NINJ1
prerank,dopamine metabolic process (GO:0042417),-0.5797566744283342,-1.6850211336512761,0.008620689655172414,0.323027133887864,0.999,9/18,23.84%,PRKN;TGFB2;MAOA;MAOB;MOXD1;GCH1;ATP7A;DRD2;COMT
prerank,positive regulation of synaptic transmission (GO:0050806),-0.4286380022066837,-1.6850043496982583,0.0,0.3164695240931902,0.999,30/72,18.62%,RIMS1;SLC8A3;GRIN2A;SHANK3;SYT1;GRIN2B;STX4;LGI1;SLC24A2;SQSTM1;EPHB2;CACNG7;NRXN1;LGMN;TSHZ3;CACNG4;RELN;CHRNA7;DTNBP1;APP;NFATC4;CACNG2;ADRA1A;DLG4;ADCY8;CACNG3;CACNG8;PRKCZ;NLGN1;STX1B
prerank,error-prone translesion synthesis (GO:0042276),0.7979215423123919,1.6844805638685345,0.03229974160206718,0.27109984818867977,1.0,9/21,6.48%,POLK;RFC4;POLH;RPA1;PRIMPOL;RFC2;RPA2;RFC1;RFC3
prerank,protein localization to microtubule organizing center (GO:1905508),0.8510299234570673,1.6825500581022106,0.016574585635359115,0.27553655115577386,1.0,7/15,6.85%,STIL;SPAG5;CEP192;PCM1;CCDC14;C2CD3;CEP83
prerank,negative regulation of DNA recombination (GO:0045910),0.7547344459892943,1.68252929079651,0.007882882882882882,0.273736473848226,1.0,13/43,8.37%,POLQ;PARPBP;RMI2;ATRX;ZRANB3;TERF1;RTEL1;MSH3;BLM;KLHL15;RIF1;POLR2A;SMCHD1
prerank,establishment of spindle localization (GO:0051293),0.8497487218286497,1.6811277795977353,0.01692524682651622,0.2761974155375131,1.0,2/14,0.75%,NUSAP1;ESPL1
prerank,positive regulation of histone methylation (GO:0031062),0.7798085264019713,1.6810427448399665,0.022222222222222223,0.27455519273513757,1.0,7/24,9.84%,BRCA1;PHF19;PAXIP1;AUTS2;RIF1;PHF1;KMT2A
prerank,cellular response to hydroxyurea (GO:0072711),0.8676274583088357,1.6806204551044799,0.033846153846153845,0.27393458272980875,1.0,6/10,6.93%,ATRX;DDX11;TIMELESS;BLM;SPIDR;FMR1
prerank,cellular response to ionizing radiation (GO:0071479),0.7382894665454897,1.680443407097751,0.008888888888888889,0.272689056876411,1.0,12/47,7.59%,ECT2;RAD51AP1;FIGNL1;RAD51;INTS7;RAD1;BLM;NET1;SPIDR;MAP3K20;NUCKS1;NIPBL
prerank,response to hydroxyurea (GO:0072710),0.8520022064858396,1.6798710738358826,0.03328290468986384,0.2727502319515836,1.0,6/11,6.93%,ATRX;DDX11;TIMELESS;BLM;SPIDR;FMR1
prerank,regulation of centrosome duplication (GO:0010824),0.776673598633824,1.6794818968976113,0.01875,0.27216420572315697,1.0,4/29,1.11%,CCNF;STIL;CEP295;GEN1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.8261451317378433,1.6729437791410935,0.027932960893854747,0.29150577518519694,1.0,5/15,5.20%,EZH2;FAM83D;ATAD5;DDRGK1;DYRK3
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7871761875798505,1.6722476941972222,0.03367875647668394,0.2919450141456609,1.0,5/21,2.18%,PLK1;CDC20;UBE2C;UBE2S;FBXO5
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.8096020212515118,1.6709973026093103,0.04281767955801105,0.29439706643840685,1.0,6/14,10.61%,RAD51AP1;TIMELESS;ARID2;FUS;MRNIP;MMS19
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.8276058828500146,1.6707998941678062,0.03880597014925373,0.29316383595844187,1.0,7/12,11.07%,BRCA1;RBM15;PCGF5;LRIF1;SMCHD1;HNRNPU;RBM15B
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.8431939179710141,1.669730539050383,0.0213089802130898,0.29499303835415247,1.0,2/10,5.16%,BRCA1;CTBP1
prerank,DNA-dependent DNA replication (GO:0006261),0.7024473539541753,1.6691171931122737,0.0,0.29521803569730215,1.0,42/128,8.71%,POLE;RAD51;DBF4;MCM5;POLA1;WDHD1;ORC1;PRIM2;POLA2;MCM8;CDC45;RFC4;PRIM1;MCM10;MCM6;MCM7;MCM2;RPAIN;MGME1;TOPBP1;GINS3;CDC6;PSMC2;RPA1;PSMD5;PRIMPOL;POLD3;DNA2;RFC2;BLM;RECQL;MCM3;POLD1;RPA2;MCM4;RFC1;RFC3;ORC2;ORC3;CDK2;PSMB1;PSMD14
prerank,positive regulation of DNA repair (GO:0045739),0.7263174733087742,1.6681103761764813,0.01557285873192436,0.2964449790811045,1.0,16/46,11.29%,BRCA1;DDX11;RNF168;TIMELESS;EYA4;DHX9;SLF1;SPIDR;UBE2N;UIMC1;TRIM28;SMCHD1;MGMT;HMGB1;EYA2;PCNA
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.7153122400417338,1.6680301725925246,0.006198347107438017,0.2948813488517667,1.0,15/78,6.37%,CCNF;CCNB1;CDKN3;PLK1;CCNE2;CCNB2;SPDYA;PSRC1;CDKN2D;CDKN2C;CDC6;CCNA2;BLM;CCNA1;CCNE1
prerank,positive regulation of macrophage migration (GO:1905523),-0.5541726101746414,-1.6646492292573813,0.004149377593360996,0.36689179010795886,1.0,8/19,22.05%,PTK2;MAPK3;MAPK1;THBS1;CX3CL1;CMKLR1;IL34;P2RX4
prerank,protein monoubiquitination (GO:0006513),0.7413132751347769,1.66402011241547,0.0220162224797219,0.30633496897506163,1.0,11/36,9.71%,DTL;UHRF1;UBE2T;RAD18;FANCL;RNF40;CUL3;UBE2R2;KLHL22;LEO1;OBI1
prerank,negative regulation of histone modification (GO:0031057),0.8040141430610785,1.663642475500434,0.026124818577648767,0.3056861146314916,1.0,2/14,5.16%,BRCA1;CTBP1
prerank,chloride transport (GO:0006821),-0.3901547434688181,-1.6634474149015006,0.0,0.3635073422660116,1.0,26/74,19.08%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;ANO10;GABRA5;CLIC5;GABRB2;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;TTYH3;SLC1A1;SLC12A2;CLCN2;FXYD1;LRRC8A
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7032766617682952,1.6620344702692305,0.0,0.30908732251660953,1.0,22/84,9.60%,CCNB1;CDK1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;FBXO5;ANAPC7;RB1;AURKA;PSMC2;CDC27;PSMD5;BUB3;CDK2;PSMB1;CUL3;PSMD14;PSMD1;SKP2
prerank,smooth muscle tissue development (GO:0048745),-0.675801481033156,-1.6607464749969203,0.005747126436781609,0.36493976385424004,1.0,6/10,15.54%,PROX1;MYLK;NF1;PTCH1;ENG;STRA6
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5671868236868869,-1.6569259985458045,0.013043478260869565,0.3688905905883434,1.0,12/19,28.28%,MAPK8;SLCO1C1;MAP2K5;KLF4;CHRNA7;APP;KLF2;WFS1;PAX8;MAPK7;TMEM106A;EGF
prerank,regulation of DNA metabolic process (GO:0051052),0.7317337828537264,1.6567481749376152,0.016835016835016835,0.32499582707713204,1.0,17/44,13.90%,TICRR;PIF1;KPNA2;USP1;POLH;HNRNPD;MPHOSPH8;SMARCAD1;YLPM1;GRHL2;UBE2N;NUCKS1;HDAC8;TERF2;STOX1;WDR70;SMG6
prerank,DNA geometric change (GO:0032392),0.7741413349922179,1.6549152511294636,0.03201970443349754,0.32937324159657094,1.0,13/24,11.47%,PIF1;DDX11;HMGB2;ZRANB3;RTEL1;DNA2;DHX9;BLM;MRE11;RECQL;HMGB3;HMGB1;ANXA1
prerank,phagosome acidification (GO:0090383),-0.49861888796154813,-1.653748658377184,0.02843601895734597,0.3720954454984408,1.0,14/26,32.34%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;RAB38;ATP6V1G2;ATP6V1B2;RAB39A;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.8074975943409204,1.6535958398277686,0.03382949932341001,0.3320641223444539,1.0,4/16,4.18%,BRCA1;PAXIP1;AUTS2;BCOR
prerank,negative regulation of double-strand break repair (GO:2000780),0.759226229661654,1.6531533228016977,0.022700119474313024,0.331483474454364,1.0,8/30,8.37%,POLQ;PARPBP;RMI2;AUNIP;KLHL15;RIF1;UBR5;SMCHD1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.4771330205442588,-1.6503236272652513,0.005813953488372093,0.37605138042213,1.0,8/32,10.44%,PLA2G4A;PLAAT3;ABHD12;ABHD16A;PLA1A;OSBPL10;SLC27A1;SERINC1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.5849280087808404,-1.6495712096812747,0.017064846416382253,0.3720447236547252,1.0,6/15,8.46%,ACVR1;SMAD7;ACVR2A;FKBP1A;ACVR2B;DACT1
prerank,cell cycle G1/S phase transition (GO:0044843),0.714566920275661,1.6488595372118475,0.009615384615384616,0.3444802084673707,1.0,21/61,10.73%,CDKN3;POLE;CCNE2;DBF4;E2F1;SPDYA;CDKN2D;CDKN2C;RB1;E2F3;KHDRBS1;CCNA2;EIF4E;CCNE1;USP37;CUL5;CDK2;CUL3;CUL4B;CDC25A;CRLF3
prerank,DNA strand elongation (GO:0022616),0.7967258286069807,1.6481694134605283,0.03415300546448088,0.34494951938808865,1.0,9/18,6.48%,POLA1;RFC4;MCM7;GINS3;POLD3;MRE11;MCM3;MCM4;RFC3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.7071303069537531,1.648099447228354,0.006376195536663124,0.34318032576178154,1.0,19/72,9.33%,E2F7;CCNB1;E2F8;CDK1;GTSE1;ATRX;E2F1;PAXIP1;AURKA;TFDP1;CNOT1;CHEK2;MDM4;CNOT6L;PML;CNOT6;ING4;CDC25C;PLAGL1
prerank,positive regulation of DNA replication (GO:0045740),0.8058709889750519,1.6460425184393679,0.03536067892503536,0.34830778451680205,1.0,6/16,5.71%,ATAD5;GLI2;STN1;DNA2;DHX9;FAF1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8296272250020917,1.6450541629734778,0.03784570596797671,0.34578792273942544,1.0,5/12,3.64%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8296272250020917,1.6450541629734778,0.03784570596797671,0.34578792273942544,1.0,5/12,3.64%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.8296272250020917,1.6450541629734778,0.03784570596797671,0.34578792273942544,1.0,5/12,3.64%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,hyaluronan metabolic process (GO:0030212),0.7772484123491962,1.643634112701407,0.03205128205128205,0.34848826517449977,1.0,4/23,3.28%,HMMR;HAS3;SPAM1;HYAL1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.7148476488030886,1.6421031501833874,0.005574136008918618,0.3500862911206723,1.0,10/51,6.17%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,mitotic nuclear membrane organization (GO:0101024),0.7148476488030886,1.6421031501833874,0.005574136008918618,0.3500862911206723,1.0,10/51,6.17%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,nucleosome assembly (GO:0006334),0.7477939762905405,1.6411094941119584,0.02527075812274368,0.35166236918210414,1.0,13/31,13.55%,ASF1B;CHAF1B;ATRX;HMGB2;NAP1L1;ANP32B;HAT1;RBBP4;UBN1;NASP;SPTY2D1;SOX9;CHAF1A
prerank,heme catabolic process (GO:0042167),-0.6044632724065875,-1.640816595421329,0.011320754716981131,0.3843092654651835,1.0,3/14,8.13%,SLCO2B1;HMOX2;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6044632724065875,-1.640816595421329,0.011320754716981131,0.3843092654651835,1.0,3/14,8.13%,SLCO2B1;HMOX2;ABCG2
prerank,negative regulation of protein secretion (GO:0050709),-0.45845086753146375,-1.6403380784762374,0.007692307692307693,0.3789798611675153,1.0,15/38,23.06%,PRKN;APOE;KCNB1;SERGEF;NR1H3;OPRM1;IRS1;CYP51A1;RHBDF1;RAB11FIP1;MIDN;ADRA2A;RHBDF2;DRD2;DPH3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.7361734568097746,1.6378247614513732,0.013605442176870748,0.36120034687367925,1.0,14/40,8.69%,ANKLE1;WDR76;KMT5A;RFWD3;FBXO5;USP1;POLH;MAPT;NSMCE4A;RPA2;UBE2N;FMR1;ETAA1;BCLAF1
prerank,mitotic DNA replication (GO:1902969),0.8636594158152617,1.6376409731455364,0.0315955766192733,0.35983561715102785,1.0,8/10,10.53%,POLA1;CDC45;MCM6;MCM2;GINS3;MCM3;MCM4;GINS1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6077030538018726,-1.637262872234865,0.02821316614420063,0.3823777776564894,1.0,4/12,8.32%,UNC13B;RIMS1;SYT1;SYT7
prerank,RNA biosynthetic process (GO:0032774),0.723054539015843,1.6372362309529325,0.032219570405727926,0.3593697550058448,1.0,11/31,11.88%,POLA1;PRIM2;TTF2;POLA2;PRIM1;NAT14;SETX;TAF12;POLR2A;TTF1;TAF4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.6029256255431983,-1.6367682358734001,0.024922118380062305,0.37725477166052657,1.0,10/13,27.32%,EDEM2;EDEM1;SAR1A;CD81;BCAP31;SAR1B;SORL1;SEC16B;TMEM30A;SEC16A
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5439508740361949,-1.6361381948735758,0.029661016949152543,0.3729567351285037,1.0,8/20,12.68%,ANO6;PDCD4;PLCG1;SFRP4;GSN;THBS1;PIAS4;RGCC
prerank,negative regulation of chemokine production (GO:0032682),-0.5865240735315351,-1.635897087375468,0.02711864406779661,0.3678212848013304,1.0,5/14,17.26%,APOD;MAP2K5;KLF4;C1QTNF3;LGALS9
prerank,regulation of mitotic cell cycle (GO:0007346),0.6799137260387333,1.6344097913287774,0.0,0.3672000023432471,1.0,38/171,10.88%,KIF20B;MKI67;NEK2;CCNB1;CDK1;DLGAP5;BUB1B;PLK1;CKS2;BORA;CDC20;UBE2C;UBE2S;FBXO5;ANAPC7;RB1;TTC28;PSMC2;CDC27;PSMD5;GBF1;OBSL1;EIF4E;ERCC3;BUB3;CDC25B;SCRIB;CCDC57;RNF40;PSMB1;BTG3;PSMD14;CDC25C;PSMD1;GAS1;HNRNPU;TAL1;PSMB9
prerank,regulation of cell cycle phase transition (GO:1901987),0.6897764909699903,1.631943850905759,0.0031185031185031187,0.37382457751794845,1.0,18/91,6.71%,CCNB1;CDK1;BUB1B;PLK1;GTSE1;CDC20;UBE2C;DBF4;UBE2S;ATP2B4;FBXO5;ANAPC7;PSMC2;CDC27;PSMD5;ERCC3;BUB3;FBXW7
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.8371965031302172,1.6313786571039381,0.0377643504531722,0.3738485167371797,1.0,3/12,5.21%,TICRR;TIPIN;BLM
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5961098383744977,-1.6299258438541546,0.01812688821752266,0.37967582504175357,1.0,5/12,17.57%,APOD;IFT20;CBLB;NDRG4;CBL
prerank,telomere maintenance via telomere trimming (GO:0090737),0.858414027075675,1.6284576540726547,0.03453453453453453,0.37813681846694985,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,t-circle formation (GO:0090656),0.858414027075675,1.6284576540726547,0.03453453453453453,0.37813681846694985,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.858414027075675,1.6284576540726547,0.03453453453453453,0.37813681846694985,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,catecholamine metabolic process (GO:0006584),-0.5950827316477119,-1.6281549038359824,0.025362318840579712,0.3791047360983175,1.0,6/14,23.84%,PRKN;RNF180;DDC;ATP7A;DRD2;COMT
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8167929711941566,1.6277195127646393,0.05091937765205092,0.3786090944636422,1.0,4/12,5.45%,EZH2;CYP26B1;CNOT1;ASXL1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.7371768682978933,1.6263071532840583,0.04523809523809524,0.3814391379860474,1.0,5/28,5.53%,SKA3;SKA1;SKA2;STMN1;MAPT
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.737585564510672,1.6261448125556561,0.03827751196172249,0.3800011921556817,1.0,13/29,15.38%,MEIOC;E2F1;THRAP3;EIF4ENIF1;FMR1;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15;PABPC1;GDNF
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3399602010508626,-1.6256295693612144,0.0,0.3805908932131519,1.0,68/224,17.60%,GRM7;UNC13B;GRIK1;DLGAP1;GABRB1;GABRB3;SLC1A2;CHRM2;GRIN2A;GABRA2;SLC6A1;GRM3;SPG11;ATXN3;CALM1;AMPH;APBA1;GLRB;SYN2;SYT1;GLRA1;GRIN2B;PTCHD1;KCNQ3;HOMER1;GRIK4;RPS6KA2;CAMK4;GABRA3;HTR2C;PLP1;GLRA3;NRXN1;CACNA1B;CAMK1;PRKACB;MINK1;GABRA5;GIPC1;CHRNA7;CHRFAM7A;GABRB2;HCRTR2;GRIA1;PRKAR1B;GABRG2;MAPK1;SYNJ2BP;HTR4;CAMKK2;GRM5;CACNB2;DLG4;SDCBP;GRM1;GRIN1;GABRG1;CPLX1;DTNA;CHRM3;SLC1A1;LRP6;HTR2A;SNAP25;CACNB1;GRIA2;SYT10;SYPL1
prerank,hyaluronan catabolic process (GO:0030214),0.7993570340027594,1.6252146042995363,0.04365620736698499,0.3812129528805622,1.0,3/18,3.28%,HMMR;SPAM1;HYAL1
prerank,microtubule polymerization (GO:0046785),0.7498128018165443,1.6240893415490332,0.03671970624235006,0.3829167961740549,1.0,11/28,15.28%,TPX2;CKAP5;TUBGCP5;MAPT;NDE1;CCDC57;TPPP;AKAP9;TUBGCP3;PIN1;HDGFL3
prerank,nuclear membrane reassembly (GO:0031468),0.7018372586151393,1.6234024421191087,0.011061946902654867,0.3834162617791315,1.0,10/54,6.17%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,positive regulation of telomere capping (GO:1904355),0.7910997518647617,1.6227433691476187,0.04417670682730924,0.38379635530463657,1.0,4/17,3.73%,NEK2;AURKB;RTEL1;HNRNPD
prerank,regulation of integrin activation (GO:0033623),0.7961333186314333,1.617823429855973,0.04794520547945205,0.39914669701548333,1.0,1/15,0.13%,KIF14
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4855675162517102,-1.616581364985944,0.0,0.4024074249369033,1.0,16/30,23.34%,OCLN;JAM2;PECAM1;ACTB;CLDN5;ESAM;F11R;CDH5;TJP1;CLDN12;SLC1A1;SLC12A2;GJB6;LAMA2;CLDN1;MFSD2A
prerank,midbody abscission (GO:0061952),0.7808449250069419,1.6159147879367093,0.051175656984785614,0.40392645558609486,1.0,2/17,1.01%,CEP55;KIF20A
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.815368079464557,1.612991504043079,0.053545586107091175,0.411959723588087,1.0,5/11,7.09%,ASF1B;ATRX;HAT1;RBBP4;UBN1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5073452204699697,-1.6096998921039118,0.03137254901960784,0.41764246770000124,1.0,4/21,6.12%,PLA2G4A;PLAAT3;PLA1A;OSBPL10
prerank,insulin receptor signaling pathway (GO:0008286),-0.38729892360967033,-1.6090843804209147,0.0,0.4133186315944845,1.0,26/69,14.76%,FOXO1;ATP6V0A1;GRB14;GRB10;ATP6V0D1;ATP6V1E1;INSR;ATP6V0B;PIK3R3;AKT2;PIK3R1;ATP6V0A4;FOXC2;IRS2;IGF2;NAMPT;GPLD1;BCAR3;IRS1;CAV2;GRB2;ATP6V0C;ATP6V1H;SHC1;GSK3A;APC
prerank,mitotic cytokinetic process (GO:1902410),0.7604127222742171,1.6060355337750427,0.0559254327563249,0.43501056758498985,1.0,3/20,3.25%,CEP55;KIF20A;RHOA
prerank,positive regulation of double-strand break repair (GO:2000781),0.7092372675079229,1.6041183214432018,0.02558139534883721,0.440246300438334,1.0,17/39,15.24%,RAD51AP1;DDX11;TIMELESS;ARID2;PRKDC;SLF1;SPIDR;RIF1;FUS;MRNIP;SMCHD1;MGMT;PARP9;MMS19;KMT5C;FOXM1;SHLD2
prerank,dendritic spine organization (GO:0097061),-0.47766352224334163,-1.6009654190159013,0.011834319526627219,0.43205272251790605,1.0,11/26,13.64%,CTNND2;DOCK10;SHANK3;PAK3;INSR;DIP2A;EPHB2;LGMN;CHRNA7;SHANK1;DLG4
prerank,regulation of muscle contraction (GO:0006937),-0.4854787068731769,-1.600813292068627,0.010810810810810811,0.42651955517009754,1.0,9/26,16.92%,CHRM2;CAV1;ANXA6;TPM1;ATP1A2;ENO1;MYL9;PLCE1;SRI
prerank,protein heterooligomerization (GO:0051291),-0.5434688547594576,-1.6007751684423237,0.029411764705882353,0.4208560445904757,1.0,7/17,14.10%,FARSB;KCNC2;CPSF6;GRIN2B;FARSA;CPSF7;GRIN1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.4458166366921522,-1.5996715589784423,0.016483516483516484,0.41817255796934466,1.0,23/31,38.87%,PEX1;DNAJC19;HSPD1;AIFM1;PEX5;TIMM44;PEX6;TOMM70;DNAJC15;PAM16;TIMM17A;PEX26;TIMM17B;CHCHD4;PEX10;ROMO1;GRPEL1;PEX16;DNLZ;TOMM40L;PEX2;PEX14;TIMM50
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.7206144417911929,1.5985204904718433,0.028368794326241134,0.45949567613135156,1.0,15/37,11.29%,POLK;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA
prerank,regulation of secretion (GO:0051046),-0.5831724374280605,-1.5978227746911875,0.04666666666666667,0.4178876743492393,1.0,9/13,30.38%,MYO6;SGK1;GPLD1;KCNQ1;FGF10;POFUT2;EGF;ERBB3;OPRK1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.642020878261175,-1.5970931184420867,0.017123287671232876,0.41463362406168247,1.0,5/11,18.02%,PRKN;ADCK1;OMA1;BNIP3;VAT1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.7407632803656962,1.5945768949054995,0.0546583850931677,0.4724052505384393,1.0,4/22,8.57%,FANCA;CBFB;LAG3;IRF1
prerank,phagosome maturation (GO:0090382),-0.4560009173928219,-1.5939511523892023,0.014084507042253521,0.4185737395946503,1.0,19/35,32.34%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;MCOLN1;RAB38;ATP6V1G2;MREG;ATP6V1B2;RAB14;RAB32;RAB39A;ATP6V1F;ATP6V0D2;RAB31;ATP6V0E1
prerank,ERAD pathway (GO:0036503),-0.3803366437778278,-1.5925888352698343,0.0,0.4174536847950487,1.0,39/83,24.46%,PRKN;UBE4A;ATXN3;HSP90B1;ERLEC1;OS9;TRIM25;ECPAS;RNF103;EDEM1;UFD1;DERL1;SELENOS;HSPA5;UBXN4;RHBDD2;SGTA;STUB1;YOD1;RCN3;SGTB;DNAJC18;POMT2;UBXN6;DNAJB9;ERLIN2;SEC61B;AUP1;DNAJB12;SYVN1;UBE2G2;UBXN8;GET4;SEL1L;UBE4B;TOR1A;FAM8A1;WFS1;RNF103-CHMP3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.7135598859203883,1.5921330025512248,0.03044496487119438,0.4796456916681223,1.0,15/39,11.29%,POLK;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5044315856767158,-1.5885553113055622,0.028688524590163935,0.42409704034789997,1.0,10/22,14.11%,CYRIB;TMSB4X;KANK3;KANK4;PFN1;SSH1;SLIT2;GSN;ARFGEF1;TMSB10
prerank,positive regulation of DNA metabolic process (GO:0051054),0.6863102659792409,1.5883465365453333,0.02505446623093682,0.49229865335460254,1.0,17/61,11.29%,BRCA1;RAD51;ATRX;RNF168;EYA4;RTEL1;FGFR4;DHX9;MRE11;PML;UBE2N;UIMC1;TRIM28;SMCHD1;HMGB1;EYA2;PCNA
prerank,rRNA metabolic process (GO:0016072),-0.32556480315100306,-1.5882019509659948,0.0,0.4202819674867499,1.0,80/160,27.93%,RPL13;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RRP1B;RRP1;RPL19;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;RPL29;MDN1;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;EXOSC2;PIH1D1;EBNA1BP2;DDX54;RPL4;BYSL;DEDD2;IMP3;DDX47;BOP1;EXOSC3;NIFK;RPS25;EXOSC5;POP5;WDR18;PDCD11
prerank,protein prenylation (GO:0018342),0.8229097874122178,1.587549662230038,0.054313099041533544,0.49291699921215065,1.0,1/10,0.45%,AIPL1
prerank,positive regulation of intracellular transport (GO:0032388),0.6990521536553747,1.5867320666471236,0.029511918274687854,0.49370169382051027,1.0,7/38,7.68%,KIF20B;SPAG5;NEDD4;PCM1;NUMA1;TPR;RAB29
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.8077788006140378,1.5847703695261999,0.0536231884057971,0.49902145687165345,1.0,1/12,0.19%,BRCA1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.6622961079450146,1.5843716018205853,0.0,0.49820161445394834,1.0,30/148,7.33%,TPX2;BRCA1;EXO1;CDK1;BRIP1;BARD1;RMI2;AURKB;RFC4;KMT5A;AURKA;TOPBP1;RBBP8;RPA1;CHEK2;MDM4;TAF3;RAD1;DNA2;RFC2;BLM;MRE11;RPA2;RFC3;RBBP4;RBBP7;PML;RRS1;CHEK1;TAF12
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4165351539265737,-1.5843383093687207,0.008695652173913044,0.4268090983145761,1.0,22/43,34.35%,IGF1;GAS6;TLR4;CD34;LBP;PTPN22;SELENOS;CHRNA7;CX3CL1;SYT11;TRIM27;DICER1;LGALS9;ZC3H12A;CD274;NLRC3;IRAK3;CACTIN;TNFAIP3;NR1H4;RARA;PTPN6
prerank,determination of bilateral symmetry (GO:0009855),0.7350130222159909,1.5841650141967527,0.07365792759051186,0.49661137806843675,1.0,5/24,9.03%,STIL;DNAH11;CFAP53;MKKS;NPHP3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.6703169326580058,1.5836704778308774,0.0040858018386108275,0.4961409783950984,1.0,18/104,7.13%,CCNF;CCNB1;CDKN3;EZH2;INCENP;CCNE2;CCNB2;CDKN2D;CDKN2C;KSR1;RB1;RHOA;CDC6;CCNA2;BLM;CCNA1;CCNE1;ETAA1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.7740276228862932,1.5828420317569194,0.05733333333333333,0.4968254376525446,1.0,1/16,0.19%,BRCA1
prerank,regulation of multicellular organismal development (GO:2000026),0.7305794410543313,1.5819842749878288,0.05493133583021224,0.49780725092115363,1.0,5/25,8.94%,CDK1;RACGAP1;HPSE;NIPBL;CCSAP
prerank,positive regulation of protein binding (GO:0032092),-0.3867264963455151,-1.581944585620215,0.0,0.42947199510965084,1.0,20/56,11.05%,PRKN;MARK3;PSEN1;EPB41;TIAM1;CAV1;APOE;CLDN5;VTN;HIPK2;FKBP1A;RALB;LRP1;NVL;PPP2CB;DACT1;B2M;DERL1;ABL1;APP
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.3969552266226204,-1.5813387642845422,0.02586206896551724,0.42633367381360177,1.0,16/51,19.55%,PTK2;VEGFC;ANO6;GAS6;LGMN;MAPK3;MAPK1;THBS1;VEGFA;PLA2G7;CMKLR1;LGALS9;IL34;VEGFB;CREB3;VEGFD
prerank,cellular response to zinc ion (GO:0071294),-0.5816569031970895,-1.5810754180344555,0.021505376344086023,0.4220184507309549,1.0,11/15,22.05%,GLRA1;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;P2RX4
prerank,actin filament polymerization (GO:0030041),0.7269064961500057,1.5796514904411452,0.04495747266099635,0.5047883505313372,1.0,1/29,0.03%,DIAPH3
prerank,protein export from nucleus (GO:0006611),0.7306224161893992,1.5785167969653844,0.05307599517490953,0.5067580443283157,1.0,10/27,12.90%,ANKLE1;CCHCR1;RANBP17;XPO1;XPO4;CSE1L;TPR;SMURF1;NUP214;STRADA
prerank,negative regulation of viral life cycle (GO:1903901),-0.5594342553716194,-1.5782776095657112,0.016286644951140065,0.42549540256233925,1.0,7/15,16.82%,MID2;LY6E;SNX3;IFITM3;GSN;BST2;IFITM2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.7480176443795177,1.577788482407622,0.06919060052219321,0.5072001702163967,1.0,8/19,9.14%,TYMS;ADK;ADA;POLD3;DCK;HPRT1;POLD1;CDA
prerank,"base-excision repair, AP site formation (GO:0006285)",0.7703756797566318,1.5768135427293877,0.056833558863328824,0.5086168672389428,1.0,2/17,1.68%,NEIL3;TERF1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.7429613799031137,1.5765041859008329,0.06233766233766234,0.507383494072118,1.0,2/21,4.77%,TPX2;SPEF1
prerank,positive regulation of neuron migration (GO:2001224),0.8035833875714142,1.574957521168655,0.062402496099843996,0.5110629586313791,1.0,1/11,0.10%,KIF20B
prerank,synaptonemal complex organization (GO:0070193),0.7744026755835356,1.5747070765040132,0.06786703601108034,0.5074777139913247,1.0,2/15,3.39%,TRIP13;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.7744026755835356,1.5747070765040132,0.06786703601108034,0.5074777139913247,1.0,2/15,3.39%,TRIP13;RAD21
prerank,regulation of protein localization to nucleus (GO:1900180),0.6859959693174087,1.5746127414456108,0.04735062006764374,0.5055691886922271,1.0,11/43,11.69%,CDK1;PLK1;GTSE1;GSK3B;CTNNA1;TPR;WWTR1;YAP1;PARP9;EIF2AK3;ILRUN
prerank,histone monoubiquitination (GO:0010390),0.7314552142817248,1.5736349162781191,0.0625,0.5068025629663392,1.0,8/24,9.30%,UHRF1;RNF168;TRIM37;BCOR;RNF40;KDM2B;LEO1;CUL4B
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6013451785781536,-1.5730569115197985,0.03618421052631579,0.4364093111837843,1.0,7/13,25.58%,GLUL;GLS;NOS3;PRODH;GLUD1;NOS1;GLS2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5745106393721493,-1.5726309388471795,0.031496062992125984,0.4325436155988533,1.0,8/16,29.55%,BMPR2;PLCB3;ACE;PRCP;GSK3A;DRD2;ADM;GPR37L1
prerank,response to muramyl dipeptide (GO:0032495),-0.6027460565100483,-1.5720665515152257,0.043478260869565216,0.4294915842354996,1.0,6/12,16.26%,TRIM41;NOD1;PTPN22;ARHGEF2;CHMP5;ERBIN
prerank,regulation of cell cycle (GO:0051726),0.6566730377361535,1.5711821541017634,0.0,0.5140688287568143,1.0,54/271,10.73%,CENPF;DTL;KIF20B;BRCA1;PRR11;CCNB1;CDKN3;DLGAP5;PLK1;BIRC5;BARD1;MASTL;CKS2;FIGNL1;CCNB2;TGM1;PCLAF;DDIAS;CDKN2D;FBXO5;CDKN2C;RB1;TTC28;RASSF1;FGFR2;LIN54;GBF1;UHRF2;CTBP1;LIN52;TCF7L2;RBBP4;PML;MAP3K20;MYBL2;CHEK1;FBXL8;LIN9;HTRA2;RNF40;LIN37;MFN2;IRF1;ING4;GRK5;PLAGL1;SKP2;CSNK2A2;FBXL17;CDC25A;CDC123;TGFBR1;HNRNPU;CRLF3
prerank,regulation of protein export from nucleus (GO:0046825),0.7265459371591113,1.570947087909215,0.05875,0.5127500496089407,1.0,9/23,9.93%,BARD1;GTSE1;GSK3B;XPO4;ANP32B;TCF7L2;TPR;EMD;RANGAP1
prerank,positive regulation of DNA recombination (GO:0045911),0.7141406325456745,1.5707425120476062,0.06690997566909976,0.5112337169179648,1.0,9/27,12.71%,RAD51AP1;TIMELESS;PAXIP1;ARID2;RIF1;FUS;MRNIP;MMS19;KMT5C
prerank,ceramide catabolic process (GO:0046514),-0.5686815093161816,-1.5702070531312609,0.03484320557491289,0.4304403212169507,1.0,6/14,13.79%,HEXB;ACER2;ASAH1;ACER3;HEXA;ASAH2
prerank,lymphocyte mediated immunity (GO:0002449),-0.605904199348831,-1.56969909352627,0.02631578947368421,0.4266571037559359,1.0,3/12,12.98%,JAG1;MSH2;GNL1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.6958864880783325,1.569141224669384,0.04441913439635535,0.5151466080170355,1.0,10/37,9.80%,SKA3;SKA1;SKA2;STMN1;GSK3B;MAPT;BICD2;TPPP;ROCK1;MARK2
prerank,regulation of spindle assembly (GO:0090169),0.7201688984997846,1.5689378069243287,0.07106598984771574,0.5136912796844854,1.0,9/25,10.90%,PLK1;SPAG5;GPSM2;CEP97;NUMA1;TPR;CCSAP;HNRNPU;DRG1
prerank,response to light stimulus (GO:0009416),0.676688909039385,1.5685823025774333,0.0314192849404117,0.5126978532251047,1.0,9/55,6.09%,DTL;PCLAF;ZRANB3;CDKN2D;USP1;PRIMPOL;ERCC4;POLD1;ERCC3
prerank,regulation of dopamine secretion (GO:0014059),-0.46884571411654413,-1.5683065839661787,0.03783783783783784,0.42644221031169915,1.0,11/25,22.19%,PRKN;SYT1;SYT7;DTNBP1;KCNA2;SYT11;SYT12;SYT10;SYT6;SYT2;DRD2
prerank,zinc ion homeostasis (GO:0055069),-0.45176135388945127,-1.5680942466775012,0.029585798816568046,0.4225613389873998,1.0,14/28,20.87%,PRKN;SLC39A10;SLC39A13;SLC39A7;SLC30A1;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,cellular response to fluid shear stress (GO:0071498),-0.5863897903637311,-1.565361051824047,0.045454545454545456,0.4256559482241871,1.0,9/12,25.44%,MEF2C;MAP2K5;KLF4;HDAC3;SREBF2;KLF2;MTSS1;ASS1;MAPK7
prerank,positive regulation of chromosome organization (GO:2001252),0.77947760577606,1.5644488452580123,0.06320224719101124,0.5262735662888526,1.0,6/15,6.69%,ATRX;DDX11;RTEL1;RAD21;MRE11;PML
prerank,positive regulation of protein export from nucleus (GO:0046827),0.7491613975112804,1.5627044402551495,0.06504065040650407,0.5306676806058602,1.0,7/15,9.68%,GTSE1;GSK3B;XPO4;ANP32B;TCF7L2;TPR;EMD
prerank,protein heterotetramerization (GO:0051290),-0.5784316118292816,-1.5626627240246944,0.02857142857142857,0.4300217544479888,1.0,7/13,20.26%,FARSB;CPSF6;GRIN2B;FARSA;CPSF7;GRIN1;CBR4
prerank,negative regulation of protein depolymerization (GO:1901880),0.7196289209304394,1.5621786420520396,0.07711757269279393,0.5304113004287889,1.0,2/24,4.77%,TPX2;SPEF1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.8222277634088437,1.5616155996733962,0.06202723146747353,0.5303315768011485,1.0,5/10,7.13%,WDR76;RFWD3;RPA2;DDX39B;ETAA1
prerank,positive regulation of telomere maintenance (GO:0032206),0.7013266602706744,1.5607309077358196,0.054502369668246446,0.5314507812922675,1.0,7/31,6.69%,NEK2;ATRX;AURKB;RTEL1;HNRNPD;MRE11;PML
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4448218237240353,-1.560414133373078,0.056910569105691054,0.4322096796445021,1.0,15/37,14.10%,GRM7;GRIK1;GRIN3A;GRIN2A;GRM3;GRID2;KCNB1;CPEB4;GRIN2B;HOMER1;GRIK4;APP;GRM5;GRM1;GRIN1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4276875236101103,-1.5602451593095101,0.007142857142857143,0.4283059266183339,1.0,6/38,4.31%,CAMK2D;CTNNA3;CACNA2D1;CAV1;KCNJ3;BIN1
prerank,positive regulation of cellular respiration (GO:1901857),-0.621313086787172,-1.558984153842239,0.032448377581120944,0.4279275149685075,1.0,7/11,24.97%,IFNAR1;PINK1;NUPR1;IL10RB;PARK7;ISCU;PRELID1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.5311075460649226,-1.5588450675735168,0.027450980392156862,0.42383214441294825,1.0,7/17,16.70%,PCSK5;PCSK6;FURIN;LMF1;NR1H3;HDAC9;NR1H2
prerank,protein oxidation (GO:0018158),0.8010648178171673,1.5581448308767658,0.0694645441389291,0.5388756719129105,1.0,3/11,2.55%,LOXL3;LOXL2;LOX
prerank,tRNA modification (GO:0006400),-0.39343108571127255,-1.556745140941295,0.0,0.42587219340137017,1.0,27/62,25.84%,TRMT9B;ANKRD16;DTWD2;MTO1;PUS10;AARS1;NSUN2;THUMPD3;TRMT61B;OSGEP;CDKAL1;QTRT2;TRMT1;TPRKB;TRUB1;METTL1;PUS3;THUMPD1;QTRT1;TRMT10A;LCMT2;TRMO;WDR6;DTWD1;WDR4;GTPBP3;ALKBH1
prerank,positive regulation of protein kinase activity (GO:0045860),0.6464175703895021,1.5564773217957806,0.004016064257028112,0.5430670507894254,1.0,23/148,9.98%,TPX2;CENPE;KIF14;ECT2;EZH2;INCENP;CLSPN;BORA;SPDYA;MAP4K4;RHOA;PRNP;STK3;NRK;EFNA1;ETAA1;CCN1;EPHA4;MRNIP;NOX4;AGT;MARK2;DDR2
prerank,mismatch repair (GO:0006298),0.7068558525897656,1.5564531992598802,0.06968215158924206,0.5408491335449793,1.0,14/27,17.29%,EXO1;RPA1;MSH3;POLD3;POLD1;RPA2;MLH1;SETD2;RNASEH2A;PCNA;MSH6;PMS1;MSH5;MCM9
prerank,DNA duplex unwinding (GO:0032508),0.6792402118229715,1.5559482605266117,0.04362050163576881,0.540532038830813,1.0,15/50,6.09%,PIF1;RAD51;DDX11;MCM6;MCM7;MCM2;RTEL1;RPA1;CHD1L;DHX9;BLM;MRE11;RECQL;MCM4;ERCC3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7248802243731391,1.5557535213819027,0.07351077313054499,0.5389576452520084,1.0,7/24,14.43%,BRCA1;HPSE;SULF2;SULF1;EIF2AK3;RORA;ARNT
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5272217427884263,-1.5547928391561,0.03383458646616541,0.427561164924579,1.0,7/17,16.43%,PRKG1;MEF2C;PDCD4;SOD2;TPM1;TAFA5;TGFB3
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7783012840761698,1.554646777143127,0.07172995780590717,0.5407215062683391,1.0,3/14,4.13%,BRCA1;PAXIP1;AUTS2
prerank,potassium ion homeostasis (GO:0055075),-0.49208444026097675,-1.5534802326920463,0.020080321285140562,0.4271030821207524,1.0,7/23,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;SLC12A9;ATP1A2;SLC12A2
prerank,cellular response to inorganic substance (GO:0071241),0.7308737333540791,1.552940809338367,0.06847545219638243,0.5450970812461805,1.0,8/21,7.95%,ATRX;DDX11;AQP1;TIMELESS;BLM;SPIDR;FMR1;CDK2
prerank,gas transport (GO:0015669),0.8232318646300343,1.55209266917897,0.07643312101910828,0.5460428586313021,1.0,2/10,1.82%,RHAG;AQP1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.4161649110571924,-1.5518623393288165,0.02459016393442623,0.42737964372690695,1.0,14/41,19.48%,IGF1;GAS6;TLR4;CD34;LBP;PTPN22;SELENOS;CHRNA7;CX3CL1;SYT11;TRIM27;DICER1;LGALS9;ZC3H12A
prerank,protein autoubiquitination (GO:0051865),0.6672832823825146,1.548731440816895,0.0368763557483731,0.5566453431936293,1.0,7/61,4.25%,BRCA1;UHRF1;UBE2T;RAD18;TRIM37;RNF220;UHRF2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.740294531208795,1.5467845786178094,0.0663265306122449,0.5619116042304294,1.0,2/21,1.19%,BRCA1;SLC18A2
prerank,smoothened signaling pathway (GO:0007224),0.6882865481803883,1.546179147046631,0.06347305389221557,0.5620254911716454,1.0,3/32,1.27%,STIL;GLI2;GLI3
prerank,positive regulation of B cell proliferation (GO:0030890),0.7147066452422117,1.5457142863836275,0.036057692307692304,0.5615955317845034,1.0,1/29,0.09%,TNFSF13B
prerank,peptidyl-arginine modification (GO:0018195),-0.5607052309485459,-1.544992877149441,0.05136986301369863,0.4431227350724809,1.0,6/15,20.20%,ART3;KRTCAP2;PRMT8;PRMT1;PARK7;PADI2
prerank,regulation of telomere maintenance (GO:0032204),0.713251279451862,1.5449755736129673,0.0603448275862069,0.5622639326655732,1.0,15/26,18.76%,PIF1;ATRX;RTEL1;HNRNPD;ERCC4;MRE11;YLPM1;PML;HDAC8;TERF2;SMG6;GNL3;TINF2;TERF2IP;RAD50
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6096901596273799,-1.5440073359708844,0.04075235109717868,0.4416499650742333,1.0,9/11,33.90%,UQCRC2;UQCRB;UQCR10;UQCRQ;UQCRC1;CYC1;UQCRFS1;CYCS;UQCC3
prerank,regulation of chromatin organization (GO:1902275),0.7743259520122016,1.5434116531038582,0.08923512747875353,0.5657835574513576,1.0,1/14,0.23%,MKI67
prerank,positive regulation of cellular protein localization (GO:1903829),0.6620063711284729,1.5407260087181203,0.0220125786163522,0.5739657315712033,1.0,16/69,11.13%,NDC80;CDK1;PLK1;GTSE1;CENPQ;RANGRF;GSK3B;DDRGK1;NUMA1;PDZK1;MAPT;WWTR1;YAP1;SNX33;PARP9;EIF2AK3
prerank,histone H4-K5 acetylation (GO:0043981),0.7579254468161413,1.5401296458813591,0.07714285714285714,0.571771900656786,1.0,2/15,2.62%,KANSL1;KANSL2
prerank,histone H4-K8 acetylation (GO:0043982),0.7579254468161413,1.5401296458813591,0.07714285714285714,0.571771900656786,1.0,2/15,2.62%,KANSL1;KANSL2
prerank,telomere maintenance (GO:0000723),0.6689723277352345,1.540024793673843,0.040437158469945354,0.5699572448930468,1.0,27/50,19.61%,RAD51;TERF1;SMC6;RTEL1;RPA1;SMC5;STN1;ERCC4;POLD3;DNA2;PRKDC;BLM;MRE11;POLD1;RPA2;RIF1;PCNA;NSMCE2;TERF2;TEP1;TINF2;ATR;ACD;TERF2IP;RAD50;SP100;TERT
prerank,Golgi inheritance (GO:0048313),0.7889255243272785,1.5392563472579832,0.08591549295774648,0.5705669074948279,1.0,2/11,3.74%,CDK1;GBF1
prerank,microtubule bundle formation (GO:0001578),0.6779717477972808,1.539238872184303,0.059770114942528735,0.5683761025132296,1.0,7/42,4.91%,PLK1;KIF20A;CDK5RAP2;PSRC1;SPAG16;SPEF1;NUMA1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.6857427635540047,1.5371763916677819,0.06674473067915691,0.574195490790764,1.0,9/33,7.95%,PIF1;RAD51;TERF1;RTEL1;RPA1;STN1;MRE11;RFC1;CDK2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6962038007876247,1.5364679083338586,0.06745562130177515,0.574651835226252,1.0,4/32,4.77%,TPX2;STMN1;DYRK1A;SPEF1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.7285519353436481,1.5360429162382125,0.07881136950904392,0.5740265290791772,1.0,5/22,8.29%,SHCBP1;NAP1L1;SLC16A2;KDM2B;LRRK2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.6716855113299489,1.5357753865890487,0.04480874316939891,0.5728176646767659,1.0,19/53,16.09%,BRCA1;ANKLE1;RNF168;EYA4;DHX9;NSMCE4A;UBE2N;FMR1;UIMC1;TRIM28;SMCHD1;BCLAF1;EYA2;PCNA;SPRED1;BRCC3;NSMCE1;FXR1;SPRED2
prerank,DNA modification (GO:0006304),0.7325316731060625,1.5353693917555895,0.07329842931937172,0.5720921668041473,1.0,2/22,1.68%,NEIL3;TERF1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.6724853153787453,1.5349478108306434,0.04035874439461883,0.5714998735954256,1.0,14/46,9.68%,ECT2;GTSE1;GSK3B;XPO4;ANP32B;NEDD4;KHDRBS1;DHX9;NRDE2;TCF7L2;TPR;UBR5;TRIM28;EMD
prerank,response to steroid hormone (GO:0048545),-0.44856086526221284,-1.5346183181562507,0.04060913705583756,0.4665722926114918,1.0,18/31,25.79%,CAV1;PAQR8;TGFB2;AR;ATP1A1;ABHD2;NR1H3;ATP1A3;CATSPER2;THBS1;ATP1A2;TGFB3;WBP2;ABCA2;PAQR7;URI1;UBE3A;CATSPER3
prerank,glucose import (GO:0046323),-0.5702222850937063,-1.5339491206997276,0.04276315789473684,0.4640764657662561,1.0,6/13,21.40%,SLC2A1;SLC27A1;SLC2A3;ZDHHC7;SLC2A10;SLC27A4
prerank,retinoic acid metabolic process (GO:0042573),0.7616691809980398,1.5323666878495343,0.08192090395480225,0.5792203867420292,1.0,4/14,9.15%,ALDH8A1;CYP26B1;ALDH1A2;SCPEP1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5943017188040995,-1.5310744720424565,0.04560260586319218,0.4688949260773382,1.0,6/12,21.65%,PODXL;JAG1;PROM1;PTPRO;KLF15;BASP1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.39865451721294687,-1.5289361951067297,0.015384615384615385,0.47067671441497155,1.0,26/63,19.28%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;SLC25A3;GABRA5;GABRB2;SLC5A6;SLC5A5;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;SLC1A1;SLC12A2;SLC25A11;LRRC8A;SLC26A2
prerank,vacuolar acidification (GO:0007035),-0.4896275932110912,-1.5288575948871448,0.04265402843601896,0.46660263901371485,1.0,15/21,33.43%,ATP6V0A1;DMXL2;ATP6V0D1;ATP6V0A4;GRN;ATP6V1H;PPT1;ATP6AP2;TMEM9;CLN5;TMEM199;CLN3;ATP6V0D2;ATP6V0E1;CLN6
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7771722985989836,1.528578975182728,0.07964601769911504,0.5893376201565553,1.0,5/12,12.26%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7771722985989836,1.528578975182728,0.07964601769911504,0.5893376201565553,1.0,5/12,12.26%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2
prerank,liver development (GO:0001889),0.6792192747321094,1.5281571553404358,0.07953216374269007,0.5886732661234928,1.0,11/32,16.75%,E2F7;E2F8;AURKA;TGFBR3;PHF2;NPHP3;ANXA1;GFER;PKD2;PCK2;COBL
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7036991714786296,1.5278166765690875,0.0782608695652174,0.5877822766446202,1.0,7/26,14.43%,BRCA1;HPSE;SULF2;SULF1;EIF2AK3;RORA;ARNT
prerank,regulation of dendritic spine development (GO:0060998),-0.526079357047535,-1.5277660035416951,0.0379746835443038,0.46579293018463686,1.0,8/19,8.17%,GRIN3A;CPEB3;PSEN1;MEF2C;SHANK3;APOE;KIF1A;CAMK1
prerank,metal ion transport (GO:0030001),-0.3412863860828539,-1.5276770850791697,0.0,0.46185282013775936,1.0,27/86,16.93%,CACNA2D1;GRIN3A;RYR3;NIPA1;PSEN1;SLC8A3;TRPM7;CALCRL;TRPC5;CAV1;RYR2;NIPA2;SLC3A2;CACNG7;TPT1;RAMP1;RAMP2;CACNA1B;TRPC3;TRPC1;CHRNA7;SLC30A1;ATP2B2;NIPAL3;PANX1;CACNG3;CACNG8
prerank,cell proliferation in forebrain (GO:0021846),0.8055230570735058,1.5276718183478353,0.08970588235294118,0.5861744643128285,1.0,3/10,6.66%,KIF14;PCM1;AKNA
prerank,positive regulation of nuclear division (GO:0051785),0.7057314460099685,1.5267124543469957,0.09571788413098237,0.5874464095798838,1.0,3/25,2.78%,NUSAP1;AURKA;PHIP
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5288081146906457,-1.5262942837200446,0.047058823529411764,0.4618374664985806,1.0,9/18,21.40%,CDH8;UNC13B;GRIK1;GRID2;GRIK4;SLC17A6;GRIA2;GRIK2;GRID1
prerank,acylglycerol metabolic process (GO:0006639),-0.42586857815535306,-1.524722058241856,0.046153846153846156,0.4621267180938243,1.0,10/37,9.48%,CAV1;APOE;PLAAT3;DGKB;ABHD6;ABHD12;DGKG;LMF1;DGKI;ABHD2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.6620423871692815,1.523992273196427,0.03597883597883598,0.5952803036146029,1.0,24/60,16.14%,CCNB1;CDK1;MED26;PPM1D;CBFB;PAXIP1;MOV10;MED14;SRF;TCF7L2;MED30;ATF7IP;TRIM28;MED24;MED15;SOX9;HEY2;MED1;CDK8;MED27;TNRC6C;NFKB1;TP53;PTEN
prerank,epithelial cell-cell adhesion (GO:0090136),0.785629733792193,1.5209916654457474,0.08761329305135952,0.6042555704038636,1.0,3/11,4.54%,SERPINB8;PLEKHA7;KIT
prerank,peroxisomal membrane transport (GO:0015919),-0.4534567648025331,-1.5200541064947581,0.03723404255319149,0.47218391708431473,1.0,12/27,22.31%,PEX1;FIS1;ABCD4;ALDH3A2;PEX3;PEX5;PEX6;ABCD2;GDAP1;PXMP4;PEX26;PXMP2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.7586488626055465,1.5169182825606096,0.0794979079497908,0.6172967687064845,1.0,1/15,0.19%,BRCA1
prerank,histone H4-K16 acetylation (GO:0043984),0.7246111711041472,1.5162571533390836,0.09433962264150944,0.6175412591078642,1.0,5/19,9.84%,KANSL1;KANSL2;ING4;MSL3;KMT2A
prerank,mRNA stabilization (GO:0048255),0.6717036047669084,1.5148671748902294,0.07283236994219654,0.620550153136739,1.0,13/40,10.93%,MEIOC;E2F1;SYNCRIP;DHX9;THRAP3;EIF4ENIF1;YBX3;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15
prerank,neuron remodeling (GO:0016322),-0.6323168976005573,-1.514670334709681,0.05187319884726225,0.4842323654134189,1.0,8/10,26.80%,APP;SCARF1;CX3CL1;FARP2;ADGRB3;EPHA8;ANKS1A;C1QA
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.537438670498559,-1.5138606348108479,0.056962025316455694,0.48220013032704684,1.0,4/15,9.47%,ATP1B1;KCNJ3;ATP1A1;KCNN2
prerank,regulation of telomere capping (GO:1904353),0.7124334263320248,1.5137763781805968,0.07875,0.6225494380077012,1.0,4/23,3.73%,NEK2;AURKB;RTEL1;HNRNPD
prerank,nucleosome organization (GO:0034728),0.660695291000368,1.512272143524439,0.0429042904290429,0.6261054407404159,1.0,20/55,13.55%,CHAF1B;ATRX;HMGB2;NAP1L1;SMARCC1;CTCF;LIN54;NFE2;ARID2;ANP32B;ARID1A;SETD2;SRCAP;SMARCA4;ANP32E;NASP;SPTY2D1;SOX9;MCM3AP;CHAF1A
prerank,regulation of microtubule depolymerization (GO:0031114),0.701181116779143,1.5121634636979737,0.0845959595959596,0.6242027477642352,1.0,1/25,0.06%,TPX2
prerank,positive regulation of chromatin organization (GO:1905269),0.7750896675799541,1.5095174200366352,0.09025787965616046,0.6318687579457901,1.0,9/12,18.30%,ATRX;TERF1;MIER1;UBE2N;TAL1;TERF2;TINF2;ACD;TERF2IP
prerank,telomere capping (GO:0016233),0.7257799116798419,1.508285070696078,0.09175531914893617,0.6342355494856161,1.0,11/16,18.76%,TERF1;STN1;PRKDC;MRE11;TERF2;TINF2;ACD;DCLRE1A;TERF2IP;DCLRE1C;RAD50
prerank,piRNA metabolic process (GO:0034587),0.7347368336308333,1.5082004771377122,0.09450830140485313,0.632252527876567,1.0,3/19,6.25%,MYBL1;MAEL;EXD1
prerank,renal absorption (GO:0070293),-0.6073972729374918,-1.5055797207632733,0.052478134110787174,0.5036951929508507,1.0,8/10,38.37%,SGK1;SLC15A2;GSN;KLHL3;KCNQ1;MAGED2;HYAL2;HAS2
prerank,hemidesmosome assembly (GO:0031581),-0.5932534001775152,-1.5051324799775796,0.04938271604938271,0.5007593354999178,1.0,6/11,27.04%,ITGA6;LAMA3;ITGB4;CD151;PLEC;LAMC2
prerank,negative regulation of T cell differentiation (GO:0045581),0.7730563986857408,1.50490379926689,0.09836065573770492,0.6424535076447009,1.0,3/10,8.57%,GLI3;LAG3;IRF1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4147157033275553,-1.5042262282989731,0.036231884057971016,0.4995197209733112,1.0,13/36,14.73%,MECOM;PRKN;FOXO1;ZMYND11;IGBP1;DUSP3;CYLD;DACT1;PTPN22;HDAC3;PINK1;SH3RF2;DUSP1
prerank,RNA stabilization (GO:0043489),0.668382529277374,1.5034331316567626,0.08654970760233918,0.6456252085210967,1.0,12/33,10.93%,MEIOC;E2F1;TENT2;PHAX;THRAP3;EIF4ENIF1;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15
prerank,regulation of platelet activation (GO:0010543),-0.5079905849638421,-1.5034245540916686,0.03317535545023697,0.4981290827632344,1.0,8/21,8.02%,PLA2G4A;APOE;NOS3;TLR4;PLEK;THBD;LYN;PRKCQ
prerank,vascular transport (GO:0010232),-0.36546392553916734,-1.5033730079262306,0.0,0.4941200282359448,1.0,29/81,16.25%,SLC6A6;SLC16A12;SLC1A2;ATP8A1;SLC6A1;SLC13A3;SLC2A1;SLC44A1;SLC7A2;INSR;SLCO1C1;SLC22A8;SLCO2B1;LRP1;SLC7A5;SLC27A1;ABCC4;ABCG2;SLC5A6;SLC15A2;SLC5A5;SLC22A5;SLC16A1;ATP1A2;ABCC5;SLC2A3;SLC4A8;SLC1A1;SLC12A2
prerank,negative regulation of DNA replication (GO:0008156),0.7621093410775183,1.5033199270878264,0.09167842031029619,0.643740911547847,1.0,4/13,4.39%,TERF1;PDS5A;CDC6;WAPL
prerank,negative regulation of mRNA processing (GO:0050686),0.7459970845371209,1.503216386462903,0.08495821727019498,0.6418817451264883,1.0,5/15,8.15%,BARD1;SRSF4;SRSF10;SRSF7;SAP18
prerank,nuclear migration (GO:0007097),0.7513848134173737,1.5030108149599213,0.09251101321585903,0.6403874726395702,1.0,8/13,15.62%,SYNE3;SYNE2;PCM1;CLMN;CEP120;FBXW11;DOCK7;SUN2
prerank,protein localization to chromatin (GO:0071168),0.7173823338905022,1.5029244694559731,0.11155378486055777,0.6384130002728223,1.0,7/18,8.18%,PLK1;MCM8;SGF29;RAD21;WAPL;NIPBL;MRNIP
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.6406327317622595,1.5027929405024614,0.030687830687830688,0.6366648664692938,1.0,21/72,11.79%,POLK;ANKLE1;RFC4;RPA1;CHD1L;ERCC4;RNASE6;POLD3;DNA2;RFC2;MRE11;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA;RNASE1;ENPP1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6190914268047543,-1.502224917363486,0.04777070063694268,0.4937829333777429,1.0,8/10,33.48%,MAP2K5;KLF4;TLE5;MAPK7;IRAK3;PTPRC;SH2B3;SIGIRR
prerank,protein acetylation (GO:0006473),0.6814266076008856,1.5008388111892348,0.0830367734282325,0.6416147099896268,1.0,4/30,5.53%,ESCO2;DSCC1;HAT1;MAPT
prerank,positive regulation of histone modification (GO:0031058),0.6737046866583545,1.500269762036125,0.07407407407407407,0.6415613986077225,1.0,8/33,7.80%,BRCA1;PAXIP1;CTBP1;ARRB1;UBE2N;FMR1;NIPBL;ZBTB7B
prerank,positive regulation of endocytosis (GO:0045807),-0.407713302662786,-1.500246135857597,0.017543859649122806,0.49634300865993375,1.0,18/45,19.71%,SGIP1;APOE;VTN;ANO6;LRP1;BICD1;CLIP3;DAB2;B2M;HNRNPK;LDLRAP1;HIP1;CBLL1;CBL;PPT1;NLGN1;NCKAP1L;CD151
prerank,chromatin assembly or disassembly (GO:0006333),0.7602788357328637,1.499474759448231,0.08283132530120482,0.6422717636477424,1.0,7/11,18.78%,CHAF1B;RBBP4;HDAC8;CHAF1A;TP53;SUV39H2;HIRIP3
prerank,regulation of osteoblast proliferation (GO:0033688),0.7204177521592529,1.4993464121714009,0.09436435124508519,0.6405201211754621,1.0,7/17,11.40%,HPSE;RHOA;FGFR2;CCN1;NPR3;PLXNB1;BMP2
prerank,neuromuscular process controlling balance (GO:0050885),-0.580050660764799,-1.4990401448539472,0.0625,0.49606260062316804,1.0,4/12,12.24%,PCDH15;NRXN1;TPP1;SHANK1
prerank,response to UV (GO:0009411),0.6379986028614778,1.497598824296425,0.026804123711340205,0.644839174110437,1.0,26/95,14.30%,DTL;POLK;AURKB;PCLAF;ZRANB3;AQP1;CDKN2D;USP1;POLH;BMF;PRIMPOL;NEDD4;ERCC4;POLD1;ERCC3;FMR1;MAP3K4;CDC25A;USP28;XPA;PCNA;MSH6;USP47;YY1;SMPD1;RUVBL2
prerank,regulation of neuron migration (GO:2001222),0.6766197584971567,1.4952398047315538,0.09825870646766169,0.6515202850967383,1.0,6/26,10.71%,KIF20B;ULK4;PHACTR1;NIPBL;SRGAP2;PLXNB2
prerank,chromatin assembly (GO:0031497),0.6794212030561028,1.4949297815631613,0.06526806526806526,0.6504879292846165,1.0,8/38,6.49%,CHAF1B;ATRX;HMGB2;NAP1L1;CTCF;LIN54;ANP32B;RBBP4
prerank,protein polymerization (GO:0051258),0.6518081791264035,1.4929087885737253,0.056043956043956046,0.655790457701582,1.0,7/55,5.53%,DIAPH3;UBE2C;CKAP5;UBE2S;UBE2K;DIAPH1;MAPT
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.708108343411101,1.4913619639866424,0.08300907911802853,0.6591833607551381,1.0,10/19,18.36%,PIF1;TERF1;STN1;HNRNPA1;HNRNPU;TERF2;SRC;TINF2;ACD;EXOSC10
prerank,glycerolipid metabolic process (GO:0046486),-0.5949337202682441,-1.4911024904983294,0.04081632653061224,0.5168837299053939,1.0,8/11,30.26%,DGKB;DGKG;PIP5K1A;DGKQ;GAL3ST1;PLA2G15;PGP;PNPLA3
prerank,regulation of chromatin binding (GO:0035561),0.775912808019658,1.4900924218788025,0.11093990755007704,0.6617377659158129,1.0,4/10,10.39%,DDX11;BTAF1;WAPL;PARP9
prerank,indolalkylamine catabolic process (GO:0046218),0.7647613132124601,1.4887351170214054,0.11377245508982035,0.6645775872089952,1.0,3/10,13.21%,ACMSD;KMO;IL4I1
prerank,transport across blood-brain barrier (GO:0150104),-0.3597435657713915,-1.4874791420976499,0.0,0.5242012466024081,1.0,29/83,16.25%,SLC6A6;SLC16A12;SLC1A2;ATP8A1;SLC6A1;SLC13A3;SLC2A1;SLC44A1;SLC7A2;INSR;SLCO1C1;SLC22A8;SLCO2B1;LRP1;SLC7A5;SLC27A1;ABCC4;ABCG2;SLC5A6;SLC15A2;SLC5A5;SLC22A5;SLC16A1;ATP1A2;ABCC5;SLC2A3;SLC4A8;SLC1A1;SLC12A2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5699748185308551,-1.4872708837092206,0.047337278106508875,0.5206495813730092,1.0,6/12,16.82%,MID2;LY6E;SNX3;IFITM3;GSN;IFITM2
prerank,chordate embryonic development (GO:0043009),0.6442546156997061,1.4859713319864463,0.0499457111834962,0.6727750332300734,1.0,9/55,8.21%,BRCA1;STIL;FGFR2;ALDH1A2;SULF2;ZNF568;GRHL2;SULF1;LMX1B
prerank,cilium assembly (GO:0060271),0.6183778945677298,1.4852565299219003,0.001,0.6730311188427062,1.0,66/296,10.83%,NEK2;CDK1;KIF24;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;IFT80;CEP57;HYLS1;CEP89;BBS9;HAUS4;HAUS6;DZIP1L;SCLT1;ACTR1A;DNAAF3;ACTR3;CEP43;WDR35;PARVA;ASAP1;GBF1;CEP97;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;TNPO1;C2CD3;OCRL;HAUS7;TXNDC15;MKKS;WDR11;NDE1;CEP83;RILPL1;NUDCD3;RFX2;CNTRL;SSX2IP;HAUS1;CCDC57;CFAP52;SPATA6;CEP76;WDPCP;NPHP3;ALMS1;ODF2;SDCCAG8;RAB1A;NINL;RSPH9;NPHP1;TRAPPC14;TTC39C
prerank,negative regulation of organelle assembly (GO:1902116),0.6653196023202542,1.485174093682333,0.07529411764705882,0.671090915124939,1.0,11/35,12.60%,BRCA1;CDK5RAP2;TRIM37;CEP97;EVI5L;LRRK2;YAP1;TBC1D7;TMEM39A;SCFD1;SMAD4
prerank,acidic amino acid transport (GO:0015800),-0.5033968525044263,-1.484660181619409,0.051470588235294115,0.5251920220161981,1.0,8/17,15.85%,SLC6A6;SLC1A2;SLC6A1;SLC25A13;SLC25A12;GIPC1;LRRC8D;SLC1A1
prerank,error-free translesion synthesis (GO:0070987),0.7082339765549138,1.4831819606348662,0.09583858764186633,0.6764830901027522,1.0,8/22,6.48%,RFC4;POLH;RPA1;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.642121839251818,1.4827433662657574,0.07789232531500573,0.6760160127350282,1.0,13/45,14.34%,ZWILCH;BUB1B;BUB1;WEE1;ZW10;CHEK1;SCRIB;BTG3;GAS1;TOM1L2;PLK2;CDKN1B;SMAD3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6766838062188675,1.4817242237505959,0.07692307692307693,0.6776863483388141,1.0,6/31,2.56%,E2F7;RBL1;WEE1;CDKN2D;CDKN2C;RB1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.573302915613822,-1.4805975098107065,0.07926829268292683,0.5344966447073978,1.0,6/11,16.50%,CALM1;NOS3;QDPR;GCH1;PRKG2;PTS
prerank,pore complex assembly (GO:0046931),0.7203587102268239,1.4803245181664462,0.11286089238845144,0.6807474156412883,1.0,7/19,6.58%,PLEKHA7;NDC1;NUP205;TSPAN33;AFDN;AHCTF1;TPR
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7695439840451348,1.479678617482565,0.12286158631415241,0.680904001972245,1.0,4/10,12.60%,BRCA1;CHEK1;KMT2A;SMAD4
prerank,protein-DNA complex assembly (GO:0065004),0.6206059715557057,1.4779420958707536,0.02032520325203252,0.6854983629771416,1.0,36/116,13.55%,CHAF1B;RAD51;ATRX;MCM5;ORC1;HMGB2;MCM8;DMC1;NAP1L1;MCM6;MCM7;MCM2;CDC6;PSMC2;RPA1;PSMD5;CHD1L;ANP32B;MCM3;RPA2;MCM4;ERCC3;ORC2;TCF4;ORC3;PSMB1;PSMD14;CUL4B;PSMD1;PSMB9;XPA;CENPV;SPTY2D1;SOX9;ORC6;CHAF1A
prerank,dopaminergic neuron differentiation (GO:0071542),0.7096647499502722,1.4768921736791973,0.11866666666666667,0.6871212979867645,1.0,3/19,10.19%,EN1;LMX1B;NR4A2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6794721170375412,1.4768137269389943,0.09626955475330927,0.6851641398951358,1.0,7/29,9.17%,BRCA1;CBFB;CNOT1;DDRGK1;VPS18;KANK2;YAP1
prerank,activation of protein kinase activity (GO:0032147),0.6190301502233967,1.4765000863028988,0.025693730729701953,0.6841623672378514,1.0,15/106,9.92%,TPX2;KIF14;ECT2;CLSPN;BORA;MAP4K4;STK3;NRK;IL18;TXN;TNFRSF10B;ANGPT1;OSBPL8;MARK2;MAPKAP1
prerank,catecholamine biosynthetic process (GO:0042423),-0.5741767304550145,-1.4761757456983609,0.07207207207207207,0.5444364746668114,1.0,4/11,19.19%,TGFB2;MOXD1;GCH1;DDC
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.7072457493997081,1.4756087068028125,0.099601593625498,0.6852530480044347,1.0,5/17,6.80%,DHDDS;ALG14;ALG13;SRD5A3;MPDU1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6636407018146109,1.475437139736243,0.08823529411764706,0.6836928187123976,1.0,5/33,5.39%,ECT2;AQP1;SETX;FXN;NET1
prerank,aerobic electron transport chain (GO:0019646),-0.35074628291962867,-1.4752229559239376,0.021739130434782608,0.543093294914759,1.0,33/68,25.20%,COX6C;COX4I1;COX5A;COX7B;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;COX7C;NDUFS3;UQCRC2;NDUFB3;NDUFS4;NDUFA5;UQCRB;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFAF1;NDUFB6;NDUFA11;COX8A;NDUFB10;NDUFB11;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,tryptophan catabolic process (GO:0006569),0.7442169550280994,1.4751626512726923,0.12152269399707175,0.6825080542157206,1.0,3/11,13.21%,ACMSD;KMO;IL4I1
prerank,cellular response to light stimulus (GO:0071482),0.6287088762433176,1.4743405884901015,0.056745182012847964,0.6834100905804612,1.0,20/66,17.19%,POLK;AURKB;AQP1;BMF;NEDD4;ERCC4;POLD1;FMR1;CDC25A;USP28;PCNA;USP47;YY1;SMPD1;RUVBL2;INO80;TP53;METTL3;PTPRK;ATR
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.6669397656557549,1.4734323672539391,0.11866501854140915,0.684597900183724,1.0,8/27,14.73%,RRM2;TYMS;RRM1;CTPS1;GUK1;DTYMK;DUT;AK7
prerank,regulation of interleukin-4 production (GO:0032673),-0.4880844228638384,-1.472017808238797,0.061224489795918366,0.5493552022747856,1.0,10/21,28.18%,LEF1;SLC7A5;PRKCQ;CEBPB;DDIT3;LGALS9;PRKCZ;CD86;SYK;FCER1G
prerank,positive regulation of organelle assembly (GO:1902117),0.6513397320812377,1.4716494845852797,0.06927374301675977,0.6891465618362236,1.0,15/44,11.30%,SPAG5;PLK4;GPSM2;ASAP1;CNOT1;CNOT6L;NUMA1;G3BP1;SH3GLB1;CNOT6;TAPT1;SDC1;ARHGAP35;CEP120;STX18
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6442476684970363,1.471596919871238,0.04559915164369035,0.6871484076410684,1.0,10/66,3.71%,KIF14;E2F7;RBL1;WEE1;E2F1;CDKN2D;CDKN2C;RB1;HYAL1;TFDP1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.6319030384297389,1.4705975808919518,0.044919786096256686,0.6886360070259726,1.0,12/66,11.13%,ECT2;CDK1;PLK1;GTSE1;TPR;NMD3;WWTR1;UBR5;TRIM28;YAP1;PARP9;EIF2AK3
prerank,modulation by symbiont of host process (GO:0044003),-0.5993207874156807,-1.4697398415465746,0.075,0.5530045843715898,1.0,8/10,32.34%,B2M;PGK1;ENO1;UBB;RPS27A;UBC;MRC1;UBA52
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5513724563474568,-1.4689925262688588,0.06020066889632107,0.5512556757852124,1.0,6/13,21.79%,TMSB4X;NOS3;PINK1;ENO1;PPARGC1A;NOS1
prerank,negative regulation of viral transcription (GO:0032897),-0.540006577488158,-1.4686844151948593,0.053156146179401995,0.5480702643111875,1.0,10/13,31.64%,MID2;IFITM3;TRIM27;TRIM14;TRIM21;TRIM11;TRIM32;ZFP36;HEXIM1;TRIM13
prerank,regulation of intracellular protein transport (GO:0033157),0.6562147353400309,1.4678012060929573,0.09058823529411765,0.6970908605291133,1.0,4/32,7.68%,KIF20B;PCM1;TPR;RAB29
prerank,myotube cell development (GO:0014904),-0.6028784810121685,-1.4672811592730766,0.07917888563049853,0.5483279279126303,1.0,4/10,11.42%,IGF1;CAV2;SELENON;SIX1
prerank,embryonic organ development (GO:0048568),0.6299590621235116,1.4666142728129428,0.061621621621621624,0.6993204378223571,1.0,22/61,16.86%,STIL;PBX4;GLI2;GLI3;FOXE1;PBX3;BMPR1A;TEAD1;FGFR2;KIT;ERCC3;KMT2A;TAL1;TEAD3;RBPJ;NES;HEY2;RARB;GDNF;SALL1;COBL;TEAD4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.6634078457189629,1.4664862285160087,0.0914419695193435,0.697622303315462,1.0,11/35,11.29%,POLE;RFC4;RPA1;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3;MBD4;PCNA
prerank,telomere organization (GO:0032200),0.6416556146601887,1.466223722531681,0.0947603121516165,0.6964351077629479,1.0,22/43,19.61%,TERF1;RTEL1;RPA1;STN1;ERCC4;POLD3;DNA2;PRKDC;BLM;MRE11;POLD1;RPA2;RIF1;PCNA;TERF2;TINF2;ATR;ACD;TERF2IP;RAD50;SP100;TERT
prerank,diol metabolic process (GO:0034311),-0.47562032869057425,-1.4660634719092736,0.06172839506172839,0.548105613740109,1.0,8/19,16.50%,CALM1;NOS3;PLPP3;DEGS2;ASAH2;GCH1;PRKG2;PTS
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5190854029046533,-1.465857324199445,0.0726643598615917,0.5446646342799487,1.0,7/15,21.79%,INPP5K;ATP1A2;TRIM27;SLC30A1;ADRA2A;PACSIN3;NOS1
prerank,determination of left/right symmetry (GO:0007368),0.6582859008400086,1.4650274828045657,0.1038961038961039,0.698568362184651,1.0,5/36,9.03%,STIL;DNAH11;CFAP53;MKKS;NPHP3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.593429208977678,-1.4646062412899528,0.06382978723404255,0.5449537246435346,1.0,5/10,16.43%,CCT5;TCP1;CCT7;CCT2;DKC1
prerank,peroxisome organization (GO:0007031),-0.4501707968683878,-1.464175067208742,0.04326923076923077,0.5426393616410564,1.0,8/25,13.66%,PLAAT3;PEX1;FIS1;ABCD4;PEX3;LONP2;PEX6;ABCD2
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.6080829946962409,1.4638199089931898,0.0,0.7010361615538262,1.0,56/306,7.95%,BRCA1;EXO1;TICRR;CDK1;MRPL36;BRIP1;POLE;CLSPN;PIF1;BARD1;RMI2;DBF4;MCM5;POLA1;ORC1;PCLAF;E2F1;TYMS;TIPIN;POLA2;MCM8;CDC45;RFC4;NAP1L1;TIMELESS;FAM111A;MCM10;MCM6;MCM7;MCM2;PABPC4;TOPBP1;RBBP8;CDC6;AGO2;RPA1;LARGE1;RAD1;POLD3;DNA2;RFC2;SRBD1;BLM;MRE11;MRPL18;MCM3;POLD1;RPA2;MCM4;RFC3;ORC2;CHEK1;POLR2A;RNASEH2A;ORC3;CDK2
prerank,nuclear pore complex assembly (GO:0051292),0.7721683318649557,1.4636055291503267,0.10939907550077041,0.699649097287772,1.0,4/10,6.58%,NDC1;NUP205;AHCTF1;TPR
prerank,membrane repolarization (GO:0086009),-0.5247484434969655,-1.4635747158967816,0.06,0.5406989117569546,1.0,8/15,31.95%,ATP1B1;ATP1A1;ATP1B3;ATP1A2;KCNQ1;ATP1B2;KCNIP2;KCNE4
prerank,striated muscle tissue development (GO:0014706),-0.4385204162672319,-1.463412518088029,0.018292682926829267,0.5374201654441181,1.0,7/29,11.42%,MEF2C;PGM5;CAV1;IGSF8;BMPR2;MYL6;SIX1
prerank,DNA methylation or demethylation (GO:0044728),0.6976720884383951,1.462913083206746,0.11182519280205655,0.6979215673842056,1.0,5/19,8.11%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP
prerank,DNA alkylation (GO:0006305),0.6976720884383951,1.462913083206746,0.11182519280205655,0.6979215673842056,1.0,5/19,8.11%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.6362376693128872,1.4616155004944869,0.06774193548387097,0.700587544759071,1.0,23/59,16.14%,CCNB1;CDK1;MED26;PPM1D;CBFB;SETX;MOV10;MED14;TCF7L2;MED30;TRIM28;BCLAF1;MED24;MED15;SOX9;TWIST1;MED1;CDK8;MED27;TNRC6C;NFKB1;TP53;PTEN
prerank,response to nutrient levels (GO:0031667),-0.5056668715854061,-1.4609040073970954,0.07569721115537849,0.5413526663149986,1.0,5/17,10.95%,KCNB1;EIF4G1;ULK1;PRKAA1;MTOR
prerank,long-term synaptic potentiation (GO:0060291),-0.4840307708590761,-1.4603078178017166,0.056768558951965066,0.5393904158804442,1.0,7/21,11.23%,SLC8A3;GRIN2A;GRIN2B;STX4;SLC24A2;TSHZ3;NFATC4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6791712243035097,1.4600772644688755,0.09394313967861558,0.7040515506832201,1.0,11/24,18.36%,PIF1;TERF1;STN1;ERCC4;HNRNPA1;HNRNPU;TERF2;SRC;TINF2;ACD;EXOSC10
prerank,water transport (GO:0006833),0.7348097677161916,1.4571041684493917,0.10898379970544919,0.7133797256758034,1.0,2/12,5.71%,AQP1;PDPN
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.43813466868077283,-1.4562906198410865,0.06358381502890173,0.5491839999193432,1.0,12/29,15.20%,CYRIB;PRKN;SHANK3;KANK3;KANK4;PFN1;SSH1;TJP1;SLIT2;SHANK1;ARFGEF1;FKBP4
prerank,regulation of nervous system development (GO:0051960),0.6495565104312939,1.4562136748259462,0.09302325581395349,0.7144615409125658,1.0,6/37,10.56%,KIF14;HMGB2;BHLHE41;NPHP3;YAP1;YTHDF2
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.487059694186864,-1.455582181691405,0.0502092050209205,0.5477354656841802,1.0,6/19,18.03%,PTK2;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,telomere maintenance via recombination (GO:0000722),0.7471417055769608,1.4553014479252395,0.11209439528023599,0.7157379040380023,1.0,4/11,4.47%,RAD51;SMC6;SMC5;ERCC4
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.4865924923834952,-1.45434539811067,0.06589147286821706,0.5480927391383601,1.0,10/18,18.42%,SHANK3;CACNG7;NRXN1;TSHZ3;CACNG4;RELN;CACNG2;CACNG3;CACNG8;NLGN1
prerank,protein neddylation (GO:0045116),-0.5495793713753854,-1.4536972679077458,0.07241379310344828,0.5463351230306442,1.0,5/13,15.14%,DCUN1D3;RBX1;DCUN1D5;DCUN1D4;DCUN1D2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6541556264722551,1.4529823713168446,0.09429569266589057,0.7221317539039962,1.0,6/31,6.78%,PLK1;CDC20;UBE2C;UBE2S;FBXW7;UBE2N
prerank,tryptophan metabolic process (GO:0006568),0.7373982585052623,1.4529156397656313,0.13421828908554573,0.7201915323851281,1.0,3/11,13.21%,ACMSD;KMO;IL4I1
prerank,T cell differentiation in thymus (GO:0033077),0.7225516339818732,1.4527461201195655,0.12482662968099861,0.7186889517676062,1.0,2/14,2.15%,GLI3;FADD
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4998202937367692,-1.4516559985822106,0.06884057971014493,0.5486200735470048,1.0,5/17,12.98%,STAT3;JAG1;TLR4;MSH2;GNL1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.47575070882725107,-1.4512556964945498,0.07456140350877193,0.5461161680650204,1.0,8/19,22.21%,MAOB;NOX1;PRDX2;PRDX1;GPX1;PRDX3;PARK7;PRDX5
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.544213533506708,-1.4510719494143611,0.08196721311475409,0.5429639464099233,1.0,6/12,21.97%,MAOA;HNMT;SMS;OAZ2;DDC;ATP7A
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5847283849767395,-1.4505654528920953,0.07526881720430108,0.54082411073437,1.0,5/10,12.52%,AKT2;CTTNBP2NL;IRS2;INPP5K;THBS1
prerank,organophosphate catabolic process (GO:0046434),0.7613386105217109,1.4505119607919619,0.13884785819793205,0.7249147047185786,1.0,2/11,6.98%,PON1;ENPP2
prerank,DNA packaging (GO:0006323),0.7072623700185994,1.4502050498795185,0.1083676268861454,0.7238675846901245,1.0,6/16,15.83%,CHAF1B;HAT1;RBBP4;CHAF1A;KAT6A;TP53
prerank,regulation of interleukin-10 production (GO:0032653),-0.3787771501896609,-1.4490714867091175,0.061946902654867256,0.5419639679306388,1.0,7/44,8.62%,STAT3;TRIB2;TLR4;PIBF1;CD34;TNFRSF21;HSPD1
prerank,cardiac muscle cell contraction (GO:0086003),-0.47305734656453297,-1.4479157540100953,0.06563706563706563,0.5424317290656361,1.0,7/19,18.25%,CAMK2D;CACNA2D1;SCN1A;ATP1A1;GSN;SCN1B;PIK3CA
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6722796085483561,1.446841716565711,0.11642156862745098,0.7340034754774158,1.0,6/26,11.37%,BRCA1;CNOT1;VPS18;SMARCA4;KANK2;HDAC1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.6714201514483943,1.4456102498557337,0.12102689486552567,0.73640644035666,1.0,1/26,0.19%,BRCA1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.6547339724056981,1.4450462899673755,0.11990407673860912,0.7362991573257657,1.0,5/30,8.91%,BRCA1;FADD;GSK3B;SERPINE1;TNFRSF10B
prerank,spinal cord development (GO:0021510),0.7219495885222809,1.4445161703339726,0.12445730824891461,0.7360823892567748,1.0,2/12,1.21%,GLI2;LOXL3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4446450335023759,-1.4442448734342461,0.07526881720430108,0.5503965593892621,1.0,11/26,25.98%,HSP90AB1;INSR;TLR4;KLF4;KLF2;PTGS2;DDAH2;P2RX4;ASS1;EDN1;TMEM106A
prerank,cellular response to alcohol (GO:0097306),0.6300451821549211,1.4436948216557162,0.10376282782212087,0.7370160745400147,1.0,9/42,11.56%,BRCA1;RAD51;GRAMD1C;BLM;CTNNA1;SPIDR;LARP1;AHR;KLF9
prerank,regulation of multicellular organism growth (GO:0040014),-0.5218939373219992,-1.443145349334635,0.09782608695652174,0.5503640736101785,1.0,5/15,16.36%,MBD5;IGF1;APP;PTCH1;PPIB
prerank,tRNA methylation (GO:0030488),-0.4178616124116425,-1.4429510539053176,0.06172839506172839,0.5474915810673623,1.0,21/34,36.54%,MTO1;NSUN2;THUMPD3;TRMT61B;DALRD3;TRMT1;METTL1;TRMT10A;LCMT2;TRMO;WDR6;GTPBP3;TRMT44;TRMT1L;TRMT10C;METTL6;TYW3;TRMT12;BCDIN3D;TRMT112;HSD17B10
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.49549165000848283,-1.4409404997012605,0.05,0.5510384917538975,1.0,9/18,18.34%,EPHA5;RPS6KA5;CRTC1;RELN;CRTC3;ADCY8;LRP8;VEGFA;CRTC2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.4146549503631703,-1.4408935773408837,0.03977272727272727,0.5477558482936078,1.0,8/30,21.17%,STAT3;TLR4;PIBF1;CD34;HSPD1;LGALS9;PRKCZ;CD274
prerank,potassium ion import across plasma membrane (GO:1990573),-0.38562377881321025,-1.4407053742924714,0.03875968992248062,0.544814616138276,1.0,11/41,17.53%,ATP1B1;KCNJ3;KCNJ6;ATP1A1;ATP1B3;ATP1A3;SLC12A9;KCNJ10;ATP1A2;SLC12A2;KCNK9
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.6207107406501398,1.440181701375926,0.08396946564885496,0.7482468268036969,1.0,6/51,5.03%,NEK2;PIF1;AURKB;TERF1;STN1;HNRNPA1
prerank,purine-containing compound salvage (GO:0043101),0.7241240022365271,1.439744548855645,0.12750716332378223,0.7476841230192962,1.0,4/12,5.27%,ADK;ADA;DCK;HPRT1
prerank,positive regulation of histone acetylation (GO:0035066),0.6665211535745034,1.4395264904735054,0.12944162436548223,0.7463459339922761,1.0,3/23,6.67%,BRCA1;PAXIP1;ARRB1
prerank,exit from mitosis (GO:0010458),0.7240970514842942,1.4369363476703987,0.12280701754385964,0.7539477149072007,1.0,2/12,2.03%,UBE2C;UBE2S
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.3834492447614607,-1.4365687326834717,0.04918032786885246,0.5542446873396719,1.0,26/46,31.28%,FIS1;DNAJC19;HSPD1;AIFM1;TIMM44;PINK1;TOMM70;HK1;BCAP31;GDAP1;AIP;FBXO7;TOMM34;DNAJC15;PAM16;TIMM17A;TOMM7;TIMM17B;CHCHD4;TIMM9;TIMM13;TOMM22;TIMM8B;ROMO1;GRPEL1;TOMM5
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.33905808278620797,-1.4365360511459573,0.0,0.550918613464502,1.0,39/87,25.25%,IMMP2L;TTC19;COX16;UQCC1;NDUFS5;OXA1L;NDUFS1;OMA1;AIFM1;NDUFA9;COX19;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;UQCC2;NDUFA6;NDUFB9;DMAC2;ACAD9;PET100;COX20;SMIM20;COX17;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;COX14;TIMMDC1;NDUFA10;COA8;NDUFS6;NDUFA1;CHCHD4
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.6148138483231047,1.4360436181608374,0.0550935550935551,0.7552705370676421,1.0,18/73,10.06%,PHF19;EZH2;PPM1D;BAZ1B;DEK;SUZ12;CTCF;POLR1A;MPHOSPH8;EED;MYO1C;POLR1B;RBBP4;RBBP7;PHF1;PHF2;EPC1;TAF1D
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.6257428674095031,1.435677687121503,0.1016949152542373,0.7544566804454537,1.0,7/47,6.71%,BRCA1;ACMSD;ATP2B4;ROCK2;GCK;ERFE;FBXW7
prerank,covalent chromatin modification (GO:0016569),0.6986087433436774,1.4356371910572008,0.13478260869565217,0.7524378459266207,1.0,2/14,1.39%,AURKB;HELLS
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.7472462692994714,1.4347389914901951,0.13737075332348597,0.753658251953819,1.0,7/10,18.45%,RTEL1;RIF1;TERF2;ACD;DCLRE1A;TERF2IP;DCLRE1C
prerank,protein targeting to peroxisome (GO:0006625),-0.4287762899817654,-1.4336027912116753,0.040229885057471264,0.5565230749876454,1.0,17/29,34.36%,PEX1;FIS1;ALDH3A2;PEX3;LONP2;PEX5;PEX6;ABCD2;GDAP1;PXMP4;PEX26;PXMP2;HACL1;PEX11B;PEX10;ACBD5;PEX16
prerank,histone lysine methylation (GO:0034968),0.6399863682533908,1.432831386397743,0.12186379928315412,0.7587270765539171,1.0,5/33,5.85%,EZH2;SETD6;PAXIP1;SETDB2;SETD3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6547199921059891,1.4322659684371468,0.11534025374855825,0.7586758363111279,1.0,6/33,2.56%,E2F7;RBL1;WEE1;CDKN2D;CDKN2C;RB1
prerank,positive regulation of tissue remodeling (GO:0034105),0.7434715396452828,1.4313158443461804,0.13122171945701358,0.7600382046799107,1.0,3/10,9.38%,ROCK2;IL18;ROCK1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.44173975901264484,-1.4312859490026728,0.07614213197969544,0.5607518268994253,1.0,10/25,25.13%,HSP90AB1;INSR;TLR4;KLF4;KLF2;PTGS2;DDAH2;P2RX4;ASS1;EDN1
prerank,response to amyloid-beta (GO:1904645),-0.3852043221399274,-1.4302660033714074,0.045871559633027525,0.5608138588870142,1.0,16/44,14.10%,CACNA2D1;PSEN1;GRIN2A;IGF1;TLR4;LRP1;CASP4;VCAM1;LGMN;CACNA1B;CHRNA7;ATP1A3;APP;GRM5;MMP2;GRIN1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5805863088838681,-1.4300978153411472,0.09597523219814241,0.5579624140409654,1.0,4/10,23.40%,PFKP;HK1;PFKM;PFKL
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4411347306471354,-1.4300816913866765,0.0821256038647343,0.5513312550090032,1.0,12/23,21.79%,EP300;HSP90AB1;HIPK2;DAB2;GIPC1;THBS1;SDCBP;CITED2;SLC2A10;TGFB1I1;SNW1;CDKN1C
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4411347306471354,-1.4300816913866765,0.0821256038647343,0.5513312550090032,1.0,12/23,21.79%,EP300;HSP90AB1;HIPK2;DAB2;GIPC1;THBS1;SDCBP;CITED2;SLC2A10;TGFB1I1;SNW1;CDKN1C
prerank,fluid transport (GO:0042044),0.7188156544616028,1.4283573537189231,0.133428981348637,0.7691958380046863,1.0,2/12,5.71%,AQP1;PDPN
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7312761117362023,1.428250641216547,0.1441578148710167,0.7674186655942213,1.0,4/10,9.74%,CBFB;ZBTB7B;SH3RF1;HMGB1
prerank,telomere maintenance via telomerase (GO:0007004),0.6445698257748482,1.4279076405502256,0.11890606420927467,0.766567794072755,1.0,14/28,19.61%,PIF1;TERF1;RTEL1;RPA1;MRE11;RFC1;CDK2;TERF2;ANKRD28;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,somite development (GO:0061053),0.713813620671823,1.4275557581814386,0.15592203898050974,0.7657053587628126,1.0,4/11,9.90%,LOXL3;PPP2R3A;SFRP2;MEOX2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.5784437892986668,-1.427128329158662,0.08074534161490683,0.5572403194295216,1.0,6/10,32.66%,NR1H3;ABCD2;NR1H2;SLC45A3;MID1IP1;MLXIPL
prerank,embryonic axis specification (GO:0000578),0.6984835917046213,1.4269932027847112,0.15655853314527504,0.7656423708388799,1.0,1/15,0.41%,STIL
prerank,vasoconstriction (GO:0042310),0.7344311408902727,1.4267492576594905,0.13153961136023917,0.7644341592537425,1.0,1/11,0.68%,KEL
prerank,nuclear transport (GO:0051169),0.7087264040311142,1.4261728996625194,0.13858695652173914,0.7644260523204085,1.0,7/16,17.33%,XPO1;NUP205;PSIP1;RBM15B;NXT1;NUP98;NXT2
prerank,regulation of myelination (GO:0031641),0.6735978414204388,1.4261302065102424,0.1417910447761194,0.7624769695086316,1.0,1/25,0.13%,KIF14
prerank,neural tube development (GO:0021915),0.7161741912181788,1.4261139850962412,0.12934631432545202,0.7604096729802117,1.0,3/15,6.59%,STIL;ALDH1A2;GRHL2
prerank,response to muscle stretch (GO:0035994),-0.5061923655937867,-1.425295386396613,0.09061488673139159,0.559368415909111,1.0,5/15,12.26%,PTK2;CDH2;RYR2;CTNNB1;GSN
prerank,positive regulation of rRNA processing (GO:2000234),-0.5768515042444236,-1.4252331252854213,0.09970674486803519,0.5562684889039287,1.0,9/10,39.98%,HEATR1;WDR75;BUD23;RIOK2;DIMT1;RIOK1;TRMT112;SIRT7;WDR43
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.4287751330922334,-1.425108746533337,0.046511627906976744,0.5535137766731594,1.0,16/29,30.56%,MCTP1;APOE;EPHB2;SHISA6;NETO1;RAB5A;APP;NSMF;DLG4;GRIK2;DRD2;SHISA9;SHISA7;CAMK2B;RAB3GAP1;CLN3
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.5851224704828976,-1.4244667936934365,0.09036144578313253,0.5525250752883781,1.0,8/10,36.28%,OGT;SELENOS;ZNF692;DGKQ;PDK2;SIRT7;USP7;SDHAF3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.4856468568908134,-1.4243180011135332,0.08163265306122448,0.549932210638617,1.0,11/18,18.62%,RIMS1;SHANK3;NRXN1;RELN;CHRNA7;SHANK1;DLG4;GRIN1;PRKCZ;NLGN1;STX1B
prerank,female gamete generation (GO:0007292),0.6537568541394831,1.4239101911501315,0.11070559610705596,0.7664379735891753,1.0,10/29,19.56%,TRIP13;MCM8;DMC1;KMT2D;TOB2;USP9X;METTL3;MCM9;MARF1;FMN2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.39375178712623965,-1.4236657685567944,0.036585365853658534,0.5487110041514518,1.0,16/31,32.76%,KCNB1;SYT1;SYT7;SYT11;SYT12;SCAMP5;ADRA2A;SYT10;SYT6;SYT2;CACNA1H;RAB3GAP1;CACNA1I;SYT13;SYT3;CBARP
prerank,odontogenesis (GO:0042476),0.6447653713693219,1.4231814691539784,0.11507479861910241,0.7669904434584868,1.0,12/35,12.62%,GLI2;AQP1;FGFR2;BCOR;LAMB1;ANKRD11;AXIN2;WNT6;EDA;HDAC1;BMP2;HDAC2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.47664528748959845,-1.4229233228846352,0.039525691699604744,0.5478932980695909,1.0,6/18,19.30%,TLR4;LBP;HSPD1;THBS1;NECTIN2;KARS1
prerank,epithelial cell differentiation (GO:0030855),0.598690520129485,1.4227077566561805,0.05664263645726056,0.7667811575709308,1.0,12/88,11.47%,E2F7;E2F8;CDK1;SCUBE1;FGFR2;RAB10;GRHL2;SCRIB;FN3K;PCNA;HDAC1;ANXA1
prerank,spermatid development (GO:0007286),0.6486074130353974,1.422639077123994,0.1272294887039239,0.7648820047846773,1.0,4/32,7.18%,MEIOC;CEP57;MKKS;RFX2
prerank,protein K11-linked ubiquitination (GO:0070979),0.6578073739869083,1.4217152502186439,0.1353658536585366,0.7661432961629387,1.0,5/27,3.64%,UBE2T;UBE2C;UBE2S;ANAPC7;CDC27
prerank,regulation of transposition (GO:0010528),0.7225008484827031,1.4215654982684147,0.14701803051317613,0.7646325104995887,1.0,1/13,1.03%,MYBL1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5559521288926843,-1.4208047703763445,0.09907120743034056,0.5507742065711091,1.0,6/11,21.79%,CAMK2D;CACNA2D1;BIN1;CACNB2;CACNB1;NOS1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.6153547595374147,1.420137667734148,0.1130820399113082,0.7678541292032101,1.0,15/46,17.20%,KIF14;RHOA;ATRNL1;PARVA;ITGB7;LAMB1;EFNA1;TMEFF2;SRGAP2;RAC1;ITGA8;ITGAV;NTN4;FERMT3;ANTXR1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.402632696356439,-1.4185193874881212,0.0851063829787234,0.5548165030537239,1.0,9/34,6.83%,PTK2;FLT1;TEK;PIK3R3;PDGFRB;PIK3R1;FGF2;PIK3R4;PIK3IP1
prerank,regulation of protein acetylation (GO:1901983),0.7275046389229216,1.4184201401212477,0.14556040756914118,0.7718855403045394,1.0,3/12,4.23%,CEP295;GSK3B;FAM161A
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3970058520791167,-1.4176593344077912,0.057971014492753624,0.5546006179045506,1.0,15/33,22.53%,NRG3;GRIK1;IQSEC2;GRID2;BCR;GRIK4;CACNA1B;RELN;PSMC5;LRP8;SLC4A8;NLGN1;GRIK2;GRID1;BDNF
prerank,linoleic acid metabolic process (GO:0043651),-0.49205157062133525,-1.417473405637995,0.07377049180327869,0.5520735487370999,1.0,10/17,46.83%,PNPLA8;ACSL1;ELOVL1;FADS1;GSTM2;ALOX12;ELOVL2;ALOXE3;ALOX5;FADS2
prerank,renal system development (GO:0072001),0.6223185294880905,1.417467430984365,0.09596510359869138,0.7732895325550493,1.0,12/52,15.41%,CENPF;GLI2;SULF2;SULF1;NPHP3;AGT;C1GALT1;TGFBR1;TBX18;IFT27;ITGA8;GREB1L
prerank,histone H2A monoubiquitination (GO:0035518),0.6766355507223567,1.4160793350740994,0.1402116402116402,0.7763293522098963,1.0,6/17,9.30%,RNF168;TRIM37;BCOR;PCGF5;KDM2B;CUL4B
prerank,sodium ion transport (GO:0006814),-0.3222767632794811,-1.4155222547637087,0.0,0.5548198730474081,1.0,22/85,16.25%,SLC6A6;SLC8A3;ATP1B1;SLC6A1;HCN1;ANO6;SLC24A2;SGK1;SCN1A;FGF13;SCN9A;ATP1B3;NDUFA9;SLC5A6;SLC5A5;ATP1A2;SCN3A;SCN8A;SCN1B;SLC4A8;SLC6A11;SLC12A2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.7187171103597743,1.4150720935165266,0.1377245508982036,0.7780022416382844,1.0,4/12,7.60%,GLI2;MYCBP2;NFIB;EPHA4
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.55856621988401,-1.414554471172457,0.1111111111111111,0.5547676155368219,1.0,3/11,7.70%,ATP1B1;KCNJ3;ATP1A1
prerank,skeletal system morphogenesis (GO:0048705),0.6243825958086129,1.4145273222551016,0.1204954954954955,0.7778486970679043,1.0,11/42,10.48%,RAB33B;CYP26B1;WWOX;FGFR2;HOXC4;PDGFRA;RFLNA;ANKRD11;DSCAML1;HOXB3;TGFBR1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.667943109165049,1.4135179566508072,0.12598425196850394,0.7791994059940646,1.0,3/20,6.67%,BRCA1;PAXIP1;ARRB1
prerank,response to organonitrogen compound (GO:0010243),-0.3879868706606768,-1.4126173056312934,0.036231884057971016,0.5578716112997679,1.0,14/38,23.09%,PRKN;GLRB;ERLEC1;GLRA1;GLRA3;DERL1;MTOR;RCN3;RRAGC;UBXN6;DNAJB12;SYVN1;DRD2;SEL1L
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4058658387442736,-1.4126016567696398,0.0975609756097561,0.5548510711388214,1.0,10/33,17.38%,PRKG1;APOD;MEF2C;PDCD4;SOD2;TPM1;OGN;TAFA5;TGFB3;NDRG4
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.49063473803225,-1.4119220529737992,0.10071942446043165,0.5539103201247076,1.0,11/14,43.88%,UQCC2;RPUSD4;FASTKD2;RMND1;COA3;MPV17L2;TRMT10C;C1QBP;FASTKD3;RPUSD3;NGRN
prerank,receptor-mediated endocytosis (GO:0006898),-0.3097122482137289,-1.4118886957705725,0.0,0.5510083321212687,1.0,45/132,19.63%,DNM3;SGIP1;CALCRL;LRP1B;MICALL1;CAV1;APOE;FNBP1L;TMEM108;INSR;HSP90B1;AP2A2;LRP1;ACKR3;RAMP1;DNM1;GPR107;DAB2;RAMP2;HSPH1;CD81;VLDLR;CAV2;SCARF1;AP2M1;PDLIM7;GRB2;ARHGAP27;IGF2R;CTSL;LDLRAP1;AP2S1;AP1S1;AP2A1;FCHO2;LRP6;CLTB;CUBN;LMBRD1;STAB1;PPT1;SORL1;GRK4;LRP3;SPARC
prerank,protein sumoylation (GO:0016925),0.6152925116855383,1.4116167979424397,0.1222466960352423,0.7841916048957418,1.0,30/49,25.25%,NDC1;NUP155;SAE1;NUP205;NUP160;NUP85;TPR;TRIM28;RANGAP1;NSMCE2;SUMO2;NUP214;TRPM4;RANBP2;NUP133;NUP42;NUP98;NUP210;EGR2;NUP188;NUP35;NUP43;PIAS1;UBA2;NUP93;UBE2I;NUP107;STX1A;SEH1L;EYA1
prerank,artery development (GO:0060840),-0.44347559894731065,-1.411382609147759,0.06912442396313365,0.5497410130267287,1.0,13/23,19.33%,SMAD7;BMPR2;ACVRL1;ACVR2B;NF1;TBX1;VEGFA;ENG;STRA6;ROBO2;PDE2A;SLC2A10;NRP1
prerank,nuclear export (GO:0051168),0.6005828178605443,1.4111555490038377,0.065625,0.7838347511509861,1.0,22/80,12.90%,ANKLE1;CCHCR1;RANBP17;NUP155;XPO1;XPO4;SRSF4;PHAX;HNRNPA1;EIF4E;UPF3B;CSE1L;WASHC4;TPR;DDX39B;SRSF7;SMURF1;SRSF3;SRRM1;ATXN1;NUP214;STRADA
prerank,retrograde axonal transport (GO:0008090),-0.5163511541512806,-1.4110373893013646,0.08178438661710037,0.547949542355756,1.0,6/16,10.40%,TMEM108;KIF1A;MAP1A;KIF5B;NEFL;ACTR10
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.6373853792291096,1.4109894620326437,0.13609467455621302,0.7822950315712224,1.0,14/29,19.61%,PIF1;TERF1;RTEL1;RPA1;MRE11;RFC1;CDK2;TERF2;ANKRD28;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,histone H4 acetylation (GO:0043967),0.6142447658298863,1.4101998861391936,0.10654827968923418,0.7831223222068996,1.0,21/47,18.79%,KANSL1;BRCA2;KANSL2;HAT1;ING4;MSL3;EP400;EPC1;KMT2A;JADE1;ACTL6B;RUVBL2;PER1;TRRAP;BRD8;PHF20;ZZZ3;KANSL3;NAA60;NAA40;JADE3
prerank,nucleotide biosynthetic process (GO:0009165),0.6854862764366422,1.4097508826422052,0.14749661705006767,0.7826811511913331,1.0,6/18,11.44%,RRM2;RRM1;HPRT1;PRPS1L1;PRPS1;ADSL
prerank,actin polymerization or depolymerization (GO:0008154),0.6124231268345594,1.4084579307586271,0.12144420131291028,0.7854007474991002,1.0,10/50,14.60%,DIAPH3;DIAPH1;MICAL3;ABI1;ARHGAP6;TWF1;RAC1;SVIL;DSTN;CAPG
prerank,histone modification (GO:0016570),0.5871212853699251,1.407898412084029,0.055327868852459015,0.785388144615732,1.0,20/109,10.23%,UHRF1;EZH2;INCENP;AURKB;SGF29;BAZ1B;EYA4;MIER1;CCNA2;TBL1XR1;UBE2N;MIDEAS;CDK2;RCOR1;MSL3;USP21;USP16;MIER3;MTA3;EYA2
prerank,nucleoside salvage (GO:0043174),0.7304213695579445,1.4077483608347994,0.13943028485757122,0.7838667314922825,1.0,4/10,9.14%,TK1;DCK;HPRT1;CDA
prerank,cellular response to UV (GO:0034644),0.5986539334903829,1.4073201653304057,0.0776495278069255,0.7834890364625392,1.0,26/76,17.19%,POLK;AURKB;AQP1;HYAL1;BMF;NEDD4;ERCC4;POLD1;FMR1;CHEK1;CUL4B;CDC25A;USP28;XPA;PCNA;PPID;USP47;YY1;SMPD1;RUVBL2;STK11;INO80;TP53;METTL3;PTPRK;ATR
prerank,regulation of establishment of cell polarity (GO:2000114),0.6888440757002077,1.4073031274605017,0.16056338028169015,0.7814953557671298,1.0,2/16,3.09%,KIF20B;ROCK2
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.42888631529350824,-1.406647155768375,0.05365853658536585,0.5585782969154522,1.0,7/25,14.10%,PRKN;TMTC2;TRPM7;CAV1;FAM20A;SELENON;GRIN1
prerank,fatty acid biosynthetic process (GO:0006633),-0.3527014075931445,-1.406580157431887,0.047619047619047616,0.5558573038242066,1.0,27/63,31.53%,ELOVL7;HACD3;ACLY;HACD2;GPX4;LIAS;HACD1;ABHD2;PTGS2;ASAH2;DEGS1;EPHX2;XBP1;ELOVL6;DECR2;ACOT7;CBR4;HPGD;SCD;ELOVL1;FADS1;ACSBG1;TECR;ALOX12;HSD17B8;OXSM;TECRL
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6776150613657183,1.4061014182099314,0.14266666666666666,0.7837894539684804,1.0,5/18,9.38%,KIF20B;ROCK2;RIPOR2;LLGL2;ROCK1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3693561609093733,-1.4059842921245984,0.045112781954887216,0.5547795091380933,1.0,19/39,24.35%,RPS15;RPS7;RPS6;RPS14;RPSA;RPS28;RPS5;RPS24;RPS19;RPS27;METTL17;SNU13;RIOK2;ERAL1;LTV1;NOB1;EMG1;SURF6;MRPS7
prerank,positive regulation of synapse assembly (GO:0051965),-0.4186301058422833,-1.4059580588883454,0.05113636363636364,0.5519195183559263,1.0,14/27,23.77%,PTPRD;SYNDIG1;GRID2;AGRN;EPHB2;IL1RAPL1;SEMA4D;NRXN1;LRRC4B;NLGN1;IL1RAP;BDNF;DLG5;SRPX2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.33227249079916577,-1.405840896716577,0.022727272727272728,0.5494266194051167,1.0,33/69,25.20%,COX6C;COX4I1;COX5A;COX7B;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;COX7C;NDUFS3;UQCRC2;NDUFB3;NDUFS4;NDUFA5;UQCRB;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFAF1;NDUFB6;NDUFA11;COX8A;NDUFB10;NDUFB11;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5953829480065678,-1.405726941029723,0.08459214501510574,0.5468712502906444,1.0,8/10,34.92%,HSP90AB1;LAPTM4B;FURIN;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6341934059177747,1.4053495770102769,0.12748538011695906,0.7824964189301695,1.0,15/32,20.11%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,tRNA export from nucleus (GO:0006409),0.6341934059177747,1.4053495770102769,0.12748538011695906,0.7824964189301695,1.0,15/32,20.11%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,regulation of histone acetylation (GO:0035065),0.6171735921182782,1.405207782536189,0.13317479191438764,0.7809717689014979,1.0,6/33,9.84%,BRCA1;PAXIP1;CTBP1;ARRB1;CHEK1;KMT2A
prerank,positive regulation of dephosphorylation (GO:0035306),0.6608403347307261,1.4044069637555305,0.13784764207980654,0.7819372300703791,1.0,11/27,16.18%,CDCA2;PPP1R7;MTMR9;CALM2;BMP2;SMPD1;CAMTA1;PTPA;PIN1;SRC;ANKLE2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4580367465023722,-1.4038067727510728,0.107981220657277,0.5498239492293164,1.0,8/20,13.50%,CAMK2D;PSEN1;FIS1;PACS2;TGM2;BCL2;TMCO1;BCAP31
prerank,regulation of protein neddylation (GO:2000434),-0.5733832663839346,-1.4032511942935069,0.08928571428571429,0.548761031765158,1.0,7/10,30.05%,DCUN1D3;DCUN1D5;DCUN1D4;DCUN1D2;HIF1A;RPL11;COPS9
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.342043699018152,-1.4031372299733342,0.022222222222222223,0.5462481712985601,1.0,32/69,24.46%,UBE4A;HSP90B1;OS9;TRIM25;ECPAS;RNF103;EDEM2;EDEM1;UFD1;DERL1;SELENOS;HSPA5;UBXN4;RHBDD2;SGTA;STUB1;YOD1;SGTB;DNAJC18;DNAJB9;ERLIN2;SEC61B;AUP1;DNAJB12;SYVN1;UBE2G2;UBXN8;SEL1L;UBE4B;FAM8A1;WFS1;RNF103-CHMP3
prerank,nucleotide-excision repair (GO:0006289),0.5895213035011846,1.4028076096056876,0.053497942386831275,0.7858150328704866,1.0,18/101,7.46%,POLK;BRIP1;POLE;POLA1;BRCA2;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;PRPF19;POLR2A
prerank,regulation of coagulation (GO:0050818),-0.555339647327754,-1.4023993683102796,0.10884353741496598,0.5456900029716896,1.0,2/11,5.30%,CAV1;EPHB2
prerank,peptide biosynthetic process (GO:0043043),-0.28983223805438035,-1.401861079766074,0.0,0.5444230632251187,1.0,79/153,21.25%,EEF1A1;RPL13;FARSB;RPS8;PCSK5;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;GGT5;MRRF;RPL8;FURIN;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;SARS1;RPL12;RPL27;RPL24;MRPS5;RPS12;RPS4X;RPS27;RPL27A;RPS9;WARS1;MRPS18A;MRPS15;RPL30;MRPS21;MRPS6;RPL19;RPL28;MRPL27;RPL31;RPL13A;RPL36A;RPLP2;RPL29;HBS1L;PCSK1;MRPL23;DHPS;MRPL9;TNIP1;RPLP0;RPL10A;RPS6KB2;RPS10;RPL35;RPS26
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6995776873582826,1.4010941445378902,0.15261627906976744,0.7899771198236785,1.0,5/13,15.76%,KPNA2;KPNA3;RANBP2;KPNA4;IPO5
prerank,tRNA wobble uridine modification (GO:0002098),-0.5124566169456934,-1.400431382193051,0.09667673716012085,0.545738083599892,1.0,7/14,25.82%,ELP3;TRMT9B;MTO1;TRMU;DPH3;ELP4;GTPBP3
prerank,regulation of B cell proliferation (GO:0030888),0.6198603823208257,1.3998336801595064,0.1021566401816118,0.7925457931160373,1.0,1/44,0.09%,TNFSF13B
prerank,bicarbonate transport (GO:0015701),0.6531244806249524,1.399522641647981,0.15106117353308365,0.7916392367745057,1.0,7/25,14.87%,RHAG;AQP1;SLC4A2;CYB5RL;SLC39A8;CA2;CYB5R1
prerank,in utero embryonic development (GO:0001701),0.6595191737126975,1.3991987269621213,0.14912280701754385,0.790766845543882,1.0,6/25,11.40%,STIL;FGFR2;ZNF568;LMX1B;TGFBR1;BMP2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3823150964225466,-1.3991535285104288,0.057971014492753624,0.5466820604416597,1.0,18/39,21.48%,PIP4K2A;PIK3R3;PIP4K2B;SOCS2;PIK3C2B;PIK3R1;EFR3A;SOCS5;ITPKB;PI4KA;SMG1;PIK3CD;TMEM150A;PIK3CA;EFR3B;ITPKC;PIP4K2C;PIK3R2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6924417862479882,1.3988513274410255,0.13739376770538245,0.7900420546968544,1.0,7/15,12.62%,GLI2;ANKRD11;WNT6;EDA;HDAC1;BMP2;HDAC2
prerank,negative regulation of transposition (GO:0010529),0.691671516224622,1.3975261168399096,0.16395663956639567,0.7926958591520168,1.0,4/16,13.46%,MYBL1;MOV10;TUT7;TUT4
prerank,cellular response to interleukin-4 (GO:0071353),-0.5757645170541681,-1.3973986096742215,0.09620991253644315,0.5492530674249401,1.0,4/10,21.09%,LEF1;STAT6;XBP1;SHPK
prerank,regulation of telomerase activity (GO:0051972),0.6151659832653464,1.396827266978876,0.11371237458193979,0.7933733983570715,1.0,6/45,6.59%,NEK2;PIF1;AURKB;TERF1;ERCC4;GRHL2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.49595405225257516,-1.3953706361488283,0.11637931034482758,0.5524566971510106,1.0,3/16,1.04%,MCTP1;RIMS1;MEF2C
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6169507057466566,1.3947907666189983,0.14105504587155962,0.7987323183607157,1.0,4/35,5.03%,NEK2;AURKB;RTEL1;HNRNPA1
prerank,sympathetic nervous system development (GO:0048485),-0.5041114097178532,-1.3940605407996371,0.10948905109489052,0.5531773248449839,1.0,6/15,19.33%,NRP2;SEMA3A;NF1;CTNNB1;SOX4;NRP1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.43688332449406986,-1.3939483148691434,0.04807692307692308,0.5507747761747015,1.0,13/25,18.42%,MEF2C;SHANK3;SHISA6;CACNG7;CACNG4;MINK1;RELN;SHANK1;CACNG2;PRRT1;CACNG3;CACNG8;NLGN1
prerank,embryonic digestive tract development (GO:0048566),0.6571951129411435,1.3934998690221736,0.15712383488681758,0.8015193664801833,1.0,7/18,13.81%,GLI2;GLI3;FGFR2;PDGFRA;NIPBL;RBPMS2;RARB
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5015190198843776,-1.3928797634082533,0.10877192982456141,0.5509977718133456,1.0,11/15,32.40%,ENTPD1;CMPK1;ENTPD2;AK5;AK4;ENTPD5;CMPK2;AK1;NME2;ENTPD3;ENTPD6
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.47858508165595265,-1.3928177502389527,0.1111111111111111,0.5485794907483016,1.0,10/16,32.98%,PINK1;NUPR1;COX7A2;UQCC2;ATP7A;AK4;PDE12;MLXIPL;PPIF;VCP
prerank,secretory granule organization (GO:0033363),-0.5600257271512121,-1.3924619356727932,0.12804878048780488,0.5469008553628705,1.0,5/10,14.61%,LYST;SRGN;DTNBP1;BLOC1S2;VPS33B
prerank,tRNA transport (GO:0051031),0.6288776403634366,1.3924363457589275,0.1303344867358708,0.8031967659693888,1.0,21/35,25.20%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35;NUP43;TOMM20;NUP93;NUP107;SSB;SEH1L
prerank,prostanoid metabolic process (GO:0006692),0.7081564346110566,1.3923526664459047,0.15242165242165243,0.8015413351086877,1.0,4/13,7.45%,PTGR1;PTGR2;HPGDS;PTGS1
prerank,oogenesis (GO:0048477),0.6931494298486404,1.3909597826259694,0.15775401069518716,0.8045777355109516,1.0,5/15,19.56%,TRIP13;KMT2D;METTL3;MARF1;FMN2
prerank,ncRNA export from nucleus (GO:0097064),0.6214720104111858,1.38938941142242,0.1306884480746791,0.8083728684563318,1.0,16/36,20.11%,NDC1;NUP155;NUP205;NUP160;PHAX;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.424357391587154,-1.388041561548977,0.08379888268156424,0.557315621859038,1.0,12/27,26.82%,CAMK2D;AHNAK;CALM1;FKBP1A;SELENON;CACNB2;CACNB1;ADRA2A;PDE4D;NOS1;JPH2;JPH4
prerank,regulation of catabolic process (GO:0009894),0.654337082554247,1.3877837338217687,0.16129032258064516,0.8121553423455691,1.0,3/18,5.71%,FAM83D;CHEK2;FAF1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.40533231120572605,-1.3864508208883402,0.08484848484848485,0.5594600917535891,1.0,15/30,23.75%,RASGRF1;IGF1;IRS2;LYN;TGM2;RELN;RASGEF1A;SHOC2;GRB2;SHC1;ERBIN;LRRC59;JAK2;MMD2;FGF10
prerank,histone methylation (GO:0016571),0.6362762839358459,1.3864187133207262,0.1597051597051597,0.8151531896999737,1.0,2/26,2.23%,EZH2;SETD6
prerank,relaxation of muscle (GO:0090075),-0.5162711328365841,-1.3862894415652307,0.11612903225806452,0.5573884272131715,1.0,8/13,25.08%,CAMK2D;ATP1B1;ATP1A1;GSN;ATP1A2;PIK3CA;P2RX4;GSTM2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5277927973083255,-1.385648633298315,0.1362126245847176,0.5566287245727372,1.0,3/13,2.53%,PSEN1;TMSB4X;PER2
prerank,transition metal ion homeostasis (GO:0055076),-0.4188707094542711,-1.385552596646894,0.07575757575757576,0.5542523243267068,1.0,9/28,18.30%,PRKN;FBXL5;FTL;HMOX2;NEO1;B2M;IREB2;CUTC;COMMD1
prerank,kidney development (GO:0001822),0.5955249515519098,1.384442478792988,0.091005291005291,0.8203074149612737,1.0,15/65,15.41%,CENPF;GLI2;SULF2;NIPBL;SULF1;KANK2;NPHP3;AGT;C1GALT1;TGFBR1;CTSH;IFT27;ITGA8;GDNF;GREB1L
prerank,peptidyl-lysine monomethylation (GO:0018026),0.7327360439258691,1.384305160170076,0.16307692307692306,0.8188529308155829,1.0,5/10,7.49%,KMT5A;SETD6;SETD3;EEF1AKMT2;SETD2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.695088217691546,1.3842979682154823,0.16110304789550073,0.8168776951074131,1.0,3/11,3.24%,FADD;TICAM1;COLEC12
prerank,regulation of phospholipase C activity (GO:1900274),-0.4990573590590132,-1.38318484389008,0.08992805755395683,0.5585152236871984,1.0,8/15,10.85%,FLT1;PDGFRB;NTRK3;FGF2;BICD1;PLCG1;ESR1;ABL1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4114082146281774,-1.3828732172377085,0.07692307692307693,0.5569167425087708,1.0,13/26,20.87%,SLC39A10;SLC39A13;SLC39A7;SLC30A1;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5180391711505165,-1.3815278807506695,0.13190184049079753,0.5581709119165961,1.0,3/12,7.99%,PRKG1;MEF2C;TPM1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5744055207291957,-1.3815158080167462,0.10979228486646884,0.5555946773889675,1.0,2/10,2.43%,KCNAB1;CAV1
prerank,cell differentiation in hindbrain (GO:0021533),-0.5434198191014854,-1.381491625656822,0.12974683544303797,0.5530736017777016,1.0,3/11,4.85%,OPHN1;GRID2;PROX1
prerank,signal peptide processing (GO:0006465),-0.5582099584662925,-1.380700984478109,0.11003236245954692,0.5530773124731044,1.0,7/11,26.41%,PCSK5;FURIN;SPCS2;PARL;CLN5;SPCS1;SEC11A
prerank,pre-replicative complex assembly (GO:0036388),0.5883681919119239,1.379984133854638,0.10695187165775401,0.830801788056101,1.0,17/64,10.88%,MCM5;ORC1;MCM8;MCM6;MCM7;MCM2;CDC6;PSMC2;PSMD5;MCM3;MCM4;ORC2;ORC3;PSMB1;PSMD14;PSMD1;PSMB9
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.49334314460930806,-1.3794043159621754,0.09574468085106383,0.554388362173145,1.0,9/15,22.30%,TMSB4X;FGF2;LGMN;FGF1;MET;THBS1;SMOC2;P2RX4;HSPB1
prerank,epiboly involved in wound healing (GO:0090505),0.6862718277183055,1.3791162841475493,0.15577190542420027,0.8318372061723688,1.0,9/16,15.78%,RHOA;PDPN;CCN1;TMEFF2;ARHGAP35;MRTFA;CD44;RHOC;LCP1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.42947959113204814,-1.3790679832278256,0.07784431137724551,0.5528289945707994,1.0,13/26,21.77%,SGIP1;ITSN2;FNBP1L;AP2A2;GPR107;AP2M1;AP2S1;AP2A1;FCHO2;CLTB;LMBRD1;FCHSD2;ITSN1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.6121803516020106,1.378167813902948,0.148664343786295,0.8333713766392967,1.0,3/32,5.03%,NEK2;AURKB;HNRNPA1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.538555313924957,-1.3776359357448675,0.11641791044776119,0.5545611503325489,1.0,2/11,8.02%,MALT1;PRKCQ
prerank,transepithelial transport (GO:0070633),-0.5074570204972941,-1.3755104091359747,0.12109375,0.5585807469642573,1.0,5/15,16.25%,SLC1A2;ABCG2;GPLD1;SLC1A1;SLC12A2
prerank,regulation of embryonic development (GO:0045995),0.6248697538642372,1.3752771081002668,0.14302059496567507,0.8421158192401988,1.0,6/34,9.03%,CDK1;RACGAP1;NIPBL;WDPCP;CCSAP;NPHP3
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.6999157978361676,1.3747290700710404,0.15036496350364964,0.8420531170938691,1.0,5/11,8.17%,MPHOSPH8;SETDB2;TPR;ATF7IP;TRIM28
prerank,negative regulation of secretion (GO:0051048),-0.559263599889121,-1.3745575823341203,0.11504424778761062,0.5587125266296754,1.0,7/10,28.82%,NR1H3;VAMP8;VAMP3;PTGER3;CD74;EGF;ERBB3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.37089965527782354,-1.3742079314848774,0.09090909090909091,0.5572073502311065,1.0,8/39,4.32%,MAML3;STAT3;EP300;MAML2;JAG1;ZMIZ1;TGFB2;NOS3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6771617887900367,1.3741108057848062,0.18410041841004185,0.8423361992982049,1.0,4/13,6.80%,ALG14;ALG13;SRD5A3;MPDU1
prerank,response to hydrogen peroxide (GO:0042542),0.6089360146942592,1.373659036715357,0.13727678571428573,0.8419486590985401,1.0,6/45,5.76%,ECT2;AQP1;SETX;FXN;NET1;STK24
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.4073450836763828,-1.3732956126682134,0.05806451612903226,0.5574652538991196,1.0,13/30,27.90%,ELOVL7;HACD3;HACD2;ABCD4;HACD1;ACSL6;ABCD2;ELOVL6;SLC27A4;ACSL1;ELOVL1;ACSBG1;TECR
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4858635203228416,-1.3721866904179052,0.10266159695817491,0.5580074312074875,1.0,9/17,33.39%,SLC7A5;PRKCQ;CEBPB;LGALS9;PRKCZ;CD86;SYK;FCER1G;RARA
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5337968541555634,-1.3713038777446507,0.11486486486486487,0.5579141825849306,1.0,6/12,30.21%,TLR4;GRIN1;RAB27A;ZNF205;SLC5A3;ADGRB1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.6256287433416924,1.3712139080274273,0.15878787878787878,0.8489990014268787,1.0,10/26,18.77%,RRM2;RRM1;LARGE1;TKT;ALG8;ST3GAL4;ST3GAL2;GK5;GK;GCNT1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6327581340221311,1.3707480168204098,0.14783653846153846,0.8487508555679386,1.0,8/30,7.52%,DDIAS;CDKN2D;FBXO5;DYRK1A;RTEL1;DDX39B;SFRP2;YJU2
prerank,nuclear pore organization (GO:0006999),0.6976326590220341,1.3701867154530047,0.152327221438646,0.848806279770908,1.0,12/14,26.68%,NDC1;NUP205;AHCTF1;TPR;NUP133;NUP98;NUP35;NUP93;NUP107;SEH1L;RTN4;NUP153
prerank,histone H2A ubiquitination (GO:0033522),0.6660335348712226,1.3701520473053637,0.16005291005291006,0.8468609797789514,1.0,5/17,9.30%,RNF168;TRIM37;BCOR;KDM2B;CUL4B
prerank,mRNA methylation (GO:0080009),-0.494815083721858,-1.3697250966529908,0.13013698630136986,0.5602959100777848,1.0,8/15,16.74%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;ZC3H13;CMTR1;CBLL1
prerank,regulation of B cell apoptotic process (GO:0002902),0.6864197875316501,1.3695486424514651,0.16005873715124816,0.8470631987736758,1.0,2/12,2.98%,AURKB;FNIP1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.42596962436114083,-1.369152885079471,0.1,0.559687415821399,1.0,3/23,7.30%,PLA2G4A;PLAAT3;PNPLA8
prerank,mesenchymal cell differentiation (GO:0048762),0.5942825152944105,1.3675432707062347,0.1248642779587405,0.8523997979075175,1.0,18/51,13.44%,FAM83D;LOXL3;LOXL2;TGFBR3L;ROCK2;GSK3B;FGFR2;TGFBR3;AKNA;TRIM28;ROCK1;FBXL17;TGFBR1;LIMS1;BMP2;RBPJ;SOX9;HEY2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.558138472599165,-1.3672348711542093,0.11490683229813664,0.5625890481142208,1.0,9/10,43.85%,NAF1;DKC1;RPUSD4;GAR1;NOP10;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,protein localization to Golgi apparatus (GO:0034067),0.6253193490599973,1.3667930004657483,0.16585956416464892,0.8531140074995716,1.0,7/27,12.34%,RAB33B;GBF1;OBSL1;BICD2;VPS13A;GAK;ZDHHC15
prerank,tetrahydrofolate metabolic process (GO:0046653),0.699756607132223,1.36525024756668,0.1619190404797601,0.8565985352926538,1.0,3/10,5.67%,TYMS;MTHFD1L;MTHFR
prerank,negative regulation of cytokine production (GO:0001818),-0.28814913452335955,-1.3646339572703183,0.0,0.5678411847661048,1.0,47/163,19.48%,APOD;LEF1;RPS6KA5;TMSB4X;TRIB2;MAP2K5;RNF135;GAS6;TLR4;PIBF1;TRIM25;KLF4;PDCD4;IKBKE;CD34;TNFRSF21;CYLD;UFD1;PTPN22;SELENOS;SARS1;SRGN;CHID1;IRF3;THBS1;RGCC;CX3CL1;SYT11;TRIM27;RNF125;ABCD2;HDAC7;HDAC9;TBK1;C1QTNF3;IFIH1;PPP1R11;SSC5D;DDIT3;CMKLR1;LGALS9;NLRC5;UBA7;SLC2A10;NCKAP1L;INHBA;ZC3H12A
prerank,positive regulation of chemotaxis (GO:0050921),-0.3745131064495783,-1.3642963881283647,0.043478260869565216,0.5662163367381084,1.0,16/43,22.30%,TMSB4X;STX4;PDGFRB;NTRK3;STX3;FGF2;LGMN;MEGF8;MET;THBS1;PPM1F;VEGFA;SMOC2;NRP1;P2RX4;HSPB1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.6045058221600347,1.3638166064095658,0.1419141914191419,0.8596822074870615,1.0,10/49,11.94%,KIF14;GSK3B;IAPP;PMEPA1;ANKRD27;SMAD6;RIOK3;HMGB1;PYDC1;AIDA
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.516938306927553,-1.3631732277136264,0.1254355400696864,0.5671215876562908,1.0,5/13,18.96%,GOT2;DLST;ADHFE1;GOT1;GPT2
prerank,primary neural tube formation (GO:0014020),0.6285967109615829,1.3629169850881424,0.1430260047281324,0.8609298338277169,1.0,6/30,10.71%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;PLXNB2
prerank,inhibitory synapse assembly (GO:1904862),-0.5318950451449035,-1.3628720641268217,0.14285714285714285,0.5655501181022691,1.0,5/11,11.29%,GABRB3;GABRA2;FGF13;GABRB2;GABRG2
prerank,neural tube closure (GO:0001843),0.6224044191123648,1.3628616774588254,0.14597701149425288,0.8591110174532991,1.0,7/34,10.71%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;KDM2B;PLXNB2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6246892787511102,1.3626836782240725,0.16947115384615385,0.857709675894153,1.0,8/28,11.74%,CDK5RAP2;CKAP5;PSRC1;NUMA1;MAPT;DRG1;AKAP9;RAC1
prerank,tube closure (GO:0060606),0.6263477629067088,1.3623344025106041,0.14688601645123384,0.8569579491539782,1.0,6/31,10.71%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;PLXNB2
prerank,regulation of striated muscle contraction (GO:0006942),-0.4058221403156237,-1.3622440437252037,0.07222222222222222,0.5651161051490109,1.0,9/27,22.05%,SMAD7;SLC8A3;CALM1;RYR2;ATP1A2;SRI;CALM3;NOS1;P2RX4
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4854754672019406,-1.3616689563451068,0.13131313131313133,0.5643391423498283,1.0,6/15,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.42049013280548886,-1.3607032733663957,0.09595959595959595,0.564611423213858,1.0,14/26,18.62%,RIMS1;SLC8A3;SHANK3;TMEM108;NRXN1;RELN;CHRNA7;APP;SHANK1;DLG4;GRIN1;PRKCZ;NLGN1;STX1B
prerank,skeletal muscle tissue development (GO:0007519),-0.39233383925515547,-1.3605426535791916,0.08108108108108109,0.5626830716240038,1.0,7/32,11.42%,MEF2C;CAV1;IGSF8;MYL6;CAV2;SELENON;SIX1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6490613060012947,1.3604787194912789,0.16923076923076924,0.8617937285432348,1.0,4/20,9.14%,ACMSD;GCK;ERFE;CDA
prerank,epithelial to mesenchymal transition (GO:0001837),0.5906858798299702,1.3570089171311694,0.1447661469933185,0.8725530775430912,1.0,16/47,13.44%,FAM83D;LOXL3;LOXL2;TGFBR3L;ROCK2;GSK3B;TGFBR3;AKNA;TRIM28;ROCK1;TGFBR1;LIMS1;BMP2;RBPJ;SOX9;HEY2
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.3430777037883833,-1.3564128049432504,0.03389830508474576,0.5720873883186735,1.0,27/64,32.11%,PLA2G4A;SCP2;ACSL4;GPX4;PNPLA8;ACSL5;ACSL6;PTGS2;ASAH2;EPHX2;ELOVL6;GPX1;ACAD9;HPGD;SLC27A4;ACSL1;ELOVL1;AIG1;FADS1;GSTM2;HACL1;ACSBG1;ALOX12;CPT1A;PNPLA3;PLA2G4C;FAAH
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6697344676579406,1.356158707857253,0.1950207468879668,0.8736356817702032,1.0,3/15,13.21%,ACMSD;KMO;IL4I1
prerank,central nervous system neuron differentiation (GO:0021953),-0.3900144589732261,-1.354602086226203,0.08904109589041095,0.5748306548301294,1.0,13/33,22.17%,SPOCK1;NTRK2;OPHN1;GRID2;PROX1;MDGA2;CTNNB1;SOX4;LRP6;TOX;GBA2;ATP7A;ZC4H2
prerank,regulation of T cell differentiation (GO:0045580),0.61376496453225,1.3544841019329459,0.17330210772833723,0.8776908081061664,1.0,2/33,2.36%,FANCA;CBFB
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.49137851222184553,-1.3535632378741012,0.11764705882352941,0.5754367492929199,1.0,8/14,19.13%,ETNK1;SLC27A1;CHKA;ETNK2;PCYT2;SELENOI;CHKB;LPIN1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.49313396704547086,-1.353241762369089,0.1705685618729097,0.5740166740356901,1.0,5/14,13.12%,IGF1;GRN;TNFRSF1B;CX3CL1;SYT11
prerank,negative regulation of transferase activity (GO:0051348),0.618372208267084,1.352735711696087,0.15726290516206481,0.8820804898701871,1.0,12/28,15.83%,PIF1;TERF1;FBXO5;GSK3B;ERCC4;MAPT;HNRNPU;BAG5;EIF4A2;CDKN1B;SRC;TP53
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6236246387519484,1.3524178068162842,0.17921146953405018,0.8812311685574468,1.0,6/33,6.40%,EZH2;FAM83D;HYAL1;TFDP1;DDRGK1;LSM11
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6802386188967247,1.3518655507037458,0.19127988748241911,0.881175176811037,1.0,3/12,9.14%,TK1;DCK;CDA
prerank,inorganic ion transmembrane transport (GO:0098660),0.6930240280062877,1.3517233266242645,0.1696969696969697,0.8796891745294965,1.0,1/12,0.91%,RHAG
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.40599196292290585,-1.3517202252053322,0.07894736842105263,0.5761009552271873,1.0,9/27,20.57%,RIMS1;SYT1;SYT7;SYT11;SYT12;ARL8B;SYT10;SYT6;SYT2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.47713379145476786,-1.350784822998819,0.16376306620209058,0.5763521438404738,1.0,8/15,34.09%,NR1H3;NR1H2;PPARGC1A;SLC45A3;MID1IP1;MLXIPL;PPARG;NR4A3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5784720584061444,1.350623579719439,0.10559662090813093,0.8816290509116191,1.0,10/72,7.46%,SHCBP1;CEP57;SETX;FGFR4;FGFR2;RBFOX2;HNRNPA1;FRS2;HNRNPH1;POLR2A
prerank,nuclear membrane organization (GO:0071763),0.6520487195587039,1.3504460096234017,0.17006802721088435,0.8802285393810486,1.0,2/19,1.13%,PLK1;NEMP1
prerank,engulfment of apoptotic cell (GO:0043652),0.6571808830868985,1.3490840309850076,0.19080779944289694,0.8832075814846454,1.0,1/15,0.66%,XKR5
prerank,regulation of glucose metabolic process (GO:0010906),-0.39566399211905706,-1.34905411434857,0.08333333333333333,0.5792863514212243,1.0,10/34,14.46%,PRKN;OGT;AKT2;IRS2;GPLD1;PDK1;SELENOS;IRS1;ZNF692;DGKQ
prerank,positive regulation of nervous system development (GO:0051962),-0.35620743632102403,-1.347991463930067,0.07407407407407407,0.5800698501505204,1.0,23/42,27.95%,PTPRD;SYNDIG1;GRID2;EPHB2;NUMBL;IL1RAPL1;NUMB;NRXN1;TGM2;OPRM1;FAIM;LRRC4B;NLGN1;IL1RAP;SNW1;BDNF;DLG5;SRPX2;SERPINF1;TRIM32;GPER1;SOX11;EPHB3
prerank,signal release from synapse (GO:0099643),-0.36235997569981104,-1.347826253044854,0.08620689655172414,0.5781560774728965,1.0,13/43,17.37%,PCLO;SYN3;RIMS1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;DVL1;CPLX1;SNAP25;SYT10
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.6706126165186516,1.3476420292056768,0.1712707182320442,0.8863034373465337,1.0,8/14,19.61%,ATRX;BRCA2;TERF2;TINF2;ATR;ACD;TERF2IP;TERT
prerank,innate immune response in mucosa (GO:0002227),-0.5434557105678258,-1.3475100239014481,0.15966386554621848,0.5768556017263412,1.0,2/10,10.51%,DEFA6;RPL39
prerank,neuron migration (GO:0001764),-0.3478302162110666,-1.3473605128014254,0.034482758620689655,0.5749906425251268,1.0,20/48,19.33%,ASTN2;MEF2C;SPOCK1;DNER;NTRK2;CDKL5;ELP3;ADGRL3;NRCAM;MAP1B;FGF13;SEMA3A;RELN;LRP12;VEGFA;DCX;DDIT4;GPM6A;TUBB2A;NRP1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.44438330949840793,-1.3470996456898465,0.1050228310502283,0.5734337346767239,1.0,13/20,30.22%,CDC73;MEIS2;CDK6;MEIS1;HOXA5;PRMT1;HOXA9;PTK2B;MAFB;HSPA9;ZFP36;HOXB8;CIB1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3884465153063373,-1.3458620300659894,0.08571428571428572,0.5747681315693899,1.0,10/29,16.08%,PTK2;FLT1;TEK;PDGFRB;FGF2;PIK3R4;IRS1;CD81;EPHA8;TNFAIP8L3
prerank,organelle assembly (GO:0070925),0.5578127395727642,1.3456584938653549,0.005,0.8918173268044872,1.0,67/384,10.88%,CENPF;CENPE;NEK2;CENPA;DLGAP5;KIF24;ANLN;HAUS8;PLK4;IFT80;HYLS1;CEP89;BBS9;CCDC61;HAUS4;HAUS6;DZIP1L;SCLT1;VPS37B;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;PATL1;EXOC4;KIF27;PCM1;TUBGCP5;OCRL;MAPT;HAUS7;TXNDC15;LSM3;EIF4ENIF1;MKKS;G3BP1;WDR11;CEP83;ATG7;VPS37A;RILPL1;NUDCD3;RFX2;SSX2IP;STAM;HAUS1;CCDC57;CFAP52;GOLGA8B;ZFYVE1;WDPCP;ATP2A2;NPHP3;LIMD1;RAB1A;RB1CC1;YTHDF2;CENPW;TRAPPC14;TTC39C;VTA1
prerank,regulation of mitochondrial translation (GO:0070129),-0.4233006011358793,-1.3455629894747392,0.07476635514018691,0.5733461955373831,1.0,17/21,44.17%,UQCC2;MTG2;TSFM;RPUSD4;ALKBH1;FASTKD2;RMND1;COA3;MPV17L2;TRMT10C;C1QBP;FASTKD3;MTG1;SHMT2;RPUSD3;NGRN;MALSU1
prerank,regulation of synapse maturation (GO:0090128),0.7018442676633249,1.3452181187801857,0.17076923076923076,0.8913525979209559,1.0,2/10,4.55%,CDC20;ADGRL1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5399258098787039,-1.3436171705993822,0.13003095975232198,0.5742933227944199,1.0,5/10,15.63%,AP2A2;VLDLR;AP2M1;AP2S1;AP2A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5399258098787039,-1.3436171705993822,0.13003095975232198,0.5742933227944199,1.0,5/10,15.63%,AP2A2;VLDLR;AP2M1;AP2S1;AP2A1
prerank,DNA methylation (GO:0006306),0.6274873676920273,1.3424943664875788,0.17919799498746866,0.8993919765443605,1.0,7/23,14.28%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP;METTL4;DNMT3A
prerank,fatty acid elongation (GO:0030497),-0.5023012723547249,-1.3423790326298801,0.12350597609561753,0.5753628164798432,1.0,7/13,27.90%,ELOVL7;HACD3;HACD2;HACD1;ELOVL6;ELOVL1;TECR
prerank,chromatin organization (GO:0006325),0.5523175696094162,1.3421306761744758,0.0951417004048583,0.8986351045583815,1.0,36/132,15.73%,PHF19;EZH2;ATRX;DDX11;HMGB2;LOXL2;SMARCC1;RB1;BAZ1B;CHD1L;SMARCAD1;SETDB2;TCF7L1;NUDT5;HMGN2;HP1BP3;RBBP4;ARID1A;NUCKS1;SETD2;PHF1;SMARCA4;HDAC8;HDAC1;SOX9;HDAC2;MCM3AP;TADA2A;ACTL6B;KDM5C;RUVBL2;BAZ1A;SOX1;INO80;DR1;CHD1
prerank,V(D)J recombination (GO:0033151),0.6850385555521358,1.3411210187821438,0.1708029197080292,0.9003179938648982,1.0,4/11,15.43%,HMGB2;PRKDC;HMGB1;DCAF1
prerank,lipoprotein catabolic process (GO:0042159),-0.5388878259439874,-1.3410670183066544,0.1476923076923077,0.5768233892651105,1.0,8/11,27.00%,APOE;LYPLA1;ABHD17C;CTSD;PPT1;LYPLAL1;LYPLA2;ABHD17B
prerank,histone ubiquitination (GO:0016574),0.6387204531146431,1.3404900138261826,0.19041450777202074,0.9006101058646415,1.0,4/21,9.10%,UHRF1;UBE2N;RNF40;LEO1
prerank,genitalia development (GO:0048806),-0.5194565741758289,-1.3404617176894196,0.12138728323699421,0.5763495076117146,1.0,6/12,27.80%,DNAJC19;TBX3;PTPN11;STRA6;CHD7;FOXF2
prerank,defense response to protozoan (GO:0042832),-0.5182905202294582,-1.340325546150012,0.14242424242424243,0.5745119329191531,1.0,10/12,43.12%,LYST;GBP4;GBP6;CD40;BATF;GBP7;MYD88;SLC11A1;GBP2;BATF2
prerank,mRNA modification (GO:0016556),-0.4358499136088748,-1.3402155893743557,0.15137614678899083,0.5726885479925575,1.0,10/22,16.74%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;ZC3H13;TRUB1;CMTR1;DKC1;CBLL1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6381614699551708,1.3396323856183843,0.17938931297709923,0.9017341833462729,1.0,9/21,13.64%,PAXIP1;SETX;MED14;SRF;MED30;BCLAF1;MED24;TWIST1;MED1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6403864102445695,1.3383202091276318,0.19270833333333334,0.9044325416084474,1.0,10/21,15.94%,PNLDC1;CNOT1;CNOT6L;SAMD4A;TUT7;CNOT6;PAN3;TUT4;CNOT7;CNOT4
prerank,UV-damage excision repair (GO:0070914),0.6717202614085344,1.3379348835359137,0.19287833827893175,0.9039117331141315,1.0,5/12,15.20%,POLA1;POLD3;CUL4B;XPA;INO80
prerank,cytoskeleton organization (GO:0007010),0.5571856951830364,1.3377056845375401,0.09191919191919191,0.9027964818932669,1.0,29/114,13.66%,DIAPH3;SYNE3;MAST2;PHIP;ARHGAP10;RHOA;OBSL1;PACSIN2;AJUBA;DIAPH1;MICAL3;CNN2;FGD4;ANK1;PRPF40A;PDZD8;FGD1;WDPCP;SH3D19;LIMD1;STRIP2;EPB41L3;FGD6;RND2;RAC1;DMTN;DES;LARP4;PRKCI
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.48101700991287455,-1.3376180763755676,0.1392857142857143,0.577414347515402,1.0,7/15,24.36%,VEGFC;NTRK3;SCG2;VEGFA;VEGFB;VEGFD;CXCL12
prerank,negative regulation of translational initiation (GO:0045947),0.6691113436170293,1.3375287001047669,0.19094766619519093,0.9014410076309706,1.0,6/13,17.58%,AGO2;TPR;FMR1;LARP1;RBM4;PAIP2B
prerank,cellular response to amyloid-beta (GO:1904646),-0.3746697347415684,-1.3372476136513074,0.10884353741496598,0.5762206665518191,1.0,13/35,14.10%,CACNA2D1;PSEN1;GRIN2A;IGF1;TLR4;LRP1;CASP4;VCAM1;LGMN;ATP1A3;APP;GRM5;GRIN1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.642934037199592,1.3372057214607806,0.18242343541944075,0.9006102464007005,1.0,1/20,0.19%,BRCA1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6513958728710452,1.3370685547803824,0.19525065963060687,0.8990930884533984,1.0,8/18,22.48%,AQP1;NR3C1;HNRNPU;ANXA1;KLF9;PCK2;UBE2L3;ZFP36L1
prerank,positive regulation of cartilage development (GO:0061036),0.6534789503102856,1.3368892788459754,0.1904127829560586,0.8977840660740468,1.0,6/17,12.56%,BMP1;LOXL2;SOX6;TAPT1;BMP2;SOX9
prerank,endoderm development (GO:0007492),-0.49616501675281,-1.3367665506067081,0.1392857142857143,0.5752702699549754,1.0,3/13,15.07%,KIF16B;DUSP1;SOX17
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.5579192528047987,1.3362251745578786,0.005,0.8982605173191313,1.0,101/417,15.03%,DEPDC1;CENPF;BRCA1;EZH2;BIRC5;LOXL3;GLI3;HMGB2;E2F1;CBX5;RBM15;FOXE1;ATOH8;BTAF1;ILF3;KMT5A;SFMBT1;TIMELESS;LOXL2;RB1;SP3;TWIST2;CTCF;ZEB1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;SETDB2;MBD1;KHDRBS1;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;IKZF1;GZF1;SCML2;YAF2;TCF7L2;HOXA7;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;SFRP2;NIPBL;POU2F1;ZHX2;UIMC1;ATF7IP;SAP18;TRIM28;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;LIMD1;NONO;ARID4A;EPC1;MTA3;NR3C1;SFPQ;RUNX1T1;LIMS1;RBM15B;DKK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;ZHX3;ATXN1;FBXW11;RBPJ;SOX9;SMAD4;HDAC2;ATF5;TWIST1;HEY2;USP47;BTRC;BCL7A;EIF4A2;FOXK2;CDKN1B;KDM5C;PCGF6;FOXM1;QARS1;PER1;YEATS2;RBAK
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.666206419998354,1.335834831567955,0.17723342939481268,0.897722998978428,1.0,3/13,7.80%,GLI3;CBFB;ZBTB7B
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6383203412135829,1.335522746252871,0.1926729986431479,0.8968803932921421,1.0,6/19,10.90%,PLK1;CEP97;TPR;CCSAP;HNRNPU;DRG1
prerank,lipoxygenase pathway (GO:0019372),0.6662786766934509,1.3354296445685416,0.18559556786703602,0.8952427784719934,1.0,1/14,0.82%,PON1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.418471554475137,-1.3353944469780832,0.13023255813953488,0.5768996817645434,1.0,12/24,26.82%,CAMK2D;CALM1;FKBP1A;AKAP6;SELENON;SRI;PDE4D;CALM3;NOS1;GSTM2;JPH2;JPH4
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.2787240292589359,-1.33515528739643,0.0,0.5753600064354535,1.0,77/168,21.25%,RPL13;AGO1;RPS8;NBDY;RPS23;RPS29;RPL37A;RPS21;RPL38;PARN;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;CSDE1;RPS14;RPSA;RPL10;ATM;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;DDX5;DCP1B;RPS4X;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RPL19;RPL28;EIF4A3;RPL31;RBM8A;SMG1;MTPAP;RPL13A;RPL36A;DCPS;TENT4B;RPLP2;RPL29;TNKS1BP1;CNOT11;ZC3H12A;RPLP0;DCP1A;RPL10A;RPS10;NCBP1;RPL35;RPS26
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.37593775924044115,-1.3350500146740993,0.08823529411764706,0.5734267890379889,1.0,21/38,25.20%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;NDUFA10;NDUFS6;NDUFA1
prerank,cellular protein catabolic process (GO:0044257),-0.3337889286698684,-1.3342844537084233,0.056179775280898875,0.5733981631807691,1.0,23/59,21.47%,PRKN;ADAMTS12;UBE2G1;CTSC;CLPX;MALT1;AP2A2;CTSB;LGMN;CTSZ;BNIP3L;BNIP3;VLDLR;AP2M1;RAB12;CTSL;AP2S1;AP2A1;UBE2G2;CTSF;FAP;YME1L1;CTSS
prerank,positive regulation of macrophage activation (GO:0043032),-0.45573299472854634,-1.3341729334452372,0.10526315789473684,0.5715123064344094,1.0,5/17,19.30%,TLR4;LBP;HSPD1;THBS1;KARS1
prerank,axonal transport (GO:0098930),0.5972380667900719,1.3336803611375199,0.16917728852838934,0.8998140566508388,1.0,1/36,0.11%,KIF4A
prerank,central nervous system myelination (GO:0022010),-0.5191444950522018,-1.3334973011043405,0.14492753623188406,0.5711730799685164,1.0,4/11,13.78%,B4GALT5;B4GALT6;PLP1;TENM4
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.4994263908195637,-1.3333474240489396,0.15172413793103448,0.5694425619940185,1.0,8/13,18.75%,ERLEC1;OS9;EDEM2;EDEM1;YOD1;BCAP31;SVIP;UBE2G2
prerank,relaxation of cardiac muscle (GO:0055119),-0.5007445188028898,-1.3320522330235958,0.15960912052117263,0.5707104631074983,1.0,8/13,25.08%,CAMK2D;ATP1B1;ATP1A1;GSN;ATP1A2;PIK3CA;P2RX4;GSTM2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4959707245607662,-1.3313270175604581,0.15658362989323843,0.5704219720673122,1.0,8/14,29.12%,ANO6;PDCD4;PLCG1;THBS1;RGCC;ECSCR;GPER1;CD40
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.6107377642655522,1.3309326658608458,0.17341772151898735,0.9080794390458821,1.0,7/26,12.18%,CCNB1;EIF4E;CDC25B;CCDC57;CUL3;TAL1;PRKCA
prerank,"wound healing, spreading of cells (GO:0044319)",0.6198341562921624,1.3307257876700345,0.1927860696517413,0.9068483464256524,1.0,12/24,15.78%,RHOA;PDPN;CCN1;ARHGAP24;TMEFF2;ARHGAP35;MRTFA;ADAM17;ITGA5;CD44;RHOC;LCP1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6023520288555713,1.3300932009598163,0.18138424821002386,0.9071629406301842,1.0,13/30,18.66%,PIF1;TERF1;STN1;ERCC4;HNRNPA1;HNRNPU;TERF2;SRC;TP53;TINF2;ACD;EXOSC10;NIBAN2
prerank,anterograde axonal transport (GO:0008089),0.6023501249663763,1.329917837432468,0.17848970251716248,0.9058673381978077,1.0,2/37,3.22%,KIF4A;TRAK1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.4805168899424565,-1.329793916704338,0.14432989690721648,0.5723661699531192,1.0,6/15,13.88%,AKT2;PPM1K;IRS2;GPLD1;IRS1;LDLRAP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5795175444456335,1.3297855380093044,0.15102481121898598,0.9043981626826985,1.0,26/59,18.71%,CDK1;CIT;DYRK1A;ROCK2;GSK3B;NLK;PRKDC;DYRK3;WNK1;CHEK1;CDC42BPA;LRRK2;ROCK1;MARK2;CSNK2A2;CDC42BPG;TGFBR1;PRKCA;PDPK1;PRKD1;PRKD2;STK39;HIPK3;WNK3;OXSR1;HIPK1
prerank,sodium ion homeostasis (GO:0055078),-0.4288624719919972,-1.3284564705037554,0.11304347826086956,0.5740401744042215,1.0,6/21,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,acyl-CoA metabolic process (GO:0006637),-0.3804336803190986,-1.3281459676421932,0.10144927536231885,0.5727599448162466,1.0,14/35,27.84%,ACOT11;SUCLG2;ACBD6;DLST;ACACB;HMGCS2;ACSL6;DBI;ACSF2;ACOT7;ACOT13;MCEE;ACOT6;HMGCS1
prerank,B cell homeostasis (GO:0001782),-0.5604018073929705,-1.3281370319829882,0.14626865671641792,0.5707019705288979,1.0,3/10,6.74%,DOCK10;MEF2C;LYN
prerank,regulation of axon regeneration (GO:0048679),0.6602016577228653,1.3268816175031413,0.18604651162790697,0.9129793766290936,1.0,5/12,11.38%,RTN4R;STK24;EPHA4;CNTF;PTPRS
prerank,neurotransmitter secretion (GO:0007269),-0.35870792573282195,-1.3263224327050511,0.09615384615384616,0.5736605239485837,1.0,13/44,17.37%,PCLO;SYN3;RIMS1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;DVL1;CPLX1;SNAP25;SYT10
prerank,sulfate transport (GO:0008272),0.6744894871095575,1.3262598261817151,0.19751381215469613,0.9133815510646729,1.0,1/14,0.73%,RACGAP1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.592508653598819,1.3259339252463864,0.18671248568155785,0.9126480363318108,1.0,5/38,8.91%,BRCA1;FADD;GSK3B;SERPINE1;TNFRSF10B
prerank,signal transduction by p53 class mediator (GO:0072331),0.6065209572047761,1.3257871445320313,0.20259128386336867,0.9112195574634836,1.0,7/30,10.89%,E2F7;ATRX;PAXIP1;MDM4;HINT1;BOK;NDRG1
prerank,natural killer cell mediated immunity (GO:0002228),0.6473637026494502,1.3256419135780586,0.19568151147098514,0.9097599595649878,1.0,2/15,5.54%,ULBP1;RAET1E
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5415116401362627,-1.3255531075332794,0.15759312320916904,0.5735152927646153,1.0,6/10,15.05%,GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,positive regulation of transporter activity (GO:0032411),0.6684327192759842,1.3250436663043619,0.20457796852646637,0.909974540682397,1.0,5/13,17.53%,PON1;PDZK1;KMT2A;STK39;WNK3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4911052060943566,-1.324769046264031,0.14473684210526316,0.5735243666565072,1.0,5/13,25.13%,TLR4;NAMPT;SELENOS;JAK2;EDN1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.5272540878000407,-1.3247495531274618,0.175,0.5694581971437616,1.0,6/11,21.47%,CCT5;TCP1;CCT7;CCT2;DKC1;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.5272540878000407,-1.3247495531274618,0.175,0.5694581971437616,1.0,6/11,21.47%,CCT5;TCP1;CCT7;CCT2;DKC1;MEPCE
prerank,tRNA wobble base modification (GO:0002097),-0.5027657715758396,-1.3247075783650502,0.14556962025316456,0.5675529547303566,1.0,7/14,25.84%,ELP3;TRMT9B;MTO1;DPH3;ELP4;GTPBP3;ALKBH1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4731528483131838,-1.3244610589758896,0.11956521739130435,0.5661990920555129,1.0,5/15,9.37%,ABHD12;ABHD16A;GOT2;GGT5;PRODH
prerank,iron ion transport (GO:0006826),-0.34260926719441753,-1.3242252859977481,0.07017543859649122,0.5648909299073219,1.0,11/47,14.97%,ATP6V0A1;FTH1;ATP6V0D1;ATP6V1E1;SCARA5;ATP6V0B;ATP6V0A4;IREB2;ATP6V0C;ATP6V1H;MCOLN1
prerank,positive regulation of protein processing (GO:0010954),-0.45379845439947764,-1.324055170127856,0.13821138211382114,0.5633999515546707,1.0,6/19,18.88%,CCBE1;GSN;PLGRKT;ENO1;NKD2;CLEC3B
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.34036096626306755,-1.323935672648754,0.06756756756756757,0.5617699402475778,1.0,20/56,22.47%,HSP90B1;TAB2;TLR4;CTSB;SFTPA2;SFTPA1;TAB3;LGMN;NOD1;LBP;IRAK4;CTSL;CNPY3;UNC93B1;UBB;TIFA;CTSS;S100A1;RPS27A;UBC
prerank,positive regulation of telomerase activity (GO:0051973),0.5967003374349258,1.3237699392488234,0.16745283018867924,0.9126892300345155,1.0,2/33,1.02%,NEK2;AURKB
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.6358119504308911,1.323655908208544,0.2054263565891473,0.9111142813866081,1.0,9/20,15.49%,MOV10;AGO2;CNOT1;AJUBA;NRDE2;CNOT6;LIMD1;CNOT7;TNRC6C
prerank,cardiolipin metabolic process (GO:0032048),-0.48455009034354823,-1.3229792850606428,0.15359477124183007,0.5623442138208701,1.0,4/13,7.30%,PLA2G4A;HADHB;SLC27A1;PNPLA8
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3365019733900362,-1.3226364165071796,0.06818181818181818,0.5614061910521625,1.0,34/54,36.41%,DCUN1D3;SMAD7;OGT;PRMT3;CAV1;PER2;UFL1;SQSTM1;PINX1;DNAJA1;CTNNB1;SPRY2;SOX4;SH3RF2;PIAS3;UBXN1;PRKCG;PARK7;MINAR1;RPS3;TRIM21;RPL11;U2AF2;COPS9;ADGRB1;TNFAIP3;SPOPL;VPS28;AKT1;BAG2;HSPA1A;SIRT7;ARRB2;CHP1
prerank,positive regulation of B cell activation (GO:0050871),0.5808982358925502,1.3222824502134072,0.1568627450980392,0.9140804405464982,1.0,3/50,3.93%,TNFSF13B;PAXIP1;MMP14
prerank,positive regulation of intracellular protein transport (GO:0090316),0.5493620880358855,1.3219804149272671,0.07489878542510121,0.9132317826396563,1.0,27/144,10.35%,KIF20B;ECT2;GTSE1;E2F1;SAE1;MIEF2;GSK3B;XPO4;TFDP1;ANP32B;PCM1;PRNP;PDZK1;MYO1C;LEPROT;TCF7L2;TPR;FBXW7;RNF31;RAB29;SH3GLB1;UBR5;TRIM28;HTRA2;EMD;CSNK2A2;MIEF1
prerank,myelination (GO:0042552),-0.345591227256961,-1.321722559224648,0.09322033898305085,0.5621138432465393,1.0,21/46,24.19%,SLC8A3;MAL;B4GALT5;TNFRSF21;B4GALT6;PLP1;ACER3;NF1;ABCD2;ARHGEF10;SCN8A;DEGS1;CMTM8;GAL3ST1;ADGRG6;LGI4;PLLP;EIF2B2;PMP22;MARVELD1;GPC1
prerank,lipid transport (GO:0006869),-0.29446336895406056,-1.320470799148004,0.03225806451612903,0.5634593790950188,1.0,35/97,25.83%,CERT1;PLTP;ATP8A1;APOE;SLCO1C1;SLCO2B1;GOT2;SCP2;PEX3;ABCA5;SLC27A1;ABCC4;ATP8B1;CHKA;SLCO2A1;LBP;MTTP;SPNS2;GLTP;ABCD2;TNFAIP8L3;STARD5;PRELID3B;OSBP;SLC27A4;ACSL1;OSBPL2;PLEKHA8;ABCA2;MFSD2A;NPC2;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.45753920599531717,-1.320143091549788,0.15734265734265734,0.5623274055289704,1.0,6/15,16.43%,NAF1;CCT5;TCP1;CCT7;CCT2;DKC1
prerank,selective autophagy (GO:0061912),-0.32216088943855953,-1.3197464048281158,0.045454545454545456,0.5615721740450853,1.0,23/56,22.55%,PRKN;DYNC1LI2;UFL1;BECN1;SQSTM1;UBA5;DYNC1I2;ULK1;DYNC1LI1;ATM;PEX5;DYNLL2;KLHL3;WDFY3;USP30;AUP1;ATG2B;TEX264;UBB;PARK7;RPS27A;UBC;WDR81
prerank,fibrinolysis (GO:0042730),0.6572107315753313,1.3196842033686225,0.19859154929577466,0.9197144451262096,1.0,4/13,18.51%,PLAU;SERPINE1;PLAUR;PLAT
prerank,electron transport chain (GO:0022900),-0.47802451515726635,-1.3194814552570162,0.15547703180212014,0.5603551964894877,1.0,9/15,30.25%,PDIA5;NDUFA5;PPARGC1A;ETFRF1;ETFDH;ETFB;NDOR1;CYB561;UQCRFS1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5695608080466245,1.3188084107004585,0.16042780748663102,0.9209357540889602,1.0,9/60,6.59%,NEK2;AURKB;DSCC1;RFC4;FGFR4;RFC2;HNRNPA1;RFC3;GRHL2
prerank,regulation of phosphate metabolic process (GO:0019220),0.6437579698546713,1.3179270133070344,0.1977715877437326,0.922096163069736,1.0,2/16,2.72%,BARD1;MCM7
prerank,cellular response to alkaloid (GO:0071312),0.6442060401408154,1.3178750225266145,0.19618528610354224,0.9203456539632554,1.0,5/17,9.40%,RAD51;CASP7;BLM;SPIDR;SLC8A1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5594914927183323,1.3172093235423796,0.16281512605042017,0.9208204018591698,1.0,23/70,17.67%,KIF14;RB1;RHOA;ATRNL1;PARVA;ITGB7;LAMB1;GRHL2;EFNA1;RILPL1;TMEFF2;SRGAP2;YTHDF2;RAC1;ITGA8;ITGAV;NTN4;UNK;TBCD;METTL3;FERMT3;ANTXR1;ABI2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5157994835296619,-1.3160496054831787,0.13538461538461538,0.567819026417997,1.0,6/11,17.83%,PARP8;PARP12;TIPARP;PARP6;PARP16;PARP10
prerank,cellular protein-containing complex assembly (GO:0034622),0.5502626270550455,1.3154538477588817,0.07035175879396985,0.9255050230114127,1.0,20/159,9.55%,CENPF;CENPE;CENPA;DLGAP5;ANLN;NDC1;NUP205;DNAAF3;DHX9;MAPT;EIF4H;MKKS;AHCTF1;TPR;TCF4;NCK1;DNAI4;ANGPT1;LONP1;PICALM
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5420864298012044,-1.3153212263873997,0.1710914454277286,0.567916542933911,1.0,5/10,13.64%,SHANK3;NETO1;RAB5A;APP;DLG4
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.339267533041365,-1.3145753392795367,0.09411764705882353,0.5679151870763937,1.0,15/57,18.26%,GRM7;CHRM2;GABBR1;GNAI1;PSAP;GNAL;GPR37;OPRM1;HTR4;ADCY3;ADCY8;ADCY4;CHRM3;ADRA2A;PDE2A
prerank,regulation of microtubule nucleation (GO:0010968),0.674009878363023,1.3143910279533955,0.18694362017804153,0.927327169349072,1.0,2/10,2.26%,CKAP5;RANGRF
prerank,regulation of macrophage activation (GO:0043030),-0.3934148186163705,-1.3137767037169101,0.07784431137724551,0.5680174774445329,1.0,18/30,38.83%,TLR4;LBP;HSPD1;NR1H3;MYO18A;THBS1;KARS1;ZC3H12A;SHPK;SPHK1;MFHAS1;LRFN5;CD74;MIF;PJA2;TNIP2;FCGR2B;CEBPA
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6068948228524549,1.3137108852284836,0.20876288659793815,0.9279137902128739,1.0,3/22,3.50%,MASTL;ROCK2;GSK3B
prerank,positive regulation of viral life cycle (GO:1903902),0.6067038332867775,1.3130659205282125,0.2076923076923077,0.9283052171991699,1.0,3/22,6.93%,KPNA2;VPS37B;FMR1
prerank,nucleus organization (GO:0006997),0.576730384533702,1.313038470669193,0.17206703910614526,0.9264983331330306,1.0,7/47,7.63%,CEP55;NDC1;NUP155;NUP205;NUMA1;TPR;LEMD3
prerank,negative regulation of cilium assembly (GO:1902018),0.6656602876925655,1.3128588843698816,0.2034383954154728,0.9252336702646237,1.0,7/12,18.56%,CEP97;EVI5L;YAP1;TBC1D7;MAP4;ODF2L;LIMK2
prerank,regulation of nervous system process (GO:0031644),-0.452988466201551,-1.3113654575620426,0.1634980988593156,0.5725489916098918,1.0,8/18,11.05%,DLGAP1;DLGAP4;SLC8A3;TMEM108;NOS3;HTR2C;CHRNA7;APP
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4161358387590798,-1.310432926739128,0.1050228310502283,0.5728923995700723,1.0,6/23,19.48%,CARD16;IGF1;GAS6;CX3CL1;GIT1;ZC3H12A
prerank,regulation of calcium ion transport (GO:0051924),-0.3527931457439106,-1.3102609472181992,0.08450704225352113,0.5713981600805897,1.0,18/54,22.05%,CACNA2D1;EPB41;SARAF;HOMER1;MYLK;CAMK2G;INPP5K;BCL2;CTNNB1;CACNB2;CRACR2A;SRI;ADRA2A;PLPP4;PACSIN3;NOS1;CD84;P2RX4
prerank,peptidyl-threonine modification (GO:0018210),0.5658321082717297,1.309799108633971,0.1695095948827292,0.9344385937790914,1.0,24/66,16.33%,CDK1;CIT;DYRK1A;ROCK2;GSK3B;NLK;GALNT1;PRKDC;DYRK3;WNK1;CHEK1;CDC42BPA;LRRK2;ROCK1;MARK2;CSNK2A2;CDC42BPG;TGFBR1;PRKCA;PDPK1;PRKD1;PRKD2;STK39;HIPK3
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4266629697424769,-1.309761899626141,0.1449814126394052,0.5708739452455545,1.0,7/18,16.43%,PARN;NAF1;CCT5;TCP1;CCT7;CCT2;DKC1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.41353123374219786,-1.3095755157968847,0.10843373493975904,0.5694133260057397,1.0,6/22,8.62%,CYRIB;STX7;MALT1;FBXO38;B2M;HSPD1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6028531359544905,1.3095449451267005,0.1961023142509135,0.9334888159942963,1.0,4/28,8.17%,ECT2;TPR;UBR5;TRIM28
prerank,negative regulation of hemostasis (GO:1900047),-0.5051588992226872,-1.3091879068176415,0.13782051282051283,0.568515415790649,1.0,4/12,6.10%,APOE;VTN;THBD;CD34
prerank,L-amino acid transport (GO:0015807),-0.3873597585373206,-1.3091069631852577,0.05952380952380952,0.5668922343117959,1.0,6/28,5.85%,SLC1A2;SLC7A2;SLC25A13;SLC25A12;SLC3A2;SLC7A5
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6642767130634675,1.3090351640673616,0.20088626292466766,0.9333316125746276,1.0,1/11,0.73%,BARD1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5330028527447495,-1.3087418986999397,0.13836477987421383,0.5660253427610824,1.0,2/10,8.29%,PRKN;OXA1L
prerank,regulation of anoikis (GO:2000209),-0.44673226613931727,-1.3087110128309933,0.1459227467811159,0.5642701008867158,1.0,9/19,21.74%,PTK2;CAV1;SIK1;TLE1;BCL2;PIK3CA;TLE5;MYBBP1A;PTRH2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5356038286949356,-1.3085179130689921,0.15476190476190477,0.562977457226746,1.0,3/10,6.74%,STAT3;STAT6;LYN
prerank,sprouting angiogenesis (GO:0002040),0.5702202674588949,1.3083174135059308,0.16666666666666666,0.9339978092183642,1.0,12/51,14.42%,E2F7;E2F8;LOXL2;PARVA;SRF;ADGRA2;ROBO1;ANGPT1;NR4A1;RSPO3;EFNB2;MIA3
prerank,response to estrogen (GO:0043627),0.5879484159244656,1.3077742594609427,0.189718482252142,0.9340573512129956,1.0,1/31,0.19%,BRCA1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5682770092785916,1.3073089335504358,0.17016574585635358,0.9338305382071034,1.0,10/51,11.05%,KIF20B;MAP4K4;SNX1;NRK;ANKRD27;LRRK2;DNM2;SRGAP2;EPB41L3;PLXNB1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.371549506489783,-1.3071444340038048,0.09448818897637795,0.5646964965428236,1.0,11/39,12.68%,KRIT1;TEK;ANO6;GAS6;PDCD4;CDH5;PLCG1;RAMP2;THBS1;SCG2;RGCC
prerank,thyroid hormone generation (GO:0006590),0.6660880709238935,1.3063623806267837,0.1926040061633282,0.9353482360386975,1.0,2/10,8.46%,FOXE1;CPQ
prerank,aggrephagy (GO:0035973),-0.3875254257135885,-1.3058210071515397,0.10734463276836158,0.5662937074251057,1.0,12/27,22.55%,PRKN;DYNC1LI2;SQSTM1;DYNC1I2;DYNC1LI1;DYNLL2;WDFY3;UBB;PARK7;RPS27A;UBC;WDR81
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5272453956048335,-1.3056730178403197,0.166189111747851,0.564891241731206,1.0,5/10,22.19%,SMARCD3;CTNNB1;CX3CL1;VEGFA;DRD2
prerank,polyamine metabolic process (GO:0006595),-0.47745592670332637,-1.3056698431579086,0.15625,0.5630745095125532,1.0,8/13,38.18%,SAT1;SMS;OAZ2;DHPS;PAOX;HDAC10;ODC1;SRM
prerank,membrane depolarization (GO:0051899),-0.3880552796398437,-1.3055096790595706,0.11920529801324503,0.5616968939255642,1.0,20/32,37.86%,CAV1;SCN1A;CACNA1B;SCN9A;CACNG4;ABL1;CACNG2;SCN3A;SCN8A;SCN1B;P2RX4;P2RX7;CACNA1H;CACNB3;CACNA1I;YWHAH;SCN3B;CHRNA4;CACNA1A;KCNH2
prerank,negative regulation of platelet activation (GO:0010544),-0.45348458076566117,-1.3051854997378842,0.14007782101167315,0.5607596350473346,1.0,4/16,5.31%,PRKG1;APOE;NOS3;THBD
prerank,retinal metabolic process (GO:0042574),0.6612518506476887,1.3048217586547879,0.19574468085106383,0.9389673746862695,1.0,3/12,4.67%,ALDH8A1;ABCA4;RDH11
prerank,organelle transport along microtubule (GO:0072384),0.5873139094851613,1.3031227001881414,0.2156398104265403,0.9430715836846519,1.0,9/31,12.13%,ARHGAP21;TRAK1;MAPT;RHOT1;BICD2;NDE1;UXT;RAB1A;FBXW11
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.5442487846989906,1.3010295175816151,0.007,0.9486251721671375,1.0,123/497,15.61%,DEPDC1;CENPF;BRCA1;EZH2;BIRC5;LOXL3;GLI3;HMGB2;E2F1;CBX5;TYMS;RBM15;FOXE1;ATOH8;TERF1;BTAF1;PDS5A;ILF3;SYNCRIP;KMT5A;SFMBT1;TIMELESS;LOXL2;RB1;SP3;TWIST2;CDC6;CTCF;GSK3B;ZEB1;CNOT1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;SETDB2;WAPL;MBD1;KHDRBS1;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;IKZF1;EIF4ENIF1;GZF1;SCML2;YAF2;TCF7L2;SAMD4A;HOXA7;CAPRIN1;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;FMR1;SFRP2;NIPBL;POU2F1;ZHX2;UIMC1;ATF7IP;SAP18;LARP1;TRIM28;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;LIMD1;NONO;ARID4A;EPC1;MTA3;NR3C1;SFPQ;RUNX1T1;LIMS1;MRPL13;RBM15B;DKK3;EIF2AK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;ENPP1;ZHX3;ATXN1;FBXW11;RBPJ;SOX9;SMAD4;HDAC2;ATF5;TWIST1;HEY2;RBM4;DHFR;USP47;BTRC;BCL7A;FOXK2;CDKN1B;KDM5C;PCGF6;FOXM1;EPRS1;QARS1;PER1;YEATS2;RBAK;CNOT7;KAT6A;FXR1;PASK
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5648765870747265,1.3003764998082374,0.1838074398249453,0.9491856928562379,1.0,5/55,5.62%,HMMR;HPSE;SPAM1;HYAL1;GPC6
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.49654537984888536,-1.2999802604656017,0.1415929203539823,0.5732990496106578,1.0,6/12,19.76%,CAMK2D;CALM1;CAV1;SRI;PDE4D;CALM3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5464675273866562,1.2999091931590536,0.15098241985522234,0.9489679176641955,1.0,22/88,16.22%,KIF14;CCNF;PSMC2;PSMD5;FBXL7;FBXW7;CUL5;FBXL8;PSMB1;PSMD14;CUL4B;PSMD1;SKP2;FBXL17;PSMB9;FBXW11;BTRC;FBXO27;PSMC6;FBXO17;FBXL14;AMN1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6492390884570841,1.299154498523974,0.1971223021582734,0.9497391411844877,1.0,6/13,16.11%,MOV10;ZC3HAV1;CNOT1;RC3H1;CNOT7;PNPT1
prerank,epithelial cell morphogenesis (GO:0003382),0.6372482212738309,1.2988125733437625,0.2288021534320323,0.9490630414163177,1.0,5/17,13.50%,COL22A1;COL18A1;GRHL2;RILPL1;COL15A1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3994861101495021,-1.2984308903708988,0.12446351931330472,0.575424520391392,1.0,11/24,19.33%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;MEGF8;SEMA3B;VEGFA;SEMA3C;SEMA5B;NRP1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.6541523285516637,1.2982334680735295,0.20977011494252873,0.9492674175242876,1.0,4/12,7.95%,RFWD3;PRKDC;RPA2;CDK2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4423348621046286,-1.2977488169370612,0.14122137404580154,0.5752533368610938,1.0,5/17,10.12%,TGFB2;TAOK2;LYN;MID1;STK25
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.43189413988710523,-1.29687594718653,0.1645021645021645,0.5755524459276636,1.0,13/20,31.66%,APOE;SREBF2;ARV1;FMO5;LDLRAP1;DGKQ;EPHX2;ABCA2;RAN;MBTPS1;ACADVL;MBTPS2;NR1H4
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.42355832281081673,-1.2927884188653846,0.13095238095238096,0.5841827707752463,1.0,15/20,37.45%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B;SEMA6C;SEMA3G;SEMA4C;SEMA4A;SEMA3E;SEMA4G;SEMA3F
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.4724312420173945,-1.2920343324547272,0.174496644295302,0.5842697028408471,1.0,5/14,13.66%,AKT2;IRS2;LONP2;IRS1;ABCD2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4455363206558923,-1.2919894595289245,0.15862068965517243,0.5825343011738829,1.0,2/17,2.92%,PLA2G4A;PLAAT3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.47811835878450937,-1.2919875152596465,0.17716535433070865,0.5807138814827146,1.0,8/13,31.53%,ELOVL7;HACD3;HACD2;HACD1;ELOVL6;ELOVL1;TECR;TECRL
prerank,long-term memory (GO:0007616),-0.432915092395061,-1.2916055117362746,0.14814814814814814,0.5799878812462106,1.0,7/19,12.24%,CPEB3;APOE;RASGRF1;SGK1;CAMK4;NFATC4;SHANK1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6096394838282454,1.2913254948555095,0.20843989769820973,0.9726636866076995,1.0,1/21,0.46%,CDK1
prerank,response to progesterone (GO:0032570),-0.43573696304534093,-1.2908741296219897,0.13846153846153847,0.5799703213068178,1.0,10/18,25.79%,CAV1;TGFB2;ABHD2;NR1H3;CATSPER2;THBS1;TGFB3;WBP2;UBE3A;CATSPER3
prerank,regulation of lipid kinase activity (GO:0043550),0.6682480469980674,1.2906565883529044,0.21037037037037037,0.9731777924036529,1.0,2/11,2.56%,RBL1;RB1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.5916384217738585,1.2902005292665368,0.21256038647342995,0.9727396619863212,1.0,10/33,11.27%,TTF2;SETX;CSTF3;FIP1L1;SLBP;LSM11;WDR33;PCF11;SCAF8;CPSF4
prerank,negative regulation of coagulation (GO:0050819),-0.4676470414615581,-1.290171511102247,0.14814814814814814,0.5800583966580001,1.0,4/14,6.10%,APOE;VTN;THBD;CD34
prerank,negative regulation of cell aging (GO:0090344),0.6347423458731742,1.2895356078773574,0.2024793388429752,0.9732070437596971,1.0,7/16,15.02%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;FOXM1;SLC30A10
prerank,regulation of establishment of protein localization (GO:0070201),0.6372180384901949,1.2894858268012857,0.21074964639321075,0.9714456095626244,1.0,4/13,12.15%,CEP295;SPIDR;CEP120;SCFD1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.41193335182091845,-1.2890461477192914,0.14418604651162792,0.581271577547303,1.0,14/22,32.10%,RPL23;RPS15;RPS7;RPS20;RPL37;ATM;DDX5;UBB;CDK5RAP3;EEF1E1;HEXIM1;CHD5;HIC1;SPRED3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.4695494087914213,-1.288296554073588,0.17028985507246377,0.5813918140390976,1.0,8/15,22.30%,TMSB4X;FGF2;LGMN;MET;VEGFA;SMOC2;P2RX4;HSPB1
prerank,protein import into nucleus (GO:0006606),0.5526845155867994,1.2880650438960628,0.18288770053475936,0.9746126326166523,1.0,26/66,20.52%,KPNA2;RANBP17;NUP155;KPNA3;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;RANBP2;IPO11;NXT1;NUP133;KPNA4;IPO5;NXT2;FAM53B;IPO9;NUP188;NUP35;IPO4
prerank,negative regulation of insulin secretion (GO:0046676),-0.43611072377638255,-1.2871342472713063,0.15053763440860216,0.5827764339132162,1.0,6/17,17.16%,PRKN;KCNB1;KLF7;IRS1;MIDN;ADRA2A
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6176481452395277,1.2859455945667722,0.22673656618610746,0.9785137965241316,1.0,8/19,19.33%,ATRX;TERF1;POLR2A;TERF2;TINF2;ACD;TERF2IP;POLR2B
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6176481452395277,1.2859455945667722,0.22673656618610746,0.9785137965241316,1.0,8/19,19.33%,ATRX;TERF1;POLR2A;TERF2;TINF2;ACD;TERF2IP;POLR2B
prerank,presynapse assembly (GO:0099054),-0.44219234898515536,-1.2854535620626146,0.14960629921259844,0.5854451080367724,1.0,7/16,19.55%,PCLO;PTPRD;LRRTM3;IL1RAPL1;DVL1;NLGN1;FZD1
prerank,cardiac muscle contraction (GO:0060048),-0.3791236342911124,-1.2843896448381877,0.11904761904761904,0.5864556065625142,1.0,9/34,19.40%,CAMK2D;ATP1B1;RYR2;TPM1;GSN;ATP1A2;SCN1B;PIK3CA;KCNQ1
prerank,endochondral bone morphogenesis (GO:0060350),-0.4997818930853707,-1.2837048843883538,0.20597014925373133,0.5865223635630497,1.0,3/11,7.11%,MEF2C;BMPR2;FOXC1
prerank,regulation of intracellular signal transduction (GO:1902531),0.5333556232662459,1.2832438468130436,0.015,0.986421412573246,1.0,104/420,15.83%,TPX2;BRCA1;ECT2;EXO1;CDK1;BRIP1;FAM83D;BARD1;RACGAP1;RMI2;AURKB;ARHGAP22;ARHGAP11A;ARHGAP21;RFC4;KMT5A;MAP4K4;ULK4;AURKA;DEPDC1B;ARHGAP10;TOPBP1;ARHGAP28;RHOA;RBBP8;RPA1;CHEK2;MDM4;TAF3;RAD1;DNA2;WDR54;RFC2;ARHGAP18;BLM;MRE11;OCRL;NET1;MAPT;RHOT1;VRK2;STK3;RPA2;NRK;FGD4;RFC3;RBBP4;RBBP7;PML;ARHGAP36;RRS1;VAV2;CHEK1;TAF12;GNA13;FGD1;INPP5B;CDK2;ARHGAP24;LRRK2;SYDE2;ARHGAP19;RHOQ;IKBKG;CSNK2A2;MAPKAP1;SRGAP2;SRGAP3;PPP2R5C;MYO9B;ARHGAP6;ARHGAP35;TAF15;ARHGAP23;ARHGEF18;HDAC1;EZR;FAM13B;RAC1;TAF4;RRAS;PDPK1;TRIM6;SSRP1;HDAC2;DLG1;SPRED1;XIAP;PAK1IP1;ITFG2;PIP5K1C;STK11;PTPN13;ITGAV;PIN1;SLC15A4;TAOK1;PRKAG1;KAT6A;RHOC;PRKD2;NF2;PPP2R5B;TP53
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.35826210748556336,-1.2830592890019759,0.10897435897435898,0.5863769753335735,1.0,14/36,20.05%,FHIT;HSP90AB1;OPHN1;OGT;MAP1A;GIPC1;CCAR2;SDCBP;UBXN1;PRKCG;RYBP;AQP11;GABARAPL2;PARK7
prerank,rRNA processing (GO:0006364),-0.2980994079290935,-1.283018467482107,0.0,0.5846775269346317,1.0,82/172,27.09%,RPL13;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RSL1D1;RPL39;KRR1;RPL12;RPL27;RPL24;NSA2;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RRP1B;RRP1;RPL19;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;RPL29;MDN1;RIOK2;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;THUMPD1;NOP2;EXOSC2;PIH1D1;RRP15;EBNA1BP2;DDX54;RPL4;BYSL;IMP3;DDX47;BOP1;EXOSC3;RPS25;EXOSC5;POP5
prerank,neurogenesis (GO:0022008),0.5733455762017248,1.2821984554958366,0.20601336302895323,0.9884014318683193,1.0,7/43,6.30%,WDR62;CDK5RAP2;CIT;TRAK1;LPAR1;MAPT;CXCR4
prerank,positive regulation of coagulation (GO:0050820),0.6667415307737171,1.2818389510218773,0.2302936630602782,0.985844637185338,1.0,4/10,14.13%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.6667415307737171,1.2818389510218773,0.2302936630602782,0.985844637185338,1.0,4/10,14.13%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,positive regulation of ERAD pathway (GO:1904294),-0.476079721172457,-1.2817698065919565,0.20846905537459284,0.5862171587484105,1.0,4/13,13.50%,ATXN3;CAV1;SGTA;BCAP31
prerank,maintenance of protein location in nucleus (GO:0051457),0.6136808329075372,1.2799705212237222,0.2179144385026738,0.990740308451294,1.0,9/20,19.17%,BARD1;TAF3;PML;RANGAP1;HNRNPU;MORC3;SUN2;SP100;SUN1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.5044775695800441,-1.2797709041470346,0.1687116564417178,0.5896769841810723,1.0,5/11,23.69%,UFD1;DERL1;POMT2;AUP1;TOR1A
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6234367877054078,1.2797192985745849,0.24281609195402298,0.989645064483589,1.0,1/15,1.27%,GLI3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.6393032665447986,1.2791119511337614,0.23333333333333334,0.9899243011403164,1.0,5/15,8.27%,RAB10;RTN3;LNPK;ATL2;ARL6IP1
prerank,photoreceptor cell development (GO:0042461),-0.4680392671582193,-1.2784751284823752,0.18493150684931506,0.59131999212613,1.0,6/14,23.34%,RORB;VEGFA;DCX;AHI1;RP1;MFSD2A
prerank,positive regulation of catabolic process (GO:0009896),0.5516473413856197,1.276549832595122,0.17868675995694294,0.9972689769459412,1.0,6/65,8.39%,DTL;BARD1;GSK3B;NEDD4;ATG7;SMURF1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6021104134926025,1.2759373014317477,0.22138364779874214,0.9976384621919252,1.0,9/22,15.83%,PAXIP1;PSMC2;MED14;SRF;MED30;MED24;MED1;PSMC6;TP53
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.37738310611223896,-1.27555951929618,0.13333333333333333,0.5972977668067874,1.0,12/32,26.78%,CAV1;AKAP6;CEMIP;PLCG1;TRPC3;TRPC1;CX3CL1;GRIN1;P2RX4;P2RX7;GPER1;THY1
prerank,neural crest cell migration (GO:0001755),-0.3637393793373054,-1.275521119346742,0.10179640718562874,0.5955961776473407,1.0,22/36,37.45%,SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;TBX1;SEMA3B;SEMA3C;SEMA5B;NRP1;SEMA6C;SEMA3G;SEMA4C;SOX10;SOX8;SEMA4A;HTR2B;SEMA3E;SEMA4G;SEMA3F
prerank,regulation of membrane repolarization (GO:0060306),-0.4860281212889017,-1.2750373702518694,0.16770186335403728,0.595133570351066,1.0,3/13,3.48%,CACNA2D1;CAV1;AKAP6
prerank,negative regulation of cellular senescence (GO:2000773),0.6431428927335616,1.2747455203787552,0.21207865168539325,1.0,1.0,6/13,15.02%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;SLC30A10
prerank,regulation of intracellular transport (GO:0032386),0.564666575568296,1.273771628253844,0.21689497716894976,1.0,1.0,9/38,15.78%,SPAG5;ATPSCKMT;NUMA1;LRRK2;GAS1;NUP214;SCFD1;RBM4;LCP1
prerank,motile cilium assembly (GO:0044458),0.631041804071312,1.272565893937525,0.21940298507462686,1.0,1.0,4/12,14.75%,DNAAF3;SPATA6;RSPH9;E2F4
prerank,respiratory electron transport chain (GO:0022904),-0.47488928193533914,-1.2722556086528758,0.18120805369127516,0.6005932096540216,1.0,10/14,30.44%,SLC25A13;SLC25A12;GPD2;NDUFA5;PPARGC1A;ETFRF1;ETFDH;ETFB;UQCRFS1;SLC25A18
prerank,respiratory system development (GO:0060541),0.5733518518743659,1.269483206929341,0.21133412042502953,1.0,1.0,7/32,11.52%,GLI2;LOXL3;FGFR2;PDPN;SMCHD1;NPHP3;NKX2-1
prerank,nucleic acid metabolic process (GO:0090304),0.5421020991132735,1.269123586839153,0.19406150583244963,1.0,1.0,23/69,19.33%,ANKLE1;KPNA2;TOPBP1;HNRNPD;RBFOX2;DNA2;HNRNPA1;DNASE2;HNRNPH1;POLR2A;HNRNPU;MMS19;HNRNPL;ENPP1;HNRNPH2;DXO;HNRNPA2B1;DDX1;METTL3;RAD50;XRN2;HNRNPR;POLR2B
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5381251048273332,1.2690135175437418,0.1671858774662513,1.0,1.0,11/87,7.46%,SHCBP1;CEP57;SETX;FGFR4;HYAL1;FGFR2;RBFOX2;HNRNPA1;FRS2;HNRNPH1;POLR2A
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.48684967125913114,-1.2689277373572705,0.19932432432432431,0.6075036915419454,1.0,9/13,20.27%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;IRS1;DYRK2;SORBS1
prerank,modification-dependent protein catabolic process (GO:0019941),0.5320525238015745,1.268832803319311,0.10130391173520562,1.0,1.0,31/193,8.71%,DTL;UHRF1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;RNF168;ANAPC7;AURKA;FEM1C;PSMC2;CDC27;UBE2K;NEDD4;FBXL7;UBR4;KLHL15;SIAH2;SPSB2;RNF43;BUB3;ARRB1;ELOC;RC3H2;RNF40;SMURF1;CUL3;UBE2R2;PSMD14
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5008604818284051,-1.2687868088883076,0.1895424836601307,0.6061279419309559,1.0,9/12,20.27%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;IRS1;DYRK2;SORBS1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5599602815843193,1.2684869947304713,0.1905286343612335,1.0,1.0,9/48,12.41%,BRCA1;E2F1;CHEK2;PRKDC;PML;HTRA2;BOK;USP28;MSH6
prerank,protein homooligomerization (GO:0051260),0.5281920248882567,1.268326310882806,0.1435793731041456,1.0,1.0,24/114,16.11%,ECT2;POLQ;TK1;UPB1;ALDH1A2;BLM;HPRT1;TRPA1;ATL2;ATL3;FUS;USP16;APIP;TRPM2;ACACA;APPL2;MICU1;TRPM4;EHD1;GSDMD;VSTM5;SLC1A5;PKD2;PNPT1
prerank,positive regulation of immune effector process (GO:0002699),-0.3880488896332666,-1.2676679260875114,0.14736842105263157,0.6074840688634973,1.0,7/27,17.26%,DDX60;LBP;RPS19;MYO18A;CD81;XBP1;LGALS9
prerank,thymus development (GO:0048538),0.6242711675694897,1.2669350915416748,0.24822695035460993,1.0,1.0,3/13,10.48%,FOXE1;FADD;TGFBR1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6170859987015214,1.2664982569048844,0.23221476510067113,1.0,1.0,2/16,5.54%,ULBP1;RAET1E
prerank,regulation of isotype switching (GO:0045191),0.6304200242668817,1.2661841888865228,0.2421340629274966,1.0,1.0,5/14,15.24%,PAXIP1;RIF1;KMT5C;SLC15A4;SHLD2
prerank,positive regulation of protein import (GO:1904591),0.581157471510043,1.26601836627423,0.21680876979293545,1.0,1.0,4/30,8.17%,ECT2;TPR;UBR5;TRIM28
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3281916264194561,-1.2657065354491042,0.13636363636363635,0.6106361831516465,1.0,19/48,26.82%,CAMK2D;CALM1;FKBP1A;AKAP6;CEMIP;PLCG1;TRPC1;SELENON;CX3CL1;SRI;PDE4D;CALM3;NOS1;PTK2B;GSTM2;JPH2;GPER1;THY1;JPH4
prerank,vitamin D metabolic process (GO:0042359),-0.4662365917223546,-1.2655566625278878,0.21241830065359477,0.609178866310607,1.0,4/13,25.89%,LGMN;PIAS4;CUBN;CYP2R1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.37486275035023753,-1.2655271950433253,0.13917525773195877,0.6074624940057428,1.0,9/27,16.08%,PTK2;FLT1;TEK;PDGFRB;FGF2;PIK3R4;IRS1;EPHA8;TNFAIP8L3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5087116777926735,-1.2646513304171163,0.20180722891566266,0.6078653946886112,1.0,5/11,14.68%,GIGYF1;IGF1;PIK3R1;IRS1;GIGYF2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3101244321131597,-1.2645681503793693,0.09090909090909091,0.6062957306867836,1.0,15/72,7.53%,PTK2;FLT1;TEK;NTRK2;INSR;IGF1;TGFB2;PDGFRB;BECN1;NTRK3;PIK3R1;FGF2;IRS2;LYN;SEMA4D
prerank,positive regulation of protein deacetylation (GO:0090312),0.6242195246945097,1.2644640991474854,0.2274618585298197,1.0,1.0,4/14,7.80%,DYRK1A;CTBP1;NIPBL;ZBTB7B
prerank,synapse assembly (GO:0007416),-0.2935955080123295,-1.2643599925204956,0.04838709677419355,0.6050985569449512,1.0,13/67,5.66%,DNM3;GABRB3;CDH2;DNER;GABRA2;SHANK3;SPOCK2;LRRTM3;GRID2;ADGRL3;NRCAM;SDK2;FGF13
prerank,neural crest cell development (GO:0014032),-0.33153792304458324,-1.262651500641856,0.13138686131386862,0.6079044451851403,1.0,31/44,42.25%,CDH2;SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;TBX1;SEMA3B;SEMA3C;SEMA5B;NOLC1;KLHL12;SEMA6C;SOX11;SEMA3G;SEMA4C;SOX10;SOX8;SEMA4A;KBTBD8;HTR2B;SEMA3E;SEMA4G;SEMA3F;PDCD6;SNAI2;NRTN;SEMA4F;NRG1
prerank,positive regulation of protein transport (GO:0051222),0.5282839452970912,1.262581102855434,0.21535181236673773,1.0,1.0,12/67,13.77%,KIF20B;FRMD4A;PCM1;MYH10;BMP6;TPR;RAB29;EZR;SYTL4;ACHE;PPID;ADAM9
prerank,chromatin disassembly (GO:0031498),0.6253470537001201,1.2608914134257778,0.22320117474302498,1.0,1.0,5/14,8.78%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,nucleosome disassembly (GO:0006337),0.6253470537001201,1.2608914134257778,0.22320117474302498,1.0,1.0,5/14,8.78%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2942397796630517,-1.260217408077033,0.04838709677419355,0.6122324773147468,1.0,30/75,23.34%,MEF2C;OPHN1;DCC;PAK3;ACTB;S100A6;KLF7;NRCAM;MAP1B;TAOK2;BRSK1;MAP1A;BTBD3;TMEM106B;MINK1;CTNNA2;APP;MEF2A;SLITRK1;NTNG1;DVL1;SHTN1;APBB1;BAIAP2;SLITRK4;S100B;PLPPR4;DRD2;ZDHHC17;MFSD2A
prerank,apoptotic DNA fragmentation (GO:0006309),0.609512333687634,1.2594800537220292,0.24305555555555555,1.0,1.0,3/16,9.74%,HMGB2;DNASE2;HMGB1
prerank,regulation of Golgi organization (GO:1903358),0.6287954752289316,1.25928826392333,0.24069148936170212,1.0,1.0,5/17,11.55%,RAB33B;USP6NL;ARMH3;STX18;AKAP9
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.367579571048678,-1.2588250722318957,0.13142857142857142,0.6141254758188139,1.0,11/31,23.45%,PRKN;ATXN3;HSPA5;PACRG;STUB1;DNAJC18;TM7SF3;HSPB8;DNAJB12;UBE2W;BAG3
prerank,response to ATP (GO:0033198),-0.44294923806141345,-1.2587946807231374,0.19753086419753085,0.6124340956808291,1.0,9/18,28.47%,RYR3;HSP90B1;TRPC3;SSH1;DGKQ;P2RX4;P2RX7;ABCC9;P2RY12
prerank,positive regulation of programmed cell death (GO:0043068),0.5202759030357071,1.2582079909599648,0.07915831663326653,1.0,1.0,43/272,11.40%,TOP2A;ECT2;MELK;BARD1;E2F1;STPG1;ITGB3BP;FADD;STK17B;BMF;IAPP;AIFM2;FAM162A;NET1;CCAR1;FAF1;STK3;ERCC3;FGD4;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;LRRK2;ING4;BCLAF1;KLF11;TNFRSF10B;DNM2;HMGB1;APAF1;BOK;IP6K2;ARHGEF18;QRICH1;BMP2
prerank,positive regulation of response to stimulus (GO:0048584),0.5550086294122492,1.257916197956317,0.22654462242562928,1.0,1.0,7/40,8.69%,ANKLE1;ECHDC3;DHX9;NSMCE4A;FMR1;CD80;BCLAF1
prerank,regulation of adaptive immune response (GO:0002819),0.6049350516217115,1.2578754329318091,0.24771838331160365,1.0,1.0,5/18,13.21%,FADD;IRF1;SAMSN1;AHR;IL4I1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4859763447129668,-1.2575546872290355,0.19607843137254902,0.6138800189838434,1.0,4/12,4.31%,CTNNA3;CAV1;RYR2;BIN1
prerank,natural killer cell activation (GO:0030101),0.5984124590254958,1.2568542381236125,0.25647668393782386,1.0,1.0,5/23,12.75%,ULBP1;NFIL3;ELF4;SNX27;CASP8
prerank,supramolecular fiber organization (GO:0097435),0.5273188550238385,1.256581895571161,0.05,1.0,1.0,51/333,12.11%,KIF18B;KIF14;KIF2C;KIF24;FIGNL1;KIF18A;BMP1;SPTA1;LOXL3;CKAP5;KATNAL2;COL22A1;SHROOM3;STMN1;LOXL2;LOX;TRIOBP;TSPAN33;RHOA;COL4A6;CGNL1;IAPP;COL4A4;PCM1;TUBGCP5;TPM4;SIAH2;MAPT;MYO1C;COL18A1;COL5A2;CDC42EP2;FAT1;COL23A1;ADAMTS14;FBLN5;B4GALT7;CORO1B;TPPP;ADAMTS2;DDR2;SAMD14;FIGN;TLL2;TGFBR1;RND2;RAC1;COL4A5;CALB1;COL12A1;P3H1
prerank,peptidyl-lysine modification (GO:0018205),0.5278521602643368,1.2561614488163901,0.1690427698574338,1.0,1.0,46/99,25.25%,LOXL3;NDC1;NUP155;SAE1;LOXL2;LOX;NUP205;ATPSCKMT;NUP160;SENP1;NUP85;NDUFAB1;TPR;EEF1AKMT2;TRIM28;RANGAP1;VIPAS39;NSMCE2;SUMO2;NUP214;TRPM4;RANBP2;P3H4;NUP133;NUP42;PLOD2;NUP98;NUP210;EGR2;NUP188;NUP35;HDAC4;PLOD1;SIRT2;SIRT3;NUP43;PIAS1;UBA2;LOXL1;NUP93;UBE2I;NUP107;STX1A;EEF1AKMT1;SEH1L;EYA1
prerank,cilium organization (GO:0044782),0.5212204760671009,1.2556717173248857,0.08208208208208208,1.0,1.0,40/209,10.83%,KIF24;MNS1;PLK4;IFT80;HYLS1;CEP89;BBS9;DZIP1L;SCLT1;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;OCRL;TXNDC15;MKKS;RTTN;WDR11;CEP83;RILPL1;NUDCD3;RFX2;SSX2IP;CCDC57;CFAP52;WDPCP;NPHP3;ODF2;RAB1A;TRAPPC14;TTC39C
prerank,heart looping (GO:0001947),0.5568899446145773,1.2554697695023334,0.2290950744558992,1.0,1.0,5/39,9.03%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,protein O-linked mannosylation (GO:0035269),0.5926727338211765,1.255155619951261,0.2430647291941876,1.0,1.0,6/18,11.99%,POMT1;LARGE1;CRPPA;FKRP;RXYLT1;TMTC4
prerank,epithelium development (GO:0060429),0.5295752863784573,1.2549799511592215,0.17142857142857143,1.0,1.0,14/107,11.40%,STIL;CDK1;LOXL3;TIMELESS;FGFR2;ALDH1A2;PPP2R3A;GRHL2;FN3K;KANK2;MEOX2;ERRFI1;PCNA;BMP2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.449788416617909,-1.2544207866796346,0.19858156028368795,0.6204112002739071,1.0,7/16,19.29%,PPP1R16B;FGF2;AGTR1;THBS1;VEGFA;GATA2;FGFBP1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4097906535102004,-1.2538080460380023,0.16346153846153846,0.6201991948031653,1.0,7/20,15.14%,PRKN;DCUN1D3;HSP90AB1;ZMIZ1;DCUN1D5;PINK1;DCUN1D2
prerank,keratan sulfate metabolic process (GO:0042339),-0.3557185672023555,-1.2534396806161587,0.16891891891891891,0.6194939100485084,1.0,14/31,17.46%,GNS;FMOD;B4GALT5;HEXB;B3GNT2;ST3GAL6;B4GALT6;PRELP;HEXA;OGN;LUM;B4GALT4;GALNS;CHST2
prerank,positive regulation of protein metabolic process (GO:0051247),0.5243064855696702,1.2531361924310482,0.17090539165818922,1.0,1.0,14/110,9.87%,DTL;UHRF1;BARD1;ROCK2;GSK3B;NEDD4;IL18;SLC25A37;ATG7;CD80;SMURF1;ABCB10;AGT;RAB1A
prerank,regulation of cellular metabolic process (GO:0031323),-0.3355191377224252,-1.2527551610665475,0.0975609756097561,0.6195776933194704,1.0,11/45,13.48%,PRKN;KIF16B;TBC1D16;ACLY;RNF34;ACACB;PARL;SSH1;STUB1;PINK1;MPV17
prerank,digestive tract development (GO:0048565),0.5597761499919027,1.2527364321955312,0.23627684964200477,1.0,1.0,6/32,7.59%,GLI2;GLI3;CLMP;FGFR2;KIT;NIPBL
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.45242909356340033,-1.252662296316208,0.17624521072796934,0.618066551140973,1.0,4/16,7.68%,KCNC2;APOE;NOS3;GUCY1A1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.500773192263515,-1.252252129967389,0.2084592145015106,0.6173398102977244,1.0,4/11,4.12%,ACVR1;SMAD7;TGFBR2;TGFB2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6510651453568594,1.2521516409430546,0.2525697503671072,1.0,1.0,7/11,22.33%,PDPN;ENPP2;CORO1B;CD44;SRC;RREB1;ARPIN
prerank,regulation of protein dephosphorylation (GO:0035304),0.5682466124595179,1.2517484667066314,0.23711340206185566,1.0,1.0,11/37,17.46%,CDCA2;PPP1R7;PPP1R8;CALM2;ENSA;SMPD1;CAMTA1;PTPA;PIN1;ANKLE2;PPP6R2
prerank,calcium ion transport (GO:0006816),-0.2814586540324857,-1.251496708519667,0.08,0.6176377716290967,1.0,33/113,16.93%,CACNA2D1;GRIN3A;RYR3;PSEN1;SLC8A3;TRPM7;CALCRL;TRPC5;CAV1;RYR2;FKBP1A;ANO6;GAS6;SLC24A2;TRPC4AP;SLC3A2;CACNG7;TPT1;RAMP1;RAMP2;CACNA1B;TRPC3;TRPC1;CHRNA7;TRPM3;TMCO1;CACNB2;ATP2B2;MCOLN1;PANX1;CACNG3;CRACR2A;CACNG8
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.383579044246908,-1.2508348348190128,0.17258883248730963,0.6176642374111714,1.0,6/26,9.74%,CAV1;WDFY1;IFI35;LBP;PTPN22;NR1H3
prerank,fatty acid oxidation (GO:0019395),-0.3113379869057422,-1.2504296037508773,0.1125,0.6168879993071844,1.0,15/57,16.01%,ADIPOR2;HADHB;ACADM;CROT;SCP2;ABCD4;MECR;ALDH3A2;HADH;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2;ADH5
prerank,calcium import into the mitochondrion (GO:0036444),0.6472581293250861,1.2494925333071103,0.23952095808383234,1.0,1.0,5/10,20.72%,MCU;MCUB;MICU1;MAIP1;MICU2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.541134169365577,1.2490196582733497,0.20342612419700215,1.0,1.0,6/63,12.29%,TNFSF13B;IL18;CD80;NCK1;ANXA1;NCK2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.5941191617370923,1.2487951721533483,0.24285714285714285,1.0,1.0,6/20,17.39%,PLK1;IPO7;CDKN1B;IPO5;PTEN;TFAP4
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.45423890975087067,-1.2483342124027101,0.20503597122302158,0.6205367527340706,1.0,6/14,36.11%,PIBF1;THBS1;CMKLR1;IRAK3;C1QBP;JAK3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5510814813110488,1.2476662658969473,0.23015873015873015,1.0,1.0,17/41,20.11%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;NUP98;NUP210;LACC1;NUP188;NUP35
prerank,granulocyte differentiation (GO:0030851),0.6044704385344655,1.2476404185932342,0.23790322580645162,1.0,1.0,6/18,10.56%,E2F1;LBR;DEK;PML;CDK2;TAL1
prerank,receptor recycling (GO:0001881),-0.5201954095189043,-1.2475610300620101,0.22131147540983606,0.6208930474579244,1.0,6/10,29.68%,ARFGEF2;SORL1;NSG1;PHETA1;PLEKHJ1;REP15
prerank,regulation of microtubule-based movement (GO:0060632),-0.50119628322423,-1.2472589857854797,0.19384615384615383,0.619861507680936,1.0,9/11,45.28%,LAMP1;IGBP1;TTC21B;DYNLT2B;CFAP298;DRC1;HAP1;CCDC65;HDAC6
prerank,establishment of protein localization to organelle (GO:0072594),0.5278533658376737,1.2470562294299918,0.22128556375131717,1.0,1.0,20/72,17.49%,NEURL1B;RANBP17;NUP155;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;ZDHHC15;IPO11;NXT1;NUP133;IPO5;NXT2;FAM53B
prerank,L-serine metabolic process (GO:0006563),-0.49684054521532706,-1.246439203277787,0.21212121212121213,0.62051185899214,1.0,7/10,43.39%,SERINC3;PSAT1;CBS;PSPH;SHMT2;PHGDH;SHMT1
prerank,response to acidic pH (GO:0010447),-0.4637706631479521,-1.245694492607714,0.21035598705501618,0.6208559884200178,1.0,7/13,36.63%,GPR4;LGMN;CTSS;SLC9A1;PKD2L1;CHP1;PKD1L3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5346379415619514,1.244384305287767,0.2167019027484144,1.0,1.0,16/72,11.29%,POLK;RFC4;RPA1;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;PRPF19;POLR2A;CUL4B;XPA;PCNA
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5197956190955904,1.2437662021797353,0.13768844221105528,1.0,1.0,51/153,18.83%,CDK1;TTK;CLSPN;PLK1;MASTL;MAST2;DYRK1A;AURKA;ROCK2;GSK3B;NLK;PRKDC;DYRK3;VRK2;WNK1;CDK2;LRRK2;ROCK1;MARK2;CSNK2A2;CAMK1D;TGFBR1;EIF2AK3;PRKCB;PRKCA;ULK2;PDPK1;CSNK1G2;MAPKAPK3;PRKCE;PRKD1;PRKCI;CAB39;PLK2;MORC3;VRK1;PRKD2;STK39;HIPK3;ATR;CSNK1A1;MAST4;CSNK1G1;SRPK2;PIKFYVE;MAST1;PKN2;MAPK14;HIPK1;RIPK1;CAMKV
prerank,early endosome to late endosome transport (GO:0045022),-0.41701058337654984,-1.2436661541800147,0.1894273127753304,0.6243327695008014,1.0,5/20,12.93%,STX8;KIF16B;BECN1;RAB5A;HOOK1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.5691489709615227,1.2429950192699166,0.2541371158392435,1.0,1.0,9/32,16.18%,CDCA2;PPP1R7;CALM2;PPP1R15B;SMPD1;CAMTA1;PTPA;PIN1;ANKLE2
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2784324849685597,-1.2428434831061992,0.07142857142857142,0.6248128417466102,1.0,42/107,24.57%,PRKN;RASGRF1;RASGRF2;HSP90B1;ERLEC1;UFL1;ATF6;OS9;PIK3R1;UBA5;MAP3K5;CASP4;ATG10;DERL1;SELENOS;AIFM1;HSPA5;JUN;BCL2;PDIA4;THBS1;TMCO1;RCN3;BCAP31;CEBPB;TMTC3;NIBAN1;CREB3L1;SCAMP5;DDIT3;UBXN6;DNAJB9;DNAJB12;SYVN1;TMEM33;PIK3R2;ATP2A3;CDK5RAP3;SEL1L;WFS1;ERP44;MBTPS1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.54075357299627,1.2420292564935533,0.2384180790960452,1.0,1.0,3/46,6.34%,LMNB1;ANXA2;CNN2
prerank,protein methylation (GO:0006479),0.550776462075799,1.2416139356967035,0.2638731596828992,1.0,1.0,4/40,6.99%,EZH2;ATPSCKMT;SETD3;EEF1AKMT2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4329736218398207,-1.2410656663814945,0.2135593220338983,0.6277520121231623,1.0,11/15,31.97%,PKM;KLF4;FGF2;FGF1;TJP1;VEGFA;S100A1;JAK1;JMJD8;SMAD1;BMPER
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.41873260867870393,-1.2407195669640225,0.19215686274509805,0.6269996338728668,1.0,5/19,19.48%,CARD16;IGF1;CX3CL1;GIT1;ZC3H12A
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5055017841872806,-1.2406998120797212,0.18518518518518517,0.6253693256989105,1.0,7/10,41.54%,TXN2;MTRR;CBS;CTH;ADO;MPST;BLMH
prerank,regulation of organelle assembly (GO:1902115),0.528343539345566,1.240637894066123,0.22694300518134716,1.0,1.0,18/72,14.95%,STIL;CEP295;USP6NL;IFT140;TBC1D13;TBC1D2B;STAM;CEP76;ALMS1;SPICE1;NPRL3;SDCCAG8;TBC1D19;STX18;EZR;ATG3;PLK2;MTMR3
prerank,regulation of gene silencing by RNA (GO:0060966),0.5386413867752664,1.2403966247536695,0.22065217391304348,1.0,1.0,19/50,20.11%,NDC1;NUP155;NUP205;NUP160;AGO2;NUP85;TPR;FMR1;POLR2A;PUM2;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5386413867752664,1.2403966247536695,0.22065217391304348,1.0,1.0,19/50,20.11%,NDC1;NUP155;NUP205;NUP160;AGO2;NUP85;TPR;FMR1;POLR2A;PUM2;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,respiratory tube development (GO:0030323),0.5663765026457872,1.2402479574701213,0.2545676004872107,1.0,1.0,6/28,11.52%,GLI2;LOXL3;FGFR2;PDPN;NPHP3;NKX2-1
prerank,regulation of protein catabolic process (GO:0042176),0.524272973259403,1.2393276987367834,0.18724279835390947,1.0,1.0,9/99,6.96%,DTL;FAM83D;BARD1;GSK3B;CHEK2;MDM4;NEDD4;FAF1;ATG7
prerank,carboxylic acid catabolic process (GO:0046395),0.6230632903573824,1.2387702342140106,0.26453488372093026,1.0,1.0,1/12,0.82%,PON1
prerank,endocrine system development (GO:0035270),0.5790394823319922,1.2385697240743823,0.25673940949935814,1.0,1.0,5/21,11.52%,GLI2;FOXE1;TGFBR1;DKK3;NKX2-1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5915894883469555,1.2383843586071284,0.25868725868725867,1.0,1.0,8/22,16.91%,TGM1;FGFR2;CASK;KLF9;NOTCH2;PRKD1;MED1;PTPRK
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.42542899032067494,-1.2383692185347026,0.2015810276679842,0.6298088793278399,1.0,3/18,4.31%,CAMK2D;CAV1;BIN1
prerank,regulation of glucose import (GO:0046324),-0.36790500091387635,-1.2378927158580222,0.17058823529411765,0.6292306617145482,1.0,12/30,14.62%,OCLN;GRB10;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;SELENOS;IRS1;PTPN11;GSK3A
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5425720823264308,1.2375638688938977,0.23851203501094093,1.0,1.0,11/48,10.06%,ATAD2;BAZ1B;DEK;POLR1A;MYO1C;POLR1B;ELOF1;ARID1A;CHEK1;PHF2;TAF1D
prerank,translation (GO:0006412),-0.2540675881728831,-1.2374000312027764,0.0,0.628815025179963,1.0,89/208,21.68%,EEF1A1;RPL13;FARSB;RPS8;RPS23;RPS29;RPL37A;RPS21;LARS2;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;EEF2;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;AARS1;RPLP1;RPS13;RARS1;RPL9;RPL37;MRRF;RPL8;FARSA;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;SARS1;RWDD1;RPL12;RPL27;RPL24;MRPS5;RPS12;RPS4X;RPS27;RPL27A;RPS9;N6AMT1;WARS1;MRPS18A;MRPS15;RPL30;EEF1B2;MRPS21;MRPS6;RPL19;RPL28;MRPL27;RPL31;RPL13A;RPL36A;TARS1;NARS1;RPLP2;RPL29;HBS1L;MRPL23;DHPS;KARS1;MRPL9;TNIP1;RPLP0;RPL10A;RPS6KB2;TSFM;RPS10;RPL35;RPS26;MRPL51;TMA7
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.3833248485095263,-1.2364235906410146,0.18285714285714286,0.6295832214447634,1.0,9/27,15.31%,PLAAT3;ETNK1;SLC27A1;PNPLA8;CHKA;ETNK2;PCYT2;SELENOI;CHKB
prerank,ribosome assembly (GO:0042255),-0.3289614788462395,-1.236260061798172,0.16,0.628343926651265,1.0,29/47,34.10%,RPL3;RPS15;RPS14;RPSA;BRIX1;RPL10;RPS28;RPS5;RPS19;RPL24;TRAF7;RPS27;DHX29;MDN1;MTERF3;ERAL1;RPLP0;NOP2;MRPS7;BOP1;RPL11;MRPS11;MRPL22;DDX3X;RSL24D1;NLE1;MPV17L2;C1QBP;PWP2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5245656253713354,1.2357183883673142,0.20143149284253578,1.0,1.0,12/98,9.87%,CCNB1;UHRF1;CDK1;ANXA2;XDH;ARRB1;FMR1;SCRIB;RAB29;ANGPT1;AGT;RAB1A
prerank,sphingosine biosynthetic process (GO:0046512),-0.49354531722514416,-1.2344779569254785,0.17771084337349397,0.6297669201825725,1.0,6/11,23.86%,ACER2;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,sphingoid biosynthetic process (GO:0046520),-0.49354531722514416,-1.2344779569254785,0.17771084337349397,0.6297669201825725,1.0,6/11,23.86%,ACER2;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,synaptic vesicle localization (GO:0097479),-0.4729503562532909,-1.2344192275571908,0.19682539682539682,0.6282491608321255,1.0,7/13,18.49%,SPG11;SYNDIG1;KIF5B;KIF5C;SYNJ1;NLGN1;RAB27A
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4743131259117714,-1.2341984680355114,0.2255892255892256,0.6254701454421048,1.0,6/13,28.89%,STAT3;GRB2;SHC1;IL15;JAK1;PLCB1
prerank,cellular response to interleukin-15 (GO:0071350),-0.4743131259117714,-1.2341984680355114,0.2255892255892256,0.6254701454421048,1.0,6/13,28.89%,STAT3;GRB2;SHC1;IL15;JAK1;PLCB1
prerank,protein homotetramerization (GO:0051289),0.534575205324102,1.2335079546694643,0.24282560706401765,1.0,1.0,11/49,12.52%,TK1;UPB1;ALDH1A2;HPRT1;TRPA1;USP16;APIP;TRPM2;ACACA;APPL2;TRPM4
prerank,response to interleukin-4 (GO:0070670),-0.4971871849108175,-1.2325725409324253,0.2175141242937853,0.6281201922991745,1.0,3/10,21.09%,LEF1;XBP1;SHPK
prerank,cytoplasmic microtubule organization (GO:0031122),0.5262329250924734,1.2312973692932467,0.2392502756339581,1.0,1.0,15/54,18.56%,FIGNL1;KATNAL2;RHOA;PCM1;TUBGCP5;NUMA1;MAPT;TPPP;FIGN;EZR;DLG1;TUBGCP3;TRPV4;CLASP1;LIMK2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.43317585607298204,-1.2311010116674637,0.19923371647509577,0.630404870603573,1.0,3/16,12.83%,CLDN5;CLDN11;CLDN12
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6195654185695127,1.2309383764892659,0.2633863965267728,1.0,1.0,5/12,12.82%,DPYD;CTPS1;CDA;DPYSL4;DPYSL3
prerank,protein import into peroxisome matrix (GO:0016558),-0.4789784740984111,-1.2308265889326675,0.21428571428571427,0.6294732970650628,1.0,4/12,10.96%,PEX5L;PEX1;PEX5;PEX6
prerank,phosphate ion homeostasis (GO:0055062),0.6443174950094994,1.2299292047152819,0.24423963133640553,1.0,1.0,2/10,11.79%,FGFR4;ENPP1
prerank,protein autoprocessing (GO:0016540),0.6003614510913682,1.229324408144122,0.26549865229110514,1.0,1.0,3/17,8.22%,FAM111A;FXN;HTRA2
prerank,diol biosynthetic process (GO:0034312),-0.4499325784224817,-1.2292675668440727,0.20522388059701493,0.6317204591847366,1.0,8/15,23.86%,ACER2;ASAH1;ACER3;QDPR;ASAH2;GCH1;ABCA2;SPHK1
prerank,regulation of leukocyte activation (GO:0002694),-0.44971827026889066,-1.2292026046664482,0.23448275862068965,0.63024723881407,1.0,8/14,32.53%,LYN;MYO18A;SHPK;MFHAS1;GPER1;CD74;MIF;PJA2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5118880678841858,-1.2291729300791379,0.22085889570552147,0.6286979606028689,1.0,4/10,21.46%,SLC2A1;SLC27A1;SLC27A4;ACSL1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.5126297578059182,1.228870649945458,0.1663306451612903,1.0,1.0,33/140,11.74%,ECT2;RACGAP1;ARHGAP22;ARHGAP11A;ARHGAP21;DEPDC1B;ARHGAP10;ARHGAP28;RHOA;CGNL1;ARHGAP18;OCRL;NET1;RHOT1;FGD4;ARHGAP36;VAV2;GNA13;FGD1;INPP5B;ARHGAP24;SYDE2;ARHGAP19;RHOQ;SRGAP2;SRGAP3;MYO9B;ARHGAP6;ARHGAP35;ARHGAP23;ARHGEF18;FAM13B;RAC1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6337373675926917,1.228845118707894,0.26207906295754024,1.0,1.0,3/11,10.10%,E2F2;ADAMTS9;PIK3CB
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5649189229681393,1.2287702304302595,0.25485436893203883,1.0,1.0,10/26,17.86%,CDK5RAP2;PSRC1;NUMA1;MAPT;DRG1;AKAP9;RAC1;STMN2;TRPV4;CLASP1
prerank,polarized epithelial cell differentiation (GO:0030859),0.6108526017021197,1.2283386224420014,0.27155172413793105,1.0,1.0,6/13,16.27%,RHOA;RAB10;RAP2A;SCRIB;EZR;MSN
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.46344393161753217,-1.227632603423303,0.19444444444444445,0.6311449739946993,1.0,5/12,16.43%,CCT5;TCP1;CCT7;CCT2;DKC1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5552692345228825,1.2264594124354642,0.2398609501738123,1.0,1.0,2/37,4.74%,BRCA1;WDR54
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5959648812134644,1.2257671532496135,0.2621870882740448,1.0,1.0,7/16,16.31%,TERF1;RTEL1;ERCC4;TERF2;SMG6;HNRNPA2B1;TINF2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.5115661897513645,1.2251233019000893,0.012,1.0,1.0,176/807,15.43%,DEPDC1;CENPF;BRCA1;E2F7;NR2E3;E2F8;UHRF1;EZH2;EN1;PLK1;BIRC5;AURKB;GLI2;LOXL3;TCFL5;GLI3;HMGB2;E2F1;CBX5;RBM15;FOXE1;ATOH8;BTAF1;ILF3;KMT5A;SFMBT1;TIMELESS;LOXL2;TRIM37;ZFP69;CBFB;RB1;SP3;ETV6;TWIST2;FNIP1;MIER1;WWOX;SP2;HDGF;CTCF;FGFR2;ZEB1;JAZF1;CNOT1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;MDM4;TAF3;SETDB2;MBD1;KHDRBS1;HIVEP1;CUX1;FHL2;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;TBL1XR1;IKZF1;MCPH1;BMP6;GZF1;LCOR;SCML2;YAF2;TCF7L2;ORC2;HOXA7;TPR;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;EFNA1;GLIS3;RIF1;SFRP2;NIPBL;POU2F1;ZBTB2;MXD1;ZBTB7B;ZHX2;UIMC1;FOXO3;ATF7IP;SAP18;TRIM28;KDM2B;LIN37;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;ZFP90;KLF11;MIER3;KANK2;LIMD1;YAP1;NONO;VHL;ARID4A;UXT;EPC1;HMGB1;HDAC8;MTA3;NR4A2;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;RUNX1T1;LIMS1;KCNIP3;RBM15B;DKK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;EZR;NKX2-1;ZHX3;ATXN1;FBXW11;RBPJ;SOX9;SMAD4;HDAC2;SAP130;ATF5;ELK4;IRF2BP1;PPID;TWIST1;HEY2;USP9X;MED1;USP47;DLG1;BTRC;RARB;YY1;BCL7A;ZMYM5;FOXK2;CDKN1B;KDM5C;PCGF6;DNMT3A;FOXM1;SMAD3;FOXP4;QARS1;SOX1;PER1;YEATS2;RBAK;OTUD7B;DR1;CNOT7;KAT6A;DCAF1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.5205946002673448,1.2250582042605909,0.21887966804979253,1.0,1.0,11/80,9.25%,BRCA1;PLK1;PAXIP1;FANCI;MYCBP2;FBXW7;UBE2N;LRRK2;CUL3;ANGPT1;TBC1D7
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5811485338492333,1.2242255553380588,0.26648721399730824,1.0,1.0,6/18,11.40%,BHLHE41;FRS2;SOX6;CCN3;HDAC1;BMP2
prerank,cobalamin metabolic process (GO:0009235),-0.41066081613860106,-1.2234080080655563,0.16731517509727625,0.6403832787895555,1.0,7/17,25.37%,ABCD4;CUBN;LMBRD1;MTRR;MMAA;MTR;TCN2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2834914805914827,-1.2233523333124465,0.08695652173913043,0.6388942162496071,1.0,18/76,17.16%,CHRM2;ANO1;HOMER1;HTR2C;GPR4;TGM2;ESR1;OPRM1;GNA14;AGTR1;GRM5;ADRA1A;GRM1;HTR2A;PTH1R;PLCE1;CMKLR1;ADRA2A
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.35139036736314117,-1.2232496389200465,0.15862068965517243,0.6374912271013701,1.0,13/34,16.14%,MEF2C;GRIN2A;GABRA2;GRID2;GLRA1;GRIN2B;GABRA3;GABRA5;GABRG2;GRIN1;GSK3A;GABRG1;INSYN2A
prerank,regulation of RNA export from nucleus (GO:0046831),0.613787057320327,1.223068102880306,0.2682926829268293,1.0,1.0,5/11,7.49%,KHDRBS1;DHX9;NRDE2;TPR;SETD2
prerank,determination of heart left/right asymmetry (GO:0061371),0.5387026306820603,1.2228725012225403,0.25655644241733183,1.0,1.0,5/42,9.03%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,cellular response to interleukin-12 (GO:0071349),0.5303684383950402,1.2224942398346346,0.2681564245810056,1.0,1.0,9/48,17.29%,LMNB1;ANXA2;CNN2;CAPZA1;HNRNPA2B1;LCP1;MSN;SIRPA;CD47
prerank,negative regulation of protein processing (GO:0010955),0.6247682720568769,1.222399245952271,0.2559171597633136,1.0,1.0,4/12,9.99%,PRNP;SERPINE1;LRRK2;GAS1
prerank,endothelial cell differentiation (GO:0045446),-0.4731435918663056,-1.2220706765418043,0.2260061919504644,0.6390256694322655,1.0,6/12,8.29%,JAG1;BMPR2;ACVRL1;PROX1;TIE1;ACVR2B
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4278395194378683,-1.222067063061895,0.1843137254901961,0.6374126594892993,1.0,9/15,23.09%,HSP90B1;OS9;UFD1;DERL1;SELENOS;SEC61B;AUP1;SYVN1;SEL1L
prerank,positive regulation of cell population proliferation (GO:0008284),0.5107625618555168,1.2217597986207533,0.048,1.0,1.0,72/423,13.39%,PRC1;KIF20B;KIF14;EZH2;TTK;BIRC5;SAPCD2;E2F1;TIPIN;SPDYA;MATK;AQP1;HPSE;NAP1L1;FBXO5;BMPR1A;PHIP;FGFR4;HYAL1;CEP43;FGFR2;FXN;GAREM1;DDRGK1;LAMB1;DHX9;CNOT6L;CCAR1;BMP6;TCF7L2;RTKN2;IL18;TGFBR3;DERL2;CDC25B;PDGFRA;SFRP2;CCN1;SAAL1;POU3F2;WWTR1;CDK2;CNOT6;GRK5;CUL3;YAP1;MAP3K3;PIM1;AGT;DDR2;CDC123;S1PR2;TGFBR1;HNRNPU;RBPMS2;CRKL;CNTF;HDAC1;BMP2;STOX1;GLP2R;RBPJ;GJA1;ADAM17;KMT2D;TRPM4;SOX9;HDAC2;IL31RA;CTSH;LRP5;NES
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.4258701406465678,-1.2211730489247155,0.20077220077220076,0.6382604059140555,1.0,10/17,19.76%,SMAD7;CALM1;EIF4G1;INPP5K;SPRY2;CADM4;DGKQ;PPEF2;DDIT4;CALM3
prerank,alpha-amino acid catabolic process (GO:1901606),0.5531514290474091,1.2211680562599312,0.26024096385542167,1.0,1.0,5/29,13.21%,ACMSD;ACAT1;KMO;HOGA1;IL4I1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.29684706897909363,-1.220841490809413,0.14285714285714285,0.6374858973421852,1.0,24/71,22.47%,PRKN;CHFR;OTUD7A;ADAMTS12;CTSC;ATXN3;CLPX;MALT1;CTSB;VPS4B;LGMN;OMA1;CTSZ;STUB1;CTSL;NGLY1;CTSF;UBB;FAP;UBE2W;YME1L1;CTSS;RPS27A;UBC
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.538881152968648,1.2201132962092098,0.25678733031674206,1.0,1.0,14/41,17.40%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.39512807762386026,-1.2194468020397982,0.20802919708029197,0.6394266135302087,1.0,5/18,17.16%,PRKN;KCNB1;IRS1;MIDN;ADRA2A
prerank,lung development (GO:0030324),0.5540760332399136,1.2190606750184378,0.256198347107438,1.0,1.0,7/33,11.52%,GLI2;LOXL3;FGFR2;PDPN;NPHP3;ERRFI1;NKX2-1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.38491335748141453,-1.218399491195422,0.2037914691943128,0.6405376220693505,1.0,8/23,18.03%,PTK2;LYN;MAPK3;MAPK1;SLIT2;THBS1;CMKLR1;IL34
prerank,regulation of microtubule-based process (GO:0032886),0.5463678431582714,1.2179939516907285,0.25943396226415094,1.0,1.0,15/36,17.86%,MACF1;AURKA;GSK3B;MEMO1;DIAPH1;MAPT;BICD2;TPPP;ROCK1;MARK2;ATF5;MAP6;TAOK1;EPHA3;CLASP1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.5234155107334194,1.2174959896128206,0.256989247311828,1.0,1.0,23/62,20.11%,NDC1;NUP155;NUP205;NUP160;AGO2;AJUBA;DHX9;NUP85;TPR;FMR1;POLR2A;LIMD1;PUM2;NUP214;RANBP2;NUP133;FXR1;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5753870419167612,1.216743224487222,0.2784163473818646,1.0,1.0,6/22,17.39%,PLK1;IPO7;CDKN1B;IPO5;PTEN;TFAP4
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.2743424015480111,-1.2165864001874047,0.10526315789473684,0.6437155574782513,1.0,19/100,7.53%,PTK2;FLT1;TEK;NTRK2;PIP4K2A;PPP1R16B;INSR;IGF1;TGFB2;PDGFRB;BECN1;PIP4K2B;NTRK3;PIK3R1;FGF2;IRS2;LYN;PIK3IP1;SEMA4D
prerank,protein complex oligomerization (GO:0051259),0.5143127704854964,1.2161494050282395,0.23173277661795408,1.0,1.0,19/85,16.72%,ECT2;POLQ;UPB1;BLM;ATL2;ATL3;STOML2;FUS;MCU;WDCP;BOK;MICU1;EHD1;GSDMD;VSTM5;PKD2;PNPT1;UGDH;LRRC8C
prerank,positive regulation of calcium ion transport (GO:0051928),-0.33694813190899214,-1.2159661059717453,0.14965986394557823,0.6438064892279055,1.0,11/36,25.13%,CAV1;PDGFRB;MYLK;TRPC3;CACNB2;GRIN1;CRACR2A;P2RX4;WFS1;CXCL12;P2RX7
prerank,regulation of cellular component organization (GO:0051128),0.5118568335547838,1.2156523628855662,0.17777777777777778,1.0,1.0,22/135,12.83%,KIF14;MKI67;HJURP;RAB33B;AURKA;ROCK2;STON1;PACSIN2;NEDD4;NET1;STON2;NCLN;ZFYVE16;ROCK1;PICALM;AGT;HNRNPU;BAG5;METTL4;SSRP1;ATF5;ITCH
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.452664707226641,-1.215536299674571,0.21069182389937108,0.6431598764859349,1.0,7/13,27.32%,SAR1A;CD81;SAR1B;SORL1;SEC16B;TMEM30A;SEC16A
prerank,sodium ion transmembrane transport (GO:0035725),-0.28686698515768594,-1.2152097790427687,0.0784313725490196,0.6424612386171534,1.0,19/84,16.25%,SLC6A6;SLC8A3;ATP1B1;SLC6A1;HCN1;ANO6;SLC24A2;SCN1A;ATP1A1;SCN9A;ATP1B3;ATP1A3;ATP1A2;SCN3A;SCN8A;SCN1B;SLC4A8;SLC6A11;SLC12A2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.36493366908766717,-1.2150424756456262,0.22151898734177214,0.6412785412250388,1.0,14/27,34.37%,GAS6;TLR4;PTPN22;SELENOS;CX3CL1;SYT11;C1QTNF3;NCKAP1L;ZC3H12A;NLRC3;IRAK3;TNFAIP3;PTPN6;CD200R1
prerank,negative regulation of nuclear division (GO:0051784),0.6166952450212816,1.2148420311109964,0.2688821752265861,1.0,1.0,3/11,11.98%,FBXO5;CHEK1;TOM1L2
prerank,icosanoid biosynthetic process (GO:0046456),-0.48666573918905653,-1.213688446659539,0.22392638036809817,0.6435017633606112,1.0,1/10,0.17%,PLA2G4A
prerank,protein import into peroxisome membrane (GO:0045046),-0.3923869068106922,-1.2135056549144454,0.20642201834862386,0.642402495906786,1.0,9/22,22.31%,FIS1;ALDH3A2;PEX3;PEX5;ABCD2;GDAP1;PXMP4;PEX26;PXMP2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.558435910186047,1.212845256226955,0.2667493796526055,1.0,1.0,8/26,15.72%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2;CAMTA1;LMCD1;STIMATE
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3744178942317467,-1.2119487011668588,0.1989795918367347,0.6449443986917561,1.0,12/24,35.91%,TAPBP;SEC24B;B2M;ACE;BCAP31;SAR1B;TAP2;FCER1G;ABCB9;CALR;SEC13;CANX
prerank,regulation of acrosome reaction (GO:0060046),-0.49831463722412345,-1.2119207238000786,0.2389937106918239,0.6434398190865472,1.0,3/10,28.89%,GLRA1;CACNA1H;PLCB1
prerank,negative regulation of heart contraction (GO:0045822),-0.47552599374010374,-1.2119128441811313,0.24702380952380953,0.6418798226508168,1.0,7/11,40.76%,ATP1A2;SRI;PDE4D;ZC3H12A;PLN;SPX;PIK3CG
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5132787260835173,1.2112931685028376,0.25523012552301255,1.0,1.0,17/74,15.38%,BRCA1;FADD;PHIP;EYA4;GSK3B;SIAH2;TCF7L2;SERPINE1;SH3RF1;TNFRSF10B;EYA2;TGFBR1;CASP8;BIRC6;ITGAV;SRC;GDNF
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.48350988618592233,-1.2112397448825358,0.2515151515151515,0.6420359042982975,1.0,7/11,45.56%,AKAP6;LRRC38;KCNIP2;LRRC55;NOS1AP;TREM2;RNF207
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3226005715299839,-1.2111988280146921,0.10869565217391304,0.6405828070031129,1.0,14/40,18.62%,UNC13B;PCLO;RIMS1;SNAP47;SYT1;STX4;STX3;SYT7;SNPH;SNAP29;CPLX1;SNAP25;SYT10;STX1B
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3409686674686402,-1.211180673191156,0.14184397163120568,0.6390702905162423,1.0,13/37,17.02%,FHIT;HSP90AB1;OGT;HIPK2;RPL23;RPS7;MAP1A;GIPC1;SGTA;CCAR2;SDCBP;UBXN1;RYBP
prerank,peptidyl-lysine methylation (GO:0018022),0.5688604251001219,1.2110497118121872,0.2832512315270936,1.0,1.0,6/26,7.49%,KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,ribosomal small subunit assembly (GO:0000028),-0.4147608466763614,-1.2109603391153825,0.21691176470588236,0.6381415120631031,1.0,7/16,11.77%,RPS15;RPS14;RPSA;RPS28;RPS5;RPS19;RPS27
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.506005926504044,1.2109577794790354,0.089,1.0,1.0,52/314,11.24%,KIF14;CCNF;CCNB1;CDK1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;FBXO5;ANAPC7;RB1;AURKA;FEM1C;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;SPSB3;KLHL15;SIAH2;SPSB2;TBL1XR1;FAF1;BUB3;ARRB1;PML;FBXW7;DERL2;CUL5;FBXL8;CDK2;AGAP3;PSMB1;SMURF1;CUL3;PSMD14;KCTD2;KLHL22;CUL4B;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;SMURF2;DCAF12
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6135295216924406,1.2107297464947333,0.2701492537313433,1.0,1.0,4/12,8.17%,MPHOSPH8;SETDB2;ATF7IP;TRIM28
prerank,organelle disassembly (GO:1903008),0.5435405708195999,1.210688611389034,0.26573426573426573,1.0,1.0,12/33,17.31%,CDK1;GBF1;DDRGK1;DYRK3;RB1CC1;ULK2;VRK1;ATG2A;GFM2;MCTS1;DENR;MTIF3
prerank,amide biosynthetic process (GO:0043604),0.5425650339774276,1.209346108244345,0.2711306256860593,1.0,1.0,10/47,14.82%,RHD;SLC25A15;CERS6;CERS5;PAM;SLC25A2;ASMT;AGK;SMPD1;SPTLC2
prerank,cellular response to reactive oxygen species (GO:0034614),0.5279566956652418,1.2086567910149115,0.250814332247557,1.0,1.0,10/59,11.47%,ECT2;AQP1;SETX;FXN;NET1;MAPT;PDGFRA;AGAP3;TRPM2;ANXA1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.37573496693187153,-1.208536609863242,0.205,0.6427602041156977,1.0,10/26,13.59%,OCLN;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;CLIP3;IRS1;PTPN11
prerank,barbed-end actin filament capping (GO:0051016),0.5767575499296794,1.2084077184958368,0.2823529411764706,1.0,1.0,8/18,15.61%,TRIOBP;ADD2;TWF1;CAPZA1;ADD3;SVIL;CAPG;ADD1
prerank,actin filament capping (GO:0051693),0.5767575499296794,1.2084077184958368,0.2823529411764706,1.0,1.0,8/18,15.61%,TRIOBP;ADD2;TWF1;CAPZA1;ADD3;SVIL;CAPG;ADD1
prerank,regulation of actomyosin structure organization (GO:0110020),0.6069761253335856,1.2077655568791734,0.2797704447632712,1.0,1.0,5/13,15.85%,ROCK2;ALMS1;ROCK1;RAC1;FHOD1
prerank,regulation of cellular respiration (GO:0043457),-0.4137234722714129,-1.2075559658998158,0.21132075471698114,0.6437169364419268,1.0,7/17,26.30%,IFNAR1;TRAP1;CBFA2T3;IL10RB;PRDM16;PRELID1;NOA1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.45153962538677117,-1.2073931766121593,0.22028985507246376,0.6425119718264923,1.0,3/13,2.43%,CAMK2D;CALM1;CAV1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.34486571449054065,-1.2071988732665864,0.13793103448275862,0.6414236934420211,1.0,12/35,12.68%,FLT1;KRIT1;MEF2C;CAV1;APOE;NF1;ATP5F1A;CAV2;SYNJ2BP;THBS1;SCG2;RGCC
prerank,cellular response to organic substance (GO:0071310),-0.26238195982547363,-1.206789040744647,0.1,0.6409223876957839,1.0,45/116,24.64%,STAT3;ACVR1;LEF1;ACVR2A;MAPK8;TGFBR2;BMPR2;AKAP6;ACVRL1;MAP2K5;NFAT5;SOCS2;KLF4;IL1RAPL1;RAMP1;TIPARP;RAMP2;ACVR2B;INPP5K;CTNNB1;SLIT2;PTPN14;PTPN11;ASAH2;LDLRAP1;SHC1;TBK1;SLC1A1;ROBO2;DCPS;ADRA2A;ERBB2;PTPN9;BMPR1B;CLEC3B;PTPN12;PARK7;CERS1;NOS1;RACK1;SLIT3;SPHK1;URI1;ARL6IP5;PLK5
prerank,regulation of hydrolase activity (GO:0051336),-0.2961991751142474,-1.2062382799471874,0.1206896551724138,0.6407994847667806,1.0,17/71,12.12%,PRKG1;PTK2;EPHA5;CHN2;NTRK2;FGD5;CAV1;VAV3;RABGAP1;TDG;ARHGEF5;NF1;ARHGAP44;PLXNC1;RASIP1;RAB3GAP2;ARHGAP27
prerank,protein targeting to mitochondrion (GO:0006626),-0.3185191994294019,-1.2059510557557018,0.18823529411764706,0.6400452096937259,1.0,28/52,31.75%,IMMP2L;FIS1;DNAJC19;HSPD1;AIFM1;IMMP1L;TIMM44;TOMM70;BCAP31;GDAP1;AIP;FBXO7;TOMM34;DNAJC15;PAM16;TIMM17A;TOMM7;TIMM17B;CHCHD4;TIMM9;TIMM13;TOMM22;TIMM8B;NDUFA13;ROMO1;GRPEL1;TOMM5;TIMM29
prerank,histone H4 deacetylation (GO:0070933),0.6272605813113029,1.2056402673107338,0.271889400921659,1.0,1.0,5/10,12.62%,SMARCAD1;RCOR1;HDAC8;HDAC1;HDAC2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.6102660710558612,1.2054452026759528,0.2857142857142857,1.0,1.0,5/12,13.47%,NEDD4;KHDRBS1;TPR;NUP214;RBM4
prerank,protein-containing complex subunit organization (GO:0043933),0.5095798245936178,1.2049730748784084,0.21747967479674796,1.0,1.0,23/109,14.67%,KNTC1;FANCA;NDC1;KPNA3;NUP205;TEAD1;MDM4;ADD2;ZW10;TPR;PML;DARS1;YAP1;PICALM;IKBKG;KMT2A;CAPZA1;SOX9;DMTN;PPID;EPRS1;CAPG;NUP133
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.569990207877191,1.204772934217516,0.2866323907455013,1.0,1.0,7/21,11.15%,RPA1;CHD1L;ERCC4;RPA2;ERCC3;CUL4B;XPA
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.569990207877191,1.204772934217516,0.2866323907455013,1.0,1.0,7/21,11.15%,RPA1;CHD1L;ERCC4;RPA2;ERCC3;CUL4B;XPA
prerank,positive regulation of glucose import (GO:0046326),-0.39810027517157776,-1.2029475696145093,0.23788546255506607,0.6462335737301712,1.0,9/21,13.59%,OCLN;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;IRS1;PTPN11
prerank,dendritic cell chemotaxis (GO:0002407),0.6019660768094734,1.202856190981497,0.2801724137931034,1.0,1.0,4/14,12.52%,CXCR4;HMGB1;TRPM2;TRPM4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5952109477202217,1.2024472693028325,0.2731034482758621,1.0,1.0,8/14,20.61%,ADK;LHPP;ADSL;PFAS;RFK;GART;PPAT;ADSS2
prerank,negative regulation of cell development (GO:0010721),0.5522080209519323,1.2024341114071204,0.2898550724637681,1.0,1.0,6/25,11.97%,GSK3B;FBN1;PCM1;FBXW7;RFLNA;APPL2
prerank,positive regulation of apoptotic process (GO:0043065),0.4972980748159706,1.201887725237803,0.12,1.0,1.0,44/293,11.40%,TOP2A;ECT2;MELK;BARD1;E2F1;STPG1;ITGB3BP;FADD;STK17B;BMF;IAPP;AIFM2;FAM162A;PRNP;NET1;CCAR1;FAF1;STK3;ERCC3;FGD4;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;ING4;BCLAF1;KLF11;TNFRSF10B;DNM2;HMGB1;APAF1;TGFBR1;BOK;IP6K2;ARHGEF18;QRICH1;BMP2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5688450929743409,1.2017875359230592,0.2922885572139303,1.0,1.0,8/24,12.41%,ZRANB3;RTEL1;MSH3;ERCC4;BLM;KMT2A;TERF2;MSH6
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4106090444614408,-1.2017759876394591,0.189873417721519,0.6477179442496033,1.0,5/18,8.00%,FLT1;MEF2C;FGF2;PLCG1;IGF2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4658346278038401,-1.201017344875006,0.23948220064724918,0.6481306104232257,1.0,7/11,29.59%,ATF6;HSPA5;CEBPB;CREB3L1;DDIT3;ATF6B;MBTPS2
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4321439491460327,-1.2009907671992928,0.23461538461538461,0.6466634106760863,1.0,8/16,39.61%,TRIB2;TNFRSF21;CD274;TYROBP;JAK3;FCGR2B;DLL1;AGER
prerank,proteoglycan biosynthetic process (GO:0030166),-0.35483935795665267,-1.2008405000447868,0.20212765957446807,0.645513378667849,1.0,12/31,19.05%,IGF1;BMPR2;CSGALNACT1;CHST9;FAM20B;NDST3;HS3ST3B1;EXTL3;CANT1;BMPR1B;B3GAT2;XYLT2
prerank,regulated exocytosis (GO:0045055),-0.25741453855687974,-1.2006578171428566,0.0,0.6444893553447105,1.0,54/173,20.57%,CYRIB;PCLO;RIMS1;VWF;TMSB4X;PECAM1;TIMP3;CALM1;VEGFC;IGF1;SYT1;APOOL;TGFB2;RAB27B;GAS6;PLEK;PSAP;ISLR;LYN;ABCC4;IGF2;SYT7;LHFPL2;ENDOD1;SCG3;SRGN;APP;TAGLN2;CHID1;THBS1;SYT11;SYT12;RAB11FIP2;RAB11FIP1;VEGFA;TMX3;HABP4;STEAP2;CPLX1;LAMP2;SCCPDH;TGFB3;SNAP25;SYT10;ACTN1;VEGFB;SYT6;TEX264;CLEC3B;VEGFD;SPARC;LGALS3BP;ITGB3;SYT2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3944496660292911,-1.1998736877247347,0.22,0.6450901947085855,1.0,7/21,10.95%,MEF2C;HSP90AB1;CALM1;PDGFRB;PLEK;GPLD1;MTOR
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5833181243807939,1.1997880327021304,0.28230337078651685,1.0,1.0,1/13,1.19%,GLI2
prerank,pseudouridine synthesis (GO:0001522),-0.4473090275157512,-1.1994882001833531,0.23487544483985764,0.6445960504885095,1.0,11/13,42.88%,PUS10;TRUB1;DKC1;PUS3;GAR1;NOP10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,response to alcohol (GO:0097305),-0.3615203804566325,-1.1992956260261671,0.21505376344086022,0.6435494402018067,1.0,6/27,4.69%,GRIN3A;GRIN2A;TGFBR2;GLRA1;GRIN2B;GOT2
prerank,regulation of mast cell activation (GO:0033003),-0.4811967599540585,-1.1990522917113748,0.2693409742120344,0.6426709785891135,1.0,9/10,49.96%,LYN;NECTIN2;CD84;CRLF2;MILR1;CD300LF;TSLP;PLSCR1;CD226
prerank,clathrin coat assembly (GO:0048268),-0.42829600638711385,-1.198338184578593,0.24034334763948498,0.6430599055054621,1.0,7/15,19.84%,SGIP1;NSG2;AP2S1;HIP1;FCHO2;CLTB;NSG1
prerank,negative regulation of wound healing (GO:0061045),-0.3546737958356261,-1.1981276874540923,0.16759776536312848,0.6421232541130949,1.0,6/28,6.10%,PHLDB2;APOE;VTN;THBD;FGF2;CD34
prerank,positive regulation of neuron differentiation (GO:0045666),0.5274684847241341,1.1978595910385073,0.2909930715935335,1.0,1.0,4/40,6.82%,ECT2;RHOA;ZEB1;TCF4
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5427662720970192,1.1978276187564956,0.27539779681762544,1.0,1.0,6/27,9.98%,E2F1;AQP1;DHX9;PDGFRA;AGT;DDR2
prerank,regulation of cell population proliferation (GO:0042127),0.5026736356055842,1.197814252787139,0.027,1.0,1.0,106/691,12.76%,PRC1;KIF20B;KIF14;SHCBP1;E2F7;CDKN3;UHRF1;EZH2;TTK;BIRC5;RAB33B;SAPCD2;TCFL5;HMGB2;TIPIN;SPDYA;MATK;CDKN2D;NAP1L1;FBXO5;TIMELESS;PPM1D;CDKN2C;KSR1;BMPR1A;PHIP;PDS5B;FGFR4;RHOA;CEP43;CDC6;CTCF;FGFR2;FXN;GAREM1;DDRGK1;RBFOX2;ALDH1A2;MDM4;ARID2;KIT;PRKDC;CNOT6L;CTBP1;CCAR1;PDPN;NMI;COL18A1;BMP6;PTPN2;TCF7L2;RTKN2;HP1BP3;RBBP4;PML;DERL2;CDC25B;PDGFRA;SFRP2;POU3F2;WWTR1;CLMN;CDK2;BTG3;SMAD6;CNOT6;IRF1;ING4;GRK5;CDCA7;CUL3;KLF11;AXIN2;KANK2;YAP1;VHL;ABI1;ELN;NPR3;NOX4;AGT;PPP2R5C;CDC123;S1PR2;TGFBR1;LIMS1;TRAPPC14;BOK;CRKL;CNTF;HDAC1;BMP2;STOX1;P3H1;GLP2R;PLPP1;NCK2;ADAM17;KMT2D;WNT9A;TRPM4;SOX9;TES;HDAC2;ATF5;IL31RA
prerank,embryonic digit morphogenesis (GO:0042733),0.5738469223247632,1.197704787063538,0.2728494623655914,1.0,1.0,8/18,18.17%,GLI3;MAP3K20;WDPCP;HDAC1;HDAC2;TWIST1;SALL1;OSR1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.4879989854007952,-1.1974062025791437,0.22740524781341107,0.6425432805705901,1.0,5/10,26.48%,DIP2A;PRKAA1;KLF15;PARK7;MYOCD
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.36720298195613493,-1.1968102798842584,0.2087912087912088,0.6425865843936974,1.0,13/26,32.32%,EPHA5;KLF7;STX4;ANO1;GPLD1;ADCY8;ADRA2A;EFNA5;PIM3;BAIAP3;ADCY5;NR1H4;CFTR
prerank,regulation of ERAD pathway (GO:1904292),-0.47667272405432864,-1.196605948860836,0.25382262996941896,0.641622092331005,1.0,6/11,27.85%,ATXN3;UBXN1;AQP11;TMEM259;USP19;RNFT1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4013086000954304,-1.1962476704389116,0.17959183673469387,0.6410272422069492,1.0,8/17,18.55%,HSP90B1;OS9;UFD1;DERL1;SELENOS;SEC61B;AUP1;SYVN1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.487920237768391,-1.1960058657167516,0.27350427350427353,0.6401295366627506,1.0,8/10,33.47%,SLC1A2;SLC25A13;SLC25A12;SLC1A1;ARL6IP5;SLC25A18;SLC1A6;PRAF2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.32225092607238714,-1.1950620909779215,0.19858156028368795,0.6410770123593681,1.0,17/40,19.78%,SGIP1;INSR;VTN;BICD1;DAB2;B2M;HNRNPK;SFRP4;LDLRAP1;HIP1;VEGFA;PICK1;CBL;PPT1;AHI1;TBC1D5;DGKD
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6048409610895489,1.194804149426771,0.2976878612716763,1.0,1.0,3/13,9.93%,BARD1;TPR;RANGAP1
prerank,intestinal lipid absorption (GO:0098856),0.6201143819533409,1.194751860685315,0.28424153166421207,1.0,1.0,3/11,20.17%,SOAT2;LDLR;UGCG
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3523980238738248,-1.1944040848759234,0.2094240837696335,0.6412323730695771,1.0,8/29,19.73%,PLA2G4A;PLAAT3;PNPLA8;NR1H3;LPCAT2;DBI;NR1H2;PLA2G12A
prerank,regulation of viral life cycle (GO:1903900),0.5650239041206946,1.194382626968112,0.2758169934640523,1.0,1.0,2/21,2.48%,KPNA2;TRIML2
prerank,negative regulation of vascular permeability (GO:0043116),-0.45643760120613697,-1.1942077520677712,0.23529411764705882,0.6403325658766853,1.0,7/12,23.72%,PDE3A;CLDN5;RAMP2;SLIT2;VEGFA;PDE2A;SH3GL2
prerank,protein-DNA complex disassembly (GO:0032986),0.578327201382215,1.1940795329436518,0.29756795422031473,1.0,1.0,5/16,8.78%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,pulmonary valve development (GO:0003177),-0.39656816797604644,-1.1937949337763838,0.2324561403508772,0.6399570631109719,1.0,9/18,16.20%,JAG1;BMPR2;TGFB2;NOS3;TNFRSF1B;SLIT2;HEYL;STRA6;ROBO2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.548323647767315,1.1930882590804954,0.2829028290282903,1.0,1.0,8/23,14.77%,PLK1;UBE2K;S1PR2;CALM2;STOX1;TRIM6;CAB39;RPTOR
prerank,import into cell (GO:0098657),0.5254205915470899,1.1928703155411795,0.2734646581691773,1.0,1.0,4/41,8.06%,NEURL1B;TSPO2;SLC19A1;SLC16A2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.35661064342371696,-1.1928038209293763,0.18674698795180722,0.6409699101616654,1.0,12/30,20.05%,FHIT;HSP90AB1;OGT;MAP1A;GIPC1;SGTA;CCAR2;SDCBP;UBXN1;RYBP;SVIP;PARK7
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.296593541263346,-1.1923979104925042,0.11764705882352941,0.6391530674904049,1.0,24/56,25.20%,NDUFS5;OXA1L;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFB9;DMAC2;ACAD9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;TIMMDC1;NDUFA10;NDUFS6;NDUFA1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.296593541263346,-1.1923979104925042,0.11764705882352941,0.6391530674904049,1.0,24/56,25.20%,NDUFS5;OXA1L;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFB9;DMAC2;ACAD9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;TIMMDC1;NDUFA10;NDUFS6;NDUFA1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3437944135744795,-1.1923507313998942,0.19161676646706588,0.6378218491992677,1.0,20/33,34.93%,IGF1;PIK3C2B;PIK3R1;MYO16;NYAP2;NF1;IRS1;HTR2A;ERBB2;PIK3CD;PIK3CA;PIK3R2;EDN1;PIK3R5;ERBB3;PIK3C2A;C1QBP;AKT1;TYRO3;HTR2B
prerank,peptidyl-serine modification (GO:0018209),0.49694209701748926,1.1919776004436888,0.1903807615230461,1.0,1.0,49/166,18.83%,CDK1;TTK;CLSPN;PLK1;MASTL;MAST2;DYRK1A;AURKA;ROCK2;GSK3B;GALNT1;PRKDC;DYRK3;VRK2;WNK1;CDK2;LRRK2;ROCK1;MARK2;CSNK2A2;CAMK1D;TGFBR1;EIF2AK3;PRKCB;PRKCA;ULK2;PDPK1;CSNK1G2;MAPKAPK3;PRKCE;PRKD1;PRKCI;CAB39;PLK2;MORC3;VRK1;PRKD2;STK39;HIPK3;ATR;CSNK1A1;MAST4;CSNK1G1;SRPK2;MAST1;PKN2;MAPK14;HIPK1;CAMKV
prerank,bile acid and bile salt transport (GO:0015721),-0.36157471752277687,-1.1915410295960802,0.21195652173913043,0.6383736097765287,1.0,4/24,7.82%,SLCO1C1;SLCO2B1;ABCC4;ATP8B1
prerank,histone deacetylation (GO:0016575),0.5126740149734866,1.1911178585405806,0.29133858267716534,1.0,1.0,14/43,14.80%,MIER1;SMARCAD1;TBL1XR1;MIDEAS;RCOR1;MSL3;MIER3;HDAC8;MTA3;SFPQ;HDAC1;HDAC2;ELK4;PER1
prerank,regulation of protein kinase activity (GO:0045859),0.5009501799211836,1.1904465396727222,0.22974358974358974,1.0,1.0,12/106,10.11%,CENPE;ECT2;SPDYA;RB1;CEP43;TAB1;CCN1;WWTR1;MRNIP;GNAQ;DDR2;CEP85
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4692155904263059,-1.1902165154611715,0.26791277258566976,0.6404356552720827,1.0,3/10,19.55%,CTNNB1;LRP6;FZD1
prerank,positive regulation of cell communication (GO:0010647),-0.355546770230187,-1.1900104534588496,0.17341040462427745,0.6395575956784946,1.0,12/28,27.00%,RIMS1;SYT1;LGI1;HOMER1;DLG4;GRIK2;KCTD13;CDKN2AIP;NMU;EDN1;SOX11;EDN3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5896389588550596,1.189766040949289,0.29172714078374457,1.0,1.0,4/14,13.64%,LOXL3;LIMS1;DMTN;PRKD1
prerank,C4-dicarboxylate transport (GO:0015740),-0.4379422009927342,-1.1877772060829597,0.23465703971119134,0.6435560297444471,1.0,6/14,18.11%,SLC1A2;SLC25A13;SLC25A12;LRRC8D;SLC1A1;SLC25A11
prerank,protein mannosylation (GO:0035268),0.5500246468070854,1.1870435846073524,0.30200501253132833,1.0,1.0,6/22,11.99%,POMT1;LARGE1;CRPPA;FKRP;RXYLT1;TMTC4
prerank,replicative senescence (GO:0090399),0.5963629054768841,1.1867896756991443,0.2985507246376812,1.0,1.0,6/12,19.61%,CHEK2;CHEK1;SERPINE1;TP53;ATR;TERT
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5969196700721706,1.1854310586591246,0.30248618784530384,1.0,1.0,4/13,14.37%,DYRK1A;YJU2;TWIST1;CD44
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.36336279927814924,-1.1844209785672006,0.22119815668202766,0.6507815436100322,1.0,10/28,13.93%,SHANK3;APOE;SQSTM1;EPHB2;LGMN;RELN;CHRNA7;ABL1;APP;ADCY8
prerank,positive regulation of cell cycle (GO:0045787),0.5056263103309654,1.1840419205108912,0.27467811158798283,1.0,1.0,12/62,12.39%,CCNB1;TGM1;SPDYA;PSRC1;FGFR2;EIF4E;CDC25B;CHEK1;CCDC57;TAL1;PRKCA;ADAM17
prerank,receptor metabolic process (GO:0043112),-0.31430282248788194,-1.1837678412873829,0.13953488372093023,0.650987051801764,1.0,16/53,12.14%,DNM3;KIF16B;CALCRL;CAV1;BECN1;LRP1;ACKR3;PIK3R4;RAMP1;DNM1;RAMP2;LGMN;CD81;AP2M1;GRB2;ARFGEF2
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.33760249754756816,-1.1836712443336859,0.22297297297297297,0.6497752222307124,1.0,16/32,26.58%,PSEN1;TMSB4X;INSR;IGF1;PFKFB3;PRKAA1;APP;PINK1;NUPR1;ENO1;PPARGC1A;P2RX7;HIF1A;ENTPD5;PRXL2C;BEND3
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3732838182841888,-1.1836280379678963,0.2409090909090909,0.6484629592862116,1.0,4/22,3.48%,ATP1B1;CALM1;RYR2;AKAP6
prerank,positive regulation of protein acetylation (GO:1901985),0.6006004465091515,1.182583634019794,0.3008474576271186,1.0,1.0,2/12,4.23%,CEP295;FAM161A
prerank,positive regulation of protein catabolic process (GO:0045732),0.5057868612683806,1.1825153498647345,0.2598752598752599,1.0,1.0,19/84,17.03%,DTL;BARD1;GSK3B;NEDD4;FAF1;ATG7;SMURF1;SH3D19;SNX33;SMURF2;EZR;ITCH;ADAM9;PLK2;CDKN1B;NKD1;MSN;AMER1;WWP1
prerank,regulation of humoral immune response (GO:0002920),-0.3115164917016683,-1.1822685029159776,0.14285714285714285,0.6503651756256896,1.0,19/44,39.05%,VTN;CD81;C4B;C1QB;GATA6;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;FCGR2B;C7
prerank,regulation of viral transcription (GO:0046782),-0.33045117375499533,-1.1822002427198,0.22058823529411764,0.6491063119611646,1.0,23/39,31.64%,MID2;CCNT1;NELFB;IFITM3;TRIM27;TRIM14;POLR2K;POLR2H;POLR2F;POLR2C;TRIM21;TRIM11;TRIM32;TARBP2;POLR2E;ZFP36;NELFCD;MDFIC;HEXIM1;POLR2J;NELFE;POLR2D;TRIM13
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5041483241267272,1.182122249244839,0.2569089048106448,1.0,1.0,20/87,14.39%,E2F7;RBL1;WEE1;CDKN2D;FBXO5;CDKN2C;RB1;AURKA;PSMC2;PSMD5;FBXL7;PSMB1;PSMD14;KANK2;PSMD1;PSMB9;JADE1;USP47;DLG1;PSMC6
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.45411784116980936,-1.1817082638919971,0.24752475247524752,0.648934106588704,1.0,5/11,22.21%,PRDX2;PRDX1;GPX1;PRDX3;PRDX5
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5918626092668945,1.1815360506010582,0.2936046511627907,1.0,1.0,5/12,18.14%,CBFB;ELF2;ELF1;RC3H1;RUNX1
prerank,fatty acid transport (GO:0015908),-0.4077887142848339,-1.1811240097983355,0.24150943396226415,0.6490211054650683,1.0,13/17,45.97%,APOE;GOT2;SLC27A1;SLC27A4;ACSL1;MFSD2A;FABP5;PPARG;SLC27A3;FABP3;SLC27A6;CD36;CPT1B
prerank,response to histamine (GO:0034776),-0.47299783577068033,-1.180995066441865,0.2703488372093023,0.6479341794780754,1.0,4/10,11.29%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,epithelial tube morphogenesis (GO:0060562),-0.3471411294428814,-1.180600043484982,0.18666666666666668,0.6474673317263865,1.0,14/32,16.18%,ACVR1;MEF2C;PODXL;RYR2;ACVRL1;RHOB;PAK1;RASIP1;CTNNB1;MEGF8;SLIT2;MET;SOX17;MTSS1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.5156799623437889,1.1804351072006443,0.29444444444444445,1.0,1.0,15/48,17.40%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;PNPT1;NUP98;NUP210
prerank,aortic valve morphogenesis (GO:0003180),0.5313118924406812,1.1803029234193132,0.3094384707287933,1.0,1.0,10/30,13.44%,RB1;ROCK2;EFNA1;SMAD6;ROBO1;ROCK1;ELN;SOX9;TWIST1;HEY2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5438322799131137,1.1802407906227934,0.29797377830750893,1.0,1.0,8/28,15.24%,AUNIP;PRKDC;RIF1;MRNIP;SMCHD1;PARP9;KMT5C;SHLD2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.46265318654988713,-1.1799669568600362,0.2765957446808511,0.6476276637976447,1.0,6/11,14.65%,MAP3K5;GSKIP;PRODH;PDK1;STK25;DIABLO
prerank,protein modification by small protein conjugation (GO:0032446),0.4981371139800136,1.179675168933348,0.1,1.0,1.0,73/361,14.67%,BRCA1;CCNF;UHRF1;PLK1;BARD1;UBE2T;UBE2C;RAD18;NDC1;NUP155;SAE1;UBE2S;RFWD3;RNF168;ANAPC7;TRIML2;NUP205;NUP160;BRAP;PDZRN3;CDC27;RNF220;UBE2K;DDRGK1;UHRF2;NEDD4;FBXL7;MYCBP2;PRKDC;SPSB2;NUP85;RNF43;TPR;ARRB1;ELOC;FBXW7;UBE2N;ATG7;CUL5;TRIM28;VPS18;RNF40;SMURF1;CUL3;UBE2R2;LEO1;VHL;CUL4B;FBXL17;RANGAP1;HERC2;FBXO45;TRIM63;ARRDC1;SMURF2;PCNA;NSMCE2;SUMO2;NUP214;FBXW11;TRPM4;TRIM6;RANBP2;ITCH;ATG3;USP9X;CRBN;BTRC;FBXO25;HLTF;TRIM5;BIRC6;NUP133
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.6227149845750068,1.1796176213169731,0.30303030303030304,1.0,1.0,3/11,11.30%,ATL2;ARL6IP1;STX18
prerank,neurotransmitter transport (GO:0006836),-0.27016111721901825,-1.1792084509592438,0.15,0.6480880479510687,1.0,21/73,16.79%,UNC13B;SYN3;RIMS1;GLUL;SLC1A2;GABRA2;GLS;APBA1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;SLC17A6;ATP1A2;DVL1;CPLX1;SLC1A1;SYNJ1;SNAP25
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.40674671024807985,-1.179074197026427,0.25793650793650796,0.6470311263797416,1.0,2/17,3.48%,KCNAB1;AKAP6
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4995765696110318,1.1788869581756172,0.26791277258566976,1.0,1.0,17/85,13.64%,UHRF1;RAB33B;HYAL1;FGFR2;LAMB1;PRKDC;MCC;BMP6;TCF7L2;TGFBR3;SFRP2;YAP1;ANGPT1;LIMS1;NR4A1;SOX9;PRKD1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.43867970006207335,-1.1778987572364557,0.2765273311897106,0.6487551344368901,1.0,6/13,34.29%,OXA1L;SZT2;ABL1;ATP7A;MT3;NOD2
prerank,heart morphogenesis (GO:0003007),-0.3032194779202687,-1.1769647515564834,0.18072289156626506,0.6499220389128858,1.0,15/50,15.07%,PTK2;ACVR1;INSR;RYR2;FKBP1A;ACVRL1;TGFB2;NOS3;TBX3;MEGF8;HEYL;TBX1;VEGFA;ENG;SOX17
prerank,mitochondrion distribution (GO:0048311),0.6021368011178361,1.1767171306982571,0.29518072289156627,1.0,1.0,3/12,8.29%,TRAK1;MAPT;LRRK2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4793837393623622,-1.1761635326669966,0.25766871165644173,0.6504728743511695,1.0,2/10,0.92%,CPEB3;CDC73
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.41056433794003805,-1.1759493918881359,0.24481327800829875,0.6497137613483618,1.0,12/18,31.40%,GOT2;SLC25A13;SLC25A12;MTHFD1;SMS;GOT1;NIT2;ASS1;ASPG;ADI1;ASNS;NAT8L
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5036268186408781,1.1753196199908278,0.27388535031847133,1.0,1.0,6/72,5.70%,TPX2;STMN1;DYRK1A;IAPP;SPEF1;SSH2
prerank,RNA export from nucleus (GO:0006405),0.4953954993285829,1.1747714298807523,0.26482617586912066,1.0,1.0,31/100,17.40%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;HNRNPA1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5657645698916459,1.1747697760437907,0.3171052631578947,1.0,1.0,3/20,9.55%,SAPCD2;RHOQ;PICALM
prerank,gene silencing by miRNA (GO:0035195),0.5335301275131236,1.174592012157524,0.31338028169014087,1.0,1.0,12/32,15.49%,ZC3H7A;MOV10;AGO2;CNOT1;AJUBA;CNOT6;LIMD1;PUM2;RBM4;CNOT7;ZC3H7B;TNRC6C
prerank,cognition (GO:0050890),-0.3270678613126734,-1.1744878825384735,0.1693548387096774,0.6519009583389527,1.0,18/42,27.66%,SHROOM4;PTCHD1;NF1;BBS4;SOBP;CHMP2B;CHRNA7;APP;GRM5;STRA6;CYFIP1;MFSD2A;CTNS;JAKMIP1;DOP1B;NSUN5;DGCR2;CHD7
prerank,cellular response to hormone stimulus (GO:0032870),-0.29244741873829766,-1.174256360178874,0.10526315789473684,0.6510615804330186,1.0,22/69,17.16%,THRB;STAT3;MEF2C;CAV1;AR;SOCS2;CTSB;RAMP1;RAMP2;ATP1A1;INPP5K;ATP1A3;SLC5A5;SFR1;SLIT2;ATP1A2;NSMF;SERPINB9;CTSL;ROBO2;XBP1;ADRA2A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3854066980804317,-1.1737456314913,0.2627450980392157,0.6508644363533379,1.0,4/20,3.07%,CAMK2D;ATP1B1;CALM1;RYR2
prerank,negative regulation of response to wounding (GO:1903035),0.5628468426361601,1.1732062030034585,0.3035019455252918,1.0,1.0,5/19,11.38%,RTN4R;CASK;EPHA4;SERPINE1;PTPRS
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4687261328181055,-1.1729029013656604,0.26785714285714285,0.6515967346777503,1.0,5/10,19.76%,CACNA2D1;CALM1;CACNB2;SRI;CALM3
prerank,gland development (GO:0048732),0.4994531948972539,1.172805943648818,0.2941810344827586,1.0,1.0,21/59,19.04%,GLI2;FOXE1;FADD;FGFR2;TGFBR3;PHF2;ARHGAP35;TGFBR1;DKK3;EZR;ANXA1;NKX2-1;SOX9;GFER;PKD2;MSN;SALL1;COBL;IGSF3;ZBTB1;WNT4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.24746452186803483,-1.1726125270341088,0.08333333333333333,0.6508687548995253,1.0,31/100,15.33%,PRKN;FHIT;COP1;SMAD7;HSP90AB1;NUB1;OGT;RNF180;TRIB2;UFL1;GNA12;RBX1;RNF144B;DAB2;CBFA2T3;MAP1A;SOCS5;ARAF;RNF19B;UBQLN4;GIPC1;STUB1;RNF217;ARIH2;CCAR2;SDCBP;SH3RF2;GSK3A;NKD2;ELOB;DVL1
prerank,response to interferon-alpha (GO:0035455),-0.4114843866958391,-1.1725880091125498,0.25793650793650796,0.6495201884837571,1.0,7/16,16.82%,IFNAR1;RO60;GAS6;IFITM3;ADAR;BST2;IFITM2
prerank,skeletal system development (GO:0001501),0.4884488646865074,1.1721833298129651,0.23363544813695872,1.0,1.0,26/148,12.56%,EN1;RAB33B;BMP1;GLI2;MATN3;HYAL1;WWOX;FGFR2;FBN1;MMP14;DDRGK1;SULF2;BMP6;SOX6;SLC10A7;PAPSS2;RFLNA;SULF1;ANKRD11;NPR3;TGFBR1;EIF2AK3;BMP2;P3H1;GJA1;SOX9
prerank,regulation of heart contraction (GO:0008016),-0.2643799774878368,-1.1720292001890886,0.09090909090909091,0.6495089099363702,1.0,30/90,22.37%,CAMK2D;RYR3;SMAD7;SLC8A3;ATP1B1;CALM1;RYR2;TGFB2;DMPK;ATP1A1;TPM1;ATP1B3;NPR1;TRPC1;ATP1A3;ATP1A2;ATP2B2;ATP2B3;GSK3A;SRI;TBX2;PDE4D;FXYD1;KCNQ1;CALM3;KCNJ12;NOS1;ATP2A3;P2RX4;S100A1
prerank,pyroptosis (GO:0070269),0.5723936711222812,1.1717744814007893,0.30972222222222223,1.0,1.0,4/15,14.52%,DHX9;APIP;CASP8;GSDMD
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.48947622707866334,1.1715312846276904,0.113,1.0,1.0,66/366,12.05%,ESCO2;PHF19;EZH2;ATRX;MYBL1;NSD2;TCFL5;E2F1;DSCC1;BRCA2;FBXO5;RB1;SP3;LIN54;HNRNPD;NLK;AJUBA;CHEK2;NFIA;CCNA2;SMC3;NFIL3;EIF4E;TCF7L1;SRSF10;CCAR1;GZF1;YAF2;SOX6;HP1BP3;USP37;GON4L;PML;PSPC1;MYBL2;NUCKS1;POLR2A;FUS;ORC3;MYCBP;WWTR1;PHF1;PRRX2;FOXO3;LMX1B;BNC2;MSL3;LIMD1;DNM2;NONO;NFYA;VHL;OBI1;ZNHIT3;ERC1;NR3C1;HINT1;SFPQ;TGFBR1;SLC39A8;POFUT1;NCOA2;BMP2;AHR;ATXN1;SPTY2D1
prerank,P-body assembly (GO:0033962),0.5760974696529637,1.171415576373143,0.30389221556886226,1.0,1.0,7/12,17.41%,PATL1;LSM3;EIF4ENIF1;LIMD1;RC3H1;LSM4;EDC3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3181475333523777,-1.1705426026293928,0.16923076923076924,0.6517290964260227,1.0,9/41,6.47%,CACNA2D1;RYR3;SLC8A3;GRIN2A;RYR2;GRIN2B;SLC24A2;FGF2;HTR2C
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.48911576831707865,1.1695253108148356,0.004,1.0,1.0,345/1646,15.87%,DEPDC1;CENPF;BRCA1;E2F7;NR2E3;E2F8;RRM2;MXD3;PHF19;ATAD2;EZH2;BRIP1;EN1;BIRC5;E2F2;ATRX;MYBL1;PBX4;POLA1;NSD2;GLI2;CDK5RAP2;LOXL3;ORC1;TCFL5;GLI3;LCORL;HMGB2;E2F1;BRCA2;CBX5;TYMS;RBM15;FOXE1;ATOH8;HAS3;CDC45;BTAF1;ZBTB8A;ILF3;NAT14;MED26;ATP2B4;PSRC1;KMT5A;SFMBT1;FBXO5;TIMELESS;DYRK1A;LOXL2;ZFP69;BRD9;CBFB;SMARCC1;ZNF32;RB1;PBX3;BAZ1B;SP3;CDK14;HOXC5;DEK;PHIP;ZFP41;ETV6;TWIST2;ELF2;TRAK1;TEAD1;SP2;ZSCAN29;RAD21;RBBP8;HDGF;CDC6;CTCF;E2F3;ZEB1;LIN54;TFDP1;HNRNPD;NFE2;TFCP2L1;NLK;MPHOSPH8;MED14;EED;RBFOX2;DAP;BCOR;AJUBA;CHEK2;RFXAP;MDM4;ZNF260;SETDB2;MBD1;NFIA;KHDRBS1;HIVEP1;KIT;CUX1;PCGF5;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;CTBP1;EPC2;BLM;SRSF10;TSHZ1;ELF4;NFIB;THRAP3;KLF13;ZNF568;ZNF697;MAEL;CCAR1;TBL1XR1;SP8;IKZF1;SETD3;NUP85;CCNA1;GZF1;LCOR;PCBD2;SCML2;HOXC4;YAF2;TCF7L2;PSIP1;MED30;SOX6;ELF1;CCNE1;HP1BP3;HOXA7;GMEB1;GRHL2;GON4L;ARRB1;PML;SCMH1;ELOC;GATAD2A;TCF4;PSPC1;MIDEAS;ARID1A;MYBL2;GLIS3;TASP1;RFX2;SFRP2;ELK1;NUCKS1;POLR2A;FUS;NIPBL;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;MAMSTR;SIM1;ZBTB7B;MYCBP;WWTR1;SRCAP;ZFX;PHF1;PHF2;LIN9;ZHX2;UIMC1;PRRX2;OLIG2;FOXO3;ATF7IP;CD80;SAP18;TRIM28;LMX1B;KDM2B;PLAGL2;SMAD6;ZNF23;BNC2;RCOR1;IRF1;ING4;HMGB3;BCLAF1;CREB5;MED24;SMARCA4;MSL3;USP21;USP16;ZFP90;KLF11;LIMD1;DNM2;ZBTB25;HOXB3;YAP1;NONO;NFYA;VHL;ARID4A;PLAGL1;ZIC5;PICALM;ZBTB20;UXT;EPC1;ZNHIT3;HMGB1;AGT;ERC1;KMT2A;HOXB6;MEOX2;MTA3;NR4A2;CARF;MYPOP;NR3C1;HINT1;PARP9;SFPQ;TGFBR1;TAL1;TADA1;MMS19;RUNX1T1;CRLF3;SLC39A8;TEAD3;LIMS1;ZBTB24;TAF15;RBM15B;POFUT1;DKK3;NCOA2;SMURF2;PRKCB;PCNA;ZNF585B;ZNF585A;CHD2;QRICH1;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;KLF9;HTATSF1;TBX18;ZHX3;ATXN1;SPTY2D1;FBXW11;RBPJ;NR4A1;METTL4;ZIC4;KMT2D;SOX9;SMAD4;HDAC2;ZNF394;ATF5;IL31RA;ZNF496;ILF2;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;NCOA7;TADA2A;IRF2BP1;TWIST1;HEY2;DHFR;ACTL6B;MED1;USP47;BTRC;FOXL1;GPBP1L1;POU2F2;YY1;BCL7A;RLF;FOXK2;CDKN1B;KDM5C;CAMTA1;PCGF6;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;QARS1;ZFP91;JMJD1C;BAZ1A;SOX1;E2F4;PER1;YEATS2;RBAK;ZNF445;MED27;PRDM8;EFEMP1;HDGFL3;CNOT7;ATF1;KAT6A;TRRAP;MLF2;HOXB7;BICRA;CHD1;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,protein autophosphorylation (GO:0046777),0.49062013250200875,1.1693030238374307,0.23162134944612287,1.0,1.0,38/157,15.61%,NEK2;MELK;AURKB;DYRK1A;STK17B;AURKA;FGFR4;GSK3B;FGFR2;STK10;CHEK2;KIT;VRK2;STK24;MUSK;PDGFRA;EPHA4;LRRK2;GRK5;MAP3K3;PIM1;MARK2;DDR2;EIF2AK3;ULK2;PDPK1;AAK1;SIK2;MAPKAPK3;MEX3B;PRKD1;VRK1;STK11;TAOK1;SRC;PRKD2;STK39;PASK
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.49427625766131433,1.1691438831656917,0.27384615384615385,1.0,1.0,30/96,17.40%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,regulation of protein import into nucleus (GO:0042306),0.5225240556357996,1.169029937015374,0.2951388888888889,1.0,1.0,4/36,8.17%,ECT2;TPR;UBR5;TRIM28
prerank,positive regulation of innate immune response (GO:0045089),0.5333732004574165,1.1685377359087372,0.3217286914765906,1.0,1.0,10/30,17.16%,FADD;UBE2K;DHX9;NMI;RIOK3;POLR3D;AKIRIN2;TRIM6;SLC15A4;MAVS
prerank,regulation of filopodium assembly (GO:0051489),-0.3248493959388244,-1.167658590781147,0.1984732824427481,0.6578744519202474,1.0,11/38,9.20%,PPP1R16B;ARAP1;FNBP1L;AGRN;GAP43;PIK3R1;PALM;MYO10;RAB5A;CAPZB;ARHGAP44
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5531597469581874,1.167197654769178,0.3147208121827411,1.0,1.0,11/20,21.69%,ROCK2;RHOQ;LLGL2;ROCK1;DLG1;LCP1;FHOD1;NCKAP1;RAB13;FMNL2;IKBKB
prerank,heterochromatin assembly (GO:0031507),0.5636728503783118,1.1671952700349475,0.2997416020671835,1.0,1.0,5/20,11.99%,HELLS;NRDE2;SMCHD1;HDAC1;CENPV
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3085745643890231,-1.1668754418719485,0.22388059701492538,0.6584101089048747,1.0,12/40,21.58%,APOE;CREBL2;TLR4;LARP6;MTOR;RGCC;GRIN1;CREB3L1;TGFB3;RAB27A;SORBS1;SUCO
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3282042086947674,-1.1666118076064727,0.2074074074074074,0.657669804908849,1.0,11/37,13.88%,PRKG1;MEF2C;IGF1;PDCD4;FGF2;SOD2;TPM1;JUN;MMP2;TAFA5;LDLRAP1
prerank,positive regulation of secretion (GO:0051047),0.5973740363701393,1.1657306898857474,0.2943786982248521,1.0,1.0,1/11,1.82%,AQP1
prerank,apical junction assembly (GO:0043297),0.5118230930574519,1.1655199541141006,0.30486486486486486,1.0,1.0,5/53,6.59%,ECT2;RHOA;AFDN;CTNNA1;GRHL2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3545999698694987,-1.165428355421661,0.23834196891191708,0.6592526882381285,1.0,6/25,13.08%,AKAP6;CEMIP;PLCG1;TRPC1;CACNB2;CX3CL1
prerank,glycolipid metabolic process (GO:0006664),-0.2984561165836293,-1.1651196558148869,0.16666666666666666,0.6586173347519044,1.0,18/47,23.95%,HEXB;ST3GAL6;PSAP;ASAH1;ST6GALNAC3;ESYT1;B3GALNT1;HEXA;ST8SIA6;GBGT1;GLTP;CTSA;SCCPDH;GBA2;ST6GALNAC4;ABCA2;ESYT3;NEU1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5837473723355069,1.1642711214662855,0.30273972602739724,1.0,1.0,3/15,7.26%,IQGAP2;ACTR3;ARPC5L
prerank,nitrogen compound transport (GO:0071705),0.4811473712780899,1.16425011951654,0.2401614530776993,1.0,1.0,11/141,7.77%,CENPF;RHAG;SLC18A2;NDC1;AQP1;ZG16;SLC6A2;PDPN;SLC38A4;SLC25A47;SLC16A10
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4511372538381179,-1.1635646379948097,0.2755417956656347,0.6613467975433704,1.0,9/12,48.95%,INPP5K;PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.4250043674664265,-1.1635040452779783,0.26277372262773724,0.6600977591270113,1.0,10/14,22.66%,VEGFC;FOXC1;VEGFA;PIK3CD;VEGFB;PIK3CA;NRP1;VEGFD;NUS1;FLT4
prerank,cellular response to insulin stimulus (GO:0032869),-0.2609645525225908,-1.1623204381084367,0.08333333333333333,0.6616517419367456,1.0,38/124,14.89%,TBC1D4;FOXO1;ATP6V0A1;GRB14;GRB10;ATP6V0D1;ATP6V1E1;INSR;ATP6V0B;PIK3R3;PKM;AKT2;PIK3R1;ATP6V0A4;FOXC2;IRS2;SLC27A1;IGF2;NAMPT;INPP5K;GPLD1;SELENOS;BCAR3;IRS1;HDAC5;CAV2;PARP1;GRB2;ATP6V0C;KAT2B;RAB12;GOT1;ATP6V1H;SHC1;GSK3A;HDAC9;APC;ZDHHC7
prerank,actin crosslink formation (GO:0051764),0.5914818053284938,1.162152324737476,0.29777777777777775,1.0,1.0,4/12,15.78%,GAS2L3;DPYSL3;BAIAP2L1;LCP1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3077473235675712,-1.1615803046037687,0.2074074074074074,0.6619485322110065,1.0,13/41,14.92%,SMAD7;MEF2C;JAG1;TGFBR2;FKBP1A;CPE;TGFB2;PROX1;TPM1;SOX4;HEYL;GSK3A;ENG
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5978950339390806,1.1614888461329562,0.31993817619783615,1.0,1.0,4/11,18.73%,FADD;PRKCA;CASP8;RIPK1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6051605096621523,1.16129996747436,0.3086232980332829,1.0,1.0,1/10,1.05%,BMP1
prerank,negative regulation of cellular protein localization (GO:1903828),0.5216261548391676,1.1609010419376862,0.3218116805721097,1.0,1.0,12/34,16.79%,ROCK2;GSK3B;MAPT;LEPROT;CTNNA1;RIPOR2;PICALM;SNX33;ILRUN;OTUD7B;LZTFL1;UBXN2B
prerank,organelle organization (GO:0006996),0.484133182594344,1.1607793377387288,0.134,1.0,1.0,67/388,13.66%,DIAPH3;KIF4A;CDCA8;CEP55;MNS1;ARHGAP21;USP6NL;SYNE3;MAST2;MTFR2;MIEF2;PHIP;ARHGAP10;GBF1;OBSL1;PACSIN2;AJUBA;FAM161A;LNPK;DIAPH1;TSPO2;NUMA1;DYRK3;COG1;ZW10;RHOT1;MICAL3;TMEM11;CNN2;FGD4;ATL2;ANK1;PRPF40A;ATL3;STOML2;RAB29;PDZD8;FGD1;VPS18;LRRK2;GOLGA8B;GOLGA5;ZFYVE16;WDPCP;SH3D19;LIMD1;ODF2;LONP1;STRIP2;RAB1A;PITPNB;YTHDF2;NIPSNAP2;FGD6;CENPW;EIF2AK3;BAG5;GAK;FANCG;GORASP2;DMTN;DES;PPID;PPRC1;LARP4;PRKD1;PRKCI
prerank,carbohydrate transport (GO:0008643),0.5900560254859528,1.1605409816780115,0.30466472303207,1.0,1.0,1/11,1.82%,AQP1
prerank,regulation of T cell cytokine production (GO:0002724),-0.4289763988009431,-1.159341617092629,0.2829581993569132,0.6662713632885642,1.0,4/15,11.61%,SMAD7;MALT1;B2M;TNFRSF1B
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.34618644784348984,-1.1590008864240455,0.2159090909090909,0.6657281683042751,1.0,12/29,25.64%,APOE;CREBL2;SLC27A1;GPLD1;NR1H3;MTOR;NR1H2;SORBS1;SLC45A3;MFSD2A;CTDNEP1;MID1IP1
prerank,positive regulation of T cell differentiation (GO:0045582),0.5133942941044192,1.158968247025364,0.3111888111888112,1.0,1.0,2/36,1.27%,GLI2;GLI3
prerank,organic hydroxy compound transport (GO:0015850),-0.3228088221269724,-1.1589275533089334,0.22131147540983606,0.6645393197319294,1.0,12/36,31.66%,SLCO1C1;SLCO2B1;ABCC4;ATP8B1;SLC16A1;STRA6;STARD5;OSBP;NPC2;SLC5A3;RBP4;NR1H4
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3143579389632843,-1.1588732971562723,0.21487603305785125,0.6633026647429073,1.0,14/39,20.19%,SH3KBP1;STAM2;DUSP3;EPN1;TSG101;LGMN;TGFA;GRB2;SPRY2;ARHGEF7;ERBB2;CBL;PTPN12;HBEGF
prerank,tetrapyrrole metabolic process (GO:0033013),-0.3881476499768777,-1.1587437524862543,0.21721311475409835,0.6622779938957783,1.0,7/18,25.37%,ABCD4;CUBN;LMBRD1;MTRR;MMAA;MTR;TCN2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.35462702009941516,-1.1585592913887215,0.2028985507246377,0.661460501838644,1.0,16/24,36.58%,ATF6;GCN1;HSPA5;KLF2;CEBPB;VEGFA;CREB3L1;DDIT3;MAPK7;HIF1A;ATF6B;MBTPS2;MT3;CHD6;NFE2L2;ATF3
prerank,negative regulation of ossification (GO:0030279),0.5405783430051029,1.158501798965883,0.31389578163771714,1.0,1.0,8/23,16.06%,BCOR;CHSY1;SMAD6;ENPP1;RBPJ;TRPM4;SOX9;SFRP1
prerank,nuclear envelope organization (GO:0006998),0.553897491454149,1.158279042988834,0.3142857142857143,1.0,1.0,6/20,15.62%,NEMP1;NUP155;LEMD3;EMD;TOR1B;SUN2
prerank,atrial septum morphogenesis (GO:0060413),-0.47438263102024786,-1.1582216022414764,0.2874251497005988,0.6609047921100529,1.0,4/10,12.73%,ACVR1;BMPR2;TGFB2;SOX4
prerank,axonemal dynein complex assembly (GO:0070286),0.5327406518720298,1.1579170914390986,0.31025957972805934,1.0,1.0,8/27,19.01%,DNAAF3;DNAH1;DNAI4;DNAAF5;LRRC49;SPAG1;ODAD1;DNAH8
prerank,embryonic organ morphogenesis (GO:0048562),0.5033588329531921,1.1577856860518185,0.30855855855855857,1.0,1.0,15/42,19.70%,FOXE1;MFAP2;FGFR2;FBN1;HOXC4;PDGFRA;NIPBL;DSCAML1;HOXB3;RBPMS2;MFAP5;EFEMP1;HOXA3;DYNC2I1;ALDH1A3
prerank,regulation of macrophage migration (GO:1905521),-0.47709190342873853,-1.1572341565978042,0.27485380116959063,0.6620625795355343,1.0,8/10,45.65%,MTUS1;CD81;PTK2B;P2RY12;CD200R1;CX3CR1;EMILIN1;CSF1
prerank,regulation of macrophage differentiation (GO:0045649),0.5625220844720314,1.1563332588146917,0.3206214689265537,1.0,1.0,4/15,12.75%,FADD;PTPN2;PRKCA;CASP8
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5620807164844414,1.1562370114263008,0.3005390835579515,1.0,1.0,7/18,18.14%,RB1;PDPN;DDR2;BMP2;SMAD3;CLASP1;RUNX1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5085816434770267,1.1562333582962543,0.30056497175141245,1.0,1.0,16/44,16.35%,MOV10;ROCK2;AGO2;ZC3HAV1;CNOT1;FTO;EIF4ENIF1;ROCK1;YTHDF2;MEX3D;RC3H1;PABPC1;CNOT7;TNRC6C;PNPT1;METTL3
prerank,intraciliary retrograde transport (GO:0035721),0.5845912323013531,1.1556401248648818,0.3155680224403927,1.0,1.0,2/12,3.88%,WDR35;IFT140
prerank,dendritic cell differentiation (GO:0097028),-0.36693780755268374,-1.1554779913246414,0.21393034825870647,0.6650729302953702,1.0,4/22,6.74%,TGFBR2;GAS6;CAMK4;LYN
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6019270086473729,1.1554556457455902,0.3110773899848255,1.0,1.0,4/10,18.16%,WNK1;ADAM17;STK39;OXSR1
prerank,neuron projection organization (GO:0106027),-0.39896662240981595,-1.1547847148305046,0.2831541218637993,0.6654400118194704,1.0,10/15,19.57%,PSEN1;INSR;LGMN;MAP1A;CHRNA7;ATP1A3;APP;ABCD2;PICK1;DCTN1
prerank,purine-containing compound catabolic process (GO:0072523),0.578465549679726,1.1537696801945967,0.3178519593613933,1.0,1.0,3/13,9.06%,DPYD;XDH;ITPA
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5794936118923293,1.1536777612196367,0.31926863572433195,1.0,1.0,4/14,8.15%,SRSF4;SRSF10;SRSF7;SAP18
prerank,mRNA export from nucleus (GO:0006406),0.4877581891650129,1.153171110156065,0.28512820512820514,1.0,1.0,31/102,17.40%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;IWS1;DHX38;NUP98;NUP210
prerank,positive regulation of dendritic spine development (GO:0060999),-0.38635859237463704,-1.1526849970289976,0.26141078838174275,0.6692937794481264,1.0,8/20,14.40%,CPEB3;PSEN1;SHANK3;APOE;CAMK1;RELN;SHANK1;LRP8
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4106173962843733,-1.1526283857588702,0.27946127946127947,0.6680640910437841,1.0,7/15,22.19%,NF1;SMARCD3;CTNNB1;CX3CL1;VEGFA;TAFA1;DRD2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4791576981830824,1.1523366802557615,0.2535211267605634,1.0,1.0,18/175,11.48%,TNFSF13B;BRCA1;MAP3K14;HYAL1;PSMC2;PSMD5;ACTN4;DHX9;NPNT;YBX3;FOXO3;PSMB1;PSMD14;PSMD1;EDA;LIMS1;PSMB9;PYDC1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.42125892705070245,-1.1520863691598722,0.2668918918918919,0.668174495058496,1.0,4/13,17.37%,KCNB1;SYT1;SCAMP5;SYT10
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4793777998918691,1.1517189909379546,0.30186721991701243,1.0,1.0,23/88,16.42%,HAS3;FNIP1;HYAL1;GSK3B;BMF;TRABD2B;AJUBA;FAF1;SLF1;SPIDR;TPR;CDC42EP2;STAM;SH3GLB1;TPPP;SDC1;TAL1;STX18;PRKCA;SYNPO2;SMAD3;RHOC;SMPD3
prerank,regulation of proteolysis (GO:0030162),0.5007856119412244,1.1510866903068122,0.31596452328159647,1.0,1.0,11/48,13.89%,PLK1;FADD;FGFR4;DNAJC1;FBXW11;HDAC2;CASP8;ITCH;PLAUR;BTRC;SPOP
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3400437080571721,-1.1502497260727693,0.2265193370165746,0.6715035993442046,1.0,8/30,13.05%,EP300;SAFB2;AR;PRMT2;KDM4C;DAB2;DDX5;HEYL
prerank,mRNA transport (GO:0051028),0.48756002204200993,1.1502461290219872,0.2893923789907312,1.0,1.0,31/101,17.40%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;FMR1;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3672173191341419,-1.1501415908679289,0.2576419213973799,0.670441821090793,1.0,5/19,13.66%,ABHD5;AKT2;IRS2;IRS1;ABCD2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.31043321074273156,-1.1500855784302053,0.26582278481012656,0.6692025742201135,1.0,12/34,22.05%,SMAD7;ATP1B1;CALM1;RYR2;ADRA1A;SRI;PDE4D;KCNQ1;ZC3H12A;CALM3;NOS1;P2RX4
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5756631322131399,1.1497650858169683,0.3328591749644381,1.0,1.0,5/14,16.27%,RHOA;RAP2A;SCRIB;EZR;MSN
prerank,platelet degranulation (GO:0002576),-0.26235157978102186,-1.1495198213832414,0.19047619047619047,0.6692721611812662,1.0,40/118,20.57%,CYRIB;VWF;TMSB4X;PECAM1;TIMP3;CALM1;VEGFC;IGF1;APOOL;TGFB2;RAB27B;GAS6;PLEK;PSAP;ISLR;LYN;ABCC4;IGF2;LHFPL2;ENDOD1;SCG3;SRGN;APP;TAGLN2;CHID1;THBS1;VEGFA;TMX3;HABP4;LAMP2;SCCPDH;TGFB3;ACTN1;VEGFB;TEX264;CLEC3B;VEGFD;SPARC;LGALS3BP;ITGB3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.47604514176526513,-1.1488624854790668,0.3112391930835735,0.6696351883541996,1.0,6/10,21.77%,AKT2;IRS2;GPLD1;IRS1;PTH1R;SLC45A3
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3100696644059276,-1.1487944608794203,0.2413793103448276,0.6684799774039669,1.0,10/39,14.56%,PTK2;PODXL;JAG1;MAP2K5;NEXMIF;KLF4;FXYD5;RGCC;PPM1F;VEGFA
prerank,carnitine metabolic process (GO:0009437),-0.4412849228251319,-1.1486046700378476,0.24926686217008798,0.6676491382962334,1.0,4/12,11.12%,TMLHE;ACADM;CROT;BBOX1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.36403512207688415,-1.1480414334332647,0.24186046511627907,0.6676397869970413,1.0,9/23,12.93%,KIF1B;MYO10;DYNC1I2;KIF1A;KIF5B;KIF5C;TUBA1A;TUBA1B;HOOK1
prerank,protein polyubiquitination (GO:0000209),0.4787539717398884,1.1472978809976735,0.185,1.0,1.0,57/297,15.05%,DTL;BRCA1;CCNF;BARD1;UBE2T;UBE2C;UBE2S;RNF168;ANAPC7;CBFB;TRIML2;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;SIAH2;FBXW7;FBXO30;UBE2N;PRPF19;FBXL8;RNF31;RC3H2;UBR5;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;PSMD1;SKP2;TPP2;FBXL17;UBOX5;PSMB9;SMURF2;FBXW11;TRIP12;TRIM6;ITCH;IRF2BP1;UBE2J1;BTRC;FBXO27;ZNRF2;SPOP;RC3H1;TRIM5;PSMC6;RNF114;UBE2QL1;ZNRF1;ZFP91;FBXO17;NPEPPS
prerank,histone H2A acetylation (GO:0043968),0.5568507951784252,1.1466346465827284,0.34081346423562414,1.0,1.0,10/16,23.74%,MSL3;EP400;EPC1;RUVBL2;TRRAP;BRD8;NAA40;MEAF6;ACTL6A;MORF4L2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.45719340478165993,-1.1463244175985934,0.29260450160771706,0.6706019057092566,1.0,3/11,9.42%,MERTK;GAS6;SELENOS
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.4425755274436135,-1.146187285467851,0.3116438356164384,0.6695486257848444,1.0,5/12,19.45%,AKT2;IRS2;IRS1;ABCD2;PPARGC1A
prerank,cortical cytoskeleton organization (GO:0030865),0.5054497866792441,1.1459221570984781,0.3440366972477064,1.0,1.0,20/41,22.90%,ROCK2;RHOA;RHOQ;LLGL2;ROCK1;EPB41L3;RND2;EZR;RAC1;DLG1;RHOC;LCP1;FHOD1;NCKAP1;RAB13;TRPV4;FMNL2;RND3;IKBKB;RHOH
prerank,phospholipid catabolic process (GO:0009395),-0.3597193943543162,-1.1458572037574648,0.2488479262672811,0.6690597274750018,1.0,7/24,14.75%,GPCPD1;PLA2G4A;ABHD12;PNPLA6;ENPP6;GDPD3;GDPD1
prerank,cellular response to peptide (GO:1901653),-0.2854886054092636,-1.1448715721705929,0.23170731707317074,0.6701321876136493,1.0,20/56,14.10%,CACNA2D1;PSEN1;GRIN2A;CAV1;IGF1;TLR4;LRP1;RPL23;CASP4;TRIM41;VCAM1;LGMN;NOD1;PTPN22;ATP1A3;APP;ARHGEF2;GRM5;CHMP5;GRIN1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.46904383356987134,-1.1446906646156032,0.32456140350877194,0.6692608618573022,1.0,4/11,7.95%,FOXO1;ATP6V0D1;CAV1;FAS
prerank,cardiac conduction system development (GO:0003161),0.5382744094636968,1.1440696747540415,0.33705080545229243,1.0,1.0,7/24,13.44%,BMPR1A;TBX18;GJA1;SMAD4;NOTCH2;MAML1;HEY2
prerank,ubiquinone biosynthetic process (GO:0006744),-0.41255673204578064,-1.1440396861325808,0.2689393939393939,0.6696610924871307,1.0,6/15,12.22%,COQ8B;COQ5;NDUFA9;COQ10A;COQ3;PDSS2
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.38019884483009303,-1.1431571533317086,0.25660377358490566,0.6704247086163002,1.0,5/20,10.73%,IL1R1;MALT1;B2M;DENND1B;CD81
prerank,blood vessel diameter maintenance (GO:0097746),0.5130180953782273,1.1431366883174297,0.34624697336561744,1.0,1.0,7/34,9.77%,KEL;ROCK2;SCPEP1;ROCK1;BDKRB2;KCNMB2;AGT
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39186044324155345,-1.1427132320660411,0.24369747899159663,0.6701159943613725,1.0,4/18,9.25%,OCLN;SLC2A1;CLIP3;INPP5K
prerank,leukotriene biosynthetic process (GO:0019370),-0.42960287659981256,-1.1425394272927938,0.28413284132841327,0.6692548559831595,1.0,2/14,7.68%,PLA2G4A;GGT5
prerank,T cell differentiation (GO:0030217),0.5081147380684188,1.1424675556593251,0.3431151241534989,1.0,1.0,8/40,12.39%,GLI3;FADD;KIT;LEPR;PTPN2;ANXA1;LMBR1L;ADAM17
prerank,epithelial cell migration (GO:0010631),0.5084791162448549,1.142188969346274,0.3436426116838488,1.0,1.0,7/37,9.38%,ANLN;LOXL2;RHOA;KIT;ADGRA2;KANK2;ROCK1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.3840022357402101,-1.1419511812299625,0.2923728813559322,0.6695221553226554,1.0,9/19,19.05%,CSGALNACT1;HS6ST3;NDST3;NDST1;HS3ST3B1;NDST2;EXTL3;NDST4;XYLT2
prerank,negative regulation of telomere maintenance (GO:0032205),0.5695040990835869,1.1410115698377605,0.3238095238095238,1.0,1.0,7/15,18.76%,TERF1;RTEL1;ERCC4;TERF2;SMG6;TERF2IP;RAD50
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4461355315179071,-1.140977384420756,0.3115727002967359,0.6708083072228085,1.0,5/12,14.56%,STAT3;SDK2;PROM1;RORB;VEGFA
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3588594200000098,-1.140889933253517,0.24423963133640553,0.6697286981980981,1.0,8/24,25.83%,PLA2G4A;CDS2;SLC27A1;PNPLA8;SERAC1;PLA2G12A;PLA2G15;ABCA3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3763871713203458,-1.1407946983127906,0.3076923076923077,0.6686301172130139,1.0,4/21,3.48%,CAMK2D;CALM1;RYR2;AKAP6
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.3444227646984635,-1.1406422528669427,0.255,0.6677669915348861,1.0,9/25,19.33%,PSEN1;ITGA6;AR;APP;THBS1;SDCBP;PTH1R;NCKAP1L;NRP1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.570122156305181,1.140338432660234,0.318941504178273,1.0,1.0,4/14,15.24%,PAXIP1;RIF1;KMT5C;SHLD2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5012177511446156,1.1402169539916747,0.32195676905574516,1.0,1.0,5/43,9.03%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,endodermal cell fate commitment (GO:0001711),-0.47041146365900655,-1.1400102334429463,0.3048780487804878,0.668084030094853,1.0,4/10,17.59%,CDC73;RTF1;SOX17;SOX2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5575878400123917,1.1398211003388699,0.3209549071618037,1.0,1.0,6/16,15.24%,PRKDC;RIF1;SMCHD1;PARP9;KMT5C;SHLD2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5724229337661833,1.1394016568087173,0.3373134328358209,1.0,1.0,2/12,8.14%,IL18;CD80
prerank,coenzyme A biosynthetic process (GO:0015937),0.5809984324232517,1.1393942328911246,0.33185840707964603,1.0,1.0,7/11,24.89%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5809984324232517,1.1393942328911246,0.33185840707964603,1.0,1.0,7/11,24.89%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5809984324232517,1.1393942328911246,0.33185840707964603,1.0,1.0,7/11,24.89%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.47674101102500277,1.1390964187909516,0.197,1.0,1.0,77/341,16.79%,DTL;KIF14;UHRF1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;RNF168;ANAPC7;AURKA;VPS37B;FEM1C;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;UBR4;SPSB3;KLHL15;SIAH2;SPSB2;TBL1XR1;FAF1;RNF43;BUB3;ARRB1;PML;ELOC;FBXW7;VPS37A;RC3H2;AGAP3;RNF40;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;KCTD2;KLHL22;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;ARRDC1;SMURF2;ADRM1;FBXW11;TRIP12;ITCH;COPS3;USP9X;CRBN;BTRC;SPOP;RC3H1;PSMC6;RNF114;ZNRF1;BIRC6;ANAPC15;OTUD7B;ASB2;NTAN1;CNOT4;FBXL14;RAD23B;ANAPC5;SIAH3;UBXN2B
prerank,mitochondrial fusion (GO:0008053),0.5450566540594003,1.138585420881298,0.3243606998654105,1.0,1.0,8/18,20.47%,MIEF2;STOML2;MFN2;MIEF1;CHCHD3;MFN1;MIGA2;SPG7
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.323301040742461,-1.1385249051319282,0.24324324324324326,0.6703870441528587,1.0,13/32,20.66%,EP300;FHIT;PPP1R13B;CDIP1;HIPK2;MSH2;DDX5;DYRK2;DDIT4;RRP8;SNW1;BCL3;MYBBP1A
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5401321399362344,1.138453033222246,0.31926121372031663,1.0,1.0,2/18,3.93%,PLK1;MMP14
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.39133655003148404,-1.1381931486669576,0.2786885245901639,0.669922853306918,1.0,13/20,37.03%,ACLY;ACSL4;PPT1;CBR4;SCD;FASN;FAR2;HSD17B8;DGAT2;FITM2;GCDH;SCD5;PPT2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4800663270225588,1.1376696673688276,0.3145491803278688,1.0,1.0,28/101,16.96%,UHRF1;PLK1;FADD;FGFR4;LARP4B;HNRNPD;PRKDC;UPF3B;FAF1;SAMD4A;FMR1;ATG7;AGT;PLXNB2;METTL5;EZR;EIF3C;FBXW11;HDAC2;CASP8;LARP4;BTRC;FXR1;PASK;MSN;METTL3;AMER1;PYM1
prerank,negative regulation of translation (GO:0017148),0.4809851508191849,1.137334931781627,0.31524008350730687,1.0,1.0,26/87,16.35%,TYMS;ILF3;SYNCRIP;ROCK2;AGO2;CNOT1;FTO;EIF4ENIF1;SAMD4A;CAPRIN1;TPR;FMR1;LARP1;CPEB2;ROCK1;YTHDF2;MRPL13;EIF2AK3;MEX3D;RBM4;DHFR;EPRS1;CNOT7;FXR1;UNK;METTL3
prerank,positive regulation of vasculature development (GO:1904018),0.4767868832830701,1.1373208399125327,0.3029682702149437,1.0,1.0,20/94,14.27%,BRCA1;VASH2;AQP1;ANGPT4;HYAL1;AGO2;ADAM12;ANXA3;SFRP2;HSPB6;SERPINE1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PRKD1;ITGB1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4808040288352306,1.1369642631118761,0.3076923076923077,1.0,1.0,10/76,9.25%,BRCA1;SAE1;PAXIP1;FANCI;MYCBP2;FBXW7;LRRK2;CUL3;ANGPT1;TBC1D7
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.558955642000813,1.1367901983113946,0.3585164835164835,1.0,1.0,7/15,15.49%,AGO2;CNOT1;EIF4ENIF1;TENT4A;PABPC1;CNOT7;TNRC6C
prerank,regulation of cartilage development (GO:0061035),0.558259600055625,1.1362408838958127,0.32390745501285345,1.0,1.0,5/18,12.56%,BMP1;SOX6;TAPT1;BMP2;SOX9
prerank,artery morphogenesis (GO:0048844),-0.33538694969884464,-1.1361008822582501,0.24489795918367346,0.673957056306191,1.0,14/30,21.15%,SMAD7;JAG1;BMPR2;TGFB2;PDGFRB;LRP1;NF1;TBX1;VEGFA;ENG;STRA6;TBX2;NRP1;HPGD
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3261268622260729,-1.1360857806264981,0.2155688622754491,0.6726830994297742,1.0,17/34,23.86%,FLT1;SEMA6A;VEGFC;FOXC1;RAMP2;SPRY2;VEGFA;ITGB1BP1;VEGFB;PIK3CA;NRP1;VEGFD;MT1G;HSPB1;NUS1;FLT4;SPHK1
prerank,digestive tract morphogenesis (GO:0048546),0.5562228126589612,1.135689226535979,0.3398876404494382,1.0,1.0,4/14,10.81%,FGFR2;PDGFRA;NIPBL;RBPMS2
prerank,regulation of actin filament-based process (GO:0032970),0.48521096137089315,1.1352655075137106,0.3194888178913738,1.0,1.0,13/70,12.64%,IQGAP3;IQGAP2;ROCK2;RHOA;ARHGAP18;CNN2;RHOQ;ROCK1;ARHGAP35;RND2;EZR;RAC1;DMTN
prerank,embryonic eye morphogenesis (GO:0048048),0.5859346415379559,1.1346392269959737,0.3406754772393539,1.0,1.0,5/11,15.22%,MFAP2;FBN1;KDM2B;MFAP5;EFEMP1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5834253382299177,1.134519946173819,0.3293233082706767,1.0,1.0,3/11,18.14%,CBFB;HMGB1;RUNX1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5603435079280445,1.1344776457406267,0.3478854024556617,1.0,1.0,6/15,13.29%,MTHFD1L;FGFR2;PDGFRA;NIPBL;TGFBR1;TWIST1
prerank,cellular macromolecule catabolic process (GO:0044265),0.4895065949513,1.134156180921108,0.3446019629225736,1.0,1.0,16/49,18.76%,PABPC4;HNRNPD;CHEK2;RNASE6;SIAH2;RNASEH2A;ADAMTS9;HTRA2;PPP1R8;EXOSC7;STT3B;FBXO27;FBXO17;PNPT1;RIPK1;XRN2
prerank,mitochondrial transport (GO:0006839),-0.29064750805810846,-1.1335685266124376,0.2375,0.6778523163098341,1.0,28/53,31.41%,FIS1;DNAJC19;SLC25A13;MTX2;OXA1L;SLC25A24;BCL2;BNIP3;TIMM44;TOMM70;BCAP31;GDAP1;SLC25A4;AIP;FBXO7;TOMM34;BCL2L1;TIMM17A;TOMM7;TIMM17B;TIMM9;TMEM14C;TMEM14A;TIMM13;TOMM22;TIMM8B;TOMM5;BAK1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3556925117006781,-1.132938860654868,0.25,0.6781562099476436,1.0,11/26,23.86%,NOS3;ACER2;ASAH1;ACER3;CYB5R3;ASAH2;GCH1;DDAH2;NOS1;ABCA2;SPHK1
prerank,negative regulation of bone mineralization (GO:0030502),0.5682445756138756,1.1327814580040865,0.3300561797752809,1.0,1.0,4/13,12.52%,BCOR;RFLNA;ENPP1;TRPM4
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5379644945618328,1.1318686568697858,0.3258575197889182,1.0,1.0,8/18,16.42%,SETD3;EEF1AKMT2;SETD2;KMT2A;KMT2D;ASH1L;SETD4;SUV39H2
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.25374219732551473,-1.131604952623797,0.13793103448275862,0.6804201366844602,1.0,35/109,19.88%,PLA2G4A;PIP4K2A;INPP4B;PLAAT3;MTMR10;PIK3R3;PDGFRB;PIP4K2B;PLEK;PIK3C2B;PLCB3;PIK3R1;FGF2;PIK3R4;PLCG1;SLC27A1;RAB5A;MTMR4;RUFY1;INPP5K;PIP5K1A;BMX;INPP5D;SYNJ2;CDS1;PIK3R6;SYNJ1;PI4KA;IMPA1;INPP4A;PIK3CD;PIK3CA;PIP4P1;PLA2G12A;CDIPT
prerank,myeloid cell development (GO:0061515),0.5524293292612403,1.1315153796819573,0.3401360544217687,1.0,1.0,8/18,17.24%,ANXA2;KIT;ABCB10;DMTN;MED1;SRC;ALAS2;FOXP1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.35862992238824215,-1.131416970653034,0.27411167512690354,0.679572073652568,1.0,14/24,24.18%,PRKN;SELENOS;NR1H3;CREB3L1;UBXN1;NR1H2;XBP1;AQP11;SYVN1;CREB3;PARK7;BCL2L1;RACK1;WFS1
prerank,protein phosphorylation (GO:0006468),0.4733501399855707,1.131410307588795,0.157,1.0,1.0,106/479,15.61%,NEK2;MELK;CDK1;INCENP;TTK;CLSPN;PLK1;BIRC5;MASTL;AURKB;NEK3;CIT;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;MAP4K4;DYRK1A;STK17B;BAZ1B;BMPR1A;CDK14;AURKA;ROCK2;FGFR4;MAP4K2;GSK3B;FGFR2;STK10;NLK;CHEK2;MYLK3;KIT;CCNA2;PRKDC;CTBP1;DYRK3;VRK2;STK24;STK3;MUSK;NRK;MAP3K1;CCNE1;TGFBR3;WNK1;MAP3K20;CDC25B;PDGFRA;CHEK1;CDC42BPA;EPHA4;CDK2;LRRK2;GRK5;MAP3K3;ABI1;ROCK1;PIM1;ERC1;MARK2;CSNK2A2;DDR2;PXK;CDC42BPG;CAMK1D;TGFBR1;SRPK1;EIF2AK3;LMTK3;PRKCB;BMP2;PRKCA;ULK2;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MAPKAPK3;MEX3B;STRADA;BTK;CDK19;PRKCE;MAML1;PRKD1;PRKCI;CAB39;PLK2;PRDX4;NRBP1;MORC3;VRK1;CDK8;BIRC6;STK11;TAOK1;EFEMP1;PRKAG1;SRC;PRKD2;STK39;PASK
prerank,response to amino acid (GO:0043200),-0.34517767186283255,-1.1310728578418747,0.28,0.6791063182976318,1.0,11/31,16.81%,CPEB3;GLRB;CPEB4;GLRA1;SH3BP4;GLRA3;MTOR;NSMF;GRIN1;RRAGC;XBP1
prerank,negative regulation of anoikis (GO:2000811),-0.41535630163157017,-1.1303029712120791,0.3016949152542373,0.6798388655457006,1.0,4/14,10.54%,PTK2;CAV1;TLE1;BCL2
prerank,regulation of cell morphogenesis (GO:0022604),0.5155465162566162,1.1300063059345986,0.33657351154313486,1.0,1.0,8/30,14.37%,MACF1;MOV10;PHIP;PDPN;PDZD8;SH3D19;LARP4;CD44
prerank,positive regulation of cellular process (GO:0048522),0.47317391018137606,1.1289012090116948,0.14,1.0,1.0,80/565,12.76%,PRC1;KIF20B;KIF14;EZH2;TTK;BIRC5;SPAG5;ANKLE1;SAPCD2;TGM1;RAD18;TIPIN;SPDYA;MATK;NAP1L1;FBXO5;SMC6;ECHDC3;PHIP;FGFR4;CSPP1;COLEC12;HYAL1;CEP43;CDC6;FGFR2;SMC5;FXN;MMP14;GAREM1;DDRGK1;ACTN4;CNOT6L;NUMA1;SRF;MAPT;CCAR1;NSMCE4A;FAF1;PDPN;BMP6;RTKN2;DERL2;FMR1;CDC25B;PDGFRA;CHEK1;SFRP2;PPP3CA;EPHA4;POU3F2;WWTR1;CDK2;CNOT6;GRK5;CUL3;BCLAF1;AXIN2;KLHL22;TPPP;VHL;CAMK1D;CDC123;S1PR2;TGFBR1;TAL1;CRKL;CNTF;HDAC1;ACACA;RAC1;STOX1;PRKCA;GLP2R;ADAM17;KMT2D;TRPM4;SOX9;HDAC2;IL31RA
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5145389599173449,1.1282284720702027,0.3672248803827751,1.0,1.0,12/29,21.10%,FADD;UBE2K;USP18;PTPN2;YTHDF2;TRIM6;CNOT7;IFNAR2;METTL3;MAVS;PTPN1;ISG15
prerank,protein ubiquitination (GO:0016567),0.47406940464584085,1.1281438803673243,0.165,1.0,1.0,90/471,14.64%,DTL;BRCA1;CCNF;UHRF1;PLK1;BARD1;UBE2T;UBE2C;RAD18;UBE2S;RFWD3;RNF168;ANAPC7;TRIM37;CBFB;TRIML2;BRAP;PDZRN3;PSMC2;CDC27;RNF220;PSMD5;UBE2K;UHRF2;NEDD4;FBXL7;MYCBP2;PRKDC;SIAH2;SPSB2;RNF43;FANCL;ARRB1;ELOC;FBXW7;FBXO30;UBE2N;PRPF19;CUL5;FBXL8;RNF31;RC3H2;UBR5;VPS18;RNF40;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;SH3RF1;KLHL22;LEO1;VHL;CUL4B;PSMD1;SKP2;OBI1;TPP2;FBXL17;HERC2;FBXO45;UBOX5;PSMB9;TRIM63;ARRDC1;SMURF2;PCNA;FBXW11;TRIP12;TRIM6;ITCH;ATG3;IRF2BP1;UBE2J1;USP9X;CRBN;BTRC;FBXO27;ZNRF2;FBXO25;SPOP;RC3H1;HLTF;TRIM5;PSMC6;RNF114;UBE2QL1;ZNRF1;BIRC6
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4714791676009441,1.1264929753898199,0.139,1.0,1.0,118/572,15.21%,E2F7;NR2E3;E2F8;UHRF1;EZH2;EN1;PLK1;ATRX;AURKB;GLI2;TCFL5;GLI3;E2F1;CBX5;FOXE1;KMT5A;LOXL2;TRIM37;ZFP69;CBFB;RB1;ETV6;FNIP1;MIER1;WWOX;SP2;HDGF;CTCF;FGFR2;ZEB1;JAZF1;CNOT1;EED;BCOR;MDM4;TAF3;NEDD4;HIVEP1;CUX1;FHL2;BHLHE41;NFIL3;SRF;CTBP1;NFIB;ZNF568;TBL1XR1;MCPH1;BMP6;GZF1;LCOR;TCF7L2;ORC2;HOXA7;TPR;GATAD2A;EFNA1;GLIS3;RIF1;NIPBL;ZBTB2;MXD1;ZBTB7B;ZHX2;FOXO3;KDM2B;LIN37;SMARCA4;ZFP90;KLF11;MIER3;KANK2;YAP1;VHL;UXT;EPC1;HMGB1;HDAC8;MTA3;NR4A2;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;KCNIP3;SMURF2;HDAC1;BMP2;EZR;NKX2-1;ATXN1;RBPJ;SOX9;SMAD4;HDAC2;SAP130;ELK4;IRF2BP1;PPID;TWIST1;HEY2;USP9X;MED1;DLG1;RARB;YY1;ZMYM5;DNMT3A;FOXM1;SMAD3;FOXP4;SOX1;PER1;YEATS2;OTUD7B;DR1
prerank,nuclear body organization (GO:0030575),0.5727422755864332,1.1264092622801343,0.3578643578643579,1.0,1.0,3/12,6.69%,DYRK3;SERBP1;PML
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5321298618458369,1.1261827664116002,0.34159061277705344,1.0,1.0,5/21,14.65%,MASTL;GSK3B;PPP1R8;ENSA;PTPA
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3721380120513139,-1.1255837111878928,0.3157894736842105,0.6887731058486196,1.0,8/20,18.64%,MCCC1;BCKDHA;HIBADH;ACAD8;BCAT1;ECHS1;BCKDK;MCCC2
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3721380120513139,-1.1255837111878928,0.3157894736842105,0.6887731058486196,1.0,8/20,18.64%,MCCC1;BCKDHA;HIBADH;ACAD8;BCAT1;ECHS1;BCKDK;MCCC2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.33075604943789777,-1.1251254303431732,0.24598930481283424,0.6873214451971933,1.0,9/29,21.11%,CROT;ACOT11;ACLY;ACBD6;ACSL6;DBI;ACSF2;ACOT7;ACOT13
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.33075604943789777,-1.1251254303431732,0.24598930481283424,0.6873214451971933,1.0,9/29,21.11%,CROT;ACOT11;ACLY;ACBD6;ACSL6;DBI;ACSF2;ACOT7;ACOT13
prerank,retina homeostasis (GO:0001895),-0.3543599009200955,-1.1250740480655275,0.2634146341463415,0.686202475776217,1.0,6/23,13.15%,ACTB;POTEF;B2M;WHRN;BBS4;PRDX1
prerank,striated muscle contraction (GO:0006941),-0.29415893978925267,-1.1247749470047919,0.2,0.6856248808435115,1.0,24/53,39.74%,ATP1B1;RCSD1;RYR2;TPM1;ATP1A2;SCN1B;DTNA;STAC;PIK3CA;KCNQ1;NOS1;ALDOA;SCN4B;MYH14;STAC3;SCN3B;MYL4;CASQ2;TNNI1;GAA;KCNH2;STAC2;TTN;SCN5A
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2638691332879455,-1.1243962332011188,0.17857142857142858,0.6853749808408582,1.0,14/75,13.14%,CACNA2D1;SLC8A3;ATP1B1;SLC39A10;SLC6A1;KCNJ3;SLC24A2;KCNJ6;ATP1A1;ATP1B3;ATP1A3;SLC12A9;KCNJ10;ATP1A2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.35361849799656053,-1.124229490139347,0.27,0.6844538700284826,1.0,12/24,16.83%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;INPP5K;SELENOS;IRS1;PPP1R3B;GSK3A;DYRK2
prerank,regulation of immune effector process (GO:0002697),-0.30204418528715365,-1.1239706948904287,0.22522522522522523,0.6838159990838741,1.0,18/41,39.05%,VTN;CD81;C4B;C1QB;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;FCGR2B;C7
prerank,membrane repolarization during action potential (GO:0086011),-0.42782408633649716,-1.123536562381978,0.31347962382445144,0.6836565524115497,1.0,5/13,31.95%,ATP1B1;ATP1A1;KCNQ1;KCNIP2;KCNE4
prerank,substrate-dependent cell migration (GO:0006929),-0.41862142153615245,-1.1234500437871477,0.2953020134228188,0.6826138939206676,1.0,11/14,31.33%,OPHN1;VEGFC;SDCBP;EPHA8;ITGB1BP1;SHTN1;NRP1;ANKS1A;P2RY12;PTPRC;ITGA2
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5307795943551388,1.1234002948355037,0.3670076726342711,1.0,1.0,8/24,13.64%,CBFB;ROCK2;NUMA1;HOXA7;GRHL2;ROCK1;ERRFI1;MED1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3691538332060944,-1.1229667706676887,0.2809917355371901,0.6825110211178018,1.0,5/19,10.95%,CHD8;AR;ICE1;ZNF76;MTOR
prerank,eosinophil migration (GO:0072677),-0.4214590657960824,-1.1229640121686228,0.29491525423728815,0.6799973255902805,1.0,12/14,57.88%,SCG2;CX3CL1;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.4214590657960824,-1.1229640121686228,0.29491525423728815,0.6799973255902805,1.0,12/14,57.88%,SCG2;CX3CL1;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,cellular response to interferon-beta (GO:0035458),0.5582810307520119,1.1226915208177908,0.3430232558139535,1.0,1.0,5/14,16.11%,UBE2K;HTRA2;IRF1;TRIM6;PNPT1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5855003012472546,1.1224425239094549,0.3416422287390029,1.0,1.0,3/10,7.96%,PDE3B;WNK1;SERPINE1
prerank,dendritic cell migration (GO:0036336),0.5505215642789075,1.1220581891028794,0.34620689655172415,1.0,1.0,4/16,12.52%,CXCR4;HMGB1;TRPM2;TRPM4
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5560270722480943,1.121501549688094,0.3554301833568406,1.0,1.0,7/13,19.31%,AGO2;CNOT1;EIF4ENIF1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4887457352559938,1.12084684474328,0.343646408839779,1.0,1.0,14/52,11.08%,RBM15;TRA2B;RBFOX2;KHDRBS1;HNRNPA1;THRAP3;MBNL3;RBM25;FMR1;SAP18;CELF2;HNRNPU;RBM15B;HNRNPL
prerank,positive regulation of hydrolase activity (GO:0051345),0.4733299682801965,1.120842298193558,0.30870445344129555,1.0,1.0,24/137,13.08%,ECT2;EZH2;ARHGAP11A;HMGB2;USP6NL;MAP4K4;RHOA;GSK3B;RTN4R;EVI5L;NET1;AFDN;RSU1;TBC1D7;PICALM;MTMR9;SRGAP2;LIMS1;CALM2;PLXNB1;BMP2;DOCK11;SNX18;CTSH
prerank,response to copper ion (GO:0046688),0.5304664428962467,1.1206803272940593,0.35170603674540685,1.0,1.0,3/20,5.24%,AQP1;LOXL2;PRNP
prerank,regulation of blood circulation (GO:1903522),-0.31591540120000916,-1.1206255833461058,0.22602739726027396,0.6845189440006922,1.0,13/34,22.37%,CAMK2D;ECE1;PER2;DMPK;TPM1;ACE;AGTR1;SRI;TBX2;FXYD1;KCNQ1;KCNJ12;S100A1
prerank,smooth muscle contraction (GO:0006939),0.5554145508248322,1.120357703253522,0.3557422969187675,1.0,1.0,6/14,16.38%,ROCK2;ROCK1;SLC8A1;BDKRB2;SMTN;TPCN2
prerank,cartilage development (GO:0051216),0.5003657509448483,1.1192200117893636,0.35170893054024255,1.0,1.0,16/49,18.17%,HYAL1;DDRGK1;SULF2;WNT2B;NFIB;SOX6;SULF1;CCN3;BMP2;SOX9;CD44;SNX19;ITGB8;TRPV4;RUNX1;OSR1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5632888701091682,1.1192107529470754,0.35051546391752575,1.0,1.0,4/12,10.32%,NIN;PCM1;BICD2;NINL
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5229022165321263,1.1191263134789524,0.3520408163265306,1.0,1.0,7/21,13.44%,ROCK2;BCOR;ROCK1;ENPP1;TRPM4;SOX9;HEY2
prerank,axoneme assembly (GO:0035082),0.5124198157598304,1.1189245634872949,0.3460591133004926,1.0,1.0,7/30,16.50%,DNAAF3;SPAG16;SPEF1;DNAI4;RSPH9;TTLL3;SPAG1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4064007085089131,-1.1188295378670776,0.32978723404255317,0.6878029969913568,1.0,3/14,6.59%,PUM1;DDX60;ZDHHC5
prerank,nucleoside phosphate catabolic process (GO:1901292),0.554494902321639,1.1187818693676885,0.33954154727793695,1.0,1.0,4/13,11.79%,SMPDL3A;ENPP3;ITPA;ENPP1
prerank,positive regulation of hormone secretion (GO:0046887),-0.39993849545914323,-1.1181487422688754,0.3168724279835391,0.6883494230675383,1.0,11/17,46.51%,SNX4;C1QTNF3;VAMP8;EDN1;SOX11;EDN3;SPP1;GRP;VAMP7;RASL10B;NMB
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3724849114284629,-1.118084483807636,0.29554655870445345,0.6872646396767434,1.0,8/20,25.61%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2;NEDD4L;ATP6AP1
prerank,regulation of T cell chemotaxis (GO:0010819),0.5695851725321718,1.1178695890765058,0.3392070484581498,1.0,1.0,4/11,18.16%,WNK1;ADAM17;STK39;OXSR1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3769932978092744,-1.1174146657714112,0.308300395256917,0.6876883177696962,1.0,13/18,35.42%,COX16;OXA1L;COX19;PET100;COX20;SMIM20;COX17;COX14;COA8;COA5;COA3;SURF1;FASTKD3
prerank,cristae formation (GO:0042407),-0.33358000912488905,-1.1173393403467793,0.2596685082872928,0.6866087092821543,1.0,14/27,25.82%,APOOL;ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;DNAJC11;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;MICOS13;ATP5ME
prerank,monocyte chemotaxis (GO:0002548),-0.33518580475583537,-1.11732661748043,0.26256983240223464,0.6853837632534272,1.0,5/32,13.08%,FLT1;PTPRO;RPS19;TNFRSF11A;CX3CL1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.3767005876787838,-1.1173131244450187,0.308300395256917,0.6841601753997612,1.0,8/17,26.62%,KCNB1;SLC4A8;SCAMP5;SYT10;NLGN1;RAB27A;RAB3D;CACNA1H
prerank,regulation of mRNA stability (GO:0043488),0.4689494206865286,1.1173120686973568,0.3192346424974824,1.0,1.0,38/145,15.53%,MEIOC;E2F1;XPO1;ROCK2;PSMC2;PSMD5;HNRNPD;FTO;TNPO1;SERBP1;THRAP3;EIF4ENIF1;SAMD4A;FMR1;FUS;RC3H2;LARP1;PSMB1;PSMD14;AXIN2;PUM2;ROCK1;PSMD1;HNRNPU;YTHDF2;PSMB9;TENT5D;TAF15;EXOSC7;NUP214;PRKCA;MEX3D;RC3H1;PABPC1;PSMC6;ZC3H14;GDNF;FXR1
prerank,regulation of stem cell population maintenance (GO:2000036),0.5311519089793841,1.1170250112916165,0.35170603674540685,1.0,1.0,2/18,3.90%,LOXL2;CNOT1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5152048680444461,1.1170043793561,0.3594306049822064,1.0,1.0,8/26,16.42%,ATPSCKMT;SETD3;SETD2;KMT2A;KMT2D;KMT5C;SETD4;SUV39H2
prerank,lysine metabolic process (GO:0006553),0.5755777292545371,1.1169410331761902,0.34643377001455605,1.0,1.0,1/12,1.41%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.5755777292545371,1.1169410331761902,0.34643377001455605,1.0,1.0,1/12,1.41%,SLC25A21
prerank,positive regulation of protein maturation (GO:1903319),-0.45782104390486744,-1.1167918510395698,0.34782608695652173,0.68426725639303,1.0,3/11,15.03%,CCBE1;SOX4;NKD2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4276086720213411,-1.116558475322029,0.3365695792880259,0.6835852286404864,1.0,2/11,4.12%,MEF2C;TGFB2
prerank,response to laminar fluid shear stress (GO:0034616),-0.4468556843074361,-1.1150921520752834,0.3438485804416404,0.6859529521615259,1.0,5/10,11.66%,SMAD7;MAP2K5;KLF4;SREBF2;KLF2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5014475145566125,1.1142887474476664,0.3462857142857143,1.0,1.0,11/40,14.34%,EZH2;LOXL2;PDPN;TCF7L2;WWTR1;AXIN2;TGFBR1;BMP2;SMAD4;TWIST1;SMAD3
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.33222384610451383,-1.1141955776962065,0.3057324840764331,0.6868389960540094,1.0,17/32,34.91%,ADIPOR2;APOE;CREBL2;ASAH1;ASXL3;MTOR;PRKAG2;SORBS1;AVIL;MID1IP1;GPER1;MLXIPL;AKT1;FITM2;STAR;C3;PDK4
prerank,positive regulation of heart contraction (GO:0045823),-0.3636572165302636,-1.114164836854672,0.30666666666666664,0.6856976551339898,1.0,11/19,32.55%,RYR2;TGFB2;ATP1A2;ADRA1A;GSK3A;KCNQ1;EDN1;ADM;EDN3;CHGA;SCN3B
prerank,positive regulation of cellular component organization (GO:0051130),0.46380913341809443,1.1135068787424884,0.33401430030643514,1.0,1.0,20/107,10.56%,CDC20;HAS3;RB1;FNIP1;HYAL1;GSK3B;ASAP1;BMF;TRABD2B;AJUBA;ADGRL1;ABCB4;FAF1;SLF1;SPIDR;CDC42EP2;SH3GLB1;TPPP;TGFBR1;TAL1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5328392332490712,1.1134834833210847,0.3673469387755102,1.0,1.0,6/18,14.27%,ITGB7;ADD2;PODXL2;ROCK1;SLC39A8;ITGB1
prerank,negative regulation of phosphatase activity (GO:0010923),0.5170093166520344,1.1131797349641814,0.3554140127388535,1.0,1.0,2/25,3.50%,MASTL;GSK3B
prerank,regulation of cell projection organization (GO:0031344),0.5506692224969277,1.1126926756526052,0.37735849056603776,1.0,1.0,2/13,2.76%,MACF1;MOV10
prerank,response to zinc ion (GO:0010043),-0.345808132723719,-1.112669335588866,0.3163265306122449,0.6880917641653487,1.0,12/25,22.05%,GLRA1;SLC30A4;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;P2RX4
prerank,regulation of monooxygenase activity (GO:0032768),-0.3477180251992697,-1.1121682412538507,0.29767441860465116,0.6880741406176437,1.0,5/23,5.48%,CALM1;CAV1;NOS3;LYPLA1;NOSTRIN
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5554189029868547,1.1120629317947603,0.3588235294117647,1.0,1.0,5/11,9.37%,AJUBA;DHX9;FMR1;LIMD1;PUM2
prerank,positive regulation of response to wounding (GO:1903036),-0.3412195715207176,-1.112054415606938,0.2898550724637681,0.6871050130645595,1.0,10/24,22.63%,PTK2;OCLN;VTN;MYLK;GRN;SCARF1;ARFGEF1;ADRA2A;HBEGF;CLDN1
prerank,regulation of aerobic respiration (GO:1903715),-0.3930444470446782,-1.1120149327938746,0.33554817275747506,0.6859774855039794,1.0,6/15,26.17%,CBFA2T3;PINK1;COX7A2;UQCC2;ATP7A;AK4
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.534994862703977,1.1115484991203028,0.34854771784232363,1.0,1.0,7/16,16.25%,GBF1;DDRGK1;LRRK2;TAPT1;MIA3;VAPA;BCAP29
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5219185376004565,1.111543752365675,0.3756345177664975,1.0,1.0,10/22,18.36%,ERI2;ERI1;RRS1;RPP40;EXOSC7;ERI3;WDR12;NOL9;ABT1;EXOSC10
prerank,intracellular lipid transport (GO:0032365),-0.35611574656315315,-1.1115029713888407,0.2702702702702703,0.6860917864914375,1.0,9/21,25.64%,CERT1;ABCD4;ACACB;ARV1;ABCD2;PRKAG2;PLEKHA8;NPC2;MID1IP1
prerank,connective tissue development (GO:0061448),0.508007756753556,1.1112173191882293,0.36143187066974597,1.0,1.0,12/35,17.52%,HYAL1;DDRGK1;SULF2;SOX6;SULF1;PGRMC2;SOX9;LRP5;CD44;SPTLC2;ITGB8;SH3PXD2B
prerank,cellular response to mechanical stimulus (GO:0071260),0.48245002048660923,1.1106390474503565,0.3584905660377358,1.0,1.0,12/46,12.75%,AQP1;FADD;MAP3K14;CASP8AP2;MAP3K1;CNN2;CHEK1;IRF1;TNFRSF10B;PIEZO1;SOX9;CASP8
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5472620469240694,1.110527545601607,0.34507042253521125,1.0,1.0,5/13,15.75%,EFL1;LRRK2;RHOQ;GNAI3;MFN1
prerank,bicellular tight junction assembly (GO:0070830),0.49439689893777183,1.1102963388431653,0.3446327683615819,1.0,1.0,3/46,6.59%,ECT2;AFDN;GRHL2
prerank,regulation of lamellipodium organization (GO:1902743),0.5597121424256235,1.1097754188845714,0.3557692307692308,1.0,1.0,5/14,14.37%,PDPN;TWF1;RAC1;DMTN;CD44
prerank,regulation of phosphorylation (GO:0042325),0.46197454686696704,1.1095020518788226,0.3444782168186423,1.0,1.0,29/120,16.68%,BARD1;NDC1;NUP155;CDKN2D;CDKN2C;NUP205;MCM7;PHIP;NUP160;FNIP1;GCK;NUP85;TPR;PML;ROCK1;PLXNB2;DSCAM;NUP214;KCTD20;RANBP2;CDKN1B;BTBD10;NUP133;PIN1;PRKAG1;NUP42;SESN2;ANKLE2;NUP98
prerank,import into nucleus (GO:0051170),0.47501242987065967,1.109405693082749,0.3700534759358289,1.0,1.0,24/73,20.52%,RANBP17;NUP155;RPAIN;E2F3;HNRNPA1;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;IPO11;NXT1;NUP133;IPO5;GEMIN7;NXT2;FAM53B;IPO9;NUP188;SNRPB;IPO4
prerank,RNA polyadenylation (GO:0043631),0.5127819173271688,1.1091043868183577,0.3574051407588739,1.0,1.0,11/26,16.11%,TENT2;CSTF3;FIP1L1;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;PABPC1;PNPT1
prerank,mRNA polyadenylation (GO:0006378),0.5127819173271688,1.1091043868183577,0.3574051407588739,1.0,1.0,11/26,16.11%,TENT2;CSTF3;FIP1L1;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;PABPC1;PNPT1
prerank,histone H3 deacetylation (GO:0070932),0.5348912588706662,1.108575172439042,0.334716459197787,1.0,1.0,7/15,14.80%,SMARCAD1;HDAC8;SFPQ;HDAC1;HDAC2;ELK4;PER1
prerank,cellular senescence (GO:0090398),0.5201314646280045,1.1085459568467917,0.3709090909090909,1.0,1.0,9/27,19.53%,SMC6;SMC5;SRF;PML;NSMCE2;TERF2;KAT6A;MAPK14;PRKCD
prerank,negative regulation of immune system process (GO:0002683),0.5434069406914848,1.108293078256394,0.3617021276595745,1.0,1.0,3/16,12.56%,FADD;HOXA7;SOX9
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4936815241722179,1.1081185641809066,0.3654524089306698,1.0,1.0,10/35,15.63%,NLK;KIT;LEPROT;VHL;OCIAD2;CRLF3;PIGU;ADIPOR1;OCIAD1;NF2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.46194011531592843,1.107700908077502,0.261,1.0,1.0,60/259,15.42%,KIF24;PLK4;IFT80;HYLS1;CEP89;MAP4K4;BBS9;DZIP1L;SCLT1;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;KIT;SPEF1;OCRL;NTN1;TXNDC15;RAP2A;MKKS;WDR11;FGD4;CEP83;RILPL1;NUDCD3;RFX2;SSX2IP;FGD1;CCDC57;CFAP52;WDPCP;NPHP3;RAB1A;SRGAP2;S1PR2;FGD6;TRAPPC14;TTC39C;EZR;RAC1;CC2D2A;DMTN;EHD1;TTLL3;EXOC8;ARF4;ITGB1;CEP162;VSTM5;LZTFL1;EMP1
prerank,collagen fibril organization (GO:0030199),0.469037504896136,1.1074003489522422,0.34407484407484407,1.0,1.0,21/88,14.40%,BMP1;LOXL3;COL22A1;LOXL2;LOX;COL4A6;COL4A4;COL18A1;COL5A2;COL23A1;ADAMTS14;ADAMTS2;DDR2;TLL2;TGFBR1;COL4A5;COL12A1;P3H1;COL15A1;COL20A1;P3H4
prerank,regulation of apoptotic process (GO:0042981),0.45994474344928216,1.1073750962912103,0.182,1.0,1.0,104/676,13.99%,TOP2A;KIF14;ECT2;MELK;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;E2F1;STPG1;AQP1;ITGB3BP;FADD;MAP4K4;STK17B;SETX;PHIP;ARHGAP10;ANGPT4;STEAP3;GSK3B;BMF;FXN;DDRGK1;IAPP;ACTN4;ANP32B;AIFM2;FHL2;PRKDC;FAM162A;MRE11;NET1;SIAH2;CCAR1;FAF1;PDPN;STK3;ERCC3;ANXA5;RBM25;FGD4;TMEM219;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;ARL6IP1;SMAD6;ING4;GRK5;BCLAF1;KLF11;SH3RF1;TNFRSF10B;DNM2;MGMT;ANGPT1;VHL;PIM1;SKP2;HMGB1;APIP;AGT;ERC1;GAS1;APAF1;BOK;NDRG1;ANP32E;IP6K2;ARHGEF18;QRICH1;HDAC1;BMP2;ANXA1;CHM;SOX9;HDAC2;NOTCH2;ATF5;CASP8;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;PPID;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;SMPD1
prerank,regulation of transport (GO:0051049),-0.31075262532434544,-1.10711701216355,0.22142857142857142,0.6957768911702374,1.0,14/36,25.72%,PRKN;MYO6;EPB41;ACTB;ICA1;DNAJA1;WWC1;PINK1;RAB11A;NRP1;GAPVD1;MBTPS1;ARL6IP5;POFUT2
prerank,glutamate metabolic process (GO:0006536),-0.381800862640317,-1.106674585300881,0.30701754385964913,0.695609020854325,1.0,9/19,25.58%,GLUL;GLS;GOT2;PRODH;GOT1;ALDH5A1;GLUD1;OAT;GLS2
prerank,cellular component assembly (GO:0022607),0.4615352932181665,1.1064378022169605,0.277,1.0,1.0,54/253,16.37%,KNTC1;FANCA;TRIP13;CHAF1B;HAS3;KPNA3;RHOA;TEAD1;RAD21;PARVA;SPAG16;RTN3;MDM4;SPEF1;ADD2;ZW10;NLGN3;RBBP4;GRHL2;PML;QSOX1;ARL6IP1;DARS1;CORO1B;RHOQ;YAP1;PICALM;IKBKG;KMT2A;HAS1;RSPH9;YTHDF2;LIMS1;CAPZA1;EZR;RAC1;GORASP2;SOX9;DMTN;DPYSL3;BAIAP2L1;TTLL3;PPID;CHAF1A;P3H4;EPRS1;CAPG;ADD1;LCP1;TP53;SYCP2;TINF2;NLGN2;NCKAP1
prerank,regulation of peptidase activity (GO:0052547),-0.3830609919132637,-1.1062174161620066,0.2948717948717949,0.6955145274697365,1.0,6/19,13.29%,CST3;CAV1;PSMA3;FURIN;PINK1;RCN3
prerank,positive regulation of ATPase activity (GO:0032781),0.48864396441907054,1.1060928707470477,0.35583524027459956,1.0,1.0,3/41,4.75%,UHRF1;MSH3;DHX9
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3830727270274086,-1.1060412023655914,0.33955223880597013,0.694781652919184,1.0,11/16,25.82%,ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;ATP5ME
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5449705469214348,1.1056453533360218,0.3527027027027027,1.0,1.0,6/15,20.22%,ADGRV1;KIT;MKKS;LHFPL5;KCNA1;PIEZO2
prerank,regulation of biomineral tissue development (GO:0070167),0.4990942134285645,1.1055363262069036,0.3613861386138614,1.0,1.0,9/26,15.98%,FBXO5;ROCK2;ROCK1;DDR2;ENPP1;SOX9;TWIST1;HEY2;NOTUM
prerank,reverse cholesterol transport (GO:0043691),-0.406187579544409,-1.1051608692212225,0.3219178082191781,0.6956982183530699,1.0,2/13,6.91%,APOE;ABCA5
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5175843892370512,1.1050275752660903,0.3553299492385787,1.0,1.0,7/22,16.18%,CDKN2D;CDKN2C;CDA;ROCK1;CDKN1B;TP53;ANKLE2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4904711975688669,1.1047944054098973,0.37946943483275664,1.0,1.0,6/37,7.67%,IFT80;WDR35;IFT140;PCM1;TNPO1;SSX2IP
prerank,regulation of stem cell proliferation (GO:0072091),0.5347303730494132,1.1046826655076891,0.37254901960784315,1.0,1.0,9/17,24.25%,HMGB2;YAP1;HNRNPU;GJA1;TERT;FBLN1;EIF2AK2;ZFP36L1;KDM1A
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5647951767404193,1.1044985539795131,0.3621933621933622,1.0,1.0,3/11,10.12%,DDX11;SMARCA4;NOL11
prerank,positive regulation of transferase activity (GO:0051347),0.4671539026618209,1.1039647709849978,0.3424242424242424,1.0,1.0,18/142,7.60%,NEK2;PLK1;AURKB;DSCC1;RFC4;FGFR4;FGFR2;HNRNPD;KIT;RFC2;MRE11;MUSK;RFC3;GRHL2;FBXW7;UBE2N;PDGFRA;EPHA4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4116565385710236,-1.1037315911041439,0.3385579937304075,0.6980714665840789,1.0,8/13,29.59%,NR1H3;NUPR1;NR1H2;AQP11;MANF;WFS1;USP19;MBTPS2
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.33211232819244485,-1.1031386777780468,0.3027027027027027,0.6983255831638434,1.0,9/27,12.68%,DACH1;BMPR2;ACVRL1;PDGFRB;FGF2;PINX1;ATM;NABP2;RGCC
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.38082760924132714,-1.10305644164674,0.30584192439862545,0.6973043701008019,1.0,3/16,3.07%,CAMK2D;CALM1;RYR2
prerank,positive regulation of behavior (GO:0048520),-0.45605722963078177,-1.1029522081524947,0.3333333333333333,0.6963257586706147,1.0,3/10,5.06%,SGIP1;MEF2C;CFAP20
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5109973787025899,1.102628244105887,0.35976331360946745,1.0,1.0,8/27,17.19%,KMT5A;DYRK1A;YJU2;TWIST1;SPRED1;CD44;SPRED2;ATR
prerank,aortic valve development (GO:0003176),0.4914681884963619,1.102610540184952,0.3697674418604651,1.0,1.0,11/34,13.44%,RB1;ROCK2;EFNA1;SMAD6;ROBO1;ROCK1;ELN;BMP2;SOX9;TWIST1;HEY2
prerank,cyclooxygenase pathway (GO:0019371),0.5632292055424055,1.101781564452631,0.37367624810892586,1.0,1.0,3/10,7.45%,PTGES2;HPGDS;PTGS1
prerank,protein localization to nucleus (GO:0034504),0.4695587628561198,1.1015599070307147,0.3682051282051282,1.0,1.0,27/102,17.76%,PLK1;RANBP17;NUP155;RPAIN;E2F3;TAF3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;PML;RRS1;HNRNPU;XPA;IPO7;APPL2;NUP214;IPO11;NXT1;MORC3;NUP133;TOR1B;IPO5;NXT2;FAM53B;PIKFYVE
prerank,regulation of complement activation (GO:0030449),-0.29686661240433265,-1.101371023436476,0.25217391304347825,0.6989178391137808,1.0,17/40,39.05%,VTN;CD81;C4B;C1QB;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;C7
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4582043435327712,-1.1012383016656715,0.35454545454545455,0.6980504577712333,1.0,5/10,32.82%,EP300;KAT2B;KAT7;CREBBP;ESCO1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.4230772899936552,-1.1010979652912145,0.36363636363636365,0.6971383596152069,1.0,2/13,3.89%,LAMP1;STX4
prerank,regulation of activated T cell proliferation (GO:0046006),0.4925756394777524,1.1008502910891464,0.36151960784313725,1.0,1.0,6/30,13.96%,FADD;PRNP;IL18;SCRIB;HMGB1;RC3H1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.45746355450582016,1.1005730280017947,0.35612244897959183,1.0,1.0,31/114,22.98%,TNFSF13B;MAP3K14;PSMC2;PSMD5;ACTN4;FOXO3;PSMB1;PSMD14;PSMD1;EDA;LIMS1;PSMB9;PYDC1;ADAM17;PSMC6;PLVAP;TP53;TNFRSF25;PSMB2;PSME4;PSMB7;RIPK1;PSMD11;TRAF6;PSME3;TRAF2;IKBKB;PSMD13;BIRC2;PSMB8;PSMD4
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.43280615764057284,-1.1004219439443594,0.3363914373088685,0.697695347366777,1.0,6/11,24.60%,SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.554919253223497,1.099903307892189,0.37359550561797755,1.0,1.0,4/13,13.02%,XPO1;NMD3;RRS1;SDAD1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4017381654983011,-1.0996602282053067,0.33223684210526316,0.698360438819227,1.0,7/14,21.77%,AKT2;IRS2;GPLD1;IRS1;NNMT;PPARGC1A;SLC45A3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3093773349908483,-1.0995109269264138,0.31343283582089554,0.6975446092796369,1.0,9/37,13.78%,PTPRD;FAT4;GRID2;IL1RAPL1;VCAM1;NECTIN3;CADM3;HMCN1;TENM4
prerank,inner dynein arm assembly (GO:0036159),0.5661349159831772,1.0988839080957908,0.3562691131498471,1.0,1.0,2/10,10.86%,DNAH1;DNAAF5
prerank,autophagy of peroxisome (GO:0030242),-0.4110609324720339,-1.0985806786829826,0.3265993265993266,0.6986729849497415,1.0,5/12,17.36%,SQSTM1;PIK3R4;ATM;PEX5;USP30
prerank,ether lipid biosynthetic process (GO:0008611),-0.4522256398048631,-1.0983025412246927,0.3504273504273504,0.6982263335396752,1.0,4/10,11.45%,PLA2G4A;CHPT1;DHRS7B;LPCAT2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.45172852604001557,-1.0982052150610178,0.3554913294797688,0.6972377593847774,1.0,2/10,8.26%,TLR4;NAMPT
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.5150155168583865,1.0981826297197606,0.36917098445595853,1.0,1.0,3/23,9.74%,HMGB2;DNASE2;HMGB1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5086470495904216,1.0980678635122623,0.37135614702154623,1.0,1.0,4/21,11.77%,CYP26B1;LPIN2;AGXT;HOGA1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4596118336480994,1.0978029211550757,0.35555555555555557,1.0,1.0,30/113,15.83%,TERF1;FNIP1;GSK3B;PSMC2;RPA1;ASAP1;BMF;TRABD2B;CHD1L;AJUBA;ERCC4;FAF1;RPA2;SLF1;ERCC3;SPIDR;CDC42EP2;SH3GLB1;TPPP;CUL4B;TAL1;XPA;PIEZO1;ABCA1;PSMC6;CAPG;SRC;RHOC;LCP1;TP53
prerank,contractile actin filament bundle assembly (GO:0030038),0.5541145282238524,1.0962241200863905,0.38461538461538464,1.0,1.0,6/15,15.32%,RHOA;ARRB1;PHACTR1;CUL3;ITGB1;SRC
prerank,stress fiber assembly (GO:0043149),0.5541145282238524,1.0962241200863905,0.38461538461538464,1.0,1.0,6/15,15.32%,RHOA;ARRB1;PHACTR1;CUL3;ITGB1;SRC
prerank,plasma membrane invagination (GO:0099024),0.5005879861947791,1.096206904236987,0.37001209189842804,1.0,1.0,5/29,13.44%,AURKB;RHOA;SNX33;SNX18;DOCK1
prerank,anterior/posterior axis specification (GO:0009948),-0.38945771113966265,-1.0958781253493768,0.33559322033898303,0.7018282879384972,1.0,3/15,16.64%,TASOR;TBX3;DDIT3
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.39391331926531536,-1.0956582727267106,0.3320610687022901,0.6999988025382237,1.0,6/16,15.61%,APOD;PHLDB2;ACVRL1;DUSP22;THBS1;ITGB1BP1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.39391331926531536,-1.0956582727267106,0.3320610687022901,0.6999988025382237,1.0,6/16,15.61%,APOD;PHLDB2;ACVRL1;DUSP22;THBS1;ITGB1BP1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.49854647579920897,1.0953958845295992,0.37410071942446044,1.0,1.0,4/29,6.78%,PLK1;FBXO5;FBXW7;UBE2N
prerank,icosanoid metabolic process (GO:0006690),0.48610220033491613,1.0952835683288773,0.3714622641509434,1.0,1.0,12/40,20.69%,PON1;PTGR1;ABCC10;PTGS1;DAGLB;PON2;DPEP1;PTGIS;DPEP2;PON3;DAGLA;MAPKAPK2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5569240297983205,1.0951234325123387,0.36857142857142855,1.0,1.0,7/12,19.09%,ADA;HPRT1;PRPS1L1;PRPS1;ADSL;GART;PPAT
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.42303360097776144,-1.094878363630928,0.35353535353535354,0.7007211709407277,1.0,7/12,29.59%,SREBF2;DGKQ;CLCN2;ABCA2;RAN;MBTPS1;MBTPS2
prerank,positive regulation of protein sumoylation (GO:0033235),0.5565145896814199,1.0947190182553883,0.37168141592920356,1.0,1.0,5/10,22.97%,SAE1;GNL3;HDAC4;PIAS1;UBA2
prerank,sphingolipid metabolic process (GO:0006665),-0.24211112018291445,-1.094586921158932,0.2222222222222222,0.7002111829938827,1.0,39/108,23.95%,CERT1;ELOVL7;HEXB;SGMS2;HACD3;ACER2;PLPP3;HACD2;PSAP;ASAH1;ALDH3A2;ST6GALNAC3;ACER3;ESYT1;B3GALNT1;HACD1;HEXA;SERINC1;DEGS2;SPNS2;ARV1;GLTP;CTSA;ASAH2;DEGS1;GAL3ST1;ELOVL6;PPT1;VAPB;CERS1;GBA2;SPTSSA;SGPL1;ABCA2;ELOVL1;ESYT3;PLA2G15;SPHK1;NEU1
prerank,lipid phosphorylation (GO:0046834),-0.450716749617054,-1.0944995808904983,0.3664772727272727,0.699261534034375,1.0,6/10,24.52%,DGKB;DGKG;DGKI;DGKQ;DGKD;DGKK
prerank,positive regulation of cellular component movement (GO:0051272),0.5042328168730731,1.0942038644995278,0.3754740834386852,1.0,1.0,8/24,14.69%,CCDC25;ACTN4;NTN1;PDPN;TGFBR1;ADAM17;TWIST1;STK11
prerank,organic substance transport (GO:0071702),0.4580360159734711,1.0940938599222836,0.355464759959142,1.0,1.0,8/121,7.10%,CENPF;SLC18A2;NDC1;ZG16;ABCA4;SLC6A2;SLC19A1;ABCA9
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.46554303254774454,1.093041787658168,0.38963730569948185,1.0,1.0,16/87,12.64%,IQGAP3;IQGAP2;ROCK2;RHOA;ARHGAP18;PDGFRA;RHOQ;ROCK1;ARHGAP35;TRPM2;TWF1;RND2;EZR;RAC1;NOTCH2;DMTN
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5345334940753073,1.0926471111591742,0.3829787234042553,1.0,1.0,4/13,10.26%,SRSF10;PRPF19;PRPF3;LSM2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.4259908146174276,-1.0921647796679548,0.35276073619631904,0.7039385916799166,1.0,3/11,9.05%,TNFRSF21;LYN;ATM
prerank,fatty acid catabolic process (GO:0009062),-0.26974274961183675,-1.0917713316177555,0.2903225806451613,0.7037607434719072,1.0,25/67,26.46%,HADHB;ACADM;CROT;PCCB;SCP2;ABCD4;MECR;ALDH3A2;HADH;ABHD2;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2;NUDT7;LPIN1;SLC27A4;PECR;MCEE;AIG1;PLA2G15;MMAA;HACL1;ILVBL
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5653821102737882,1.0916562289740908,0.37227414330218067,1.0,1.0,3/10,13.96%,PRNP;SCRIB;RC3H1
prerank,positive regulation of organelle organization (GO:0010638),0.49525355707081914,1.0913374445944335,0.37777777777777777,1.0,1.0,10/32,15.21%,GSK3B;ANXA2;LNPK;ATL3;SORBS3;HTRA2;STX18;ANXA1;ADRB2;UVRAG
prerank,regulation of viral entry into host cell (GO:0046596),-0.3308994001790634,-1.0907262955703056,0.3352601156069364,0.7050812680967863,1.0,11/30,17.26%,MID2;LY6E;SNX3;TRIM25;IFITM3;GSN;TRIM27;TRIM14;NECTIN2;IFITM2;LGALS9
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3420228226340616,-1.0894965700638057,0.28431372549019607,0.7069256993135573,1.0,6/25,5.66%,CAMK2D;CTNNA3;CALM1;CAV1;RYR2;FGF13
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5626133018003818,1.0888356881382448,0.38580246913580246,1.0,1.0,4/10,16.27%,RHOA;RAP2A;EZR;MSN
prerank,B cell receptor signaling pathway (GO:0050853),-0.3119268591561445,-1.08860813641045,0.30625,0.7080508527516718,1.0,9/32,19.23%,MEF2C;VAV3;BCL2;BMX;RFTN1;PIK3CD;BCAR1;CD38;NCKAP1L
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5121244973258022,1.088528845135825,0.38,1.0,1.0,7/25,11.44%,ADK;ADA;DCK;HPRT1;PRPS1L1;PRPS1;ADSL
prerank,regulation of metal ion transport (GO:0010959),-0.37928757443591976,-1.088316228765914,0.34523809523809523,0.7076154986662608,1.0,4/16,10.54%,CACNA2D1;EPB41;CAMK2G;BCL2
prerank,regulation of cellular component biogenesis (GO:0044087),0.4814003806837778,1.088083832822821,0.36811254396248533,1.0,1.0,8/39,12.05%,HJURP;ROCK2;NCLN;ROCK1;AGT;BAG5;EZR;SPTY2D1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.49019654465600887,1.088047794956404,0.3957845433255269,1.0,1.0,10/33,15.83%,ATOH8;TEAD1;KLF5;SRF;FOXO3;SMARCA4;NR3C1;SMAD3;GNL3;TP53
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4856604738902453,1.087513587568929,0.4006772009029345,1.0,1.0,4/42,7.96%,HMGB2;AQP1;RNASE6;SERPINE1
prerank,negative regulation of chemotaxis (GO:0050922),-0.3151764336363009,-1.086860032348158,0.33974358974358976,0.7100210807501519,1.0,13/31,19.19%,SEMA6A;SEMA6D;SEMA7A;DUSP3;SEMA4D;SEMA3A;SLIT2;ANGPT2;THBS1;SEMA3B;ROBO2;SEMA3C;SEMA5B
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4655420389248219,1.086492737116446,0.371900826446281,1.0,1.0,17/94,12.41%,BRCA1;E2F1;CHEK2;ITPR1;PRKDC;STK24;PML;CUL5;HTRA2;CUL3;TNFRSF10B;APAF1;HINT1;BOK;LGALS12;QRICH1;MSH6
prerank,regulation of DNA binding (GO:0051101),0.47766868891367753,1.0862862038206003,0.38800904977375567,1.0,1.0,3/44,1.44%,HJURP;HMGB2;E2F1
prerank,regulation of centrosome cycle (GO:0046605),0.5191119090583932,1.0859618583572692,0.39819587628865977,1.0,1.0,2/21,2.75%,GEN1;AURKA
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.45014527119644343,-1.0858041365150795,0.3323442136498516,0.7114092346677751,1.0,5/10,19.23%,TGFBR2;PRKCQ;CD81;LGALS9;NCKAP1L
prerank,dorsal/ventral pattern formation (GO:0009953),0.5113367787586072,1.0857552741568823,0.38420348058902276,1.0,1.0,5/20,11.94%,GLI2;BMPR1A;LMX1B;DSCAML1;AIDA
prerank,RNA destabilization (GO:0050779),0.5184114749437094,1.0857501769578728,0.38070404172099087,1.0,1.0,8/18,16.35%,ROCK2;FTO;ROCK1;YTHDF2;MEX3D;DXO;ZC3H18;METTL3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5315894243605604,1.0848932342830402,0.3603851444291609,1.0,1.0,5/15,16.35%,USP18;PTPN2;YTHDF2;CNOT7;METTL3
prerank,microtubule anchoring at centrosome (GO:0034454),0.5664789611161933,1.0846465182021052,0.37037037037037035,1.0,1.0,3/10,10.32%,NIN;PCM1;NINL
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.35318977827216563,-1.0846319501641313,0.3236514522821577,0.7132014895193527,1.0,7/20,17.19%,OGT;ASAH1;CYLD;STUB1;NUPR1;SDCBP;BIRC3
prerank,actin nucleation (GO:0045010),0.5206123001402446,1.0843164343477067,0.38382541720154045,1.0,1.0,3/21,7.26%,IQGAP2;ACTR3;ARPC5L
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.42971484298337337,-1.0832396350712759,0.3675496688741722,0.7156515827393631,1.0,6/11,25.76%,PRKN;PINK1;FBXO7;PARK7;RACK1;HIF1A
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3218109898839836,-1.083148819886764,0.3147208121827411,0.7146763112463809,1.0,6/27,5.85%,SLC1A2;SLC7A2;SLC25A13;SLC25A12;SLC3A2;SLC7A5
prerank,embryonic limb morphogenesis (GO:0030326),0.48238209490033157,1.0831080518972007,0.3903002309468822,1.0,1.0,14/34,20.39%,GLI3;CYP26B1;AFF3;MAP3K20;NIPBL;WDPCP;CACNA1C;HDAC1;HDAC2;TWIST1;SALL1;OSR1;SKI;FBXW4
prerank,Golgi organization (GO:0007030),0.4628076059564344,1.0831042564995494,0.38555442522889116,1.0,1.0,28/112,18.49%,CDK1;ARHGAP21;USP6NL;GBF1;OBSL1;COG1;ZW10;ATL2;ATL3;RAB29;LRRK2;GOLGA8B;GOLGA5;RAB1A;BAG5;GAK;GORASP2;VTI1A;PRKD1;VRK1;BET1;TMED3;UBXN2B;CSNK1A1;COG4;CLASP1;TMED10;PI4K2B
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.36286581145047414,-1.0830787197807243,0.36213991769547327,0.7136470321298841,1.0,11/17,39.20%,TEK;NTRK3;ABL1;BAIAP2;NRP1;FES;BCAS3;HRAS;NTF3;HCK;HCLS1
prerank,tight junction assembly (GO:0120192),0.4782775364771852,1.0829202084020058,0.3939732142857143,1.0,1.0,3/49,6.59%,ECT2;AFDN;GRHL2
prerank,basement membrane organization (GO:0071711),0.5457351665495096,1.082503460740592,0.385049365303244,1.0,1.0,4/14,15.48%,NID2;LAMB1;NID1;NTN4
prerank,response to growth factor (GO:0070848),-0.2942864795258575,-1.082130951828327,0.3418803418803419,0.7148516064334114,1.0,20/41,25.44%,ACVR1;ACVR2A;TGFBR2;BMPR2;ACVRL1;MAP2K5;KLF4;ACVR2B;CTNNB1;SHC1;ERBB2;SOX2;BMPR1B;NOS1;RACK1;GATA6;SPHK1;URI1;PLK5;MAPK7
prerank,regulation of protein kinase A signaling (GO:0010738),0.5129558580582214,1.0819153704338742,0.38461538461538464,1.0,1.0,7/20,17.32%,ADGRV1;IAPP;LRRK2;ADRB2;RAMP3;PRKAR2B;PRKAR2A
prerank,negative regulation of gene expression (GO:0010629),0.45392674517812787,1.0818695549210342,0.338,1.0,1.0,71/302,16.35%,PHF19;EZH2;RBL1;HELLS;TYMS;ATOH8;ILF3;SYNCRIP;ATP2B4;PPM1D;RB1;BMPR1A;AURKA;MOV10;ROCK2;SUZ12;AGO2;CNOT1;DDRGK1;MPHOSPH8;EED;SETDB2;MAPT;XDH;EIF4ENIF1;SAMD4A;RBBP4;CAPRIN1;RBBP7;FBXW7;FMR1;SFRP2;PHF1;LARP1;ROBO1;YAP1;VHL;SLC24A3;PICALM;EPC1;LSM2;PARP9;YTHDF2;FLOT2;ATP2B1;MRPL13;EIF2AK3;CRKL;HDAC1;BMP2;TERF2;STOX1;CENPV;RBMS3;TRIM6;NOTCH2;DXO;PTBP2;HEY2;RBM4;DHFR;YY1;DNMT3A;EPRS1;CNOT7;TNRC6C;FXR1;NFKB1;SFRP1;PNPT1;METTL3
prerank,regulation of ion transport (GO:0043269),-0.2561591968787438,-1.081531767923119,0.25,0.7151386423579801,1.0,28/76,23.69%,PRKN;NKAIN2;SYT1;KCNJ3;KCNJ6;SIK1;ATP1A1;NKAIN4;SYT7;B2M;DTNBP1;KCNJ10;KCNA2;SYT11;SYT12;WWP2;VAMP3;SYT10;NKAIN3;SYT6;ITGB3;SYT2;KCNJ12;NOS1;P2RX4;DRD2;NEDD4L;TOR1A
prerank,nucleocytoplasmic transport (GO:0006913),0.47756091774224296,1.0811796139677037,0.393348623853211,1.0,1.0,10/40,17.33%,XPO1;NUP205;PHAX;HNRNPA1;RBM15B;ATXN1;NXT1;NUP98;GEMIN7;NXT2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.30435941261359284,-1.080999495893999,0.3008130081300813,0.7153848193742995,1.0,5/39,2.63%,PTK2;PTPRG;SMAD7;PODXL;JAG1
prerank,neurotransmitter uptake (GO:0001504),-0.4110897766259584,-1.0802074390843681,0.3536231884057971,0.7162361946161148,1.0,9/12,46.56%,GLUL;ATP1A2;SNAP25;SLC22A2;SLC1A6;SLC22A3;SLC29A2;SLC29A4;SLC38A1
prerank,RNA transport (GO:0050658),0.46302913624205627,1.0800829980959974,0.39034627492130114,1.0,1.0,18/71,16.55%,CKAP5;NUP155;SRSF4;HNRNPA1;EIF4E;UPF3B;SLBP;TPR;DDX39B;FMR1;SRSF7;SRSF3;SRRM1;NUP214;SIDT1;HNRNPA2B1;PNPT1;DHX38
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.34300242932267283,-1.0794713180321747,0.35294117647058826,0.716905785275828,1.0,5/22,17.16%,APOD;PRKAA1;ASXL3;CCDC3;ADRA2A
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.27923824031129874,-1.079462811589616,0.3394495412844037,0.7157299445743593,1.0,16/50,16.68%,SMAD7;OGT;PRMT3;CAV1;PER2;UFL1;SQSTM1;PINX1;DNAJA1;ABL1;LIMK1;SPRY2;SOX4;SH3RF2;UBXN1;PRKCG
prerank,regulation of synapse assembly (GO:0051963),-0.2870194437390118,-1.079411195259053,0.26666666666666666,0.7146316159726795,1.0,18/46,23.78%,PTPRD;MEF2C;SYNDIG1;GRID2;EPHB2;IL1RAPL1;EIF4G1;NRXN1;APP;SLITRK1;LRRC4B;ROBO2;NLGN1;IL1RAP;BDNF;DLG5;SRPX2;SLIT1
prerank,purine nucleotide catabolic process (GO:0006195),0.5438382453066958,1.0793201641645531,0.3967310549777117,1.0,1.0,6/13,24.41%,XDH;ITPA;HINT1;PNP;NT5E;GDA
prerank,protein import into mitochondrial matrix (GO:0030150),-0.36772501695203125,-1.0788026131223583,0.3715415019762846,0.7150235597330185,1.0,12/18,38.87%,DNAJC19;TIMM44;TOMM70;DNAJC15;PAM16;TIMM17A;TIMM17B;ROMO1;GRPEL1;DNLZ;TOMM40L;TIMM50
prerank,positive regulation of JNK cascade (GO:0046330),-0.25545802001227536,-1.0785138146280029,0.2786885245901639,0.714604402879384,1.0,39/70,39.61%,TNFRSF19;SH3RF3;HIPK2;TPD52L1;TAOK2;ANKRD6;MAP3K5;DUSP22;SEMA3A;MINK1;APP;SDCBP;SH3RF2;TIRAP;GADD45B;FLT4;MAP3K11;WNT16;PTK2B;MAPK8IP1;MFHAS1;EDA2R;PLCB1;MBIP;GADD45G;DUSP19;TRAF1;HRAS;PJA2;CCL19;EDAR;NOD2;DUSP15;PYCARD;GADD45A;UNC5CL;FCGR2B;RASSF2;AGER
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.26915656207896815,-1.0784345767698047,0.3,0.7136401436251392,1.0,26/70,19.34%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3863344442660358,-1.0782137320485365,0.35766423357664234,0.7130306042753737,1.0,5/15,13.87%,GRM7;GRM3;HOMER1;GRM5;GRM1
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2594361830768924,-1.0779677028119543,0.3235294117647059,0.7125101109735716,1.0,17/66,25.98%,STAT3;CARD16;IGF1;MALT1;TLR4;APP;CX3CL1;PANX1;LGALS9;TRIM16;GIT1;EGR1;ZC3H12A;HSPB1;JAK2;P2RX7;TMEM106A
prerank,regulation of cation transmembrane transport (GO:1904062),0.4892613302178902,1.0778105572025183,0.3903030303030303,1.0,1.0,9/29,17.53%,ATP2B4;RANGRF;PDZK1;WNK1;SNTA1;KCNIP3;DLG1;DPP6;WNK3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.46772579326674163,1.077609304390723,0.40044493882091214,1.0,1.0,19/52,17.41%,PNLDC1;CNOT1;PATL1;CNOT6L;LSM3;SAMD4A;RC3H2;TUT7;CNOT6;LSM2;PAN3;EXOSC7;TUT4;LSM7;RC3H1;CNOT7;LSM4;CNOT4;EDC3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.46095191814176806,1.077049887957474,0.4059196617336152,1.0,1.0,22/74,17.86%,EZH2;LOXL2;USF3;PDPN;EFNA1;SFRP2;WWTR1;AXIN2;TGFBR1;BMP2;NKX2-1;SMAD4;ADIPOR1;TWIST1;SPRED1;SMAD3;SFRP1;SPRED2;PTEN;EPHA3;SMAD2;CLASP1
prerank,lymphocyte proliferation (GO:0046651),0.4992469550537651,1.0770150520267163,0.3896595208070618,1.0,1.0,5/22,16.27%,HELLS;ELF4;CTPS1;LMBR1L;MSN
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5555931944225785,1.0767796586569132,0.3939393939393939,1.0,1.0,3/10,7.60%,ANXA2;EFNA1;EPHA4
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4837593349664956,1.076776716805086,0.39792387543252594,1.0,1.0,7/37,11.81%,PABPC4;HNRNPD;RNASE6;NUDT5;RNASEH2A;PPP1R8;EXOSC7
prerank,peptide cross-linking (GO:0018149),0.5084043896414738,1.0766980218681343,0.3962962962962963,1.0,1.0,1/25,1.15%,TGM1
prerank,secretion (GO:0046903),-0.3942112468785206,-1.0763671399033399,0.367003367003367,0.7153493828318408,1.0,4/14,10.61%,RIMS1;SLC22A6;NPR1;TPD52
prerank,blood vessel morphogenesis (GO:0048514),-0.2713515627684502,-1.076272420290893,0.34523809523809523,0.7144154197066669,1.0,17/54,15.85%,FLT1;SMAD7;CDH2;CAV1;TGFBR2;PROX1;RAMP2;NF1;RASIP1;CUL7;CCBE1;TBX1;VEGFA;ENG;SOX17;STRA6;SLC1A1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3978880416496364,-1.0759274586810859,0.3512658227848101,0.7140432905421813,1.0,6/13,16.50%,CALM1;NOS3;QDPR;GCH1;PRKG2;PTS
prerank,"DNA-templated transcription, termination (GO:0006353)",0.46496288226601307,1.0755373128618144,0.3920515574650913,1.0,1.0,17/68,13.15%,TTF2;SETX;POLR1A;CSTF3;FIP1L1;POLR1B;SLBP;ERCC3;LSM11;POLR2A;WDR33;PCF11;TAF1D;SCAF8;CPSF4;TTF1;POLR1G
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.45018563572962716,1.0755151713948194,0.281,1.0,1.0,93/476,14.34%,BRCA1;ATAD2;MYBL1;PBX4;GLI2;CDK5RAP2;GLI3;HMGB2;E2F1;BRCA2;FOXE1;ATOH8;HAS3;ILF3;NAT14;PSRC1;DYRK1A;SMARCC1;SP3;PHIP;ELF2;TEAD1;CTCF;HNRNPD;NFE2;MED14;CHEK2;NFIL3;BLM;ELF4;NFIB;THRAP3;TBL1XR1;SETD3;NUP85;PCBD2;YAF2;MED30;ELF1;PML;TCF4;ARID1A;TASP1;ELK1;FOXO3;ATF7IP;CD80;TRIM28;IRF1;CREB5;MED24;SMARCA4;USP21;USP16;ZFP90;DNM2;YAP1;NFYA;VHL;PICALM;EPC1;AGT;KMT2A;PARP9;TGFBR1;TAL1;MMS19;CRLF3;TAF15;QRICH1;HDAC1;BMP2;AHR;NKX2-1;FBXW11;SOX9;SMAD4;HDAC2;ATF5;IL31RA;ZNF496;ILF2;BRD4;RAI1;LRP5;RORA;HEY2;MED1;BTRC;RLF;FOXK2;FOXM1;SMAD3
prerank,negative regulation of programmed cell death (GO:0043069),0.4462895770754671,1.0744309204564626,0.31931931931931934,1.0,1.0,61/355,16.33%,KIF14;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;AQP1;MAP4K4;SETX;PHIP;ARHGAP10;ANGPT4;GSK3B;FXN;DDRGK1;AIFM2;FHL2;PRKDC;MRE11;SIAH2;PDPN;ANXA5;ARL6IP1;SMAD6;GRK5;SH3RF1;KANK2;MGMT;ANGPT1;VHL;PIM1;APIP;ERC1;HDAC1;ANXA1;SOX9;HDAC2;NOTCH2;ATF5;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;CD44;BIRC6;SRC;GDNF;TNFAIP8;NFKB1;TP53;SFRP1;ANKLE2;HIPK3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5083989466109425,1.0744146429418717,0.39303482587064675,1.0,1.0,9/26,14.77%,MTBP;HYAL1;CDC6;TFDP1;LSM11;ANXA1;ADAM17;ADAMTS1;RPTOR
prerank,response to prostaglandin E (GO:0034695),0.5430221474320196,1.0741703004644538,0.3865814696485623,1.0,1.0,4/10,22.04%,TGFBR3;ADCY6;SFRP1;GNB1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.363741934540272,-1.0739260599255875,0.3702290076335878,0.7180264554406751,1.0,11/17,25.82%,ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;ATP5ME
prerank,mitochondrion disassembly (GO:0061726),-0.3033303412291899,-1.0738841466500857,0.34057971014492755,0.7169395361873641,1.0,14/34,19.95%,PRKN;FIS1;WDR45B;BECN1;SQSTM1;ULK1;BNIP3;PINK1;ATG9A;USP30;ATG2B;FBXO7;FUNDC1;GABARAPL2
prerank,cilium movement (GO:0003341),0.46589560137201846,1.0737791976116995,0.38985005767012687,1.0,1.0,7/47,10.86%,DNAH11;CFAP53;SPEF1;DNAH1;DNAI4;RSPH9;DNAAF5
prerank,positive regulation of RNA splicing (GO:0033120),0.486623022666055,1.0732108947186494,0.372289156626506,1.0,1.0,11/29,21.29%,DYRK1A;SETX;TRA2B;THRAP3;POLR2A;DAZAP1;NUP98;HNRNPLL;SLC38A2;TRA2A;RBMX
prerank,regulation of kinase activity (GO:0043549),0.4578708955707962,1.073058071475642,0.3975026014568158,1.0,1.0,11/89,7.60%,ECT2;RBL1;RB1;FGFR4;FGFR2;KIT;MRE11;MAPT;MUSK;PDGFRA;EPHA4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4210345848036632,-1.0728490454014439,0.35202492211838005,0.718286045628669,1.0,7/12,26.43%,HSPA5;SGTA;SGTB;SEC61B;SEC62;SEC63;SEC61A2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5179754218145222,1.0728424281746882,0.3855421686746988,1.0,1.0,4/18,10.43%,STMN1;CUL3;RIPOR2;ARHGAP35
prerank,monocarboxylic acid transport (GO:0015718),-0.27855371491236236,-1.0723555160360687,0.3258426966292135,0.7182819749656191,1.0,13/51,17.60%,SLC16A12;SLCO1C1;SLCO2B1;SLC27A1;ABCC4;ATP8B1;SLCO2A1;ABCG2;SLC5A6;SLC16A1;SLC16A4;SLC6A11;STARD5
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.43092839513830566,-1.0719630466280943,0.3554913294797688,0.7181033354286648,1.0,1/10,0.01%,PRKG1
prerank,regulation of cytoskeleton organization (GO:0051493),0.44923068167646263,1.0719566567619137,0.38256410256410256,1.0,1.0,22/108,12.66%,IQGAP3;IQGAP2;ROCK2;RHOA;GSK3B;SPEF1;DIAPH1;ARHGAP18;MAPT;BICD2;SORBS3;RHOQ;TPPP;ROCK1;MARK2;ARHGAP35;PLXNB1;RND2;EZR;RAC1;DMTN;CLIC4
prerank,regulation of ATP metabolic process (GO:1903578),0.4628122913983756,1.071528422424387,0.3971238938053097,1.0,1.0,15/54,17.40%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;ATP5IF1;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,cellular response to organic cyclic compound (GO:0071407),0.44935740645501115,1.0712908126932956,0.4012096774193548,1.0,1.0,30/141,16.27%,BRCA1;RAD51;AQP1;ROCK2;CASP7;ABCB4;DIAPH1;BLM;LCOR;CTNNA1;SPIDR;IL18;LARP1;LRRK2;RIOK3;P2RY1;NR3C1;TRPM2;AHR;EZR;AKAP9;DMTN;RORA;MED1;RUVBL2;RAMP3;ADCY6;PKD2;SFRP1;MSN
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5108525599966672,1.071256992064295,0.4075520833333333,1.0,1.0,6/20,15.57%,PPIL1;FKBP5;PPIG;PPID;PIN1;PPWD1
prerank,regulation of microtubule polymerization (GO:0031113),0.4827633682048783,1.0708065065217063,0.3886966551326413,1.0,1.0,9/40,11.74%,CDK5RAP2;STMN1;PSRC1;DYRK1A;NUMA1;MAPT;DRG1;AKAP9;RAC1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5425253033262576,1.0706085452723366,0.4064327485380117,1.0,1.0,5/11,18.43%,DCK;ENPP3;ERH;SLC19A2;SLC25A19
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3628102271094494,-1.0702173477476495,0.3735408560311284,0.7212452511152353,1.0,8/17,24.09%,COX6C;COX4I1;COX5A;COX7B;COX7C;NDUFA4;COX8A;COX5B
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.4472406107161719,1.070032079285318,0.327,1.0,1.0,72/327,16.24%,PHF19;EZH2;ATRX;MYBL1;NSD2;TCFL5;E2F1;BRCA2;RB1;SP3;LIN54;HNRNPD;NLK;AJUBA;CHEK2;ACTN4;NFIA;NFIL3;TCF7L1;SRSF10;CCAR1;GZF1;YAF2;SOX6;HP1BP3;GON4L;PML;PSPC1;MYBL2;POLR2A;FUS;MYCBP;WWTR1;PHF1;PRRX2;LMX1B;BNC2;MSL3;LIMD1;DNM2;NONO;NFYA;VHL;ZNHIT3;ERC1;NR3C1;HINT1;SFPQ;TGFBR1;SLC39A8;POFUT1;NCOA2;BMP2;AHR;ATXN1;SPTY2D1;KMT2D;ATF5;RORA;GPBP1L1;FOXK2;JMJD1C;SOX1;RBAK;PRDM8;EFEMP1;TRRAP;MLF2;HOXB7;TP53;DRAP1;RALY
prerank,negative regulation of hippo signaling (GO:0035331),0.5471802046791518,1.0699311171512915,0.39477726574500765,1.0,1.0,7/12,22.84%,CIT;AJUBA;LIMD1;SHANK2;MAPK14;WWC2;VGLL4
prerank,tyrosine metabolic process (GO:0006570),0.5629552143122457,1.0699128706636853,0.3997093023255814,1.0,1.0,4/11,22.11%,TYR;IL4I1;THAP4;GSTZ1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5419024134616224,1.0698622316322497,0.4076809453471196,1.0,1.0,5/12,10.71%,ROCK2;PRNP;ROCK1;PICALM;FLOT2
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.40674069347522607,-1.0696396745292138,0.38387096774193546,0.721460139246933,1.0,4/12,24.76%,SCP2;ACSL1;ELOVL1;FADS1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.2856009779881655,-1.069271523133742,0.3302752293577982,0.721224828074544,1.0,17/45,20.19%,PTK2;KIF16B;RPS6KA5;PIK3R1;PLCG1;TGFA;GRB2;PTPN11;SHC1;ERBIN;PLCE1;CBL;PIK3CA;BCAR1;SHC3;DGKD;HBEGF
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.4468677230822712,1.0688889963908697,0.17,1.0,1.0,336/1668,15.87%,BRCA1;CKAP2;E2F7;CCNB1;NR2E3;E2F8;UHRF1;CDK1;MXD3;ATAD2;EZH2;BRIP1;EN1;PLK1;E2F2;ATRX;AURKB;MYBL1;PBX4;GLI2;TCFL5;GLI3;RBL1;LCORL;HMGB2;E2F1;CBX5;FOXE1;ATOH8;ZBTB8A;MED26;ATP2B4;KMT5A;FADD;PPM1D;LOXL2;TRIM37;ZFP69;BRD9;CBFB;SMARCC1;ZNF32;RB1;PBX3;BAZ1B;SP3;SETX;BMPR1A;HOXC5;DEK;MOV10;PHIP;ZFP41;ETV6;TWIST2;FNIP1;ELF2;MIER1;ACTR3;TRAK1;TEAD1;WWOX;SP2;ZSCAN29;RAD21;RBBP8;HDGF;AGO2;CTCF;E2F3;FGFR2;SENP1;ZEB1;JAZF1;TFDP1;BCL2L12;NFE2;TFCP2L1;CNOT1;GALR1;DDRGK1;MED14;EED;AUTS2;BCOR;RFXAP;MDM4;TAF3;ZNF260;RGMA;NFIA;HIVEP1;KIT;CUX1;PCGF5;SSBP3;DHX9;WIZ;FHL2;PRKDC;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;CTBP1;EPC2;TSHZ1;ELF4;ASXL1;NFIB;THRAP3;KLF13;ZNF568;ZNF697;TBL1XR1;SP8;LPIN2;IKZF1;MCPH1;MLLT10;SETD3;BMP6;GZF1;LCOR;HOXC4;TCF7L2;PSIP1;MED30;SOX6;ELF1;IL18;ORC2;HOXA7;GMEB1;TPR;GRHL2;AKNA;ARRB1;ELOC;GATAD2A;TCF4;MIDEAS;ARID1A;EFNA1;MYBL2;GLIS3;RFX2;RIF1;SFRP2;ELK1;NUCKS1;PPP3CA;CCN1;FUS;NIPBL;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;MAMSTR;FHL5;SIM1;ZBTB7B;WWTR1;SRCAP;ZFX;PHF2;LIN9;SERPINE1;ZHX2;PRRX2;OLIG2;FOXO3;SAP18;TRIM28;LMX1B;KDM2B;LIN37;PLAGL2;SMAD6;ZNF23;RCOR1;PELP1;IRF1;ZFP64;HMGB3;BCLAF1;CREB5;MED24;RHOQ;SMARCA4;USP16;ZFP90;KLF11;NCK1;MIER3;KANK2;ZBTB25;HOXB3;YAP1;NFYA;VHL;ARID4A;PLAGL1;ZIC5;MED15;ZBTB20;UXT;EPC1;HMGB1;IKBKG;KMT2A;HOXB6;HDAC8;MEOX2;MTA3;NR4A2;CARF;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;TAL1;TADA1;CRLF3;TEAD3;ZBTB24;KCNIP3;NCOA2;SMURF2;PRKCB;ZNF585B;ZNF585A;CHD2;HDAC1;BMP2;AHR;EZR;NKX2-1;KLF9;HTATSF1;TBX18;MRTFA;NFATC2IP;ZHX3;ATXN1;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;ZIC4;KMT2D;SOX9;SMAD4;HDAC2;ZNF394;RPRD1A;SAP130;ATF5;ZNF496;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;IL4I1;NCOA7;TADA2A;IRF2BP1;PPID;TWIST1;MAML1;HEY2;USP9X;PPRC1;ACTL6B;PRKD1;MED1;DLG1;ARF4;FOXL1;RARB;POU2F2;YY1;ZMYM5;RLF;FOXK2;CAMTA1;PCGF6;DNMT3A;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;ZFP91;CDK8;JMJD1C;BAZ1A;SOX1;E2F4;PER1;YEATS2;RBAK;ZNF445;PIN1;MED27;OTUD7B;INO80;DR1;HDGFL3;GDNF;ATF1;KAT6A;DCAF1;TNRC6C;ZNF507;HOXB7;PRKD2;PKD2;CSRP3;CHD1;ZNF112;NFKB1;ZBTB7C;PPIL4;TP53;FHOD1;PKNOX2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.47016985873700884,1.0687306815491795,0.40757238307349664,1.0,1.0,12/43,15.83%,ATOH8;TEAD1;KLF5;SRF;NFIB;FOXO3;SMARCA4;NR3C1;SOX9;SMAD3;GNL3;TP53
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5227219878712077,1.0685655836837291,0.3997194950911641,1.0,1.0,3/15,9.13%,GSTO2;HNRNPA1;CPEB2
prerank,activin receptor signaling pathway (GO:0032924),-0.37848351529756286,-1.0685599227796374,0.39245283018867927,0.7217143786321902,1.0,3/15,8.29%,ACVR1;ACVR2A;ACVR2B
prerank,regulation of cell killing (GO:0031341),-0.38529017705206503,-1.068456897247596,0.3835125448028674,0.7208169564618774,1.0,3/16,10.17%,MAPK8;TGFB2;NOX1
prerank,positive regulation of isotype switching (GO:0045830),0.5284134318030661,1.0684513125022155,0.39918809201623817,1.0,1.0,4/15,15.24%,PAXIP1;RIF1;KMT5C;SHLD2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.42350855881386973,-1.0682778257624566,0.3792134831460674,0.7200953198682442,1.0,1/11,0.28%,STAT3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.26132860697686405,-1.0682020194751427,0.34,0.7191376272933209,1.0,26/73,19.34%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3878104985401864,-1.0679802437316113,0.3580645161290323,0.7185140119462633,1.0,4/14,21.07%,CROT;SCP2;DECR2;AMACR
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.4401929479183737,-1.067274124292456,0.3954154727793696,0.7190231023131755,1.0,2/10,0.68%,DLGAP1;DLGAP4
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.37367131418727284,-1.0669452356809992,0.33203125,0.7175698635264606,1.0,4/17,10.43%,STAT3;SOCS2;IRS2;IRS1
prerank,cellular response to interleukin-7 (GO:0098761),-0.37367131418727284,-1.0669452356809992,0.33203125,0.7175698635264606,1.0,4/17,10.43%,STAT3;SOCS2;IRS2;IRS1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2654094310735153,-1.0660297591669947,0.3469387755102041,0.7187439604241332,1.0,26/71,19.34%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,synapse organization (GO:0050808),-0.22808262757347164,-1.065835143752181,0.26666666666666666,0.7180526649608105,1.0,17/125,4.75%,DNM3;UNC13B;CTNND2;PTPRD;PSEN1;CDH2;SLC8A3;DNER;SLC6A1;SHANK3;ARHGAP39;PAK3;SPOCK2;ADGRL3;NRCAM;AGRN;SDK2
prerank,regulation of presynapse organization (GO:0099174),-0.3509093616201031,-1.0653788628895229,0.36818181818181817,0.7169823414452763,1.0,6/18,15.67%,PTPRD;IL1RAPL1;EIF4G1;APP;SLITRK1;LRRC4B
prerank,regulation of presynapse assembly (GO:1905606),-0.3509093616201031,-1.0653788628895229,0.36818181818181817,0.7169823414452763,1.0,6/18,15.67%,PTPRD;IL1RAPL1;EIF4G1;APP;SLITRK1;LRRC4B
prerank,heme biosynthetic process (GO:0006783),0.495379948814708,1.0653770447161808,0.39421813403416556,1.0,1.0,7/22,16.87%,HMBS;FXN;COX10;ABCB10;CPOX;ATP5IF1;ALAS2
prerank,regulation of protein localization to membrane (GO:1905475),-0.3167957975751894,-1.065164161485348,0.32786885245901637,0.7164051595529882,1.0,10/28,16.13%,PRKN;STX8;ACTB;STX7;AR;SPTBN1;GSN;LDLRAP1;ZDHHC7;VAMP8
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.4871889895942543,1.0651518457386093,0.4068627450980392,1.0,1.0,8/29,13.79%,RAB33B;COG1;GOLGA5;COPB2;COPZ1;VTI1A;GOSR1;TRAPPC10
prerank,transition metal ion transport (GO:0000041),-0.3029812200437699,-1.0650508578710778,0.3356164383561644,0.715562840355081,1.0,11/35,21.97%,FTH1;TRPC5;TRPC3;TRPC1;IREB2;SLC31A2;SLC30A1;ATOX1;CUTC;COX17;ATP7A
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2598749525548602,-1.064698252900544,0.3541666666666667,0.7153451140490846,1.0,26/78,17.95%,STX8;PRKCH;ACTB;STX7;STX4;AR;SQSTM1;LRP1;EPHB2;PIK3R1;STX3;CLIP3;ZDHHC5;NUMB;DAB2;KIF5B;SPTBN1;AP2M1;LDLRAP1;ZDHHC7;NKD2;ZDHHC8;VAMP8;STAC;PTPN9;DPP10
prerank,protein deubiquitination (GO:0016579),0.44435928919252754,1.0646263271186172,0.37374749498997994,1.0,1.0,60/242,19.02%,BRCA1;CDK1;CLSPN;BARD1;CDC20;USP1;RHOA;PSMC2;PSMD5;MDM4;USP18;CCNA2;TAB1;ASXL1;SIAH2;RHOT1;CCNA1;USP37;STAM;UIMC1;PSMB1;PSMD14;USP21;USP16;PSMD1;SKP2;IKBKG;CDC25A;TGFBR1;PSMB9;USP28;SMURF2;ADRM1;SMAD4;ADRB2;USP9X;USP47;YY1;FOXK2;BRCC3;SMAD3;OTUD1;PSMC6;OTUD7B;INO80;TRRAP;TP53;TAF10;PTEN;RAD23B;USP48;PSMB2;WDR20;SMAD2;USP14;PSME4;PSMB7;RIPK1;USP46;USP20
prerank,cellular glucose homeostasis (GO:0001678),-0.27860192172992754,-1.064575174190678,0.3464566929133858,0.7145205644941488,1.0,15/41,21.90%,UNC13B;FOXO1;KCNB1;GAS6;PIK3R1;PRKAA1;SOX4;HK1;ADCY8;LRRC8D;XBP1;LRRC8A;PPARGC1A;PIK3R2;RACK1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.28083967223897166,-1.0645490162685698,0.29906542056074764,0.7134543802774251,1.0,12/45,13.70%,CAMK2D;TRIM25;MID1;VCAM1;TRIM8;B2M;IRF2;CAMK2G;IFNGR2;IRF3;IRF9;IFNGR1
prerank,apoptotic cell clearance (GO:0043277),0.47779684144660756,1.064306965728898,0.40024183796856105,1.0,1.0,6/30,15.00%,XKR5;HMGB1;ANXA1;RAC1;TXNDC5;ITGAV
prerank,histone mRNA catabolic process (GO:0071044),0.5288840778884306,1.0639347878981982,0.3932107496463932,1.0,1.0,5/15,13.46%,TENT2;ERI1;TUT1;TUT7;TUT4
prerank,amino acid import (GO:0043090),-0.35277974275677404,-1.0635227188410181,0.3817427385892116,0.7147951900238303,1.0,5/21,5.85%,SLC6A6;SLC6A1;SH3BP4;SFXN2;SLC7A5
prerank,ganglioside metabolic process (GO:0001573),-0.33777923050161063,-1.0634232916708777,0.34051724137931033,0.7139245537305304,1.0,6/20,10.93%,ST8SIA4;HEXB;ST6GALNAC3;ST6GALNAC5;HEXA;ST8SIA6
prerank,heart development (GO:0007507),-0.22810182495513365,-1.0626878021821795,0.1,0.7145926122541176,1.0,43/150,18.28%,PTK2;ACVR1;TEK;ECE1;TCF25;MEF2C;ADAP2;TGFBR2;PCSK5;INSR;TAB2;FKBP1A;BMPR2;ACVRL1;TGFB2;RBM20;NTRK3;POU6F1;FOXC2;MTHFD1;FOXC1;RAMP2;ERBB4;NF1;PDLIM2;MEF2A;MEGF8;PDLIM7;SOX4;KAT2B;CACYBP;TBX1;PTPN11;VEGFA;HDAC9;SOX17;STRA6;PLCE1;CRELD1;NDRG4;CITED2;TBX2;PDLIM1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.25916717726571703,-1.0618202824337273,0.33783783783783783,0.7156319687992878,1.0,21/54,23.02%,HEATR3;RPL35A;RPL3;NVL;RPL14;BRIX1;RPL10;RSL1D1;RPL24;TRAF7;NSA2;LAS1L;SNU13;LTO1;MDN1;RPLP0;RPL10A;NOP2;SURF6;RRP15;EBNA1BP2
prerank,protein modification by small protein removal (GO:0070646),0.4430292226814476,1.0615265317170504,0.3713713713713714,1.0,1.0,62/252,19.02%,BRCA1;CDK1;CLSPN;BARD1;CDC20;USP1;RHOA;PSMC2;SENP1;PSMD5;MDM4;USP18;CCNA2;TAB1;ASXL1;SIAH2;RHOT1;CCNA1;USP37;STAM;UIMC1;PSMB1;PSMD14;USP21;USP16;PSMD1;SKP2;IKBKG;CDC25A;TGFBR1;PSMB9;USP28;SMURF2;ADRM1;SMAD4;COPS3;ADRB2;USP9X;USP47;YY1;FOXK2;BRCC3;SMAD3;OTUD1;PSMC6;OTUD7B;INO80;TRRAP;TP53;TAF10;PTEN;RAD23B;USP48;PSMB2;WDR20;SMAD2;USP14;PSME4;PSMB7;RIPK1;USP46;USP20
prerank,inositol lipid-mediated signaling (GO:0048017),-0.2885118680015963,-1.0612958043602145,0.31666666666666665,0.7157733440321093,1.0,18/50,21.48%,OGT;ADAP2;IGF1;PDGFRB;PIK3C2B;KCNH1;PLCB3;PIK3R1;IRS2;IRS1;TNFAIP8L3;PI4KA;PLCE1;PIK3CD;PIK3CA;EXOC1;PLCH1;PIK3R2
prerank,regulation of protein kinase C signaling (GO:0090036),0.5324160777153474,1.0611638326114539,0.3939828080229226,1.0,1.0,2/14,2.62%,ADGRV1;ULK4
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5023210357603723,1.0610037990691987,0.3973684210526316,1.0,1.0,5/18,10.35%,MIEF2;AURKA;MCU;DDHD1;MIEF1
prerank,amide transport (GO:0042886),-0.31070991028471895,-1.0607347812480896,0.3263157894736842,0.7160445565395454,1.0,10/26,20.05%,CERT1;PLTP;SLC27A1;ABCG2;SLC5A6;GLTP;AQP11;SLC38A5;TAP2;DISP1
prerank,autonomic nervous system development (GO:0048483),-0.3770512348863424,-1.0598492241100264,0.3402777777777778,0.717129886706298,1.0,9/17,33.25%,SEMA3A;NF1;SOX4;NRP1;KIF26A;EDNRB;SOX11;SOX10;SOX8
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3086325240049633,-1.0590192586147344,0.3023255813953488,0.7181429287501837,1.0,15/34,28.16%,PTPRB;PTPRZ1;DUSP3;DUSP22;PTPN22;PTPRO;PTPN11;DUSP1;PTPN9;PTPN12;PTPRT;PGP;PTPRF;DUSP8;DUSP6
prerank,eye morphogenesis (GO:0048592),0.5016110620111924,1.058849233565568,0.40583554376657827,1.0,1.0,11/19,19.70%,MFAP2;FBN1;COL5A2;NIPBL;MFAP5;NKD1;EFEMP1;AGTPBP1;SHROOM2;SKI;ALDH1A3
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.4187913971260883,-1.0586320661869477,0.39755351681957185,0.7179222686662713,1.0,2/12,8.37%,STAT3;ESR1
prerank,actomyosin structure organization (GO:0031032),0.45067497372624493,1.0586145006104086,0.41983122362869196,1.0,1.0,20/75,16.49%,CIT;ROCK2;RHOA;MYLK3;CSRP2;MYH10;ARRB1;EPB41L2;CDC42BPA;PHACTR1;CUL3;ROCK1;CDC42BPG;EPB41L3;TMOD3;ITGB1;FRMD6;SRC;CSRP3;TNNT3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4462385953650646,1.0585550135006758,0.4157303370786517,1.0,1.0,17/101,15.59%,EZH2;INCENP;SPDYA;ATP2B4;PSRC1;RHOA;KIT;ETAA1;LRRK2;ROBO1;CALM2;ADAM17;ADRB2;CAB39;RPTOR;SRC;PKD2
prerank,diacylglycerol metabolic process (GO:0046339),-0.34219004283918897,-1.058457507987086,0.36,0.7172002645046639,1.0,13/23,36.90%,DGKB;DGKG;DGKI;DGKQ;PLCE1;DGKD;PLA2G15;DGKK;PNPLA2;LIPE;DGAT2;ANG;DGKA
prerank,vesicle organization (GO:0016050),-0.2771061883175615,-1.0582314329630482,0.3137254901960784,0.7166519763105461,1.0,15/46,14.61%,CAV1;FNBP1L;SQSTM1;CD34;LAPTM4B;DNM1;USP8;SAR1A;VPS11;CHMP2B;SRGN;CAV2;ARFGEF2;HOOK1;VPS33B
prerank,response to estradiol (GO:0032355),-0.3073624903490153,-1.058184864903384,0.3539325842696629,0.7156681246247428,1.0,7/31,11.74%,STAT3;SOCS2;CCDC62;STRN3;GGT5;ESR1;CTNNB1
prerank,fatty acid transmembrane transport (GO:1902001),-0.3473893740535364,-1.0581558277966552,0.3483606557377049,0.7146241890015929,1.0,6/19,19.09%,SLC2A1;ABCD4;SLC27A1;ACACB;ABCD2;PRKAG2
prerank,positive regulation of proteolysis (GO:0045862),0.4524737877646203,1.0577308904974922,0.4063526834611172,1.0,1.0,12/55,13.77%,PLK1;FADD;FGFR4;SH3D19;SNX33;FBXW11;HDAC2;CASP8;ATP5IF1;CTSH;BTRC;ADAM9
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3421897552434666,-1.0574951388843965,0.37142857142857144,0.7151695557765172,1.0,8/21,26.48%,ACVR1;MEF2C;SIK1;VEGFA;MYH11;KDM6B;CBY1;MYOCD
prerank,myoblast differentiation (GO:0045445),-0.3867334165633638,-1.0572492799962718,0.39403973509933776,0.7147247772094948,1.0,7/14,11.68%,DDX17;JAG1;IGF1;PLEKHM3;HINFP;MBNL1;DDX5
prerank,gluconeogenesis (GO:0006094),-0.2873344482841855,-1.0568588151179517,0.29508196721311475,0.7145928953814078,1.0,16/39,22.24%,PER2;GOT2;SLC25A13;SLC25A12;MDH1;MDH2;PGK1;GOT1;ENO1;PGAM1;SLC25A11;CRTC2;PPARGC1A;GAPDH;ALDOC;TPI1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4775978302670935,1.0565139413829725,0.4221165279429251,1.0,1.0,9/34,14.34%,E2F1;ASXL1;ANKRD26;WWTR1;YAP1;RUNX1T1;ENPP1;RORA;SMAD3
prerank,mitochondrial fission (GO:0000266),-0.3638475901573378,-1.0562053198989305,0.3694915254237288,0.7150861369542884,1.0,4/16,7.00%,DNM3;PRKN;FIS1;DNM1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.35741866787717613,-1.0553764836112751,0.3392857142857143,0.7160006689660167,1.0,4/18,18.82%,LYN;GPLD1;CMKLR1;BCAR1
prerank,cellular response to amino acid starvation (GO:0034198),-0.24954599321742596,-1.0553611988905431,0.3968253968253968,0.7149449551132134,1.0,21/71,15.14%,ATP6V0D1;MAPK8;ATP6V1E1;ATP6V0B;MIOS;SESN3;WDR59;MAP3K5;FAS;RNF152;GCN1;SZT2;MAPK3;MTOR;MAPK1;ATP6V0C;KPTN;CEBPB;ATP6V1H;RRAGC;DAPL1
prerank,regulation of neuron differentiation (GO:0045664),0.4478968388774185,1.0552895944298295,0.41350210970464135,1.0,1.0,7/76,9.38%,ECT2;CDK5RAP2;RHOA;ZEB1;TCF4;LRRK2;ROCK1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.32998527792654614,-1.0549335245594849,0.39090909090909093,0.7149644535575566,1.0,18/25,34.94%,LYST;VPS4B;LAPTM4B;CHMP2B;CHMP5;CHMP1A;LEPROTL1;UBXN6;CHMP2A;CHMP3;MVB12A;TMEM50B;CHMP7;DENND10;TMEM50A;VCP;CHMP4C;CHMP1B
prerank,regulation of cellular senescence (GO:2000772),0.48050481011502116,1.054870709008078,0.40492957746478875,1.0,1.0,9/28,19.61%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;SLC30A10;PNPT1;YPEL3;TERT
prerank,cell-substrate junction assembly (GO:0007044),-0.2970909458158846,-1.0548535686207994,0.38513513513513514,0.7140642189305875,1.0,12/33,20.27%,ITGA6;THSD1;TAOK2;BCR;LAMA3;ITGB4;PIP5K1A;ARHGEF7;ACTN1;CD151;PLEC;SORBS1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.4967360824774872,1.0543896597181142,0.41146496815286626,1.0,1.0,1/21,0.82%,PON1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.390289888815988,-1.0538438892318498,0.3591549295774648,0.7154416573361808,1.0,2/15,4.12%,SMAD7;TGFB2
prerank,phosphorylation (GO:0016310),0.4408987301767848,1.0538052958667583,0.374,1.0,1.0,85/385,15.61%,NEK2;MELK;CDK1;PLK1;BIRC5;AURKB;NEK3;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;MAP4K4;DYRK1A;STK17B;BMPR1A;CDK14;AURKA;ROCK2;MAP4K2;GSK3B;STK10;NLK;CHEK2;MYLK3;PRKDC;CTBP1;DYRK3;VRK2;STK24;STK3;NRK;MAP3K1;CCNE1;WNK1;MAP3K20;CDC25B;CHEK1;CDC42BPA;CDK2;LRRK2;GRK5;LIMD1;ROCK1;PIM1;MARK2;PXK;PIK3CB;CDC42BPG;TGFBR1;SRPK1;EIF2AK3;LMTK3;PRKCB;BMP2;DGKE;PRKCA;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MEX3B;STRADA;BTK;CDK19;AGK;PRKCE;MAML1;PRKD1;PANK2;PRKCI;PLK2;NRBP1;MORC3;VRK1;CDK8;BIRC6;STK11;TAOK1;PRKAG1;PRKD2;STK39;PASK
prerank,response to X-ray (GO:0010165),0.5263136854171733,1.0537677491799953,0.4096728307254623,1.0,1.0,5/14,14.15%,BLM;NUCKS1;NIPBL;ANXA1;BRCC3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5344199326743709,1.053752697721287,0.42589928057553955,1.0,1.0,4/13,19.13%,SRF;NFIB;SOX9;NFATC3
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.46139121432039615,1.0536375079050195,0.41379310344827586,1.0,1.0,16/44,20.66%,AQP1;CDKN2D;FNIP1;SIAH2;ARL6IP1;SH3RF1;CAST;USP47;XIAP;CD44;SRC;NGF;LAMTOR5;DPEP1;DNAJB6;SNCA
prerank,regulation of response to oxidative stress (GO:1902882),-0.40705760160308824,-1.0531669716491319,0.36503067484662577,0.7159265213021603,1.0,4/11,12.39%,PRKN;MCTP1;SELENON;PINK1
prerank,positive regulation of angiogenesis (GO:0045766),0.4423099699471264,1.0530409179080644,0.4138634046890928,1.0,1.0,21/108,14.27%,BRCA1;VASH2;AQP1;ANGPT4;HYAL1;AGO2;ADAM12;ANXA3;SFRP2;HSPB6;SERPINE1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PRKD1;ITGA5;ITGB1
prerank,receptor internalization (GO:0031623),-0.2822014509115856,-1.0527824365905591,0.336283185840708,0.7158202780932243,1.0,13/44,13.88%,DNM3;CALCRL;CAV1;LRP1;ACKR3;RAMP1;DNM1;RAMP2;RAB5A;CD81;AP2M1;GRB2;LDLRAP1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5082134132541074,1.0521385333022435,0.4093333333333333,1.0,1.0,1/17,0.52%,DLGAP5
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5026182140151945,1.0520146589189314,0.4140127388535032,1.0,1.0,6/19,13.68%,PARD3B;SCRIB;MARK2;CLIC4;PRKCI;DLG1
prerank,negative regulation by host of viral process (GO:0044793),-0.4283062131435149,-1.0518544934843308,0.39118457300275483,0.7169848006861838,1.0,1/10,0.22%,PRKN
prerank,cellular response to ketone (GO:1901655),0.4658655118749421,1.0517258568313632,0.4105642256902761,1.0,1.0,12/35,17.75%,AQP1;ROCK2;LARP1;NR3C1;AHR;KLF9;ADCY6;SRC;SFRP1;PCK2;MSN;ADCY2
prerank,filopodium assembly (GO:0046847),0.5095390232656075,1.0513343301995222,0.42318059299191374,1.0,1.0,8/16,15.14%,SPEF1;FGD4;FGD1;SRGAP2;S1PR2;FGD6;EZR;VSTM5
prerank,post-translational protein modification (GO:0043687),0.4425433983257286,1.0509632901779073,0.386,1.0,1.0,45/332,12.61%,DTL;ESCO2;CCNF;MATN3;DSCC1;F5;FEM1C;ASB15;PSMC2;PSMD5;FBN1;OBSL1;LAMB1;FBXL7;SPSB3;SPSB2;RBBP7;ELOC;FBXW7;FBXO30;CUL5;CCN1;FBXL8;QSOX1;KLHL5;PSMB1;FN3K;SUMF2;CUL3;PSMD14;KLHL22;VHL;CUL4B;PSMD1;SKP2;DCAF10;RAB1A;WSB2;PSMB9;STT3A;APLP2;CHM;FBXW11;STT3B;DCAF7
prerank,stress granule assembly (GO:0034063),-0.3439287875639781,-1.0507132883700385,0.35185185185185186,0.718615049714097,1.0,5/20,8.25%,DDX6;RPS23;UBAP2L;BICD1;CSDE1
prerank,cellular response to ATP (GO:0071318),-0.3841860736808938,-1.0498454199019989,0.41044776119402987,0.7196250915035953,1.0,6/14,28.47%,RYR3;HSP90B1;SSH1;P2RX4;P2RX7;P2RY12
prerank,positive regulation of DNA binding (GO:0043388),0.4746259038648084,1.04984357552298,0.41745283018867924,1.0,1.0,11/31,20.27%,HMGB2;RB1;TXN;HMGB1;TRIM6;PLAUR;TWIST1;NGF;NIBAN2;SKI;TRAF6
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3015223826297831,-1.04971412471256,0.3641304347826087,0.718876422085489,1.0,10/33,13.35%,EP300;SAFB2;UFL1;AR;UBA5;PRMT2;KDM4C;ESR1;DDX5;KCTD6
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.33244442032540034,-1.0495645557446098,0.33653846153846156,0.7181941738835835,1.0,5/24,7.11%,KRIT1;TEK;GAS6;CDH5;RAMP2
prerank,cellular response to acid chemical (GO:0071229),-0.3183054145929549,-1.0494182081892343,0.33796296296296297,0.7174575962223234,1.0,10/27,16.81%,CPEB3;CPEB4;GLRA1;SH3BP4;MTOR;KLF2;NSMF;VEGFA;RRAGC;XBP1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5086104450453632,1.0489424140126795,0.42933333333333334,1.0,1.0,1/18,0.97%,CEP295
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3380502037833774,-1.0487383667695664,0.36637931034482757,0.7181024990922217,1.0,6/22,9.74%,WDFY1;IFI35;LYN;LBP;PTPN22;NR1H3
prerank,protein ADP-ribosylation (GO:0006471),-0.31741582177824207,-1.0475261125357707,0.358974358974359,0.720061346456748,1.0,8/28,13.03%,PARP8;PARP12;TIPARP;ART3;PARP6;PARP1;SIRT5;PARP16
prerank,mRNA destabilization (GO:0061157),0.46069928752501943,1.0474962219923791,0.419838523644752,1.0,1.0,11/38,13.96%,MOV10;ROCK2;CNOT1;FTO;RC3H2;TUT7;ROCK1;YTHDF2;MEX3D;TUT4;RC3H1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.36259131024398283,-1.0471336296820333,0.366412213740458,0.7199299345833435,1.0,6/17,19.33%,VTN;IGF1;PDGFRB;S100A11;CCN4;NRP1
prerank,ribosomal large subunit assembly (GO:0000027),-0.32534516171514516,-1.0469106028847388,0.3951219512195122,0.7193658465551447,1.0,14/24,31.65%,DHX30;RPL3;BRIX1;RPL10;RPL24;TRAF7;MDN1;RPLP0;NOP2;BOP1;RPL11;FASTKD2;RSL24D1;NLE1
prerank,regulation of feeding behavior (GO:0060259),-0.4192501550676629,-1.0468747402799892,0.4180327868852459,0.7183939126915607,1.0,3/11,5.06%,SGIP1;STAT3;CFAP20
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.49466796484846376,1.0468431227003785,0.4082687338501292,1.0,1.0,2/22,2.26%,PPM1G;PPM1D
prerank,regulation of neuron death (GO:1901214),0.4456149231231157,1.0468360996790633,0.43067226890756305,1.0,1.0,10/82,9.78%,KIF14;GSK3B;PRNP;MAPT;RILPL1;RAB29;HTRA2;LRRK2;PICALM;IKBKG
prerank,protein K63-linked ubiquitination (GO:0070534),0.46823131511920074,1.0467384143763763,0.4208754208754209,1.0,1.0,6/41,7.16%,UBE2T;UBE2S;RNF168;NEDD4;UBE2N;PRPF19
prerank,positive regulation of kinase activity (GO:0033674),0.4386943618565598,1.0466722165094906,0.43451776649746193,1.0,1.0,12/107,8.18%,CENPE;SPDYA;FGFR4;FGFR2;KIT;MRE11;MAPT;MUSK;PDGFRA;CCN1;EPHA4;MRNIP
prerank,RNA processing (GO:0006396),0.43702343133772076,1.0466442856753428,0.4201005025125628,1.0,1.0,55/176,17.96%,SYNCRIP;SETX;PABPC4;SNRNP25;TENT2;SRSF4;HNRNPD;CSTF3;LSM3;NRDE2;DDX39B;TENT4A;HNRNPH1;SRSF7;YJU2;RBMS2;FUS;DHX8;PPIG;CELF2;TUT1;TUT7;HNRNPUL1;TSEN34;PRPF3;NONO;SF3A2;SFPQ;HNRNPU;FASTKD5;SNRNP48;IVNS1ABP;HNRNPL;SRPK1;SRRM1;SNRNP35;ATXN1;RNGTT;SF3B3;TUT4;RBM4;WBP4;RBMS1;TSEN2;LUC7L3;KIN;HNRNPA2B1;LSM4;ZCCHC8;METTL3;NOL9;PRPF4;PRPF18;SRPK2;PDCD7
prerank,sterol transport (GO:0015918),-0.3499224502484644,-1.0464406571183413,0.3922413793103448,0.7184890820653754,1.0,6/19,23.35%,CAV1;ARV1;LDLRAP1;OSBP;OSBPL2;NPC2
prerank,ion homeostasis (GO:0050801),0.478939315896754,1.0463806771036828,0.4094292803970223,1.0,1.0,4/30,8.20%,RHAG;RANGRF;WNK1;SLC4A2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4681358799875267,1.0460952028362642,0.4102870813397129,1.0,1.0,9/29,16.14%,USF3;EFNA1;SFRP2;NKX2-1;ADIPOR1;SPRED1;SFRP1;SPRED2;PTEN
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5017401008229345,1.0458849096287408,0.4229195088676671,1.0,1.0,3/18,9.74%,FADD;IL18;HMGB1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5409175449919301,1.0457936836256592,0.4098124098124098,1.0,1.0,4/11,14.29%,FRS2;SOX6;BMP2;EFNB2
prerank,regulation of dendrite extension (GO:1903859),-0.3612442693405944,-1.0453082926322956,0.40784313725490196,0.7200422212038327,1.0,3/18,3.34%,RIMS1;ITSN2;SYT1
prerank,regulation of transmembrane transport (GO:0034762),-0.31245025074931887,-1.0448156416471375,0.3670886075949367,0.7201321262370696,1.0,8/31,12.01%,OCLN;SLC2A1;ACTB;KCNJ3;CTTNBP2NL;KCNJ6;BCL2;KCNJ10
prerank,maturation of 5.8S rRNA (GO:0000460),0.5051242628619266,1.0446552269110028,0.42216358839050133,1.0,1.0,7/17,21.17%,PRKDC;MPHOSPH6;MAK16;WDR12;NOL9;EXOSC10;URB1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5071570951048655,1.0439556722289518,0.40804597701149425,1.0,1.0,2/14,8.14%,IL18;CD80
prerank,histone acetylation (GO:0016573),0.4423054979816497,1.0434550328091003,0.43130990415335463,1.0,1.0,25/69,18.79%,BRCA2;SGF29;HAT1;TAF12;ING4;MSL3;EP400;EPC1;TADA1;TADA2A;JADE1;ACTL6B;RUVBL2;PER1;YEATS2;DR1;KAT6A;TRRAP;BRD8;TAF10;PHF20;ZZZ3;NAA60;NAA40;JADE3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.45942516313457316,1.0433892023535212,0.4529346622369878,1.0,1.0,1/55,0.19%,BRCA1
prerank,protein modification process (GO:0036211),0.4487772931835267,1.0433814617857327,0.4409282700421941,1.0,1.0,33/76,25.30%,TGM1;UBE2S;LOXL2;LOX;GGCX;PRKDC;ST8SIA2;PHKA2;B4GALT7;DUSP12;RPN2;SEPHS1;NAGPA;ATG3;ST3GAL1;UBL5;PLOD2;NTAQ1;PLAT;YES1;UBE2D3;ICMT;UBE2L3;NEDD8;PIGH;FBXO22;PARP4;USP25;UBE2I;FBXW2;RABGGTB;UBL4A;ADPRH
prerank,leukocyte tethering or rolling (GO:0050901),0.5031840970493641,1.0433093902278636,0.403899721448468,1.0,1.0,6/17,18.77%,ITGB7;ADD2;PODXL2;ROCK1;ITGB1;GCNT1
prerank,response to tumor necrosis factor (GO:0034612),0.4379987336938985,1.0432302199699715,0.42857142857142855,1.0,1.0,6/91,7.40%,BRCA1;HYAL1;DHX9;AFF3;NPNT;YBX3
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5380975462173666,1.0428534296790302,0.4194977843426883,1.0,1.0,2/10,5.53%,TERF1;MAPT
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4886568272612325,1.0427756408156936,0.4211212516297262,1.0,1.0,4/22,12.64%,BARD1;LRRK2;RANGAP1;DMTN
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.4699669102375191,1.0426789138602641,0.43211334120425027,1.0,1.0,10/31,16.27%,RHOA;PARD3B;RAP2A;ANK1;SCRIB;MARK2;EZR;PRKCI;DLG1;MSN
prerank,response to organophosphorus (GO:0046683),0.5137660770074972,1.0426000984008732,0.4020172910662824,1.0,1.0,2/16,6.48%,TYMS;RFC3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.46091490184793354,1.0424845446389075,0.4412442396313364,1.0,1.0,22/42,23.91%,SMARCC1;SMARCAD1;RBBP4;ARID1A;SRCAP;SMARCA4;ANP32E;HDAC1;NASP;SPTY2D1;HDAC2;ACTL6B;INO80;MBD3;MBD2;ZNHIT1;ARID1B;CHD4;ACTL6A;SMARCC2;CECR2;SMARCB1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.48818872212436143,1.042012829771895,0.4087968952134541,1.0,1.0,6/20,16.84%,B4GALT1;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.2969983042167671,-1.041988256556547,0.32894736842105265,0.7258528825077215,1.0,14/32,19.29%,RHOJ;MAP2K5;KLF4;FGF2;FOXC2;HDAC5;PTGS2;THBS1;HDAC7;VEGFA;HDAC9;ITGB1BP1;GATA2;FGFBP1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4361235535731466,1.0417191192538933,0.334,1.0,1.0,163/834,15.85%,BRCA1;CKAP2;E2F7;NR2E3;E2F8;UHRF1;ATAD2;DLGAP5;E2F2;ATRX;MYBL1;GLI2;GLI3;RBL1;HMGB2;E2F1;ATOH8;FADD;PAXIP1;SP3;SETX;BMPR1A;PHIP;ACTR3;TEAD1;WWOX;AGO2;E2F3;FGFR2;SENP1;TFDP1;BCL2L12;GALR1;DDRGK1;MED14;AUTS2;RFXAP;RGMA;NFIA;HIVEP1;PCGF5;SSBP3;DHX9;PRKDC;KLF5;SRF;ELF4;ASXL1;NFIB;THRAP3;TBL1XR1;LPIN2;MLLT10;SETD3;BMP6;HOXC4;TCF7L2;MED30;ELF1;IL18;HOXA7;GRHL2;AKNA;ARRB1;TCF4;MYBL2;GLIS3;SFRP2;ELK1;PPP3CA;CCN1;POU2F1;POU3F2;FHL5;WWTR1;SERPINE1;FOXO3;LMX1B;PELP1;IRF1;ZFP64;BCLAF1;MED24;RHOQ;SMARCA4;USP16;NCK1;LEO1;HOXB3;YAP1;PLAGL1;EPC1;HMGB1;IKBKG;KMT2A;HDAC8;MEOX2;NR4A2;NR3C1;SFPQ;HNRNPU;TAL1;CRLF3;NCOA2;HDAC1;BMP2;AHR;NKX2-1;MRTFA;NFATC2IP;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;KMT2D;SOX9;SMAD4;HDAC2;ATF5;BRD4;TCF20;ELK4;LRP5;RORA;IL4I1;NCOA7;TWIST1;PLXND1;MAML1;HEY2;PPRC1;PRKD1;MED1;ARF4;RARB;POU2F2;YY1;RLF;FOXK2;RUVBL2;FOXM1;SMAD3;ARNT;CDK8;SOX1;E2F4;PER1;PIN1;INO80;DR1;GDNF;ATF1;KAT6A;ZNF507;HOXB7;PRKD2;PKD2;GNL3;CSRP3;NFKB1;TP53;FHOD1
prerank,negative regulation of binding (GO:0051100),0.4407137340939441,1.041360737213842,0.45625,1.0,1.0,22/81,19.68%,AURKB;DDX11;E2F1;BTAF1;AURKA;ARHGAP28;GSK3B;WAPL;LRRK2;ROCK1;PSME3IP1;ILRUN;MITD1;NES;PIN1;TFAP4;DNAJB2;SP100;STYX;ZFPM1;PRKCD;IFIT2
prerank,detection of visible light (GO:0009584),0.49911974545271826,1.0412627051056067,0.40827586206896554,1.0,1.0,3/16,18.08%,ABCA4;GNAQ;CEP250
prerank,regulation of wound healing (GO:0061041),-0.27458938260255833,-1.0409503733113377,0.3893805309734513,0.727299840748301,1.0,7/42,5.67%,PTK2;OCLN;CAV1;VTN;EPHB2;MYLK;FGF2
prerank,motor neuron axon guidance (GO:0008045),0.502553166131147,1.040927001062817,0.41853932584269665,1.0,1.0,4/15,11.74%,NTN1;NTN3;EPHA4;RAC1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.40287443087159347,-1.0407692185591166,0.3970149253731343,0.7266802699258056,1.0,7/11,30.23%,PARN;DKC1;TENT4B;EXOSC2;EXOSC3;EXOSC5;FBL
prerank,chondrocyte differentiation (GO:0002062),0.4840585804293352,1.0406061358339058,0.42266824085005905,1.0,1.0,13/32,20.05%,SULF2;WNT2B;NFIB;SOX6;SULF1;EIF2AK3;CCN3;BMP2;SOX9;SNX19;RUNX1;OSR1;CREB3L2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5358926304661704,1.0404139478037002,0.42725880551301687,1.0,1.0,3/10,8.29%,TXN;PYCR1;LRRK2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5479888671960168,1.0402831571606672,0.41310975609756095,1.0,1.0,3/10,12.56%,LOXL2;SOX6;SOX9
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5397661013610768,1.0402388824038804,0.4256259204712813,1.0,1.0,1/11,1.19%,SLC18A2
prerank,external encapsulating structure organization (GO:0045229),0.43186619385142877,1.0398199442175993,0.4202607823470411,1.0,1.0,46/205,15.00%,TGM1;MATN3;COL22A1;NID2;MMP28;MMP24;MMP25;MFAP2;LOX;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;SLC39A8;NID1;COL4A5;POSTN;ADAMTSL3;COL15A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;MFAP5;ITGA8;ITGAV
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3813050348593541,-1.0396741102859537,0.3951890034364261,0.7282803252046101,1.0,4/14,26.61%,PTGS2;OSMR;PARK7;PTGER3
prerank,positive regulation of ruffle assembly (GO:1900029),-0.41138368951387033,-1.0390020925549854,0.40066225165562913,0.7288098734260855,1.0,9/13,32.31%,FAM98A;PFN1;PLEKHM1;EPS8L2;NLGN1;P2RY12;DEF8;EPS8;HRAS
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5290142369474887,1.0389655017908572,0.44837340876944837,1.0,1.0,5/13,12.33%,BMPR1A;FGFR2;TGFBR3;PIM1;RBPJ
prerank,lipid oxidation (GO:0034440),-0.39417002145488367,-1.0383686030647532,0.39520958083832336,0.729307742496119,1.0,3/12,19.45%,ADIPOR2;PLA2G7;PPARGC1A
prerank,regulation of cilium movement (GO:0003352),0.5505859736902764,1.038249827201612,0.4218009478672986,1.0,1.0,1/10,3.41%,DNAH11
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.506793163386808,1.0382482957205688,0.43466666666666665,1.0,1.0,3/16,7.30%,DDIAS;CDKN2D;SFRP2
prerank,regulation of cellular component movement (GO:0051270),0.4484034264810441,1.0381145430105805,0.43687150837988825,1.0,1.0,12/49,12.39%,ROCK2;RHOA;ACTN4;MEMO1;MYCBP2;DIAPH1;ARHGAP18;PDPN;TGFBR3;ROCK1;TGFBR1;ADAM17
prerank,negative regulation of stress fiber assembly (GO:0051497),0.48175790379072453,1.0380771313119392,0.44025157232704404,1.0,1.0,7/24,12.73%,STMN1;ARHGAP28;CGNL1;TMEFF2;ARHGAP6;ARHGEF18;WASF2
prerank,"phototransduction, visible light (GO:0007603)",0.5062440688090549,1.0374495526676144,0.41737891737891736,1.0,1.0,2/14,8.66%,ABCA4;GNAQ
prerank,positive regulation of lipid localization (GO:1905954),-0.4046293170954426,-1.037419033000359,0.41411042944785276,0.7304908613365114,1.0,3/11,8.09%,LRP1;IKBKE;VSTM2A
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.47239602480725656,1.0373712806295439,0.4280254777070064,1.0,1.0,7/24,16.87%,HMBS;FXN;COX10;ABCB10;CPOX;ATP5IF1;ALAS2
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.35357838705867617,-1.0366229173120487,0.41825095057034223,0.7313576835817692,1.0,4/17,9.01%,CPEB3;CPSF6;CCNT1;CPSF7
prerank,ceramide transport (GO:0035627),-0.38995286171243115,-1.0364700166449148,0.42160278745644597,0.7306251628390441,1.0,6/12,23.08%,CERT1;PLTP;PSAP;GLTP;PLEKHA8;ABCA2
prerank,macromolecule catabolic process (GO:0009057),-0.31538450542483903,-1.0362013106607812,0.39790575916230364,0.7301967120367232,1.0,8/26,10.95%,KIF16B;CLPX;BECN1;PIK3R4;LGMN;TPP1;SIAH1;MTOR
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.44834479062766436,1.036141335480963,0.44395604395604393,1.0,1.0,16/52,18.34%,E2F1;SAE1;TFDP1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;CSNK2A2;CASP8;NPEPPS;UBL5;TP53;PPP3R1;YWHAQ;BAD
prerank,cellular response to misfolded protein (GO:0071218),-0.3371481667187767,-1.036105593729742,0.43621399176954734,0.7293060765372079,1.0,10/20,23.69%,ATXN3;UFD1;DERL1;STUB1;DNAJC18;POMT2;AUP1;DNAJB12;UBE2W;TOR1A
prerank,macrophage chemotaxis (GO:0048246),0.5423865925422714,1.0357346525424267,0.43478260869565216,1.0,1.0,1/10,4.98%,CKLF
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5440045652578629,1.0355981572136197,0.442572741194487,1.0,1.0,5/10,20.57%,ADA;WNK1;PIEZO1;FERMT3;DPP4
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5334828449245956,1.0352054766748207,0.430416068866571,1.0,1.0,2/12,2.25%,STMN1;DYRK1A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.3833547948158227,-1.0351778870960653,0.42201834862385323,0.730587544270385,1.0,4/13,15.21%,UPP2;NT5M;TDG;SMUG1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3260892885196838,-1.0346550812376227,0.3939393939393939,0.7307274504233308,1.0,10/22,23.09%,OS9;RNF103;EDEM2;EDEM1;MAN1A2;SYVN1;UBB;RPS27A;UBC;SEL1L
prerank,regulation of lipid storage (GO:0010883),0.48722413216044586,1.0344029214032453,0.4132985658409387,1.0,1.0,6/22,15.77%,FTO;PTPN2;FBXW7;ITGAV;NFKB1;LPL
prerank,sphingosine metabolic process (GO:0006670),-0.35626342460509847,-1.0342218722718124,0.38652482269503546,0.7307205868597003,1.0,7/17,23.86%,ACER2;PLPP3;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,regulation of steroid metabolic process (GO:0019218),-0.3249803821600845,-1.032998049908194,0.3972602739726027,0.732586440901384,1.0,7/23,16.42%,APOE;ASAH1;STUB1;ARV1;FMO5;DGKQ;EPHX2
prerank,serine family amino acid metabolic process (GO:0009069),-0.35731984644682124,-1.0323124410265327,0.40977443609022557,0.733195278678626,1.0,12/16,49.34%,MTHFD1;SARS1;CBS;THNSL2;SEPHS2;CTH;SEPSECS;PSPH;SHMT2;SHMT1;GLYAT;DAO
prerank,transferrin transport (GO:0033572),-0.2965499821781429,-1.0319888824062555,0.38095238095238093,0.7329082358688572,1.0,16/33,32.34%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;MCOLN1;ARHGAP1;ATP6V1G2;ATP6V1B2;ATP6AP1;REP15;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,anion transmembrane transport (GO:0098656),-0.2461729340965792,-1.031903815321508,0.4262295081967213,0.7320670931272922,1.0,22/67,19.08%,SLC16A12;SLC1A2;SLC13A3;SLC7A2;SLC13A4;SLC25A13;SFXN2;SLC25A12;SLC3A2;SLC7A5;SLC27A1;SLC5A6;LRRC8B;ABCC5;LRRC8D;SLC25A4;SLC35A2;SLC1A1;SLC38A5;SLC25A11;SLC25A38;LRRC8A
prerank,glycerophospholipid metabolic process (GO:0006650),-0.24625590499702696,-1.0317805421990351,0.4,0.7312973396863789,1.0,26/75,19.47%,GPCPD1;PLA2G4A;PDGFRB;ABHD6;ABHD12;PNPLA6;PLA1A;PLEK;PLCB3;PLCG1;ENPP6;GPLD1;PIGV;SERINC1;GDPD3;PIGX;PIP5K1A;PIGQ;GDPD1;PIGB;PIGP;PLA2G7;SYNJ1;HDHD5;ACP6;PIGF
prerank,transcription by RNA polymerase II (GO:0006366),0.4323853068947025,1.0312794012774293,0.441,1.0,1.0,62/305,13.81%,NR2E3;E2F2;TRIP13;TCFL5;TTF2;MED26;PMF1;CBFB;SETX;DEK;TEAD1;E2F3;TFDP1;CSTF3;FIP1L1;TAF3;MBD1;INTS7;PHAX;KLF13;TBL1XR1;SLBP;ERCC3;ELOF1;LSM11;ELOC;GLIS3;TAF12;POLR2A;SETD2;POU2F1;ZBTB7B;WWTR1;NR2C2AP;WDR33;LEO1;YAP1;NFYA;PCF11;NR4A2;NR3C1;SCAF8;INTS8;TEAD3;TAF15;GTF2A1;CPSF4;HDAC1;ADRM1;TAF4;RBPJ;NR4A1;RNGTT;SSRP1;NOTCH2;RPRD1A;RORA;MAML1;DDX21;MED1;RARB;POU2F2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.4341779778218479,1.0312423274240001,0.46421267893660534,1.0,1.0,20/110,11.94%,HJURP;RB1;FNIP1;GSK3B;BMF;TRABD2B;IAPP;AJUBA;FAF1;SLF1;SPIDR;CDC42EP2;SH3GLB1;NCLN;ATF7IP;RIOK3;TPPP;TAL1;ABCA1;AIDA
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4702611141657179,1.0309421611009384,0.4404332129963899,1.0,1.0,6/30,11.74%,RTN4R;LPAR1;NET1;ARRB1;ROBO1;RAC1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4685100660812915,1.0308761014632402,0.42685851318944845,1.0,1.0,9/30,15.10%,SAE1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;CSNK2A2;NPEPPS;UBL5
prerank,calcium ion import (GO:0070509),0.47489471775843806,1.030855420554305,0.43596059113300495,1.0,1.0,10/28,20.72%,MCU;ATP2A2;SLC8A1;MCUB;CACNA1C;MICU1;MAIP1;TRPV4;CACNA1G;MICU2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3724094258043795,-1.0308175240266582,0.41155234657039713,0.7326545919001355,1.0,6/15,13.22%,PSEN1;APOE;CHRNA7;APP;CRYAB;PFDN5
prerank,anion transport (GO:0006820),-0.2934922094131845,-1.030596839419436,0.39520958083832336,0.7320212735821264,1.0,8/33,14.41%,SLC13A3;SLCO2B1;SLC13A4;SLC22A6;ABCG2;SLC17A6;LRRC8B;LRRC8D
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.48509429579394997,1.0303322556140302,0.42506459948320413,1.0,1.0,7/21,16.85%,BMPR1A;BMP6;WWTR1;TGFBR1;CCN3;SMAD4;VEPH1
prerank,positive regulation of histone deacetylation (GO:0031065),0.5182174320767754,1.0303135001957273,0.4335766423357664,1.0,1.0,5/12,15.59%,CTBP1;NIPBL;ZBTB7B;PRKD1;PRKD2
prerank,negative regulation of proteolysis (GO:0045861),0.4667479457878747,1.0301885402749893,0.43309859154929575,1.0,1.0,7/34,9.99%,DNAJC1;PRNP;EFNA1;EPHA4;LRRK2;ROCK1;GAS1
prerank,negative regulation of metabolic process (GO:0009892),-0.2600625330041086,-1.0300909079222174,0.36363636363636365,0.7321548529168894,1.0,15/54,16.70%,LNPEP;MAP2K6;FIS1;NOVA2;ZNF423;ABHD6;TLR4;ACOT11;FOXC2;ACVR2B;NR1H3;ZDHHC7;CCDC3;DDIT3;NR1H2
prerank,positive regulation of heart rate (GO:0010460),-0.3513684635356032,-1.0300852383608488,0.376984126984127,0.7311102522113283,1.0,9/17,27.00%,RYR2;TPM1;ADRA1A;PDE4D;KCNQ1;ADRA1B;EDN1;ADM;EDN3
prerank,positive regulation of phagocytosis (GO:0050766),-0.26785665658787056,-1.0296165904304007,0.4095238095238095,0.7311298343109485,1.0,28/47,44.90%,MERTK;ANO6;GAS6;MYO18A;C4B;GATA2;RAB27A;NCKAP1L;C2;IL15;TUB;FCER1G;PTPRC;ABCA7;CALR;RAB31;LYAR;C3;PYCARD;SLC11A1;LMAN2;FCGR2B;CD300LF;CCL2;TREM2;IL2RG;AHSG;PLA2G5
prerank,regulation of hemopoiesis (GO:1903706),0.5375095383478047,1.0292610420415162,0.4303599374021909,1.0,1.0,4/10,22.61%,CBFB;PRKCB;RUNX1;MYSM1
prerank,brain development (GO:0007420),0.4303352049171504,1.0292490829843925,0.45491388044579534,1.0,1.0,19/136,13.39%,CENPF;PBX4;CDK5RAP2;PBX3;NFIB;MKKS;CXCR4;SOX6;GRHL2;NIPBL;DSCAML1;UTP3;PLXNB2;DHX37;NKX2-1;ATXN1;FBXW11;TMX2;NES
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4608368391442431,1.0287916411216855,0.4334511189634865,1.0,1.0,8/33,15.59%,KCNN4;PRNP;PTPN2;RAB29;IKBKG;EZR;RC3H1;PRKD2
prerank,positive regulation of dendrite extension (GO:1903861),-0.36384257780137674,-1.0287255981621855,0.42045454545454547,0.7321577512482117,1.0,3/17,3.34%,RIMS1;ITSN2;SYT1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4158318062856837,-1.0286186210937045,0.43026706231454004,0.7313882622624039,1.0,8/11,46.14%,LYN;TIRAP;MFHAS1;TNFAIP3;PJA2;TREM2;TLR6;TLR1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.44174220559344074,1.0285052098024985,0.4618599791013584,1.0,1.0,13/76,13.39%,SPAG5;PLK4;GPSM2;MYLK3;NUMA1;CDC42EP2;SORBS3;NCK1;NCK2;SYNPO2;BAIAP2L1;PRKCE;NES
prerank,glucose metabolic process (GO:0006006),-0.2568474985870607,-1.028169380971707,0.36619718309859156,0.7313221505840818,1.0,22/58,25.05%,APOD;PER2;GOT2;SLC25A13;SLC25A12;IRS2;MDH1;OMA1;MDH2;PGK1;GOT1;ENO1;PGAM1;SLC25A11;CRTC2;PPARGC1A;GAPDH;ALDOC;TPI1;GALM;BRAT1;ALDOA
prerank,folic acid-containing compound metabolic process (GO:0006760),0.48629563442774365,1.0275047076300388,0.4307891332470893,1.0,1.0,6/19,19.03%,MTHFD1L;MTHFR;SLC19A1;DHFR;GGH;MTHFS
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4898720526692655,1.0272797616959524,0.42876712328767125,1.0,1.0,4/18,14.42%,FGL1;WNK1;IL4I1;MIA3
prerank,extracellular matrix organization (GO:0030198),0.42798061193625486,1.0272718371701681,0.443,1.0,1.0,60/276,15.00%,BMP1;LOXL3;MATN3;COL22A1;HAS3;NID2;LOXL2;MMP28;MMP24;MMP25;MFAP2;LOX;SCUBE1;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;QSOX1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;HAS1;TLL2;TGFBR1;SLC39A8;NID1;COL4A5;COL12A1;P3H1;POSTN;ADAMTSL3;EXOC8;COL15A1;COL20A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;P3H4;MFAP5;CAPG;ITGA8;ITGAV
prerank,ganglioside biosynthetic process (GO:0001574),-0.36176758895063554,-1.0271936084021638,0.42124542124542125,0.7324547969944023,1.0,6/15,10.93%,ST8SIA4;B4GALT5;B4GALT6;ST6GALNAC3;ST6GALNAC5;ST8SIA6
prerank,hemopoiesis (GO:0030097),0.4356819052438948,1.026787600320783,0.46409989594172735,1.0,1.0,18/87,16.06%,MELK;ETV6;FGFR2;FUT10;KIT;WNT2B;RTKN2;TGFBR3;SFRP2;KMT2A;YTHDF2;TAL1;RRAS;NOTCH2;MFAP5;KAT6A;TP53;SFRP1
prerank,"phagocytosis, engulfment (GO:0006911)",0.4591828155652038,1.0266117659942893,0.4490521327014218,1.0,1.0,1/36,0.66%,XKR5
prerank,retinoid metabolic process (GO:0001523),0.44222194321628094,1.0259140680781464,0.45110410094637227,1.0,1.0,10/71,10.41%,ALDH8A1;CYP26B1;ABCA4;ALDH1A2;RDH11;GPC6;RDH12;ALDH1A1;SCPEP1;SDC1
prerank,cardiac muscle cell development (GO:0055013),0.48372918229364936,1.0257243568956178,0.4265463917525773,1.0,1.0,7/20,15.71%,OBSL1;MYLK3;PDGFRA;SLC8A1;PDLIM5;HEY2;CSRP3
prerank,histone mRNA metabolic process (GO:0008334),0.4735655210830089,1.0246888345026188,0.43548387096774194,1.0,1.0,6/27,8.22%,TENT2;SLBP;LSM11;ERI1;TUT1;TUT7
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.49717618332082697,1.0245517451846256,0.4338896020539153,1.0,1.0,6/19,12.33%,BMPR1A;FGFR2;TGFBR3;PIM1;TGFBR1;RBPJ
prerank,regulation of cell adhesion (GO:0030155),0.4293476533710037,1.0245225133467428,0.4777777777777778,1.0,1.0,24/129,15.59%,KIF14;ROCK2;HYAL1;PDE3B;CXCR4;IL18;EFNA1;PLAU;PPP3CA;EPHA4;RIPOR2;RSU1;ANGPT1;ROCK1;YTHDF2;PLXNB2;PLXNB1;DSCAM;PRKCA;PLXND1;MIA3;ITGAV;SRC;PRKD2
prerank,mRNA splice site selection (GO:0006376),0.4600957027472217,1.02423900022864,0.43825665859564167,1.0,1.0,10/30,19.69%,SETX;SRSF10;PSIP1;CELF2;SF3A2;LUC7L3;PRPF39;SFSWAP;LUC7L2;SF3A3
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.42457541956427336,-1.0240332599582418,0.4403409090909091,0.7389640266779793,1.0,2/10,1.79%,APOD;LRCH1
prerank,sulfur compound catabolic process (GO:0044273),-0.27612916746730737,-1.023486063647209,0.4142857142857143,0.7392898477537512,1.0,12/38,16.97%,GNS;FMOD;HEXB;GGT5;PRELP;TXN2;HEXA;OGN;LUM;IDS;NUDT7;GALNS
prerank,cell-matrix adhesion (GO:0007160),0.42963114460475643,1.023434095246011,0.4588477366255144,1.0,1.0,21/95,16.91%,OTOA;NID2;HPSE;TRIP6;ITGB7;NPNT;SGCE;FBLN5;ADAMTS9;RAC1;MKLN1;ADAM9;ITGB1;CD44;ITGA8;ITGAV;SRC;RCC2;ITGB8;FERMT3;PTPRK
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.49569729989487343,1.0234048465664554,0.4093484419263456,1.0,1.0,5/14,14.73%,SMPDL3A;ENPP3;ITPA;ENPP1;AK7
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5104534105172228,1.0228376575390188,0.4405594405594406,1.0,1.0,4/13,12.82%,ECHDC3;ERFE;ZBTB7B;GKAP1
prerank,synaptic vesicle cycle (GO:0099504),-0.29793594355688485,-1.0228191845201042,0.3941176470588235,0.7398471414672189,1.0,12/30,18.42%,PCLO;RIMS1;SYNDIG1;BRSK1;PLD2;RAB5A;SYT7;SLC17A6;CPLX1;SNAP25;SYT10;NLGN1
prerank,positive regulation of developmental growth (GO:0048639),-0.2664721206952307,-1.022684802528369,0.39622641509433965,0.739133728924556,1.0,8/49,4.79%,RUFY3;RIMS1;ITSN2;CDKL5;INSR;SYT1;AGRN;SEMA7A
prerank,protein N-linked glycosylation (GO:0006487),0.4374971518804707,1.0215530698442812,0.4596340150699677,1.0,1.0,15/66,14.56%,ALG14;B4GALT1;ALG13;SRD5A3;MPDU1;B4GALT7;MAGT1;RPN2;SLC39A8;STT3A;STT3B;MAN1C1;ALG8;UBE2J1;ST3GAL1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.2870390362315157,-1.0211345665035974,0.40131578947368424,0.7417994638316429,1.0,13/35,19.33%,NRP2;SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;MET;FARP2;SEMA3B;SEMA3C;PLXNA4;SEMA5B;NRP1
prerank,establishment of endothelial barrier (GO:0061028),-0.2949882442227549,-1.020564339536699,0.3712871287128713,0.7421242520735264,1.0,11/29,20.76%,PPP1R16B;PECAM1;RAP1A;F11R;TJP1;RAP2C;PDE2A;PDE4D;RAB1B;ROBO4;RAPGEF3
prerank,regulation of cellular catabolic process (GO:0031329),-0.25228300081021726,-1.0204447484374155,0.4794520547945205,0.7413962033773729,1.0,30/62,28.52%,PRKN;EP300;PIP4K2A;DRAM2;ACER2;PIP4K2B;PSAP;LONP2;MTMR4;ATM;DAPK2;ABL1;OSBPL7;NUPR1;RRAGC;FBXL2;USP33;DDIT3;USP10;RMC1;PIP4K2C;PIK3R2;HSPB1;SCARB2;RAB39B;SMCR8;RRAGD;GPR137;KEAP1;RRAGA
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.36530518656490285,-1.0203207211562177,0.44814814814814813,0.7406413634964605,1.0,8/16,27.66%,ABHD5;SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1;PNPLA2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.476872844875589,1.0200962614872262,0.4520547945205479,1.0,1.0,8/23,16.14%,OCRL;INPP5B;MTMR1;MTMR2;MTMR9;PIP4P2;MTMR3;PTEN
prerank,protein localization to vacuole (GO:0072665),-0.3897229523359265,-1.01967722855743,0.4123076923076923,0.7411056312660097,1.0,7/13,23.17%,SH3BP4;SZT2;CD81;KPTN;MFSD1;LMBRD1;GLMP
prerank,protein-containing complex assembly (GO:0065003),0.4281291184820111,1.0196494767520945,0.448,1.0,1.0,69/259,18.73%,KNTC1;FANCA;PLEKHA7;F5;KPNA3;FADD;TSPAN33;TEAD1;GSK3B;MDM4;FBXL7;DHX9;ADD2;TCF7L1;BLM;ZW10;AFDN;TCF7L2;PML;STOML2;LRRK2;MCU;DARS1;CUL3;SMARCA4;AXIN2;TRAPPC6B;LEO1;YAP1;PICALM;IKBKG;KMT2A;RAB1A;WDCP;RSPH9;CDC123;BOK;CAPZA1;HDAC1;F8;SCFD1;KMT2D;SOX9;DMTN;CASP8;SEC24D;PPID;TRAPPC10;TLE4;GSDMD;EPRS1;CAPG;ANKRD28;TLE3;TRRAP;TP53;BET1;AMER1;FERMT3;TRAPPC9;TFAP4;SH3PXD2B;CSNK1A1;USO1;FANCC;BAD;TMED10;KIFAP3;RIPK1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5295739100577102,1.018641891512892,0.44891640866873067,1.0,1.0,5/10,15.83%,PSMC2;ATF7IP;HMGB1;PSMC6;TP53
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.426813245459896,1.018585524111401,0.4767676767676768,1.0,1.0,33/138,16.93%,NR2E3;E2F2;MED26;TEAD1;E2F3;TAF3;TBL1XR1;ERCC3;TAF12;POLR2A;WWTR1;NR2C2AP;YAP1;NR4A2;NR3C1;TEAD3;TAF15;GTF2A1;HDAC1;TAF4;RBPJ;NR4A1;NOTCH2;RORA;MAML1;MED1;RARB;NRBP1;MED27;DR1;TAF10;TEAD4;CCN2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4675871292599916,1.018563621191024,0.4517704517704518,1.0,1.0,7/25,14.43%,HMGB2;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.3614507638041965,-1.0184417777007997,0.4100418410041841,0.7430163699913466,1.0,5/17,16.67%,CAV1;KLF7;MAFG;CEBPB;AJAP1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4252630699593306,1.0180915752368132,0.431,1.0,1.0,214/1082,16.11%,BRCA1;CKAP2;E2F7;NR2E3;E2F8;UHRF1;ATAD2;E2F2;ATRX;MYBL1;PBX4;GLI2;CDK5RAP2;GLI3;RBL1;HMGB2;E2F1;BRCA2;FOXE1;ATOH8;HAS3;ILF3;NAT14;PSRC1;FADD;DYRK1A;SMARCC1;SP3;SETX;BMPR1A;PHIP;ELF2;ACTR3;TEAD1;WWOX;AGO2;CTCF;E2F3;FGFR2;SENP1;TFDP1;HNRNPD;BCL2L12;NFE2;GALR1;DDRGK1;MED14;AUTS2;CHEK2;RFXAP;RGMA;NFIA;HIVEP1;PCGF5;SSBP3;DHX9;PRKDC;NFIL3;KLF5;SRF;BLM;ELF4;ASXL1;NFIB;THRAP3;TBL1XR1;LPIN2;MLLT10;SETD3;NUP85;BMP6;PCBD2;HOXC4;YAF2;TCF7L2;MED30;ELOF1;ELF1;IL18;HOXA7;GRHL2;AKNA;ARRB1;PML;DDX39B;TCF4;ARID1A;MYBL2;GLIS3;TASP1;CHEK1;SFRP2;ELK1;PPP3CA;CCN1;POU2F1;POU3F2;FHL5;WWTR1;SERPINE1;FOXO3;ATF7IP;CD80;TRIM28;LMX1B;PELP1;IRF1;ZFP64;BCLAF1;CREB5;MED24;RHOQ;SMARCA4;USP21;USP16;ZFP90;NCK1;DNM2;HOXB3;YAP1;NFYA;VHL;PLAGL1;PICALM;EPC1;HMGB1;AGT;IKBKG;KMT2A;HDAC8;MEOX2;NR4A2;NR3C1;SCAF8;PARP9;SFPQ;TGFBR1;HNRNPU;TAL1;MMS19;CRLF3;TAF15;EIF2AK3;NCOA2;QRICH1;HDAC1;BMP2;AHR;NKX2-1;MRTFA;NFATC2IP;FBXW11;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;KMT2D;SOX9;SMAD4;HDAC2;ATF5;IL31RA;ZNF496;ILF2;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;IL4I1;NCOA7;TWIST1;MAML1;HEY2;PPRC1;PRKD1;MED1;ARF4;BTRC;RARB;POU2F2;YY1;RLF;FOXK2;RUVBL2;FOXM1;SMAD3;ARNT;CDK8;SOX1;E2F4;RPTOR;PER1;PIN1;INO80;DR1;GDNF;ATF1;KAT6A;ZNF507;HOXB7;PRKD2;PKD2;BICRA;CSRP3;NFKB1;TP53;FHOD1;CDCA4;BRD8;SFRP1;DRAP1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.22259757140501008,-1.0180474260875743,0.5,0.7429182856371381,1.0,51/172,19.88%,PLA2G4A;PLD1;PIP4K2A;INPP4B;SLC44A1;CHPT1;DGKB;ETNK1;PIK3R3;ABHD5;PIP4K2B;CDS2;PIK3C2B;PIK3R1;FGF2;PIK3R4;PLD2;SLC27A1;AGPAT5;RAB5A;CHKA;ETNK2;DGKG;MTMR4;RUFY1;PCYT2;INPP5K;STARD7;LPCAT2;SELENOI;PIP5K1A;BMX;INPP5D;DGKQ;SYNJ2;CHKB;CDS1;SLC44A5;PIK3R6;SYNJ1;PI4KA;IMPA1;INPP4A;PIK3CD;PIK3CA;HDHD5;ACP6;LPIN1;PLA2G12A;DGKD;CDIPT
prerank,regulation of mitochondrial fission (GO:0090140),0.46958637535178815,1.017743775529082,0.45294855708908405,1.0,1.0,7/24,10.35%,MIEF2;AURKA;MAPT;LRRK2;MCU;DDHD1;MIEF1
prerank,negative regulation of blood pressure (GO:0045776),-0.3833088832172752,-1.0176812259434722,0.43010752688172044,0.7428037446084086,1.0,5/13,22.19%,BMPR2;NOS3;PRCP;NOS1;DRD2
prerank,response to exogenous dsRNA (GO:0043330),0.48895776695423476,1.016485480428562,0.4314789687924016,1.0,1.0,3/18,4.75%,TICAM1;COLEC12;DHX9
prerank,response to gamma radiation (GO:0010332),0.4710785790951292,1.0159935793031984,0.45692883895131087,1.0,1.0,3/24,9.17%,FANCD2;MAP3K20;YAP1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5028062122732013,1.0157209946622352,0.44428772919605075,1.0,1.0,5/14,17.32%,ATP2B4;PKIG;ADRB2;PRKAR2B;PRKAR2A
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.3077801480764928,-1.0153755707092451,0.43820224719101125,0.7472103325168993,1.0,11/27,21.40%,GRB14;PIP4K2A;GRB10;PIP4K2B;PRKCQ;INPP5K;IRS1;GSK3A;PRKCZ;PIP4K2C;SLC27A4
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.48885664746469637,1.0152729750982052,0.44962216624685136,1.0,1.0,2/22,4.11%,VKORC1L1;ALDH1A2
prerank,inositol phosphate metabolic process (GO:0043647),-0.2603050479677225,-1.0149750350431725,0.3838383838383838,0.7470996433077124,1.0,17/46,20.67%,INPP4B;CALM1;IPPK;PPIP5K2;PLCB3;FGF2;PLCG1;NUDT3;INPP1;ITPKB;INPP5D;SYNJ1;PLCE1;IMPA1;INPP4A;ITPKC;PLCH1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.5070241543092626,1.0149665720685348,0.4549237170596394,1.0,1.0,4/14,15.59%,KCNN4;RAB29;IKBKG;PRKD2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5185311440165941,1.0148813848872082,0.453125,1.0,1.0,2/13,6.96%,SAE1;ATG7
prerank,mesenchyme development (GO:0060485),0.5019788579786021,1.0147965201482085,0.4491180461329715,1.0,1.0,5/15,15.59%,FGFR2;SFRP2;TGFBR1;BMP2;PKD2
prerank,vesicle transport along microtubule (GO:0047496),0.4821289141079631,1.0147159647844761,0.457286432160804,1.0,1.0,13/23,25.91%,TRAK1;NDE1;RAB1A;FBXW11;KIFAP3;FYCO1;DYNC1I1;DYNC1H1;KIF5A;KIF13A;HTT;PAFAH1B1;KIF1C
prerank,mitochondrion localization (GO:0051646),0.48309155202401416,1.0143859305153575,0.41968911917098445,1.0,1.0,5/19,15.75%,TRAK1;LRRK2;MFN2;MARK2;MFN1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4367554949756954,1.0142319224719512,0.48881789137380194,1.0,1.0,19/66,16.91%,BRCA2;ATOH8;FGFR2;CASK;NFIB;MCC;XDH;TGFBR3;FBXW7;SFRP2;SULF1;ROBO1;KLF9;SOX9;ATP5IF1;MED1;SFRP1;TINF2;PTPRK
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.3372312256525461,-1.014050144076339,0.4,0.748419789296397,1.0,8/19,20.39%,EP300;CDIP1;HIPK2;MSH2;DYRK2;DDIT4;SNW1;BCL3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4708546636952003,1.0135466841467378,0.4731182795698925,1.0,1.0,12/29,18.92%,ZC3H7A;DGCR8;AGO2;TUT7;PUM2;TUT4;SMAD3;HNRNPA2B1;ZC3H7B;METTL3;SMAD2;SPOUT1
prerank,RNA splicing (GO:0008380),0.43379289226528805,1.0134079698000356,0.4690721649484536,1.0,1.0,28/95,17.96%,SYNCRIP;SNRNP25;SRSF4;TRA2B;SRSF10;NRDE2;DDX39B;SRSF7;YJU2;FUS;DHX8;PPIG;PRPF3;NONO;SFPQ;SNRNP48;IVNS1ABP;SRPK1;SRRM1;SNRNP35;SF3B3;WBP4;LUC7L3;LSM4;PRPF4;PRPF18;SRPK2;PDCD7
prerank,heterochromatin organization (GO:0070828),0.5066325302619359,1.012848697325372,0.43209876543209874,1.0,1.0,4/14,8.37%,LOXL2;SETDB2;HP1BP3;SMCHD1
prerank,stabilization of membrane potential (GO:0030322),0.49413467351608714,1.0122315325762457,0.44505494505494503,1.0,1.0,4/16,12.53%,KCNN4;KCNK2;KCNK12;KCNK6
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4453581481192162,1.0122286281557529,0.46788990825688076,1.0,1.0,4/47,9.77%,UHRF1;EIF4E;FOXO3;AGT
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4515849042970507,1.0111848510374015,0.4530321046373365,1.0,1.0,9/31,18.34%,E2F1;GSK3B;TFDP1;BOK;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,secondary palate development (GO:0062009),-0.3702332130702104,-1.010796824123173,0.43157894736842106,0.7551176070399129,1.0,3/14,4.12%,LEF1;TGFBR2;TGFB2
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3167666755069253,-1.0107960374286187,0.42790697674418604,0.7540659112083811,1.0,4/25,5.24%,STAT3;IFNAR1;STAT6;SOCS2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.43162300099616285,1.0107459992111993,0.4984126984126984,1.0,1.0,23/73,21.08%,FADD;SENP1;DAP;ANP32B;CASP8AP2;FAM162A;MAPT;XDH;ROBO1;TNFRSF10B;APAF1;BOK;EIF2AK3;CASP8;SMAD3;BCL2L13;NGF;TNFSF10;BAD;RIPK1;COL4A3;SNCA;TRAF2
prerank,rRNA 3'-end processing (GO:0031125),0.5318860044996703,1.0106782313526306,0.46153846153846156,1.0,1.0,5/10,18.36%,ERI2;ERI1;EXOSC7;ERI3;EXOSC10
prerank,glycosphingolipid metabolic process (GO:0006687),-0.26492586554247366,-1.010482175126647,0.4423076923076923,0.7536974202099261,1.0,12/42,13.32%,HEXB;PSAP;ASAH1;B4GALT6;ST6GALNAC3;ST8SIA1;ESYT1;B3GALNT1;ST6GALNAC5;HEXA;GLTP;CTSA
prerank,prostanoid biosynthetic process (GO:0046457),-0.35454695661791763,-1.0103779934022241,0.4357142857142857,0.7528778520972588,1.0,4/15,12.36%,PLA2G4A;PTGDS;PNPLA8;PTGS2
prerank,RNA catabolic process (GO:0006401),0.45164512741418805,1.0097261383888416,0.4612794612794613,1.0,1.0,12/46,16.35%,PABPC4;HNRNPD;RNASE6;DNA2;RNASEH2A;PPP1R8;LSM2;YTHDF2;EXOSC7;DXO;PNPT1;METTL3
prerank,positive regulation of cyclase activity (GO:0031281),-0.3717426591483014,-1.0093788142429476,0.4405594405594406,0.7542564685264845,1.0,4/14,9.92%,MAPK8;NOS3;NF1;MAPK3
prerank,RNA 3'-end processing (GO:0031123),0.42715111688294144,1.0092900022963869,0.4743040685224839,1.0,1.0,17/69,13.46%,TENT2;SRSF4;CSTF3;FIP1L1;UPF3B;DDX39B;TENT4A;SRSF7;TUT1;TUT7;WDR33;PCF11;SRSF3;SRRM1;CPSF4;RPRD1A;TUT4
prerank,autophagy of mitochondrion (GO:0000422),-0.27773783070724556,-1.0091862160001572,0.4297520661157025,0.7536744426337527,1.0,14/38,19.95%,PRKN;FIS1;WDR45B;BECN1;SQSTM1;ULK1;BNIP3;PINK1;ATG9A;USP30;ATG2B;FBXO7;FUNDC1;GABARAPL2
prerank,morphogenesis of an epithelium (GO:0002009),0.46055088152917617,1.0091526526056984,0.44103194103194104,1.0,1.0,5/25,12.56%,TIMELESS;FGFR2;KDM2B;TBX18;SOX9
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.21711064538255673,-1.008935916410443,0.5,0.7532189582501142,1.0,43/119,21.48%,PIP4K2A;INPP4B;PIK3R3;PIP4K2B;SOCS2;PIK3C2B;PIK3R1;FGF2;PIK3R4;SLC27A1;EFR3A;RAB5A;DPM1;SOCS5;MTMR4;RUFY1;INPP5K;PIGV;PIP5K1A;ITPKB;PIGQ;BMX;INPP5D;SYNJ2;PIGB;PIGP;CDS1;PIK3R6;SYNJ1;PGAP2;PI4KA;SMG1;IMPA1;INPP4A;PIK3CD;TMEM150A;PIK3CA;PIGF;CDIPT;EFR3B;ITPKC;PIP4K2C;PIK3R2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3411171406124715,-1.0087247780946198,0.44313725490196076,0.7527152993303451,1.0,8/18,23.09%,OS9;RNF103;EDEM2;SYVN1;UBB;RPS27A;UBC;SEL1L
prerank,regulation of Rho protein signal transduction (GO:0035023),0.43202917589845075,1.008613516402978,0.46602972399150744,1.0,1.0,15/72,11.78%,STMN1;RTN4R;LPAR1;NET1;ARRB1;CUL3;RIPOR2;ROBO1;KANK2;EPS8L1;MYO9B;ARHGAP35;ARHGEF18;RAC1;ABCA1
prerank,axon development (GO:0061564),-0.23834307138851077,-1.0084798168362308,0.4186046511627907,0.7523399673499931,1.0,21/78,14.13%,GRM7;DCC;PAK3;ACTB;S100A6;CAMSAP2;KLF7;NRCAM;MAP1B;TAOK2;BRSK1;EPHB2;GAP43;PLP1;MAP1A;CTNNA2;APP;RTN4RL1;SLITRK1;NREP;NTNG1
prerank,neuropeptide signaling pathway (GO:0007218),-0.2607325498443887,-1.0084605697332782,0.46153846153846156,0.7513553304622861,1.0,9/58,10.55%,SORCS3;SORCS1;GLRB;GLRA1;CPE;GLRA3;GPR37;OPRM1;HCRTR2
prerank,central nervous system neuron development (GO:0021954),-0.36045475553672585,-1.0084136196807623,0.43359375,0.7504437291897658,1.0,4/15,6.94%,HSP90AB1;NTRK2;B4GALT5;B4GALT6
prerank,fatty acid beta-oxidation (GO:0006635),-0.25593557241160736,-1.0083076031559233,0.43820224719101125,0.7496587057494352,1.0,12/51,15.95%,HADHB;ACADM;CROT;SCP2;ABCD4;MECR;HADH;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2
prerank,heart contraction (GO:0060047),-0.2788580459225826,-1.008031220010442,0.4195804195804196,0.7492919638588651,1.0,9/41,19.40%,ATP1B1;RYR2;TPM1;ACE;ATP1A2;SCN1B;GPX1;PIK3CA;KCNQ1
prerank,organophosphate ester transport (GO:0015748),-0.30962565071106996,-1.007953818875836,0.4311111111111111,0.7484733154172056,1.0,11/24,25.83%,PLTP;SCP2;MTTP;TNFAIP8L3;PRELID3B;OSBPL2;NPC2;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5190326227838392,1.0076771007197811,0.4599406528189911,1.0,1.0,1/10,2.44%,ADGRV1
prerank,GTP metabolic process (GO:0046039),0.4865333559612853,1.0071180579888828,0.42954856361149113,1.0,1.0,5/15,15.75%,EFL1;LRRK2;RHOQ;GNAI3;MFN1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.45245791094692656,1.0061160993035723,0.4380952380952381,1.0,1.0,9/31,13.29%,TWIST2;CRIM1;SMAD6;TMEM64;LIMD1;TRPM4;SOX9;LRP5;TWIST1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3356456547417912,-1.005563719114826,0.4232081911262799,0.7532872395929892,1.0,10/17,39.74%,RYR2;KCNQ1;NEDD4L;KCNJ8;PKP2;GPD1L;KCNE4;SCN3B;KCNH2;SCN5A
prerank,regulation of defense response to virus (GO:0050688),0.5060512887605412,1.0052576145899847,0.44459644322845415,1.0,1.0,6/14,23.19%,DHX9;ILRUN;ITCH;RNF216;ELMOD2;PCBP2
prerank,phospholipid transport (GO:0015914),-0.2529870196140798,-1.0049640584315427,0.41237113402061853,0.7536993242306174,1.0,21/52,25.83%,PLTP;ATP8A1;APOE;SCP2;ATP8B1;ATP8A2;ATP9B;MTTP;ATP9A;TNFAIP8L3;PRELID3B;OSBPL2;MFSD2A;NPC2;SCARB2;PITPNC1;TMEM30A;PRELID3A;ATP10B;PRELID1;ABCA3
prerank,regulation of rRNA processing (GO:2000232),-0.35298021171038685,-1.0049069095422187,0.43728813559322033,0.7528454630054235,1.0,10/16,35.75%,USP36;HEATR1;WDR75;KAT2B;BUD23;RIOK2;DIMT1;RIOK1;TRMT112;SIRT7
prerank,cellular response to hexose stimulus (GO:0071331),-0.3120426189934413,-1.0048677515072126,0.4213197969543147,0.7519149847341665,1.0,7/23,16.81%,UNC13B;KCNB1;GAS6;PRKAA1;SOX4;ADCY8;XBP1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.439522458724463,1.0046619428626582,0.4760845383759733,1.0,1.0,6/45,12.60%,TTK;BMPR1A;BMP6;TGFBR1;BMP2;SMAD4
prerank,extracellular structure organization (GO:0043062),0.4171651833880435,1.0040279743029263,0.4859437751004016,1.0,1.0,46/204,15.00%,MATN3;COL22A1;NID2;MMP28;MMP24;MMP25;MFAP2;LOX;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;TGFBR1;SLC39A8;NID1;COL4A5;POSTN;ADAMTSL3;COL15A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;MFAP5;ITGA8;ITGAV
prerank,positive regulation of cell migration (GO:0030335),0.42083585139348806,1.0038371065092966,0.4844844844844845,1.0,1.0,49/253,15.62%,KIF20B;ARHGEF39;GTSE1;FBXO5;MAP4K4;SYNE2;TWIST2;TRIP6;ROCK2;HYAL1;CEP43;AGO2;MMP14;DDRGK1;ACTN4;LAMB1;KIT;SPAG9;CCAR1;PDPN;MYO1C;ENPP2;PDGFRA;PLAU;PPP3CA;CCN1;NIPBL;DDR2;TGFBR1;GAB1;SMURF2;CRKL;BMP2;PRKCA;ADAM17;SOX9;DMTN;CTSH;PRKCE;DOCK1;ADAM9;INSL3;ITGB1;MIA3;SEMA3D;SRC;ELP6;RHOC;SUN2
prerank,ephrin receptor signaling pathway (GO:0048013),-0.23161540746898254,-1.0037670396397806,0.5555555555555556,0.7536025464776618,1.0,27/82,19.18%,PTK2;EPHA5;PSEN1;PAK3;TIAM1;ACTB;VAV3;GRIN2B;AP2A2;EPHB2;NCSTN;LYN;DNM1;PAK1;AP2M1;MMP2;PTPN11;SDCBP;AP2S1;EPHA8;GRIN1;AP2A1;ARHGEF7;PSEN2;ARPC5;GIT1;EFNB3
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26378856065793305,-1.0037608841847527,0.4519230769230769,0.7525855766615867,1.0,8/46,8.37%,PLA2G4A;PLD1;DGKB;ABHD5;PLD2;SLC27A1;AGPAT5;DGKG
prerank,lipid modification (GO:0030258),-0.28415826712351056,-1.0037358065048645,0.4253731343283582,0.7516106777502101,1.0,11/37,21.13%,PLPPR1;DGKB;PLPP3;DGKG;DGKI;DGKQ;PLA2G7;EPHX2;PLPP4;DGKD;PLPPR4
prerank,response to amino acid starvation (GO:1990928),-0.23641428378809806,-1.0033776190168906,0.47619047619047616,0.7514328156358882,1.0,21/72,15.14%,ATP6V0D1;MAPK8;ATP6V1E1;ATP6V0B;MIOS;SESN3;WDR59;MAP3K5;FAS;RNF152;GCN1;SZT2;MAPK3;MTOR;MAPK1;ATP6V0C;KPTN;CEBPB;ATP6V1H;RRAGC;DAPL1
prerank,steroid catabolic process (GO:0006706),-0.4145114338696471,-1.0028817379083044,0.4588235294117647,0.7516105838765745,1.0,4/10,34.54%,HSD17B11;SPP1;YWHAH;HSD11B1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4245691885982004,1.0026039177785215,0.4911550468262227,1.0,1.0,11/86,12.63%,KIF14;DENND4C;MFN2;KANK2;EPS8L1;MAPKAP1;MYO9B;CRKL;ARHGEF18;DENND1A;NOTCH2
prerank,synaptic vesicle transport (GO:0048489),-0.39769395710816613,-1.0021659645933387,0.46130952380952384,0.7523590270400082,1.0,6/11,23.69%,SPG11;KIF5B;KIF5C;SYNJ1;RAB27A;TOR1A
prerank,cellular response to oxygen levels (GO:0071453),-0.40899936813706306,-1.002145464765789,0.4507462686567164,0.7513919964136733,1.0,5/10,27.83%,ATP6V0D1;CPEB4;PICK1;ATP6AP1;TMEM199
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2585655726775284,-1.0019029592118598,0.4423076923076923,0.7509696261555064,1.0,8/48,8.37%,PLA2G4A;PLD1;DGKB;ABHD5;PLD2;SLC27A1;AGPAT5;DGKG
prerank,actin filament bundle organization (GO:0061572),0.4456865678110321,1.0012702761468084,0.4625445897740785,1.0,1.0,13/33,22.66%,ADD2;RFLNA;CORO1B;EZR;DMTN;DPYSL3;BAIAP2L1;ADD1;LCP1;SHROOM2;SHROOM1;PLS1;MYO1B
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3130996267738658,-1.0007219005749781,0.4426229508196721,0.7529040708986625,1.0,5/25,3.74%,MEF2C;GRIN2A;GRID2;GLRA1;GRIN2B
prerank,B cell mediated immunity (GO:0019724),-0.40107081870034494,-1.0005965265944368,0.4514285714285714,0.7522150866727068,1.0,4/10,38.41%,MSH2;CD74;FCER1G;FCGR2B
prerank,chemical synaptic transmission (GO:0007268),-0.3114733736404961,-1.0,1.0,0.7496530097135099,1.0,82/284,17.60%,CDH8;GRM7;UNC13B;GRIK1;DLGAP1;GABRB1;SYN3;RIMS1;GABRB3;SLC1A2;CHRM2;GRIN2A;GABRA2;SLC6A1;GRM3;SPG11;KIF1B;ATXN3;CALM1;AMPH;APOE;APBA1;GLRB;GRID2;SYN2;SYT1;GLRA1;LIN7A;GRIN2B;PTCHD1;KCNQ3;BRSK1;HOMER1;SHISA6;GRIK4;RPS6KA2;CAMK4;GABRA3;HTR2C;RIC3;PLP1;GLRA3;NRXN1;CACNA1B;CAMK1;PRKACB;MINK1;GABRA5;SNPH;GIPC1;CHRNA7;CHRFAM7A;GABRB2;HCRTR2;GRIA1;PRKAR1B;SLC17A6;GABRG2;MAPK1;SYNJ2BP;HTR4;CAMKK2;GRM5;CACNB2;DLG4;SDCBP;GRM1;GRIN1;TBC1D24;GABRG1;DVL1;CPLX1;DTNA;CHRM3;SLC1A1;LRP6;HTR2A;SNAP25;CACNB1;GRIA2;SYT10;SYPL1
prerank,axonogenesis (GO:0007409),-0.2727695754510124,-1.0,1.0,0.7496530097135099,1.0,90/237,19.34%,PTK2;ENAH;SH3KBP1;EPHA5;TNR;UNC5D;NRP2;NRXN3;RPS6KA5;HSP90AB1;SHANK3;SPG11;OPHN1;DCC;SEMA6A;PAK3;BSG;GRB10;ACTB;B4GALT5;CNTN6;FEZ1;S100A6;KLF7;NRCAM;LGI1;SEMA6D;MAP1B;TAOK2;SEMA7A;BRSK1;EPHB2;PIK3R1;IRS2;PLCG1;ULK1;B4GALT6;SEMA4D;NRXN1;MAP1A;PRKCQ;KIF5B;SEMA3A;PTPRO;SPTBN1;DAB1;LAMA3;RELN;KIF5C;MAPK3;CTNNA2;SIAH1;NOTCH3;GFRA1;FEZ2;GFRA2;VLDLR;APP;MAPK1;PDLIM7;SLIT2;GRB2;UNC5C;SLITRK1;PTPN11;CNTN2;EPHA8;NTNG1;SEMA3B;SHC1;DOK5;SCN1B;UNC5B;ROBO2;USP33;SEMA3C;SHTN1;APBB1;PIK3CD;PIK3CA;NEXN;TUBB3;BAIAP2;SLITRK4;SHC3;ROBO4;EFNB3;SEMA5B;NRP1;CYFIP1
prerank,ncRNA processing (GO:0034470),-0.25590994857201016,-1.0,1.0,0.7496530097135099,1.0,91/200,27.09%,RPL13;AGO1;AGO3;SRRT;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;PUS10;RPS7;NVL;RPL18A;RPS6;RPL14;AARS1;RPLP1;RPL9;RPL37;RPL8;RPS14;INTS3;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;SARS1;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;ADAR;EXOSC9;RRP1B;RRP1;RPL19;DICER1;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;AGO4;RPLP2;RPL29;MDN1;INTS12;KARS1;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;EXOSC2;PIH1D1;EBNA1BP2;DDX54;RPL4;BYSL;INTS1;IMP3;DDX47;INTS11;BOP1;EXOSC3;RPS25;EXOSC5;TARBP2;POP5
prerank,ribosome biogenesis (GO:0042254),-0.23394334587504315,-1.0,1.0,0.7496530097135099,1.0,81/187,23.97%,GLUL;RPL13;HEATR3;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NAF1;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;DHX29;EXOSC9;RRP1B;RRP1;RPL19;METTL17;RPL28;RBIS;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;LTO1;RPL29;MDN1;RIOK2;LSG1;RPLP0;LTV1;RPL10A;RPL35;NOB1;NOLC1;EMG1;SURF6;EXOSC2;PIH1D1;EBNA1BP2;RAN;TSC1;DDX54;RPL4
prerank,regulation of cell motility (GO:2000145),0.4186193160492257,0.999825385201792,0.49847405900305186,1.0,1.0,17/121,13.36%,KIF14;CCDC25;MACF1;ROCK2;RHOA;MEMO1;DIAPH1;ARHGAP18;NTN1;ENPP2;ROCK1;PLXNB2;PLXNB1;TBCCD1;RAC1;TWIST1;PLXND1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4970932133631822,0.9991936978454524,0.43434343434343436,1.0,1.0,5/14,18.17%,ZEB1;XDH;SPRED1;SPRED2;OSR1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.43620775932774614,0.9991842505834696,0.47802197802197804,1.0,1.0,16/50,19.36%,AQP1;CDKN2D;FNIP1;BCL2L12;SIAH2;ARL6IP1;SH3RF1;PLAUR;USP47;XIAP;CD44;SRC;NGF;LAMTOR5;DPEP1;DNAJB6
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4330250077062713,0.9991272130430656,0.48355263157894735,1.0,1.0,6/49,4.45%,HMGB2;RBM15;CBFB;MOV10;NFE2;RAB7B
prerank,activation of GTPase activity (GO:0090630),0.4249210547854039,0.9989841850449754,0.4911550468262227,1.0,1.0,12/89,9.93%,ECT2;ARHGAP22;USP6NL;EVI5L;TBC1D25;TBC1D13;TBC1D2B;SCRIB;ARHGAP24;SYDE2;TBC1D7;RANGAP1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.21472916275514503,-0.9986985676227053,0.5384615384615384,0.7517693980983001,1.0,31/107,20.87%,SLC8A3;ATP1B1;SLC39A10;CAV1;RYR2;SLC39A13;SLC24A2;DMPK;CDH5;TPT1;HTR2C;CHRNA7;TMCO1;SLC39A7;SLC30A1;ATP2B2;ATP2B3;HTR2A;PTH1R;RMDN3;MT2A;VAPB;SLC24A4;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.38086332752026303,-0.998212653892441,0.4407894736842105,0.751880484814083,1.0,4/12,6.94%,HSP90AB1;B4GALT5;EPHB2;B4GALT6
prerank,actin cytoskeleton reorganization (GO:0031532),0.4301599749425777,0.9971958296658532,0.4983922829581994,1.0,1.0,27/63,22.88%,RHOA;PARVA;AUTS2;KIT;PDLIM4;RAP2A;NRK;CDC42BPA;PHACTR1;MCU;CDC42BPG;S1PR2;GAB1;EZR;ANXA1;DMTN;MKLN1;SIPA1L1;ANTXR1;TRPV4;PTPN1;SYDE1;WHAMM;FER;FLNA;CXADR;MYH9
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3003256554739715,-0.9971331117918649,0.4375,0.7534005189716806,1.0,5/27,5.66%,CAMK2D;CTNNA3;CAV1;RYR2;FGF13
prerank,positive regulation of cholesterol transport (GO:0032376),0.4576521734336847,0.9969808086821623,0.4580335731414868,1.0,1.0,2/27,4.57%,PON1;ABCB4
prerank,sulfur compound transport (GO:0072348),0.45143832156524166,0.996736922616234,0.4610705596107056,1.0,1.0,1/27,0.73%,RACGAP1
prerank,cellular component disassembly (GO:0022411),0.43403987177643905,0.9967160001846161,0.46885245901639344,1.0,1.0,11/53,17.52%,BMP1;SCUBE1;MMP14;DYRK3;ADAMTS5;TLL2;EXOC8;CD44;CAPG;LCP1;SH3PXD2B
prerank,hematopoietic stem cell proliferation (GO:0071425),0.5091592897767796,0.9964426817549987,0.46776611694152925,1.0,1.0,4/11,10.56%,ETV6;WNT2B;SFRP2;YTHDF2
prerank,ESCRT complex disassembly (GO:1904896),-0.4118895693708556,-0.9963996087402184,0.46518105849582175,0.7531308685505987,1.0,6/10,27.22%,VPS4B;CHMP2B;CHMP5;CHMP1A;CHMP2A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),-0.4118895693708556,-0.9963996087402184,0.46518105849582175,0.7531308685505987,1.0,6/10,27.22%,VPS4B;CHMP2B;CHMP5;CHMP1A;CHMP2A;CHMP7
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.468905149855125,0.9948918230232565,0.47665847665847666,1.0,1.0,5/26,13.64%,KNSTRN;GAREM1;PDPK1;SOX9;MED1
prerank,positive regulation of transport (GO:0051050),0.4211955218714945,0.9937940595515209,0.49054621848739494,1.0,1.0,10/85,11.47%,SPAG5;PON1;GSK3B;ANXA2;NUMA1;FMR1;KMT2A;CAMK1D;BOK;ANXA1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4148083009022343,0.9931445110927631,0.5035105315947843,1.0,1.0,35/166,15.16%,NR2E3;E2F2;NAT14;MED26;TEAD1;E2F3;POLR1A;TAF3;TBL1XR1;POLR1B;ERCC3;TAF12;POLR2A;WWTR1;NR2C2AP;YAP1;TAF1D;NR4A2;NR3C1;TEAD3;TAF15;GTF2A1;HDAC1;TAF4;RBPJ;NR4A1;NOTCH2;POLR1G;RORA;MAML1;MED1;RARB;NRBP1;TFB1M;MED27
prerank,immunoglobulin mediated immune response (GO:0016064),-0.40302404512147544,-0.9930637052135045,0.4660493827160494,0.7602328782112353,1.0,4/10,38.41%,CD81;CD74;FCER1G;FCGR2B
prerank,regulation of water loss via skin (GO:0033561),0.4890788088288555,0.9923280954418902,0.4596888260254597,1.0,1.0,1/15,1.85%,STMN1
prerank,establishment of skin barrier (GO:0061436),0.4890788088288555,0.9923280954418902,0.4596888260254597,1.0,1.0,1/15,1.85%,STMN1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.26996780837398293,-0.9922417934414338,0.46017699115044247,0.7613658581652704,1.0,16/44,24.50%,APOE;PDCD4;LYN;DNAJA1;PTPN22;STK38;NF1;INPP5K;SPRY2;DUSP1;SORL1;UCHL1;CDK5RAP3;BMP7;CD300A;MAPK8IP1
prerank,B cell proliferation (GO:0042100),-0.34134481595463173,-0.9920941288082449,0.4666666666666667,0.760762280914845,1.0,7/17,32.88%,MEF2C;HSPD1;BCL2;CD180;CD40;PTPRC;CR2
prerank,ncRNA metabolic process (GO:0034660),0.45034712422557543,0.9919907308983216,0.48259860788863107,1.0,1.0,6/37,8.22%,DGCR8;AGO2;MAPT;MAEL;EXD1;TUT7
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.49500003188101527,0.9918763517597262,0.4617524339360223,1.0,1.0,5/13,17.16%,DHX9;AGPAT2;AGPAT1;AXL;MAVS
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.39925857769826334,-0.991583820897795,0.4803370786516854,0.7609887863694089,1.0,4/10,23.39%,PLA2G4A;PNPLA8;PLA2G7;PLA2G15
prerank,regulation of stress fiber assembly (GO:0051492),0.42070842848161044,0.9915707407847956,0.4947257383966245,1.0,1.0,23/74,17.86%,STMN1;ARHGAP28;ROCK2;RHOA;CGNL1;LPAR1;SORBS3;TMEFF2;ALMS1;ROCK1;ARHGAP6;TGFBR1;ARHGEF18;RAC1;WASF2;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47;CLASP1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.4939932388209104,0.991337430158632,0.4506849315068493,1.0,1.0,4/14,18.16%,WNK1;ADAM17;STK39;OXSR1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.2320833188660015,-0.9913336307815876,0.42105263157894735,0.7606705920000544,1.0,21/69,21.48%,OGT;IGF1;PDGFRB;PIK3C2B;KCNH1;PLCB3;PIK3R1;IRS2;MYO16;NYAP2;NF1;IRS1;HTR2A;PI4KA;PLCE1;ERBB2;PIK3CD;PIK3CA;EXOC1;PLCH1;PIK3R2
prerank,megakaryocyte differentiation (GO:0030219),0.5187760484234224,0.9912346316084097,0.4782608695652174,1.0,1.0,4/11,19.41%,KIT;TAL1;MED1;ZFPM1
prerank,toxin transport (GO:1901998),0.5158741948961048,0.9912251036344552,0.4878419452887538,1.0,1.0,3/10,17.20%,ANTXR2;RAB29;ANTXR1
prerank,regulation of autophagosome maturation (GO:1901096),0.4979483030776541,0.991166396206476,0.4549237170596394,1.0,1.0,6/13,20.07%,TBC1D25;TMEM39A;ADRB2;UVRAG;CLEC16A;FYCO1
prerank,establishment of epithelial cell polarity (GO:0090162),0.47864503098971295,0.9911633473230188,0.47297297297297297,1.0,1.0,10/19,26.19%,RHOA;RAP2A;CYTH3;EZR;MSN;CLASP1;SIPA1L3;GOLPH3;CYTH1;CDC42
prerank,negative regulation of biosynthetic process (GO:0009890),0.4938316660686697,0.9907291542418175,0.48525469168900803,1.0,1.0,1/16,1.19%,SLC18A2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3100104247836566,-0.9899766626145986,0.42201834862385323,0.7631554876397917,1.0,2/23,0.29%,CAMK2D;CACNA2D1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.25456851063160035,-0.9892628315176111,0.4189189189189189,0.7638937111011272,1.0,25/58,25.77%,CERT1;ELOVL7;SGMS2;HACD3;ACER2;PLPP3;HACD2;ALDH3A2;ACER3;HACD1;ST8SIA6;DEGS2;SPNS2;GBGT1;DEGS1;SCCPDH;ELOVL6;VAPB;CERS1;SPTSSA;SGPL1;ELOVL1;SPHK1;SPTSSB;KDSR
prerank,myelination in peripheral nervous system (GO:0022011),-0.37513859344905065,-0.9890906399048986,0.4612794612794613,0.7633221306819767,1.0,6/13,25.69%,NF1;ARHGEF10;DICER1;ADGRG6;LGI4;PRX
prerank,regulation of trophoblast cell migration (GO:1901163),0.4977722832682566,0.9890324310490181,0.47606019151846785,1.0,1.0,3/14,12.35%,AGO2;SMURF2;GJA1
prerank,cardiac muscle cell action potential (GO:0086001),-0.29166229967885987,-0.9890153091010346,0.4642857142857143,0.7624680081490922,1.0,6/30,14.98%,CACNA2D1;ATP1B1;SCN1A;ATP1A1;ATP1A2;SCN1B
prerank,negative regulation of cation channel activity (GO:2001258),-0.3023637494945482,-0.9888078920536651,0.45454545454545453,0.7619824385554956,1.0,5/26,7.79%,KCNAB1;CALM1;FKBP1A;EPHB2;GNB5
prerank,regulation of insulin secretion (GO:0050796),-0.22803108039233524,-0.9883512591281949,0.5666666666666667,0.7620558148079714,1.0,27/101,21.39%,PRKN;EPHA5;MYRIP;SLC2A1;KCNC2;PER2;RAP1A;KCNB1;IRS2;ACSL4;SYT7;HADH;KCNS3;IRS1;SOX4;MIDN;SNAP25;UQCC2;ADRA2A;PICK1;TM7SF3;LRRC8A;CACNA2D2;EFNA5;RAPGEF3;NNAT;GLUD1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4606491428588788,0.9882545964483764,0.4749082007343941,1.0,1.0,9/25,19.67%,CEP97;EVI5L;ARHGAP24;YAP1;TBC1D7;ODF2L;LIMK2;PRKCD;PLXNB3
prerank,positive regulation of cell junction assembly (GO:1901890),-0.24869042284832152,-0.9881403627819625,0.48314606741573035,0.7614918533063616,1.0,26/56,28.44%,PTPRD;TEK;SYNDIG1;CAV1;GRID2;CLDN5;EPHB2;IL1RAPL1;CNTNAP2;NRXN1;ABL1;PPM1F;VEGFA;LRRC4B;NLGN1;NRP1;IL1RAP;BDNF;DLG5;SRPX2;TSC1;THY1;EPHA2;EPHB3;COL16A1;ACE2
prerank,axonal transport of mitochondrion (GO:0019896),0.517116980638447,0.9879958109606962,0.4903129657228018,1.0,1.0,2/11,5.53%,TRAK1;MAPT
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4933043983667612,0.9878802272858276,0.4645441389290883,1.0,1.0,4/13,12.60%,BMPR1A;BMP6;TGFBR1;SMAD4
prerank,regulation of fat cell differentiation (GO:0045598),0.4209215785541479,0.9877456212668296,0.5,1.0,1.0,24/74,19.41%,E2F1;FTO;ASXL1;ANKRD26;SFRP2;WWTR1;TMEM64;YAP1;RUNX1T1;BMP2;ENPP1;TRPM4;LRP5;RORA;SMAD3;MEDAG;WDFY2;LPL;SFRP1;AAMDC;FRZB;SYAP1;ZFPM2;ZFPM1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.39832776603631576,-0.9875402617825222,0.4745762711864407,0.7617881658873347,1.0,4/10,18.94%,APOD;LRP1;NDRG4;PTPN12
prerank,quinone biosynthetic process (GO:1901663),-0.36907206099620066,-0.9875086889881672,0.5094339622641509,0.760877174010177,1.0,5/14,12.22%,COQ8B;COQ5;COQ10A;COQ3;PDSS2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.3996471749603805,-0.987285601122909,0.4597014925373134,0.7604123706402119,1.0,5/10,18.17%,NEXMIF;RGCC;PPM1F;VEGFA;NOTCH4
prerank,positive regulation of binding (GO:0051099),0.41998298810092627,0.9865994897860647,0.4933196300102775,1.0,1.0,15/84,11.40%,PON1;DDX11;HMGB2;STMN1;GSK3B;DHX9;ADD2;STK3;TCF7L2;NMD3;TXN;LRRK2;HMGB1;PARP9;BMP2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.3786522589129103,-0.9865316907697086,0.47540983606557374,0.7613050874567677,1.0,6/13,19.33%,TGFBR2;CTNNB1;VEGFA;ENG;NOTCH4;NRP1
prerank,calcium ion homeostasis (GO:0055074),-0.22189955503025138,-0.986481514989958,0.6341463414634146,0.7604093388572806,1.0,21/95,16.64%,TMTC2;SLC8A3;ATP1B1;CAV1;RYR2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;FAM20A;CHRNA7;SELENON;TMCO1;SLC30A1;GRIN1;ATP2B2;ATP2B3;HTR2A;PTH1R;RMDN3
prerank,histone H3 acetylation (GO:0043966),0.43252656006369383,0.9861289014559441,0.4598623853211009,1.0,1.0,14/40,18.79%,BRCA2;SGF29;TAF12;ING4;TADA1;TADA2A;JADE1;PER1;YEATS2;DR1;KAT6A;TAF10;NAA60;JADE3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.40488501967497514,-0.9859440577279937,0.4682080924855491,0.7607581845722571,1.0,4/10,24.36%,GAS6;LYN;LGALS9;CXCL12
prerank,neurotrophin signaling pathway (GO:0038179),-0.3090579163460753,-0.9855152069070376,0.4727272727272727,0.7607992725277518,1.0,9/21,29.26%,NTRK2;RAP1A;KIDINS220;GRB2;DDIT4;BCAR1;BDNF;ZFYVE27;SOS1
prerank,folic acid metabolic process (GO:0046655),0.46600854595247665,0.9848596299982384,0.4689119170984456,1.0,1.0,4/18,13.54%,MTHFD1L;MTHFR;SLC19A1;DHFR
prerank,regulation of cytoplasmic translation (GO:2000765),0.4784467450857277,0.9848358060661192,0.47307132459970885,1.0,1.0,4/14,9.13%,DHX9;FMR1;YBX3;CPEB2
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2325585879679807,-0.9846555401190282,0.4146341463414634,0.7617971056810331,1.0,33/87,28.16%,FOXO1;SEMA6A;TIMP3;CAV1;APOE;TLR4;WNK2;EPHB2;IGBP1;DUSP3;LYN;STK38;NF1;INPP5K;LMO3;SYNJ2BP;SPRY2;DUSP1;ITGB1BP1;SORL1;PPEF2;TNIP1;UCHL1;PIK3R2;RPS6KA6;CDK5RAP3;BMP7;CD300A;P2RX7;GPER1;DAG1;IRAK3;DUSP6
prerank,protein targeting to lysosome (GO:0006622),0.4604426934587142,0.9841240549836744,0.46511627906976744,1.0,1.0,4/20,12.19%,AP4M1;NEDD4;ZFYVE16;NAGPA
prerank,cardiocyte differentiation (GO:0035051),-0.4027580811454562,-0.9839506181736843,0.47230320699708456,0.7625061162507786,1.0,6/10,26.48%,TGFB2;SIK1;KDM6B;GATA6;CBY1;MYOCD
prerank,cellular component maintenance (GO:0043954),0.4988031886565346,0.9837756981442387,0.4810126582278481,1.0,1.0,3/12,9.30%,LNPK;PRNP;MTMR2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5001638990982962,0.9835021311951995,0.4769452449567723,1.0,1.0,6/12,20.61%,LHPP;ADSL;PFAS;GART;PPAT;ADSS2
prerank,cellular response to glucose stimulus (GO:0071333),-0.2907460850707831,-0.9834559020066829,0.46153846153846156,0.7628284655789912,1.0,8/30,16.81%,UNC13B;KCNB1;GAS6;PRKAA1;SOX4;RAB11FIP2;ADCY8;XBP1
prerank,regulation of establishment of planar polarity (GO:0090175),0.41954857387079886,0.9833157808855282,0.5082135523613963,1.0,1.0,15/88,11.74%,SAPCD2;VANGL1;RHOA;PSMC2;PSMD5;SPEF1;DAAM1;PSMB1;SMURF1;PSMD14;NPHP3;PSMD1;PSMB9;SMURF2;RAC1
prerank,regulation of translational initiation (GO:0006446),0.4205908936081869,0.9832686341847633,0.5,1.0,1.0,18/63,17.58%,AGO2;CTIF;KHDRBS1;EIF4H;TPR;FMR1;LARP1;NCK1;CDC123;YTHDF2;EIF2AK3;NCK2;RBM4;PPP1R15B;EIF4A2;DDX1;EIF3H;PAIP2B
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4752183359684006,0.9831000476334049,0.48230668414154654,1.0,1.0,4/18,9.55%,ROCK2;EFNA1;EPHA4;PICALM
prerank,positive regulation of protein polymerization (GO:0032273),0.4262431302815348,0.9830751968179702,0.5106157112526539,1.0,1.0,13/65,13.19%,CDK5RAP2;PSRC1;NUMA1;MAPT;CDC42EP2;NCK1;TPPP;DRG1;AKAP9;RAC1;NCK2;BAIAP2L1;PRKCE
prerank,regulation of organelle organization (GO:0033043),0.4179120577672679,0.9824711303261465,0.5233545647558386,1.0,1.0,18/80,12.66%,RAB33B;USP6NL;MIEF2;TBC1D25;SPEF1;DIAPH1;MAPT;RHOT1;ARMH3;ARL6IP1;MARK2;PLXNB1;STX18;EZR;AKAP9;STOX1;CENPV;CLIC4
prerank,limb morphogenesis (GO:0035108),0.4654759230184885,0.9822263941393683,0.4773022049286641,1.0,1.0,3/20,7.59%,GLI3;CYP26B1;NIPBL
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.40719947113435795,-0.9820600460666069,0.48324022346368717,0.7649838140678115,1.0,4/10,24.41%,CST3;TNFRSF1B;FAP;TNFRSF1A
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.31074822468673313,-0.9818961133936249,0.4563106796116505,0.7643304788454283,1.0,8/24,19.54%,NBL1;ANO6;LYN;LGMN;SLIT2;DUSP1;PLA2G7;CREB3
prerank,T cell homeostasis (GO:0043029),0.5120760548591169,0.981801546343792,0.4864864864864865,1.0,1.0,1/10,2.15%,FADD
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.3707870052202607,-0.9812873000737871,0.5015384615384615,0.7647478153421742,1.0,4/12,12.33%,OS9;RER1;HSPA5;KDELR3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3442995095705606,-0.9812072006292661,0.49333333333333335,0.7639608202023863,1.0,9/18,19.29%,RHOJ;FGF2;FOXC2;PTGS2;HDAC7;VEGFA;HDAC9;GATA2;FGFBP1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.35176942442679615,-0.9810961789197389,0.43508771929824563,0.7632217267590157,1.0,6/15,22.19%,GNAL;BBS4;ADCY3;SYT10;SLC24A4;DRD2
prerank,positive regulation of locomotion (GO:0040017),-0.2975485158077763,-0.9809245190283562,0.5384615384615384,0.7626590974677507,1.0,6/27,5.46%,SPOCK2;STX4;PDGFRB;AKT2;CFAP20;STX3
prerank,endocytic recycling (GO:0032456),-0.2494570959171906,-0.9805853970775538,0.5061728395061729,0.7624901906437175,1.0,10/50,8.24%,VPS35L;MICALL1;VPS53;STX6;SNX4;ANKRD50;SNX3;EHD4;CCDC93;ENTR1
prerank,regulation of potassium ion transport (GO:0043266),-0.2886310333299171,-0.9802834237381809,0.4268292682926829,0.7621758850956422,1.0,13/31,34.06%,KCNIP4;KCNAB1;KIF5B;KCNN2;ADRA2A;DPP10;NOS1;DRD2;PTK2B;KCNIP1;KCNIP2;CASQ2;CACNA1D
prerank,retinol metabolic process (GO:0042572),0.49695303976331373,0.9799451974087996,0.4786206896551724,1.0,1.0,2/14,5.88%,RDH11;RDH12
prerank,regulation of neuron projection arborization (GO:0150011),0.4818275213026981,0.9798021917363451,0.4710860366713681,1.0,1.0,3/15,11.17%,MACF1;MOV10;GRIP1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5083360991889676,0.9797874559549581,0.4852941176470588,1.0,1.0,5/10,18.95%,ING4;FOXM1;TP53;TFAP4;SP100
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3794365946040573,-0.9795823548531208,0.47491638795986624,0.762916671098954,1.0,4/12,13.93%,STX4;ANO1;GPLD1;ADCY8
prerank,positive regulation of T cell migration (GO:2000406),0.46531394898857315,0.9794255100393249,0.477124183006536,1.0,1.0,5/20,18.16%,RHOA;WNK1;ADAM17;STK39;OXSR1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4450758496932481,0.9793652758535765,0.4823529411764706,1.0,1.0,8/33,14.43%,HMGB2;RAB7B;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.43427564677808533,0.979003317878066,0.5017301038062284,1.0,1.0,16/38,22.30%,SAE1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;LRRK2;CSNK2A2;ATP5IF1;NPEPPS;UBL5;SIAH3;SREBF1;UBE2D3;UBE2L3;ATG13
prerank,neuron cell-cell adhesion (GO:0007158),-0.3660569536933711,-0.9787959649815405,0.4864864864864865,0.7637510948114922,1.0,4/14,7.62%,ASTN2;NRXN3;NCAM2;NRXN1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3808925993346306,-0.9787124588613272,0.47634069400630913,0.7629853861986793,1.0,10/11,61.94%,PKD2L1;PKD1L3;LPO;RTP4;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.2726602633747265,-0.9785923640836134,0.5133333333333333,0.7623277333174028,1.0,11/35,18.02%,SGIP1;VTN;BICD1;B2M;HNRNPK;SMAP1;LDLRAP1;BMP2K;HIP1;CBL;PPT1
prerank,regulation of cilium assembly (GO:1902017),0.4214042558579325,0.9782049042079339,0.49785867237687365,1.0,1.0,14/62,12.88%,USP6NL;CEP97;IFT140;EVI5L;TBC1D13;TBC1D2B;YAP1;TBC1D7;SDCCAG8;TAPT1;ARHGAP35;CEP120;TBC1D19;ATG3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.368872196332104,-0.9777973792668694,0.5,0.7632202849198035,1.0,4/13,16.62%,BPNT2;TPST1;ABHD14B;TPST2
prerank,ether lipid metabolic process (GO:0046485),0.48475138604609663,0.9775937916173059,0.4664764621968616,1.0,1.0,4/14,11.76%,AGMO;AGPS;PEDS1;TMEM86B
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4503654897034971,0.9772335890345352,0.4690265486725664,1.0,1.0,7/23,18.34%,E2F1;TFDP1;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4503654897034971,0.9772335890345352,0.4690265486725664,1.0,1.0,7/23,18.34%,E2F1;TFDP1;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4957067970261075,0.9765825207224154,0.4947526236881559,1.0,1.0,2/11,11.74%,STMN1;RAC1
prerank,bone development (GO:0060348),0.4385004782039501,0.9760889562491604,0.5011261261261262,1.0,1.0,13/39,20.38%,CYP26B1;FGFR2;SULF2;SLC10A7;SULF1;P3H1;GJA1;LRP5;TP53;NOTUM;SH3PXD2B;SKI;RANBP3L
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.41491644826836827,0.9757111326394212,0.5116022099447514,1.0,1.0,8/59,15.77%,ACMSD;CYP39A1;ALDH1A2;NDUFAB1;ACACA;HOGA1;ELOVL4;LPL
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.44240965938056775,0.9756202437422128,0.47721822541966424,1.0,1.0,10/31,19.64%,FGFR2;HOXC4;PDGFRA;DSCAML1;HOXB3;TGFBR1;TWIST1;OSR1;HOXA3;DYNC2I1
prerank,primary miRNA processing (GO:0031053),0.5183748350488249,0.9755068583980329,0.5059701492537313,1.0,1.0,5/10,17.83%,DGCR8;SMAD3;HNRNPA2B1;METTL3;SMAD2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2913048994741654,-0.975457066814867,0.48205128205128206,0.7678819649017777,1.0,7/29,19.54%,JAM2;ANO6;GAS6;LGMN;PLA2G7;LGALS9;CREB3
prerank,pulmonary valve morphogenesis (GO:0003184),-0.3303789570575497,-0.9748768771934134,0.45454545454545453,0.7683423986449842,1.0,7/17,16.20%,JAG1;TGFB2;NOS3;SLIT2;HEYL;STRA6;ROBO2
prerank,organic acid transport (GO:0015849),-0.22479653730844487,-0.97452279635793,0.5161290322580645,0.7682091652536527,1.0,26/94,23.58%,SLC6A6;SLC13A3;SLC7A2;SLCO1C1;SFXN5;SLCO2B1;GOT2;SLC3A2;SLC27A1;ABCC4;ATP8B1;SLC22A6;ABCG2;SLC5A6;SLC7A6;SLC16A1;LRRC8D;SLC38A5;STARD5;SLC25A11;SLC6A15;SLC27A4;ACSL1;SLC36A1;MFSD2A;SLC7A14
prerank,protein deacetylation (GO:0006476),0.4203221044255417,0.9743659180131885,0.47801578354002255,1.0,1.0,9/41,12.62%,MIER1;TBL1XR1;MIDEAS;RCOR1;MSL3;MIER3;MTA3;HDAC1;HDAC2
prerank,cellular defense response (GO:0006968),-0.26186867658795465,-0.9743061482295775,0.4596774193548387,0.7677642521201492,1.0,8/40,23.70%,BECN1;LSP1;RAB23;LBP;CCR9;LGALS3BP;NCF2;PTK2B
prerank,negative regulation of RNA splicing (GO:0033119),0.4660211020140908,0.9742321038958386,0.4816272965879265,1.0,1.0,6/19,17.74%,SRSF4;SRSF10;SRSF7;SAP18;PTBP2;SFSWAP
prerank,cellular calcium ion homeostasis (GO:0006874),-0.20858334370589593,-0.9742265393853774,0.6086956521739131,0.7670152857275417,1.0,29/133,16.64%,CAMK2D;PSEN1;SLC8A3;ATP1B1;TRPC5;CAV1;RYR2;ANXA6;PACS2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;TRPC3;TRPC1;CHRNA7;BCL2;HCRTR2;CAV2;TMCO1;SLC30A1;ADCY8;ATP2B2;ATP2B3;SMDT1;HTR2A;PTH1R;RMDN3
prerank,RNA metabolic process (GO:0016070),0.4093930384881716,0.974145320163436,0.547112462006079,1.0,1.0,34/127,16.59%,SYNCRIP;SETX;PABPC4;TENT2;AGO2;HNRNPD;FTO;RBFOX2;RNASE6;DHX9;HNRNPA1;DDX39B;HNRNPH1;POLR2A;RBMS2;RNASEH2A;DHX8;CELF2;HNRNPUL1;PPP1R8;HNRNPU;HNRNPL;RNASE1;EXOSC7;ATXN1;HNRNPH2;RNGTT;RBM4;RBMS1;HNRNPA2B1;PNPT1;METTL3;NOL9;PRPF4
prerank,inner mitochondrial membrane organization (GO:0007007),-0.24808355560290044,-0.9741302170377882,0.5135135135135135,0.7662896700556822,1.0,25/47,31.75%,APOOL;MTX2;ATP5PF;ATP5F1A;ATP5PO;GHITM;ATP5MF;ATP5MC3;DNAJC11;TOMM70;ATP5PD;ATP5F1B;MTX3;ATP5F1D;ATP5F1E;ATP5MG;MICOS13;TIMM9;ATP5ME;TIMM13;HSPA9;TIMM8B;NDUFA13;ROMO1;TIMM29
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4194835978212231,0.9737786223680293,0.5279241306638567,1.0,1.0,30/70,24.77%,CBFB;PSMC2;PSMD5;PRKDC;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,protein tetramerization (GO:0051262),0.4141989620128281,0.9737155384949059,0.5272536687631028,1.0,1.0,11/67,12.52%,TK1;UPB1;ALDH1A2;HPRT1;TRPA1;USP16;APIP;TRPM2;ACACA;APPL2;TRPM4
prerank,excitatory postsynaptic potential (GO:0060079),-0.33531751831520995,-0.9734905488046101,0.462882096069869,0.7667770791793479,1.0,4/19,3.74%,MEF2C;GRIN2A;GRID2;GRIN2B
prerank,response to nitric oxide (GO:0071731),0.4826545438479843,0.9732644290433521,0.4861111111111111,1.0,1.0,3/13,7.95%,AQP1;TXN;CDK2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.48007598445696587,0.9732593938530547,0.4822888283378747,1.0,1.0,5/15,22.48%,NR3C1;HNRNPU;ANXA1;UBE2L3;ZFP36L1
prerank,response to reactive oxygen species (GO:0000302),-0.24401153470405842,-0.9727870416138966,0.5217391304347826,0.767408853190293,1.0,22/54,23.88%,APOD;APOE;MAPK8;MAPK9;SOD2;TPM1;JUN;MAPK3;STK25;MAPK1;CAMKK2;MPV17;TXNRD2;CHUK;GLRX2;GPX1;PRDX3;PRDX5;ERCC6L2;RPS3;COA8;PDK2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4183287299771047,0.9727469259683136,0.5114254624591947,1.0,1.0,8/56,12.60%,TTK;BMPR1A;BMP6;PMEPA1;SMAD6;TGFBR1;BMP2;SMAD4
prerank,estrogen metabolic process (GO:0008210),-0.3507319029006397,-0.9727334915889143,0.4659498207885305,0.7665871115434092,1.0,8/15,49.17%,HSD17B11;HSD17B7;HSD17B8;HSD17B10;HSD17B2;SULT1A1;HSD17B14;HSD17B1
prerank,carbohydrate biosynthetic process (GO:0016051),0.4522599828111132,0.9727261306584634,0.47631241997439183,1.0,1.0,6/21,16.84%,B4GALT1;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5063998631058891,0.9726580111702979,0.5185185185185185,1.0,1.0,3/11,13.47%,ARRB1;GRK3;ADRB2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4118819746980918,0.9725045676442012,0.514018691588785,1.0,1.0,29/84,19.97%,RBM15;SRSF4;TRA2B;RBFOX2;KHDRBS1;HNRNPA1;SRSF10;THRAP3;MBNL3;RBM25;FMR1;SRSF7;SAP18;CELF2;SRSF3;HNRNPU;RBM15B;HNRNPL;SRPK1;RBM4;DAZAP1;FXR1;NUP98;SFSWAP;SRPK2;CWC22;LARP7;KHDRBS3;TRA2A
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.21205843396560048,-0.972452665219172,0.6,0.7663227001095507,1.0,20/112,13.70%,STAT3;PSEN1;IGF1;GAS6;TLR4;EPHB2;CD34;LBP;PTPN22;SELENOS;CHRNA7;APP;ARHGEF2;ARFGEF2;THBS1;CX3CL1;SYT11;TRIM27;PTPN11;IFNGR1
prerank,cardiac myofibril assembly (GO:0055003),0.47914348476872515,0.972370788264794,0.4884353741496599,1.0,1.0,3/15,7.02%,OBSL1;MYLK3;PDGFRA
prerank,myeloid dendritic cell activation (GO:0001773),-0.3689269620939794,-0.9721529091042886,0.4775641025641026,0.7660589505315969,1.0,2/12,6.22%,TGFBR2;CAMK4
prerank,regulation of extracellular matrix organization (GO:1903053),0.4774220777424592,0.9720419048904805,0.4881450488145049,1.0,1.0,6/15,18.14%,RB1;FGFR4;AGT;DDR2;RIC1;RUNX1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.41463438401045816,0.9716954404582675,0.5121693121693122,1.0,1.0,1/69,0.13%,KIF14
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.29434166292238073,-0.9712482675880505,0.4827586206896552,0.7672103911051317,1.0,9/27,14.62%,PSEN1;BRSK1;HOMER1;IL1RAPL1;CAMK2G;CTNNA2;NCS1;NTNG1;GSK3A
prerank,long-chain fatty acid transport (GO:0015909),-0.29103918785561217,-0.9706808129409721,0.4774193548387097,0.7675270424462736,1.0,12/30,30.25%,APOE;ABCD4;SLC27A1;ACACB;ABCD2;PRKAG2;SLC27A4;ACSL1;MFSD2A;MID1IP1;FABP5;CPT1A
prerank,extracellular matrix assembly (GO:0085029),0.45843206284623444,0.9703959209983014,0.4909560723514212,1.0,1.0,5/23,10.17%,HAS3;LAMB1;QSOX1;FBLN5;HAS1
prerank,negative regulation of cellular component organization (GO:0051129),0.42089419070324485,0.9701224141122514,0.5190274841437632,1.0,1.0,13/74,13.64%,PON1;RTEL1;GSK3B;IAPP;BMP6;TMEFF2;RIOK3;DNM2;MTMR2;SNX33;TERF2;AIDA;PRKD1
prerank,organonitrogen compound catabolic process (GO:1901565),-0.2496393594835303,-0.9699975495226549,0.42696629213483145,0.7680596546354208,1.0,20/57,23.67%,PLA2G4A;LNPEP;CLPX;RENBP;PNPLA8;TPP1;TXN2;SIAH1;ACE;MTOR;ENPEP;RIDA;PLA2G7;PPT1;BCKDK;NAGK;CLN5;SGPL1;PLA2G15;USE1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.360903883894398,-0.9694274483311227,0.5033557046979866,0.7685145353593913,1.0,7/13,36.53%,PIK3R4;IRAK4;UNC93B1;PIK3AP1;EPG5;TNIP2;MYD88
prerank,sensory perception of taste (GO:0050909),-0.3949206307792948,-0.9688655487722306,0.486404833836858,0.7689280098812772,1.0,8/10,56.23%,PKD2L1;PKD1L3;ASIC1;CD36;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,inorganic anion transport (GO:0015698),0.42925309310879234,0.9686434410666497,0.5307692307692308,1.0,1.0,8/53,13.30%,RACGAP1;ANO9;ENPP3;CLCN1;ENPP1;CLIC4;SLC25A30;CLIC1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.3063721021018069,-0.9685223695029258,0.5067264573991032,0.7687519073263639,1.0,7/24,18.60%,PDE3A;PEX5L;GNAI1;PRKAR1B;UBE2B;PDE2A;PDE4D
prerank,regulation of stem cell differentiation (GO:2000736),0.4166912535333843,0.9684046716709446,0.5350052246603971,1.0,1.0,32/89,22.98%,CBFB;BMPR1A;PSMC2;PSMD5;PRKDC;PDGFRA;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;HNRNPU;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;GDNF;OCIAD1;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4
prerank,cellular protein modification process (GO:0006464),0.4061446937865807,0.9679299956836561,0.662,1.0,1.0,240/983,19.98%,DTL;CCNF;NEK2;MELK;CDK1;PLK1;BIRC5;AURKB;TGM1;MATN3;NEK3;F5;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;UBE2S;PPM1G;MAP4K4;DYRK1A;PPM1D;LOXL2;STK17B;LOX;TRIOBP;BMPR1A;CDK14;AURKA;ROCK2;FEM1C;ASB15;MAP4K2;GSK3B;PSMC2;ZC3HAV1;GGCX;LARGE1;PSMD5;FBN1;STK10;OBSL1;NLK;CHEK2;MYLK3;FUT10;LAMB1;FBXL7;PRKDC;ST8SIA2;LHPP;SPSB3;B3GNT8;CTBP1;DYRK3;TAB1;PPP2R3A;SPSB2;VRK2;SSH2;STK24;STK3;SETD3;NRK;MAP3K1;CCNE1;RBBP7;ELOC;FBXW7;FBXO30;WNK1;MAP3K20;ATG7;CDC25B;CHEK1;CUL5;PPP3CA;CCN1;CDC42BPA;FBXL8;ST3GAL3;PHKA2;QSOX1;KLHL5;CDK2;B4GALT7;PORCN;LRRK2;PSMB1;FN3K;SUMF2;GRK5;CUL3;PSMD14;KLHL22;DUSP12;VHL;MTMR2;CUL4B;ROCK1;PIM1;PSMD1;RPN2;SKP2;DCAF10;ST3GAL5;MARK2;RAB1A;PXK;UST;CDC42BPG;PPP2R5C;PARP9;TGFBR1;WSB2;PTPN21;PSMB9;PIGU;SRPK1;EIF2AK3;LMTK3;PRKCB;PTPRS;BMP2;ANXA1;STT3A;APLP2;CHM;P3H1;FBXW11;SEPHS1;PRKCA;NAGPA;PDPK1;GRK3;STT3B;AAK1;CSNK1G2;DCAF7;SIK2;PPP1CC;MEX3B;ATG3;STRADA;BTK;CDK19;PRKCE;COPS3;MAML1;PRKD1;PRKCI;ARF4;BTRC;FBXO27;PLK2;ST3GAL4;MACROD2;NRBP1;MORC3;PSMC6;MIA3;PIGT;VRK1;ST3GAL1;CDK8;BIRC6;PTPRA;STK11;PTPN13;FBXO17;PTPRU;MTMR3;UBL5;TAOK1;PRKAG1;ST3GAL2;CKAP4;PRKD2;STK39;PASK;ASB2;PRSS23;PPP2R5B;NOTUM;DAPP1;FBXL14;PPP2R1B;PTEN;PLOD2;FBXW10;HIPK3;UBLCP1;NTAQ1;GLRX;B3GALT2;PTPRK;GOLM1;RAB13;PTPRE;WNK3;CDKL4;CSNK1A1;PSMB2;SRPK2;MAST1;PKN2;METAP1;OXSR1;FNTB;PLAT;IGFBP3;LIMK2;PSME4;LTBP1;FBXO4;PSMB7;HIPK1;BRAF;OGFOD1;DUSP7;CLK3;STRADB;ASB3;PPM1A;CAND1;PRKCD;RAB3A;TESK2;DCAF8;PARP14;YES1;TYK2;UBE2D3;DAPK1;PTPN1;TRIB1;PRKAB1;PTPN5;PSMD11
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4003083260711142,-0.9676815789338886,0.5,0.7697518809509408,1.0,2/10,8.23%,SLC44A1;HNMT
prerank,outer dynein arm assembly (GO:0036158),0.47755711416400914,0.9673390960522688,0.4985835694050991,1.0,1.0,4/14,19.01%,DNAAF5;LRRC49;ODAD1;DNAH8
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.28796441269906303,-0.9671606344468726,0.5497076023391813,0.77006725237883,1.0,5/28,8.92%,CYRIB;SH3KBP1;PRKCQ;HSPD1;XRCC6
prerank,neutrophil activation (GO:0042119),-0.361892355449328,-0.9669708523812438,0.47770700636942676,0.7695740099388177,1.0,5/12,32.77%,KMT2E;IL15;SYK;FCER1G;TYROBP
prerank,organelle fusion (GO:0048284),0.4510823006302361,0.9666335515843548,0.4880201765447667,1.0,1.0,9/22,21.24%,MIEF2;VPS18;MFN2;MIEF1;CHCHD3;MFN1;MIGA2;SPG7;EEA1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5001516098804099,0.9665233202439271,0.4946889226100152,1.0,1.0,3/11,6.26%,AGO2;NECAB1;SOAT1
prerank,T cell activation (GO:0042110),0.4127415919300623,0.9662690085807258,0.534957627118644,1.0,1.0,15/69,16.27%,ADA;KIT;LEPR;PTPN2;PPP3CA;SCRIB;RAB29;CTPS1;NCK1;NCK2;LMBR1L;CASP8;CD44;LCP1;MSN
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2558976624479159,-0.9660191905621289,0.5238095238095238,0.770773601127736,1.0,13/43,17.57%,SH3KBP1;STAM2;DUSP3;EPN1;TSG101;SOCS5;ZGPAT;TGFA;GRB2;SPRY2;CBLB;ARHGEF7;CBL
prerank,mitochondrion organization (GO:0007005),-0.2014869153833962,-0.9659719653289172,0.5,0.7699335416933669,1.0,61/165,23.13%,DNM3;PRKN;IMMP2L;SLC25A36;FIS1;DNAJC19;NOS3;ADCK1;MTX2;ESRRA;ALAS1;DNM1;OXA1L;HSPD1;NDUFS1;OMA1;AIFM1;CHCHD2;TFB2M;BNIP3L;BNIP3;TIMM44;CAV2;PARP1;MEF2A;SIRT5;PINK1;SUPV3L1;TOMM70;MPV17;BCAP31;GDAP1;COX7A2;SSBP1;ATP5F1B;SLC25A4;TFAM;MTX3;HIGD1A;USP30;PRDX3;ATP5F1D;AIP;FBXO7;PPARGC1A;PARK7;TOMM34;BCL2L1;GABPA;ATCAY;VPS13D;YME1L1;POLG2;TIMM17A;TOMM7;ATP7A;TIMM17B;WDR81;FMC1;SLIRP;RAB38
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.2590628359603239,-0.9656760274026547,0.5348837209302325,0.7696629380975402,1.0,7/39,7.76%,CAMK2D;FGF14;HECW1;WNK2;FGF13;NETO1;FXYD5
prerank,tRNA 5'-leader removal (GO:0001682),0.4846823230709727,0.965661621898931,0.49794238683127573,1.0,1.0,5/13,19.61%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.4231244298309841,0.9648843124138443,0.5149082568807339,1.0,1.0,14/45,18.92%,ZC3H7A;EIF4E;MATR3;FOXO3;LARP1;PUM2;PARP9;MEX3D;LARP4;RC3H1;PER1;ZC3H7B;METAP1;SPOUT1
prerank,aorta morphogenesis (GO:0035909),-0.33203285142057987,-0.9648263213893397,0.46987951807228917,0.7705788427385246,1.0,6/17,5.49%,JAG1;ACVRL1;PDGFRB;PROX1;LRP1;MYLK
prerank,actin filament-based transport (GO:0099515),0.46435758350387774,0.9646609541124455,0.5012594458438288,1.0,1.0,3/21,5.74%,SYNE2;ACTN4;MYO1C
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4549386972288929,0.9646164795015081,0.4934895833333333,1.0,1.0,4/21,10.55%,CBFB;ROCK2;ROCK1;ERRFI1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.40484283475110866,0.9645929595949485,0.5763052208835341,1.0,1.0,40/199,16.14%,PON1;BRCA2;ATP2B4;SFMBT1;LOXL2;RB1;ROCK2;USF3;GSK3B;SRF;NFIB;MCC;CHSY1;HOXA7;GRHL2;EFNA1;SFRP2;ADAMTS5;SMAD6;ALDH1A1;ROBO1;ROCK1;NPR3;ATP2B1;BMP2;NKX2-1;TBX18;RBPJ;GJA1;ADAM17;SOX9;ADIPOR1;HEY2;SPRED1;DOCK7;STK11;TLE3;SFRP1;SPRED2;PTEN
prerank,regulation of JUN kinase activity (GO:0043506),-0.277862004085086,-0.9645447151189814,0.532051282051282,0.7702032984399968,1.0,13/33,27.32%,PDCD4;MAP3K5;DNAJA1;PAK1;PTPN22;ARHGEF5;TNFRSF11A;PPEF2;RPS3;MAP3K11;MAPK8IP1;EDN1;DVL2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.43006050754684827,0.9642329583744115,0.5086306098964327,1.0,1.0,12/37,17.53%,PLK1;UBE2K;S1PR2;CALM2;STOX1;TRIM6;DMTN;CAB39;SPRED1;RPTOR;SPRED2;WNK3
prerank,regulation of platelet aggregation (GO:0090330),-0.32529544539953725,-0.9641405891821587,0.5019762845849802,0.7701762274143263,1.0,4/17,8.02%,PRKG1;F11R;LYN;PRKCQ
prerank,negative regulation of apoptotic process (GO:0043066),0.4008488687915798,0.9631871058840197,0.611,1.0,1.0,73/444,16.33%,KIF14;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;AQP1;CDKN2D;MAP4K4;RB1;SETX;PHIP;ARHGAP10;FNIP1;ANGPT4;GSK3B;FXN;DDRGK1;FHL2;PRKDC;MRE11;SIAH2;PDPN;ANXA5;KDM2B;ARL6IP1;SMAD6;GRK5;SH3RF1;YAP1;MGMT;ANGPT1;VHL;PIM1;APIP;ERC1;CSNK2A2;NR4A2;SFPQ;CNTF;HDAC1;ANXA1;PRKCA;SOX9;HDAC2;NOTCH2;ATF5;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;ITGA5;ITGB1;CD44;QARS1;BIRC6;SLC30A10;SRC;GDNF;TNFAIP8;NFKB1;TP53;SFRP1;ANKLE2;HIPK3
prerank,regulation of myoblast fusion (GO:1901739),0.4851667971318062,0.9631415345219873,0.4955223880597015,1.0,1.0,4/11,24.31%,RIPOR2;EHD1;MAPK14;EHD2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4545509284580156,0.962805358796605,0.4831763122476447,1.0,1.0,5/19,10.10%,MYO1C;XDH;JCAD;ROBO1;PIK3CB
prerank,nerve growth factor signaling pathway (GO:0038180),-0.39302124459651405,-0.9626761875112458,0.5225225225225225,0.7725079939301916,1.0,2/10,9.82%,RAP1A;KIDINS220
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.427234871686258,0.9625822450990948,0.5112359550561798,1.0,1.0,12/43,13.64%,FBXO5;BMPR1A;BMP6;NPNT;CCN1;WWTR1;YAP1;DDR2;BMP2;ZHX3;LRP5;PRKD1
prerank,RNA modification (GO:0009451),-0.24563941320144472,-0.9620073193130257,0.5119047619047619,0.7730003014998312,1.0,24/54,25.87%,TRMT9B;ANKRD16;DTWD2;PARN;AARS1;NSUN2;CDKAL1;QTRT2;ADAR;TRMT1;TRUB1;METTL1;ADARB1;MEPCE;PUS3;THUMPD1;QTRT1;NOP2;JMJD6;LCMT2;DTWD1;WDR4;ALKBH1;NSUN5
prerank,protein localization to cilium (GO:0061512),0.43903176315551545,0.9618231814579039,0.5270758122743683,1.0,1.0,4/32,7.68%,BBS9;WDR35;IFT140;RAB29
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3389686536426956,-0.9617763288184534,0.4823529411764706,0.7725652242855935,1.0,5/16,19.48%,APOD;PDCD4;CHID1;ABCD2;ZC3H12A
prerank,response to unfolded protein (GO:0006986),-0.2514935037755905,-0.9610990269060186,0.5742574257425742,0.7732979372495752,1.0,12/48,18.18%,PRKN;HSP90AB1;DNAJA1;HSPH1;HSPD1;DERL1;HSPA4L;HSPA5;PACRG;DDIT3;TM7SF3;HSPB8
prerank,mRNA 3'-end processing (GO:0031124),0.4063530494221227,0.9597558305256365,0.5568421052631579,1.0,1.0,19/78,12.67%,TENT2;SRSF4;CSTF3;FIP1L1;UPF3B;SLBP;LSM11;DDX39B;SRSF7;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;SRSF3;SRRM1;CPSF4;RPRD1A
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.286575077857785,-0.9597251922336298,0.48258706467661694,0.7755021354026364,1.0,9/29,11.84%,RPS8;RPS21;NOL10;RPS14;KRI1;RPS19;HEATR1;UTP20;NGDN
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4354962182957908,0.9593142349153381,0.5106382978723404,1.0,1.0,12/29,23.54%,FADD;WWOX;PML;HTRA2;AGT;SFRP1;PPP2R1B;TNFSF10;RIPK1;TRAF2;BID;BCL10
prerank,negative regulation of cell adhesion (GO:0007162),-0.23132021879878698,-0.9592191278611353,0.5245901639344263,0.7756516960070757,1.0,19/72,17.76%,PTK2;SPOCK1;PODXL;SEMA6A;JAG1;ACVRL1;ACER2;NEXMIF;EPHB2;SEMA4D;PTPRO;PLXNC1;FZD4;CX3CL1;DUSP1;ITGB1BP1;CORO2B;CBLL1;PLXNA4
prerank,regulation of JNK cascade (GO:0046328),-0.20546157620590075,-0.9592005446609213,0.5185185185185185,0.7747463721690988,1.0,21/101,14.06%,MECOM;PRKN;TNFRSF19;SH3RF3;HIPK2;TPD52L1;TAOK2;ZMYND11;ANKRD6;MAP3K5;DUSP3;CYLD;DUSP22;DACT1;SEMA3A;MINK1;APP;HDAC3;PINK1;SDCBP;SH3RF2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.29804172460177564,-0.9589712925731496,0.5245098039215687,0.7743118172363722,1.0,5/24,6.47%,RYR3;RYR2;ANXA6;FGF2;HTR2C
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.31256567057833123,-0.9586280654898487,0.49159663865546216,0.7741433784826466,1.0,11/20,19.33%,VTN;IGF1;PDGFRB;LRP1;S100A11;ACE;SLIT2;NDRG4;SORL1;CCN4;NRP1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4572227373162774,0.9585103753591386,0.49559748427672956,1.0,1.0,10/22,24.55%,FXN;NUBP2;CIAO3;MMS19;ISCA2;NUBP1;LYRM4;CIAO2A;NFS1;CIAPIN1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4673026907583351,0.9577019641313368,0.4835007173601148,1.0,1.0,2/14,4.54%,TICAM1;KIT
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3350193379596036,-0.9576692798204642,0.49812734082397003,0.7754293419176922,1.0,4/17,10.95%,HSP90AB1;CALM1;PDGFRB;MTOR
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.4945527711429407,0.9573581605708742,0.5235294117647059,1.0,1.0,5/12,19.92%,GSS;GCLM;BDH2;GCLC;HAGH
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4800424737396722,0.9573400785948574,0.5058823529411764,1.0,1.0,3/12,10.10%,ATP2B4;XDH;PIK3CB
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.29269880362613665,-0.9572877599436329,0.47305389221556887,0.7753962972408759,1.0,9/26,12.71%,FMOD;B4GALT5;B3GNT2;ST3GAL6;B4GALT6;PRELP;OGN;LUM;B4GALT4
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.46175966042053485,0.9572616230193703,0.50997150997151,1.0,1.0,7/16,23.33%,TRA2B;THRAP3;DAZAP1;NUP98;TRA2A;RBMX;NCL
prerank,receptor catabolic process (GO:0032801),-0.29942865899489157,-0.9570270776333105,0.547486033519553,0.7750249576993411,1.0,10/24,15.63%,KIF16B;GPRASP1;BECN1;AP2A2;PIK3R4;LGMN;VLDLR;AP2M1;AP2S1;AP2A1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.26210427207483233,-0.9569044090350268,0.5703125,0.7743804342447305,1.0,10/40,11.25%,PTK2;NUB1;HIPK2;UFL1;GNA12;RPL23;RPS7;ARAF;UBQLN4;SGTA
prerank,actin filament depolymerization (GO:0030042),0.4858413842917678,0.9564008496791822,0.5043731778425656,1.0,1.0,5/11,23.17%,MICAL3;TWF1;DSTN;CFL2;MICAL2
prerank,alanine transport (GO:0032328),-0.3971456281676643,-0.9560901655839407,0.532033426183844,0.7753882063382905,1.0,1/10,0.34%,SLC6A6
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.4010508804492548,0.9560517438816842,0.6076076076076076,1.0,1.0,72/241,19.97%,RBM15;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRRM1;CPSF4;SNRNP35;HNRNPH2;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;RBM19;HNRNPA2B1;PPWD1;LSM4;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;GEMIN7;CWC25;CWC22;PDCD7;BUD13;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;SNRPB;TRA2A
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4646442840554466,0.9557312334149383,0.5187096774193548,1.0,1.0,2/17,2.10%,SPDYA;PSRC1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4010672667100509,0.9556800843363914,0.5809716599190283,1.0,1.0,63/152,24.86%,MACF1;DEPDC1B;FGFR2;PSMC2;RNF220;PSMD5;SULF2;TBL1XR1;ADGRA2;WNK1;SFRP2;SULF1;UBR5;LRRK2;PSMB1;PSMD14;SMARCA4;AXIN2;PSMD1;LRRK1;PSMB9;SMURF2;BMP2;RSPO3;CSNK1G2;TRPM4;USP47;XIAP;PSMC6;PIN1;NFKB1;SFRP1;SALL1;AMER1;FAM53B;PSMB2;CSNK1G1;PSME4;PSMB7;CAPRIN2;SKI;PPM1A;TERT;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;PSMD13;COL1A1;ZRANB1;GPRC5B;PSMB8;PSMD4;DISC1;PSMF1;GPC3;WLS;AXIN1;PSMA5;PSMC3;TGFB1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4516338052881215,0.955673772809006,0.4894459102902375,1.0,1.0,8/20,20.27%,RB1;DDRGK1;TRIM6;TWIST1;LAMTOR5;NIBAN2;GTF2B;TRAF6
prerank,base conversion or substitution editing (GO:0016553),-0.3755864014947637,-0.9556628235053715,0.5157232704402516,0.7754232119565266,1.0,3/11,20.04%,ADAR;ADARB1;ADARB2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.44740600258119645,0.9553726243696403,0.48333333333333334,1.0,1.0,9/20,23.18%,STOML2;MCU;MCUB;MICU1;PMPCA;MAIP1;SPG7;MICU2;LETM1
prerank,macrophage activation (GO:0042116),-0.2640040216447156,-0.9548404161782111,0.4876543209876543,0.7764827389111949,1.0,9/34,14.32%,TLR4;IFI35;CD93;LBP;APP;CRTC3;CX3CL1;IFNGR1;SBNO2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.42772869902283817,0.9543511013252104,0.5141509433962265,1.0,1.0,12/36,19.67%,FADD;UBE2K;CXCR4;AGPAT2;PARP9;ADAM17;TRIM6;AGPAT1;AXL;MAVS;RIPK1;PARP14
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3529327643416463,-0.9542774679855525,0.4982456140350877,0.7769634278231008,1.0,7/15,20.34%,LEF1;EP300;CCNT1;JUN;RRP1B;TAF11;SNW1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.28853705185544587,-0.9536299611886238,0.5319148936170213,0.7775720093082683,1.0,4/29,5.24%,STAT3;IFNAR1;STAT6;SOCS2
prerank,cAMP metabolic process (GO:0046058),-0.3498703166852095,-0.9535848468465176,0.5083056478405316,0.7767367538223576,1.0,7/13,29.91%,ADCY3;ADCY8;ADCY4;PDE4D;PTHLH;EPHA2;ADCY5
prerank,mammary gland development (GO:0030879),0.445910002886149,0.9533549540629087,0.49222797927461137,1.0,1.0,3/21,10.43%,GLI2;ZBTB7B;ARHGAP35
prerank,regulation of glycolytic process (GO:0006110),0.4124819803770968,0.9532504524441789,0.5427350427350427,1.0,1.0,17/68,17.40%,NDC1;NUP155;NUP205;NUP160;PFKFB1;GCK;NUP85;TPR;ZBTB20;NUP214;RANBP2;ARNT;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,regulation of plasminogen activation (GO:0010755),-0.36667879125418823,-0.9531228709705388,0.49843260188087773,0.7768721061094995,1.0,6/12,24.46%,CTSZ;THBS1;PLGRKT;ENO1;CLEC3B;SERPINE2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4038529241297162,0.952782410467164,0.5659978880675819,1.0,1.0,20/84,15.53%,TYMS;ILF3;SYNCRIP;CNOT1;RTN3;PRNP;EIF4ENIF1;SAMD4A;CAPRIN1;FMR1;LARP1;ROCK1;MRPL13;EIF2AK3;RBM4;DHFR;EPRS1;PIN1;CNOT7;FXR1
prerank,carboxylic acid transport (GO:0046942),-0.2456403507876447,-0.9526947929391485,0.5263157894736842,0.7769091651102712,1.0,16/55,24.51%,SLC6A6;SLC16A12;SLC13A3;SLC3A2;SLC7A5;PSAP;SLC7A6;SLC16A1;SLC16A4;SLC6A11;SLC1A1;SLC38A5;SLC6A15;SLC36A1;SLC6A7;SLC16A13
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.33196059207258977,-0.9526915762432385,0.5313807531380753,0.7759818865084034,1.0,4/17,8.57%,TMSB4X;MAP2K5;KLF4;PTPN22
prerank,Golgi localization (GO:0051645),0.4899053045978594,0.9526412263138485,0.5116618075801749,1.0,1.0,3/11,15.21%,ARHGAP21;TBCCD1;UVRAG
prerank,positive regulation of glycolytic process (GO:0045821),-0.3131283796158313,-0.9525661308502222,0.5175438596491229,0.7744146213291931,1.0,6/20,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3131283796158313,-0.9525661308502222,0.5175438596491229,0.7744146213291931,1.0,6/20,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,response to ketone (GO:1901654),-0.29985013640449976,-0.9519248803168502,0.5576036866359447,0.774911473401798,1.0,12/24,25.79%,CAV1;TGFB2;ABHD2;NR1H3;CATSPER2;SLIT2;THBS1;TGFB3;WBP2;SLIT3;UBE3A;CATSPER3
prerank,isotype switching (GO:0045190),0.4960930071712232,0.9518999198097783,0.5039123630672926,1.0,1.0,2/10,12.41%,RNF168;MSH6
prerank,response to iron ion (GO:0010039),0.47872413726978436,0.951831694822157,0.5369532428355958,1.0,1.0,5/12,23.20%,FXN;BMP6;ACO1;SNCA;SLC11A2
prerank,ventricular septum morphogenesis (GO:0060412),-0.2810010695431878,-0.9517428213173752,0.5714285714285714,0.774356185891488,1.0,11/27,17.42%,ACVR1;SMAD7;TGFBR2;BMPR2;TGFB2;PROX1;SLIT2;SOX4;HEYL;ROBO2;CITED2
prerank,regulation of interleukin-13 production (GO:0032656),-0.3570813181777618,-0.951640793453882,0.5263157894736842,0.7737090017026688,1.0,4/13,18.30%,LEF1;TNFRSF21;LGALS9;PRKCZ
prerank,cellular response to osmotic stress (GO:0071470),0.45570879332141456,0.9515962340817589,0.5083870967741936,1.0,1.0,8/21,18.16%,AQP1;YBX3;CAB39;PKD2;STK39;WNK3;TRPV4;OXSR1
prerank,purine nucleotide metabolic process (GO:0006163),0.4475523938923061,0.9514254070046233,0.5120405576679341,1.0,1.0,7/24,11.44%,HPRT1;XDH;GUK1;ITPA;PRPS1L1;PRPS1;ADSL
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3201176940813131,-0.9508932972920418,0.50187265917603,0.7745328183870576,1.0,10/18,31.11%,PSEN1;APOE;NCSTN;LDLRAP1;PSEN2;NSG1;BACE1;PSENEN;CLN3;ADAM10
prerank,cardiac ventricle development (GO:0003231),0.45403524736518536,0.9507601136883732,0.4973753280839895,1.0,1.0,6/20,16.74%,MDM4;MATR3;HEY2;TMEM65;HECTD1;SALL1
prerank,protein homotrimerization (GO:0070207),-0.3427489658519677,-0.9506210591042756,0.5137931034482759,0.7733375374214303,1.0,2/14,3.00%,SLC1A2;SCARA5
prerank,protein trimerization (GO:0070206),-0.3427489658519677,-0.9506210591042756,0.5137931034482759,0.7733375374214303,1.0,2/14,3.00%,SLC1A2;SCARA5
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.42625823924167733,0.9503475221767296,0.5309218203033839,1.0,1.0,7/35,10.43%,STMN1;ARHGAP24;MFN2;CUL3;RIPOR2;MAPKAP1;ARHGAP35
prerank,membrane fusion (GO:0061025),-0.26497688801513997,-0.950106283506723,0.5159235668789809,0.7735437239991084,1.0,10/33,16.57%,DNM3;RIMS1;NAPG;DNM1;RABIF;SNAP29;NSFL1C;VPS33B;GCA;VAMP3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4146285559285855,0.9500262635111064,0.5468577728776185,1.0,1.0,10/50,13.72%,GLI3;FGFR2;TXNDC15;WDR11;TUBD1;FBXL17;GAS1;TEDC1;RORA;BTRC
prerank,response to leucine (GO:0043201),0.4938921595263923,0.9500226656996934,0.5069984447900466,1.0,1.0,5/10,16.27%,KLHL22;SESN1;RPTOR;SESN2;LARS1
prerank,cellular response to leucine (GO:0071233),0.4938921595263923,0.9500226656996934,0.5069984447900466,1.0,1.0,5/10,16.27%,KLHL22;SESN1;RPTOR;SESN2;LARS1
prerank,regulation of blood coagulation (GO:0030193),-0.2882437067529396,-0.9498115694357315,0.5058139534883721,0.7733102655011314,1.0,6/27,6.10%,CAV1;APOE;VTN;EPHB2;THBD;CD34
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.4441752125605185,0.9497893683489178,0.5049382716049383,1.0,1.0,3/24,7.30%,DDIAS;CDKN2D;SFRP2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.3303381924462995,-0.9489304764512758,0.5136186770428015,0.7744737599635987,1.0,2/17,2.43%,ADIPOR2;CAV1
prerank,regulation of protein ubiquitination (GO:0031396),0.3978180308291036,0.9487117673839985,0.5616016427104723,1.0,1.0,16/108,11.40%,BRCA1;PAXIP1;FANCI;MYCBP2;ARRB1;FBXW7;UBE2N;LRRK2;CUL3;ANGPT1;TBC1D7;HDAC8;SVBP;TGFBR1;IVNS1ABP;BAG5
prerank,ncRNA 3'-end processing (GO:0043628),0.47647120614828753,0.9486326244867942,0.5190409026798307,1.0,1.0,3/14,10.73%,INTS7;ERI1;INTS8
prerank,negative regulation of angiogenesis (GO:0016525),0.4057101365906217,0.948520755843865,0.5570680628272251,1.0,1.0,12/84,10.10%,E2F2;ATP2B4;THBS2;ANGPT4;ROCK2;PDE3B;PML;SULF1;SERPINE1;ADAMTS9;ROCK1;PIK3CB
prerank,N-glycan processing (GO:0006491),-0.3216857774801034,-0.9483142630561018,0.5062761506276151,0.774997424837965,1.0,12/18,27.61%,ST8SIA4;MAN2A1;ST8SIA1;ST8SIA6;MAN1A2;MGAT4B;PRKCSH;GNPTAB;GANC;ST8SIA3;ST8SIA5;MAN2A2
prerank,mesonephros development (GO:0001823),-0.3672967602183488,-0.9475905090414938,0.5159235668789809,0.7757406663962235,1.0,4/11,24.27%,FGF1;BMP7;FGF10;PAX8
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4493758180936606,0.9473519850413156,0.49680715197956576,1.0,1.0,7/19,13.44%,BMPR1A;MDM4;EFNA1;SMAD6;BMP2;SMAD4;HEY2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.2798483511284659,-0.9470035293963905,0.5434782608695652,0.7762876737001824,1.0,14/32,32.74%,CALM1;AKAP6;CEMIP;PLCG1;TRPC1;CX3CL1;CALM3;GSTM2;JPH2;GPER1;THY1;P2RY6;GSTO1;APLNR
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.3801042598123955,-0.9468405329039478,0.5216049382716049,0.7757259307710966,1.0,7/10,38.13%,ACADM;ETFDH;ETFB;ACADS;ACADVL;GCDH;ETFA
prerank,organic anion transport (GO:0015711),0.4049837061094739,0.9465147928204326,0.5627615062761506,1.0,1.0,15/76,18.43%,RHAG;AQP1;SLCO4A1;SLC19A1;SLC16A2;SLC4A2;CYB5RL;SLC39A8;SLCO3A1;CA2;CYB5R1;SLC25A42;LRRC8C;SLC25A17;SLC25A19
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4470511454058397,0.9463927417076416,0.5193298969072165,1.0,1.0,4/22,11.13%,DDX11;SMARCA4;NOL11;EIF2AK3
prerank,glycogen catabolic process (GO:0005980),0.460298057660872,0.9463628455660141,0.5102599179206566,1.0,1.0,4/15,10.15%,AGL;PYGB;PHKA2;RB1CC1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4472165129884662,0.9463622031698369,0.523153942428035,1.0,1.0,4/22,7.77%,VPS37B;NEDD4;VPS37A;STAM
prerank,neuron differentiation (GO:0030182),0.4008019053623124,0.9463469700424779,0.5955734406438632,1.0,1.0,17/165,10.48%,EN1;PBX4;GLI2;ATOH8;PBX3;MYEF2;TDP2;SRF;WNT2B;ERCC3;WNK1;POU3F2;OLIG2;LMX1B;WNT6;NR4A2;TGFBR1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.26353286885068666,-0.9458915756075349,0.5379310344827586,0.7770297842811946,1.0,12/34,20.57%,RIMS1;SYT1;RAB5A;SYT7;DTNBP1;SYT11;SYT12;PREPL;SYT10;SYT6;RAB27A;SYT2
prerank,T cell proliferation (GO:0042098),0.4649650950486177,0.945858567380378,0.5135908440629471,1.0,1.0,3/13,16.27%,CTPS1;LMBR1L;MSN
prerank,protein deneddylation (GO:0000338),-0.3766727983923264,-0.9457708644025032,0.5317220543806647,0.7764105478125553,1.0,7/10,30.62%,COPS8;COPS7A;COPS2;COPS4;TOR1A;COPS6;GPS1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3638598705648945,-0.9457322579526349,0.5145631067961165,0.7755912045805712,1.0,3/11,20.05%,PRKN;PINK1;PARK7
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2861244712880685,-0.9456131764957476,0.5767195767195767,0.7749651327702871,1.0,8/28,18.33%,PRKN;APOE;PDK1;ARV1;FMO5;DGKQ;EPHX2;BCKDK
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.368569667439124,-0.9451506969769267,0.5173333333333333,0.775049302256043,1.0,2/11,4.31%,CAV1;BIN1
prerank,positive regulation of developmental process (GO:0051094),0.3994645510099455,0.9450873830048585,0.6022044088176353,1.0,1.0,29/164,12.71%,CDC20;BMP1;FBXO5;PAXIP1;BMPR1A;MIEF2;AURKA;AGO2;ADGRL1;NUMA1;SRF;SOX6;FMR1;ENPP2;RIF1;MCU;CORO1B;VHL;TAPT1;DDHD1;MIEF1;GRIP1;SMURF2;BMP2;ZDHHC15;GJA1;TRPM4;SOX9;KMT5C
prerank,regulation of lymphocyte migration (GO:2000401),0.4958064664558887,0.9447804236169614,0.5243328100470958,1.0,1.0,3/10,16.27%,STK10;MIA3;MSN
prerank,chromatin remodeling (GO:0006338),0.39662163743926804,0.9442711009206979,0.5642343268242549,1.0,1.0,37/100,23.34%,ATRX;SMARCC1;RB1;BAZ1B;CHD1L;SMARCAD1;NUDT5;RBBP4;ARID1A;SRCAP;SMARCA4;HDAC1;SOX9;HDAC2;TADA2A;ACTL6B;KDM5C;RUVBL2;BAZ1A;INO80;DR1;SUV39H2;MBD3;ZBTB1;KDM4B;MBD2;ARID1B;NPM3;HDAC4;CHD4;CBX3;DAXX;MYSM1;KAT2A;ACTL6A;SMARCC2;CECR2
prerank,regulation of synapse organization (GO:0050807),0.432263545655081,0.9441846819850772,0.5181598062953995,1.0,1.0,3/26,7.60%,ARHGAP22;NEDD4;EPHA4
prerank,cellular metal ion homeostasis (GO:0006875),-0.20785953245654165,-0.9440470358162836,0.6875,0.7768057112190561,1.0,22/102,16.64%,SLC8A3;ATP1B1;CAV1;RYR2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;ATP1A1;ATP1B3;CHRNA7;ATP1A3;TMCO1;ATP1A2;SLC30A1;ATP2B2;ATP2B3;SLC12A2;HTR2A;PTH1R;RMDN3
prerank,regulation of cell growth (GO:0001558),0.39398879331443604,0.9438891396817468,0.6178535606820461,1.0,1.0,39/204,16.06%,KIF14;RAB33B;PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;CEP43;FXN;MMP14;NET1;RBBP7;PML;DERL2;SFRP2;SMARCA4;KLHL22;CDA;AGT;TGFBR1;CRLF3;IP6K2;CCN3;NDRG3;ENPP1;GJA1;ADAM17;SMAD4;ITCH;JADE1;USP47;CDKN1B;SMAD3;STK11;RPTOR;INO80;TP53;SESN2;SFRP1
prerank,embryonic skeletal system development (GO:0048706),0.4222679494583911,0.9430797730444318,0.5233100233100233,1.0,1.0,11/35,19.64%,SULF2;HOXC4;PDGFRA;SULF1;DSCAML1;HOXB3;WNT9A;OSR1;HOXA3;XYLT1;DYNC2I1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.30756937700842035,-0.9424668328394828,0.5465116279069767,0.7795491946605648,1.0,6/18,12.77%,SNX3;DAB2;VPS11;MAPK3;MAPK1;MAP2K1
prerank,regulation of cholesterol transport (GO:0032374),-0.30931756170150365,-0.9424247799992985,0.5172413793103449,0.7787269987643364,1.0,8/20,23.08%,OSBPL6;LRP1;ABCA5;NR1H3;ARV1;NR1H2;NUS1;ABCA2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4198406932000026,0.9424054383405597,0.5437003405221339,1.0,1.0,9/40,11.40%,FBXO5;ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;WNT6;ATP2B1;BMP2
prerank,regulation of osteoblast differentiation (GO:0045667),0.40206235761383013,0.9423615660684543,0.5583596214511041,1.0,1.0,21/82,13.64%,FBXO5;BMPR1A;TWIST2;FGFR2;BMP6;NPNT;CRIM1;CCN1;WWTR1;SMAD6;TMEM64;LIMD1;YAP1;DDR2;BMP2;ZHX3;TRPM4;SOX9;LRP5;TWIST1;PRKD1
prerank,histone deubiquitination (GO:0016578),0.46510536792352997,0.9421037634323443,0.5208613728129206,1.0,1.0,6/18,16.10%,UIMC1;USP21;USP16;BRCC3;TRRAP;TAF10
prerank,endoplasmic reticulum organization (GO:0007029),0.3999654680722947,0.9416982331265308,0.564021164021164,1.0,1.0,21/72,19.47%,RAB10;RTN3;LNPK;PRNP;ATL2;ATL3;LRRK2;TRAM2;EMD;EIF2AK3;STX18;GAK;MIA3;TOR1B;VAPA;TMCC1;CYB5A;REEP2;TRAM1;CCDC47;DNM1L
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.48141151921991737,0.9415522924705184,0.5342066957787481,1.0,1.0,1/11,1.68%,TERF1
prerank,membrane lipid catabolic process (GO:0046466),0.48782653035178813,0.9413539607356526,0.5273865414710485,1.0,1.0,5/10,21.94%,ENPP2;SMPD2;NAGA;PDXDC1;SMPDL3B
prerank,regulation of hippo signaling (GO:0035330),0.4531389584818994,0.9411573447832382,0.5258855585831063,1.0,1.0,6/17,18.34%,CIT;AJUBA;LIMD1;NF2;SHANK2;MAPK14
prerank,cellular response to sterol (GO:0036315),0.48056567278101425,0.9408949269765907,0.5155367231638418,1.0,1.0,5/13,20.89%,GRAMD1C;RORA;INSIG2;GRAMD1B;INSIG1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.34889042252437674,-0.9408487171461812,0.5150602409638554,0.7813905270935347,1.0,4/13,9.48%,NR3C2;AR;ESR1;ABHD2
prerank,protein acylation (GO:0043543),-0.2531903899159043,-0.940839562988857,0.5752212389380531,0.7804988238467255,1.0,11/38,15.69%,FOXO1;EP300;GLUL;ZDHHC5;ZDHHC1;ZDHHC13;KAT2B;ING5;ZDHHC7;NAA80;ZDHHC8
prerank,positive regulation of blood coagulation (GO:0030194),0.4607613712156604,0.9403071179647311,0.5433287482806052,1.0,1.0,4/17,14.13%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,neuron projection development (GO:0031175),0.3969648016637561,0.9399266700045895,0.60262891809909,1.0,1.0,39/168,17.33%,KIF20B;VASH2;STMN1;MAP4K4;ADGRV1;RB1;GSK3B;LAMB1;NEDD4;MAPT;NRK;EPHA4;ANKRD27;LRRK2;DNM2;ROCK1;MAP4;HMGB1;MARK2;SVBP;SRGAP2;SAMD14;EPB41L3;PLXNB1;FRYL;MAPK8IP3;EHD1;BLOC1S5;DOCK7;TAOK1;VAPA;HDGFL3;GDNF;DBN1;PTEN;NCKAP1;STMN2;NGF;RAB13
prerank,negative regulation of cell communication (GO:0010648),-0.2993701241311587,-0.9396544907157882,0.54,0.7824562030742023,1.0,5/21,13.51%,ACVR1;GLRA1;SOCS5;OPRM1;HHIP
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4294241890040758,0.9396159099931637,0.5206310679611651,1.0,1.0,11/27,19.31%,AGO2;AJUBA;DHX9;EIF4ENIF1;FMR1;LIMD1;PUM2;FXR1;TP53;RIPK1;TNRC6B
prerank,mitochondrion transport along microtubule (GO:0047497),0.4770207017525091,0.9393892204034082,0.5295774647887324,1.0,1.0,3/13,9.60%,MAPT;RHOT1;UXT
prerank,regulation of muscle cell differentiation (GO:0051147),0.4329633378588055,0.9390667946581361,0.5379975874547648,1.0,1.0,5/31,6.13%,CDH15;FGFR2;SPAG9;SRF;CTNNA1
prerank,regulation of leukocyte migration (GO:0002685),0.46034324708364904,0.9387397533159606,0.5154362416107383,1.0,1.0,4/16,14.42%,HOXA7;ANXA1;RAC1;MIA3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.31475956366093044,-0.9387010119942312,0.5328185328185329,0.7836487473900203,1.0,8/17,24.57%,APOE;PRKAA1;FGF1;SREBF2;ERLIN2;ABCA2;RAN;MBTPS1
prerank,regulation of GTPase activity (GO:0043087),0.39210707760084096,0.9383566284287173,0.6088264794383149,1.0,1.0,26/177,11.05%,ECT2;EZH2;ARHGAP11A;USP6NL;MAP4K4;GSK3B;RTN4R;EVI5L;OCRL;NET1;AFDN;FGD4;WNK1;VAV2;EPHA4;FGD1;LRRK2;RSU1;CPEB2;TBC1D7;PICALM;SRGAP2;PLXNB2;FGD6;LIMS1;PLXNB1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3919048512122636,0.937855605421454,0.6068895643363729,1.0,1.0,42/121,23.26%,XPO1;MOV10;PSMC2;ZC3HAV1;PSMD5;HNRNPD;CNOT1;TNPO1;SERBP1;SAMD4A;FMR1;RC3H2;PSMB1;PSMD14;PUM2;PSMD1;YTHDF2;PSMB9;EXOSC7;NUP214;PRKCA;RC3H1;PABPC1;PSMC6;ZC3H14;CNOT7;FXR1;PNPT1;PSMB2;PSME4;PSMB7;PRKCD;PSMD11;PSME3;MAPKAPK2;DIS3;PSMD13;ZFP36L1;PSMB8;PSMD4;YTHDF1;HSPA8
prerank,positive regulation of vasoconstriction (GO:0045907),-0.35256263374996255,-0.9378238101581838,0.5290102389078498,0.7847024275726184,1.0,4/13,24.73%,CAV1;ADRA1A;TBXA2R;ADRA1B
prerank,proteasomal protein catabolic process (GO:0010498),0.3894137665062953,0.9378095957567361,0.621,1.0,1.0,65/201,23.19%,KIF14;FEM1C;PSMC2;PSMD5;UBE2K;NEDD4;SPSB3;SIAH2;SPSB2;TBL1XR1;FAF1;ARRB1;PML;FBXW7;PRPF19;AGAP3;PSMB1;SMURF1;CUL3;PSMD14;KCTD2;KLHL22;CUL4B;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;SMURF2;FBXW11;ITCH;CRBN;BTRC;SPOP;PSMC6;ZNRF1;RAD23B;SIAH3;UBXN2B;WWP1;PSMB2;PLAA;HECTD3;PSME4;PSMB7;CCDC47;UBE2D3;PSMD11;ZSWIM8;HECW2;PSME3;FEM1B;CLOCK;PSMD13;PCNP;GID4;SIRT2;BIRC2;RNF216;PSMB8;PSMD4;DDB1;PCBP2
prerank,"transcription, DNA-templated (GO:0006351)",0.3894294347633557,0.9376363498288932,0.629889669007021,1.0,1.0,34/207,12.61%,TRIP13;TCFL5;E2F1;TTF2;NAT14;PMF1;CBFB;SETX;DEK;TFDP1;TAF3;MBD1;KLF13;ERCC3;ELOC;GLIS3;TAF12;POLR2A;ZBTB7B;FOXO3;GTF3C4;LEO1;NFYA;EPC1;NR4A2;MMS19;IVNS1ABP;DRG1;TAF15;GTF2A1;TTF1;TAF4;RNGTT;SSRP1
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.27248569819524104,-0.9375969370469199,0.5595238095238095,0.7843173696175572,1.0,13/33,25.58%,GLUL;GLS;GOT2;PRODH;KYAT1;GOT1;ALDH5A1;DDAH2;GLUD1;NIT2;RIMKLA;OAT;GLS2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.2661687770883807,-0.937595911593251,0.5793103448275863,0.7834175952436877,1.0,7/33,12.52%,PTPRG;KRIT1;APOE;ACVRL1;SYNJ2BP;SLIT2;THBS1
prerank,regulation of sensory perception of pain (GO:0051930),0.49287660401382805,0.9374760117008453,0.540381791483113,1.0,1.0,2/11,11.21%,ATPSCKMT;CCN3
prerank,negative regulation of synaptic transmission (GO:0050805),0.4406152451775595,0.937368486361587,0.51,1.0,1.0,9/23,19.95%,GRIK3;LRRK2;MTMR2;ACHE;PLK2;PTEN;SHANK2;STXBP1;ARF1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.44851724417021877,0.9369759834590821,0.5279583875162549,1.0,1.0,5/19,10.54%,CBFB;ROCK2;MYO1C;ROCK1;NPHP1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.40711195839195,0.936163172237857,0.5396825396825397,1.0,1.0,13/42,16.27%,CARS2;SARS2;VARS1;DARS2;DARS1;IARS2;PPA1;TARS2;PARS2;RARS2;EPRS1;QARS1;LARS1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3950502998194035,0.9361558746444444,0.5905834186284544,1.0,1.0,33/108,19.61%,CBFB;MACF1;CDK14;DEPDC1B;WWOX;FGFR2;TRABD2B;NLK;SULF2;TCF7L1;RNF43;HMGXB4;SFRP2;SULF1;LRRK2;GNAQ;SMARCA4;EMD;BMP2;RSPO3;BTRC;FOXL1;NKD1;NOTUM;SFRP1;TMEM237;SALL1;AMER1;FAM53B;RUNX1;FRZB;SKI;TERT
prerank,regulation of cell development (GO:0060284),0.4156958042738704,0.9359582623099123,0.5416178194607268,1.0,1.0,8/36,14.60%,HMGB2;BHLHE41;ADGRA2;YAP1;YTHDF2;NOTCH2;HEY2;DOCK7
prerank,regulation of cellular component size (GO:0032535),0.43101363676987847,0.9355038974426044,0.5364963503649635,1.0,1.0,11/30,17.75%,HP1BP3;VAV2;RAB22A;PICALM;EZR;RAC1;RPTOR;PTEN;LARS1;MSN;LAMTOR5
prerank,blood circulation (GO:0008015),0.4049192164089037,0.9351623887835436,0.5582959641255605,1.0,1.0,8/49,9.90%,F5;ROCK2;MYOF;SCPEP1;ROCK1;ELN;BDKRB2;MEOX2
prerank,response to axon injury (GO:0048678),-0.32074691346409406,-0.9351577601966626,0.5278810408921933,0.7883521011639119,1.0,11/18,32.77%,APOD;GAP43;RTN4RL1;NREP;P2RX4;MTR;FLRT3;MORN4;P2RY12;SARM1;TYROBP
prerank,cellular response to drug (GO:0035690),-0.2894200466067268,-0.9350283548195235,0.5824742268041238,0.7877167776589877,1.0,7/25,20.46%,MEF2C;GAS6;ACER2;GPLD1;PPM1F;KCNQ1;CERS1
prerank,protein import (GO:0017038),0.3955978040206337,0.9348989803781698,0.5632183908045977,1.0,1.0,28/84,22.02%,RANBP17;NUP155;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;SNX33;IPO7;APPL2;NUP214;IPO11;NXT1;NUP133;IPO5;NXT2;SLC25A17;FAM53B;IPO9;NUP188;PEX12;IPO4;HSPA4;RAB8B;PEX13;APPL1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.43084294711097976,0.9345210599315434,0.5288461538461539,1.0,1.0,10/32,20.02%,ACTR3;AUTS2;ENPP2;CORO1B;RAC1;WASF2;SRC;NCKAP1;ABI2;RREB1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.39189032137834484,0.9342316401545,0.664,1.0,1.0,77/264,19.97%,RBM15;COIL;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRPK1;SRRM1;CPSF4;SNRNP35;HNRNPH2;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;RBM19;HNRNPA2B1;PPWD1;LSM4;DDX1;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;GEMIN7;CWC25;SRPK2;CWC22;PDCD7;BUD13;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;TGS1;SNRPB;TRA2A
prerank,regulation of cellular response to heat (GO:1900034),0.3973105366870113,0.9336523468792346,0.5814931650893796,1.0,1.0,19/77,17.40%,NDC1;NUP155;NUP205;NUP160;GSK3B;RPA1;MAPT;NUP85;RPA2;TPR;BAG5;NUP214;RANBP2;NUP133;RPTOR;NUP42;NUP98;ATR;NUP210
prerank,response to cholesterol (GO:0070723),0.4653180498454491,0.933118060087904,0.5413223140495868,1.0,1.0,3/17,10.48%,GRAMD1C;PMVK;TGFBR1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.3653670323805261,-0.9329202726674979,0.5497076023391813,0.7913719881392652,1.0,3/11,12.80%,NOVA2;PCBP1;IGF2BP2
prerank,extracellular matrix disassembly (GO:0022617),0.40716529468812446,0.9327078774265427,0.5443592552026287,1.0,1.0,10/53,17.52%,BMP1;SCUBE1;MMP14;ADAMTS5;TLL2;EXOC8;CD44;CAPG;LCP1;SH3PXD2B
prerank,positive regulation of GTPase activity (GO:0043547),0.3912231325097023,0.9317459556803648,0.6248746238716149,1.0,1.0,24/188,11.05%,ECT2;EZH2;ARHGAP22;ARHGAP11A;USP6NL;MAP4K4;GSK3B;RTN4R;EVI5L;TBC1D25;NET1;TBC1D13;AFDN;TBC1D2B;SCRIB;ARHGAP24;SYDE2;RSU1;TBC1D7;PICALM;RANGAP1;SRGAP2;LIMS1;PLXNB1
prerank,activation of protein kinase B activity (GO:0032148),-0.27452064024534323,-0.9317206744310714,0.5894736842105263,0.7931127738917384,1.0,10/29,17.16%,INSR;IGF1;GAS6;RICTOR;NTRK3;MTOR;FGF1;PINK1;ITGB1BP1;ADRA2A
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3736609094808918,-0.9316725003958231,0.5463258785942492,0.7923450330930865,1.0,8/11,50.12%,P2RX4;CDH13;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3298377728008128,-0.9315479235466755,0.5360824742268041,0.7917393155804471,1.0,10/15,36.35%,PRKN;IGF1;GHITM;GPX1;BCL2L1;PRELID1;HGF;PPIF;AKT1;PSMD10
prerank,protein destabilization (GO:0031648),0.42051255959089595,0.9314901540009154,0.5462184873949579,1.0,1.0,6/32,13.72%,PLK1;PRNP;CUL3;FBXW11;CTSH;BTRC
prerank,regulation of tube diameter (GO:0035296),0.4533868736421373,0.9310406342819736,0.5279411764705882,1.0,1.0,6/13,19.16%,ROCK2;SCPEP1;ROCK1;ADCY6;GCLM;GCLC
prerank,vascular process in circulatory system (GO:0003018),0.4533868736421373,0.9310406342819736,0.5279411764705882,1.0,1.0,6/13,19.16%,ROCK2;SCPEP1;ROCK1;ADCY6;GCLM;GCLC
prerank,neurotransmitter biosynthetic process (GO:0042136),0.4668421687962408,0.930799710541069,0.5412445730824892,1.0,1.0,6/14,26.19%,CHAT;ACHE;DAGLB;DAGLA;SLC6A4;ALDH9A1
prerank,phospholipid metabolic process (GO:0006644),-0.2236824395300182,-0.9307982816177496,0.6271186440677966,0.7926069301553865,1.0,21/71,24.76%,PLA2G4A;PLPPR1;PIP4K2A;PLAAT3;ABHD12;PIP4K2B;PLPP3;AGPAT5;GPX4;PCYT2;PIP5K1A;TNFAIP8L3;PIP4P1;PLBD2;ACP6;PLPPR4;AGPAT4;ABCA2;PLA2G15;PGP;FADS1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4258745211303567,0.9307717783414718,0.5291970802919708,1.0,1.0,6/28,11.13%,MMP14;DLK1;ARRB1;FBXW7;YTHDF2;ARRDC1
prerank,regulation of protein localization (GO:0032880),0.40165215259156367,0.9303368938458646,0.5725190839694656,1.0,1.0,12/58,14.23%,BORA;TRIML2;DZIP1L;AFDN;TPR;FBXW7;WDPCP;PICALM;AAK1;TRIM6;DLG1;TRIM5
prerank,epidermal cell differentiation (GO:0009913),0.41323386636320475,0.9301130316668227,0.5575418994413408,1.0,1.0,8/41,13.77%,TGM1;ERCC3;HDAC1;ANXA1;HDAC2;CLIC4;MED1;ADAM9
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.355693157749005,-0.9300600463450481,0.525974025974026,0.793433560396085,1.0,9/12,42.27%,SERINC3;MTHFD1;PSAT1;CBS;SEPHS2;CTH;PSPH;GGT1;PHGDH
prerank,regulation of cholesterol efflux (GO:0010874),0.4231883963225389,0.9297983894383676,0.5256869772998806,1.0,1.0,1/30,0.82%,PON1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.47544083527597963,0.929569123169893,0.5361271676300579,1.0,1.0,2/11,4.84%,GCK;ERFE
prerank,positive regulation of cell development (GO:0010720),-0.2714134151406393,-0.9295685728399323,0.5548780487804879,0.7935532269911098,1.0,13/31,26.99%,PDE3A;NUMBL;NUMB;TGM2;OPRM1;FAIM;SNW1;SERPINF1;ATP6AP1;TRIM32;GPER1;NKX6-1;SOX11
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.44809496608649774,0.9295073772268126,0.5254691689008043,1.0,1.0,5/18,15.19%,GSK3B;POLR1A;CTNNA1;ILRUN;OTUD7B
prerank,protein deacylation (GO:0035601),-0.28641627913195256,-0.9292182933785205,0.5848214285714286,0.793425542462055,1.0,10/23,27.00%,LYPLA1;ABHD17C;HDAC5;HDAC3;SIRT5;HDAC7;PPT1;LYPLAL1;LYPLA2;ABHD17B
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.2785765788817823,-0.9291467338308389,0.6104651162790697,0.7926821303016128,1.0,11/28,21.40%,GRB14;PIP4K2A;GRB10;PIP4K2B;PRKCQ;INPP5K;IRS1;GSK3A;PRKCZ;PIP4K2C;SLC27A4
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3934583726017109,-0.9285697797232296,0.5608974358974359,0.7931904566006001,1.0,3/10,9.30%,RAP1A;CD34;TMEM100
prerank,polyol metabolic process (GO:0019751),-0.23619219532179203,-0.9279365922465099,0.5865384615384616,0.7936840543100082,1.0,16/46,20.67%,INPP4B;CALM1;IPPK;PPIP5K2;PLCB3;PLCG1;NUDT3;INPP1;ITPKB;INPP5D;SYNJ1;PLCE1;IMPA1;INPP4A;ITPKC;PLCH1
prerank,tRNA processing (GO:0008033),-0.23847953401888577,-0.9276167249018192,0.6388888888888888,0.7934870820180432,1.0,28/61,29.54%,TRMT9B;ANKRD16;DTWD2;CSTF2;AARS1;NSUN2;RTRAF;SARS1;CDKAL1;QTRT2;TRMT10B;TRMT1;TRUB1;TSEN15;METTL1;KARS1;PUS3;THUMPD1;QTRT1;TRMT10A;LCMT2;RTCB;DTWD1;WDR4;POP5;ELAC2;CLP1;PTCD1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4607693774670176,0.9275036825405845,0.5365497076023392,1.0,1.0,2/12,4.75%,COLEC12;DHX9
prerank,T cell mediated immunity (GO:0002456),-0.35314862853182966,-0.9271310409286713,0.5460992907801419,0.7936174796034209,1.0,2/13,12.98%,JAG1;GNL1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4648969616708467,0.9269468986323001,0.5423976608187134,1.0,1.0,4/13,18.34%,BMF;RHOT1;VDAC2;BAD
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.31676869489959586,-0.9268775932646914,0.55859375,0.7932722453672711,1.0,8/18,21.77%,PTPRZ1;TNFRSF21;NF1;TNFRSF1B;TENM4;DAAM2;IL34;SLC45A3
prerank,Rac protein signal transduction (GO:0016601),-0.3183619744988375,-0.9268275485682214,0.5436507936507936,0.7924761561418144,1.0,3/18,3.68%,ELMO1;TIAM1;HACD3
prerank,anterior/posterior pattern specification (GO:0009952),0.4060027071244085,0.9267244806757762,0.5848849945235487,1.0,1.0,15/53,20.51%,HOXC5;BHLHE41;HOXC4;HOXA7;HOXB3;HOXB6;TGFBR1;BMP2;LRP5;HEY2;HOXB7;SMAD2;HOXA3;SKI;HOXA6
prerank,regulation of developmental growth (GO:0048638),-0.28718084264687466,-0.9265997540013275,0.5576923076923077,0.7920944362868375,1.0,8/29,11.42%,MBD5;APOE;INSR;IGF1;NRCAM;ABL1;APP;SIX1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3367544606089391,-0.9265353308578882,0.5583941605839416,0.7913303626509447,1.0,6/16,11.73%,CAMK2D;IGF1;AKAP6;TRPC3;PARP1;MEF2A
prerank,muscle tissue development (GO:0060537),-0.35693824915129246,-0.9261458158350292,0.5379310344827586,0.7913643581822016,1.0,5/13,15.54%,PGM5;NF1;PTCH1;ENG;STRA6
prerank,positive regulation of mitochondrion organization (GO:0010822),0.39764183293430244,0.9260984488151358,0.5875402792696026,1.0,1.0,15/57,19.47%,MIEF2;AURKA;GSK3B;BMF;FAM162A;HTRA2;MCU;DDHD1;MIEF1;BOK;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,regulation of gene expression (GO:0010468),0.3873654474374825,0.9259551227082183,0.785,1.0,1.0,165/903,15.56%,BRCA1;PHF19;EZH2;TCF19;ATRX;MYBL1;NSD2;ERMAP;TCFL5;RBL1;E2F1;BRCA2;ATOH8;ZC3H7A;MED26;ATP2B4;TRIML2;RB1;SP3;BMPR1A;AURKA;MOV10;TICAM1;ROCK2;FGFR4;AGO2;CTCF;GSK3B;LIN54;HNRNPD;TRA2B;NLK;DDRGK1;AJUBA;CHEK2;SETDB2;NFIA;UBAP2;NFIL3;TCF7L1;SRSF10;MAPT;CCAR1;AFF3;XDH;MBNL3;BMP6;MUSK;AFDN;GZF1;YAF2;SOX6;HP1BP3;GON4L;PML;FBXW7;PSPC1;MYBL2;HNRNPH1;SFRP2;YBX3;CIAO3;POLR2A;FUS;MATR3;ZBTB7B;MYCBP;WWTR1;PHF1;CDK2;PRRX2;UBR5;LARP1;LMX1B;BNC2;ZFP64;MSL3;ROBO1;LIMD1;DNM2;YAP1;NONO;NFYA;ANGPT1;VHL;PUM2;SLC24A3;ROCK1;SLC8A1;WNT6;PICALM;ZNHIT3;ERC1;PIK3CB;NR3C1;HINT1;PARP9;SFPQ;TGFBR1;YTHDF2;FLOT2;SLC39A8;LIMS1;POFUT1;HNRNPL;EIF2AK3;NCOA2;CRKL;CPSF4;CNTF;HDAC1;BMP2;AHR;EZR;NKX2-1;TERF2;STOX1;ATXN1;ZUP1;SPTY2D1;RBMS3;HNRNPH2;FUBP1;RBPJ;GJA1;METTL4;KMT2D;TRIM6;SOX9;TOB2;NOTCH2;ATF5;CASP8;C1QTNF1;CTSH;RORA;TWIST1;PTBP2;HEY2;LARP4;MED1;GPBP1L1;YY1;RC3H1;ADAM19;FOXK2;TRIM5;SMAD3;RAMP3;JMJD1C;SOX1;PER1;RBAK;PIN1;PRDM8;EFEMP1;CNOT7;PRKAG1;ZC3H7B;GDNF;TRRAP;MLF2;TNRC6C;ZNF507;HOXB7
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3960570378916629,0.9258873945891872,0.5580168776371308,1.0,1.0,21/63,21.26%,FADD;PHIP;WWOX;BCL2L12;SIAH2;TCF7L2;PML;SH3RF1;TNFRSF10B;AGT;TGFBR1;CASP8;BIRC6;ITGAV;SRC;TNFSF10;RIPK1;SP100;PSME3;TRAF2;FEM1B
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4524787182153247,0.9258724729145329,0.5295735900962861,1.0,1.0,4/16,10.50%,FTO;ZBTB7B;PIM1;HNRNPU
prerank,negative regulation of locomotion (GO:0040013),-0.35792308419953145,-0.9257433007061194,0.5391849529780565,0.7913310291596005,1.0,4/12,14.35%,FRMD5;DUSP3;SPOCK3;CCDC125
prerank,cellular response to virus (GO:0098586),0.4163470331511411,0.9257139075710871,0.5504252733900364,1.0,1.0,4/30,8.98%,VWCE;GBF1;FMR1;RIOK3
prerank,type I interferon signaling pathway (GO:0060337),-0.25216868158486483,-0.9253178136080361,0.6097560975609756,0.7904134276057899,1.0,17/41,29.27%,IFNAR1;IFI35;IFITM3;IRF2;IRF3;IRF9;ADAR;IFIT1;BST2;IFI27;IFITM2;EGR1;RNASEL;STAT2;JAK1;SAMHD1;RSAD2
prerank,cellular response to type I interferon (GO:0071357),-0.25216868158486483,-0.9253178136080361,0.6097560975609756,0.7904134276057899,1.0,17/41,29.27%,IFNAR1;IFI35;IFITM3;IRF2;IRF3;IRF9;ADAR;IFIT1;BST2;IFI27;IFITM2;EGR1;RNASEL;STAT2;JAK1;SAMHD1;RSAD2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.46249189942787816,0.9249826988073001,0.5319767441860465,1.0,1.0,4/13,18.55%,TICAM1;IL18;AXL;ZBTB1
prerank,generation of neurons (GO:0048699),0.38791676111501383,0.9245831195358198,0.6549295774647887,1.0,1.0,22/190,10.71%,EN1;RACGAP1;CIT;HMGB2;ATOH8;ARTN;MYEF2;AUTS2;BHLHE41;WNT2B;MAPT;POU3F2;OLIG2;LMX1B;SH3RF1;YAP1;WNT6;MARK2;SDCCAG8;NR4A2;YTHDF2;PLXNB2
prerank,dicarboxylic acid transport (GO:0006835),-0.2685388875908092,-0.9244574107249259,0.6055555555555555,0.7914440444924636,1.0,6/28,10.33%,SLC1A2;SLC13A3;SLC25A13;SLC25A12;SLC22A6;GIPC1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.44773825020352637,0.9242735046286856,0.532,1.0,1.0,1/19,1.41%,SLC25A21
prerank,carboxylic acid metabolic process (GO:0019752),0.41328407441325304,0.924193556406676,0.5453474676089517,1.0,1.0,2/33,3.54%,PON1;GSTO2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3450555208486801,-0.9240880096861604,0.570446735395189,0.7913629570872126,1.0,8/13,27.23%,NAMPT;PTGS2;PARP16;PARP10;NAXD;NNMT;NUDT12;NAXE
prerank,vasodilation (GO:0042311),-0.3458993681113617,-0.9239381904723369,0.5533333333333333,0.7908158654345308,1.0,5/13,26.13%,NOS3;SOD2;KLF2;NOS1;GPER1
prerank,glucose transmembrane transport (GO:1904659),-0.3221281833894338,-0.923929906625279,0.5301204819277109,0.7899531948656077,1.0,6/18,32.84%,SLC2A1;SLC2A3;SLC2A10;SLC2A9;SLC5A3;SLC45A1
prerank,cellular response to copper ion (GO:0071280),0.4566291238001412,0.923597047289535,0.5285118219749653,1.0,1.0,2/16,5.24%,AQP1;PRNP
prerank,regulation of exocytosis (GO:0017157),-0.24490240725838988,-0.923509864097457,0.6304347826086957,0.7899998645883952,1.0,8/46,7.80%,STXBP5L;CADPS;SYT1;STX4;STXBP6;RAB27B;IL1RAPL1;RAB5A
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4618096409478148,0.923432164741065,0.5138282387190685,1.0,1.0,3/13,8.29%,TXN;PYCR1;LRRK2
prerank,protein alkylation (GO:0008213),-0.2894458856639561,-0.9231574065602617,0.5320197044334976,0.7899131364163617,1.0,8/22,26.40%,PRMT3;FAM98A;PRMT2;METTL21A;PRMT8;PRMT1;METTL22;GSPT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4570351322784938,0.9229701827719133,0.5310810810810811,1.0,1.0,6/15,19.31%,AGO2;CNOT1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4570351322784938,0.9229701827719133,0.5310810810810811,1.0,1.0,6/15,19.31%,AGO2;CNOT1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,regulation of sodium ion transport (GO:0002028),0.42162903666276874,0.9219255628301798,0.5685814771395076,1.0,1.0,10/34,17.53%,ATP2B4;RANGRF;NEDD4;WNK1;SNTA1;DLG1;NKAIN1;PER1;CNKSR3;WNK3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3536589303551746,-0.9216052524765301,0.5201238390092879,0.7924381427623105,1.0,3/12,5.39%,MAP2K5;TLR4;KLF4
prerank,negative regulation of cell projection organization (GO:0031345),0.39688751457199917,0.9216017958909278,0.5575418994413408,1.0,1.0,17/48,18.57%,RTN4R;LPAR1;PRNP;EPHA4;RAB29;DENND5A;PTPRS;BAG5;GAK;HDAC2;DPYSL3;EFNB2;ADCY6;PTEN;STMN2;TRPV4;MYLIP
prerank,protein-containing complex disassembly (GO:0032984),-0.22438511441374462,-0.9212096584940496,0.651685393258427,0.7924362873436963,1.0,14/54,16.16%,CAV1;TECPR1;SNX14;RPL23;TSG101;FZD2;SNAP29;CTNNB1;VPS33B;APC;DVL1;LAMP2;VAMP8;LRP6
prerank,Golgi to endosome transport (GO:0006895),0.4423470460067527,0.9210111397917676,0.538563829787234,1.0,1.0,3/16,8.09%,AP4M1;GBF1;VPS13A
prerank,stem cell differentiation (GO:0048863),0.4116155617144024,0.9207983826513291,0.5615650172612198,1.0,1.0,13/39,20.57%,SETD6;FGFR2;KIT;SETD2;FBXL17;METTL5;LMBR1L;TP53;SFRP1;MLLT3;OSR1;PSMD11;EEF1AKMT4-ECE2
prerank,cellular response to dsRNA (GO:0071359),0.4508932857264819,0.9206622154374007,0.5380359612724758,1.0,1.0,3/15,8.98%,COLEC12;DHX9;RIOK3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4650620208103156,0.9206517410048564,0.5381165919282511,1.0,1.0,5/11,20.86%,RSPO3;NKD1;SFRP1;MLLT3;CSNK1E
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.39011339124328115,0.9204842730451176,0.6024973985431842,1.0,1.0,22/88,18.63%,TYMS;ILF3;SYNCRIP;CNOT1;DNAJC1;EIF4ENIF1;SAMD4A;CAPRIN1;FMR1;LARP1;MRPL13;EIF2AK3;RBM4;DHFR;EPRS1;CNOT7;FXR1;NFKB1;PAIP2B;RIC1;PLAT;PUS7
prerank,lipoprotein localization (GO:0044872),0.47108827714078183,0.9204406031947668,0.530791788856305,1.0,1.0,5/11,19.44%,PRKCB;MIA3;UNC119;ZDHHC3;UNC119B
prerank,regulation of T cell mediated immunity (GO:0002709),0.4729390248229387,0.9200160334787085,0.5294117647058824,1.0,1.0,3/10,18.55%,HMGB1;TRPM4;ZBTB1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.35803922956326023,-0.9196676260150676,0.5774193548387097,0.7949168014973874,1.0,6/13,27.98%,TGFB2;SEMA7A;TGFB3;CD74;LAPTM5;IRAK3
prerank,microtubule anchoring (GO:0034453),0.4640610453672048,0.9195889437906968,0.5351906158357771,1.0,1.0,2/12,6.64%,PCM1;BICD2
prerank,angiogenesis involved in wound healing (GO:0060055),0.4725167762829561,0.9192618849122779,0.5577507598784195,1.0,1.0,2/11,5.10%,HPSE;SRF
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.31812445837846554,-0.9192479747923668,0.55859375,0.794982334786459,1.0,7/18,28.89%,CHRM2;AGRN;OPRM1;CHRM3;RGS10;CDK5R1;PLCB1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.45003540636850836,0.9190696355860071,0.5474934036939314,1.0,1.0,6/19,18.14%,CBFB;DHX9;ELF1;PARP9;MAVS;RUNX1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4709620979656811,0.9187096750357744,0.5441389290882779,1.0,1.0,5/11,18.95%,ING4;FOXM1;TP53;TFAP4;SP100
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.276558474645255,-0.9185379191299629,0.5478723404255319,0.7956309560196051,1.0,10/23,18.55%,HSP90B1;OS9;UFD1;DERL1;SURF4;SELENOS;PREB;SEC61B;AUP1;SYVN1
prerank,cellular response to superoxide (GO:0071451),-0.3720014519244701,-0.9176043015234285,0.5462686567164179,0.7968228934511994,1.0,6/10,21.97%,NOS3;SOD2;PRDX2;PRDX1;ADPRS;ATP7A
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.444618288985508,0.9174956449776914,0.5370121130551817,1.0,1.0,3/17,11.45%,PRNP;PTPN2;EZR
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3672730473131874,-0.917486193911065,0.5494186046511628,0.7961964584662683,1.0,4/10,17.16%,FKBP1A;BIN1;ATP1A2;ADRA2A
prerank,miRNA metabolic process (GO:0010586),0.43523476123327876,0.9168428303863861,0.5481770833333334,1.0,1.0,4/20,13.46%,DGCR8;AGO2;TUT7;TUT4
prerank,negative regulation of myotube differentiation (GO:0010832),0.45705604835778446,0.9167836344940069,0.552710843373494,1.0,1.0,3/12,11.37%,BHLHE41;CCN3;HDAC1
prerank,negative regulation of viral genome replication (GO:0045071),0.3990715044572846,0.9167391494351096,0.5675977653631284,1.0,1.0,4/40,4.06%,ILF3;FAM111A;ZC3HAV1;MPHOSPH8
prerank,positive regulation of catalytic activity (GO:0043085),-0.25740421791923285,-0.9164529717863505,0.635036496350365,0.7975474395991815,1.0,10/37,10.85%,PSEN1;CAV1;MAPK8;STX4;NCSTN;MSH2;IGF2;NHEJ1;MAPK3;ABL1
prerank,triglyceride biosynthetic process (GO:0019432),0.439404770636992,0.9164202867192723,0.5491480996068152,1.0,1.0,8/18,27.09%,LPIN2;AGMO;PCK2;GK;LPIN3;GPAM;LPGAT1;DGAT1
prerank,actin filament organization (GO:0007015),0.3865116586685728,0.9157449121539694,0.6381048387096774,1.0,1.0,34/151,17.67%,SPTA1;GAS2L3;SHROOM3;TRIOBP;RHOA;CGNL1;TPM4;MYO1C;CDC42EP2;FAT1;RFLNA;MCU;CORO1B;ABI1;SAMD14;RND2;RAC1;DMTN;DPYSL3;BAIAP2L1;SVIL;DLG1;TMOD3;DSTN;CAPG;MPRIP;RHOC;LCP1;FHOD1;DBN1;COBL;SHROOM2;TRPV4;ABI2
prerank,negative regulation of cell population proliferation (GO:0008285),0.3851292296136152,0.91552696175696,0.711,1.0,1.0,69/351,17.39%,E2F7;CDKN3;E2F1;CDKN2D;PPM1D;CDKN2C;PDS5B;CDC6;CTCF;E2F3;TFDP1;ALDH1A2;MDM4;ARID2;CTBP1;MCC;PDPN;NMI;COL18A1;PTPN2;RBBP4;TGFBR3;PML;SFRP2;CLMN;B4GALT7;SLC16A2;KDM2B;MFN2;BTG3;SMAD6;IRF1;ING4;KLF11;AXIN2;KANK2;VHL;ABI1;EMD;NOX4;PPP2R5C;PLXNB1;CCN3;BMP2;APPL2;P3H1;PLPP1;NCK2;WNT9A;SOX9;TES;ATF5;CDKN1B;ADAMTS1;MORC3;STK11;PTPRU;CNOT7;PKD2;NF2;ZBTB7C;TP53;SFRP1;PTEN;TINF2;PTPRK;NGF;SLURP1;TFAP4
prerank,alpha-amino acid metabolic process (GO:1901605),-0.23989833412288633,-0.9154910039485111,0.6494845360824743,0.7988596123390705,1.0,16/45,23.55%,GLUL;GLS;GOT2;SLC25A13;SLC25A12;MTHFD1;KYAT1;GOT1;MTRR;GPT2;DDAH2;GLUD1;ATP7A;ASS1;RIMKLA;OAT
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.31264708278977954,-0.9154366378060346,0.5671641791044776,0.7980936500545286,1.0,6/17,10.34%,NTRK2;APOE;IGF1;BIN1;RTN1;CHRNA7
prerank,potassium ion transmembrane transport (GO:0071805),-0.2017970777511011,-0.9152604439679719,0.7142857142857143,0.79760589666077,1.0,23/135,13.14%,ATP1B1;KCNAB1;KCNC2;HCN1;KCNB1;KCNJ3;SLC24A2;KCNQ3;KCNK13;KCNH1;KCNK10;KCNJ6;ATP1A1;ATP1B3;KCNN2;KCNS3;KCNH7;ATP1A3;SLC12A9;KCNJ10;KCNA6;KCNA2;ATP1A2
prerank,B cell activation involved in immune response (GO:0002312),0.4679652502350513,0.914938789900744,0.5563689604685212,1.0,1.0,2/13,12.41%,RNF168;MSH6
prerank,sarcomere organization (GO:0045214),0.4157160296092638,0.9145923038210542,0.5425400739827374,1.0,1.0,4/27,16.49%,MYLK3;CSRP2;CSRP3;TNNT3
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4224264331926725,0.9145591567768186,0.5571955719557196,1.0,1.0,12/27,25.58%,CSTF3;RNASE6;PCF11;RPP30;POP1;RNASE1;KHNYN;LACTB2;TRIR;RNASEH1;TOE1;NUDT16
prerank,cell chemotaxis (GO:0060326),0.39793675320296995,0.9144632805552135,0.5811688311688312,1.0,1.0,9/60,12.38%,HMGB2;PARVA;LPAR1;KIT;CXCR4;PDGFRA;CORO1B;CCN3;NR4A1
prerank,atrial septum development (GO:0003283),0.4640065052208653,0.9142516251293265,0.5552447552447553,1.0,1.0,4/13,13.44%,MDM4;NPHP3;NOTCH2;HEY2
prerank,regulation of protein metabolic process (GO:0051246),0.39980587496555614,0.9141852124746201,0.568,1.0,1.0,4/44,5.71%,FAM83D;ROCK2;CHEK2;FAF1
prerank,primary alcohol metabolic process (GO:0034308),-0.28605597672640526,-0.913535219571274,0.5757575757575758,0.8005183316906642,1.0,7/25,14.75%,IGF1;RDH10;GPD2;ALDH3A2;GDPD3;DHRS3;GDPD1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.36901365030107186,-0.9132348461050002,0.5681159420289855,0.8003611991934887,1.0,5/10,17.98%,ATP5F1A;ATP5PO;ATP5MC3;ATP5PD;ATP5F1D
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.39246905023923895,0.913152614495261,0.5978835978835979,1.0,1.0,30/73,24.77%,CBFB;PSMC2;PSMD5;PRKDC;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,regulation of ruffle assembly (GO:1900027),-0.2959690817805552,-0.9128703343626597,0.5954545454545455,0.800292531163409,1.0,12/23,32.31%,CAV1;FAM98A;PFN1;PLEKHM1;EPS8L2;NLGN1;P2RX4;ABI3;P2RY12;DEF8;EPS8;HRAS
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.43361594782861723,0.9123845634304132,0.5721784776902887,1.0,1.0,3/21,9.97%,GCK;GPI;TKT
prerank,cellular response to organonitrogen compound (GO:0071417),0.38365952404396414,0.9118981422713056,0.6189989785495403,1.0,1.0,21/99,16.84%,BRCA1;AQP1;DIAPH1;CTNNA1;LARP1;P2RY1;TRPM2;AHR;EZR;AKAP9;SOX9;DMTN;SLC38A9;GLRA2;RPTOR;PKD2;IPO5;SESN2;SFRP1;LARS1;LAMTOR3
prerank,cilium-dependent cell motility (GO:0060285),0.42319114081736897,0.9117757161246388,0.5514993481095176,1.0,1.0,3/22,10.32%,DNAH2;DNAH1;RSPH9
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.33201214226159576,-0.9117010228064035,0.5689655172413793,0.8019863250035776,1.0,5/14,11.92%,PRKG1;MEF2C;LRP1;TPM1;SLIT2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.41329897524268233,0.9115351631906436,0.5600961538461539,1.0,1.0,6/32,6.54%,GSK3B;OBSL1;NEDD4;CUX1;RAP2A;CAPRIN1
prerank,protein K48-linked ubiquitination (GO:0070936),0.39591242257135933,0.911361794658868,0.5791805094130675,1.0,1.0,7/54,9.60%,UBE2T;UBE2C;UBE2K;UBR5;CUL3;UBE2R2;SKP2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.24772927071987516,-0.9109436346871836,0.6410256410256411,0.802787793691844,1.0,10/44,12.01%,ATP1B1;GABBR1;ANO6;AKAP6;KCNJ3;WNK2;KCNJ6;ATP1B3;KCNN2;KCNJ10
prerank,positive regulation of translational initiation (GO:0045948),0.4414390506998175,0.9104172782681896,0.5525238744884038,1.0,1.0,4/18,10.56%,KHDRBS1;LARP1;CDC123;YTHDF2
prerank,gastrulation (GO:0007369),0.4435891871296172,0.9101390583275198,0.5450704225352113,1.0,1.0,5/15,17.83%,MKKS;NPHP3;LRP5;UGDH;SMAD2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4139366849959113,0.9097558545725059,0.5656324582338902,1.0,1.0,15/31,22.04%,CAPRIN1;EFNA1;EPHA4;LRRK2;LZTS3;PDLIM5;ZDHHC15;DBN1;PTEN;SIPA1L1;ABI2;TANC2;CAPRIN2;CDK5;NGEF
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3829591522492164,0.9096101983636955,0.6436548223350254,1.0,1.0,28/122,16.96%,ATAD5;GLI2;FGFR4;LARP4B;GCK;HNRNPD;STN1;DNA2;DHX9;PRKDC;UPF3B;FAF1;SAMD4A;NMD3;SLC25A37;FMR1;ABCB10;PLXNB2;METTL5;PCNA;EIF3C;LARP4;FXR1;PRKD2;PASK;NFKB1;METTL3;PYM1
prerank,negative regulation of interferon-beta production (GO:0032688),0.4778188657220741,0.9095663608102589,0.5625920471281296,1.0,1.0,5/10,24.06%,PTPRS;YY1;SIRPA;RELB;REL
prerank,camera-type eye development (GO:0043010),0.42056286667691267,0.9092078312363846,0.5616605616605617,1.0,1.0,8/25,22.59%,FBN1;CACNA1C;NES;EFEMP1;SHROOM2;SKI;ALDH1A3;CEP290
prerank,positive regulation of cell differentiation (GO:0045597),0.3799068974193747,0.9087159568201861,0.6953907815631263,1.0,1.0,47/237,16.06%,ECT2;EZH2;CDH15;FBXO5;LOXL2;BMPR1A;RHOA;ZEB1;SPAG9;SRF;PDPN;BMP6;CTNNA1;SOX6;IL18;TCF4;NPNT;SFRP2;CCN1;WWTR1;RIPOR2;AXIN2;TMEM64;YAP1;VHL;AGT;DDR2;TGFBR1;BMP2;ZHX3;RRAS;GJA1;TRPM4;SOX9;SMAD4;LRP5;TWIST1;RBM4;PRKD1;BLOC1S5;SMAD3;MEDAG;WDFY2;GDNF;NFKB1;LPL;SFRP1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.344542067215339,-0.908218143657725,0.5537974683544303,0.8078088969558457,1.0,5/13,7.83%,HSP90AB1;STX4;STX3;RIC3;MAP1A
prerank,glycolytic process (GO:0006096),0.408851928659182,0.9079889069820106,0.5647348951911221,1.0,1.0,4/28,8.44%,PFKFB1;GCK;GPI;PGM1
prerank,neuron projection extension (GO:1990138),-0.27136609589623145,-0.9079867794671488,0.5240963855421686,0.8074113081099459,1.0,12/32,19.34%,NRP2;HSP90AB1;SPG11;TMEM108;MAP1B;ULK1;SEMA3A;CTNNB1;CDKL3;SEMA5B;NRP1;CYFIP1
prerank,regulation of interleukin-1 production (GO:0032652),0.4517381678899064,0.9078744187540297,0.5479833101529903,1.0,1.0,6/15,20.46%,HMGB1;ANXA1;SIRPA;FOXP1;TMED10;CEACAM1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.35550795234074056,-0.9072010903579836,0.6071428571428571,0.8082247214418294,1.0,4/11,17.94%,MEF2C;LYN;LGALS9;PIK3CD
prerank,amino acid import across plasma membrane (GO:0089718),-0.2908387707341142,-0.9070153497517948,0.586046511627907,0.8077362811311342,1.0,5/24,5.85%,SLC6A6;SLC1A2;SLC7A2;SLC3A2;SLC7A5
prerank,myelin maintenance (GO:0043217),0.4777959251889804,0.9069345992856166,0.5793528505392912,1.0,1.0,4/10,21.73%,CXCR4;EPB41L3;PTEN;SOD1
prerank,regulation of microglial cell activation (GO:1903978),-0.32559356211062807,-0.9068974854951306,0.5886792452830188,0.8070684349771893,1.0,5/15,29.51%,GRN;CX3CL1;SYT11;SPHK1;PTPRC
prerank,regulation of dendrite development (GO:0050773),-0.2533576824762295,-0.9062293279862406,0.6558441558441559,0.8075952090276806,1.0,12/37,16.21%,HECW1;DCC;CDKL5;TNIK;CAMSAP2;SEMA4D;VLDLR;NSMF;ADGRB3;RTN4IP1;LRP8;CSMD3
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.32100601219556923,-0.9062261426965997,0.5354609929078015,0.805845074748834,1.0,8/15,29.33%,AP3D1;DTNBP1;BLOC1S2;AP3B2;AP3M1;AP3S1;AP3M2;BLOC1S6
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.32100601219556923,-0.9062261426965997,0.5354609929078015,0.805845074748834,1.0,8/15,29.33%,AP3D1;DTNBP1;BLOC1S2;AP3B2;AP3M1;AP3S1;AP3M2;BLOC1S6
prerank,myofibril assembly (GO:0030239),0.39518443383516694,0.906074486677699,0.5818181818181818,1.0,1.0,10/42,22.28%,OBSL1;MYLK3;CSRP2;PDGFRA;TMOD3;CSRP3;TNNT3;TMOD1;LMOD1;TMOD2
prerank,organelle fission (GO:0048285),-0.29117344728528727,-0.9060686908996596,0.5742574257425742,0.8053063020792053,1.0,4/24,7.00%,DNM3;PRKN;FIS1;DNM1
prerank,apoptotic process (GO:0006915),0.3776257216989134,0.905866072431418,0.685370741482966,1.0,1.0,36/203,16.43%,MELK;ESPL1;CIT;FADD;MCM2;BMF;CASP7;MAGI3;IAPP;DAP;AIFM2;FAM162A;STK3;ERCC3;CXCR4;CHEK1;IRF1;ING4;BCLAF1;TNFRSF10B;PLAGL1;IKBKG;APAF1;BOK;AHR;NOTCH2;CASP8;PRKCE;JADE1;STK11;FXR1;BCL2L13;RFK;AKAP1;NCKAP1;TNFRSF25
prerank,negative regulation of cell differentiation (GO:0045596),0.3787604295226875,0.9051732692895822,0.658,1.0,1.0,43/181,16.14%,E2F1;ADGRV1;RB1;TWIST2;SUZ12;USF3;ANP32B;ASXL1;ANKRD26;XDH;COL5A2;EFNA1;SFRP2;CRIM1;WWTR1;SMAD6;TMEM64;NPHP3;LIMD1;LEO1;YAP1;TGFBR1;HNRNPU;YTHDF2;RUNX1T1;NKX2-1;ABCA1;ENPP1;WNT9A;TRPM4;SOX9;ADIPOR1;LRP5;RORA;TWIST1;MED1;SPRED1;SMAD3;ITGAV;EFEMP1;SFRP1;SPRED2;PTEN
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.43287322028743913,0.9046296053625955,0.5482573726541555,1.0,1.0,2/18,9.03%,CFAP53;NPHP3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.24341466764500544,-0.9032695268258851,0.5508474576271186,0.8105032085983046,1.0,21/45,39.61%,STAT3;MALT1;TLR4;APP;PANX1;LGALS9;TRIM16;EGR1;HSPB1;JAK2;P2RX7;TMEM106A;TYROBP;CCL19;NOD2;USP50;PYCARD;MYD88;CASP1;FZD5;AGER
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.42557211539779133,0.9028680921175101,0.558974358974359,1.0,1.0,5/21,11.13%,TXNDC12;LRRK2;NCK1;BOK;EIF2AK3
prerank,response to sterol (GO:0036314),0.4783216415256226,0.9020869348020959,0.5507246376811594,1.0,1.0,5/11,20.89%,PMVK;TGFBR1;RORA;SMAD2;INSIG1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3348269374997138,-0.9019987956164165,0.5691823899371069,0.8124337539276435,1.0,1/13,0.28%,STAT3
prerank,regulation of neurogenesis (GO:0050767),0.3952881225055371,0.9016780315307946,0.5967391304347827,1.0,1.0,9/55,14.60%,HMGB2;NAP1L1;PCM1;BHLHE41;YAP1;YTHDF2;APPL2;HEY2;DOCK7
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3817786633794339,0.901642769391936,0.5923566878980892,1.0,1.0,5/66,9.15%,EZH2;KIT;LRRK2;ROBO1;MAP3K4
prerank,positive regulation of protein modification process (GO:0031401),0.3803249973261826,0.9016378976524225,0.679037111334002,1.0,1.0,38/203,15.53%,CDCA2;CEP295;DYRK1A;FNIP1;ROCK2;TRABD2B;FAM161A;LEPR;MUSK;RAP2A;ARRB1;UBE2N;EFNA1;FMR1;ATG7;TXN;CCN1;PPP1R7;LRRK2;AXIN2;ANGPT1;RB1CC1;P2RY1;CALM2;CRKL;BMP2;RAC1;ADAM17;SOX9;PLAUR;SLCO3A1;SMPD1;CAMTA1;PTPA;WDFY2;PIN1;TAOK1;FXR1
prerank,negative regulation of transport (GO:0051051),-0.23282696273357642,-0.9014394516440823,0.6699029126213593,0.812683558546026,1.0,17/51,24.60%,PRKN;MCTP1;SNX3;CTTNBP2NL;NR1H3;CRYAB;SYT11;PPM1F;SCAMP5;BST2;WWP2;NR1H2;ITGB3;PACSIN3;RACK1;NDFIP1;ARL6IP5
prerank,ureteric bud morphogenesis (GO:0060675),0.4351647005572108,0.9012615050342759,0.5606469002695418,1.0,1.0,5/16,16.74%,NPNT;BMP2;GDNF;PKD2;SALL1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4371203850366066,0.901109141846395,0.5683060109289617,1.0,1.0,6/17,24.25%,CCNE1;HNRNPU;GJA1;TERT;FERMT2;KDM1A
prerank,positive regulation of reproductive process (GO:2000243),-0.2643731551472527,-0.9006643534998664,0.5875,0.8134511074830121,1.0,13/31,33.32%,PDE3A;GLRA1;CFAP69;LHFPL2;VEGFA;PGAM4;INHBA;TACR3;PRDM9;CACNA1H;PLCB1;INHBB;C1QBP
prerank,response to interferon-beta (GO:0035456),0.4183258670784466,0.899977630902783,0.5605263157894737,1.0,1.0,6/22,16.34%,UBE2K;HTRA2;IRF1;TRIM6;PNPT1;IFNAR2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.20016028781808798,-0.8998819518426824,0.7941176470588235,0.8142520031520567,1.0,29/93,24.90%,TNFRSF19;SH3RF3;HIPK2;TPD52L1;TGFB2;TAOK2;ANKRD6;MAP3K5;MID1;DUSP22;SEMA3A;MINK1;STK25;APP;SDCBP;SH3RF2;VEGFA;ZC3H12A;PRMT1;TIRAP;GADD45B;FLT4;MAP3K11;WNT16;PTK2B;SPHK1;MAPK8IP1;ARL6IP5;MFHAS1
prerank,bile acid metabolic process (GO:0008206),-0.2771418714975149,-0.8995087866812099,0.6102564102564103,0.8142211274147637,1.0,8/27,21.62%,OSBPL6;CYP7B1;SCP2;OSBPL7;GBA2;AMACR;OSBP;OSBPL2
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3354389434642405,-0.8993667255586101,0.5821917808219178,0.8137012874930922,1.0,7/14,15.86%,PPP2R2B;PPTC7;PPP2CB;PPM1F;PPP2R2C;DUSP1;PPP5C
prerank,positive regulation of cell motility (GO:2000147),0.37646427070147886,0.8993588880009001,0.6913827655310621,1.0,1.0,23/205,7.42%,ARHGEF39;GTSE1;CCDC25;MAP4K4;SYNE2;TWIST2;TRIP6;ROCK2;CEP43;MMP14;DDRGK1;ACTN4;LAMB1;KIT;SPAG9;NTN1;CCAR1;PDPN;MYO1C;PDGFRA;PLAU;PPP3CA;CCN1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.39626939203498374,0.8993430448060166,0.59613196814562,1.0,1.0,13/44,17.29%,ROCK2;RHOA;LPAR1;SORBS3;TGFBR1;RAC1;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47
prerank,regulation of fibroblast proliferation (GO:0048145),0.39285729810541187,0.8987580512755574,0.5850945494994438,1.0,1.0,11/45,16.06%,E2F1;AQP1;DHX9;PDGFRA;B4GALT7;EMD;AGT;DDR2;MORC3;TP53;SFRP1
prerank,positive regulation of vacuole organization (GO:0044090),-0.3626292839603303,-0.8980854059419707,0.590778097982709,0.8155883574343886,1.0,5/10,11.86%,PIP4K2A;PIP4K2B;RALB;GRN;RAB3GAP2
prerank,bone morphogenesis (GO:0060349),0.45645680200772665,0.8980743929860912,0.5963431786216596,1.0,1.0,2/14,3.52%,CYP26B1;FGFR2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3639324570756344,-0.8978827737902259,0.6079545454545454,0.8151195310330522,1.0,3/10,8.57%,PDCD4;DNAJA1;PTPN22
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4666896123347933,0.8978413589354362,0.5820668693009119,1.0,1.0,1/10,2.56%,RB1
prerank,sterol metabolic process (GO:0016125),0.38656747927214363,0.897769263344372,0.6077170418006431,1.0,1.0,12/60,15.93%,LBR;CYP39A1;CYP26B1;PMVK;SOAT1;SCAP;TM7SF2;ABCA1;SOAT2;FDXR;STARD3;DHCR7
prerank,neuromuscular process (GO:0050905),-0.3175812683290733,-0.8974995005696621,0.5910931174089069,0.8150603673020341,1.0,7/16,19.57%,UBA5;NRXN1;TPP1;SHANK1;GCH1;STRA6;DCTN1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.260177234701099,-0.8972356191083354,0.6294117647058823,0.8147468824416627,1.0,15/34,34.29%,STX4;EPHB2;SLC7A5;PTPN22;VAMP3;XBP1;DNAJB9;CD86;LAPTM5;PHB2;PTPRC;RBP4;SPHK2;CLCF1;NOD2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.30178056000860587,-0.8969937315673636,0.5652173913043478,0.8143353259680757,1.0,5/18,17.19%,PUM1;DDX60;UFD1;RNF125;BIRC3
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4051317301799424,0.8969655887851734,0.588098016336056,1.0,1.0,9/38,15.15%,DHX9;NMI;BMP6;RIOK3;PUM2;POLR3D;PRKCA;AKIRIN2;SLC15A4
prerank,protein K48-linked deubiquitination (GO:0071108),-0.28672960610891374,-0.8969334943068537,0.652542372881356,0.8135976833809874,1.0,9/23,24.55%,OTUD7A;ATXN3;USP8;MINDY1;YOD1;USP33;OTUB1;MINDY2;USP34
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4457029115291964,0.8965770407191357,0.5663841807909604,1.0,1.0,7/13,21.73%,SCAP;DKK3;BMP2;NFKB1;ERLIN1;BMP5;SOD1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.4503407634463714,0.8962485299923811,0.5432835820895522,1.0,1.0,4/12,17.24%,SMARCA4;HDAC1;SFRP1;FOXP1
prerank,ureteric bud development (GO:0001657),0.431182341900721,0.8962327712429988,0.5617529880478087,1.0,1.0,6/17,18.17%,FGFR2;NPNT;BMP2;PKD2;SALL1;OSR1
prerank,carbohydrate derivative transport (GO:1901264),-0.2992567270906429,-0.8960199902722995,0.6126482213438735,0.8147081995534369,1.0,4/18,10.93%,PLTP;LBP;SLC15A2;VLDLR
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3175823605526026,-0.8958755316352435,0.5735294117647058,0.8141266681933441,1.0,7/17,19.86%,EMC2;EMC3;SGTA;EMC1;EMC9;GET4;MMGT1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.24044090967059592,-0.895788073272622,0.6324786324786325,0.8134626233514921,1.0,10/46,12.53%,SEMA6A;TIMP3;TLR4;WNK2;EPHB2;DUSP3;LYN;LMO3;SYNJ2BP;SPRY2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.42396457784877134,0.8957823949450167,0.5505761843790012,1.0,1.0,5/21,13.59%,HPRT1;XDH;ACAT1;HINT1;NUDT4
prerank,protein localization to organelle (GO:0033365),0.37840700123378357,0.8957535813978792,0.6683518705763397,1.0,1.0,25/133,16.28%,RAB33B;CNTLN;BBS9;WDR35;RPA1;GBF1;IFT140;OBSL1;PACSIN2;DDRGK1;DHX9;PRNP;RPA2;BICD2;LRRK2;TRAM2;EMD;XPA;GAK;EHD1;TOR1B;VAPA;CSRP3;DDX1;CYB5A
prerank,acetyl-CoA metabolic process (GO:0006084),0.4405099736283878,0.8954491526204263,0.5641379310344827,1.0,1.0,5/15,13.72%,PMVK;ACAT1;ACSS1;ACACA;MVK
prerank,negative regulation of cell activation (GO:0050866),-0.3248148807776561,-0.8952435776875314,0.6158940397350994,0.8137221482446981,1.0,3/14,5.31%,APOE;NOS3;THBD
prerank,proteasome assembly (GO:0043248),0.4560127305142978,0.8950466671287973,0.5576923076923077,1.0,1.0,5/11,22.98%,PSMD5;ADRM1;PSMD11;PSMD13;PSMD4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.448823814387752,0.8947413163064758,0.5682451253481894,1.0,1.0,3/15,9.98%,FGFR4;PDPN;DDR2
prerank,homocysteine metabolic process (GO:0050667),0.4610810041205695,0.8946849799208805,0.5704022988505747,1.0,1.0,3/11,18.08%,MTHFR;NOX4;DPEP1
prerank,melanocyte differentiation (GO:0030318),0.45808586505657045,0.8946735624724532,0.5846833578792342,1.0,1.0,3/11,11.79%,LRMDA;KIT;ENPP1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.45854052519383093,0.8945104686237334,0.5716440422322775,1.0,1.0,2/10,5.33%,UPB1;DPYD
prerank,negative regulation of signal transduction (GO:0009968),0.37471994500815187,0.8942322299769176,0.7337337337337337,1.0,1.0,39/249,11.79%,EZH2;GLI3;RB1;BRAP;CYP26B1;WWOX;TRABD2B;CNOT1;MMP14;NLK;NEDD4;DLK1;SULF2;NTN1;ASXL1;SIAH2;XDH;LEPROT;RNF43;PTPN2;HMGXB4;ARRB1;FBXW7;SFRP2;SULF1;LRRK2;NCK1;KANK2;MTMR2;AGT;CSNK2A2;PIK3CB;NR4A2;YTHDF2;DKK3;ARRDC1;PRKCB;BMP2;ENPP1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3941082555652519,0.8939892993301205,0.6058002148227712,1.0,1.0,10/57,14.08%,MRPL36;XPO1;RRS1;CUL4B;MRTO4;DHX37;RPS17;NOM1;SDAD1;PAK1IP1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4741985528595286,0.8934874402562553,0.5918674698795181,1.0,1.0,2/10,14.28%,PCGF5;DNMT3A
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3244943837420071,-0.8932724943211349,0.6096654275092936,0.8170280642065945,1.0,7/15,26.13%,NR1H3;GRN;ZC3H12A;CD84;CD300A;LRFN5;GPER1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3119153565844199,-0.8932159319743487,0.5913978494623656,0.8162668577877706,1.0,5/16,11.68%,DDX17;AR;SAFB;ESR1;DDX5
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4620138523493577,0.8931211348990175,0.567651632970451,1.0,1.0,3/10,19.96%,TICAM1;MIA3;CD68
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.30458488331838185,-0.8931060658682985,0.6097560975609756,0.8156577529546828,1.0,7/19,19.72%,BPNT2;TPST1;SLC35B3;ABHD14B;TPST2;SLC26A2;PAPSS1
prerank,aorta development (GO:0035904),-0.3256796484903763,-0.8920960481568951,0.6073825503355704,0.8169606631329664,1.0,7/14,18.26%,JAG1;PDGFRB;LRP1;TBX1;ROBO2;TBX2;PDE2A
prerank,skeletal muscle organ development (GO:0060538),-0.2748000376346685,-0.8914768646974669,0.6069364161849711,0.8174557189295157,1.0,8/26,21.65%,MEF2C;CAV1;IGSF8;MYL6;SIX1;STRA6;DISP1;BASP1
prerank,regulation of angiogenesis (GO:0045765),0.37411895409555435,0.8914252099718679,0.7244488977955912,1.0,1.0,31/192,14.27%,BRCA1;VASH2;AQP1;ATP2B4;THBS2;ANGPT4;ROCK2;HYAL1;AGO2;ADAM12;PDE3B;ADGRA2;ANXA3;PML;SFRP2;HSPB6;SULF1;SERPINE1;ROCK1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PLXND1;PRKD1;SPRED1;ADAMTS1;ITGB1
prerank,positive regulation of ion transport (GO:0043270),-0.2347377804963583,-0.8907438193670095,0.6576576576576577,0.81811599344473,1.0,19/48,34.06%,ANO6;SNX4;MYLK;KIF5B;CACNB2;SCN1B;VAMP8;CRACR2A;ADRA2A;P2RX4;DRD2;WFS1;P2RX7;SCN4B;RAB3B;PKP2;GPD1L;SCN3B;CACNA1D
prerank,regulation of actin nucleation (GO:0051125),0.45456144813084776,0.8901001505478252,0.5820256776034237,1.0,1.0,5/12,22.33%,ARFIP1;CORO1B;ARF1;WHAMM;ARPIN
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2939441168445628,-0.8897783976593355,0.6170212765957447,0.8191720469003212,1.0,4/19,10.35%,APOE;RIC3;CHRNA7;CHRFAM7A
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.445389379632962,0.8896924264179521,0.5792349726775956,1.0,1.0,3/15,12.06%,LARGE1;CHST3;GNPDA2
prerank,regulation of vasoconstriction (GO:0019229),-0.2682265284310926,-0.8888688099612818,0.581151832460733,0.8202114377754871,1.0,8/27,15.76%,ECE1;CAV1;PER2;BMPR2;ACE;AGTR1;ADRA1A;CHRM3
prerank,maintenance of protein localization in organelle (GO:0072595),0.42611509213613635,0.8887143105660331,0.5497311827956989,1.0,1.0,5/19,14.25%,TAF3;PML;TAPT1;HNRNPU;MORC3
prerank,vasculogenesis (GO:0001570),-0.25637623341479415,-0.8883236879833504,0.6257668711656442,0.8204343365083385,1.0,9/32,15.07%,CAV1;TGFBR2;PDGFRB;RAMP2;RASIP1;CUL7;VEGFA;ENG;SOX17
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.437718842371869,0.8879949860999845,0.5983026874115983,1.0,1.0,6/16,19.67%,LEPROT;PTPN2;VHL;ADIPOR1;NF2;PARP14
prerank,glutathione biosynthetic process (GO:0006750),0.46302472917374055,0.8876474727415131,0.591044776119403,1.0,1.0,4/11,19.92%,GSS;GCLM;GCLC;HAGH
prerank,RNA interference (GO:0016246),0.44038617214475784,0.887619150859638,0.582312925170068,1.0,1.0,3/17,6.10%,AGO2;DHX9;NRDE2
prerank,proteolysis (GO:0006508),0.371733149815225,0.88653164104213,0.752,1.0,1.0,27/252,10.45%,KEL;BMP1;VASH2;CTSE;FAM111A;MMP24;MMP25;ADGRV1;SENP1;TRABD2B;CASP7;MMP14;LVRN;NLN;CPXM1;TASP1;PLAU;CAPN15;TMPRSS5;SPPL2B;ADAMTS9;HTRA2;CPQ;VHL;LONP1;SVBP;TRHDE
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.42341012467847533,0.8864858290280576,0.5727272727272728,1.0,1.0,5/17,13.44%,BMPR1A;BMP2;RBPJ;NOTCH2;HEY2
prerank,spliceosomal snRNP assembly (GO:0000387),0.39502159506214446,0.8862058404866787,0.5988439306358382,1.0,1.0,9/38,19.77%,COIL;SRSF10;PRPF19;PRPF3;LSM2;LSM4;GEMIN7;TGS1;SNRPB
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.35418455428681084,-0.8861046560095562,0.597667638483965,0.8242434362154117,1.0,5/10,18.75%,ERLEC1;OS9;YOD1;SVIP;UBE2G2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4540189370449521,0.8856779893803054,0.6008583690987125,1.0,1.0,2/13,7.97%,LARGE1;CHST3
prerank,cardiac atrium morphogenesis (GO:0003209),-0.31065373536301255,-0.8830091583643522,0.596078431372549,0.829903359112036,1.0,3/16,4.85%,BMPR2;TGFB2;PROX1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.35776111262580246,-0.8828344046043806,0.631578947368421,0.8294131662626594,1.0,2/10,3.95%,SMAD7;MALT1
prerank,positive regulation of inflammatory response (GO:0050729),-0.21514539352673165,-0.8824859474649922,0.8157894736842105,0.8292540924788475,1.0,21/86,19.45%,SNX4;TLR4;PDCD4;GPR4;IFI35;LBP;RPS19;GRN;CD81;APP;AGTR1;OSMR;CX3CL1;NUPR1;PLA2G7;VAMP8;FEM1A;PDE2A;CCN4;KARS1;TNIP1
prerank,negative regulation of axon extension (GO:0030517),-0.2506110379704223,-0.8824600516447029,0.6966292134831461,0.8284287050027077,1.0,10/30,19.19%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;CDKL3;MAG;SEMA5B
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.37082763339318703,0.8824552070759205,0.7114228456913828,1.0,1.0,49/182,19.67%,RBL1;ATOH8;ATP2B4;RB1;BMPR1A;AURKA;MOV10;ROCK2;AGO2;DDRGK1;SETDB2;WDR54;MAPT;XDH;FBXW7;SFRP2;ROBO1;YAP1;VHL;MTMR2;SLC24A3;PICALM;PARP9;FLOT2;CRKL;HDAC1;BMP2;TERF2;STOX1;RBMS3;TRIM6;NOTCH2;HEY2;YY1;CNOT7;TNRC6C;NFKB1;SFRP1;ITGB8;LDLR;FOXP1;ANKRD13D;RUNX1;RBL2;WNT4;HAVCR2;TNRC6B;TERT;PARP14
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.27610526742385516,-0.8823283731538895,0.6844919786096256,0.8278145029120382,1.0,8/23,17.57%,CAV1;TSG101;DUSP22;SOCS5;ZGPAT;SRCIN1;CBLB;CBL
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.31223809856170953,-0.8821218637106744,0.6072727272727273,0.8273875734497648,1.0,2/15,10.54%,PRKN;BCL2
prerank,vasculature development (GO:0001944),-0.305047187631796,-0.8819459618000393,0.6234309623430963,0.8268936546886111,1.0,8/16,18.25%,BMPR2;ACVRL1;PDGFRB;CDH5;ACVR2B;STRA6;NOTCH4;PIK3CA
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4166942769276205,0.8815398300079954,0.5824607329842932,1.0,1.0,4/22,15.52%,KIT;OCIAD2;CRLF3;OCIAD1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3756621217939129,0.8809739118288489,0.625531914893617,1.0,1.0,23/65,19.38%,FBN1;PEG10;PMEPA1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;SMURF2;NKX2-1;PDPK1;ADAM17;SPRED1;HTRA3;SMAD3;PIN1;SPRED2;VEPH1;SMAD2;SKIL;LTBP1;SKI;PPM1A
prerank,regulation of receptor binding (GO:1900120),-0.3596476776460778,-0.8809306159833439,0.5909090909090909,0.8282067441303437,1.0,5/10,26.03%,ADAM15;B2M;ATP2A3;BDNF;PTPRF
prerank,cellular response to interleukin-2 (GO:0071352),-0.3465129280293334,-0.880755105701934,0.6131805157593123,0.8268427554419444,1.0,7/11,43.27%,SHC1;PTK2B;SYK;JAK1;JAK3;IL2RA;IL2RG
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.3465129280293334,-0.880755105701934,0.6131805157593123,0.8268427554419444,1.0,7/11,43.27%,SHC1;PTK2B;SYK;JAK1;JAK3;IL2RA;IL2RG
prerank,regulation of myotube differentiation (GO:0010830),0.40386977606933616,0.8806489255455879,0.5659203980099502,1.0,1.0,6/24,13.42%,MMP14;BHLHE41;CCN3;HDAC1;PIEZO1;MAML1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4322283882223745,0.8805071833675644,0.6029810298102981,1.0,1.0,5/16,12.33%,BMPR1A;FGFR2;TGFBR3;PIM1;RBPJ
prerank,mucosal immune response (GO:0002385),-0.30821568481934564,-0.8800766194622525,0.6458333333333334,0.8273654809854836,1.0,2/15,10.51%,DEFA6;RPL39
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.372863951428261,0.879975289519212,0.6200640341515475,1.0,1.0,10/65,10.88%,AURKB;AURKA;PSMC2;PSMD5;FBXL7;CHEK1;PSMB1;PSMD14;PSMD1;PSMB9
prerank,negative regulation of macrophage activation (GO:0043031),-0.3124920441415937,-0.8797994852525777,0.6106870229007634,0.8271087397087074,1.0,7/16,29.51%,NR1H3;GRN;CX3CL1;SYT11;ZC3H12A;LRFN5;PTPRC
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.27940134958672064,-0.8796311084156736,0.6243654822335025,0.8265862436300836,1.0,6/23,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,tRNA 5'-end processing (GO:0099116),0.43213612836866017,0.8792447172778937,0.5910326086956522,1.0,1.0,5/15,19.61%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,glycogen metabolic process (GO:0005977),0.40164381819468997,0.8791832688175263,0.5863354037267081,1.0,1.0,6/27,12.43%,GSK3B;AGL;PYGB;PHKA2;PGM1;GYG1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4479788792235348,0.8791186782041946,0.591776798825257,1.0,1.0,4/12,20.96%,ACTN4;DMTN;RCC2;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4479788792235348,0.8791186782041946,0.591776798825257,1.0,1.0,4/12,20.96%,ACTN4;DMTN;RCC2;FBLN1
prerank,leukotriene metabolic process (GO:0006691),0.41511565756498964,0.878857510271355,0.5801324503311258,1.0,1.0,6/19,20.69%,PTGR1;ABCC10;MGST3;DPEP1;DPEP2;MAPKAPK2
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4163218241096959,0.87874896541326,0.60125,1.0,1.0,10/21,22.80%,MACF1;ROCK2;RHOA;ROCK1;PTPRA;EPHA3;CLASP1;LDB1;VCL;SLK
prerank,copper ion homeostasis (GO:0055070),-0.2908807843089176,-0.8787283571337955,0.6300813008130082,0.8276999256294983,1.0,8/17,21.97%,APP;COX19;SLC31A2;MT2A;ATOX1;CUTC;COMMD1;ATP7A
prerank,response to peptide (GO:1901652),-0.25012207203093423,-0.8780923384936731,0.6706586826347305,0.8280619165848784,1.0,7/33,12.34%,STAT3;GNAI1;STAT6;CACNA1B;CHRNA7;IRS1;MMP2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.4298821734409517,0.8776616807321989,0.5893587994542974,1.0,1.0,4/17,11.74%,MCU;RIPOR2;CAMK1D;RAC1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.32853509464739583,-0.8776411829531052,0.6419354838709678,0.8281718534980494,1.0,5/14,31.78%,ATP1B1;ATP1B3;LRRC38;ATP1B2;KCNIP2
prerank,regulation of MAPK cascade (GO:0043408),0.36898189439446216,0.8774680591619686,0.7139979859013091,1.0,1.0,25/157,14.23%,FAM83D;MAP4K4;KSR1;ULK4;ROCK2;FGFR2;LPAR1;IAPP;KIT;WDR54;VRK2;STK3;NRK;TGFBR3;JCAD;CCN1;ROCK1;HMGB1;APIP;BMP2;RRAS;ROR1;ADRB2;SPRED1;TRIM5
prerank,wound healing (GO:0042060),0.37288317139303667,0.8774260665857485,0.6297502714440825,1.0,1.0,14/62,15.84%,HPSE;MACF1;FUT10;SRF;MYOF;PDGFRA;PPP3CA;CORO1B;TGFBR1;SYTL4;SMPD1;SMAD3;MIA3;DYSF
prerank,neutral amino acid transport (GO:0015804),-0.25745377514078993,-0.8770358867438104,0.72,0.8284601200533441,1.0,9/28,24.23%,SLC6A6;SLC3A2;SLC7A5;SLC1A1;SLC38A5;SLC6A15;SLC36A1;SLC6A7;CTNS
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2556740283065859,-0.8762747691244854,0.6823529411764706,0.8291628147380365,1.0,8/32,13.10%,FIS1;SOD2;HSPD1;ERBB4;NDUFS1;BCL2;BNIP3;CCAR2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.366548092747119,0.8762366318633008,0.799,1.0,1.0,62/348,15.83%,CENPE;TTK;PLK1;SPDYA;ATP2B4;BMPR1A;FNIP1;ANGPT4;ROCK2;UBE2K;DDRGK1;SH2D3C;PRNP;MRE11;LEPR;BMP6;MUSK;RAP2A;ARRB1;EFNA1;FMR1;ENPP2;TXN;SFRP2;CCN1;CD80;MRNIP;LRRK2;AXIN2;ANGPT1;AGT;DDR2;RB1CC1;P2RY1;S1PR2;TGFBR1;CALM2;CRKL;BMP2;AKAP9;RAC1;STOX1;ADAM17;TRIM6;SOX9;SMAD4;PLAUR;SLCO3A1;PRKD1;CAB39;ITGA5;RAMP3;CD44;DOCK7;RPTOR;WDFY2;PIN1;PRKAG1;SRC;FXR1;PRKD2;TP53
prerank,sensory perception (GO:0007600),-0.23166972150598392,-0.8762288851354526,0.7075471698113207,0.828392680041043,1.0,9/45,13.63%,PCDH15;GNAL;SCN9A;WHRN;BBS4;OPRM1;CHRNA7;KCNA2;TMEM150C
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.4509204496868334,0.8755973448206419,0.6,1.0,1.0,3/10,13.17%,FGFR2;SOX9;LRP5
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4041924846605429,0.8754900885408502,0.6015037593984962,1.0,1.0,5/24,10.35%,MIEF2;PRNP;PDZK1;MYO1C;MIEF1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.4222420821109397,0.8754310304175227,0.5878378378378378,1.0,1.0,2/18,6.71%,FBN1;FBXW7
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3665057521821006,0.8753627903405677,0.7003027245206862,1.0,1.0,34/158,18.73%,ECT2;FADD;TRIML2;TICAM1;MAP3K14;MIER1;RHOA;LPAR1;UBE2N;RNF31;TNFRSF10B;MAP3K3;IKBKG;CXXC5;PRKCB;GJA1;TRIM6;CASP8;BRD4;ROR1;DDX21;PRKD1;PLK2;TRIM5;VAPA;RHOC;DDX1;MAVS;TNFSF10;LAMTOR5;PLEKHG5;TERF2IP;ANKRD17;RIPK1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.37176912517705235,0.8751942945485692,0.6670113753877973,1.0,1.0,24/92,15.59%,ATOH8;MAP4K4;ANGPT4;ROCK2;HYAL1;GPI;ANXA3;ENPP2;ANGPT1;AGT;PIK3CB;RAC1;RRAS;PRKCA;SOX9;CTSH;PRKCE;DOCK1;PRKD1;ADAM9;INSL3;AAMP;SRC;PRKD2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.414748713553857,0.8751136192251314,0.5926412614980289,1.0,1.0,2/20,3.88%,STMN1;ADA
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.27587802747934764,-0.8750847047537501,0.5925925925925926,0.82981129345151,1.0,11/22,41.63%,APOE;CREBL2;MTOR;SORBS1;MLXIPL;ANGPTL3;AKT1;PPARG;CREB1;PPARA;EEF1A2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.34137223956224805,-0.8747739936944534,0.6242038216560509,0.8295931456105805,1.0,4/11,20.20%,NBL1;SLIT2;DUSP1;PADI2
prerank,limb development (GO:0060173),0.40287198882788716,0.8739846009249311,0.5943970767356882,1.0,1.0,3/28,6.89%,GLI3;LNPK;MAP3K20
prerank,regulation of exosomal secretion (GO:1903541),-0.2909236788001149,-0.873799449041305,0.6422764227642277,0.8306980475789548,1.0,5/19,15.43%,PRKN;VPS4B;TSG101;SDCBP;ATP9A
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3776659531078276,0.8737489923501714,0.6390977443609023,1.0,1.0,11/62,12.63%,MAP4K4;RTN4R;LPAR1;AUTS2;NET1;ARRB1;ROBO1;PIK3CB;CRKL;RAC1;NOTCH2
prerank,cellular response to calcium ion (GO:0071277),0.3754689425442266,0.873665922862761,0.639186295503212,1.0,1.0,2/67,2.44%,ECT2;ADGRV1
prerank,iron-sulfur cluster assembly (GO:0016226),0.41252928081838997,0.8736171426157521,0.599009900990099,1.0,1.0,9/24,22.55%,FXN;NUBP2;CIAO3;MMS19;ISCA2;NUBP1;LYRM4;CIAO2A;NFS1
prerank,eye photoreceptor cell development (GO:0042462),-0.3058742061401728,-0.8733436839514834,0.5951557093425606,0.8307746051039644,1.0,5/15,26.78%,BBS4;RORB;VEGFA;RP1;THY1
prerank,Rho protein signal transduction (GO:0007266),0.37961233168492436,0.873155899109357,0.62,1.0,1.0,10/53,10.41%,ROCK2;RHOA;NTN1;PDPN;CDC42EP2;GNA13;ROCK1;EPS8L1;MYO9B;ARHGAP6
prerank,actin filament bundle assembly (GO:0051017),0.38467876150486996,0.8727806232538317,0.5971731448763251,1.0,1.0,12/33,22.66%,ADD2;CORO1B;EZR;DMTN;DPYSL3;BAIAP2L1;ADD1;LCP1;SHROOM2;SHROOM1;PLS1;MYO1B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3668427487956428,0.8726622283048311,0.6876907426246185,1.0,1.0,51/129,24.86%,FGFR2;PSMC2;RNF220;PSMD5;TBL1XR1;ADGRA2;WNK1;SFRP2;UBR5;LRRK2;PSMB1;PSMD14;AXIN2;PSMD1;LRRK1;PSMB9;SMURF2;CSNK1G2;TRPM4;USP47;XIAP;PSMC6;PIN1;NFKB1;SFRP1;AMER1;FAM53B;PSMB2;CSNK1G1;PSME4;PSMB7;CAPRIN2;PPM1A;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;PSMD13;COL1A1;GPRC5B;PSMB8;PSMD4;PSMF1;GPC3;WLS;AXIN1;PSMA5;PSMC3;TGFB1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4132776239635395,0.8724502272594863,0.5875634517766497,1.0,1.0,4/22,9.55%,ROCK2;EFNA1;EPHA4;PICALM
prerank,negative regulation of endopeptidase activity (GO:0010951),0.38289001037799875,0.872415686291291,0.6153846153846154,1.0,1.0,4/47,9.77%,SERPINB8;SERPINA9;SERPINE1;AGT
prerank,entry into host (GO:0044409),-0.32491446600816254,-0.8723999667452328,0.6514084507042254,0.8318812799852289,1.0,6/13,17.57%,CTNND1;CTNNB1;GRB2;MET;CBLL1;CBL
prerank,regulation of autophagosome assembly (GO:2000785),-0.2544184069898716,-0.8722402434638943,0.6216216216216216,0.8313498043685125,1.0,10/33,13.18%,PIP4K2A;FEZ1;PIP4K2B;RALB;RAB5A;IFT20;FEZ2;RAB3GAP2;PINK1;NUPR1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4469512317797285,0.8715381988574177,0.5832083958020989,1.0,1.0,3/11,13.17%,FGFR2;SOX9;LRP5
prerank,establishment of protein localization to membrane (GO:0090150),0.37682672038923054,0.8715156351655214,0.6687830687830688,1.0,1.0,22/66,23.27%,SYNE3;VPS37B;RAB10;MYO1C;AFDN;VPS37A;ZDHHC18;CHM;ZDHHC15;GORASP2;ATG3;PRKCI;ZDHHC3;ZDHHC21;PIKFYVE;BRAF;ZDHHC24;ICMT;VPS37C;ZDHHC2;ZDHHC14;BID
prerank,negative regulation of T cell proliferation (GO:0042130),0.39888365467123843,0.8712821061317354,0.6165605095541401,1.0,1.0,5/28,13.96%,PRNP;SCRIB;CD80;IL4I1;RC3H1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.25269559035815936,-0.8708841190821092,0.6911764705882353,0.8332190387838155,1.0,8/37,15.59%,STAT3;APOD;TLR4;PDCD4;PLD3;CHID1;ABCD2;IL17D
prerank,negative regulation of cell cycle (GO:0045786),0.3699612871257029,0.8707600001336459,0.6339662447257384,1.0,1.0,16/73,17.39%,PLK1;RB1;SCRIB;HTRA2;BTG3;GAS1;BMP2;IPO7;NR4A1;CDKN1B;SMAD3;IPO5;PTEN;PTPRK;ANGEL2;TFAP4
prerank,negative regulation of cellular process (GO:0048523),0.36489610984537313,0.8706294427319337,0.841,1.0,1.0,113/521,18.98%,E2F7;CDKN3;MYBL1;RAD18;PSRC1;CDKN2D;FBXO5;PPM1D;CDKN2C;TXNDC12;RB1;PDS5B;HYAL1;SUZ12;CDC6;CTCF;ALDH1A2;MDM4;ARID2;ANP32B;SPEF1;CASK;PDE3B;CTBP1;BLM;PDPN;NMI;COL18A1;PTPN2;RBBP4;TGFBR3;RBBP7;PML;SFRP2;CCN1;CLMN;HTRA2;BTG3;SMAD6;IRF1;ING4;SMARCA4;RIPOR2;KLF11;AXIN2;NCK1;KANK2;CDA;ANGPT1;VHL;ABI1;NOX4;SRGAP2;PIP4P2;PPP2R5C;TMEM98;PLXNB2;CRLF3;PLXNB1;IP6K2;EIF2AK3;CCN3;DSCAM;BMP2;NDRG3;ENPP1;APPL2;P3H1;PLPP1;NCK2;GJA1;NR4A1;WNT9A;TES;SMAD4;ATF5;ORC6;PLXND1;JADE1;PRKD1;CDKN1B;ADAMTS1;FOXM1;SMAD3;MIA3;STK11;PTPRU;CNOT7;PKD2;NF2;ZBTB7C;TP53;DYSF;SESN2;SFRP1;PTEN;PTPRK;CCN2;NGF;SIRPA;SLURP1;TFAP4;DNAJB2;CHMP4B;IGFBP3;DCBLD2;SIPA1;FRZB;NIBAN2;PLXNA2;ADNP2;SP100;CAPRIN2
prerank,negative regulation of signaling (GO:0023057),-0.2628264757157574,-0.8702276932426377,0.5932203389830508,0.8337336299574953,1.0,5/25,13.51%,ACVR1;GLRA1;SOCS5;OPRM1;HHIP
prerank,protein palmitoylation (GO:0018345),-0.2530566262548192,-0.8702031111184646,0.6962025316455697,0.8329082337392111,1.0,12/30,23.28%,GLUL;CLIP3;ZDHHC5;ZDHHC1;ZDHHC13;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC16;ZDHHC20;ZDHHC4;ZDHHC17
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2066088282045295,-0.8692890711493186,0.8,0.833895298727271,1.0,30/91,23.32%,FTH1;SLC39A10;ATP6V0D1;SCARA5;SLC39A13;CUL1;FBXL5;FTL;HMOX2;ABCG2;APP;COX19;IREB2;SLC31A2;GLRX3;SLC39A7;SLC30A1;MT2A;ATOX1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;ATP7A;NDFIP1;ISCU
prerank,lipid homeostasis (GO:0055088),-0.21665166020536994,-0.8692410993550612,0.7362637362637363,0.833165622915235,1.0,27/57,33.80%,APOE;ADCK1;ABHD5;TLCD2;IRS2;PRKAA1;PNPLA8;NR1D2;NR1H3;RCN3;TLCD3A;XBP1;USF2;USF1;ABCA2;ABHD8;PNPLA2;CLN8;ORMDL1;DDX3X;PNPLA3;TLCD1;DGAT2;MLXIPL;ANGPTL3;FITM2;PPARG
prerank,positive regulation of cellular senescence (GO:2000774),-0.34940632630372637,-0.8687541836981157,0.6176470588235294,0.8333191903033432,1.0,4/10,28.96%,B2M;HMGA2;ABI3;EEF1E1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.40894104790426317,0.8685772511732957,0.6091370558375635,1.0,1.0,3/23,4.84%,PFKFB1;GCK;ERFE
prerank,positive regulation of viral process (GO:0048524),0.3719444916477515,0.8684954482917485,0.6365638766519823,1.0,1.0,13/60,19.33%,KPNA2;DHX9;POLR2A;LARP1;TMEM39A;SRPK1;PPID;PABPC1;CNOT7;AXL;SRPK2;PKN2;POLR2B
prerank,nucleoside catabolic process (GO:0009164),0.4452660463512876,0.8684606635386954,0.5961251862891207,1.0,1.0,2/11,5.33%,UPB1;DPYD
prerank,glucan catabolic process (GO:0009251),0.42281354333679816,0.8682579035580401,0.5857338820301783,1.0,1.0,3/15,7.72%,AGL;PYGB;PHKA2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.2817016086987528,-0.8675310887996964,0.6932773109243697,0.8349521333009965,1.0,5/20,11.05%,HSP90AB1;TXNIP;ANO6;ENTPD1;APP
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.28456280417768964,-0.8674004554649662,0.6872037914691943,0.8343609965244926,1.0,15/22,41.85%,AHNAK;GNB5;CACNB2;SRI;CACNB1;STAC;DRD2;CACNB3;STAC3;CBARP;HPCA;STAC2;GPR35;NOS1AP;DMD
prerank,regulation of store-operated calcium entry (GO:2001256),-0.34539104602338677,-0.8669847094177474,0.6202898550724638,0.8343322005217205,1.0,2/10,5.11%,SARAF;HOMER1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3258730560838481,-0.8669763041171403,0.6298932384341637,0.833494723512678,1.0,9/13,34.40%,ANO6;CLIP3;ACSL5;ACSL1;P2RX7;SLC26A6;C2CD5;NR4A3;C3
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3651892430550823,-0.8667410951848397,0.6419098143236074,0.833154796435872,1.0,2/10,1.56%,CAMK2D;HECW1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.2646942722846437,-0.8662315269313888,0.611764705882353,0.8333455416786808,1.0,13/26,33.68%,CALM1;FKBP1A;GNB5;ATP1A2;SRI;ADRA2A;CALM3;DRD2;GSTM2;GSTO1;CBARP;CASQ2;PLN
prerank,regulation of protein processing (GO:0070613),0.4089916291590012,0.8662248568687922,0.6149936467598475,1.0,1.0,3/21,9.99%,PRNP;LRRK2;GAS1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.29060064033619426,-0.8661226605032777,0.6851063829787234,0.8327175116846466,1.0,8/19,20.05%,PRKN;USP36;SREBF2;CAMKK2;PINK1;GSK3A;FBXO7;PARK7
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.2590909046652051,-0.8658858034458438,0.6666666666666666,0.8323189112861862,1.0,11/27,22.47%,MAPK8;CUL1;TAOK2;MAP3K5;MAPK3;MAPK1;CHUK;MAP2K7;UBB;RPS27A;UBC
prerank,regulation of TOR signaling (GO:0032006),0.36993217214421276,0.8656579731109186,0.6474973375931843,1.0,1.0,13/67,17.75%,FAM83D;TNFAIP8L1;FNIP1;DEPDC5;DYRK3;TBC1D7;NPRL3;SLC38A9;ITFG2;RPTOR;LARS1;LAMTOR3;LAMTOR5
prerank,negative regulation of glycolytic process (GO:0045820),0.44519881655511706,0.8655607804952676,0.5933232169954477,1.0,1.0,1/10,2.99%,PFKFB1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.44519881655511706,0.8655607804952676,0.5933232169954477,1.0,1.0,1/10,2.99%,PFKFB1
prerank,negative regulation of cell growth (GO:0030308),0.3604580056020742,0.8655517639866392,0.6933198380566802,1.0,1.0,32/121,18.98%,PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;RTN4R;RBBP7;PML;SFRP2;SMARCA4;CDA;CRLF3;IP6K2;CCN3;PTPRS;NDRG3;ENPP1;ULK2;GJA1;SMAD4;JADE1;CDKN1B;SMAD3;STK11;TP53;SESN2;SFRP1;DNAJB2;DCBLD2;SIPA1;FRZB;CAPRIN2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.30228493349127195,-0.8654528566383992,0.642023346303502,0.8323268933383602,1.0,3/18,6.15%,POLDIP3;THOC2;DDX19B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.4219229075654144,0.8653697915980708,0.6204081632653061,1.0,1.0,4/19,11.74%,MCU;RIPOR2;CAMK1D;RAC1
prerank,regulation of postsynapse organization (GO:0099175),0.40144321510138514,0.8653115254694997,0.6183574879227053,1.0,1.0,9/28,18.67%,ARHGAP22;EPHA4;LRRK2;LZTS3;PDLIM5;ZDHHC15;SIPA1L1;ABI2;TANC2
prerank,neuron apoptotic process (GO:0051402),0.415052349481885,0.8652681142125807,0.6192411924119241,1.0,1.0,2/19,5.17%,CIT;FAM162A
prerank,neural crest cell differentiation (GO:0014033),-0.2959223564896788,-0.8648714005127257,0.6738197424892703,0.8326246514019736,1.0,2/18,1.12%,MEF2C;CDH2
prerank,regulation of mitochondrion organization (GO:0010821),0.3764218483141721,0.8645277265224619,0.6193693693693694,1.0,1.0,10/47,11.84%,MIEF2;GSK3B;IAPP;MAPT;RHOT1;FBXW7;HTRA2;LRRK2;CSNK2A2;STOX1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.39582155341196723,0.864185697966723,0.6070991432068543,1.0,1.0,7/27,12.73%,STMN1;ARHGAP28;CGNL1;TMEFF2;ARHGAP6;ARHGEF18;WASF2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.36529057693450595,0.8641432748194032,0.7115188583078491,1.0,1.0,25/113,20.02%,TGM1;HMGB2;VASH2;HYAL1;FGFR2;LAMB1;BMP6;TCF7L2;YAP1;TGFBR1;BMP2;PRKCA;NR4A1;SOX9;NOTCH2;PRKD1;ARNT;PRKD2;SFRP1;NRAS;OSR1;BAD;PLXNB3;RREB1;SEMA5A
prerank,negative regulation of protein binding (GO:0032091),0.3728513826367182,0.8640384581303512,0.6474973375931843,1.0,1.0,17/71,19.68%,AURKB;DDX11;AURKA;GSK3B;LRRK2;ATP2A2;ROCK1;PSME3IP1;MITD1;NES;ADRB2;PIN1;DNAJB2;STYX;ZFPM1;PRKCD;IFIT2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.44280244932679774,0.8639402994972789,0.6147058823529412,1.0,1.0,4/11,15.63%,LEPROT;VHL;ADIPOR1;NF2
prerank,negative regulation of potassium ion transport (GO:0043267),-0.33029053599439717,-0.8639303759853442,0.6332288401253918,0.8337834119512257,1.0,5/13,23.70%,CAV1;BIN1;NOS1;NEDD4L;PTK2B
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4058025882123052,0.8639058994761649,0.597799511002445,1.0,1.0,3/25,8.29%,ITPR1;MAPT;LRRK2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2762517506198535,-0.8637553248925095,0.6590909090909091,0.833350916019786,1.0,7/21,19.55%,CAV1;FZD2;CTNNB1;APC;DVL1;LRP6;FZD1
prerank,regulation of p38MAPK cascade (GO:1900744),0.3775137639598033,0.8634614295405603,0.6144859813084113,1.0,1.0,8/35,14.80%,ULK4;XDH;MAP3K4;RELL1;BMP2;EZR;DLG1;PER1
prerank,stress-activated MAPK cascade (GO:0051403),-0.21416637523163892,-0.8633255678131824,0.775,0.8333062325306807,1.0,24/61,23.35%,MAPK10;TNFRSF19;MAPK8;TAB2;CUL1;TAOK2;MAP3K5;TAB3;MAPK9;NOD1;MINK1;MAPK3;MAPK1;CHUK;MAP2K7;LGALS9;MAP3K13;UBB;GPS2;MAP3K12;RPS27A;UBC;MAP2K4;MAP3K11
prerank,visual perception (GO:0007601),0.3659259680862474,0.8629869517649378,0.6687435098650052,1.0,1.0,7/84,8.41%,GPR179;ADGRV1;EYA4;CRYBA1;RDH12;COL18A1;TYR
prerank,phasic smooth muscle contraction (GO:0014821),-0.34826092326441827,-0.8628924459884074,0.638121546961326,0.8333355130403443,1.0,6/10,34.93%,DRD2;EDNRB;EDN1;PTGER3;EDN3;HTR2B
prerank,negative regulation of neuron projection development (GO:0010977),0.3688796935630317,0.8625535169820454,0.6388583973655324,1.0,1.0,18/56,18.57%,RHOA;RTN4R;LPAR1;EFNA1;EPHA4;RAB29;DENND5A;PTPRS;BAG5;GAK;HDAC2;DPYSL3;EFNB2;ADCY6;PTEN;STMN2;TRPV4;MYLIP
prerank,protein dephosphorylation (GO:0006470),0.3612892261326004,0.8623696754260919,0.72165991902834,1.0,1.0,39/135,19.93%,PPM1G;PPM1D;EYA4;LHPP;TAB1;PPP2R3A;SSH2;PTPN2;PPP3CA;NCK1;DUSP12;MTMR2;EYA2;PPP2R5C;PTPN21;PTPRS;FBXW11;RPRD1A;PPP1CC;PPP2R2D;BTRC;PPP1R15B;PTPRA;STK11;PTPN13;PTPRU;MTMR3;PPP2R5B;DAPP1;PPP2R1B;PTEN;UBLCP1;PTPRK;PTPRE;RPRD1B;DUSP7;PPM1A;PTPN1;PTPN5
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.42278009561593793,0.861708497731063,0.595108695652174,1.0,1.0,6/14,20.14%,RFLNA;TGFBR1;WNT9A;SOX9;EFEMP1;CHADL
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.2893929113333684,-0.8613112154135237,0.654275092936803,0.8356302081033411,1.0,3/18,11.92%,MTUS1;LYN;SLIT2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.28910100030316294,-0.8604133732915972,0.6777777777777778,0.8366069475175014,1.0,8/17,26.13%,AR;ATP1A1;ABHD2;ATP1A3;ATP1A2;BMP7;URI1;GPER1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4267434812004257,0.8603796911793464,0.5880640465793304,1.0,1.0,5/13,17.78%,RRS1;RPP40;TSR1;NOL9;ABT1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.3611512230131932,-0.860223684287585,0.6588541666666666,0.8361669359361072,1.0,2/10,1.56%,CAMK2D;HECW1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4067928082058836,0.8601778140563537,0.610608020698577,1.0,1.0,7/20,19.92%,GSS;PTDSS2;PLOD2;GCLM;MTHFS;GCLC;HAGH
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4101415999653679,0.8601594237151863,0.6155778894472361,1.0,1.0,5/20,15.59%,SPDYA;PSRC1;STOX1;ADAM17;PKD2
prerank,intracellular protein transport (GO:0006886),0.3609283004578539,0.8591769532228885,0.8058058058058059,1.0,1.0,82/304,20.52%,ANKLE1;CCHCR1;RANBP17;USP6NL;NUP155;XPO1;RANGRF;STX11;RPAIN;TRAK1;E2F3;XPO4;ARFIP1;AP4M1;FUT10;EVI5L;TBC1D25;SNX1;TNPO1;MYO1C;NUP85;TBC1D13;EIF4ENIF1;CSE1L;WDR11;TPR;VPS26C;TBC1D2B;RAB22A;RAB29;STXBP2;STAM;SMURF1;STX2;SRPRA;RAB1A;SNX27;VIPAS39;COPB2;HERC2;COPZ1;AP3B1;IPO7;APPL2;NUP214;SCFD1;EHD1;STRADA;IFT27;IPO11;ARF4;NXT1;NUP133;ARL4A;MAIP1;IPO5;STX12;NUP42;ARF3;TBC1D9;STXBP1;VPS26A;TMED3;NXT2;FAM53B;ACD;RIC1;USO1;ARL5A;TMED10;EGR2;TBC1D12;STRADB;TBC1D10A;IPO9;BCS1L;NUP188;KIF13B;ARF1;EIF2D;RANBP3L;IPO4
prerank,sensory perception of sound (GO:0007605),0.36036487652175353,0.8584674064719112,0.6485097636176773,1.0,1.0,9/88,13.19%,BIRC5;ADGRV1;KIT;MKKS;NIPBL;RIPOR2;LHFPL5;HOMER2;ROR1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3510212698907117,-0.8584294764381524,0.6418338108882522,0.8390268055158994,1.0,6/10,35.74%,GIPC1;ATP7A;CTNS;OPN3;CDH3;MFSD12
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.34217301212978085,-0.8583457701623323,0.6428571428571429,0.8375212790085842,1.0,2/10,5.39%,MAP2K5;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.34217301212978085,-0.8583457701623323,0.6428571428571429,0.8375212790085842,1.0,2/10,5.39%,MAP2K5;KLF4
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3665122207625213,0.857602059648073,0.6853582554517134,1.0,1.0,15/86,13.19%,CDK5RAP2;PSRC1;RB1;MYLK3;NUMA1;MAPT;CDC42EP2;NCK1;DRG1;AKAP9;RAC1;NCK2;SYNPO2;BAIAP2L1;PRKCE
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3820771452870674,0.857245392782985,0.6423529411764706,1.0,1.0,2/35,3.50%,MASTL;GSK3B
prerank,negative regulation of protein catabolic process (GO:0042177),-0.23126185302426303,-0.8568222437104444,0.7364341085271318,0.8396802909296223,1.0,5/40,4.87%,SNRNP70;CST3;TIMP3;BANP;SNX3
prerank,negative regulation of immune effector process (GO:0002698),0.42303718085408976,0.8566779608429814,0.593519882179676,1.0,1.0,6/13,22.02%,ENPP3;RC3H1;CD47;HAVCR2;FER;APPL1
prerank,cytosolic calcium ion transport (GO:0060401),0.39653613323738085,0.8565475160912017,0.6088607594936709,1.0,1.0,10/28,18.18%,MCU;ATP2A2;SLC8A1;MCUB;CACNA1C;ATP2B1;MICU1;ITPR3;MAIP1;JPH1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3872132183983719,0.8554172426535659,0.6054502369668247,1.0,1.0,10/35,15.32%,RBFOX2;NEDD4;ARID1A;PMEPA1;UBR5;YAP1;NR3C1;PLPP1;MED1;SRC
prerank,regulation of phospholipid metabolic process (GO:1903725),0.449291120846132,0.8553584600701274,0.6089644513137558,1.0,1.0,4/10,14.95%,MTMR1;MTMR2;MTMR9;MTMR3
prerank,mRNA processing (GO:0006397),0.35754382279539415,0.854818610309169,0.796,1.0,1.0,79/287,19.97%,RBM15;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;ERCC3;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRRM1;CPSF4;SNRNP35;HNRNPH2;RNGTT;RPRD1A;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;KIN;RBM19;HNRNPA2B1;PPWD1;LSM4;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;PRPF18;GEMIN7;CWC25;CWC22;PDCD7;BUD13;RPRD1B;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;SNRPB;ERCC2;TRA2A
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3803869678644285,0.8547473527417031,0.6129032258064516,1.0,1.0,9/39,15.97%,MAP4K4;RHOA;ACTN4;CASK;HOXA7;DMTN;NF2;TBCD;RCC2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3786525249658244,0.8546263384610513,0.6380090497737556,1.0,1.0,6/40,13.10%,SLC25A21;SLC38A7;SLC38A4;SLC19A1;SLC38A9;SLC25A30
prerank,cation transmembrane transport (GO:0098655),0.36757191950601686,0.8544801168459564,0.6330690826727067,1.0,1.0,11/44,19.08%,RHAG;SLC6A5;TRPM2;TRPM4;PKD2;SLC36A4;SLC7A1;SLC6A9;SLC25A29;SLC25A19;TRPM6
prerank,negative regulation of neuron death (GO:1901215),0.3606596451807786,0.8542993744936549,0.6818181818181818,1.0,1.0,12/93,15.38%,KIF14;GSK3B;HTRA2;KDM2B;LRRK2;IKBKG;CNTF;NENF;PRKCI;BTBD10;SLC30A10;GDNF
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4384432088802754,0.854228712606823,0.6067415730337079,1.0,1.0,2/12,12.02%,SOAT1;SOAT2
prerank,regulation of cellular response to stress (GO:0080135),0.35943452503887086,0.8542192678581363,0.7281947261663286,1.0,1.0,14/115,6.58%,NDC1;NUP155;NUP205;NUP160;ROCK2;GSK3B;RPA1;AJUBA;AIFM2;DYRK3;MAPT;NUP85;RPA2;TPR
prerank,cell projection organization (GO:0030030),0.38511548151091246,0.8542026236318949,0.5995260663507109,1.0,1.0,8/30,16.37%,PARVA;PACSIN2;RHOQ;NPHP1;RAC1;ITGB1;CAPG;NCKAP1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.43879930209537277,0.8542002418074272,0.6197604790419161,1.0,1.0,3/11,7.14%,ELOF1;ARID1A;CHEK1
prerank,endothelial cell migration (GO:0043542),0.3878655803750509,0.8541179984403514,0.6151162790697674,1.0,1.0,10/37,17.77%,LOXL2;RHOA;ADGRA2;CORO1B;LGALS12;CCN3;NR4A1;PLXND1;RAB13;PLEKHG5
prerank,neuron projection morphogenesis (GO:0048812),0.3589116098739975,0.854035173054276,0.72165991902834,1.0,1.0,15/137,11.05%,KIF20B;MAP4K4;ALCAM;FGFR2;RAB10;NRK;ANKRD27;LRRK2;DSCAML1;DNM2;FARP1;ROCK1;SRGAP2;EPB41L3;PLXNB1
prerank,glucan biosynthetic process (GO:0009250),-0.3277851442218888,-0.8537658271279767,0.6379821958456974,0.8440023991552772,1.0,2/12,2.88%,PER2;GBE1
prerank,glycogen biosynthetic process (GO:0005978),-0.3277851442218888,-0.8537658271279767,0.6379821958456974,0.8440023991552772,1.0,2/12,2.88%,PER2;GBE1
prerank,positive regulation of cell aging (GO:0090343),-0.33303019440305676,-0.8535869673895816,0.6360759493670886,0.8435461748511186,1.0,4/11,28.96%,B2M;HMGA2;ABI3;EEF1E1
prerank,positive regulation of neutrophil migration (GO:1902624),0.4137381369488475,0.8533571012746103,0.6140350877192983,1.0,1.0,4/18,11.74%,MCU;RIPOR2;CAMK1D;RAC1
prerank,cardiac muscle tissue development (GO:0048738),0.3768477636126968,0.853318984765304,0.6549835706462213,1.0,1.0,14/50,21.18%,BMPR1A;ADAMTS9;BMP2;TBX18;GJA1;SMAD4;NOTCH2;MAML1;HEY2;CSRP3;ZFPM1;NDUFV2;CACNA1G;BMP5
prerank,nucleotide metabolic process (GO:0009117),0.392807903329018,0.8526332069247566,0.6069142125480154,1.0,1.0,12/23,26.49%,DCK;NUDT5;ENPP3;GUK1;AK7;NMNAT1;NMNAT2;PNP;NMNAT3;ME1;CTPS2;AK8
prerank,metal ion homeostasis (GO:0055065),-0.23772333209630922,-0.8524336127408654,0.7142857142857143,0.8450907674426752,1.0,7/40,16.25%,TMTC2;CAV1;FAM20A;SELENON;SLC12A9;GRIN1;SLC12A2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3759837929083031,0.8522212096256419,0.641340782122905,1.0,1.0,12/45,18.73%,DYRK1A;SETX;NMD3;POLR2A;DXO;NFKB1;TP53;ZC3H18;PNPT1;HNRNPLL;SLC38A2;RIPK1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.30630591593360534,-0.8521869179485674,0.6929133858267716,0.8447582827984637,1.0,8/16,33.01%,EP300;NAA25;KAT2B;NAA80;NAA30;CREBBP;NAA16;NAA10
prerank,cellular response to interferon-gamma (GO:0071346),-0.18736511973875783,-0.8520013737359693,0.9090909090909091,0.844272144283549,1.0,19/88,17.26%,CAMK2D;TLR4;TRIM25;MID1;VCAM1;TRIM8;B2M;IRF2;CAMK2G;IFNGR2;IRF3;IRF9;CX3CL1;IFNGR1;GBP3;GBP4;RPL13A;MT2A;LGALS9
prerank,mesoderm development (GO:0007498),-0.2900554414753872,-0.8515982695870469,0.6666666666666666,0.8441969418845896,1.0,6/18,14.56%,FOXC2;TBX3;TIE1;TBX1;BMX;VEGFA
prerank,positive regulation of translation (GO:0045727),0.35842130164968206,0.8515210290925698,0.696813977389517,1.0,1.0,22/94,16.96%,LARP4B;AGO2;HNRNPD;KHDRBS1;DHX9;PRKDC;UPF3B;SAMD4A;FMR1;YBX3;LARP1;USP16;CDC123;YTHDF2;PLXNB2;METTL5;EIF3C;LARP4;FXR1;PASK;METTL3;PYM1
prerank,hexose transmembrane transport (GO:0008645),-0.285841569859648,-0.8510614439576625,0.6583333333333333,0.8444146752730667,1.0,7/21,32.84%,SLC2A1;SLC2A3;SLC2A10;SLC45A3;SLC2A9;SLC5A3;SLC45A1
prerank,regulation of endopeptidase activity (GO:0052548),0.3654946044341242,0.8506889225001066,0.6467449306296692,1.0,1.0,7/59,11.37%,SERPINB8;SERPINA9;SERPINE1;PICALM;AGT;PSMB9;HDAC1
prerank,regulation of phospholipase activity (GO:0010517),0.44396440897558753,0.8504020515658799,0.6326219512195121,1.0,1.0,2/10,12.28%,FGFR2;PDPK1
prerank,stem cell development (GO:0048864),-0.3004293616806269,-0.8502675227978062,0.68359375,0.8450817103317985,1.0,14/16,50.11%,CDH2;NOLC1;KLHL12;SOX11;PTPRC;SOX8;KBTBD8;PDCD6;SNAI2;NRG1;SHH;WNT7A;PEF1;CYP26C1
prerank,ketone body metabolic process (GO:1902224),0.44310026763822363,0.8499663122113602,0.621283255086072,1.0,1.0,3/10,18.81%,ACAT1;AACS;BDH2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.37864256791816936,0.849827543005896,0.6189349112426036,1.0,1.0,15/34,26.19%,TRIOBP;LIMS1;CRKL;RAC1;DMTN;DOCK1;DOCK5;RREB1;FERMT2;FLNA;S100A10;CRK;MYADM;P4HB;CDC42
prerank,regulation of cell migration (GO:0030334),0.3565235922806616,0.8496095008566382,0.86,1.0,1.0,71/382,16.14%,KIF14;ARHGEF39;GTSE1;MAP4K4;SYNE2;ULK4;MACF1;TWIST2;TRIP6;ROCK2;RHOA;CEP43;MMP14;DDRGK1;ACTN4;ARID2;LAMB1;KIT;SPAG9;CCAR1;PDPN;MYO1C;STK24;RAP2A;AFDN;ENPP2;PDGFRA;PLAU;SFRP2;PPP3CA;CCN1;PHACTR1;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;ROCK1;SRGAP2;SRGAP3;TGFBR1;PLXNB2;PLXNB1;BMP2;ANXA1;NKX2-1;TBCCD1;RAC1;APPL2;PRKCA;ADAM17;CLIC4;DPYSL3;CTSH;PLXND1;ADAM9;ITGB1;MIA3;NKD1;PTPRU;SEMA3D;SRC;ELP6;RHOC;SUN2;NF2;LMO4;RCC2;SFRP1;PTEN
prerank,negative regulation of growth (GO:0045926),0.3550465853424626,0.848522542720529,0.7164634146341463,1.0,1.0,32/121,18.98%,PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;RBBP7;PML;SFRP2;ING4;SMARCA4;CDA;CRLF3;IP6K2;CCN3;NDRG3;ENPP1;GJA1;SMAD4;NOTCH2;JADE1;CDKN1B;SMAD3;STK11;TP53;SESN2;SFRP1;PNPT1;DNAJB2;DCBLD2;SIPA1;FRZB;CAPRIN2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.4280724756841036,0.8480998297613104,0.6289120715350224,1.0,1.0,1/12,2.53%,GMDS
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3873562955409299,0.8479395125328131,0.6245572609208973,1.0,1.0,4/35,8.07%,PCDHGB4;CDH18;CDH24;PCDHGC3
prerank,positive regulation of interleukin-2 production (GO:0032743),0.385639870817735,0.8478194588839116,0.6124031007751938,1.0,1.0,9/25,21.51%,STOML2;CD80;ANXA1;PRKD2;RUNX1;PDE4B;TRAF6;TRAF2;PNP
prerank,lymphocyte chemotaxis (GO:0048247),-0.23679336160391384,-0.8476231280349237,0.6762589928057554,0.8493535502574008,1.0,16/34,41.86%,CYP7B1;GAS6;CX3CL1;SLC12A2;PIK3CD;CCL13;CXCL16;GPR183;CCL19;ADAM8;CH25H;CCL15;HSD3B7;PIK3CG;CCL2;CXCL10
prerank,chemical homeostasis (GO:0048878),-0.21010632743454036,-0.8474434317750981,0.7926829268292683,0.8488028355335834,1.0,28/61,33.80%,ADCK1;ABHD5;SLC4A7;WNK2;TLCD2;IRS2;PNPLA8;NR1D2;NR1H3;KLHL3;SLC4A8;TLCD3A;AQP11;TENT4B;USF2;USF1;NEDD4L;EIF5A2;ABHD8;PNPLA2;CLN8;DDX3X;PNPLA3;TLCD1;VGF;ANGPTL3;FITM2;PPARG
prerank,regulation of vasculature development (GO:1901342),0.3947505439082582,0.8473024883965437,0.6215880893300249,1.0,1.0,6/26,20.27%,VASH2;ADGRA2;PLXND1;SFRP1;SP100;EGLN1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36136320716819037,0.8469742301251794,0.6923076923076923,1.0,1.0,15/80,12.82%,ANLN;ACTR3;AUTS2;FMR1;CDC42EP2;RHOQ;RIPOR2;EPS8L1;TAPT1;ARHGAP35;CEP120;RAC1;DOCK11;WASF2;DPYSL3
prerank,endomembrane system organization (GO:0010256),0.35511298238603745,0.8469023124763948,0.7695390781563126,1.0,1.0,47/178,20.49%,ARHGAP21;USP6NL;NUP155;GBF1;OBSL1;LNPK;COG1;ZW10;WASHC4;ATL2;MYOF;ATL3;RAB22A;LEMD3;RAB29;VPS18;LRRK2;GOLGA8B;GOLGA5;RAB1A;SNX33;EIF2AK3;BAG5;GAK;GORASP2;EXOC8;PRKD1;MIA3;TOR1B;VAPA;SYP;SUN2;TMCC1;DYSF;TMED3;UBXN2B;CSNK1A1;COG4;CLASP1;TMED10;PI4K2B;SUN1;LYSMD3;DNM1L;ANK3;ATP8B2;TRAPPC8
prerank,cellular response to nutrient levels (GO:0031669),-0.21050549901825974,-0.8462815935131498,0.7878787878787878,0.8501782923617262,1.0,16/62,16.81%,FOXO1;KCNB1;BMPR2;WDR45B;RALB;EIF4G1;ULK1;PRKAA1;VPS41;MTOR;SREBF2;KLF10;RRAGC;LAMP2;USP33;XBP1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3616095687918919,0.8461670332537881,0.6530837004405287,1.0,1.0,23/59,24.71%,TICAM1;MAP3K14;ROCK2;TAB1;RNF31;ROCK1;IKBKG;ERC1;PRDX4;RIPK1;RELB;TRAF6;TANK;TRAF2;IKBKB;BIRC2;TLR7;DAB2IP;NFKBIL1;BCL10;RIPK2;REL;RELA
prerank,establishment of vesicle localization (GO:0051650),-0.2877273469581096,-0.846078149818127,0.6798561151079137,0.8497356299502306,1.0,7/18,18.49%,SPG11;KIF5B;KIF5C;SYT11;SYNJ1;RAB11A;RAB27A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.36123444662074533,0.8458462387764207,0.6745182012847966,1.0,1.0,24/67,18.34%,ROCK2;RHOA;VAV2;SULF1;NCK1;ABI1;ROCK1;CYBB;PIK3CB;SH2D2A;RAC1;NCK2;MAPKAPK3;WASF2;DOCK1;PRKD1;ITGAV;AAMP;SRC;PRKD2;NCKAP1;AXL;SHB;MAPK14
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.35940077897559297,0.8457479193693409,0.7793380140421263,1.0,1.0,50/186,18.66%,GLI3;WWOX;GSK3B;PSMC2;PSMD5;TRABD2B;BICC1;NLK;SIAH2;MCC;STK3;RNF43;TCF7L2;HMGXB4;SFRP2;WWTR1;PSMB1;CUL3;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;EMD;PSMB9;DKK3;HDAC1;BMP2;RBMS3;LZTS2;LMBR1L;SOX9;JADE1;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;TLE3;NOTUM;SFRP1;AMER1;MLLT3;CSNK1A1;PSMB2;PSME4;FRZB;PSMB7
prerank,sulfation (GO:0051923),0.42941434938170875,0.8457037712199946,0.6324167872648335,1.0,1.0,11/11,57.09%,UST;SULT4A1;SULT2A1;CHST4;SULT1C2;SULT1C4;SULT6B1;SULT1A1;SULT2B1;HS3ST5;CHST5
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.2699687522174014,-0.8452600819181308,0.7053140096618358,0.8504008494964493,1.0,6/21,20.03%,GUCY1A1;NPR1;ADCY3;ADCY8;ADCY4;AMPD2
prerank,keratinocyte differentiation (GO:0030216),0.39415822771512876,0.8449584340571613,0.6163215590742996,1.0,1.0,5/29,13.77%,TGM1;ANXA1;CLIC4;MED1;ADAM9
prerank,phospholipid biosynthetic process (GO:0008654),0.3806726693611612,0.8446424864911631,0.632438739789965,1.0,1.0,5/36,13.24%,DHDDS;LPCAT1;SRD5A3;AGK;AGPAT3
prerank,regulation of necroptotic process (GO:0060544),-0.2616248653360907,-0.8443516893712983,0.6887755102040817,0.8513387149544728,1.0,7/23,17.19%,OGT;CYLD;ARHGEF2;STUB1;SDCBP;SLC25A4;BIRC3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.407401380104392,0.8443156280006145,0.6265223274695535,1.0,1.0,3/16,7.72%,AGL;PYGB;PHKA2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3652070308536029,0.8442457793910167,0.6898395721925134,1.0,1.0,10/64,10.10%,MAP4K4;MACF1;ROCK2;RHOA;GSK3B;CASK;HOXA7;PLAU;ROCK1;PIK3CB
prerank,autophagy of nucleus (GO:0044804),0.40819129914596075,0.8441809460494342,0.6292134831460674,1.0,1.0,5/16,14.53%,ATG7;RB1CC1;ULK2;ATG3;ATG2A
prerank,neuromuscular synaptic transmission (GO:0007274),0.4024124563077111,0.8441127474244273,0.6280884265279584,1.0,1.0,4/18,13.16%,CHAT;ERC1;CHRNB1;ERC2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.2772325891234523,-0.8440974794552184,0.6746987951807228,0.8510255058618964,1.0,5/18,10.73%,CTSC;APOE;DACT1;VPS11;CD81
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3992678520006172,0.84408803645892,0.6450060168471721,1.0,1.0,6/25,12.68%,SRSF4;TRA2B;SRSF10;PRPF3;SRRM1;SF3B3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.39011494904597865,0.8440671766653869,0.6287128712871287,1.0,1.0,7/25,19.47%,BMF;FAM162A;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.406993572031614,0.8437851601202905,0.6184738955823293,1.0,1.0,5/16,16.74%,NPNT;BMP2;GDNF;PKD2;SALL1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.36832239991462545,0.8437491533654025,0.6354515050167224,1.0,1.0,10/48,13.44%,TRIOBP;OBSL1;CUX1;PRKDC;CAPRIN1;LIMS1;CRKL;RAC1;DMTN;DOCK1
prerank,histone H2B ubiquitination (GO:0033523),-0.3425972485602297,-0.8434346192330184,0.6588921282798834,0.8515717499582917,1.0,2/10,3.25%,CDC73;UBE2E1
prerank,positive regulation of T cell proliferation (GO:0042102),0.3654553860637574,0.8432795045592425,0.6436285097192225,1.0,1.0,7/55,12.29%,FADD;IL18;CD80;NCK1;HMGB1;ANXA1;NCK2
prerank,negative regulation of TOR signaling (GO:0032007),0.3748004172880527,0.8432717383215971,0.6435294117647059,1.0,1.0,9/36,15.99%,TNFAIP8L1;FNIP1;DEPDC5;TBC1D7;NPRL3;SESN1;ITFG2;STK11;SESN2
prerank,regulation of amyloid-beta formation (GO:1902003),0.3788187698534537,0.843084809652934,0.6530849825378346,1.0,1.0,7/34,9.55%,ROCK2;RTN3;PRNP;EFNA1;EPHA4;ROCK1;PICALM
prerank,phosphate ion transmembrane transport (GO:0035435),0.43472584336849485,0.843029798728185,0.6219686162624821,1.0,1.0,4/12,21.68%,SLC20A2;SLC25A30;SLC37A2;SLC37A3
prerank,regulation of T cell activation (GO:0050863),-0.22446085399177101,-0.8423842416293794,0.8088235294117647,0.8527704685402895,1.0,7/42,11.61%,CYRIB;DUSP3;PRKCQ;PTPN22;HSPD1;ABL1;TNFRSF1B
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.36105799553523155,0.8420533026867921,0.6666666666666666,1.0,1.0,22/55,24.77%,AURKA;PSMC2;PSMD5;FBXL7;PSMB1;PSMD14;PSMD1;PSMB9;ATF5;USP47;PSMC6;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,mesonephric tubule development (GO:0072164),0.41430659254735036,0.8419372548586439,0.614441416893733,1.0,1.0,5/15,18.17%,FGFR2;NPNT;PKD2;SALL1;OSR1
prerank,erythrocyte differentiation (GO:0030218),0.3689655262097246,0.8418854181746855,0.655367231638418,1.0,1.0,11/44,13.64%,KIT;TSPO2;DYRK3;IKZF1;PTPN2;TGFBR3;ABCB10;TAL1;DMTN;ATP5IF1;MED1
prerank,response to retinoic acid (GO:0032526),0.3680809933792953,0.8417970240489694,0.6735135135135135,1.0,1.0,9/59,13.08%,AQP1;CDKN2D;SETX;ASXL1;HTRA2;WNT6;WNT9A;SOX9;CTSH
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.39862512729603716,0.8415265698123467,0.6121673003802282,1.0,1.0,6/21,18.14%,CBFB;ELF2;ELF1;PRKCB;FOXP1;RUNX1
prerank,non-motile cilium assembly (GO:1905515),0.38125070911416,0.8399574890071618,0.6501182033096927,1.0,1.0,3/30,5.29%,CEP89;PCM1;C2CD3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.41941671120032664,0.839450204408697,0.6345323741007194,1.0,1.0,5/14,20.34%,ACTN4;WNK1;GLRX;WNK3;ANK3
prerank,regulation of B cell differentiation (GO:0045577),0.405564900108487,0.8394193084063685,0.6304044630404463,1.0,1.0,4/17,16.06%,MMP14;BTK;IL4I1;SFRP1
prerank,positive regulation of cell killing (GO:0031343),-0.31797815234780946,-0.8392789740348368,0.67601246105919,0.8579110583072788,1.0,4/13,27.32%,MAPK8;NOX1;SYK;DVL2
prerank,synaptic vesicle recycling (GO:0036465),-0.2513919613328047,-0.8391862158883916,0.6981132075471698,0.8572464261780056,1.0,12/31,20.57%,OPHN1;AMPH;SYT1;PLD2;RAB5A;SYT7;TBC1D24;SYNJ2;FCHO2;SYNJ1;NLGN1;SYT2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.3343159998119951,-0.8389119028177641,0.6572327044025157,0.8569824273409218,1.0,1/12,0.75%,IL1R1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.32623477708242465,-0.8388254858548604,0.660436137071651,0.8562983070567906,1.0,7/11,31.75%,TOMM70;TIMM9;TIMM13;TIMM8B;NDUFA13;ROMO1;TIMM29
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.36525476313139266,0.8384175081887505,0.6544035674470458,1.0,1.0,14/51,17.29%,ROCK2;RHOA;LPAR1;SORBS3;TGFBR1;RAC1;SYNPO2;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47
prerank,triglyceride catabolic process (GO:0019433),0.39829513092693425,0.8382467467233261,0.6189839572192514,1.0,1.0,2/19,15.77%,FABP12;LPL
prerank,muscle cell differentiation (GO:0042692),-0.24764172661560674,-0.8380682079624915,0.7272727272727273,0.856832849809085,1.0,6/32,13.44%,MEF2C;SYNE1;SPEG;NEBL;MRTFB;TBX1
prerank,regulation of immunoglobulin production (GO:0002637),-0.27406227890080803,-0.8379318951121022,0.7122641509433962,0.8562834882092234,1.0,10/23,33.99%,STX4;EPHB2;VAMP3;XBP1;DNAJB9;CD86;PHB2;PTPRC;RBP4;CLCF1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3833546780944577,0.8376153358077582,0.6514423076923077,1.0,1.0,6/29,11.15%,RPA1;CHD1L;RPA2;ERCC3;CUL4B;XPA
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.41227672775246366,0.8371136979656042,0.6175637393767706,1.0,1.0,6/14,23.85%,ZNHIT3;DDX18;WDR12;NOL9;URB1;RPL7
prerank,reticulophagy (GO:0061709),0.41982301004872374,0.8370372354048797,0.6341463414634146,1.0,1.0,4/12,14.53%,DDRGK1;RB1CC1;ULK2;ATG2A
prerank,erythrocyte development (GO:0048821),0.4383671996724416,0.8368078849939407,0.6320474777448071,1.0,1.0,4/10,16.87%,ABCB10;DMTN;MED1;ALAS2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3298068353917067,-0.8367657099756791,0.6698113207547169,0.8568523302508619,1.0,7/11,33.22%,CALM1;FKBP1A;SRI;CALM3;GSTM2;GSTO1;CASQ2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3298068353917067,-0.8367657099756791,0.6698113207547169,0.8568523302508619,1.0,7/11,33.22%,CALM1;FKBP1A;SRI;CALM3;GSTM2;GSTO1;CASQ2
prerank,sensory perception of smell (GO:0007608),-0.3417711199204268,-0.8364051393033085,0.6837349397590361,0.8566766348195187,1.0,5/11,22.19%,BBS4;ADCY3;SYT10;SLC24A4;DRD2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.36105645377091183,0.8355968144886872,0.69394261424017,1.0,1.0,10/62,12.98%,DDIAS;CDKN2D;TXNDC12;RTKN2;SFRP2;YBX3;HTRA2;LRRK2;BAG5;PLAUR
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4211574616442607,0.8355598474364395,0.6347826086956522,1.0,1.0,3/13,7.14%,ELOF1;ARID1A;CHEK1
prerank,peptidyl-proline modification (GO:0018208),0.3917635379575757,0.83509910936468,0.6426799007444168,1.0,1.0,6/25,15.57%,PPIL1;FKBP5;PPIG;PPID;PIN1;PPWD1
prerank,Notch signaling pathway (GO:0007219),0.3587412502009049,0.8347290276968785,0.6817691477885652,1.0,1.0,11/59,13.44%,DLGAP5;GMDS;POFUT1;BMP2;RBPJ;ADAM17;NOTCH2;ITCH;PLXND1;MAML1;HEY2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.35415797005988836,0.8346888069863536,0.7748743718592965,1.0,1.0,46/161,18.66%,GLI3;GSK3B;PSMC2;PSMD5;BICC1;SIAH2;MCC;STK3;TCF7L2;SFRP2;WWTR1;PSMB1;CUL3;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;EMD;PSMB9;DKK3;HDAC1;BMP2;TBX18;RBMS3;LZTS2;LMBR1L;SOX9;JADE1;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;TLE3;NOTUM;SFRP1;AMER1;MLLT3;CSNK1A1;PSMB2;PSME4;FRZB;PSMB7
prerank,chondroitin sulfate metabolic process (GO:0030204),0.37863413513211397,0.8342857411026319,0.6483790523690773,1.0,1.0,8/30,17.35%,CHST15;HYAL1;CHSY1;CHST3;DSE;BGN;UGDH;ARSB
prerank,response to chemokine (GO:1990868),0.4106516004178575,0.8342785245049886,0.6276150627615062,1.0,1.0,5/13,18.16%,RHOA;WNK1;RIPOR2;STK39;OXSR1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.40649959926626333,0.8341455990488396,0.6329787234042553,1.0,1.0,4/17,14.37%,DYRK1A;YJU2;TWIST1;CD44
prerank,positive regulation of phospholipase activity (GO:0010518),0.39026627300678757,0.8334815920182272,0.6513409961685823,1.0,1.0,6/22,13.70%,FGFR2;KIT;PDGFRA;GNA13;PDPK1;ARF4
prerank,activation of protein kinase A activity (GO:0034199),-0.29288131860267413,-0.8334431339627156,0.66796875,0.8614198878742977,1.0,5/16,14.87%,PRKACB;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.20731380904972624,-0.8333465356226959,0.7777777777777778,0.8607543455813073,1.0,23/65,26.13%,SH3KBP1;ARAP1;STAM2;DUSP3;EPN1;TSG101;TGFA;BCAR3;GRB2;SPRY2;RHBDF1;HIP1;ARHGEF7;CBL;AFAP1L2;PTPN12;DGKD;HBEGF;RHBDF2;SH3GL2;MVB12A;SHKBP1;GPER1
prerank,endothelial cell proliferation (GO:0001935),0.41003877006862166,0.8333413205498776,0.6369770580296896,1.0,1.0,2/17,3.05%,LOXL2;ANGPT4
prerank,calcium ion import across plasma membrane (GO:0098703),0.4147550414749977,0.8328917104967818,0.624103299856528,1.0,1.0,3/14,10.65%,ATP2B4;SLC8A1;TRPM2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3883885847769976,0.8326097757070313,0.6338199513381995,1.0,1.0,1/26,1.19%,SLC18A2
prerank,phosphate ion transport (GO:0006817),0.40870973975621966,0.8325989222594778,0.6330275229357798,1.0,1.0,4/16,21.68%,SLC20A2;SLC25A30;SLC37A2;SLC37A3
prerank,regulation of protein transport (GO:0051223),0.3764348936298014,0.8324668110422973,0.6303549571603427,1.0,1.0,7/27,15.78%,ARFIP1;DNAJC1;STXBP5;LLGL2;P3H1;SCFD1;LCP1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3824582127213001,0.83243598437796,0.6453143534994069,1.0,1.0,5/31,15.24%,PAXIP1;GPI;RIF1;KMT5C;SHLD2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.40905295511247924,0.8314856381811552,0.6506189821182944,1.0,1.0,7/15,25.58%,RPP40;RPP30;POP1;KHNYN;LACTB2;RNASEH1;NUDT16
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.30000831798261196,-0.8310780474358436,0.6705882352941176,0.8641279696749806,1.0,3/15,19.19%,SAT1;MOXD1;DDC
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.37213197919394264,0.8308398697351322,0.6414201183431952,1.0,1.0,5/33,9.90%,ATP2B4;ANGPT4;RHOA;HMGB1;MEOX2
prerank,regulation of cell size (GO:0008361),0.39212376482149486,0.8307512942452411,0.6584734799482536,1.0,1.0,9/23,17.75%,RHOA;VAV2;EZR;RAC1;RPTOR;PTEN;LARS1;MSN;LAMTOR5
prerank,negative regulation of peptidase activity (GO:0010466),0.36620331081935664,0.8306695383296244,0.659316427783903,1.0,1.0,4/47,9.77%,SERPINB8;SERPINA9;SERPINE1;AGT
prerank,response to glucocorticoid (GO:0051384),0.3887994423601959,0.8301275862734242,0.6201743462017435,1.0,1.0,7/26,22.48%,NR3C1;HNRNPU;ANXA1;ADAM9;PDCD7;UBE2L3;ZFP36L1
prerank,regulation of dephosphorylation (GO:0035303),0.414420702593698,0.8299549273964243,0.6265734265734266,1.0,1.0,6/15,15.32%,MTMR1;MTMR2;MTMR9;SMG6;MTMR3;SRC
prerank,sphingoid metabolic process (GO:0046519),-0.32373759103886424,-0.8299508280397705,0.7035928143712575,0.8653738259913625,1.0,8/12,38.53%,PLPP3;DEGS2;ASAH2;SPHK1;KDSR;SPHK2;SGPP1;PLPP2
prerank,embryonic hemopoiesis (GO:0035162),0.42195428075782065,0.829548545837506,0.6530303030303031,1.0,1.0,3/12,10.56%,KIT;KMT2A;TAL1
prerank,response to molecule of bacterial origin (GO:0002237),-0.20390620458346276,-0.8294705056541735,0.7735849056603774,0.8654436279757222,1.0,15/69,17.68%,CYRIB;IFNAR1;TAB2;NOS3;TLR4;LIAS;GGT5;LBP;PTPN22;TNFRSF11A;C4B;GCH1;ERBIN;LGALS9;PRDX3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3496605061250034,0.8288325318836743,0.8248248248248248,1.0,1.0,79/248,21.77%,GLI3;CDK14;GSK3B;FGFR2;PSMC2;RNF220;PSMD5;BICC1;SIAH2;MCC;TBL1XR1;ADGRA2;STK3;TCF7L2;WNK1;SFRP2;WWTR1;UBR5;LRRK2;PSMB1;CUL3;GNAQ;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;LRRK1;EMD;PSMB9;DKK3;SMURF2;HDAC1;BMP2;RBMS3;LZTS2;LMBR1L;CSNK1G2;TRPM4;SOX9;JADE1;USP47;BTRC;XIAP;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;PIN1;TLE3;NFKB1;NOTUM;SFRP1;AMER1;MLLT3;FAM53B;CSNK1A1;PSMB2;CSNK1G1;PSME4;FRZB;PSMB7;CAPRIN2;TMEM131L;PPM1A;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;FRMD8;LATS1;PSMD13;COL1A1;STK4
prerank,regulation of viral genome replication (GO:0045069),0.35696252838400677,0.8288261400513993,0.693565976008724,1.0,1.0,13/56,17.97%,ILF3;FAM111A;ZC3HAV1;LARP1;TMEM39A;SRPK1;TRIM6;PPID;PABPC1;CNOT7;MAVS;SRPK2;PKN2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.39171947210213,0.8286186233772392,0.6620428751576293,1.0,1.0,6/24,17.67%,ACTR3;AUTS2;RAC1;WASF2;NCKAP1;ABI2
prerank,regulation of protein binding (GO:0043393),0.3500733886924563,0.8284872281129179,0.7357723577235772,1.0,1.0,13/114,9.80%,PLK1;AURKB;DDX11;AURKA;GSK3B;ADD2;STK3;TCF7L2;NMD3;LRRK2;ROCK1;PSME3IP1;MARK2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27532528594425254,-0.8283752926684582,0.6896551724137931,0.8665949674915999,1.0,8/18,25.76%,PRKN;TRAP1;SOD2;PINK1;PARK7;HSPB1;MAPK7;HIF1A
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.34877713662995485,0.8274303172258413,0.7402061855670103,1.0,1.0,23/95,16.67%,HAS3;CHST15;HYAL1;B4GALT1;GPC6;CHSY1;SLC10A7;ST3GAL3;SLC35D2;B4GALT7;CHST3;ANGPT1;HAS1;UST;SDC1;HS2ST1;DSE;BGN;ST3GAL4;ST3GAL1;ST3GAL2;HSPG2;UGDH
prerank,xenobiotic transport (GO:0042908),-0.2850179834396767,-0.8269787469135906,0.726890756302521,0.8684485468498072,1.0,4/17,14.08%,SLC7A5;ABCG2;SLC15A2;ABCC5
prerank,positive regulation of cellular catabolic process (GO:0031331),0.34812682744990736,0.8266774901025249,0.7641700404858299,1.0,1.0,36/132,16.77%,TRIML2;MOV10;TICAM1;PFKFB1;GSK3B;ZC3HAV1;CNOT1;FAF1;TPCN1;SH3GLB1;FOXO3;LRRK2;SH3D19;ROCK1;ZBTB20;HMGB1;PIK3CB;SNX33;EZR;DAGLB;TRIM6;ITCH;DXO;TWIST1;PRKD1;ADAM9;PLK2;RC3H1;TRIM5;ARNT;STK11;CNOT7;ZC3H18;PNPT1;MSN;AMER1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3911849758282365,0.8265783275074803,0.6569620253164556,1.0,1.0,5/24,13.20%,VKORC1L1;GGCX;TTLL4;TTLL11;TTLL3
prerank,antibacterial humoral response (GO:0019731),0.3987817219800234,0.8263242666383833,0.628,1.0,1.0,1/16,4.48%,RNASE6
prerank,phospholipid dephosphorylation (GO:0046839),0.368373855369244,0.8259815821621496,0.6449026345933563,1.0,1.0,10/37,16.14%,OCRL;INPP5B;MTMR1;MTMR2;MTMR9;PIP4P2;PLPP1;PLPP5;MTMR3;PTEN
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2503943887691726,-0.8259315493255128,0.7157894736842105,0.8695716782871651,1.0,4/27,8.62%,CYRIB;NFAT5;PRKCQ;HSPD1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3507789847008104,0.8256569399026541,0.711882229232387,1.0,1.0,23/72,22.63%,FADD;CBFB;USP18;VRK2;PTPN2;ELF1;RNF31;SPPL2B;AGPAT2;IKBKG;CASP8;AGPAT1;IFNAR2;AXL;RUNX1;HIPK1;RIPK1;PTPN1;TRAF2;TAX1BP1;IKBKB;BIRC2;PIAS1
prerank,sodium-independent organic anion transport (GO:0043252),0.4348378473903284,0.8255038635985663,0.6349924585218703,1.0,1.0,3/10,13.35%,SLCO4A1;SLC16A2;SLCO3A1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.38159803052333147,0.8254591233632445,0.6455089820359281,1.0,1.0,10/32,16.14%,MAP4K4;CASK;HOXA7;SERPINE1;ARHGAP6;DMTN;SRC;NF2;RCC2;PTEN
prerank,epidermis development (GO:0008544),0.3592031855631962,0.825422701152189,0.6714129244249726,1.0,1.0,9/56,16.93%,FGFR2;GRHL2;SVEP1;ATP2A2;FLOT2;HDAC1;HDAC2;EMP1;CCN2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.40117221742767667,0.8248174318874523,0.6427640156453716,1.0,1.0,4/18,8.29%,GSK3B;FMR1;VPS18;LRRK2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.351927197715301,0.8247022564903657,0.7252861602497399,1.0,1.0,4/78,4.05%,PLK1;CDC20;GSK3B;DDRGK1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3932343271604633,0.8243559884350538,0.6535859269282814,1.0,1.0,7/17,22.31%,ROCK2;ROCK1;S1PR2;ADD1;ZDHHC21;IKBKB;VCL
prerank,regulation of steroid biosynthetic process (GO:0050810),0.42107814225130097,0.8243483338002029,0.6747720364741642,1.0,1.0,4/11,21.18%,FGFR4;BMP2;WNT4;BMP5
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.2924624162760083,-0.824285030550893,0.7031802120141343,0.8717991695223498,1.0,5/15,11.22%,SMAD7;RPL23;RPS7;ABL1;LIMK1
prerank,polyol biosynthetic process (GO:0046173),-0.28428420661496034,-0.8241651545733685,0.7231833910034602,0.8711583585303008,1.0,5/16,13.40%,IPPK;PPIP5K2;FGF2;ACER3;ITPKB
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.418919626915485,0.8241647708459756,0.6367461430575035,1.0,1.0,4/13,23.13%,NEDD4;NIBAN2;PTPN1;DAB2IP
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3832293024263727,0.8239216188142535,0.6653491436100132,1.0,1.0,5/21,16.67%,CHST15;CHSY1;CHST3;BGN;UGDH
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4164051424729597,0.8237561711322415,0.6397608370702541,1.0,1.0,3/12,14.04%,UST;DSE;BGN
prerank,regulation of protein targeting to membrane (GO:0090313),0.37120000793234265,0.8237468638494418,0.6706875753920386,1.0,1.0,6/28,12.64%,MIEF2;PRNP;PDZK1;MYO1C;MIEF1;DMTN
prerank,calcium ion import into cytosol (GO:1902656),0.40771877991052036,0.8234909450908222,0.6509298998569385,1.0,1.0,3/15,10.65%,ATP2B4;SLC8A1;TRPM2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3488570820262574,0.8234163016025033,0.6936353829557713,1.0,1.0,24/65,23.39%,AQP1;ANGPT4;MDM4;FAM162A;HP1BP3;CPEB2;NDRG1;RORA;TWIST1;NPEPPS;TP53;SFRP1;SUV39H2;BAD;PTGIS;TBL2;FMN2;TERT;EGLN1;SIRT2;EGLN3;ZFP36L1;KCND2;NOP53
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3752426794710185,0.8231219566009654,0.6618876941457587,1.0,1.0,6/31,12.60%,BMPR1A;FGFR2;TGFBR3;TGFBR1;RBPJ;SMAD4
prerank,regulation of axon extension (GO:0030516),0.36628867234696466,0.8228742402987507,0.6651216685979142,1.0,1.0,7/37,11.38%,MACF1;GSK3B;RTN4R;NTN1;MAPT;DNM2;PTPRS
prerank,regulation of translation (GO:0006417),0.3445510915300033,0.8228003530120277,0.8050251256281407,1.0,1.0,42/173,19.11%,TYMS;ILF3;SYNCRIP;LARP4B;CTIF;HNRNPD;CNOT1;DHX9;PRKDC;EIF4E;UPF3B;EIF4ENIF1;EIF4H;SAMD4A;CAPRIN1;FMR1;FOXO3;LARP1;PLXNB2;METTL5;MRPL13;EIF2AK3;EIF3C;RBM4;DHFR;LARP4;EIF4A2;MTRF1;EPRS1;CNOT7;FXR1;PASK;DDX1;METTL3;PYM1;NSUN3;EIF3H;PAIP2B;METAP1;PUS7;OGFOD1;ETF1
prerank,lipoprotein transport (GO:0042953),0.4247081785812658,0.8227016100831059,0.6464497041420119,1.0,1.0,4/10,19.44%,PRKCB;MIA3;UNC119;UNC119B
prerank,positive regulation of cilium assembly (GO:0045724),0.39849388242358597,0.8225979669504622,0.6587301587301587,1.0,1.0,3/18,11.01%,TAPT1;ARHGAP35;CEP120
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.28152937964240193,-0.8222693977465286,0.7015503875968992,0.8738385452225879,1.0,5/16,20.56%,MEF2C;BOC;BTG1;LRRC8A;HIF1AN
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.39374694153814943,0.8216833479835663,0.6542056074766355,1.0,1.0,4/16,12.82%,UPB1;DPYD;DPYSL4;DPYSL3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4095388971993563,0.8215795539552384,0.657258064516129,1.0,1.0,1/15,2.25%,DYRK1A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.2706569349084113,-0.8214721230499438,0.7131474103585658,0.8743791456847335,1.0,2/20,1.56%,CAMK2D;HECW1
prerank,regulation of interleukin-2 production (GO:0032663),0.35705149270920994,0.8214136557905438,0.6808755760368663,1.0,1.0,13/43,21.51%,PRNP;STOML2;CD80;EZR;ANXA1;HOMER2;PRKD2;RUNX1;HAVCR2;PDE4B;TRAF6;TRAF2;PNP
prerank,prostaglandin metabolic process (GO:0006693),0.3769769533133125,0.8211216016425156,0.6593406593406593,1.0,1.0,7/26,18.39%,PTGR1;PTGR2;HPGDS;PTGS1;DAGLB;PLAA;PTGIS
prerank,cellular response to fatty acid (GO:0071398),-0.319669156314797,-0.8209635876341957,0.6818181818181818,0.8744610665966841,1.0,8/12,42.60%,IRS1;ZC3H12A;NR1H4;DGAT2;PDK4;PDK3;KCNK4;PID1
prerank,autophagosome maturation (GO:0097352),-0.23561414884296666,-0.8206834498465394,0.7832167832167832,0.8741200438926474,1.0,18/32,34.31%,CALM1;TECPR1;SNX14;TSG101;SNAP29;VPS33B;LAMP2;VAMP8;GABARAPL2;CHMP3;MAP1LC3A;VPS33A;MAP1LC3B;CLN3;EPG5;ATG14;VCP;GABARAP
prerank,lung epithelium development (GO:0060428),0.4338118383652999,0.8205301051816177,0.6578947368421053,1.0,1.0,2/10,10.55%,GRHL2;ERRFI1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.315676313978975,-0.8199426804129331,0.7052980132450332,0.8747161156210306,1.0,3/13,13.91%,GLUL;GOT2;GOT1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.350649241601787,0.8197586772938652,0.7150313152400835,1.0,1.0,18/75,19.80%,PLK1;RB1;PKIG;SLC8A1;AGT;PIK3CB;IPO7;LRP5;SMPD1;CDKN1B;IPO5;PTEN;PRKAR2B;PRKAR2A;TFAP4;DUSP7;PRKCD;PTPN1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.27114858296660777,-0.8196266442448179,0.7304347826086957,0.8744000361085644,1.0,5/21,17.59%,GRIN2B;DELE1;GRIN1;BIRC3;SOX2
prerank,response to purine-containing compound (GO:0014074),-0.2875398711637944,-0.8194549833053365,0.7624521072796935,0.8738607057504922,1.0,9/17,32.59%,RYR2;TRPC3;DGKQ;NDUFS4;P2RX4;P2RX7;ABCC9;P2RY6;VGF
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3471947122319315,0.8189579557777947,0.7066381156316917,1.0,1.0,8/70,12.25%,PON1;CHAT;LPCAT1;LPIN2;ENPP2;CSNK2A2;TMEM86B;ACHE
prerank,hepaticobiliary system development (GO:0061008),0.3835763477348121,0.8189457946578006,0.6509803921568628,1.0,1.0,7/20,19.04%,TGFBR3;NIPBL;PHF2;GFER;PKD2;COBL;WNT4
prerank,sensory perception of light stimulus (GO:0050953),0.3465926276058113,0.8188656475764384,0.720954356846473,1.0,1.0,7/87,8.41%,GPR179;ADGRV1;EYA4;CRYBA1;RDH12;COL18A1;TYR
prerank,eye development (GO:0001654),0.3549067788476495,0.8181672219035004,0.6929824561403509,1.0,1.0,12/54,19.29%,PBX4;PBX3;FBN1;COL5A2;NIPBL;CACNA1C;MAB21L2;EFEMP1;SHROOM2;SH3PXD2B;HIPK1;SKI
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3864007249705659,0.8175620137559193,0.6472972972972973,1.0,1.0,5/19,16.06%,MAP4K4;ROCK1;LIMS1;RAC1;SFRP1
prerank,sulfur amino acid metabolic process (GO:0000096),0.3876326826346853,0.8172609094979448,0.675776397515528,1.0,1.0,3/24,9.69%,AHCY;MTHFR;NOX4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.2383879451704517,-0.8172346686863893,0.7673267326732673,0.8771210665798577,1.0,10/27,22.47%,TAB2;TLR4;TAB3;HSPD1;IRAK4;TNIP1;UBB;TIRAP;RPS27A;UBC
prerank,superoxide anion generation (GO:0042554),0.40165227165544887,0.816981969806527,0.6614285714285715,1.0,1.0,2/13,9.83%,NOX4;CYBB
prerank,regulation of neuroinflammatory response (GO:0150077),-0.27277854107354316,-0.8167770781708757,0.7701612903225806,0.8770629006228415,1.0,4/19,13.18%,IGF1;TNFRSF1B;PTGS2;NUPR1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2253193779345147,-0.8162242876571069,0.7251908396946565,0.8772345780106645,1.0,14/37,23.10%,NACC2;CAV1;FIS1;BECN1;RPS7;SIAH1;BCL2;NUPR1;BCAP31;DDIT3;UBB;BCL2L1;RACK1;RPS3
prerank,negative regulation of developmental process (GO:0051093),0.34713959219632684,0.8161961273639388,0.7384453781512605,1.0,1.0,14/69,14.33%,SFMBT1;LOXL2;ROCK2;SUZ12;ANP32B;NFIB;MAPT;ROCK1;PTPRS;BMP2;SOX9;HEY2;RC3H1;FOXM1
prerank,cochlea morphogenesis (GO:0090103),0.4234373009553751,0.8158217257402937,0.6730486008836525,1.0,1.0,2/10,12.56%,TBX18;SOX9
prerank,regulation of immune response (GO:0050776),0.34329420130098065,0.8157810391323889,0.78159757330637,1.0,1.0,14/135,14.27%,ULBP1;FGL1;COLEC12;ITGB7;RAET1E;LAG3;SPPL2B;IRF1;AHR;APPL2;CASP8;IL4I1;XIAP;ITGB1
prerank,acute-phase response (GO:0006953),-0.31702464174185874,-0.8153381764219697,0.6967741935483871,0.8780309833465123,1.0,3/12,20.74%,LBP;CEBPB;IL22
prerank,regulation of inclusion body assembly (GO:0090083),0.41569305522214645,0.8151273714363974,0.6631578947368421,1.0,1.0,5/11,24.10%,BAG5;DNAJB2;DNAJB6;SACS;SNCAIP
prerank,protein localization to cell surface (GO:0034394),0.37821920121507874,0.8149358889319053,0.6633291614518148,1.0,1.0,8/26,16.91%,FBLN5;SMURF1;ANGPT1;PIGU;MESD;PTPRU;UNC50;PTPRK
prerank,positive regulation of mRNA processing (GO:0050685),0.37826210830402546,0.8146503437473404,0.6565389696169088,1.0,1.0,8/21,23.33%,TRA2B;THRAP3;LEO1;DAZAP1;NUP98;TRA2A;RBMX;NCL
prerank,response to calcium ion (GO:0051592),0.34276126719195343,0.8146326453713649,0.7433264887063655,1.0,1.0,18/102,16.00%,ECT2;ADGRV1;NEDD4;PPP3CA;KCNMB2;KCNMB3;CARF;TRPM2;CALM2;ITPR3;DMTN;CLIC4;ADAM9;SMPD1;KCNMB4;PKD2;ADD1;STIM1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.37195913723731827,0.8137984912542934,0.6437346437346437,1.0,1.0,9/26,23.18%,IRF1;FLOT2;APPL2;LGR4;SMPDL3B;APPL1;BIRC2;GPR108;NFKBIL1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.34032480728495096,0.8133240226921382,0.889,1.0,1.0,55/348,14.35%,BRCA1;E2F1;MED26;MOV10;TICAM1;ROCK2;FGFR4;AGO2;CTCF;GSK3B;ANXA2;DDRGK1;MPHOSPH8;SETDB2;BMP6;MUSK;AFDN;ARRB1;FMR1;SCRIB;RAB29;ZBTB7B;UBR5;ATF7IP;TRIM28;ROBO1;YAP1;ANGPT1;SLC24A3;ROCK1;WNT6;PIK3CB;TGFBR1;LIMS1;EIF2AK3;CNTF;BMP2;EZR;NKX2-1;TERF2;STOX1;RBMS3;FUBP1;RBPJ;GJA1;SOX9;ITCH;C1QTNF1;CTSH;TWIST1;HEY2;MED1;ADAM19;SMAD3;RAMP3
prerank,gliogenesis (GO:0042063),0.40183724760262407,0.8119623502173182,0.6675639300134589,1.0,1.0,4/15,16.35%,MMP24;NFIB;ANXA1;METTL3
prerank,response to organic cyclic compound (GO:0014070),0.3506305805005543,0.8113291058296128,0.6830357142857143,1.0,1.0,8/52,13.54%,CDKN2D;FGFR4;ABCB4;IL18;LRRK2;TRPM2;ANXA1;DHFR
prerank,outflow tract septum morphogenesis (GO:0003148),0.38410302797601664,0.8112644879262307,0.6662531017369727,1.0,1.0,6/24,12.60%,BMPR1A;FGFR2;PARVA;SMAD6;ROBO1;SMAD4
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.38027134047828137,0.8108919192204046,0.6482670089858793,1.0,1.0,7/21,19.54%,HPSE;SULF2;SULF1;HS2ST1;UGDH;XYLT1;GLCE
prerank,Ras protein signal transduction (GO:0007265),0.34254301330231274,0.810854057205758,0.7849898580121704,1.0,1.0,35/137,18.34%,KSR1;GPSM2;RB1;BRAP;ROCK2;RASSF1;RHOA;CCNA2;NTN1;PDPN;RAP2A;G3BP1;CDC42EP2;GNA13;CDK2;TRIM28;ROCK1;EPS8L1;MYO9B;ARHGAP6;USP28;CRKL;RAC1;RRAS;PRKD1;PLK2;TP53;NCKAP1;RRAS2;ABI2;PLEKHG5;NRAS;KRAS;ARHGAP29;MAPK14
prerank,defense response to tumor cell (GO:0002357),-0.32359313041547805,-0.8105031298337899,0.7138643067846607,0.8856477632097883,1.0,5/10,27.36%,KLF4;PRDX2;ABI3;PLK5;LAPTM5
prerank,positive regulation of macroautophagy (GO:0016239),-0.2202608134256172,-0.8103860501681028,0.8796296296296297,0.8850146890917143,1.0,18/48,24.65%,PIP4K2A;SESN3;EPM2A;PIP4K2B;RALB;BNIP3L;BNIP3;RAB3GAP2;IRGM;PINK1;SLC25A4;TBK1;HSPB8;PIP4K2C;VPS13D;PAFAH1B2;BAG3;SMCR8
prerank,snRNA processing (GO:0016180),0.39491643616631206,0.8093724540483093,0.660377358490566,1.0,1.0,3/16,10.73%,INTS7;TUT1;INTS8
prerank,peptide metabolic process (GO:0006518),0.3494250347434471,0.8084447518642397,0.7262032085561497,1.0,1.0,8/75,10.45%,RHD;DNPEP;LVRN;NLN;CPXM1;HPGDS;CPQ;TRHDE
prerank,cellular response to chemical stress (GO:0062197),0.3401373108072549,0.8073061893759162,0.739085239085239,1.0,1.0,27/96,19.14%,VKORC1L1;SETX;SRXN1;VRK2;ATG7;PYCR1;FOXO3;HTRA2;LRRK2;SOD3;STX2;CPEB2;LONP1;NOX4;CYBB;STOX1;PRKD1;GPX8;PKD2;SESN2;PNPT1;RAD52;CCS;TRPV4;FANCC;ADNP2;PYROXD1
prerank,lipid catabolic process (GO:0016042),-0.2747057441487728,-0.8073036362993263,0.708,0.8896059534075723,1.0,2/18,4.80%,PLAAT3;PLA1A
prerank,cellular response to unfolded protein (GO:0034620),-0.24626812156285185,-0.80687220148499,0.7814207650273224,0.8895184033549111,1.0,6/26,18.18%,PRKN;HSPD1;HSPA5;PACRG;TM7SF3;HSPB8
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.2614828995198524,-0.806140287348686,0.7718446601941747,0.889951044003472,1.0,7/23,18.36%,HSP90AB1;NR1H3;IFNGR2;IRGM;IFNGR1;NR1H2;NLRC5
prerank,snRNA 3'-end processing (GO:0034472),0.39371052901440196,0.8058249089104794,0.6888888888888889,1.0,1.0,4/19,11.81%,INTS7;TUT1;INTS8;EXOSC7
prerank,amino sugar metabolic process (GO:0006040),-0.32931876641327834,-0.8057640479191622,0.7166666666666667,0.8897322360587433,1.0,2/10,3.56%,CSGALNACT1;ST6GAL1
prerank,mitochondrial translational termination (GO:0070126),0.3364562072855673,0.8057366462586936,0.7349896480331263,1.0,1.0,23/88,22.01%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,protein glycosylation (GO:0006486),0.3382787042485206,0.8056550639275465,0.7909090909090909,1.0,1.0,24/125,16.84%,POMT1;TRAK1;LARGE1;B4GALT1;FUT10;GALNT1;ST8SIA2;B3GNT8;ST3GAL3;B4GALT7;MAGT1;RPN2;ST3GAL5;SLC39A8;POFUT1;STT3A;STT3B;MAN1C1;ALG8;ST3GAL4;ST3GAL1;ST3GAL2;PLOD2;B3GALT2
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.37880820428791606,0.8050857507859787,0.67625,1.0,1.0,6/25,12.60%,BMPR1A;NUMA1;CCN1;SULF1;RBPJ;SMAD4
prerank,spliceosomal complex assembly (GO:0000245),0.3511365340106343,0.8049099229119033,0.7131608548931384,1.0,1.0,11/46,17.78%,SETX;SRSF10;DDX39B;PRPF19;CELF2;SF3A2;SRPK1;LUC7L3;DDX1;SRPK2;LUC7L2
prerank,organic cation transport (GO:0015695),0.36853979398681763,0.8041468247163263,0.6547945205479452,1.0,1.0,9/20,26.67%,PDZK1;SLC22A18;SLC25A42;SLC25A29;SLC25A19;SEC14L1;SLC22A4;SLC47A1;RALBP1
prerank,acylglycerol catabolic process (GO:0046464),-0.24400383456058006,-0.803537264062924,0.8181818181818182,0.8929158834501296,1.0,4/30,9.48%,ABHD6;ABHD12;ABHD16A;ABHD2
prerank,positive regulation of gene expression (GO:0010628),0.33711510467833794,0.8034548137861834,0.929,1.0,1.0,82/442,17.08%,BRCA1;E2F1;MED26;DYRK1A;BAZ1B;SETX;DEK;MOV10;TICAM1;ROCK2;FGFR4;LARP4B;AGO2;CTCF;GSK3B;POLR1A;HNRNPD;DDRGK1;PRKDC;UPF3B;MYO1C;BMP6;MUSK;POLR1B;AFDN;SAMD4A;TENT4A;FMR1;POLR2A;ZBTB7B;PHF2;UBR5;AGPAT2;ROBO1;YAP1;ANGPT1;SLC24A3;ROCK1;WNT6;AGT;TAF1D;PIK3CB;TGFBR1;PLXNB2;LIMS1;METTL5;EIF2AK3;CNTF;BMP2;EZR;NKX2-1;TERF2;STOX1;EIF3C;RBMS3;FUBP1;RBPJ;GJA1;SOX9;C1QTNF1;CTSH;POLR1G;TWIST1;HEY2;DDX21;LARP4;MED1;ADAM19;SMAD3;RAMP3;AGPAT1;PRKAG1;TNRC6C;FXR1;PASK;TP53;MSN;METTL3;ITGB8;PYM1;NGF;HNRNPLL
prerank,lysosome organization (GO:0007040),-0.21800622961830862,-0.803396800114671,0.8580246913580247,0.8923085978586408,1.0,16/36,26.92%,ZKSCAN3;CLVS1;TPP1;TMEM106B;ACP2;GRN;MTOR;HOOK1;HPS4;CLN5;TFEB;MBTPS1;ATP10B;GNPTAB;VPS33A;AKTIP
prerank,glycoprotein metabolic process (GO:0009100),0.3477587651135135,0.8033362748688253,0.7122381477398015,1.0,1.0,12/53,15.46%,HPSE;LARGE1;ST8SIA2;B4GALT7;ADAMTS9;GANAB;STT3B;MAN1C1;FBXO27;ST3GAL4;FBXO17;ST3GAL2
prerank,cGMP biosynthetic process (GO:0006182),-0.32561279147021915,-0.8029621263261111,0.7232704402515723,0.8922027642513621,1.0,2/10,9.96%,GUCY1A1;NPR1
prerank,T cell receptor signaling pathway (GO:0050852),0.3356937178437747,0.8029348113042821,0.8010050251256281,1.0,1.0,45/138,24.99%,ERMAP;THEMIS;PSMC2;PSMD5;KHDRBS1;EIF2B1;WNK1;UBE2N;STOML2;RNF31;RC3H2;PSMB1;PSMD14;NCK1;PSMD1;IKBKG;PIK3CB;PSMB9;FBXW11;PDPK1;BTRC;RC3H1;PSMC6;PRKD2;NFKB1;PSMB2;PSME4;PSMB7;PDE4B;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;EIF2B5;PSMB8;FYN;PSMD4;BCL10;RIPK2;PSMF1;PSMA5;RELA;PSMC3;SPPL3
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.2824249863200316,-0.8025657278520397,0.7231404958677686,0.8920487603969208,1.0,6/17,18.03%,BIN1;PTPRZ1;TNFRSF1B;TENM4;DICER1;IL34
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.25254275042779456,-0.8015763205605271,0.7615062761506276,0.8928550999840882,1.0,9/22,19.76%,CALM1;TAOK2;ACE;RAP2C;PDGFD;NBN;VEGFA;TNKS1BP1;CALM3
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.41224649281107123,0.8014593801088352,0.6781954887218045,1.0,1.0,3/11,10.24%,LEPROT;PICALM;SNX33
prerank,glycine transport (GO:0015816),0.4196406864342537,0.8013320241694727,0.6800618238021638,1.0,1.0,3/10,17.83%,SLC6A5;SLC6A17;SLC6A9
prerank,bile acid biosynthetic process (GO:0006699),-0.26040776831444534,-0.8011911879600191,0.7546296296296297,0.8926267429571532,1.0,7/24,21.62%,OSBPL6;CYP7B1;SCP2;OSBPL7;AMACR;OSBP;OSBPL2
prerank,positive regulation of bone resorption (GO:0045780),-0.32726136365750286,-0.8010399468487768,0.7325227963525835,0.8920193791209029,1.0,7/11,36.56%,TNFRSF11A;PLEKHM1;ATP6AP1;SYK;DEF8;SPP1;ADAM8
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.36007623952417855,0.8008396611193239,0.6883720930232559,1.0,1.0,5/36,7.41%,MOV10;AGO2;NLK;TCF7L2;PPP3CA
prerank,apical protein localization (GO:0045176),0.4153075473582044,0.8007199140683896,0.6780415430267063,1.0,1.0,1/10,1.69%,SHROOM3
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.33742226636114286,0.800604926370266,0.796969696969697,1.0,1.0,42/124,24.77%,VANGL1;MOV10;RHOA;AGO2;PSMC2;PSMD5;NLK;DAAM1;TCF7L2;SFRP2;PPP3CA;PSMB1;SMURF1;PSMD14;PSMD1;PSMB9;SMURF2;RAC1;PSMC6;TNRC6C;SFRP1;PPP3R1;PSMB2;PSME4;FRZB;PSMB7;WNT4;TNRC6B;PSMD11;ARHGEF19;PSME3;PSMD13;GNB1;CELSR1;PSMB8;GNAO1;PSMD4;PSMF1;AP2B1;PPP3CB;PSMA5;PSMC3
prerank,rRNA methylation (GO:0031167),0.3739398280125714,0.8004914857748046,0.6738305941845765,1.0,1.0,7/22,17.46%,MRM1;MRM3;METTL15;METTL5;TFB1M;MRM2;NSUN3
prerank,microvillus organization (GO:0032528),0.4046176706405291,0.800446754106259,0.6782106782106783,1.0,1.0,3/13,11.45%,MAP4K4;RAP2A;EZR
prerank,membrane raft organization (GO:0031579),0.39301864669163455,0.7997189971930609,0.6685714285714286,1.0,1.0,5/15,25.00%,ANXA2;FLOT2;FA2H;S100A10;MYADM
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.28704639555436545,-0.7996133689099748,0.7394366197183099,0.8936266021547608,1.0,7/15,24.60%,SIK1;SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.277433179736943,-0.7993083625528806,0.7615658362989324,0.893341997181216,1.0,1/17,0.17%,PLA2G4A
prerank,mitochondrial translational elongation (GO:0070125),0.33230438814478014,0.7992368377155878,0.7450980392156863,1.0,1.0,22/88,22.01%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,cellular response to hypoxia (GO:0071456),0.33113071919576964,0.7991702889244248,0.775178026449644,1.0,1.0,48/126,24.77%,AQP1;ANGPT4;PSMC2;PSMD5;MDM4;FAM162A;HP1BP3;ELOC;PSMB1;PSMD14;LIMD1;CPEB2;VHL;PSMD1;PSMB9;NDRG1;STOX1;RORA;TWIST1;PSMC6;ARNT;NPEPPS;TP53;SFRP1;SUV39H2;PSMB2;BAD;PTGIS;PSME4;PSMB7;TBL2;FMN2;TERT;PSMD11;EGLN1;PSME3;PSMD13;SIRT2;EGLN3;ZFP36L1;PSMB8;PSMD4;KCND2;NOP53;PSMF1;PSMA5;HIF3A;PSMC3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2965665418176373,-0.7991648084232335,0.7220216606498195,0.8927404843319189,1.0,2/14,4.30%,CARD16;GAS6
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3339692959918563,0.7985258338249297,0.7818930041152263,1.0,1.0,28/108,21.08%,FADD;SENP1;DAP;ANP32B;CASP8AP2;FAM162A;MAPT;XDH;HTRA2;ROBO1;TNFRSF10B;HMGB1;APAF1;BOK;UACA;EIF2AK3;CASP8;SMAD3;BCL2L13;NGF;TNFSF10;BAD;RIPK1;DAPK1;COL4A3;PRR7;SNCA;TRAF2
prerank,zymogen activation (GO:0031638),0.3572930530597827,0.7985182098402009,0.7125,1.0,1.0,8/39,19.10%,FADD;MMP14;PLAU;CASP8;CTSH;BAD;PLAT;TBC1D10A
prerank,muscle cell migration (GO:0014812),0.4240274193992426,0.7982093454123428,0.6559633027522935,1.0,1.0,4/10,18.51%,ROCK1;CCN3;AAMP;PLAT
prerank,zinc ion transport (GO:0006829),0.3786487136920699,0.7981818585202077,0.6735218508997429,1.0,1.0,6/21,15.02%,SLC39A11;TRPM2;SLC39A8;SLC30A9;SLC39A6;SLC30A10
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.39691819064065414,0.7981349866095463,0.6431784107946027,1.0,1.0,2/12,10.50%,RNF168;HNRNPU
prerank,regulation of cellular localization (GO:0060341),0.35509120598134825,0.7977393479031849,0.6954087346024636,1.0,1.0,7/46,13.73%,SPAG5;NUMA1;STXBP2;LRRK2;MAD1L1;LRP5;GOSR1
prerank,negative regulation of protein modification process (GO:0031400),0.3444917660265399,0.7976800357311845,0.7489451476793249,1.0,1.0,27/79,21.60%,ATP2B4;GSK3B;PRKDC;PRNP;MAPT;XDH;WWTR1;LRRK2;PPP1R8;TPPP;SNTA1;CRKL;P3H1;ENSA;PPP1R15B;PTPA;PTPN13;PTEN;TINF2;SIRPA;TERF2IP;IGFBP3;DNAJC10;XRCC1;PNKP;FBLN1;FKBP8
prerank,regulation of bone mineralization (GO:0030500),0.3512749509272847,0.7971499013042685,0.7272727272727273,1.0,1.0,12/55,13.29%,ADGRV1;BMPR1A;BCOR;BMP6;CCN1;SLC8A1;DDR2;ATP2B1;BMP2;ENPP1;TRPM4;TWIST1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3798399880401892,0.7966158165004744,0.6886543535620053,1.0,1.0,7/18,26.14%,ADAMTS9;STT3B;FBXO27;FBXO17;NAGA;DERA;OGA
prerank,ethanol metabolic process (GO:0006067),0.413443865792506,0.7964406789370055,0.6876790830945558,1.0,1.0,2/12,9.51%,ALDH1A1;ACSS1
prerank,protein kinase A signaling (GO:0010737),0.40508236651788,0.7962950109073571,0.6888888888888889,1.0,1.0,5/12,25.96%,EZR;LCP1;RAB13;PRKACA;RDX
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3796348428607314,0.7961954289312305,0.6891534391534392,1.0,1.0,6/20,22.11%,GSTO2;HPGDS;GSTT1;MGST3;GSTM5;GSTZ1
prerank,glutathione derivative metabolic process (GO:1901685),0.3796348428607314,0.7961954289312305,0.6891534391534392,1.0,1.0,6/20,22.11%,GSTO2;HPGDS;GSTT1;MGST3;GSTM5;GSTZ1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3222166084927628,-0.7952739702654711,0.7227414330218068,0.8985390631662171,1.0,3/11,9.04%,PRKN;DAB2;VPS11
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3350561923139562,0.7951509911923188,0.8423694779116466,1.0,1.0,32/166,16.97%,ATAD5;GLI2;FGFR4;LARP4B;GCK;HNRNPD;STN1;DNA2;DHX9;PRKDC;UPF3B;FAF1;PTPN2;SAMD4A;NMD3;SLC25A37;FMR1;ABCB10;PLXNB2;METTL5;PCNA;EIF3C;LARP4;SMAD3;ARNT;FXR1;PRKD2;PKD2;PASK;METTL3;PYM1;LDLR
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.22924854150309512,-0.7950868035363237,0.8235294117647058,0.8979866079131881,1.0,4/30,7.70%,CACNA2D1;RYR2;SCN1A;ATP1A1
prerank,phospholipid translocation (GO:0045332),0.35969435029017616,0.7948688135607342,0.6674846625766871,1.0,1.0,3/28,4.57%,PLSCR2;ABCA4;ABCB4
prerank,regulation of histone deacetylation (GO:0031063),0.38651341498478176,0.7947351157618084,0.6904422253922967,1.0,1.0,3/13,7.80%,CTBP1;NIPBL;ZBTB7B
prerank,regulation of smooth muscle contraction (GO:0006940),0.3814760160621452,0.7945660665941326,0.6693548387096774,1.0,1.0,6/20,16.79%,SRF;SETD3;ATP2B1;ADRB2;KCNB2;ZDHHC21
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3779269947761179,0.7943817595448658,0.6905405405405406,1.0,1.0,5/19,15.72%,ADGRL1;PRNP;TRPM2;DMTN;STIMATE
prerank,protein localization to phagophore assembly site (GO:0034497),-0.31164313738086663,-0.7937065301892406,0.7119741100323624,0.8995567135425484,1.0,2/11,4.47%,WDR45B;PACS2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3633992444072719,0.7933406536220682,0.6850490196078431,1.0,1.0,3/26,6.52%,FBN1;PTPN2;HOXA7
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3759990650522941,0.7932618177199849,0.6777070063694267,1.0,1.0,7/23,17.83%,TGFBR3L;TGFBR3;DKK3;SMURF2;SMAD4;SMAD3;SMAD2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.33903951307176855,0.7929687110448757,0.7560718057022175,1.0,1.0,29/72,24.77%,MAP3K14;PSMC2;PSMD5;PSMB1;PSMD14;TNFRSF10B;PSMD1;PSMB9;FBXW11;BTRC;PSMC6;ZFP91;PSMB2;PSME4;PSMB7;RELB;PSMD11;TRAF6;PSME3;TRAF2;PSMD13;BIRC2;PSMB8;PSMD4;PSMF1;REL;PSMA5;RELA;PSMC3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3457936212589346,0.7929015147054981,0.6972789115646258,1.0,1.0,23/47,28.16%,TRIOBP;ACTN4;PDPN;LIMS1;CRKL;RAC1;DMTN;DOCK1;RCC2;DOCK5;RREB1;FERMT2;FBLN1;FLNA;S100A10;CRK;MYADM;P4HB;CDC42;CORO1C;KANK1;MYOC;CARMIL1
prerank,cholesterol homeostasis (GO:0042632),0.33583170835933934,0.792793427736689,0.7315789473684211,1.0,1.0,12/64,16.97%,CYP39A1;FGFR4;SOAT1;IL18;ABCA1;SOAT2;EHD1;LRP5;RORA;LPL;RALY;LDLR
prerank,cGMP metabolic process (GO:0046068),-0.30097946493411765,-0.7927420843071031,0.7385159010600707,0.9003779655586279,1.0,3/12,18.26%,GUCY1A1;NPR1;PDE2A
prerank,regulation of gastrulation (GO:0010470),-0.29066986556601127,-0.7926448072571946,0.6981818181818182,0.899723212750019,1.0,4/14,27.77%,PHLDB2;TENM4;RACK1;DAG1
prerank,tRNA aminoacylation (GO:0043039),0.34759528055443745,0.7926206824771341,0.6756756756756757,1.0,1.0,10/37,16.27%,SARS2;VARS1;DARS2;DARS1;IARS2;PPA1;RARS2;EPRS1;QARS1;LARS1
prerank,microvillus assembly (GO:0030033),0.3950707445352865,0.7925035096978986,0.6808510638297872,1.0,1.0,3/14,11.45%,MAP4K4;RAP2A;EZR
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.40908188268484014,0.792438550599295,0.6930983847283406,1.0,1.0,1/12,6.38%,IL18
prerank,regulation of neuron apoptotic process (GO:0043523),0.3342585608250711,0.7921097677736144,0.764344262295082,1.0,1.0,1/96,0.13%,KIF14
prerank,regulation of erythrocyte differentiation (GO:0045646),0.35147602779147935,0.7920412527976531,0.6832369942196532,1.0,1.0,13/35,23.51%,HMGB2;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT;MAPK14;ZFPM1;LDB1;ZFP36L1;STAT5B;ANKRD54
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3781609215323853,0.7917276262112092,0.6812169312169312,1.0,1.0,3/21,13.21%,FGL1;SAMSN1;IL4I1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3906696437427787,0.7915306124990029,0.6857923497267759,1.0,1.0,3/16,20.27%,RHOA;ST3GAL4;TRAF6
prerank,membrane depolarization during action potential (GO:0086010),-0.23744082418702286,-0.79138377366915,0.7572815533980582,0.9010210477234555,1.0,12/26,34.06%,SCN1A;SCN9A;ATP1A2;SCN3A;SCN8A;SCN1B;SCN4B;CACNA1H;CACNA1I;YWHAH;SCN3B;CACNA1D
prerank,regulation of mRNA metabolic process (GO:1903311),0.40279865857895897,0.791382068654538,0.6707132018209409,1.0,1.0,4/11,17.76%,DHX9;SRPK1;IWS1;SRPK2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4010294873553911,0.79135985409666,0.6827880512091038,1.0,1.0,1/13,2.15%,FADD
prerank,global genome nucleotide-excision repair (GO:0070911),0.3603904576839952,0.7912753162069465,0.6916461916461917,1.0,1.0,11/26,23.16%,CHD1L;ERCC4;ERCC3;CUL4B;XPA;RAD23B;ERCC2;RNF111;GTF2H1;DDB2;DDB1
prerank,sterol homeostasis (GO:0055092),0.3355473012635199,0.7907136255484273,0.7363445378151261,1.0,1.0,12/65,16.97%,CYP39A1;FGFR4;SOAT1;IL18;ABCA1;SOAT2;EHD1;LRP5;RORA;LPL;RALY;LDLR
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4002151745943059,0.7905523090751648,0.6852941176470588,1.0,1.0,1/11,2.67%,BMPR1A
prerank,protein transport (GO:0015031),0.33198673207658663,0.7904939091015933,0.9069069069069069,1.0,1.0,52/332,16.66%,CENPF;NEURL1B;NDC1;USP6NL;STX11;ZG16;MACF1;STEAP3;ARFIP1;AP4M1;RAB10;EVI5L;TBC1D25;SNX1;TBC1D13;WDR11;VPS26C;TBC1D2B;RAB22A;SLC10A7;RAB29;STXBP2;STX2;DNM2;RAB1A;SVBP;SNX27;VIPAS39;COPB2;SNX33;HERC2;COPZ1;ARRDC1;PRKCB;AP3B1;ABCA1;SCFD1;EHD1;IFT27;TOM1;ARF4;ARRDC2;RAMP3;MIA3;ARL4A;UNC119;STX12;ARF3;TBC1D9;STXBP1;VPS26A;TMED3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.35205725954381856,0.7902785722077994,0.7086705202312139,1.0,1.0,9/39,16.74%,GLI2;NPNT;SFRP2;BMP2;NKX2-1;LRP5;GDNF;PKD2;SALL1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3977778073640303,0.7901618757856701,0.6775106082036775,1.0,1.0,3/14,11.68%,UPB1;DPYD;ERH
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4073678638923347,0.7900337613816392,0.6763803680981595,1.0,1.0,1/10,4.54%,KIT
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.36844368112257925,0.7900291688612955,0.6784363177805801,1.0,1.0,6/21,17.24%,KCNN4;RAB29;IKBKG;PRKCB;PRKD2;FOXP1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.24611151084855215,-0.7898313828209059,0.8,0.9027417239439908,1.0,4/24,7.53%,PECAM1;F11R;VCAM1;SEMA4D
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3818386869202981,0.7896363356803068,0.6783707865168539,1.0,1.0,5/16,18.52%,LEPROT;STAM;VTA1;CHMP4A;CHMP4B
prerank,cellular response to retinoic acid (GO:0071300),0.35272145399533006,0.7893399920472078,0.7102272727272727,1.0,1.0,6/42,12.56%,AQP1;SETX;HTRA2;WNT6;WNT9A;SOX9
prerank,protein localization to synapse (GO:0035418),-0.3021090028256065,-0.7890161604176259,0.7317880794701986,0.9031559339305881,1.0,5/12,18.42%,PCLO;NRXN1;SHANK1;DLG4;NLGN1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3767310177624171,0.7888092408353683,0.6900510204081632,1.0,1.0,6/20,19.61%,ZC3H7A;AGO2;PUM2;ZC3H7B;SPOUT1;TERT
prerank,regulation of phagocytosis (GO:0050764),-0.20045660316446184,-0.7887912160662037,0.8604651162790697,0.9026806790129138,1.0,23/53,38.41%,MERTK;GAS6;SNX3;TGM2;SYT7;SYT11;GATA2;RAB27A;RACK1;SPHK1;IL15;SYK;TUB;FCER1G;PTPRC;ABCA7;CALR;LYAR;HCK;PYCARD;SLC11A1;LMAN2;FCGR2B
prerank,mRNA metabolic process (GO:0016071),0.3358134371183775,0.7886624541828411,0.7628004179728317,1.0,1.0,24/90,19.77%,SRSF4;CSTF3;LSM3;SLBP;LSM11;SRSF7;PRPF3;NONO;SF3A2;PCF11;LSM2;SFPQ;YTHDF2;DXO;KIN;HNRNPA2B1;TP53;PNPT1;HIPK3;METTL3;PRPF18;HNRNPR;SF3A3;SNRPB
prerank,protein O-linked glycosylation (GO:0006493),0.3343660516708382,0.7884706437700353,0.768595041322314,1.0,1.0,16/96,16.25%,POMT1;TRAK1;LARGE1;CRPPA;GALNT1;B3GNT8;FKRP;ST3GAL3;C1GALT1;POFUT1;RXYLT1;TMTC4;ST3GAL4;ST3GAL1;ST3GAL2;PLOD2
prerank,regulation of primary metabolic process (GO:0080090),0.3320318270709282,0.7883148061142078,0.7892603850050659,1.0,1.0,32/126,20.44%,ZFP69;ROCK2;FGFR4;PSMC2;PSMD5;PMVK;TBL1XR1;PSMB1;NQO1;PSMD14;NFYA;PSMD1;PSMB9;NCOA2;TM7SF2;ACACA;PLPP1;ADIPOR1;MED1;MVK;PSMC6;AZIN1;DHCR7;LDLR;PSMB2;SREBF1;PSME4;PSMB7;TGS1;PRKAB1;PSMD11;PSME3
prerank,regulation of cell junction assembly (GO:1901888),0.35950837331641106,0.7881878422866228,0.6839506172839506,1.0,1.0,5/27,12.32%,CBFB;ROCK2;MYO1C;ROCK1;PDLIM5
prerank,positive regulation of type 2 immune response (GO:0002830),-0.286021580726181,-0.7881307413058184,0.7425742574257426,0.9029401080040962,1.0,8/14,34.29%,DENND1B;CD81;PRKCZ;CD86;CD74;RSAD2;RARA;NOD2
prerank,regulation of protein localization to centrosome (GO:1904779),0.4117345896296561,0.7878879380477951,0.6905829596412556,1.0,1.0,3/10,18.08%,GSK3B;UBXN2B;CEP250
prerank,cellular response to growth factor stimulus (GO:0071363),0.3288224002858903,0.7876876772069458,0.8167170191339376,1.0,1.0,31/151,14.37%,KNSTRN;SETX;BMPR1A;HYAL1;WWOX;GAREM1;ACAP2;MAPT;BMP6;SOX6;HTRA2;CORO1B;EMD;GAS1;HAS1;NR3C1;TGFBR1;LIMS1;CRKL;BMP2;ANXA1;APPL2;PDPK1;NR4A1;SOX9;SMAD4;EHD1;PRKD1;MED1;SMAD3;CD44
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.383445617659149,0.7876590827674819,0.6697368421052632,1.0,1.0,6/17,19.95%,ARFIP1;CORO1B;WASF2;NCKAP1;ABI2;ARF1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.32827621162591397,0.7872324295231782,0.8348439073514602,1.0,1.0,43/173,20.79%,SPTA1;F5;RANGRF;ACTR1A;SPTB;GBF1;COG1;ZW10;ATL2;ANK1;DCTN5;ATL3;RAB29;CUL3;TRAPPC6B;RAB1A;COPB2;COPZ1;CAPZA1;F8;SCFD1;SEC24D;VTI1A;ARF4;GOSR1;NRBP1;MIA3;VAPA;BET1;BCAP29;TMED3;USO1;COG4;COG8;TMED10;BET1L;PROS1;COG5;CNIH4;DYNC1I1;ANK3;TRAPPC8;WHAMM
prerank,regulation of signal transduction (GO:0009966),0.3278474742164786,0.7868348672760426,0.8495486459378134,1.0,1.0,46/190,20.17%,RGS12;CBFB;NCAM1;BRAP;FGFR2;TCF7L1;GIT2;PRNP;PTPN2;WDR11;ELF1;NUCKS1;WWTR1;SULF1;NCLN;CD80;LRRK2;GRK5;NCK1;RGS3;LLGL2;RIC8B;FBXL17;GAS1;POFUT1;NCK2;GRK3;RSPO3;SIK2;RORA;PRKD1;FOXL1;TRIM5;SRC;GDNF;ZDHHC3;TMEM237;VEPH1;RUNX1;IGFBP3;ZIC1;SP100;USP20;PTPN1;SEMA5A;UGCG
prerank,macrophage migration (GO:1905517),0.39945600205863474,0.7866230731221042,0.7,1.0,1.0,1/13,4.98%,CKLF
prerank,positive regulation of nervous system process (GO:0031646),-0.2649826584046082,-0.7861655451974484,0.7924528301886793,0.9052920808505374,1.0,5/18,15.09%,UNC13B;RIMS1;TNFRSF1B;TENM4;DICER1
prerank,positive regulation of cation channel activity (GO:2001259),-0.21394764595007798,-0.7861633249042035,0.8110236220472441,0.9044531193873253,1.0,5/40,5.30%,TMSB4X;SHANK3;CALM1;AKAP6;EPHB2
prerank,transcription by RNA polymerase III (GO:0006383),-0.22847067180452796,-0.7859481507816055,0.7797619047619048,0.9039784256538649,1.0,9/27,23.79%,RO60;SNAPC3;ICE1;POLR3K;GTF3C3;POLR3H;POLR2K;TBP;GTF3C1
prerank,negative regulation of cyclase activity (GO:0031280),0.3904582881407257,0.7850642532424434,0.6912378303198887,1.0,1.0,3/14,16.01%,ADGRV1;GNAI3;GABBR2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3415712094825689,0.7849091407235644,0.7324561403508771,1.0,1.0,20/50,24.77%,PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4079073310015973,0.7844503694578717,0.6811145510835913,1.0,1.0,1/10,4.76%,GALNT1
prerank,protein localization to cell junction (GO:1902414),0.36859788849417197,0.7842966380067642,0.6951066499372648,1.0,1.0,5/22,16.33%,CGNL1;MPP4;ARHGEF18;TJP2;NLGN2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.28540587508736437,-0.783870394450231,0.7875457875457875,0.9065744859113345,1.0,7/15,30.56%,SYN3;CNTNAP4;ADRA1A;NLGN1;DRD2;BAIAP3;CLN3
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3544352095906558,0.7834767535872513,0.7006880733944955,1.0,1.0,6/39,12.13%,TRAK1;ACTN4;MYO1C;NDE1;RAB1A;FBXW11
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3998973627616272,0.7830711762531855,0.6852941176470588,1.0,1.0,1/11,2.79%,TICAM1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.35466487711972317,0.7827617199299276,0.6907090464547677,1.0,1.0,2/27,2.26%,ATP2B4;RANGRF
prerank,mitochondrial translation (GO:0032543),0.3244123141777248,0.7825200732574051,0.7719836400817995,1.0,1.0,21/104,18.12%,MRPL36;MRPL18;IARS2;RARS2;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MTIF3;MRPL42;MRPL37;MRPL2;MRPL20
prerank,endothelial cell development (GO:0001885),0.35778954231473425,0.7824318749849092,0.6745341614906832,1.0,1.0,5/25,16.27%,COL22A1;COL18A1;EZR;COL15A1;MSN
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3819478333831181,0.7820741662533367,0.6975806451612904,1.0,1.0,1/17,1.64%,ATOH8
prerank,defense response to Gram-positive bacterium (GO:0050830),0.35509706489629167,0.7816571236040949,0.7088607594936709,1.0,1.0,2/40,4.48%,HMGB2;RNASE6
prerank,cellular copper ion homeostasis (GO:0006878),-0.2794368568118141,-0.7815663634082511,0.782608695652174,0.9094344896296473,1.0,6/14,21.97%,APP;COX19;SLC31A2;MT2A;ATOX1;ATP7A
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3709271694331344,0.7814333047566198,0.7139107611548556,1.0,1.0,7/20,20.61%,LHPP;HPRT1;ADSL;PFAS;GART;PPAT;ADSS2
prerank,membrane assembly (GO:0071709),0.3527950224714058,0.7813925001579851,0.7037037037037037,1.0,1.0,12/34,20.34%,ANXA2;NLGN3;STX2;PICALM;FLOT2;GAK;PTEN;NLGN2;UBXN2B;CHMP4B;UGCG;ANK3
prerank,mitochondrial gene expression (GO:0140053),-0.21207337033895335,-0.7813585522820785,0.8362068965517241,0.908926489024945,1.0,26/42,34.46%,LARS2;TFB2M;MRPS18A;MRPS15;MRPS21;MRPS6;TFAM;MRPL23;MRPL51;MRPL47;MRPS14;MRPS7;NOA1;MRPL16;MRPS11;MRPS16;FASTKD2;MRPL12;TEFM;QRSL1;POLRMT;GATC;TWNK;MRPS12;MRPL57;MRPS34
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3745544971415964,0.7810397274233288,0.7,1.0,1.0,5/17,12.35%,SLC8A1;GJD3;GJC1;CACNA1C;GJA1
prerank,protein localization to cell-cell junction (GO:0150105),0.3834822265324278,0.7809031461726591,0.6953455571227081,1.0,1.0,4/15,12.75%,CGNL1;SCRIB;ARHGEF18;TJP2
prerank,negative regulation of cell death (GO:0060548),0.3251880927390691,0.7808572846648271,0.755741127348643,1.0,1.0,26/88,22.80%,RAD18;TXNDC12;GSK3B;SPEF1;CCN1;HTRA2;LRRK2;NCK1;KANK2;IKBKG;SRGAP2;CCN3;NENF;PRKD1;BTBD10;CCN2;CHMP4A;CHMP4B;ADNP2;SNCA;FERMT2;INPP5A;TRAF2;CDK5;ATG5;FYN
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3835085145687823,0.7807984544071426,0.6995884773662552,1.0,1.0,1/16,2.15%,FADD
prerank,regulation of cellular protein catabolic process (GO:1903362),0.38212186864574604,0.780715865951625,0.6856763925729443,1.0,1.0,9/18,25.96%,FAF1;EZR;MSN;AMER1;RIC1;VGLL4;DAB2IP;HSP90AA1;RDX
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.36377529411455617,0.7805476892998845,0.6977040816326531,1.0,1.0,3/23,8.03%,FGFR2;TGFBR3;ADAMTS9
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3152594018277777,-0.7802633092678047,0.7296511627906976,0.9098585769411303,1.0,4/10,22.19%,CALM1;GNB5;CALM3;DRD2
prerank,regulation of interleukin-6 production (GO:0032675),-0.17328776022107661,-0.780231113780221,1.0,0.9090657677787557,1.0,21/96,20.18%,STAT3;GAS6;TLR4;LBP;PTPN22;HSPD1;SELENOS;APP;ARHGEF2;CX3CL1;SYT11;PTPN11;IL17D;C1QTNF3;IFIH1;XBP1;LGALS9;AFAP1L2;NCKAP1L;ZC3H12A;TIRAP
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3943641620720716,0.7798175271305207,0.7070707070707071,1.0,1.0,3/13,16.01%,ADGRV1;GNAI3;GABBR2
prerank,sodium ion import across plasma membrane (GO:0098719),0.37767720114629777,0.7797893337914391,0.6822558459422283,1.0,1.0,3/17,12.52%,SLC9A5;SLC8A1;TRPM4
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3569199885810474,0.7797651757282715,0.6923076923076923,1.0,1.0,4/22,11.40%,XDH;MAP3K4;RELL1;BMP2
prerank,regulation of focal adhesion assembly (GO:0051893),0.33817007530634147,0.7797568440906799,0.7481081081081081,1.0,1.0,16/54,17.86%,MAP4K4;MACF1;ROCK2;RHOA;ROCK1;ARHGAP6;LIMS1;RAC1;DMTN;PTPRA;SRC;RCC2;SFRP1;PTEN;EPHA3;CLASP1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.369815235127979,0.7797431691143745,0.6942590120160214,1.0,1.0,6/19,15.09%,RTN3;PRNP;ROCK1;PICALM;FLOT2;PIN1
prerank,endothelial tube morphogenesis (GO:0061154),0.40129219084490697,0.7796635698528398,0.6916030534351145,1.0,1.0,3/10,15.59%,RHOA;RBPJ;PRKD2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3914581169086343,0.779581339066322,0.6917404129793511,1.0,1.0,3/14,11.47%,IL18;CD80;ANXA1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3231495833540854,0.7791793970801253,0.8371859296482412,1.0,1.0,36/170,19.19%,TCF19;TRIML2;ROCK2;CTCF;HNRNPD;UBAP2;AFF3;YBX3;CIAO3;CDK2;ZFP64;MTMR1;MTMR2;SLC8A1;MTMR9;AHR;STOX1;ZUP1;FUBP1;TRIM6;TOB2;MKLN1;TRIM5;MTMR3;ZNF445;PIN1;GDNF;ZNF507;PRDM10;LDLR;SIRPA;FOXP1;MARF1;NPAT;ADNP2;ZNF462
prerank,regulation of lamellipodium assembly (GO:0010591),0.35436508340270567,0.7790167963530538,0.6956521739130435,1.0,1.0,11/34,22.31%,ACTR3;AUTS2;TWF1;RAC1;DMTN;WASF2;NCKAP1;ABI2;PLXNB3;FER;ARPC2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.23908136280406406,-0.7789898928590628,0.8540540540540541,0.9101724148332818,1.0,4/26,6.47%,RYR3;RYR2;FGF2;HTR2C
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3319674618839536,0.778698635690508,0.7647679324894515,1.0,1.0,16/79,14.11%,ATP2B4;BMPR1A;NEDD4;CASK;SULF2;CRIM1;LEMD3;SULF1;SMAD6;SMURF1;AGT;RBPMS2;SMURF2;BMP2;SMAD4;HTRA3
prerank,calcium-mediated signaling (GO:0019722),0.3264040815377687,0.7784893495117372,0.7739938080495357,1.0,1.0,19/93,16.38%,ADGRL1;PRNP;CXCR4;PPP3CA;LRRK2;MCU;ATP2A2;SLC8A1;SAMD14;CACNA1C;TRPM2;EIF2AK3;PDPK1;TRPM4;DMTN;BTK;NUDT4;STIMATE;TPCN2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2774013222018356,-0.7784778979533213,0.7832167832167832,0.9100920660266892,1.0,6/15,21.15%,APOE;FURIN;GPLD1;TNFRSF1B;ADRA2A;PACSIN3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.24551300999360634,-0.7782320101197227,0.8194444444444444,0.9096266789176477,1.0,11/24,25.50%,NUB1;CTSC;APOE;PINK1;RHBDF1;GPX1;UBB;PSME2;PTK2B;PSME1;UBE3A
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.3873388550599809,0.7781331248427472,0.6967559943582511,1.0,1.0,4/14,14.42%,RAB1A;SCAP;SEC24D;MIA3
prerank,cellular response to oxidative stress (GO:0034599),0.3285568811185674,0.7773974294311414,0.8024439918533605,1.0,1.0,35/118,20.93%,VKORC1L1;SETX;SRXN1;MAPT;VRK2;PDGFRA;PYCR1;FOXO3;AGAP3;HTRA2;LRRK2;SOD3;STX2;CPEB2;LONP1;NOX4;CYBB;PRKD1;ARNT;GPX8;PKD2;TP53;SESN2;PNPT1;RAD52;PTPRK;CCS;FANCC;ADNP2;PYROXD1;PRKCD;DAPK1;TXNRD1;SNCA;FER
prerank,negative regulation of receptor internalization (GO:0002091),0.4064721960948137,0.7773178684000462,0.7159253945480631,1.0,1.0,6/12,27.34%,WDR54;MTMR2;ANKRD13D;RIN3;LRPAP1;ATXN2
prerank,regulation of MAP kinase activity (GO:0043405),0.33045919340741065,0.7772835789462557,0.7760577915376677,1.0,1.0,7/92,10.10%,EZH2;KSR1;KIT;LRRK2;ROBO1;AGT;PIK3CB
prerank,carbohydrate catabolic process (GO:0016052),0.3453738616035067,0.7772053838440016,0.7239766081871345,1.0,1.0,4/38,8.44%,PFKFB1;GCK;GPI;PGM1
prerank,iron ion transmembrane transport (GO:0034755),0.4077562998504344,0.7771580062052666,0.7247278382581649,1.0,1.0,3/10,17.01%,SLC25A37;SLC39A8;SLC25A28
prerank,positive regulation of bone mineralization (GO:0030501),0.3557016716247311,0.7764730424464158,0.737217598097503,1.0,1.0,7/35,11.40%,ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;ATP2B1;BMP2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.32616158817344704,0.7762191275858169,0.7740932642487046,1.0,1.0,11/86,12.60%,TTK;BMPR1A;NUMA1;BMP6;CCN1;SULF1;TGFBR1;BMP2;RBPJ;ADAM17;SMAD4
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3832770631671616,0.7762151280139178,0.6865671641791045,1.0,1.0,2/13,10.50%,RNF168;HNRNPU
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3697548545757822,0.7761813641497648,0.7093184979137691,1.0,1.0,4/15,12.18%,ROCK2;ROCK1;AGT;PRKCA
prerank,membrane lipid metabolic process (GO:0006643),-0.24898467950581193,-0.7759787974845066,0.7839195979899497,0.9122470849235881,1.0,10/22,32.48%,ST3GAL6;SERINC1;B4GALT4;ARV1;GAL3ST1;ST6GALNAC4;SPHK1;TECR;SPHK2;CERKL
prerank,neuromuscular junction development (GO:0007528),0.36259578827223793,0.775806927284451,0.7119078104993598,1.0,1.0,4/24,8.29%,PDZRN3;NEDD4;MUSK;LRRK2
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.30060169269408776,-0.7754908601523188,0.7619047619047619,0.9122074186519387,1.0,2/12,3.22%,RYR2;ANXA6
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.2690833801522347,-0.7753630161210971,0.7862903225806451,0.9115673384613698,1.0,7/15,29.26%,NTRK2;GRB2;DDIT4;BCAR1;BDNF;ZFYVE27;SOS1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.2443008944201016,-0.7753153534266793,0.8356164383561644,0.9107843251798886,1.0,8/23,27.32%,MAP3K5;PAK1;ARHGEF5;TNFRSF11A;RPS3;MAP3K11;EDN1;DVL2
prerank,regulation of axonogenesis (GO:0050770),0.3374563479004031,0.775241506586285,0.7375415282392026,1.0,1.0,18/51,19.82%,RHOA;GSK3B;RTN4R;EPHA4;ROBO1;MARK2;ARHGAP35;PLXNB2;PLXNB1;PLXND1;MAP6;PTEN;SIPA1L1;NGF;PLXNA2;AMIGO1;PLXNB3;KIF13B
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3582006626048187,0.7748777189702967,0.7148058252427184,1.0,1.0,8/28,16.14%,PSMC2;DDRGK1;FBXW7;FMR1;SMURF1;ATP5IF1;PSMC6;PTEN
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3272997523300376,0.7748206539774004,0.8016359918200409,1.0,1.0,25/124,15.59%,MNS1;STMN1;RB1;GSK3B;FAM161A;LAMB1;NEDD4;MAPT;CORO1B;WDPCP;ODF2;ROCK1;MAP4;HMGB1;SAMD14;FRYL;RAC1;EHD1;BLOC1S5;PLEKHA1;DOCK7;VAPA;HDGFL3;GDNF;PKD2
prerank,myotube differentiation (GO:0014902),0.3714664952141066,0.7743422337101683,0.6968876860622463,1.0,1.0,3/17,7.57%,MYEF2;ADAM12;ADAMTS5
prerank,calcium ion transport into cytosol (GO:0060402),0.37190073169391374,0.7742383705229209,0.6973684210526315,1.0,1.0,8/21,18.18%,ATP2B4;SLC8A1;CACNA1C;TRPM2;ITPR3;GRIN2D;TRPV4;JPH1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.36217708863572584,0.7741911709580559,0.7130647130647131,1.0,1.0,7/25,17.92%,WDR54;MTMR2;PICALM;RAC1;ITGAV;UNC119;ANKRD13D
prerank,positive regulation of autophagy (GO:0010508),0.3247882170593616,0.7741383443569515,0.7761506276150628,1.0,1.0,19/81,14.69%,TRIML2;TICAM1;GSK3B;TPCN1;SH3GLB1;FOXO3;LARP1;LRRK2;ROCK1;HMGB1;IKBKG;SESN1;PIK3CB;TRIM6;GNAI3;PRKD1;PLK2;TRIM5;STK11
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.36348024405724877,0.7740246823551693,0.7050183598531212,1.0,1.0,4/25,10.90%,HAS3;B3GNT8;HAS1;HS2ST1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.389084638957869,0.7737988590542828,0.7020057306590258,1.0,1.0,5/13,15.99%,DEPDC5;SESN1;ITFG2;STK11;SESN2
prerank,negative regulation of kinase activity (GO:0033673),0.3315955745137417,0.7737199155391111,0.7351351351351352,1.0,1.0,13/62,14.58%,RB1;CEP43;TAB1;MAPT;WWTR1;GNAQ;CEP85;HNRNPU;PYDC1;PDPK1;SPRED1;CDKN1B;QARS1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.324918669961614,0.7735103319222747,0.8525576730190572,1.0,1.0,40/208,18.73%,ECT2;FADD;TRIML2;TICAM1;MAP3K14;MIER1;RHOA;LPAR1;TRIM59;UBE2N;RNF31;TNFRSF10B;RIOK3;MAP3K3;IKBKG;CXXC5;PRKCB;PDPK1;GJA1;TRIM6;CASP8;BRD4;RORA;ROR1;DDX21;PRKD1;PLK2;TRIM5;PER1;OTUD7B;VAPA;RHOC;DDX1;MAVS;TNFSF10;LAMTOR5;PLEKHG5;TERF2IP;ANKRD17;RIPK1
prerank,adherens junction organization (GO:0034332),0.3416164657295994,0.7732341549200598,0.7347391786903441,1.0,1.0,6/48,6.13%,CDH15;CDH18;CDH24;CDH4;AFDN;CTNNA1
prerank,necroptotic process (GO:0070266),0.3672787050951105,0.7730052911188434,0.6925170068027211,1.0,1.0,2/16,7.45%,TICAM1;IPMK
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.35565320475482637,0.7729782182545962,0.7183271832718328,1.0,1.0,6/28,17.02%,FADD;CASP8AP2;TNFRSF10B;CASP8;ZDHHC3;NGF
prerank,regulation of RNA splicing (GO:0043484),0.33491967257729277,0.7728830462237781,0.747872340425532,1.0,1.0,22/69,19.50%,DYRK1A;SETX;TRA2B;KHDRBS1;SRSF10;MBNL3;HNRNPH1;POLR2A;FUS;SRSF3;HNRNPL;SRPK1;HNRNPH2;METTL4;PTBP2;HNRNPLL;SRPK2;CWC22;SLC38A2;LARP7;CLK3;KHDRBS3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.3610693107856722,0.7720769608901963,0.7195571955719557,1.0,1.0,6/24,15.22%,LOXL2;SOX6;TGFBR1;WNT9A;SOX9;EFEMP1
prerank,regulation of innate immune response (GO:0045088),0.3403538365980576,0.7715551217038215,0.7433920704845814,1.0,1.0,20/57,24.21%,USP18;DHX9;NMI;IRF1;RIOK3;PARP9;POLR3D;APPL2;AKIRIN2;CASP8;XIAP;SLC15A4;IFNAR2;PTPN1;APPL1;POLR3C;BIRC2;POLR3G;ABCE1;FGR
prerank,oligodendrocyte differentiation (GO:0048709),0.36819773465848704,0.771285053677112,0.7078947368421052,1.0,1.0,5/19,15.18%,SOX6;EIF2B1;TPPP;SOX9;PRDM8
prerank,secondary alcohol biosynthetic process (GO:1902653),0.35323709965343025,0.771186509398753,0.718562874251497,1.0,1.0,7/30,18.29%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,cellular response to estradiol stimulus (GO:0071392),0.3650631416954041,0.7707834980350105,0.7102425876010782,1.0,1.0,4/18,16.06%,LCOR;RUVBL2;RAMP3;SFRP1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.28854992708814564,-0.7701525414226679,0.7794561933534743,0.9179919293781419,1.0,8/13,36.41%,IGF1;RAMP1;SLC2A10;ABCA2;PLCB1;CCL19;GOLGA2;CHP1
prerank,regulation of astrocyte differentiation (GO:0048710),0.384205938734963,0.7691133641448032,0.7064748201438849,1.0,1.0,2/12,11.40%,EPHA4;BMP2
prerank,ncRNA transcription (GO:0098781),-0.2827323821376878,-0.7689849501334719,0.739413680781759,0.9188289723246414,1.0,8/13,36.73%,SNAPC3;SPIN1;GTF3C1;NIFK;RPAP2;GTF3A;SIRT7;ANG
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3041590060017907,-0.7688543527829436,0.7905405405405406,0.9181601760056657,1.0,4/12,20.43%,ATF6;PIK3R1;XBP1;TMEM33
prerank,cellular amino acid catabolic process (GO:0009063),0.32082828981882594,0.7687985210080062,0.7747933884297521,1.0,1.0,8/87,13.21%,ACMSD;SLC25A21;ACAT1;AMT;KMO;ABAT;HOGA1;IL4I1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.36173510949639054,0.7685843274928438,0.6998769987699877,1.0,1.0,7/23,18.66%,MMP14;MYLK3;PIEZO1;MAML1;EFNB2;MAPK14;NIBAN2
prerank,cholesterol biosynthetic process (GO:0006695),0.3502560910209452,0.768529619166186,0.7238095238095238,1.0,1.0,7/31,18.29%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.34610929952710934,0.7676832412355427,0.7309941520467836,1.0,1.0,4/36,7.11%,MACF1;RAB10;AFDN;RILPL1
prerank,neuron projection regeneration (GO:0031102),-0.311642893493001,-0.7675534523064745,0.7363636363636363,0.9192904988640805,1.0,5/10,28.30%,GAP43;RTN4RL1;NREP;MTR;OMG
prerank,negative regulation of protein metabolic process (GO:0051248),0.33474901520166916,0.767337189193135,0.7444444444444445,1.0,1.0,12/48,16.97%,IAPP;MDM4;PRNP;ROCK1;FLOT2;SF3B3;PFDN4;ITGAV;PIN1;AZIN1;NFKB1;LDLR
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3862879883914635,0.7670162516037278,0.7002840909090909,1.0,1.0,3/12,12.82%,ERFE;ZBTB7B;GKAP1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.40639461592465553,0.7665477184578969,0.7125382262996942,1.0,1.0,1/10,3.48%,AGO2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2091803233985028,-0.7664524304817749,0.8787878787878788,0.920067923475279,1.0,12/41,25.08%,PLA2G4A;SCP2;GPX4;PNPLA8;DEGS1;GPX1;DECR2;ACSL1;SCD;ELOVL1;FADS1;GSTM2
prerank,hippo signaling (GO:0035329),0.3566319384102952,0.7663546523493717,0.724907063197026,1.0,1.0,11/26,22.69%,TEAD1;STK3;WWTR1;YAP1;TEAD3;TJP2;TEAD4;AMOTL1;LATS1;STK4;DCHS1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.32738614545616906,0.7663267424452901,0.8,1.0,1.0,19/80,16.96%,ROCK2;LARP4B;HNRNPD;PRKDC;UPF3B;SAMD4A;EFNA1;FMR1;EPHA4;PICALM;PLXNB2;METTL5;EIF3C;LARP4;FXR1;PASK;METTL3;SMPD3;PYM1
prerank,pinocytosis (GO:0006907),0.4016839242197159,0.7662687774298096,0.7076205287713841,1.0,1.0,3/10,20.69%,SNX33;MAPKAPK3;MAPKAPK2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3587271175063194,0.765776128955771,0.7197452229299363,1.0,1.0,3/24,6.13%,CDH15;SPAG9;CTNNA1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.35877582533573366,0.7655571725369164,0.7086513994910941,1.0,1.0,5/22,16.01%,ADGRV1;CACNA1C;GNAI3;STIM1;GABBR2
prerank,ameboidal-type cell migration (GO:0001667),-0.19576677889388538,-0.7652158682453613,0.8839285714285714,0.9210495589384204,1.0,14/51,19.19%,SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;AMOT;MEGF8;TBX1;SEMA3B;SEMA3C;PDLIM1;SEMA5B
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.34552260577899907,0.7651412750105242,0.7373380447585395,1.0,1.0,9/35,18.32%,AQP1;KSR1;AHR;PDE7B;SOX9;NUDT4;IRAG1;ADCY2;PDE7A
prerank,negative regulation of viral process (GO:0048525),0.32684672605069715,0.7648033806902423,0.7688172043010753,1.0,1.0,13/57,21.35%,ILF3;FAM111A;ZC3HAV1;PML;TRIM28;SRPK1;TRIM6;TRIM5;MAVS;SRPK2;LARP7;ISG15;EIF2AK2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3608976757009942,0.7647978605078987,0.7036553524804178,1.0,1.0,4/21,16.06%,TXNDC15;TUBD1;TEDC1;SFRP1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3212281217575148,0.7647600941933057,0.935,1.0,1.0,47/308,15.38%,EZH2;BMP1;FBXO5;LOXL2;PAXIP1;MFAP2;BMPR1A;AGO2;NUMA1;PDPN;LEPR;CXCR4;SOX6;IL18;RIF1;ZBTB7B;WWTR1;SERPINE1;MFN2;AGPAT2;AXIN2;ALMS1;ROCK1;AGT;TAPT1;TGFBR1;SMURF2;BMP2;ABCA1;APPL2;ACHE;GJA1;TRPM4;SOX9;SMAD4;KMT5C;ADIPOR1;TWIST1;ADRB2;MED1;CPT2;ACADL;SMAD3;AGPAT1;SHLD2;RBM19;GDNF
prerank,glial cell development (GO:0021782),-0.2372478912509186,-0.7642155316222778,0.8737864077669902,0.9216854378777065,1.0,12/25,30.76%,CDK6;NF1;APP;SOX4;NRROS;PICK1;CSPG5;EIF2B2;NSUN5;SOX11;SOX10;MT3
prerank,cellular response to pH (GO:0071467),0.35929579984844534,0.763856838704007,0.702557200538358,1.0,1.0,1/17,3.28%,HYAL1
prerank,intermediate filament organization (GO:0045109),-0.25837418257590705,-0.7635766808024713,0.7955390334572491,0.921845888703601,1.0,8/17,36.72%,NEFL;GFAP;KLHL24;PKP2;BFSP1;DSP;TCHH;BFSP2
prerank,visual system development (GO:0150063),0.3422045068496733,0.7633673560054726,0.7236533957845434,1.0,1.0,2/37,2.57%,PBX4;PBX3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.26964852261078737,-0.7627811890700545,0.8149606299212598,0.9222126703166831,1.0,9/17,30.22%,PODXL;TGFB2;FOXC2;NCKAP1L;RET;SYK;SKAP1;P2RY12;CIB1
prerank,translational termination (GO:0006415),0.3177414871911606,0.7621142013314385,0.7932098765432098,1.0,1.0,24/95,22.01%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;ETF1;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.33914291726421614,0.7620231507897361,0.7644394110985278,1.0,1.0,7/38,16.14%,PHLPP2;XDH;PIK3CB;PPP2R5C;PLEKHA1;PPP2R5B;PTEN
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3198802214866273,0.7615403758606802,0.7851929092805006,1.0,1.0,20/80,19.74%,AQP1;CDKN2D;FNIP1;SIAH2;HTRA2;ARL6IP1;SH3RF1;HMGB1;UACA;USP47;XIAP;CD44;SRC;NGF;TNFSF10;LAMTOR5;DPEP1;BAD;DNAJB6;DAPK1
prerank,ruffle organization (GO:0031529),-0.2614569588485028,-0.7614172029663333,0.8122743682310469,0.9233983157929396,1.0,9/16,31.87%,PLEK;TPM1;INPP5K;PIP5K1A;CYFIP1;ARFIP2;AIF1L;ARF6;CSF1R
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.3906688837076548,0.7613309081969767,0.703757225433526,1.0,1.0,4/12,20.07%,SETX;ADRB2;UVRAG;FYCO1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3862060441641914,0.7610925770764012,0.7288135593220338,1.0,1.0,4/13,19.10%,FADD;CASP8;BAD;TBC1D10A
prerank,lipid droplet organization (GO:0034389),0.36012878524146186,0.7609505566539422,0.7135483870967742,1.0,1.0,4/22,14.92%,TSPO2;ZFYVE1;PPID;FAF2
prerank,protein localization to membrane (GO:0072657),0.3142979203245797,0.7609500234234099,0.8644578313253012,1.0,1.0,39/187,17.65%,NDC1;SYNE3;NUP155;TSPAN33;ROCK2;AP4M1;RAB10;ITGB7;PDZK1;DENND4C;RAP2A;ANK1;SCRIB;RAB29;SH3GLB1;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;ZDHHC15;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;TM9SF2;ZDHHC3;NLGN2;STXBP1;DPP6;RAB13;SH3PXD2B;WNK3;TM9SF4
prerank,endosome organization (GO:0007032),-0.20203629135444548,-0.7601096540598463,0.9140625,0.9244298318989145,1.0,18/41,27.78%,SNX3;SQSTM1;LAPTM4B;DNM1;USP8;VPS11;CHMP2B;ARFGEF2;HOOK1;VPS33B;RAB27A;ALS2CL;PLEKHF1;TMEM9;SNX10;PI4K2A;AKTIP;PHETA1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3972742741206836,0.759955160752002,0.7319277108433735,1.0,1.0,1/10,5.24%,PRNP
prerank,regulation of fibrinolysis (GO:0051917),-0.2887100061132696,-0.7591116274935688,0.7585034013605442,0.9250380569991634,1.0,4/13,22.73%,THBD;THBS1;FAP;USF1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.38261379132060586,0.7588437649160826,0.7063253012048193,1.0,1.0,3/11,12.75%,AFDN;RAB1A;TJP2
prerank,positive regulation of axonogenesis (GO:0050772),0.3337939499559153,0.758769363855523,0.7358916478555305,1.0,1.0,15/43,20.64%,MACF1;RHOA;NTN1;MAPT;ROBO1;PLXNB2;PLXNB1;PLXND1;MAP6;DBN1;NGF;PLXNA2;AMIGO1;PLXNB3;GOLGA4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.313752716156527,-0.7579124124205482,0.7648809523809523,0.9259532122407568,1.0,5/10,19.86%,EMC2;EMC3;EMC1;EMC9;MMGT1
prerank,cellular response to cAMP (GO:0071320),0.34258327291327073,0.7576285885565344,0.7283653846153846,1.0,1.0,6/30,15.59%,AQP1;AHR;EZR;AKAP9;DMTN;PKD2
prerank,negative regulation of receptor binding (GO:1900121),-0.3051583168754702,-0.7573867806374575,0.7954545454545454,0.9258243588870628,1.0,4/10,26.03%,ADAM15;B2M;ATP2A3;PTPRF
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.39289932699749575,0.7570873334628306,0.7104477611940299,1.0,1.0,2/11,12.60%,ATP2B4;SMAD4
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3479539874722402,0.7570110911465285,0.729064039408867,1.0,1.0,7/27,16.57%,SGF29;MSL3;RUVBL2;KAT6A;TRRAP;BRD8;PHF20
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.34725003207800176,0.7558613299964314,0.735224586288416,1.0,1.0,10/29,15.44%,TCF7L1;TCF7L2;SMARCA4;AXIN2;LEO1;HDAC1;KMT2D;TLE4;TLE3;TRRAP
prerank,negative regulation of T cell activation (GO:0050868),0.34097793306519847,0.7558516064128918,0.7581227436823105,1.0,1.0,7/35,20.46%,FGL1;CD80;RIPOR2;IL4I1;HAVCR2;SDC4;CEACAM1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.34628123971471425,0.7556028303396847,0.7324455205811138,1.0,1.0,2/29,5.54%,FADD;RAET1E
prerank,cell-cell junction organization (GO:0045216),0.32638432809671647,0.755256769458215,0.7878787878787878,1.0,1.0,14/79,14.34%,CDH15;SDK1;CDH18;CDH24;CDH4;AFDN;CTNNA1;GJC1;TLN1;LIMS1;TJP2;TLN2;PRKCI;SMAD3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.29400084801736776,-0.755245056079514,0.7814569536423841,0.9279716830250826,1.0,2/12,13.02%,TLR4;STRAP
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.3593742739244504,0.7548786021180337,0.7287705956907478,1.0,1.0,3/22,11.45%,PRNP;PTPN2;EZR
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.2824887414200429,-0.7547743060881618,0.7956656346749226,0.9278751963587054,1.0,4/14,17.26%,TGFBR2;PTPN22;CD81;LGALS9
prerank,energy reserve metabolic process (GO:0006112),0.3538469307701666,0.7537789288490244,0.7229551451187335,1.0,1.0,2/19,5.85%,GSK3B;LEPR
prerank,response to UV-B (GO:0010224),0.38693528402656985,0.7535552536727015,0.7343065693430657,1.0,1.0,2/12,14.69%,HYAL1;STK11
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.23395973407729673,-0.7533344083413399,0.8325581395348837,0.9291222374414496,1.0,10/23,22.47%,RBX1;PARP1;XPC;COPS8;COPS7A;UBB;COPS2;COPS4;RPS27A;UBC
prerank,hexose biosynthetic process (GO:0019319),0.3297059099960259,0.7532777882949747,0.7404063205417607,1.0,1.0,5/42,8.44%,PFKFB1;CHST15;GPI;SORD;PGM1
prerank,negative regulation of phosphorylation (GO:0042326),0.32115690668786945,0.7528577810463161,0.7878787878787878,1.0,1.0,20/85,18.55%,CDKN2D;CDKN2C;PFKFB1;PRKDC;PRNP;MAPT;XDH;WWTR1;LRRK2;ROCK1;HNRNPU;CRKL;PPP1R15B;CDKN1B;PTPN13;PTEN;ANKLE2;SIRPA;TERF2IP;IGFBP3
prerank,skeletal muscle contraction (GO:0003009),-0.25315035764335003,-0.752652771820539,0.8204081632653061,0.9293284455732996,1.0,9/19,48.12%,RCSD1;STAC;MYH14;STAC3;TNNI1;STAC2;TNNC1;CCDC78;TCAP
prerank,snRNA metabolic process (GO:0016073),0.3685178565461648,0.7526055155197586,0.7449392712550608,1.0,1.0,5/17,19.91%,INTS7;TUT1;INTS8;ZCCHC8;INTS4
prerank,modified amino acid transport (GO:0072337),0.37101764819733835,0.752395001835175,0.7341597796143251,1.0,1.0,2/15,6.15%,PDPN;SLC19A1
prerank,neuron development (GO:0048666),0.31595088317707765,0.7523773576484455,0.8432760364004045,1.0,1.0,30/141,17.33%,PBX4;GLI2;STMN1;RB1;PBX3;GSK3B;LAMB1;NEDD4;TDP2;SRF;MAPT;WNK1;POU3F2;ROCK1;MAP4;HMGB1;SAMD14;FRYL;EHD1;ACTL6B;BLOC1S5;DOCK7;VAPA;HDGFL3;GDNF;UNK;TBCD;UGDH;STMN2;RAB13
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3518269276416649,0.7522495128697927,0.7069182389937106,1.0,1.0,6/23,20.57%,MCU;RIPOR2;CAMK1D;RAC1;DNM1L;DPP4
prerank,Golgi to lysosome transport (GO:0090160),0.3817443633045161,0.7522380554407471,0.7444608567208272,1.0,1.0,2/11,11.83%,AP4M1;GAK
prerank,regulation of Rac protein signal transduction (GO:0035020),0.3680426721116239,0.752091274742452,0.738255033557047,1.0,1.0,3/16,10.10%,AUTS2;ARHGAP24;PIK3CB
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3721118300450687,0.7519221015531684,0.7136871508379888,1.0,1.0,3/14,11.27%,FIP1L1;TUT1;CPSF4
prerank,membrane organization (GO:0061024),0.3149281865420656,0.7518444236583914,0.906,1.0,1.0,39/227,17.63%,CEP55;KIF20A;NEMP1;NUP155;STX11;ACTR3;PACSIN2;OCRL;STON2;MYOF;ARRB1;LEMD3;STAM;SH3GLB1;MFN2;DNM2;PICALM;EMD;FNBP1;STX18;GAK;CHRNB1;AAK1;MITD1;ADRB2;PRKCI;PIP5K1C;TOR1B;VAPA;SYP;SUN2;SNAP23;TMCC1;DYSF;EPS15L1;UBXN2B;LDLR;EPS15;USO1
prerank,sulfur compound biosynthetic process (GO:0044272),0.31680970588823965,0.7518239061029572,0.7995910020449898,1.0,1.0,27/104,19.92%,CHST15;GSTO2;B4GALT1;GSS;MAT2B;CHSY1;HPGDS;SLC10A7;PAPSS2;ST3GAL3;SLC35D2;CHST3;ANGPT1;UST;DSE;BGN;ST3GAL4;ST3GAL1;ST3GAL2;UGDH;GSTT1;MGST3;GCLM;GSTM5;GCLC;GLCE;HAGH
prerank,protein hydroxylation (GO:0018126),0.3686849709434272,0.7517633409748036,0.7146776406035665,1.0,1.0,7/15,22.17%,VIPAS39;P3H1;P3H4;PLOD2;OGFOD1;PLOD1;EGLN3
prerank,T cell migration (GO:0072678),-0.2852259497713515,-0.7514716574749526,0.7894736842105263,0.9301562491695318,1.0,9/13,49.02%,S1PR1;SLC12A2;PIK3CD;CXCL16;GPR183;PIK3CG;CXCL10;MYO1G;ZAP70
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.29576431964012384,-0.7513166220101659,0.8181818181818182,0.9295182536985296,1.0,6/11,22.71%,FAS;GSN;ST18;LGALS9;PARK7;PIH1D1
prerank,positive regulation of protein depolymerization (GO:1901881),0.3926080399567571,0.7510849351332671,0.7473841554559043,1.0,1.0,5/11,23.10%,NES;STMN2;TRPV4;SEMA5A;CFL2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3702917612967494,0.750975232508719,0.7343324250681199,1.0,1.0,6/16,20.61%,LHPP;ADSL;PFAS;GART;PPAT;ADSS2
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.32044551745857514,0.7509286049277476,0.7737068965517241,1.0,1.0,22/61,24.77%,FGFR4;PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PANK2;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,mitochondrial genome maintenance (GO:0000002),0.38050527646734444,0.7509278951688731,0.7257575757575757,1.0,1.0,2/11,9.41%,MGME1;LONP1
prerank,dermatan sulfate metabolic process (GO:0030205),0.3805914002253225,0.7506932563504722,0.7104874446085672,1.0,1.0,3/13,14.04%,UST;DSE;BGN
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3182957343717812,0.7502753574107149,0.8026584867075665,1.0,1.0,12/85,11.74%,VANGL1;RHOA;PSMC2;PSMD5;DAAM1;PSMB1;SMURF1;PSMD14;PSMD1;PSMB9;SMURF2;RAC1
prerank,positive regulation of cytokine production (GO:0001819),0.31163919140866303,0.749920464029228,0.926,1.0,1.0,73/292,24.98%,BRCA1;HPSE;FADD;TICAM1;ROCK2;RAB7B;DHX9;PRKDC;SULF2;MRE11;G3BP1;IL18;STOML2;SCRIB;ZBTB7B;SULF1;SERPINE1;CD80;AGPAT2;IRF1;HMGB1;AGT;RAB1A;POLR3D;EIF2AK3;ANXA1;ADAM17;TRIM6;RORA;TWIST1;POU2F2;ARNT;AGPAT1;SETD4;PRKD2;NFKB1;LPL;MAVS;FOXP1;LAMTOR5;LACC1;RUNX1;MAPK14;TMED10;RIPK1;HAVCR2;ZFPM1;PDE4B;TRAF6;IL16;TRAF2;ISG15;EIF2AK2;PNP;SOD1;APPL1;POLR3C;KAT2A;IL6R;POLR3G;TLR7;BCL10;RIPK2;IL6ST;CRCP;MBP;FGR;PAEP;F3;RELA;TGFB1;CD200;DHX33
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3138434440480264,0.74918823066026,0.850956696878147,1.0,1.0,30/151,18.77%,RHD;SLC25A15;CERS6;CERS5;GSTO2;LARGE1;PAM;CHAT;LPCAT1;LPIN2;SLC25A2;HPGDS;CSNK2A2;ACHE;PLPP1;CSNK1G2;PRKD1;ELOVL4;ST3GAL4;SPTLC2;TYW1;VAPA;ST3GAL2;PRKD2;ALAS2;GSTT1;MGST3;FA2H;GCNT1;GSTM5
prerank,amino acid transport (GO:0006865),0.3240226431536335,0.7491404169242855,0.7450331125827815,1.0,1.0,14/49,20.61%,SLC38A7;PDPN;SLC38A4;SLC25A47;SLC16A10;SLC38A9;SLC1A5;SLC6A17;SLC36A4;SLC7A1;SLC25A29;SLC38A2;SLC25A44;SLC7A11
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.2507911279232151,-0.7489079388039261,0.8045977011494253,0.932100896652936,1.0,4/18,19.48%,ESR1;DDX5;MAP2K1;ZC3H12A
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.28369529842286095,-0.7486693350116896,0.8144654088050315,0.9315774510824943,1.0,3/12,9.08%,ATP1B1;WNK2;ATP1B3
prerank,regulation of pseudopodium assembly (GO:0031272),-0.30658848581898634,-0.7485652179161539,0.7850467289719626,0.9300199624600988,1.0,3/10,14.76%,CDC42EP4;CDC42EP5;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.30658848581898634,-0.7485652179161539,0.7850467289719626,0.9300199624600988,1.0,3/10,14.76%,CDC42EP4;CDC42EP5;APC
prerank,detection of calcium ion (GO:0005513),0.3638890444650393,0.7482548806013574,0.7020057306590258,1.0,1.0,5/13,16.00%,KCNMB2;KCNMB3;CALM2;KCNMB4;STIM1
prerank,regulation of protein sumoylation (GO:0033233),0.3579556375004544,0.7482229039131618,0.7165991902834008,1.0,1.0,1/17,1.87%,SAE1
prerank,microtubule-based transport (GO:0099111),-0.28891428004531505,-0.7480928914698695,0.7940298507462686,0.9298075737761105,1.0,9/12,48.65%,DYNC1I2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,protein processing (GO:0016485),0.3138038189601646,0.7480775058985717,0.8312883435582822,1.0,1.0,7/102,8.22%,KEL;FAM111A;FXN;MMP14;CPXM1;STOML2;HTRA2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3516888532743696,0.7480326666723254,0.731457800511509,1.0,1.0,9/22,23.16%,CHD1L;ERCC3;CUL4B;XPA;RAD23B;ERCC2;GTF2H1;DDB2;DDB1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3680406634583322,0.7478791141302114,0.7418899858956276,1.0,1.0,2/14,7.87%,SULF2;SULF1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.38626794352994503,0.7477997366373772,0.7027027027027027,1.0,1.0,4/13,24.86%,MAPT;PRKCD;SOD1;TGFB1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.35795766667644824,0.7477491833277908,0.7211796246648794,1.0,1.0,3/17,11.40%,HTRA2;SFPQ;BAG5
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.24105827147984377,-0.7477150411901458,0.8412017167381974,0.929500715641978,1.0,5/22,11.61%,TIMP3;APOE;FURIN;GPLD1;TNFRSF1B
prerank,cytoplasmic translational initiation (GO:0002183),0.3675983220090835,0.7473159056427753,0.7162346521145976,1.0,1.0,9/17,23.42%,EIF4H;RBM4;EIF4A2;MCTS1;DENR;EIF3I;EIF2D;EIF5;EIF4B
prerank,glycerol metabolic process (GO:0006071),-0.2934328121511134,-0.7462189924072826,0.7905604719764012,0.9307121874517685,1.0,6/10,34.55%,COQ3;GOT1;TPI1;PGP;ANGPTL3;TKFC
prerank,renal filtration (GO:0097205),0.3891976140231291,0.74596109057434,0.7503805175038052,1.0,1.0,2/10,7.87%,SULF2;SULF1
prerank,MAPK cascade (GO:0000165),0.31079733672402454,0.7458060495283241,0.931,1.0,1.0,47/295,15.74%,CDK1;SPTA1;ARTN;MAP4K4;KSR1;SETX;NCAM1;BRAP;FGFR4;SPTB;FGFR2;PSMC2;PSMD5;RASA3;KIT;FRS2;NRK;IL18;MAP3K20;PDGFRA;LRRK2;PSMB1;CUL3;PSMD14;ANGPT1;MAP3K3;PSMD1;IKBKG;PIK3CB;PSMB9;FBXW11;SOX9;IL31RA;PPP1CC;CTSH;DLG1;BTRC;SPRED1;PSMC6;RGL3;PTPRA;ITGAV;TAOK1;PLVAP;RASAL3;GDNF;NFKB1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3279454248424615,0.7457349266092312,0.7633069082672707,1.0,1.0,10/41,15.32%,PRNP;FBXW7;EFNA1;EPHA4;NOX4;AGT;DOCK3;ADAM17;UNC119;SRC
prerank,regulation of receptor internalization (GO:0002090),0.3405972837516648,0.7455095310370822,0.7546728971962616,1.0,1.0,6/35,13.00%,WDR54;ARRB1;FMR1;ANGPT1;MTMR2;MKLN1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.32778801585290684,0.7450833311574087,0.7602272727272728,1.0,1.0,16/47,20.02%,SFRP2;ZBTB7B;TMEM64;PIM1;HNRNPU;BMP2;TRPM4;LRP5;MEDAG;WDFY2;LPL;SFRP1;AAMDC;FRZB;SYAP1;RREB1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3873969674633194,0.7450477859709805,0.7386706948640483,1.0,1.0,4/11,22.02%,BOK;TP53;PTGIS;SIRT2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.33056608388952424,0.7450004197861058,0.7675977653631285,1.0,1.0,2/42,6.76%,RBM15;WNK1
prerank,cardiac cell development (GO:0055006),-0.2921479905812163,-0.7449828752794777,0.8017751479289941,0.9315244397541037,1.0,3/11,16.94%,JAG1;VEGFA;MYH11
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.30188090263077416,-0.7446880375420851,0.8073654390934845,0.9311161697558714,1.0,7/10,32.74%,PDE3A;UBE2B;PDE2A;PDE4D;PDE11A;MGRN1;APLNR
prerank,canonical Wnt signaling pathway (GO:0060070),0.3238424313354596,0.7445444937769035,0.7736450584484591,1.0,1.0,17/68,19.04%,GSK3B;TCF7L1;WNT2B;TCF7L2;SFRP2;PORCN;LRRK2;WNT6;NR4A2;WNT9A;LRP5;SFRP1;PTEN;AMER1;CSNK1A1;FRZB;WNT4
prerank,positive regulation of growth (GO:0045927),0.3166674591570564,0.7442636769704171,0.7768331562167906,1.0,1.0,13/64,16.06%,HYAL1;CEP43;FXN;MMP14;DERL2;SFRP2;KLHL22;TGFBR1;ADAM17;USP47;RPTOR;INO80;SFRP1
prerank,negative regulation of neurogenesis (GO:0050768),0.33544756886787613,0.7437565587533166,0.7376294591484465,1.0,1.0,3/34,4.43%,RHOA;RTN4R;PCM1
prerank,BMP signaling pathway (GO:0030509),0.32354064528897963,0.743704884576269,0.7800650054171181,1.0,1.0,12/62,14.34%,BMPR1A;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;BMP2;SMAD4;USP9X;SMAD3
prerank,endodermal cell differentiation (GO:0035987),0.33975327008388845,0.7436831155202762,0.7518159806295399,1.0,1.0,7/31,15.00%,MMP14;LAMB1;SETD2;LEO1;COL12A1;ITGA5;ITGAV
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.37286414129057766,0.7436170963864318,0.7417503586800573,1.0,1.0,3/13,11.27%,FIP1L1;TUT1;CPSF4
prerank,ventricular septum development (GO:0003281),0.32912661034471213,0.7435683836421183,0.7526132404181185,1.0,1.0,12/37,19.41%,BMPR1A;MDM4;TGFBR3;MATR3;ROBO1;TGFBR1;SMAD4;HEY2;HECTD1;SALL1;ZFPM2;ZFPM1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.24218532079217478,-0.7434357737692601,0.8592233009708737,0.9320470334849064,1.0,4/23,17.26%,LAMP1;NECTIN2;PIK3R6;LGALS9
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.2616781021106169,-0.7434354342811386,0.7983870967741935,0.9312156279625327,1.0,5/17,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,response to metal ion (GO:0010038),0.317528562778342,0.7429530592371417,0.7807203389830508,1.0,1.0,10/67,13.77%,LOXL2;FXN;NEDD4;PAM;MAPT;PPP3CA;NDRG1;CALM2;ITPR3;ADAM9
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.35375899930912713,0.7428478758069572,0.75,1.0,1.0,3/20,13.19%,TICAM1;IL18;PRKCE
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3402292485535695,0.7425828022863671,0.7437425506555423,1.0,1.0,5/33,14.21%,E2F2;ADAMTS9;PIK3CB;PDPK1;ITGA5
prerank,muscle contraction (GO:0006936),0.3089214381725124,0.7424413927781229,0.8609137055837564,1.0,1.0,20/126,16.49%,ROCK2;TPM4;MYOF;SORBS3;ROCK1;SLC8A1;BDKRB2;EMD;GJC1;MYH2;TLN1;SNTA1;SMTN;CLCN1;CHRNB1;DES;TMOD3;DYSF;TPCN2;TNNT3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.29717519954157656,-0.7421057679694404,0.7929936305732485,0.9321569138754302,1.0,5/10,34.40%,ANO6;NCKAP1L;CD300A;RAB31;C3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.34343984097887575,0.7418919479186695,0.7496757457846952,1.0,1.0,6/25,20.27%,RB1;TRIM6;TWIST1;HEY2;NIBAN2;TRAF6
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3090752069132121,0.7416032886622179,0.8796389167502507,1.0,1.0,28/163,15.74%,ERMAP;THEMIS;PSMC2;PSMD5;KHDRBS1;EIF2B1;WNK1;UBE2N;STOML2;RNF31;RC3H2;PSMB1;PSMD14;NCK1;PSMD1;IKBKG;PIK3CB;PSMB9;PRKCB;FBXW11;PDPK1;BTK;BTRC;RC3H1;PSMC6;PLEKHA1;PRKD2;NFKB1
prerank,prostaglandin biosynthetic process (GO:0001516),0.3485640596865576,0.7414101725725883,0.7352555701179554,1.0,1.0,4/18,12.45%,PTGES2;HPGDS;PTGS1;DAGLB
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.26667470771273133,-0.7412684878071722,0.8181818181818182,0.9325020839401339,1.0,7/16,23.15%,DDX17;SLU7;DDX5;PUF60;SRSF6;SRSF9;SCNM1
prerank,action potential (GO:0001508),-0.1998248111355192,-0.7408083228069294,0.9069767441860465,0.9323301981378699,1.0,18/44,32.55%,KCNB1;AKAP6;SCN1A;SCN9A;GNA14;KCNA2;SCN3A;SCN8A;SRI;KCNQ1;GPER1;CACNA1H;MYH14;CLN3;CACNA1I;YWHAH;KCNE4;SCN3B
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.3258790312397966,0.7404711943493044,0.7697441601779755,1.0,1.0,10/47,16.80%,MAP4K4;ULK4;RAP2A;TGFBR3;MAPK8IP3;FOXM1;QARS1;PER1;TAOK1;KLHDC10
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.2649435238669402,-0.7393078367256504,0.8275862068965517,0.9334516054220021,1.0,5/16,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,negative regulation of innate immune response (GO:0045824),0.3373648039072431,0.73863246404819,0.734282325029656,1.0,1.0,9/34,22.39%,USP18;NMI;PTPN2;YTHDF2;CNOT7;METTL3;SUSD4;ISG15;FAM3A
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3110743315535573,0.738564277500724,0.7948453608247422,1.0,1.0,7/85,13.19%,BIRC5;ADGRV1;NIPBL;RIPOR2;LHFPL5;HOMER2;ROR1
prerank,gene expression (GO:0010467),0.30742673689898475,0.7383534438461314,0.954,1.0,1.0,59/348,14.26%,MRPL36;NDC1;E2F1;NUP155;SYNCRIP;SETX;NUP205;PABPC4;TSPAN33;NUP160;AGO2;SRSF4;HNRNPD;FIP1L1;SRBD1;EIF4E;UPF3B;MRPL18;NUP85;SLBP;TPR;DDX39B;HNRNPH1;TASP1;SRSF7;POLR2A;RBMS2;DHX8;CELF2;HNRNPUL1;DARS1;WDR33;NOX4;EPC1;NR4A2;SRSF3;HNRNPU;MMS19;DRG1;MRPL13;RBM15B;HNRNPL;SRRM1;CPSF4;ATXN1;MRPL55;NUP214;ASMT;RNGTT;RPS17;RANBP2;MCM3AP;MRPS33;TSPAN5;MRPS18B;RBM4;SMG6;NXT1;RBMS1
prerank,cholesterol efflux (GO:0033344),0.35491709918869,0.7382543653481743,0.7380645161290322,1.0,1.0,4/20,15.90%,SOAT1;ABCA1;SOAT2;STX12
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.36197361772237313,0.7377990210411223,0.7394843962008141,1.0,1.0,5/17,14.42%,SRF;ROBO1;NR4A1;EFNB2;MIA3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3383998203461484,0.7376279193867115,0.762936221419976,1.0,1.0,6/33,7.96%,ADA;PDE3B;EFNA1;PLAU;SFRP2;SERPINE1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.35509761679583457,0.7373620226992225,0.7285513361462729,1.0,1.0,4/15,18.34%,RIPOR2;EHD1;ADAM9;MAPK14
prerank,lamellipodium assembly (GO:0030032),0.34191419611283264,0.7372646670442846,0.7496902106567535,1.0,1.0,6/26,14.27%,KIT;SPEF1;SRGAP2;RAC1;DMTN;ITGB1
prerank,nervous system development (GO:0007399),0.30933508023868855,0.7372555196308056,0.973,1.0,1.0,68/429,17.03%,ECT2;STIL;WDR62;NAV2;CDK5RAP2;ARTN;SDK1;DYRK1A;ADGRV1;TRAK1;TEAD1;LPAR1;OBSL1;RBFOX2;ALDH1A2;FUT10;NINJ2;ST8SIA2;GSS;BTD;ADGRA2;CXCR4;SOX6;NLGN3;GRHL2;CRIM1;RAB29;POU3F2;WWTR1;WDPCP;ROBO1;DSCAML1;YAP1;FARP1;ZIC5;FBXL17;APAF1;TGFBR1;PRPS1;DPYSL4;DSCAM;ATXN1;MPZ;ACHE;ZIC4;DAGLB;NOTCH2;SH3GL3;LY6H;PLXND1;NES;ACTL6B;SMPD1;MAB21L2;CAPG;UNC119;GDNF;PKD2;PTEN;ANKLE2;NLGN2;NCKAP1;SHANK2;JRKL;ARNT2;AXL;NGF;WWP1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.32800368310619393,0.7368783887062426,0.7575057736720554,1.0,1.0,7/36,13.54%,ATP2B4;NOSIP;DNM2;NPR3;PIK3CB;TERF2;DHFR
prerank,transport along microtubule (GO:0010970),0.3645131715835418,0.7367338286314971,0.7688953488372093,1.0,1.0,1/13,1.67%,ARHGAP21
prerank,proteoglycan metabolic process (GO:0006029),0.33564030248647464,0.7366563264697091,0.7297979797979798,1.0,1.0,4/26,7.97%,HPSE;SULF2;SULF1;B4GALT7
prerank,negative regulation of neuron differentiation (GO:0045665),0.3417296098820864,0.7360028719340761,0.7358490566037735,1.0,1.0,3/22,13.64%,GSK3B;SOX9;MED1
prerank,small GTPase mediated signal transduction (GO:0007264),0.3105965446991256,0.7358137494526024,0.8314491264131552,1.0,1.0,25/103,18.34%,KSR1;RB1;BRAP;RASSF1;RRAD;CCNA2;ARHGAP18;NTN1;SIAH2;G3BP1;CDK2;TRIM28;USP28;CRKL;ARHGEF18;RAC1;RRAS;PRKD1;PLK2;TP53;TNK2;RRAS2;NRAS;KRAS;MAPK14
prerank,heart trabecula morphogenesis (GO:0061384),0.3544205900591956,0.7357637238505066,0.7638522427440633,1.0,1.0,4/18,12.33%,BMPR1A;TGFBR3;TGFBR1;RBPJ
prerank,regulation of keratinocyte migration (GO:0051547),0.3682214888036816,0.7354973324569528,0.7525325615050651,1.0,1.0,3/12,16.14%,MAP4K4;ADAM9;PTEN
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3089325497810226,0.7351539413021957,0.8533604887983707,1.0,1.0,33/118,20.81%,VASH2;PHIP;GSK3B;FGFR2;NEDD4;MAPT;ADGRA2;RAP2A;EPHA4;PDZD8;LRRK2;SH3D19;MARK2;ARHGAP35;LZTS3;PDLIM5;ZDHHC15;PLXND1;LARP4;RC3H1;GDNF;SFRP1;SIPA1L1;ABI2;CLASP1;TANC2;SP100;KIF13B;FMNL2;HECW2;EGLN1;CEACAM1;FERMT2
prerank,mesenchyme morphogenesis (GO:0072132),0.3560135820673031,0.7348665723943171,0.7526178010471204,1.0,1.0,4/17,12.56%,BMPR1A;MDM4;BMP2;SOX9
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.21860816006375072,-0.7348645825398907,0.8881987577639752,0.9384920143939921,1.0,6/31,15.53%,SCP2;LIAS;MOCS2;CYP51A1;MOCS1;GCH1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3521105178404776,0.7346556324414435,0.7336747759282971,1.0,1.0,5/19,18.55%,MMP14;PRKDC;BTK;AXL;ZBTB1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.32114752302791755,0.7339068310464703,0.7959183673469388,1.0,1.0,11/52,14.35%,ATP2B4;RANGRF;GPSM2;NUMA1;EPB41L2;PDPK1;PRKCE;PRKCI;DLG1;ITGB1;RAMP3
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.31317013064620036,0.7337806575476837,0.8195173137460651,1.0,1.0,15/77,15.32%,RB1;PHIP;FXN;SIAH2;TCF7L2;RTKN2;SH3RF1;CSNK2A2;NR4A2;TGFBR1;PLAUR;QARS1;BIRC6;ITGAV;SRC
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.35056991790113307,0.7335307306656927,0.7432795698924731,1.0,1.0,4/18,16.16%,FXN;AGT;GDNF;RFK
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.38208266035789984,0.7331906068105043,0.7333333333333333,1.0,1.0,5/10,26.75%,PTPN2;NF2;PARP14;PPP2CA;PPP2R1A
prerank,positive regulation of endopeptidase activity (GO:0010950),0.33657239048666243,0.7327577874005324,0.7481389578163772,1.0,1.0,4/26,9.55%,ROCK2;EFNA1;EPHA4;PICALM
prerank,macrophage activation involved in immune response (GO:0002281),-0.2798536382081919,-0.7323147260619581,0.8079268292682927,0.9410087412566208,1.0,4/13,14.32%,IFI35;LBP;GRN;SBNO2
prerank,translational elongation (GO:0006414),0.30303156704719586,0.7322322537858093,0.8413510747185261,1.0,1.0,24/101,22.01%,MRPL36;MRPL18;EEFSEC;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;LTN1;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3319180984684263,0.7321964333762685,0.7402439024390244,1.0,1.0,9/29,17.41%,PATL1;LSM3;CNOT6;LSM2;EXOSC7;LSM7;CNOT7;LSM4;EDC3
prerank,sensory perception of pain (GO:0019233),-0.23568007656597653,-0.7321911439880971,0.9150943396226415,0.9403243865973208,1.0,14/21,45.70%,SCN9A;OPRM1;KCNA2;NIPSNAP1;P2RX4;P2RX7;OPRK1;CHRNA4;CCR2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3451128526787523,0.7320784495447469,0.725130890052356,1.0,1.0,4/23,15.52%,KIT;OCIAD2;CRLF3;OCIAD1
prerank,cellular response to purine-containing compound (GO:0071415),0.3796408112501199,0.731367160883071,0.7291981845688351,1.0,1.0,3/10,10.65%,SLC8A1;P2RY1;TRPM2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3455900016253381,0.7313627394451704,0.7493702770780857,1.0,1.0,4/21,14.20%,BMPR1A;MFN2;GJA1;ADAMTS1
prerank,icosanoid secretion (GO:0032309),-0.28712902921877215,-0.7311182440733383,0.8013698630136986,0.9408812537191865,1.0,3/12,10.67%,ABCC4;PNPLA8;ACE
prerank,renal water homeostasis (GO:0003091),0.3451448436847274,0.7308696496050668,0.7676767676767676,1.0,1.0,9/23,24.38%,AQP1;ADCY6;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;AQP4;MYO5B;PRKACA
prerank,striated muscle cell differentiation (GO:0051146),0.3515246166529567,0.730800194588736,0.7503429355281207,1.0,1.0,3/16,11.40%,MYEF2;SDC1;BMP2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.31220803396162505,0.7307567137997313,0.7777777777777778,1.0,1.0,3/39,5.30%,RANGRF;NEDD4;PDZK1
prerank,amyloid-beta metabolic process (GO:0050435),0.353209018917609,0.7303558590071924,0.756198347107438,1.0,1.0,1/16,2.25%,DYRK1A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3258925231092957,0.7302211181733932,0.7488038277511961,1.0,1.0,9/31,17.41%,PATL1;LSM3;CNOT6;LSM2;EXOSC7;LSM7;CNOT7;LSM4;EDC3
prerank,regulation of protein secretion (GO:0050708),0.3068997168543834,0.7296657634344381,0.8496932515337423,1.0,1.0,20/119,13.77%,GCK;ARFIP1;ITPR1;FRMD4A;DNAJC1;STXBP5;MYH10;BMP6;LLGL2;CACNA1C;RAPGEF4;EZR;SYTL4;P3H1;ITPR3;PRKCA;ACHE;PPID;ENSA;ADAM9
prerank,regulation of lipid metabolic process (GO:0019216),0.3088492790513584,0.7295929334394498,0.8219037871033776,1.0,1.0,14/88,13.72%,ZFP69;FGFR4;PMVK;TBL1XR1;NFYA;NCOA2;TM7SF2;ACACA;PLPP1;ADIPOR1;RORA;MED1;PANK2;MVK
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.34890289764867916,0.7293990435848923,0.7647058823529411,1.0,1.0,4/19,14.94%,BMP6;AFDN;ADAM19;PTPRU
prerank,negative regulation of phagocytosis (GO:0050765),0.3522272645753176,0.7292716004028029,0.7472826086956522,1.0,1.0,5/17,17.29%,HMGB1;PIP4P2;DYSF;SIRPA;CD47
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.19072466105043795,-0.7291441681339771,0.898989898989899,0.9426261830072753,1.0,13/51,25.98%,STAT3;MALT1;TLR4;APP;S100A13;PANX1;LGALS9;TRIM16;EGR1;HSPB1;JAK2;P2RX7;TMEM106A
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2112325947624562,-0.7289829155311628,0.9290780141843972,0.9420222190313376,1.0,16/33,34.87%,ARAP1;TGFA;BCAR3;HIP1;ADRA2A;CBL;AFAP1L2;DGKD;HBEGF;SHKBP1;GPER1;EGF;NEU3;AKT1;PDE6H;DOK1
prerank,cAMP biosynthetic process (GO:0006171),-0.29620642739764674,-0.7286825385706691,0.8319088319088319,0.9415972903597504,1.0,3/10,14.87%,ADCY3;ADCY8;ADCY4
prerank,triglyceride homeostasis (GO:0070328),-0.22078491933678795,-0.728554166903068,0.8805970149253731,0.94092900246414,1.0,11/26,33.47%,APOE;PNPLA8;NR1H3;C1QTNF3;XBP1;NR1H4;DGAT2;MTLN;MLXIPL;ANGPTL3;FITM2
prerank,lamellipodium organization (GO:0097581),0.33506982830000775,0.7284791556253929,0.7643467643467643,1.0,1.0,6/29,14.27%,KIT;SPEF1;SNX1;RAC1;DMTN;ITGB1
prerank,negative regulation of catalytic activity (GO:0043086),0.33455762530755256,0.7276384504548778,0.7443324937027708,1.0,1.0,6/24,19.45%,NOSIP;PARP9;ATP5IF1;NES;TP53;CAND1
prerank,regulation of epithelial cell migration (GO:0010632),0.315341312221207,0.7276350259840433,0.782608695652174,1.0,1.0,20/51,24.08%,MACF1;HYAL1;MCC;ENPP2;SOX9;ADIPOR1;CTSH;PRKCE;DOCK1;INSL3;SRC;ARSB;CLASP1;DOCK5;RREB1;CEACAM1;DAB2IP;PTPN23;DUSP10;SASH1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.3609653944194159,0.7274779252809767,0.7517934002869441,1.0,1.0,3/14,14.06%,DYRK1A;ADAM17;ADAM19
prerank,negative regulation of lipid storage (GO:0010888),0.3451623238573517,0.727316694158275,0.7486702127659575,1.0,1.0,4/19,15.00%,PTPN2;OSBPL8;ABCA1;ITGAV
prerank,programmed necrotic cell death (GO:0097300),0.34518931770066297,0.7272267961052669,0.7362045760430687,1.0,1.0,2/18,7.45%,TICAM1;IPMK
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2260529545912989,-0.7272019150409199,0.8935185185185185,0.9417990359974738,1.0,8/23,37.86%,ATP6V0A4;SLC12A9;SLC12A2;PDK2;SLC9A1;PDK4;SLC12A5;KCNH2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.31405374811258596,0.7267350428810105,0.773972602739726,1.0,1.0,6/42,12.16%,MAP4K4;GSK3B;ROCK1;LIMS1;RAC1;RRAS
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3740840693178972,0.7267206444557607,0.7786377708978328,1.0,1.0,1/10,2.18%,MAP4K4
prerank,skin development (GO:0043588),0.3137017601837557,0.7264118660616328,0.7916219119226638,1.0,1.0,8/65,13.77%,TGM1;STMN1;COL5A2;ERRFI1;ANXA1;CLIC4;MED1;ADAM9
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.29694688900096283,-0.7262161579728686,0.8184713375796179,0.9413643562358026,1.0,2/12,3.48%,IGF1;AKAP6
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.29694688900096283,-0.7262161579728686,0.8184713375796179,0.9413643562358026,1.0,2/12,3.48%,IGF1;AKAP6
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3259640076703333,0.7259735470647515,0.7576499388004896,1.0,1.0,9/29,22.19%,FADD;TICAM1;IKBKG;CASP8;RIPK1;UBE2D3;TANK;IKBKB;BIRC2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.35764268350758527,0.7259232375229119,0.744475138121547,1.0,1.0,5/15,18.88%,TSEN34;CPSF4;TSEN2;DDX1;ZBTB8OS
prerank,defense response to bacterium (GO:0042742),0.30638828060817513,0.7258906091555973,0.8463114754098361,1.0,1.0,7/105,9.87%,HMGB2;AQP1;COLEC12;RNASE6;ANXA3;SERPINE1;RAB1A
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.333451129343913,0.7258896040610244,0.7682619647355163,1.0,1.0,6/26,19.61%,EYA4;HTRA2;EYA2;GDNF;PPP2R1B;TERT
prerank,microglial cell activation (GO:0001774),-0.23555993631984257,-0.7258539984627776,0.8847736625514403,0.9410079471059799,1.0,13/21,42.23%,GRN;APP;CX3CL1;IFNGR1;JAK2;C1QA;TYROBP;ITGB2;CX3CR1;ITGAM;AGER;AIF1;TREM2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.336879458552983,0.7255580599524892,0.7543424317617866,1.0,1.0,5/26,11.40%,TXN;PYCR1;HTRA2;LRRK2;BAG5
prerank,regulation of histone modification (GO:0031056),0.36504109616076574,0.7254506379802943,0.748587570621469,1.0,1.0,2/13,6.78%,MTHFR;UBE2N
prerank,mesoderm formation (GO:0001707),-0.25480304110779095,-0.7254479469965154,0.8620689655172413,0.9406401636686476,1.0,7/17,31.33%,BMPR2;ITGB4;ITGB3;HMGA2;KDM6B;SNAI1;ITGA2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.33193956034543265,0.725446390367223,0.7471264367816092,1.0,1.0,6/22,15.58%,ROCK2;ROCK1;AGT;PRKCA;SMAD4;LMCD1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3691942751452235,0.7251411792922282,0.7253731343283583,1.0,1.0,3/11,13.96%,RC3H2;ANXA1;RC3H1
prerank,sterol biosynthetic process (GO:0016126),0.32751388295351314,0.7250152001338749,0.7759433962264151,1.0,1.0,7/33,18.29%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.314503905865902,0.7249596575849904,0.7982551799345693,1.0,1.0,20/53,24.77%,PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,regulation of ossification (GO:0030278),0.3227858767319011,0.724928374990169,0.7569124423963134,1.0,1.0,10/36,16.06%,CHSY1;SMAD6;DDR2;BMP2;ENPP1;RBPJ;SOX9;TWIST1;NOTUM;SFRP1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3091891986150728,0.7247524378012933,0.8574358974358974,1.0,1.0,41/102,24.71%,GCK;RAB10;PRKDC;PDE3B;DENND4C;LPIN2;RHOQ;CPEB2;NR4A2;ENPP1;PDPK1;NR4A1;PRKCI;EPRS1;SLC30A10;ADCY6;SRC;NFKB1;PCK2;CYSLTR2;PRKAR2B;PRKAR2A;RAB13;ADCY2;INSIG2;SLC2A4;SYAP1;PRKCD;CEACAM1;INSIG1;FER;RAB8B;VAMP2;ZFP36L1;PRKAR1A;SLC25A33;RAB8A;LPIN3;RPS6KB1;PRKACA;RELA
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.35863289055252234,0.724657553551948,0.7546099290780142,1.0,1.0,5/14,18.88%,TSEN34;CPSF4;TSEN2;DDX1;ZBTB8OS
prerank,hematopoietic stem cell differentiation (GO:0060218),0.38041585781578935,0.7246220096596114,0.7484472049689441,1.0,1.0,4/10,17.01%,LMBR1L;TP53;SFRP1;MLLT3
prerank,coenzyme A metabolic process (GO:0015936),0.3639251689453812,0.7244816311806554,0.752112676056338,1.0,1.0,5/14,19.09%,ACAT1;PPCDC;PANK4;PANK2;COASY
prerank,heterotypic cell-cell adhesion (GO:0034113),0.33356658470418127,0.7243674956661079,0.7487745098039216,1.0,1.0,5/25,15.00%,PARVA;ITGB7;ITGA5;ITGB1;ITGAV
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3653442566317991,0.7242673741636908,0.7674750356633381,1.0,1.0,3/13,20.27%,RHOA;ZDHHC21;TRAF6
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3840772715863817,0.7237487646631566,0.7647058823529411,1.0,1.0,2/10,11.33%,EIF2AK3;QRICH1
prerank,negative regulation of protein polymerization (GO:0032272),0.33471571586333526,0.7234825869965821,0.7594627594627594,1.0,1.0,3/27,5.70%,STMN1;DYRK1A;SSH2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.36596544847254714,0.7233719702725225,0.7572254335260116,1.0,1.0,1/12,3.25%,RHOA
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.3692949740373432,0.7233710596754457,0.7616279069767442,1.0,1.0,3/11,19.19%,BMPR1A;HEY2;ZFPM2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3624678561598294,0.7228604458961543,0.7696709585121603,1.0,1.0,4/13,13.44%,SFRP2;RBPJ;SMAD4;HEY2
prerank,UV protection (GO:0009650),0.37324972918678406,0.7227878672942903,0.7590361445783133,1.0,1.0,4/10,23.76%,XPA;SDF4;ERCC2;ERCC5
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3782713480993226,0.7227768715555933,0.7534246575342466,1.0,1.0,2/10,12.39%,FBXW7;ADAM17
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3652671714460809,0.7226497357576016,0.7460815047021944,1.0,1.0,1/10,6.38%,IL18
prerank,regulation of tissue remodeling (GO:0034103),0.3517016712381048,0.7222113847366425,0.7559681697612732,1.0,1.0,3/18,9.98%,LEPR;IL18;DDR2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3012057562212266,-0.7221582414193289,0.7804154302670623,0.9439048717747917,1.0,6/10,44.45%,LGALS9;PTPRC;ARRB2;CX3CR1;FCGR2B;LILRB1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.30838291937746726,0.7216759349958951,0.8481404958677686,1.0,1.0,10/91,9.99%,RAB33B;STON1;RAB10;PACSIN2;STXBP5;STON2;LRRK2;ZFYVE16;PICALM;GAS1
prerank,cell projection assembly (GO:0030031),0.33658858080602727,0.7215484546151121,0.7698209718670077,1.0,1.0,5/22,16.37%,PARVA;RHOQ;RAC1;CAPG;NCKAP1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3024931087400179,0.7211065844542031,0.981,1.0,1.0,66/532,16.43%,TNFSF13B;LMNB1;BIRC5;IL1RL1;NCAM1;MAP3K14;PLP2;PSMC2;ANXA2;ZEB1;PSMD5;ACTN4;KIT;TAB1;LEPR;CNN2;IL18;PML;UBE2N;POU2F1;FOXO3;CD80;PSMB1;IRF1;PSMD14;SMARCA4;YAP1;MAP3K3;PIM1;PSMD1;IKBKG;EDA;PIK3CB;SDC1;LIMS1;PSMB9;IP6K2;CAPZA1;CRKL;CNTF;ANXA1;PYDC1;APPL2;FBXW11;ADAM17;SMAD4;ADIPOR1;IL31RA;RORA;TWIST1;BTRC;CDKN1B;TRIM5;ITGB1;CD44;PSMC6;HNRNPA2B1;PLVAP;SRC;IL1RL2;NFKB1;LCP1;TP53;MSN;IFNAR2;TNFRSF25
prerank,negative regulation of lyase activity (GO:0051350),0.35026636499792474,0.7206536061997663,0.7493261455525606,1.0,1.0,3/16,16.01%,ADGRV1;GNAI3;GABBR2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.35514549762494163,0.7203359811666944,0.7542134831460674,1.0,1.0,3/16,11.37%,SRF;ROCK1;HDAC1
prerank,early endosome to Golgi transport (GO:0034498),-0.2824577586427276,-0.7195698875494405,0.8,0.9461993962611904,1.0,6/11,25.49%,STX5;SURF4;SNX2;SNX8;RBSN;RAB6A
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.3246483749706832,0.7195247410464376,0.7593052109181141,1.0,1.0,3/24,7.08%,LEPR;COX10;COQ10B
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.34857456290545374,0.7195064471888138,0.7696404793608522,1.0,1.0,4/19,16.67%,SLC35D1;UAP1;GNPDA2;UGDH
prerank,striated muscle cell development (GO:0055002),0.35187728192953954,0.7193152507472522,0.7514204545454546,1.0,1.0,5/14,22.28%,SDC1;TMOD3;TMOD1;LMOD1;TMOD2
prerank,nucleotide catabolic process (GO:0009166),0.3557790774693872,0.7189092967567193,0.7816411682892906,1.0,1.0,6/16,25.63%,XDH;ITPA;PNP;NT5E;GDA;DERA
prerank,regulation of cytoplasmic transport (GO:1903649),-0.28576639920860203,-0.7182550848819863,0.8391167192429022,0.9469711755262956,1.0,8/11,35.96%,MAPK3;MAPK1;MAP2K1;ATP9A;CHMP3;DENND10;DNAJC13;USP7
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3299304661358663,0.7176899338047485,0.7678132678132679,1.0,1.0,5/25,9.86%,PML;EFNA1;EPHA4;PSME3IP1;CSNK2A2
prerank,atrioventricular valve development (GO:0003171),0.35462607930240736,0.7175314444294737,0.7649513212795549,1.0,1.0,3/14,11.40%,BMPR1A;MDM4;BMP2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.35043490106722247,0.7173910628468105,0.7516869095816464,1.0,1.0,4/16,13.54%,NPR3;PIK3CB;TERF2;DHFR
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3227352495551638,0.717339759400815,0.7660606060606061,1.0,1.0,9/30,22.19%,FADD;TICAM1;IKBKG;CASP8;RIPK1;UBE2D3;TANK;IKBKB;BIRC2
prerank,peptidyl-tyrosine modification (GO:0018212),0.3159381562218287,0.7171452713399592,0.8194748358862144,1.0,1.0,13/56,17.67%,DYRK1A;FGFR4;FGFR2;KIT;PDGFRA;EPHA4;ABI1;DDR2;BTK;EFEMP1;SRC;EPHA3;ABI2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3030922067180268,0.7165799825563599,0.912,1.0,1.0,35/190,16.41%,CIT;ATP2B4;TNFAIP8L1;FNIP1;CGNL1;DEPDC5;AJUBA;ITPR1;PDE3B;PHLPP2;NMI;XDH;RTKN2;TRIM59;RIOK3;LIMD1;TBC1D7;NPRL3;PIK3CB;PPP2R5C;UACA;CCN3;ADIPOR1;CASP8;PLAUR;RORA;TWIST1;SPRED1;PLEKHA1;PER1;OTUD7B;SRC;PPP2R5B;PTEN;SHANK2
prerank,regulation of receptor recycling (GO:0001919),0.3493361889002856,0.7163764994365923,0.7698630136986301,1.0,1.0,3/16,7.68%,ANXA2;SCRIB;RAB29
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.30755109950627213,0.7163360906589086,0.8180862250262881,1.0,1.0,13/75,15.59%,HMGB2;VASH2;JCAD;HMGB1;TGFBR1;BMP2;PRKCA;PDPK1;NR4A1;ADAM17;PRKD1;ARNT;PRKD2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.30419241521300405,0.7163043041411331,0.8132214060860441,1.0,1.0,21/73,21.77%,ATP2B4;FNIP1;SH2D3C;TXN;SFRP2;AKAP9;STOX1;TRIM6;PRKD1;RAMP3;CD44;DOCK7;RPTOR;PRKD2;NGF;TERF2IP;BRAF;CAPRIN2;SNCA;LATS1;STK4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.350365499848417,0.7159839015824861,0.7496542185338866,1.0,1.0,5/16,24.23%,PHIP;BMP2;IGFBP3;BMP5;IGFBP2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.25810122630521376,-0.7158754541747869,0.8161764705882353,0.948925608799258,1.0,5/16,23.88%,PRKN;PDK1;BCKDK;SCARB2;PDK2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3281961925584166,0.7156716536277354,0.7867469879518072,1.0,1.0,10/30,19.67%,PTPN2;SFRP2;SAMSN1;DMTN;NF2;SFRP1;MVP;SH3BP5;PRKCD;PARP14
prerank,epithelial structure maintenance (GO:0010669),-0.2826131888714682,-0.7156075392947548,0.852112676056338,0.9484180693585049,1.0,6/11,49.39%,STRAP;RBP4;NOD2;MUC13;PIWIL4;MUC6
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.2579672992266862,-0.7155466255546342,0.8413793103448276,0.9476562283885298,1.0,3/15,10.71%,PRKCH;FOXC1;SFRP4
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.17333894137463554,-0.7150169853830267,1.0,0.947453367872456,1.0,13/69,17.26%,STAT3;PSEN1;TLR4;EPHB2;LBP;APP;ARHGEF2;ARFGEF2;THBS1;PTPN11;IFNGR1;IFIH1;LGALS9
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.31775834566156336,0.7150100403016857,0.7497062279670975,1.0,1.0,7/33,22.48%,FADD;PRKCA;CASP8;RUNX1;RIPK1;TRAF6;ZFP36L1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.31237833532233933,0.7147846040379688,0.8120805369127517,1.0,1.0,5/50,6.33%,TRIP6;RHOA;ACTN4;NMI;RTKN2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3232240088103423,0.7146585762811603,0.7804295942720764,1.0,1.0,6/30,13.15%,POLR1A;POLR1B;ERCC3;TAF1D;TTF1;POLR1G
prerank,cellular response to BMP stimulus (GO:0071773),0.3088422930626164,0.714446654806567,0.825945945945946,1.0,1.0,13/66,14.34%,BMPR1A;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;BMP2;SOX9;SMAD4;USP9X;SMAD3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.29972645540137716,0.7136623651565887,0.8977732793522267,1.0,1.0,17/142,12.84%,ATP2B4;LPAR3;LPAR1;IAPP;CXCR4;PDGFRA;SLC8A1;BDKRB2;HMGB1;P2RY1;CACNA1C;TRPC7;ATP2B1;CALB1;ITPR3;TRPM4;C1QTNF1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3431599356992717,0.7136029352774209,0.7805851063829787,1.0,1.0,3/16,9.75%,LARGE1;ST8SIA2;ST3GAL5
prerank,regulation of interleukin-17 production (GO:0032660),0.3237167193311453,0.713459025281005,0.7787182587666264,1.0,1.0,3/31,7.80%,PRNP;IL18;ZBTB7B
prerank,negative regulation of defense response to virus (GO:0050687),0.37073116655846294,0.7126194926136649,0.7485955056179775,1.0,1.0,2/10,12.83%,ILRUN;ITCH
prerank,defense response to symbiont (GO:0140546),0.30108010018597214,0.7122612419087648,0.8385093167701864,1.0,1.0,15/92,17.16%,FADD;MOV10;MAP3K14;RNASE6;G3BP1;ATG7;TTC4;SETD2;IRF1;SKP2;RNASE1;TRIM5;CNOT7;IFNAR2;MAVS
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3171756989194865,0.711873342809604,0.7693194925028836,1.0,1.0,5/36,9.89%,ATP2B4;ANGPT4;ADAMTS9;HMGB1;SVBP
prerank,regulation of membrane depolarization (GO:0003254),0.336782122971203,0.7116111426959897,0.7694406548431105,1.0,1.0,2/18,8.29%,RANGRF;LRRK2
prerank,myoblast fusion (GO:0007520),0.3633609972836668,0.7103792911210144,0.7664670658682635,1.0,1.0,2/12,7.57%,ADAM12;ADAMTS5
prerank,cellular response to metal ion (GO:0071248),0.2970149163990793,0.7097708193828679,0.8806122448979592,1.0,1.0,15/123,15.61%,ECT2;AQP1;ADGRV1;PRNP;BMP6;LRRK2;CARF;TRPM2;DMTN;CLIC4;SMPD1;GLRA2;CDKN1B;PKD2;ADD1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.36466685653223707,0.7097144245440812,0.7765042979942693,1.0,1.0,2/12,7.48%,RAB10;SCRIB
prerank,TOR signaling (GO:0031929),0.32712185120921417,0.7094547966365474,0.7620253164556962,1.0,1.0,5/26,14.77%,FNIP1;LARP1;NPRL3;MAPKAP1;RPTOR
prerank,monocyte differentiation (GO:0030224),-0.2884564777968546,-0.7090649857230961,0.8273809523809523,0.9534287825722074,1.0,6/10,33.80%,PIR;VEGFA;MT1G;PDE1B;CSF1R;PPARG
prerank,pancreas development (GO:0031016),0.3591321566963844,0.708928143323904,0.7826704545454546,1.0,1.0,2/12,9.03%,TCF7L2;NPHP3
prerank,fat cell differentiation (GO:0045444),0.30385509651091963,0.7087070292040701,0.8103638368246968,1.0,1.0,10/57,13.64%,BBS9;CTBP1;MKKS;TCF7L2;SMAD6;OSBPL8;NR4A2;NR4A1;ATF5;MED1
prerank,COPII-coated vesicle budding (GO:0090114),0.3020045641976498,0.7085874732053926,0.8195488721804511,1.0,1.0,16/68,18.44%,F5;CUL3;TRAPPC6B;RAB1A;SCAP;F8;SCFD1;SEC24D;TRAPPC10;MIA3;ANKRD28;VAPA;BET1;TRAPPC9;USO1;TMED10
prerank,diterpenoid metabolic process (GO:0016101),0.3096138418337364,0.708265750245899,0.8141304347826087,1.0,1.0,6/55,10.41%,ABCA4;RDH11;GPC6;RDH12;ALDH1A1;SDC1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.33523391398310753,0.7078692540232818,0.7957920792079208,1.0,1.0,7/24,19.80%,NEDD4;PRKCB;ITGA5;ARNT;PRKD2;NIBAN2;PTPN1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.27207939185395635,-0.7075802544878811,0.8316151202749141,0.9542080648814038,1.0,1/12,0.38%,DOCK10
prerank,regulation of TORC1 signaling (GO:1903432),0.32174678659732414,0.7075392911843742,0.7934272300469484,1.0,1.0,10/33,17.75%,DEPDC5;DYRK3;KLHL22;SESN1;ITFG2;STK11;CLEC16A;SESN2;LARS1;LAMTOR5
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3464742368207862,0.7071412756779494,0.7701949860724234,1.0,1.0,4/15,15.77%,IL18;AGT;NFKB1;LPL
prerank,copper ion transport (GO:0006825),0.3601359929690501,0.7070089661746513,0.7668621700879765,1.0,1.0,1/11,3.07%,STEAP3
prerank,regulation of chemotaxis (GO:0050920),0.3283233012517536,0.7068851020329506,0.8098086124401914,1.0,1.0,5/30,7.02%,MYCBP2;ADGRA2;PTPN2;CXCR4;PDGFRA
prerank,regulation of protein localization to cell surface (GO:2000008),0.31720702347984525,0.7066216346654334,0.8048484848484848,1.0,1.0,5/33,10.24%,RANGRF;GBF1;LEPROT;PICALM;SNX33
prerank,mitochondrial RNA metabolic process (GO:0000959),0.33891805087605503,0.7059613451780864,0.7663934426229508,1.0,1.0,4/14,16.11%,FOXO3;FASTKD5;TFB1M;PNPT1
prerank,regulation of acute inflammatory response (GO:0002673),-0.23618437578497864,-0.7059102136815951,0.8816326530612245,0.9551599816996725,1.0,18/18,76.41%,OSMR;ADAM8;KLKB1;NLRP3;IL4;GSTP1;CREB3L3;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;DNASE1L3;F12;C2CD4A;PTGES;IL6ST
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.35443989517352414,0.7058941014316179,0.7821067821067821,1.0,1.0,5/13,25.10%,FBN1;BMP2;LTBP1;DAND5;FSTL1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3441772793504992,0.7056865283392342,0.7728531855955678,1.0,1.0,4/15,16.06%,SPEF1;NPHP3;RSPO3;SFRP1
prerank,regulation of cell aging (GO:0090342),-0.28100160734472057,-0.7055282395467782,0.8220064724919094,0.9546986944333362,1.0,2/11,10.42%,NEK6;RSL1D1
prerank,inner ear morphogenesis (GO:0042472),0.33256066549664565,0.7053475420887431,0.785175879396985,1.0,1.0,4/22,12.56%,FGFR2;TTC39C;TBX18;SOX9
prerank,cGMP-mediated signaling (GO:0019934),0.35842282642066536,0.7050469075490093,0.7835195530726257,1.0,1.0,1/13,1.82%,AQP1
prerank,positive regulation of exosomal secretion (GO:1903543),0.34207520250120294,0.7049372115356679,0.7816411682892906,1.0,1.0,5/15,21.88%,STAM;SDC1;SMPD3;SDC4;PDCD6IP
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.36104818523866994,0.7043257054069071,0.7811550151975684,1.0,1.0,2/10,10.10%,XDH;PIK3CB
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2997154658636323,0.7035944565359561,0.9031281533804238,1.0,1.0,20/159,12.04%,CDH15;SDK1;MMP24;PCDHGB4;CDH18;CDH24;ALCAM;OBSL1;ADGRL1;CDH4;GPC6;PCDHGC3;ROBO1;DSCAML1;FGFRL1;PLXNB2;DSCAM;PTPRS;EMB;MPZ
prerank,ATP transport (GO:0015867),0.3732108640749457,0.7034577498440064,0.7942942942942943,1.0,1.0,4/10,19.35%,SLC25A42;CD47;SLC25A17;SLC25A5
prerank,positive regulation of ossification (GO:0045778),0.3188146887422787,0.7033048201851975,0.8219653179190751,1.0,1.0,7/39,11.40%,ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;ATP2B1;BMP2
prerank,pre-miRNA processing (GO:0031054),0.3574399320836235,0.7033026241588637,0.7858156028368795,1.0,1.0,3/14,13.46%,AGO2;TUT7;TUT4
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.26135665396819274,-0.7032863928104288,0.8392282958199357,0.9563477446546703,1.0,6/13,30.56%,SHISA6;GRIK2;SHISA9;SHISA7;RAB3GAP1;CLN3
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.17419999371760309,-0.7032341885851545,0.9864864864864865,0.9555643613958864,1.0,11/57,14.10%,GRIN2A;FIS1;GRIN2B;MALT1;MAP3K5;LGMN;NOD1;CTSD;PPM1F;BCAP31;GRIN1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3406928146990087,0.7027005527938641,0.7786998616874136,1.0,1.0,6/15,23.24%,PIK3CB;AAK1;UNC119;TNK2;SNAP91;SCYL2
prerank,neuron fate commitment (GO:0048663),0.34675454229965874,0.7024323393627223,0.7482517482517482,1.0,1.0,2/14,10.48%,POU3F2;TGFBR1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.24477281367564852,-0.7024275681032486,0.8628158844765343,0.9556359494771494,1.0,9/16,41.76%,GSK3A;GPER1;MRAP2;CHGA;PDE6H;C3;ACP3;GRP;NECAB2
prerank,positive regulation of protein secretion (GO:0050714),0.29782766438046254,0.7022851845721477,0.8290598290598291,1.0,1.0,16/69,19.47%,GCK;FRMD4A;MYH10;BMP6;TCF7L2;MCU;EZR;SYTL4;ACHE;PPID;ADAM9;AACS;NLGN2;BAD;TMED10;DNM1L
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2958516154328063,0.7017148313748139,0.8637295081967213,1.0,1.0,22/98,18.34%,E2F1;ATP2B4;RANGRF;MIEF2;TFDP1;PRNP;PDZK1;MYO1C;MIEF1;PDPK1;CASP8;PRKCE;PRKCI;DLG1;ITGB1;RAMP3;TP53;PPP3R1;EPHA3;WNK3;YWHAQ;BAD
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3350382664548621,0.7014109344213093,0.7818877551020408,1.0,1.0,8/23,24.75%,BMF;AGK;MAIP1;BAD;HSPA4;TIMM10B;HSP90AA1;BAX
prerank,negative regulation of cellular component movement (GO:0051271),-0.25029676195930023,-0.7007934327455,0.8620689655172413,0.9566905796486578,1.0,4/15,17.87%,FRMD5;SPOCK3;CCDC125;ACTN1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.31864912039272364,0.7007349740305681,0.8027295285359801,1.0,1.0,6/27,18.25%,CHST15;CHSY1;CHST3;BGN;UGDH;XYLT1
prerank,endocardial cushion morphogenesis (GO:0003203),0.336333029620718,0.7005833288054314,0.7981888745148771,1.0,1.0,4/18,12.56%,BMPR1A;MDM4;BMP2;SOX9
prerank,negative regulation of cartilage development (GO:0061037),0.3507999472841912,0.7003472907276799,0.78328611898017,1.0,1.0,5/13,20.14%,TGFBR1;WNT9A;SOX9;EFEMP1;CHADL
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2968213469283664,0.6997662127922029,0.8414006179196705,1.0,1.0,14/88,15.59%,HMGB2;VASH2;ATOH8;XDH;SULF1;ANGPT1;TGFBR1;BMP2;PRKCA;NR4A1;ATP5IF1;PRKD1;ARNT;PRKD2
prerank,protein stabilization (GO:0050821),0.2920618252361971,0.6992059103703985,0.9175050301810865,1.0,1.0,28/168,16.19%,GTSE1;MCM8;PARVA;NLK;CHEK2;MDM4;WIZ;TSPAN1;STK3;FBXW7;EFNA1;EPHA4;NCLN;ATF7IP;GNAQ;VHL;MTMR9;FLOT2;BAG5;SUGT1;P3H1;AAK1;USP9X;MORC3;PIN1;STX12;PTEN;CDC37L1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.32387169978831176,0.6991486769883414,0.7810578105781057,1.0,1.0,5/26,12.39%,GPRC5A;FBXW7;ERRFI1;NCK2;ADAM17
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.29726822395692193,0.6990480516483545,0.832271762208068,1.0,1.0,24/67,24.77%,PSMC2;PSMD5;PSMB1;PSMD14;PSMD1;IKBKG;CYBB;PSMB9;PSMC6;ITGAV;SNAP23;PSMB2;PSME4;PSMB7;PSMD11;PSME3;SEC22B;IKBKB;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,protein maturation (GO:0051604),0.2925980360102181,0.6988469468381798,0.871900826446281,1.0,1.0,6/95,7.12%,KEL;TSPAN33;MMP14;CPXM1;NDUFAB1;TASP1
prerank,positive regulation of MAPK cascade (GO:0043410),0.2908025747139048,0.6986259848164564,0.9459459459459459,1.0,1.0,32/245,15.59%,EZH2;KSR1;ROCK2;FGFR4;FGFR2;LPAR1;GAREM1;IAPP;KIT;ARRB1;FBXW7;JCAD;PDGFRA;NPNT;LRRK2;ROBO1;ANGPT1;ROCK1;HMGB1;P2RY1;CRKL;BMP2;PRKCA;NOTCH2;ROR1;ADRB2;TRIM5;RAMP3;CD44;SLC30A10;TAOK1;PRKD2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.21773449018295735,-0.6984072700359544,0.9277777777777778,0.9584801136449779,1.0,12/25,34.87%,ARAP1;BCAR3;HIP1;CBL;AFAP1L2;DGKD;SHKBP1;GPER1;NEU3;AKT1;PDE6H;DOK1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.2375260410509264,-0.6979142919288409,0.8603773584905661,0.9581720700927203,1.0,5/16,19.33%,PDGFRB;ABL1;PDGFD;BCAR1;NRP1
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.2126330181121898,-0.6976109619882104,0.8820754716981132,0.9576932489226451,1.0,4/24,12.91%,TRAF3IP2;PTPN22;ZDHHC1;TOMM70
prerank,vesicle transport along actin filament (GO:0030050),0.34131672375832717,0.6971175143841948,0.7863577863577863,1.0,1.0,2/19,5.74%,ACTN4;MYO1C
prerank,ERBB2 signaling pathway (GO:0038128),0.3182812404446424,0.696940543078391,0.8131067961165048,1.0,1.0,5/31,15.32%,MATK;CUL5;GAB1;PRKCA;SRC
prerank,pharyngeal system development (GO:0060037),0.33818684687636835,0.6965962891731676,0.8,1.0,1.0,2/15,10.48%,BMPR1A;TGFBR1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.2686769201362412,-0.6963385683756275,0.8430769230769231,0.9582230538040011,1.0,9/12,33.43%,GRN;PPT1;ATP6AP2;TMEM9;CLN5;VPS33A;TMEM199;CLN3;CLN6
prerank,intracellular cholesterol transport (GO:0032367),0.34135494343233774,0.6961219396496945,0.7832647462277091,1.0,1.0,4/15,16.97%,TSPO2;ABCA1;RELCH;LDLR
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.26081974115586404,-0.6960725010429788,0.8741496598639455,0.9576344468315601,1.0,6/13,28.37%,SUFU;GOPC;GET4;MDFI;YWHAB;KEAP1
prerank,positive regulation of axon extension (GO:0045773),0.3221876346501859,0.6958566984291019,0.7732997481108312,1.0,1.0,4/22,11.32%,MACF1;NTN1;MAPT;DSCAM
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3453948738772781,0.695554331133098,0.7842031029619182,1.0,1.0,3/13,12.35%,GJC1;CACNA1C;GJA1
prerank,mesenchymal cell development (GO:0014031),-0.2432844590655884,-0.6954203496316372,0.8796680497925311,0.9574180517943435,1.0,8/18,33.74%,CDH2;FOXC1;HEYL;NOLC1;KLHL12;SOX11;SOX8;KBTBD8
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.348890048921349,0.6953204362986118,0.7732394366197183,1.0,1.0,3/12,15.38%,AGT;SOX9;GDNF
prerank,aromatic amino acid family metabolic process (GO:0009072),0.36040502062921675,0.6951938228009743,0.7951807228915663,1.0,1.0,3/10,17.16%,ASRGL1;IL4I1;THAP4
prerank,presynapse organization (GO:0099172),-0.2890977225941461,-0.6945748092846494,0.8466453674121406,0.9575390548092516,1.0,4/10,19.55%,LRRTM3;DVL1;NLGN1;FZD1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.29431666200472895,0.6944831565420775,0.8763931104356636,1.0,1.0,26/112,17.83%,TGFBR3L;BMPR1A;RHOA;WWOX;NLK;SOX6;TGFBR3;SMAD6;SMURF1;NR3C1;TGFBR1;LIMS1;CRKL;ARHGEF18;APPL2;SOX9;SMAD4;USP9X;ADAM9;ITGB1;SMAD3;SRC;SFRP1;PTPRK;ZFYVE9;SMAD2
prerank,adipose tissue development (GO:0060612),0.3656338551559376,0.6941599208465846,0.8100719424460432,1.0,1.0,4/11,17.52%,PGRMC2;LRP5;SPTLC2;SH3PXD2B
prerank,negative regulation of response to stimulus (GO:0048585),0.3008570068269568,0.6939263395987679,0.8366492146596859,1.0,1.0,9/60,15.02%,RBL1;FBXO5;BRAP;CASK;MAP3K3;TERF2;APPL2;TWIST1;SLC30A10
prerank,negative regulation of autophagosome assembly (GO:1902902),0.35215915196711634,0.693494273163402,0.797432239657632,1.0,1.0,6/13,21.42%,LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;SEC22B
prerank,negative regulation of autophagy (GO:0010507),0.3040827525909179,0.6925555649385482,0.8281938325991189,1.0,1.0,9/54,9.57%,BMF;DAP;EIF4E;LEPR;ATG7;QSOX1;LRRK2;KLHL22;MTMR9
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.3387440025631628,0.6918233697483106,0.7821917808219178,1.0,1.0,3/17,13.94%,CASK;SULF1;XIAP
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.2518352593514304,-0.6915368620082905,0.900709219858156,0.9597699477383674,1.0,2/14,4.59%,TMSB4X;SUFU
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.19724698572250648,-0.690657448815887,0.949685534591195,0.9598461082821632,1.0,10/30,27.64%,SELENOF;ST13;HSPA5;CCT2;DNAJC18;DNAJB12;SDF2;CHCHD4;ENTPD5;HSPA9
prerank,arachidonic acid secretion (GO:0050482),0.3640759968663543,0.6905404044205231,0.7869565217391304,1.0,1.0,2/10,11.47%,BDKRB2;ANXA1
prerank,arachidonate transport (GO:1903963),0.3640759968663543,0.6905404044205231,0.7869565217391304,1.0,1.0,2/10,11.47%,BDKRB2;ANXA1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3432574154330377,0.6894454546000024,0.7994428969359332,1.0,1.0,2/14,8.29%,TXNDC12;LRRK2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.34897882003103586,0.689396973348893,0.7962962962962963,1.0,1.0,2/10,9.28%,NCK1;VHL
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.16278935994634167,-0.6882260449240977,0.9824561403508771,0.9614693242445618,1.0,11/73,13.70%,STAT3;PSEN1;TLR4;EPHB2;LBP;APP;ARHGEF2;ARFGEF2;THBS1;PTPN11;IFNGR1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.29349899152421255,0.6881960881393074,0.8268817204301075,1.0,1.0,13/61,18.44%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,COPII vesicle coating (GO:0048208),0.29349899152421255,0.6881960881393074,0.8268817204301075,1.0,1.0,13/61,18.44%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,vesicle coating (GO:0006901),0.29349899152421255,0.6881960881393074,0.8268817204301075,1.0,1.0,13/61,18.44%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,response to UV-A (GO:0070141),-0.24245398478895747,-0.6878644548853601,0.8700361010830325,0.9610173618406552,1.0,6/14,33.91%,MMP2;CERS1;CCND1;AKT1;MMP1;OPN3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2968766993505077,0.6876972959017167,0.8347921225382933,1.0,1.0,8/55,10.80%,FADD;WWOX;BMF;PML;BCLAF1;AGT;TGFBR1;BOK
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.345155483172364,0.6873159817521467,0.7667140825035562,1.0,1.0,3/13,10.50%,ZBTB7B;PIM1;HNRNPU
prerank,negative regulation of blood coagulation (GO:0030195),0.3084810781758569,0.687307998610074,0.8275462962962963,1.0,1.0,6/38,12.98%,PDGFRA;PLAU;SERPINE1;F8;C1QTNF1;PLAUR
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.28931298464505306,0.6871570153707612,0.8731958762886598,1.0,1.0,23/93,18.98%,ATP2B4;FNIP1;SH2D3C;TXN;SFRP2;NCK1;AKAP9;STOX1;NCK2;TRIM6;DMTN;PRKD1;RAMP3;CD44;DOCK7;RPTOR;PRKD2;PTEN;CNKSR3;NGF;TERF2IP;BRAF;CAPRIN2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2923457728036294,0.6867981732205162,0.8478488982161595,1.0,1.0,28/74,24.77%,PSMC2;PSMD5;ELOC;PSMB1;PSMD14;LIMD1;VHL;PSMD1;PSMB9;STOX1;RBPJ;PSMC6;ARNT;PSMB2;PSME4;PSMB7;PSMD11;EGLN1;PSME3;PSMD13;SIRT2;EGLN3;PSMB8;PSMD4;PSMF1;PSMA5;HIF3A;PSMC3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.23991862002379383,-0.6866058490584956,0.8909090909090909,0.961443948052542,1.0,1/17,0.29%,CACNA2D1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.29805789147782946,0.6865805651068505,0.8230184581976113,1.0,1.0,11/51,14.11%,BMPR1A;FBN1;CRIM1;LEMD3;SMAD6;SMURF1;RBPMS2;SMURF2;BMP2;SMAD4;HTRA3
prerank,regulation of viral release from host cell (GO:1902186),0.3226057675934806,0.6864174561832272,0.7994791666666666,1.0,1.0,3/21,8.17%,VPS37B;PML;TRIM28
prerank,histone H3-K4 methylation (GO:0051568),0.31732951716953206,0.6861429299093315,0.8034825870646766,1.0,1.0,4/26,15.58%,PAXIP1;KMT2A;KMT2D;SETD4
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3604786895137079,0.6860554833163447,0.7905918057663126,1.0,1.0,4/10,22.12%,SMPD3;SMPD2;PRKCD;SIRT3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3604786895137079,0.6860554833163447,0.7905918057663126,1.0,1.0,4/10,22.12%,SMPD3;SMPD2;PRKCD;SIRT3
prerank,lipoprotein biosynthetic process (GO:0042158),0.3486764463831833,0.6859090519457753,0.7909774436090226,1.0,1.0,2/11,7.98%,ATG7;PORCN
prerank,cellular response to leucine starvation (GO:1990253),-0.28001808274247364,-0.6857618167216888,0.8567415730337079,0.9614056702831498,1.0,3/10,10.95%,SESN3;GCN1;MTOR
prerank,SNARE complex assembly (GO:0035493),-0.2790464378472405,-0.6855875512210963,0.8449367088607594,0.9607676778669862,1.0,4/10,20.69%,STXBP6;VAMP8;VAMP3;VAMP1
prerank,endoderm formation (GO:0001706),0.3070565869468443,0.6851668165789201,0.8122827346465817,1.0,1.0,6/35,15.00%,MMP14;LAMB1;SETD2;COL12A1;ITGA5;ITGAV
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.298163174340904,0.6850855988920971,0.8211845102505695,1.0,1.0,9/43,12.82%,ERFE;PTPN2;NUCKS1;ZBTB7B;NCK1;PRKCB;ENPP1;SIK2;GKAP1
prerank,DNA dealkylation (GO:0035510),0.36327654377358154,0.6850147492618879,0.7880597014925373,1.0,1.0,2/10,9.20%,FTO;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.36327654377358154,0.6850147492618879,0.7880597014925373,1.0,1.0,2/10,9.20%,FTO;MGMT
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.20418244669986063,-0.6849705050221334,0.8982035928143712,0.9597826664557557,1.0,15/31,31.56%,CCNH;GTF2H5;CMTR1;POLR2K;POLR2H;NCBP1;POLR2F;GTF2H2;POLR2C;RAMAC;CDK7;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,7-methylguanosine RNA capping (GO:0009452),-0.20418244669986063,-0.6849705050221334,0.8982035928143712,0.9597826664557557,1.0,15/31,31.56%,CCNH;GTF2H5;CMTR1;POLR2K;POLR2H;NCBP1;POLR2F;GTF2H2;POLR2C;RAMAC;CDK7;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,negative regulation of endocytosis (GO:0045806),0.3202714935275566,0.6847780517835336,0.7858942065491183,1.0,1.0,7/24,17.06%,MTMR2;PICALM;SNX33;RAC1;PRKD1;UNC119;EPHA3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3102389408957784,0.6846188923215571,0.8154613466334164,1.0,1.0,5/32,12.25%,CHAT;LPCAT1;LPIN2;CSNK2A2;ACHE
prerank,regulation of protein phosphorylation (GO:0001932),0.2879892235090987,0.6843859253419493,0.9468937875751503,1.0,1.0,42/256,16.14%,ECT2;PHIP;FNIP1;ROCK2;PRKDC;PRNP;XDH;LEPR;MUSK;RAP2A;ARRB1;PML;EFNA1;FMR1;CCN1;WWTR1;LRRK2;AXIN2;ANGPT1;RB1CC1;P2RY1;PPP2R5C;PLXNB2;EIF2AK3;TWF1;CRKL;BMP2;RAC1;ADAM17;SOX9;BRD4;PLAUR;SLCO3A1;PPP1R15B;WDFY2;PTPN13;PIN1;FXR1;PPP2R5B;PPIL4;SESN2;PTEN
prerank,negative regulation of interleukin-2 production (GO:0032703),0.33081481739483753,0.6842376847775509,0.8253333333333334,1.0,1.0,3/18,12.26%,PRNP;EZR;HOMER2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.22167032583329044,-0.6841654669599958,0.9318181818181818,0.9598043069660112,1.0,12/23,33.39%,GAS6;TLR4;DDIT3;LGALS9;INHBA;ZC3H12A;CD274;LAPTM5;NR1H4;INHA;C1QBP;RARA
prerank,regulation of cell death (GO:0010941),0.2867690390989621,0.6839761416759662,0.8697001034126164,1.0,1.0,15/94,14.35%,RAD18;TXNDC12;SPEF1;FAF1;RILPL1;CCN1;RAB29;LRRK2;AXIN2;NCK1;SRGAP2;CCN3;PRKD1;CDKN1B;RAMP3
prerank,regulation of pH (GO:0006885),-0.2746082959011097,-0.6834781305652651,0.8587896253602305,0.959642218409906,1.0,5/11,34.91%,ATP6V0A4;PDK2;ATP6AP1;SLC9A1;PDK4
prerank,regulation of fibroblast migration (GO:0010762),0.3186312805334536,0.6832496168007312,0.8118421052631579,1.0,1.0,7/20,14.27%,DDR2;HAS1;RAC1;APPL2;DMTN;PRKCE;ITGB1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2958584994991494,0.6828667263106151,0.8422174840085288,1.0,1.0,15/59,20.62%,SDK1;OBSL1;CDH4;ROBO1;DSCAML1;PLXNB2;DSCAM;EMB;ITGB1;AMIGO1;PLXNB3;DSG2;KIRREL3;CEACAM1;MPZL2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.22210706161439142,-0.6816350983438766,0.8945147679324894,0.960585987054047,1.0,6/20,23.60%,NUMB;DAB2;AP2M1;PKDCC;BCL2L1;ABI3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.2290608000522379,-0.6816211650351701,0.8681818181818182,0.9597685852785078,1.0,7/21,21.90%,SMAD7;CAV1;INPP5K;PPM1F;DDIT4;PDE4D;RACK1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2605019672184608,-0.6814582998127438,0.8945783132530121,0.9591023549707863,1.0,4/12,21.06%,INPP5K;JUN;HMGA2;TARDBP
prerank,negative regulation of nervous system development (GO:0051961),0.32987390032675945,0.6813709909175826,0.783748361730013,1.0,1.0,2/17,11.97%,PCM1;APPL2
prerank,synaptic membrane adhesion (GO:0099560),-0.23825152957104642,-0.6812457911474714,0.8869257950530035,0.958489565074637,1.0,4/14,15.67%,PTPRD;SLITRK1;NTNG1;LRRC4B
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28703899624345025,0.6812037013140091,0.986,1.0,1.0,67/390,17.06%,SHCBP1;CEP57;STMN1;STYK1;SETX;PHIP;ROCK2;FGFR4;ACTR3;RHOA;COL4A6;GSK3B;FGFR2;RBFOX2;KIT;SULF2;HNRNPA1;FRS2;MUSK;PTPN2;EFNA1;PDGFRA;VAV2;HNRNPH1;POLR2A;EPHA4;SULF1;RHOQ;NCK1;ANGPT1;ABI1;ROCK1;FGFRL1;BDKRB2;CYBB;DDR2;PIK3CB;CLNK;SH2D2A;GAB1;EIF2AK3;EFNB1;RAC1;ANKS1B;NCK2;MAPKAPK3;WASF2;IL31RA;POLR1G;ROR1;DOCK1;ADRB2;PRKD1;SPRED1;EFNB2;ITGAV;AAMP;ARPC1B;SRC;PRKD2;SPRED2;NCKAP1;TNK2;AXL;SIPA1L1;NGF;EPHA3
prerank,negative regulation of cell migration (GO:0030336),0.28715279714587666,0.6811844418135858,0.9214501510574018,1.0,1.0,33/137,18.55%,BMPR1A;ARID2;MCC;STK24;RAP2A;AFDN;HOXA7;SFRP2;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;SRGAP2;SRGAP3;HAS1;NKX2-1;RAC1;GJA1;CLIC4;ADIPOR1;DPYSL3;MIA3;PTPRU;NF2;SFRP1;PTEN;PTPRK;SLURP1;CLASP1;DPEP1;IGFBP3
prerank,negative regulation of viral release from host cell (GO:1902187),0.3389722041145056,0.6808902992981043,0.7889518413597734,1.0,1.0,3/13,14.23%,PML;TRIM28;TRIM5
prerank,regulation of cell-substrate adhesion (GO:0010810),0.30066307248368573,0.6808776449116558,0.7981859410430839,1.0,1.0,8/42,12.64%,RHOA;PDPN;NPNT;RSU1;PIK3CB;LIMS1;RAC1;DMTN
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3106385672537354,0.6806438711510755,0.8107784431137725,1.0,1.0,2/30,4.02%,MACF1;RAB10
prerank,positive regulation of lyase activity (GO:0051349),0.34335619055487965,0.6805410921651568,0.819718309859155,1.0,1.0,3/14,16.00%,FXN;CACNA1C;STIM1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.23182589400013076,-0.6802714622038155,0.93359375,0.9585833279884811,1.0,7/18,24.56%,RPS13;ESR1;KAT2B;ZC3H12A;PTBP1;RPS26;PTBP3
prerank,cell-cell junction assembly (GO:0007043),0.2958986333414441,0.6800517747823818,0.832438238453276,1.0,1.0,17/63,18.62%,CDH18;CDH24;RHOA;CTNNA1;GJD3;GJC1;TLN1;EPB41L3;PRKCA;GJA1;TLN2;PIP5K1C;RHOC;TBCD;TRPV4;PKN2;CDH11
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3190204622448573,0.6800297675765463,0.7987341772151899,1.0,1.0,1/23,1.27%,GLI3
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.28328105521300456,0.680028152667958,0.9202020202020202,1.0,1.0,26/149,15.74%,TRIM37;TRIML2;TICAM1;DDRGK1;RAB7B;DHX9;TAB1;RTKN2;IL18;UBE2N;RNF31;AGT;IKBKG;ERC1;EDA;FLOT2;PRKCB;TRIM6;BTK;ROR1;SLCO3A1;PRKD1;PRKCI;TRIM5;PRKD2;NFKB1
prerank,regulation of calcium ion import (GO:0090279),-0.2206501969084026,-0.6788395258554406,0.9181034482758621,0.9590888531113848,1.0,6/21,18.20%,PDGFRB;CTNNB1;TRIM27;SLC30A1;PLPP4;PSEN2
prerank,muscle tissue morphogenesis (GO:0060415),0.32863327148916016,0.6783847326982958,0.813858695652174,1.0,1.0,4/16,19.41%,TGFBR3;BMP2;HEY2;ZFPM1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.31091343767573754,0.6783323691882691,0.810126582278481,1.0,1.0,6/26,15.60%,NEDD4;AKAP9;DLG1;CAB39;ITGB1;STK39
prerank,protein localization to plasma membrane (GO:0072659),0.28126019495702353,0.6779544816758205,0.9051987767584098,1.0,1.0,40/129,23.59%,TSPAN33;ROCK2;RAB10;PDZK1;DENND4C;RAP2A;AFDN;ANK1;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;GORASP2;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;ZDHHC3;STXBP1;DPP6;RAB13;WNK3;ASB3;RAB3A;MAP7;ANK3;RAB8B;IKBKB;FLNA;RAPGEF6;ZDHHC2;PACS1;S100A10;RAB8A
prerank,intracellular sterol transport (GO:0032366),0.34542765286240956,0.6777981891483986,0.8208092485549133,1.0,1.0,3/13,15.90%,TSPO2;ABCA1;RELCH
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.261611991612937,-0.6777417682875244,0.8838709677419355,0.9592833906532517,1.0,4/12,20.57%,ABCA5;NR1H3;NR1H2;ITGB3
prerank,regulation of cellular protein localization (GO:1903827),0.29994321716673944,0.6774804620338277,0.8431818181818181,1.0,1.0,15/45,24.25%,GBF1;MAPT;GPC6;SPIDR;SETD2;PIN1;LCP1;PTPN1;CSNK1E;GPC4;PRKAA2;CCDC66;GPC3;HSP90AA1;KDM1A
prerank,negative regulation of cell junction assembly (GO:1901889),0.31915219299078934,0.6774495363270138,0.8056265984654731,1.0,1.0,7/25,16.14%,ROCK2;ROCK1;ARHGAP6;DMTN;SRC;RCC2;PTEN
prerank,regulation of gluconeogenesis (GO:0006111),0.312626816069859,0.6772873626704506,0.8083028083028083,1.0,1.0,3/27,6.20%,GCK;ERFE;PTPN2
prerank,ear morphogenesis (GO:0042471),0.32709465290103856,0.67713172272456,0.8171052631578948,1.0,1.0,5/20,18.82%,FGFR2;NIPBL;TWIST1;OSR1;ZIC1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.29955060144465406,0.6764280194840403,0.8321917808219178,1.0,1.0,7/36,14.27%,NLGN3;FBXW7;HDAC1;ADAM17;HDAC2;ADRB2;ITGB1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2184825096402697,-0.6758842986263509,0.9305555555555556,0.9603014893011601,1.0,9/21,23.46%,COX16;OXA1L;COX19;PET100;COX20;SMIM20;COX17;COX14;COA8
prerank,water-soluble vitamin metabolic process (GO:0006767),0.29051485771120544,0.6757845667301365,0.8710021321961621,1.0,1.0,15/68,19.03%,MTHFD1L;GSTO2;BTD;MTHFR;PDXK;SLC19A1;ENPP1;DHFR;PANK2;SLC19A2;RFK;CYB5A;MMAB;SLC25A19;MTHFS
prerank,protein localization to cell periphery (GO:1990778),0.2784811940255972,0.6757651209595799,0.9084435401831129,1.0,1.0,28/133,17.53%,TSPAN33;ROCK2;AP4M1;RAB10;PDZK1;DENND4C;RAP2A;ANK1;RAB29;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;ZDHHC3;STXBP1;DPP6;RAB13;WNK3
prerank,positive regulation of cell death (GO:0010942),0.292478277491409,0.6755488942586662,0.840958605664488,1.0,1.0,10/59,14.35%,GSK3B;PRNP;MAPT;FAF1;LRRK2;AXIN2;PICALM;CDKN1B;EFNB2;RAMP3
prerank,cellular response to interleukin-6 (GO:0071354),-0.2031012601242964,-0.6754556149503633,0.9619565217391305,0.9598783580030588,1.0,8/26,22.91%,STAT3;ST3GAL6;PTPN11;SBNO2;ST18;CBL;PTPRT;JAK2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.32083311465185116,0.6753093252422366,0.8259162303664922,1.0,1.0,5/20,13.44%,TGFBR3;TGFBR1;BMP2;RBPJ;HEY2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.28604842703991507,0.6751146589138369,0.8875,1.0,1.0,17/84,15.59%,ATOH8;ANGPT4;ROCK2;GPI;ANXA3;ANGPT1;HMGB1;AGT;PIK3CB;RAC1;RRAS;PRKCA;PDPK1;ADAM17;PRKD1;AAMP;PRKD2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.21628276877197203,-0.6748368741897794,0.9173553719008265,0.9597233634675807,1.0,1/21,0.29%,CACNA2D1
prerank,regulation of transferase activity (GO:0051338),-0.2342617089911117,-0.6746579581175951,0.9151943462897526,0.959063132582081,1.0,8/17,30.35%,PINX1;ATM;NABP2;FEM1A;NLRC5;SPTSSB;HMBOX1;JMJD8
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.28835140582910324,0.6742829261232984,0.8737060041407867,1.0,1.0,7/85,8.29%,PLK1;GSK3B;PSMC2;DDRGK1;FBXW7;FMR1;LRRK2
prerank,negative regulation of DNA binding (GO:0043392),0.30646840625746063,0.6742446537836632,0.8109833971902938,1.0,1.0,5/28,18.95%,E2F1;ILRUN;HEY2;TFAP4;SP100
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3512832914643489,0.6742316411855961,0.8062130177514792,1.0,1.0,3/11,15.49%,AGO2;RBM4;TNRC6C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3512832914643489,0.6742316411855961,0.8062130177514792,1.0,1.0,3/11,15.49%,AGO2;RBM4;TNRC6C
prerank,nucleic acid-templated transcription (GO:0097659),0.2973876898474713,0.6742155551425989,0.8373424971363116,1.0,1.0,6/42,10.90%,E2F1;POLR2A;EPC1;NR4A2;MMS19;DRG1
prerank,dephosphorylation (GO:0016311),0.2814116185171855,0.6734068308900911,0.9354187689202825,1.0,1.0,35/147,20.71%,PPM1G;PPM1D;LHPP;TAB1;PPP2R3A;SSH2;PPP3CA;DUSP12;MTMR2;PPP2R5C;PTPN21;PTPRS;FBXW11;PLPP1;PLPP5;PPP1CC;BTRC;PTPRA;STK11;PTPN13;PTPRU;MTMR3;PPP2R5B;DAPP1;PPP2R1B;PTEN;UBLCP1;PTPRK;PTPRE;DUSP7;PPM1A;PTPN1;PTPN5;PNKP;PPP4R1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2842455408727337,0.672861629131069,0.8650371944739639,1.0,1.0,12/76,13.68%,TRIP6;RHOA;ACTN4;NMI;RTKN2;LIMS1;UACA;CCN3;EZR;TRIM6;ADIPOR1;DLG1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.34115597983438595,0.6726461121518691,0.817351598173516,1.0,1.0,3/10,17.56%,ERRFI1;ENPP1;MVP
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.34169587950189495,0.672374930099634,0.8071428571428572,1.0,1.0,2/12,8.53%,STX11;STX2
prerank,positive regulation of immune response (GO:0050778),0.2894294376231414,0.6722686830087579,0.8618843683083511,1.0,1.0,7/64,15.15%,FADD;DHX9;NMI;RIOK3;POLR3D;AKIRIN2;SLC15A4
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.31097433214858194,0.6722308792688726,0.8092909535452323,1.0,1.0,7/30,14.34%,TGFBR3L;TGFBR3;DKK3;SMURF2;SMAD4;XIAP;SMAD3
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.28618798859354216,0.6717184600814404,0.8706365503080082,1.0,1.0,18/86,16.57%,ANGPT4;PRNP;BMP6;EFNA1;ENPP2;SFRP2;CD80;ANGPT1;AGT;SAMSN1;DMTN;ITGA5;CD44;CNOT7;SRC;TP53;SFRP1;TNK2
prerank,positive regulation of receptor internalization (GO:0002092),0.3226457361369664,0.6713020968536036,0.8056628056628057,1.0,1.0,3/22,9.24%,ARRB1;FMR1;ANGPT1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3483881919130054,0.6710487511648648,0.7993920972644377,1.0,1.0,3/11,11.10%,IPMK;PPIP5K1;IP6K2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.3235331903385939,0.6706097585175708,0.8021534320323015,1.0,1.0,3/19,6.54%,OBSL1;CUX1;CAPRIN1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.34372096730834795,0.6698316772060996,0.8279411764705882,1.0,1.0,4/11,20.91%,OCRL;INPP5B;PTEN;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.34372096730834795,0.6698316772060996,0.8279411764705882,1.0,1.0,4/11,20.91%,OCRL;INPP5B;PTEN;INPP5A
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3323191199807981,0.6693926022255827,0.8138222849083215,1.0,1.0,2/14,9.90%,RHOA;MEOX2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.2748713959584417,-0.6693296216189294,0.8738738738738738,0.9632166251353437,1.0,4/10,22.25%,CSGALNACT1;B3GAT2;XYLT2;B3GAT1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.3358873135358769,0.6692580994448474,0.8218390804597702,1.0,1.0,3/12,16.97%,IAPP;PFDN4;LDLR
prerank,regulation of interferon-beta production (GO:0032648),0.29397435654912657,0.6687094513318557,0.8357380688124306,1.0,1.0,17/46,24.06%,DHX9;IRF1;RIOK3;POLR3D;PTPRS;YY1;MAVS;SIRPA;RELB;ISG15;POLR3C;RNF216;POLR3G;TLR7;RIPK2;HSP90AA1;REL
prerank,phagosome-lysosome fusion (GO:0090385),0.34704610376989414,0.6684162752544932,0.8283132530120482,1.0,1.0,1/10,4.45%,RAB7B
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.25586487872922253,-0.6684050987806798,0.8695652173913043,0.96320915101201,1.0,3/12,14.73%,NBL1;SLIT2;DUSP1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.32991526111386704,0.6682387278093985,0.8154681139755766,1.0,1.0,3/15,15.38%,AGT;SOX9;GDNF
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.33478684915327617,0.6678517596271096,0.7967698519515478,1.0,1.0,5/16,19.11%,TBC1D25;MTRF1;CLEC16A;OGFOD1;ETF1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2911248513803508,0.6678433737068384,0.8533916849015317,1.0,1.0,9/54,12.75%,FADD;UBE2K;PTPN2;RNF31;SPPL2B;IKBKG;PYDC1;ADAM17;CASP8
prerank,serine family amino acid catabolic process (GO:0009071),0.3432091274597749,0.6678103329785721,0.8103975535168195,1.0,1.0,1/10,6.77%,AMT
prerank,ceramide biosynthetic process (GO:0046513),0.30217854913766806,0.6677302690303318,0.8428899082568807,1.0,1.0,9/40,18.68%,CERS6;CERS5;ST8SIA2;ST3GAL5;AGK;SMPD1;SPTLC2;SMPD2;FA2H
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.27062705529056996,-0.6676013073360852,0.8662613981762918,0.9630734743077795,1.0,2/10,6.08%,ST6GAL1;RENBP
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.25176500981887306,-0.6675779453456094,0.8835616438356164,0.9622802193086039,1.0,4/13,17.76%,ISCA1;GLRX3;CIAO1;LTO1
prerank,cellular response to gamma radiation (GO:0071480),0.3238566726655595,0.6672398353546263,0.8177014531043593,1.0,1.0,4/17,17.19%,MAP3K20;YAP1;TP53;ATR
prerank,negative regulation of protein phosphorylation (GO:0001933),0.27975090900003485,0.6670750361821872,0.9144008056394763,1.0,1.0,43/150,21.14%,RB1;CEP43;PRKDC;PRNP;TAB1;XDH;PMEPA1;SFRP2;WWTR1;LRRK2;SMAD6;GNAQ;NCK1;CEP85;ERRFI1;CALM2;SAMSN1;CRKL;PYDC1;ENPP1;PDPK1;NCK2;DMTN;TWIST1;SPRED1;PPP1R15B;QARS1;PTPN13;SFRP1;SPRED2;PTEN;CNKSR3;SIRPA;MVP;TERF2IP;IGFBP3;PRKCD;DNAJC10;TRIB1;CEACAM1;SNCA;FBLN1;UBASH3B
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2572319113524906,-0.6663444837256023,0.8934169278996865,0.9625683830651947,1.0,3/11,19.55%,CTNNB1;LRP6;FZD1
prerank,defense response to virus (GO:0051607),0.2810489523233306,0.6662312818300216,0.8934426229508197,1.0,1.0,16/100,17.16%,FADD;MOV10;MAP3K14;RNASE6;G3BP1;ATG7;TTC4;SETD2;IRF1;SKP2;RNASE1;TRIM5;CNOT7;AKAP1;IFNAR2;MAVS
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.27791352375702266,0.6658956356222686,0.998,1.0,1.0,75/509,15.89%,ECT2;HPSE;FADD;KSR1;ADGRV1;TRIML2;TICAM1;TRIP6;FNIP1;MAP3K14;ROCK2;MIER1;FGFR4;RHOA;FGFR2;BMF;LPAR1;IAPP;ACTN4;NEDD4;KIT;NMI;FRS2;TCF7L2;RTKN2;IL18;UBE2N;JCAD;PDGFRA;TXN;RNF31;CD80;BCLAF1;TNFRSF10B;ANGPT1;MAP3K3;PUM2;ROCK1;HMGB1;AGT;IKBKG;OSBPL8;PIK3CB;CXXC5;TGFBR1;LIMS1;BOK;GAB1;PLXNB1;PRKCB;BMP2;RAC1;PDPK1;GJA1;TRIM6;SOX9;CASP8;SLC38A9;BRD4;ROR1;ADRB2;DDX21;PRKD1;PLK2;TRIM5;ITGB1;RAMP3;RPTOR;ITGAV;VAPA;SRC;RHOC;PRKD2;TP53;DDX1
prerank,cellular response to glucose starvation (GO:0042149),0.2917446725812764,0.6658684512729404,0.8394495412844036,1.0,1.0,11/41,15.99%,HNRNPA1;SH3GLB1;FOXO3;SESN1;EIF2AK3;SIK2;ITFG2;MTMR3;PRKAG1;TP53;SESN2
prerank,neuron projection fasciculation (GO:0106030),0.34987181672163425,0.6657734269320906,0.8152492668621701,1.0,1.0,4/10,20.02%,EPHA4;ARHGAP35;AMIGO1;SEMA5A
prerank,axonal fasciculation (GO:0007413),0.3413295340544195,0.6656234861420807,0.8236953455571228,1.0,1.0,5/12,20.02%,EPHA4;ARHGAP35;EPHA3;AMIGO1;SEMA5A
prerank,postsynaptic membrane organization (GO:0001941),0.3267559892852053,0.6656111397506778,0.8204456094364351,1.0,1.0,5/17,19.55%,MUSK;NLGN3;CHRNB1;NLGN2;GPHN
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.3467409192334515,0.6655962490732136,0.8262195121951219,1.0,1.0,3/10,11.97%,PRKCB;ENPP1;APPL2
prerank,regulation of actin filament-based movement (GO:1903115),0.3514749302481594,0.6652885453524082,0.8205928237129485,1.0,1.0,1/10,5.71%,PDPN
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.28405089259583743,0.6647496907104141,0.8549946294307197,1.0,1.0,9/67,13.44%,TRIOBP;GSK3B;NPNT;RSU1;LIMS1;CRKL;RAC1;DMTN;DOCK1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.33355060788290125,0.6645911652914293,0.8261494252873564,1.0,1.0,2/12,14.42%,WNK1;MIA3
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.22703369551281338,-0.6644467085577794,0.9163179916317992,0.963436599324164,1.0,5/19,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,positive regulation of cell growth (GO:0030307),0.27607638223809094,0.6643893390352941,0.8908163265306123,1.0,1.0,19/96,17.02%,MACF1;HYAL1;CEP43;FXN;MMP14;NTN1;MAPT;DERL2;SFRP2;SMURF1;KLHL22;TGFBR1;ADAM17;USP47;RPTOR;INO80;DBN1;SFRP1;NGF
prerank,cell differentiation in spinal cord (GO:0021515),-0.2734720183069837,-0.6642851893111201,0.8788732394366198,0.9627699548839868,1.0,4/10,22.17%,MDGA2;SOX4;SOX13;ZC4H2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.28501343492383746,0.6639908953817816,0.8697033898305084,1.0,1.0,8/75,9.38%,ATP2B4;THBS2;ANGPT4;ROCK2;PDE3B;PML;SULF1;ROCK1
prerank,response to cAMP (GO:0051591),0.2929451309282339,0.663834537902165,0.8306451612903226,1.0,1.0,6/37,15.59%,AQP1;AHR;EZR;AKAP9;DMTN;PKD2
prerank,presynaptic endocytosis (GO:0140238),0.30773905000478324,0.6637227381852189,0.8104738154613467,1.0,1.0,8/24,21.89%,STON1;STON2;NLGN3;PIP5K1C;NLGN2;SNCA;VAMP2;CDK5
prerank,response to interleukin-6 (GO:0070741),-0.2822457317449935,-0.6636578866038667,0.887240356083086,0.9625089778701187,1.0,3/10,20.16%,ST3GAL6;SBNO2;PTPRT
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2855345979688197,0.6632168438582409,0.8272425249169435,1.0,1.0,7/53,9.52%,XPO1;PSMC2;DDRGK1;FBXW7;FMR1;PSMD14;PSME3IP1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.19215013305304968,-0.662785611086382,0.968944099378882,0.9624706091961154,1.0,5/33,13.80%,TLR4;CAMK4;MTOR;CEBPB;PRXL2A
prerank,urogenital system development (GO:0001655),0.3461989930346334,0.6625588234529645,0.8424962852897474,1.0,1.0,3/11,18.17%,ANXA1;SOX9;OSR1
prerank,response to interleukin-1 (GO:0070555),0.28196853191933896,0.662544045729795,0.8792016806722689,1.0,1.0,20/73,23.23%,HYAL1;MYLK3;ANXA1;PRKCA;SOX9;RC3H1;SMPD1;SRC;NFKB1;SFRP1;SIRPA;CD47;PTGIS;TRAF6;SNCA;TANK;RBMX;HDAC4;DAB2IP;CCL14
prerank,plasma membrane repair (GO:0001778),0.33355028586101737,0.662458649248967,0.8225806451612904,1.0,1.0,6/13,22.88%,MYOF;SYTL4;SMPD1;DYSF;RAB3A;MYH9
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.2804770654759093,0.6623730337287601,0.8751311647429171,1.0,1.0,14/75,19.02%,RGS12;ROCK2;GIT2;GRK5;RGS3;ROCK1;RIC8B;NMT2;RAMP3;SYP;ZDHHC3;METAP1;FNTB;USP20
prerank,negative regulation of B cell activation (GO:0050869),-0.20921623658801025,-0.6622094575820553,0.9295154185022027,0.9621172328486679,1.0,13/21,42.67%,TNFRSF21;LYN;ATM;INHBA;CD300A;LAPTM5;TNFAIP3;TYROBP;INHA;FCGR2B;ID2;BANK1;FOXJ1
prerank,cellular response to cytokine stimulus (GO:0071345),0.27689660339454386,0.6614607430406438,0.99,1.0,1.0,52/416,16.34%,BRCA1;BIRC5;SYNCRIP;RHOA;HYAL1;PLP2;GSK3B;ZEB1;UBE2K;MYLK3;KIT;DHX9;LEPR;PTPN2;CXCR4;IL18;TPR;WNK1;NPNT;YBX3;POU2F1;FOXO3;CD80;HTRA2;IRF1;RIPOR2;PIM1;PIK3CB;SDC1;HNRNPU;CRKL;CNTF;ANXA1;TRIM6;SOX9;IL31RA;DPYSL3;RORA;TWIST1;RC3H1;CDKN1B;ITGB1;SMAD3;EPRS1;PTPN13;STK39;IL1RL2;NFKB1;TP53;SFRP1;PNPT1;IFNAR2
prerank,cholesterol metabolic process (GO:0008203),0.28246344339451845,0.6610285583315529,0.8613445378151261,1.0,1.0,11/68,15.93%,LBR;PMVK;SOAT1;SCAP;TM7SF2;ABCA1;ACAT2;SOAT2;MVK;STARD3;DHCR7
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3054932699229085,0.6609422759713844,0.8295739348370927,1.0,1.0,10/30,22.73%,MAGT1;RPN2;STT3A;STT3B;ALG8;UBE2J1;OSTC;FUT8;DPM3;MCFD2
prerank,regulation of BMP signaling pathway (GO:0030510),0.27972181488081377,0.6609163195608156,0.8765560165975104,1.0,1.0,15/73,14.11%,BMPR1A;NUMA1;CRIM1;CCN1;LEMD3;SULF1;SMAD6;SMURF1;RBPMS2;SMURF2;BMP2;RBPJ;SMAD4;XIAP;HTRA3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.2616425962617657,-0.6606207286733037,0.8803418803418803,0.9626316017956761,1.0,4/11,25.98%,XBP1;JAK2;TAF7;TMEM106A
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.27619221496560636,0.6602174162406231,0.9619238476953907,1.0,1.0,35/214,17.24%,FAM83D;FGFR4;FGFR2;GAREM1;PTPN2;TGFBR3;ARRB1;FBXW7;PDGFRA;NPNT;CCN1;ANGPT1;HMGB1;APIP;P2RY1;CRKL;BMP2;EZR;RRAS;PRKCA;SMAD4;NOTCH2;ROR1;DLG1;SPRED1;RAMP3;CD44;SLC30A10;PIN1;PRKD2;SPRED2;PTEN;CNKSR3;CCN2;SIRPA
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.28495065363698807,0.659564608217732,0.8710359408033826,1.0,1.0,12/67,12.88%,USP6NL;IFT140;TBC1D13;FMR1;TBC1D2B;SDCCAG8;TRPM2;TBC1D19;TWF1;RAC1;DMTN;ATG3
prerank,cellular protein localization (GO:0034613),0.27782707123758615,0.6592615513781696,0.977,1.0,1.0,66/285,18.44%,USP6NL;CNTLN;STX11;ARFIP1;AP4M1;EVI5L;TBC1D25;SNX1;RAP2A;TBC1D13;WDR11;BICD2;VPS26C;PRPF19;TBC1D2B;RAB22A;NIPBL;RAB29;STXBP2;FBLN5;LRRK2;MFN2;SMURF1;STX2;CORO1B;AXIN2;ANGPT1;RAB1A;SNX27;VIPAS39;COPB2;HERC2;NPHP1;EPB41L3;COPZ1;PIGU;AP3B1;SCFD1;ZDHHC15;GJA1;EHD1;IFT27;HEY2;ARF4;MESD;PTPRU;ARL4A;TM9SF2;CSRP3;STX12;ARF3;TBC1D9;STXBP1;VPS26A;TMED3;UNC50;LAMTOR3;PTPRK;SH3PXD2B;ACD;RIC1;USO1;TM9SF4;CEP250;ARL5A;TMED10
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.31291984414013213,0.658770446993132,0.8265971316818774,1.0,1.0,8/21,23.18%,PDZD8;MCU;MCUB;MICU1;MAIP1;RAP1GDS1;MICU2;LETM1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.2686928668380716,-0.6584097165841382,0.8898809523809523,0.9636969886003698,1.0,1/10,5.18%,PLEK
prerank,myelin assembly (GO:0032288),0.3398379732090019,0.6581481343055581,0.8208722741433022,1.0,1.0,2/10,10.58%,TPPP;EPB41L3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.3415673929235805,0.6580528093868802,0.8144796380090498,1.0,1.0,4/10,15.59%,PRKCB;ITGA5;ARNT;PRKD2
prerank,histone lysine demethylation (GO:0070076),0.3022599018585727,0.6577751013308426,0.8231631382316313,1.0,1.0,9/25,25.23%,PHF2;KDM2B;KDM5C;JMJD1C;KDM4B;KDM2A;HR;KDM1A;KDM5A
prerank,heterocycle biosynthetic process (GO:0018130),-0.24210430804199395,-0.6572245582014064,0.9151943462897526,0.9639248906324857,1.0,4/14,15.53%,LIAS;MOCS2;MOCS1;GCH1
prerank,protein localization to lysosome (GO:0061462),0.29478952229705313,0.6565916303448563,0.8201183431952662,1.0,1.0,4/28,12.19%,AP4M1;NEDD4;ZFYVE16;NAGPA
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.2994616721455065,0.6564620965035746,0.8535353535353535,1.0,1.0,2/25,4.00%,GCK;GPI
prerank,canonical glycolysis (GO:0061621),0.3009018903031561,0.6564051110190259,0.8582375478927203,1.0,1.0,2/24,4.00%,GCK;GPI
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3009018903031561,0.6564051110190259,0.8582375478927203,1.0,1.0,2/24,4.00%,GCK;GPI
prerank,regulation of protein autophosphorylation (GO:0031952),0.2920183621173769,0.6558631589253119,0.8241500586166471,1.0,1.0,11/36,22.26%,MRE11;RAP2A;PPP2R5C;ERRFI1;CALM2;ENPP1;PPP2R5B;MVP;RAD50;TOM1L1;PDGFA
prerank,endocardial cushion development (GO:0003197),0.3125017453648634,0.6558594910753285,0.8513341804320204,1.0,1.0,4/21,12.56%,BMPR1A;MDM4;BMP2;SOX9
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.19542683176059544,-0.6555613811965783,0.9428571428571428,0.9644835557400357,1.0,9/31,26.99%,TNFRSF21;LYN;ATM;CEBPB;CD274;DLG5;CD300A;CD86;SOX11
prerank,mitochondrial protein processing (GO:0034982),0.3355407119465173,0.6552128708694805,0.8204379562043795,1.0,1.0,5/11,20.47%,STOML2;PMPCA;ATP23;MIPEP;SPG7
prerank,regulation of myeloid cell differentiation (GO:0045637),0.28135183361261656,0.6549655531797814,0.8639744952178533,1.0,1.0,9/62,12.46%,RBM15;CBFB;MOV10;NFE2;LEO1;KMT2A;PRKCB;HDAC1;KMT2D
prerank,cell junction maintenance (GO:0034331),-0.2459398513239643,-0.6549463658228087,0.9037037037037037,0.9642383611794552,1.0,8/14,41.68%,DCTN1;CLDN1;CHCHD10;CSF1R;CBLN2;F2R;CBLN1;PRTN3
prerank,lipid translocation (GO:0034204),0.3095293742553706,0.6538310322517443,0.8198924731182796,1.0,1.0,3/21,11.78%,ABCA4;ABCB4;ABCA1
prerank,extracellular transport (GO:0006858),-0.24817217548767734,-0.6536760610375041,0.8892508143322475,0.9644552641678273,1.0,10/12,48.65%,TSG101;WWP2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,cellular lipid catabolic process (GO:0044242),0.30254960161387584,0.6534752684106735,0.8324937027707808,1.0,1.0,7/27,24.09%,LPIN2;ENPP2;ACADL;ACOT8;SMPDL3B;SIRT2;LPIN3
prerank,defense response to fungus (GO:0050832),-0.2240502354788069,-0.6531315914249743,0.9274193548387096,0.9641250766613506,1.0,17/17,77.63%,GAPDH;CX3CR1;HRG;S100A9;CARD9;CLEC4D;S100A8;CLEC6A;LTF;RARRES2;CLEC4E;DEFB119;NLRP10;RNASE7;PLCG2;BCL10;FAM3A
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.3321009793973835,0.6530788440618621,0.8165266106442577,1.0,1.0,3/13,12.39%,HMGB1;PDPK1;ADAM17
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.22497374010536822,-0.652757828396729,0.9236641221374046,0.9636105046487494,1.0,6/19,21.57%,TLR4;LBP;RAB11FIP2;LGALS9;TIRAP;PIK3AP1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3125276986173543,0.6523772147399722,0.8077956989247311,1.0,1.0,3/18,15.84%,NMI;ENPP3;DYSF
prerank,aminoglycan biosynthetic process (GO:0006023),0.2860769064167407,0.6522082853070705,0.8592017738359202,1.0,1.0,16/49,23.79%,B3GNT8;GPC6;SLC35D2;B4GALT7;HAS1;SDC1;HS2ST1;HSPG2;UGDH;B3GALT2;XYLT1;SDC4;GPC4;GCNT2;EXT1;GPC3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2849108314439932,0.65219227417844,0.864406779661017,1.0,1.0,11/48,15.59%,ANGPT4;JCAD;ANGPT1;MAP3K3;HMGB1;ANXA1;PRKCA;PDPK1;ADAM17;PRKD1;PRKD2
prerank,regulation of mRNA processing (GO:0050684),0.29576295414324755,0.6518124969041352,0.8576598311218335,1.0,1.0,11/32,19.50%,KHDRBS1;DHX9;SRSF10;SRSF3;SRPK1;CPSF4;IWS1;SRPK2;CWC22;LARP7;KHDRBS3
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3350575724680922,0.6513771618606391,0.826865671641791,1.0,1.0,4/11,22.19%,YBX3;CASP8;RIPK1;BIRC2
prerank,regulation of secretion by cell (GO:1903530),0.28214707619200385,0.650716914529124,0.8735262593783494,1.0,1.0,17/54,24.10%,ARFIP1;RAB10;DNAJC1;STXBP5;FMR1;LLGL2;ANXA1;P3H1;KCNMB4;RAB13;RIC1;RAB3A;RAB8B;VAMP2;CPLANE2;RAB8A;SNCAIP
prerank,positive regulation of signal transduction (GO:0009967),0.2713487193593187,0.6506868313220444,0.975,1.0,1.0,49/238,16.89%,LOXL3;MACF1;PHIP;DEPDC1B;FGFR2;ERFE;SULF2;ASXL1;MYO1C;TXNDC15;BMP6;NLGN3;JCAD;ZBTB7B;SULF1;TUBD1;CD80;LRRK2;AGPAT2;SMARCA4;ROBO1;YAP1;TGFBR1;LIMS1;TEDC1;CCN3;PRKCB;BMP2;PRKCA;RBPJ;RSPO3;AAK1;DMTN;GKAP1;TSPAN5;MAML1;PRKCI;ITGA5;ARNT;AGPAT1;ITGAV;SRC;PRKD2;PKD2;SFRP1;PTEN;NLGN2;SALL1;AXL
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.32509569010279554,0.6498537367789634,0.8489010989010989,1.0,1.0,1/15,2.79%,TICAM1
prerank,homeostasis of number of cells (GO:0048872),0.3264971850541849,0.6495843674633647,0.8328445747800587,1.0,1.0,3/12,15.52%,OCIAD2;CCN3;OCIAD1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2834541176210287,0.6490408374618694,0.86281179138322,1.0,1.0,3/44,4.81%,LBR;CYP39A1;PMVK
prerank,potassium ion transport (GO:0006813),0.2704690237088305,0.6487937122285123,0.915650406504065,1.0,1.0,16/120,15.59%,AQP1;CCDC51;KCNN4;KCNK2;KCNH4;KCNH8;SLC9A5;KCNJ13;SLC24A3;KCNMB2;KCNMB3;KCNK12;KCNK6;KCNMB4;KCNB2;PKD2
prerank,cholesterol transport (GO:0030301),0.2868772777228965,0.648125629592668,0.8608017817371938,1.0,1.0,8/45,16.97%,TSPO2;SOAT1;ABCA1;SOAT2;STARD3;RELCH;STX12;LDLR
prerank,glycine metabolic process (GO:0006544),0.3275247997149918,0.6476670918039572,0.8476052249637155,1.0,1.0,1/12,6.77%,AMT
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.2552056847600015,-0.6475607550721025,0.8913043478260869,0.9667540431902852,1.0,2/11,12.77%,DDX5;MAP2K1
prerank,body fluid secretion (GO:0007589),-0.2322883568172853,-0.6473624409314686,0.8992805755395683,0.966090435983364,1.0,3/15,14.56%,ERBB4;NPR1;VEGFA
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3349070812941213,0.6465738819670477,0.8452012383900929,1.0,1.0,2/11,12.06%,UAP1;GNPDA2
prerank,oligosaccharide metabolic process (GO:0009311),0.2819783183315564,0.6463119557685119,0.8629834254143647,1.0,1.0,10/46,20.76%,B4GALT1;ST8SIA2;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2;MAN1B1;NAGA;FUT8
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.299278770895396,0.646202270008253,0.8320802005012531,1.0,1.0,3/24,8.08%,PRNP;FBXW7;FOXO3
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2769193823592163,0.646033397441927,0.9003147953830011,1.0,1.0,6/76,8.39%,PLK1;GSK3B;DDRGK1;FBXW7;LRRK2;SMURF1
prerank,peripheral nervous system development (GO:0007422),0.29981051227693833,0.6459458637889772,0.8370927318295739,1.0,1.0,1/23,1.71%,ARTN
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.29827251570003865,0.6459252506731613,0.8624078624078624,1.0,1.0,7/27,15.83%,PML;FBXL8;FBXL17;PPP1CC;RBM4;PER1;TP53
prerank,pentose-phosphate shunt (GO:0006098),-0.26221358038015974,-0.6456902393916477,0.8702064896755162,0.9665262623907827,1.0,4/11,21.09%,PGD;RPE;RPIA;SHPK
prerank,cellular response to lipid (GO:0071396),0.26927201544149826,0.6454777824795879,0.9519519519519519,1.0,1.0,37/191,20.27%,HMGB2;AQP1;SETX;TICAM1;ROCK2;RHOA;ABCB4;LCOR;SERPINE1;CD80;HTRA2;WNT6;HMGB1;NR3C1;AHR;WNT9A;SOX9;RORA;MED1;ADAM9;RUVBL2;RAMP3;ADCY6;NFKB1;LPL;SFRP1;MSN;AXL;EPHA3;SIRPA;ADCY2;MAPK14;PLAA;ADNP2;PDE4B;CD68;TRAF6
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2731240047021578,0.6454319915355059,0.9117043121149897,1.0,1.0,26/95,19.38%,TGFBR3L;PEG10;TGFBR3;PMEPA1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;DKK3;SMURF2;NKX2-1;PDPK1;ADAM17;SMAD4;SPRED1;HTRA3;SMAD3;STK11;PIN1;SPRED2;VEPH1;SMAD2;SKIL;SKI;PPM1A
prerank,cation transport (GO:0006812),0.26575048680248603,0.6452782810121138,0.9416498993963782,1.0,1.0,26/167,19.08%,RHAG;SLC18A2;AQP1;KCNN4;SLC38A7;KCNH4;KCNJ13;SLC8A1;KCNMB2;KCNMB3;TRPM2;PIEZO1;CHRNB1;TRPM4;KCNK6;KCNMB4;SLC22A18;KCNB2;KCNA1;SLC6A17;SLC36A4;SLC7A1;SLC6A9;SLC25A29;KCNQ4;TRPM6
prerank,I-kappaB phosphorylation (GO:0007252),0.33708229072116613,0.64523503461776,0.8516819571865444,1.0,1.0,4/10,23.13%,ERC1;PRDX4;TLR7;DAB2IP
prerank,mRNA catabolic process (GO:0006402),0.2876908367547078,0.6451997297732616,0.8795454545454545,1.0,1.0,12/44,18.76%,THRAP3;TUT7;MRTO4;LSM2;YTHDF2;DXO;TUT4;RC3H1;PNPT1;METTL3;EXOSC10;XRN2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.24138348209218108,-0.6451515084594112,0.8902439024390244,0.9661177437463049,1.0,7/12,39.88%,BCL2;TAF9B;CD74;MIF;RPL26;TAF9;TRIAP1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.2940959800407148,0.6445119952587106,0.8440251572327044,1.0,1.0,8/25,20.34%,PDZK1;WNK1;AKAP9;STK39;GLRX;WNK3;SLC6A9;ANK3
prerank,C-terminal protein amino acid modification (GO:0018410),0.32908543944192237,0.6440968612693735,0.8296296296296296,1.0,1.0,7/11,27.73%,ATG7;AGTPBP1;ICMT;ATG5;FOLH1;TTL;LCMT1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.28470683697320104,0.6437832834317448,0.8533487297921478,1.0,1.0,5/36,10.48%,RB1;BCL2L12;CSNK2A2;NR4A2;TGFBR1
prerank,regulation of monocyte differentiation (GO:0045655),-0.23344653430393195,-0.6434837964495627,0.9081272084805654,0.9665712395974118,1.0,2/14,5.29%,CDK6;ACIN1
prerank,regulation of vacuole organization (GO:0044088),0.3067002170812595,0.6432161539438501,0.8370860927152318,1.0,1.0,5/20,18.94%,ANXA2;NPRL3;MTMR3;PIKFYVE;TBC1D12
prerank,phospholipid homeostasis (GO:0055091),-0.25429017297912315,-0.6427876335983388,0.8990825688073395,0.9662666932106984,1.0,5/11,35.15%,TLCD2;RCN3;TLCD1;ANGPTL3;ABCG1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.2881993073027127,0.6423634074796057,0.8573059360730594,1.0,1.0,5/35,12.92%,IQGAP2;PDGFRA;TRPM2;NOTCH2;BAIAP2L1
prerank,androgen receptor signaling pathway (GO:0030521),0.33528517578222916,0.6423110851971816,0.8414985590778098,1.0,1.0,3/11,12.28%,ARID1A;PMEPA1;PLPP1
prerank,autophagosome assembly (GO:0000045),0.2762527021339069,0.6421742569814478,0.8879120879120879,1.0,1.0,16/52,22.41%,ATG7;MFN2;SMURF1;ATP2A2;RAB1A;RB1CC1;ULK2;ATG3;ATG2A;STX12;UBXN2B;TRAPPC8;TP53INP2;AMBRA1;ATG13;ATG5
prerank,regulation of response to stress (GO:0080134),0.3379217457449162,0.6420727693653233,0.83125,1.0,1.0,3/10,18.42%,DYRK3;STOX1;SLC38A2
prerank,transcription by RNA polymerase I (GO:0006360),0.28769180971804004,0.6416218075101191,0.8480278422273781,1.0,1.0,6/34,13.15%,POLR1A;POLR1B;ERCC3;TAF1D;TTF1;POLR1G
prerank,aminoglycan catabolic process (GO:0006026),0.29316401181353036,0.6415965516926726,0.8497536945812808,1.0,1.0,3/28,10.41%,HPSE;GPC6;SDC1
prerank,glycolipid biosynthetic process (GO:0009247),0.2838352342785135,0.6415385823637761,0.8744239631336406,1.0,1.0,12/38,22.29%,LARGE1;PIGN;PIGA;ST3GAL5;PIGU;ST3GAL4;ST3GAL2;PIGM;DPM3;PIGG;A4GALT;PIGH
prerank,regulation of cytokine production (GO:0001817),0.2686860288973864,0.6412958743180734,0.9360406091370559,1.0,1.0,20/126,21.73%,POLA1;ERMAP;MAST2;AGPAT2;AGT;ATP2B1;ANXA1;CASP8;AGPAT1;PER1;SIRPA;FOXP1;CD47;MAPK14;NLRP4;LGR4;MAPKAPK2;ISG15;EIF2AK2;SOD1
prerank,methylguanosine-cap decapping (GO:0110156),0.3312409463263441,0.6411567885128566,0.8582434514637904,1.0,1.0,1/10,4.27%,PATL1
prerank,focal adhesion assembly (GO:0048041),0.298806586408205,0.6410950715091976,0.843236409608091,1.0,1.0,7/21,20.81%,TRIP6;SRC;RCC2;PTPRK;TESK2;WHAMM;FERMT2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.2944652118523207,0.6410235658226112,0.8506731946144431,1.0,1.0,6/26,15.85%,ROCK2;ALMS1;ROCK1;RAC1;SYNPO2;FHOD1
prerank,regulation of lipase activity (GO:0060191),0.3160222791676698,0.6409320008370931,0.834733893557423,1.0,1.0,4/13,20.66%,RHOA;RHOC;LPL;SNCA
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.26621662121201173,-0.6409145963313623,0.882183908045977,0.9668282152965728,1.0,4/10,26.99%,LRP6;BMP7;ARHGAP12;SOX11
prerank,regulation of endocytic recycling (GO:2001135),-0.2582486826969924,-0.6401609861758374,0.9230769230769231,0.9665225477350048,1.0,5/11,30.57%,ATP9A;ARHGAP1;SORL1;EIPR1;PLA2G4E
prerank,cellular response to estrogen stimulus (GO:0071391),-0.23313224119895334,-0.639976564427079,0.940625,0.9658418012875458,1.0,5/14,20.55%,AR;SFR1;SERPINB9;SRA1;WBP2
prerank,Notch signaling involved in heart development (GO:0061314),0.3298025628062108,0.6399656561755026,0.8424153166421208,1.0,1.0,3/11,13.44%,RBPJ;NOTCH2;HEY2
prerank,cellular glucan metabolic process (GO:0006073),0.32231707697324663,0.6396727525727196,0.851528384279476,1.0,1.0,1/11,3.50%,GSK3B
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.22066970555202986,-0.6387897521432301,0.9230769230769231,0.9658266716470424,1.0,4/18,16.81%,ATXN3;PIK3R1;DDIT3;XBP1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.3213006936286852,0.6385483729695054,0.8467261904761905,1.0,1.0,7/13,28.18%,UAP1;GNPDA2;SLC35A3;AMDHD2;GFPT1;GFPT2;PGM3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.2774233432072424,0.638320081441893,0.8936170212765957,1.0,1.0,13/67,17.67%,DYRK1A;FGFR4;FGFR2;KIT;PDGFRA;EPHA4;ABI1;DDR2;BTK;EFEMP1;SRC;EPHA3;ABI2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.27028692396047665,0.6383021817202317,0.8801261829652997,1.0,1.0,24/70,24.77%,PSMC2;PSMD5;PSMB1;PSMD14;PSMD1;IKBKG;CYBB;PSMB9;PSMC6;ITGAV;SNAP23;PSMB2;PSME4;PSMB7;PSMD11;PSME3;SEC22B;IKBKB;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,calcium ion transmembrane transport (GO:0070588),0.27070117912110836,0.6381447901674665,0.9083333333333333,1.0,1.0,24/86,20.72%,ATP2B4;TRPA1;STOML2;MCU;ATP2A2;SLC24A3;SLC8A1;MCUB;CACNA1C;TRPM2;TRPC7;ATP2B1;MICU1;TRPM4;PMPCA;ITGAV;MAIP1;PKD2;GRIN2D;TRPV4;TRPM6;CACNA1G;SPG7;MICU2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2799562378871897,0.638003414459683,0.8815217391304347,1.0,1.0,20/52,26.04%,MTHFD1L;MTHFR;SLC19A1;HOGA1;DGLUCY;DHFR;GCLM;MTHFS;GCLC;ME3;L2HGDH;ACOT8;ME2;SLC25A32;IDH2;SDHA;ALDH18A1;FPGS;ME1;MTHFD2
prerank,cell junction assembly (GO:0034329),0.27038924716564133,0.6379358443772726,0.9139896373056995,1.0,1.0,20/100,16.41%,SDK1;CDH18;CDH24;RHOA;OBSL1;NLGN3;GRHL2;RAB29;FARP1;GJC1;TLN1;LIMS1;CAPZA1;DSCAM;ACHE;PLXND1;TLN2;PTEN;NLGN2;SHANK2
prerank,epithelial cell development (GO:0002064),0.3071716709537359,0.6378235175686783,0.8390804597701149,1.0,1.0,2/20,7.11%,GRHL2;RILPL1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3064259132959978,0.6372719279834413,0.8197596795727636,1.0,1.0,3/18,16.35%,PRKDC;IL4I1;METTL3
prerank,regulation of myoblast differentiation (GO:0045661),-0.1776771119500209,-0.6371881179408171,0.9681528662420382,0.9661541093918582,1.0,7/32,20.56%,MEF2C;BOC;TBX3;BTG1;LRRC8A;SRA1;HIF1AN
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.21019006186916972,-0.6363529068392378,0.9336099585062241,0.9659753636299584,1.0,10/18,40.87%,HEATR1;WDR75;ERBB2;POLR2K;MAF1;LYAR;SIRT7;POLR2L;WDR43;RASL11A
prerank,regulation of sequestering of triglyceride (GO:0010889),0.31898562100394,0.6360495094301891,0.8502139800285307,1.0,1.0,3/15,15.77%,OSBPL8;PLIN2;LPL
prerank,intestinal absorption (GO:0050892),-0.23941469491891684,-0.6355434544217473,0.8797250859106529,0.9657195109517391,1.0,3/13,19.40%,F11R;ADRA2A;KCNQ1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.33079353904456643,0.6355007937146496,0.8318452380952381,1.0,1.0,2/10,15.32%,LRRK2;SRC
prerank,myeloid leukocyte differentiation (GO:0002573),0.27298479252321733,0.6352405765817232,0.8777895855472901,1.0,1.0,7/65,12.76%,E2F1;DEK;KIT;PML;CDK2;CASP8;IL31RA
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.26857368981889757,0.6350799475117546,0.9029227557411273,1.0,1.0,30/88,23.37%,AP4M1;GBF1;RAB10;EXOC4;ACBD3;ARRB1;VPS13A;SH3D19;DNM2;CLVS2;SCFD1;TXNDC5;EXOC8;CLINT1;AP1B1;SNAP23;AP1M1;EPS15;CLTA;MON2;SCAMP2;ARF1;DNAJC6;EXOC2;VAMP2;MYO1B;SCAMP3;NAPA;HSPA8;GOLGB1
prerank,positive regulation of embryonic development (GO:0040019),-0.21419189722708495,-0.6343694846749937,0.9478672985781991,0.9657270305456246,1.0,6/19,28.89%,B4GALT5;NR2C2;TENM4;RACK1;ZBED3;PLCB1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.32352292695380136,0.6342270193897946,0.8380281690140845,1.0,1.0,4/13,16.97%,ABCA1;ITGB1;LPL;LDLR
prerank,positive regulation of cell adhesion (GO:0045785),0.27167375547391664,0.6335288521049564,0.8998935037273695,1.0,1.0,13/74,15.59%,HYAL1;AFDN;NPNT;SFRP2;PPP3CA;EPHA4;RSU1;LIMS1;RAC1;PRKCA;ADAM9;ITGAV;PRKD2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.29023616749782577,0.6335125728404541,0.8497536945812808,1.0,1.0,6/26,19.61%,NPR3;PIK3CB;TERF2;DHFR;GDNF;TERT
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2884567222413884,0.6333798662897125,0.8735498839907193,1.0,1.0,12/34,27.34%,TICAM1;RAB7B;PTPRS;LGR4;SMPDL3B;GPR108;DAB2IP;NFKBIL1;ACOD1;NLRP2B;LY96;TLR3
prerank,positive regulation of actin nucleation (GO:0051127),0.3258905120844546,0.6328472106776306,0.8562962962962963,1.0,1.0,5/11,23.38%,WASF2;NCKAP1;ABI2;WHAMM;WASF1
prerank,toll-like receptor signaling pathway (GO:0002224),0.2670730787287755,0.6328232743792527,0.912906610703043,1.0,1.0,11/84,13.09%,FADD;TICAM1;COLEC12;TAB1;NMI;MAP3K1;HMGB1;IKBKG;MAPKAPK3;CASP8;BTK
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2733904104657381,0.6323551027751846,0.8925886143931256,1.0,1.0,9/63,9.57%,BMF;DAP;EIF4E;LEPR;NRDE2;KLHL22;MTMR2;ROCK1;MTMR9
prerank,sensory organ development (GO:0007423),0.2743533931191487,0.6319756962433806,0.8671875,1.0,1.0,2/51,2.57%,PBX4;PBX3
prerank,peptidyl-asparagine modification (GO:0018196),0.289300420940201,0.631760528953173,0.8541409147095179,1.0,1.0,10/31,22.73%,MAGT1;RPN2;STT3A;STT3B;ALG8;UBE2J1;OSTC;FUT8;DPM3;MCFD2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2666741185231307,0.6317308566312809,0.9127725856697819,1.0,1.0,29/86,24.77%,PSMC2;PSMD5;ELOC;CHEK1;PSMB1;PSMD14;LIMD1;VHL;PSMD1;PSMB9;STOX1;PSMC6;ARNT;INO80;TP53;PSMB2;PSME4;PSMB7;PSMD11;EGLN1;PSME3;PSMD13;EGLN3;PSMB8;PSMD4;PSMF1;PSMA5;HIF3A;PSMC3
prerank,Wnt signaling pathway (GO:0016055),0.2713556796673059,0.6315386051043143,0.9105098855359001,1.0,1.0,29/92,24.26%,GSK3B;TCF7L1;WNT2B;TCF7L2;SFRP2;PORCN;LRRK2;WNT6;NR4A2;WNT9A;CSNK1G2;LRP5;BTRC;SFRP1;PTEN;VPS26A;AMER1;CSNK1A1;CSNK1G1;FRZB;WNT4;FERMT2;CSNK1E;NXN;ZRANB1;GPC4;TCF7;WLS;AXIN1
prerank,lipid droplet formation (GO:0140042),-0.2581086104755078,-0.6305817694669111,0.9226361031518625,0.9675806957698466,1.0,3/10,17.84%,CDS2;CDS1;AUP1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3025765462725087,0.6302845038266887,0.8701657458563536,1.0,1.0,2/18,10.80%,GSK3B;BOK
prerank,synaptic vesicle endocytosis (GO:0048488),0.2856842334415415,0.6294980024204946,0.8677685950413223,1.0,1.0,13/33,21.89%,STON1;STON2;NLGN3;DNM2;PICALM;GAK;PIP5K1C;NLGN2;SNCA;DNAJC6;SNAP91;VAMP2;CDK5
prerank,negative regulation of leukocyte migration (GO:0002686),0.3227003298554698,0.6292362535688188,0.8641221374045801,1.0,1.0,1/10,6.52%,HOXA7
prerank,amino sugar biosynthetic process (GO:0046349),0.3195146554779393,0.6282857595781427,0.8740629685157422,1.0,1.0,2/12,12.06%,UAP1;GNPDA2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26256185773830487,0.6281935230666377,0.9284984678243106,1.0,1.0,28/104,19.73%,BMPR1A;PEG10;PMEPA1;CRIM1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;RBPMS2;SMURF2;CCN3;BMP2;NKX2-1;PDPK1;ADAM17;SMAD4;SPRED1;HTRA3;SMAD3;PIN1;SPRED2;VEPH1;SMAD2;SKIL;SKI;PPM1A;UBE2D3
prerank,embryonic appendage morphogenesis (GO:0035113),0.3190949587049878,0.6281699525226574,0.8595988538681948,1.0,1.0,1/12,3.24%,CYP26B1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.2951941945857824,0.6278217260134399,0.8427835051546392,1.0,1.0,2/22,7.80%,IL18;ZBTB7B
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.23389420177544834,-0.6276983934678783,0.9473684210526315,0.9686170837117126,1.0,7/13,36.11%,PTPRT;JAK2;EGF;MGAT5;PTPRC;CRLF2;JAK3
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.20917300804122557,-0.6270669282589,0.9240506329113924,0.968218228598759,1.0,4/18,20.98%,BCL2;BNIP3;SLC25A4;BCL2L1
prerank,regulation of T cell migration (GO:2000404),0.3004978171975463,0.6269818807528801,0.8469798657718121,1.0,1.0,2/18,8.79%,RHOA;RIPOR2
prerank,protein insertion into membrane (GO:0051205),0.2808586522704306,0.6265208765065732,0.8764988009592326,1.0,1.0,9/32,21.74%,PRNP;TRAM2;EMD;MAIP1;VAPA;CYB5A;TRAM1;CCDC47;VAMP2
prerank,steroid biosynthetic process (GO:0006694),0.265808509738104,0.6262567111618503,0.9099783080260304,1.0,1.0,3/56,4.81%,LBR;CYP39A1;PMVK
prerank,photoperiodism (GO:0009648),0.2872504642273971,0.6259664988689381,0.8856447688564477,1.0,1.0,7/28,15.83%,PML;FBXL8;FBXL17;PPP1CC;RBM4;PER1;TP53
prerank,response to insulin (GO:0032868),0.26854666254468085,0.6259112665737093,0.9143155694879833,1.0,1.0,28/80,24.33%,GCK;RAB10;PRKDC;PDE3B;DENND4C;LPIN2;ZBTB7B;RHOQ;CPEB2;ENPP1;PDPK1;PRKCI;EPRS1;PCK2;RAB13;INSIG2;SLC2A4;SYAP1;CEACAM1;INSIG1;FER;RAB8B;VAMP2;ZFP36L1;SLC25A33;RAB8A;LPIN3;RPS6KB1
prerank,androgen metabolic process (GO:0008209),0.2983157608916265,0.6256287123624592,0.8620218579234973,1.0,1.0,2/18,13.64%,SRD5A3;MED1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.22155100984737391,-0.625253777337803,0.9272030651340997,0.9685950726173336,1.0,3/17,10.54%,FIS1;SOD2;BCL2
prerank,inflammatory response (GO:0006954),0.25837637512809225,0.6251375213743128,0.964964964964965,1.0,1.0,17/195,12.83%,LOXL3;MMP25;SCUBE1;HYAL1;KIT;CXCR4;IL18;BDKRB2;NOX4;HMGB1;IKBKG;CYBB;PXK;BMP2;ANXA1;RAC1;ITCH
prerank,platelet aggregation (GO:0070527),0.2805911063717981,0.6251028808844818,0.8739884393063584,1.0,1.0,11/33,22.88%,PDGFRA;PIK3CB;TLN1;CLIC1;STXBP1;FERMT3;METAP1;UBASH3B;FLNA;VCL;MYH9
prerank,adrenergic receptor signaling pathway (GO:0071875),0.29068854757391865,0.624993592130252,0.8637532133676092,1.0,1.0,3/20,16.79%,LMBRD2;ADRB2;ZDHHC21
prerank,heart process (GO:0003015),0.30844393443388674,0.6249106175242201,0.8722527472527473,1.0,1.0,4/14,22.80%,NOX4;RAMP3;SOD1;FYN
prerank,tRNA metabolic process (GO:0006399),0.309179233953384,0.6244084319102512,0.8548812664907651,1.0,1.0,7/17,24.78%,DARS2;RPP30;POP1;RPP21;FARS2;DTD1;SSB
prerank,regulation of programmed cell death (GO:0043067),0.25758240059208504,0.624327505989454,0.9556004036326943,1.0,1.0,18/161,12.56%,BIRC5;STEAP3;ACTN4;ANP32B;AIFM2;RBM25;TMEM219;LRRK2;TNFRSF10B;KANK2;SKP2;AGT;GAS1;APAF1;NDRG1;ANP32E;CHM;SOX9
prerank,modulation by host of symbiont process (GO:0051851),0.28201495540097954,0.6240873405923905,0.8727272727272727,1.0,1.0,6/31,17.39%,AQP1;NUCKS1;SMARCA4;HDAC1;CHD1;TFAP4
prerank,Fc receptor signaling pathway (GO:0038093),0.26178516298418975,0.624067412539477,0.9271794871794872,1.0,1.0,40/110,24.77%,PSMC2;PSMD5;KIT;TAB1;MAP3K1;VAV2;PPP3CA;PSMB1;PSMD14;PSMD1;IKBKG;PIK3CB;PSMB9;RAC1;FBXW11;PDPK1;BTK;BTRC;PSMC6;NFKB1;PPP3R1;PSMB2;PSME4;PSMB7;NFATC3;PSMD11;TRAF6;PSME3;FER;IKBKB;PSMD13;PSMB8;GAB2;PSMD4;BCL10;PSMF1;PPP3CB;PSMA5;RELA;PSMC3
prerank,magnesium ion transport (GO:0015693),-0.24712937893278458,-0.6240349806637601,0.9428571428571428,0.9685595876720642,1.0,2/12,5.21%,NIPA1;NIPA2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.2825690663353808,0.6238521949864887,0.8741176470588236,1.0,1.0,2/32,6.19%,RNASE6;HMGN2
prerank,positive regulation of metabolic process (GO:0009893),0.2599802588768197,0.6237455930744713,0.9362139917695473,1.0,1.0,18/103,14.68%,MFAP2;LEPR;PIGA;CXCR4;IL18;ZBTB7B;MFN2;ALMS1;CAMK1D;ACACA;APPL2;ACHE;GJA1;ADIPOR1;ADRB2;CPT2;ACADL;AGPAT1
prerank,ERBB signaling pathway (GO:0038127),0.2675378998116972,0.6234770283213645,0.9118279569892473,1.0,1.0,13/64,15.32%,MATK;GAREM1;CUL5;GAB1;PRKCA;PDPK1;NCK2;ADAM17;SOX9;SLC30A10;AAMP;EFEMP1;SRC
prerank,protein secretion (GO:0009306),0.273185837911227,0.6234398617027137,0.8994594594594595,1.0,1.0,14/56,21.50%,STEAP3;RAB10;PORCN;SVBP;ANXA1;ABCA1;NAGPA;MIA3;SNX19;RAB13;TMEM167A;RAB3A;RAB8B;PPY
prerank,regulation of cholesterol esterification (GO:0010872),-0.25629886602202945,-0.6232081180565333,0.9201277955271565,0.9682876922608958,1.0,2/10,12.21%,APOE;AGTR1
prerank,substantia nigra development (GO:0021762),0.27582695630066445,0.6231900405659999,0.8805970149253731,1.0,1.0,5/37,10.93%,RHOA;RAD1;CCDC14;MAPKAP1;CALM2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3046233703305157,0.6231712320722119,0.844851904090268,1.0,1.0,3/15,14.04%,UST;DSE;BGN
prerank,zinc ion transmembrane transport (GO:0071577),0.2932125785708345,0.6231244392051197,0.8509316770186336,1.0,1.0,5/22,15.02%,SLC39A11;TRPM2;SLC39A8;SLC39A6;SLC30A10
prerank,axon extension (GO:0048675),0.29208389430691606,0.6230436699742887,0.87146529562982,1.0,1.0,5/23,13.52%,ALCAM;AUTS2;NLGN3;ULK2;USP9X
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.31370315553315714,0.6229946558065754,0.8640915593705293,1.0,1.0,3/13,13.93%,DDRGK1;NCK1;PPP1R15B
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2604500337664192,0.6226282120367527,0.9258883248730965,1.0,1.0,35/104,24.77%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,cellular response to lectin (GO:1990858),0.2604500337664192,0.6226282120367527,0.9258883248730965,1.0,1.0,35/104,24.77%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,regulation of protein polymerization (GO:0032271),0.28092266944298055,0.6223171113644117,0.8869257950530035,1.0,1.0,4/35,9.19%,ARHGAP28;ARHGAP18;MAPT;TPPP
prerank,iron ion homeostasis (GO:0055072),0.27138155505861494,0.6222638560114518,0.8838219326818675,1.0,1.0,16/58,22.00%,FXN;ERFE;CYB561A3;BMP6;PICALM;SMAD4;CCDC115;ACO1;ALAS2;BDH2;CAND1;NUBP1;FRRS1;ATP6V0A2;SOD1;NEDD8
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.3115731624462944,0.6222076361685657,0.8636363636363636,1.0,1.0,2/13,10.55%,GPRC5A;ERRFI1
prerank,regulation of lipid catabolic process (GO:0050994),0.3003566670168687,0.6221358938919764,0.8592493297587132,1.0,1.0,1/19,4.92%,PDE3B
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.276262530169849,0.6213699612692358,0.8667452830188679,1.0,1.0,8/38,18.39%,ATP2B4;ROCK2;RAC1;SMAD3;PKD2;SIRPA;CD47;PTGIS
prerank,positive regulation of phospholipase C activity (GO:0010863),0.2793549818352088,0.621163352501973,0.8841743119266054,1.0,1.0,5/40,10.41%,LPAR1;KIT;PDGFRA;GNAQ;ARHGAP6
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2861681422820721,0.62086471998877,0.8582278481012658,1.0,1.0,4/25,12.85%,RNF168;LEO1;HNRNPU;BRD4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.25971680088992505,0.6204299419513146,0.9329268292682927,1.0,1.0,35/105,24.77%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,positive regulation of wound healing (GO:0090303),0.2781439088615697,0.6192109400229802,0.8866348448687351,1.0,1.0,8/36,14.27%,HPSE;SERPINE1;ANXA1;DMTN;PRKCE;INSL3;ST3GAL4;ITGB1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.30297252770360344,0.6190670919989267,0.8734353268428373,1.0,1.0,3/16,11.73%,ACAT1;ACSS1;ACACA
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2579008663719506,0.6181333429998753,0.971,1.0,1.0,35/234,14.34%,TRIM37;TRIML2;TICAM1;TFDP1;DDRGK1;RAB7B;KIT;DHX9;SRF;TAB1;STK3;ANXA3;RTKN2;IL18;UBE2N;TAF12;RNF31;SMARCA4;AGT;IKBKG;ERC1;EDA;DDR2;CAMK1D;FLOT2;PRKCB;TRIM6;BTK;ROR1;SLCO3A1;PPRC1;PRKD1;PRKCI;TRIM5;SMAD3
prerank,activation of adenylate cyclase activity (GO:0007190),-0.1745490658982502,-0.6180777086511039,0.9813664596273292,0.9706012844151434,1.0,5/35,14.87%,CAP1;LGR5;ADCY3;ADCY8;ADCY4
prerank,positive regulation of phospholipid transport (GO:2001140),0.3165598607007883,0.6169632861057662,0.8453292496171516,1.0,1.0,1/10,4.57%,ABCB4
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3028531223303594,0.6166658474811011,0.8799454297407913,1.0,1.0,1/16,5.54%,RAET1E
prerank,negative regulation of inflammatory response (GO:0050728),-0.13648757434610995,-0.6163702784317855,1.0,0.9707793694298416,1.0,22/182,11.67%,TEK;CALCRL;APOE;IGF1;KLF4;CDH5;PLCG1;RAMP1;LYN;RAMP2;GGT5;FURIN;OTULIN;PRKACB;SELENOS;NR1H3;RPS19;GRN;TNFAIP6;PRKAR1B;TNFRSF1B;HTR4
prerank,plasma membrane organization (GO:0007009),0.26272704571915206,0.6162595918826901,0.9038876889848813,1.0,1.0,19/61,22.88%,PLSCR2;PACSIN2;CXCR4;MYOF;STX2;SNX33;EPB41L3;SYTL4;SMPD1;DYSF;CHMP4A;FA2H;RAB3A;UGCG;ANK3;WHAMM;A4GALT;SNX9;MYH9
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.29037255213562035,0.6161149824450652,0.8888888888888888,1.0,1.0,4/21,19.61%,EYA4;EYA2;GDNF;TERT
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.29037255213562035,0.6161149824450652,0.8888888888888888,1.0,1.0,4/21,19.61%,EYA4;EYA2;GDNF;TERT
prerank,muscle cell development (GO:0055001),0.28200900443461707,0.6158670093973315,0.8744019138755981,1.0,1.0,6/30,15.84%,MYOF;SLC8A1;SDC1;CHRNB1;HEY2;DYSF
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2840575547206749,0.6153141184542679,0.8493670886075949,1.0,1.0,6/24,15.09%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP
prerank,glycoprotein catabolic process (GO:0006516),0.29128197119487337,0.6149787397964581,0.8690958164642375,1.0,1.0,4/17,14.93%,ADAMTS9;STT3B;FBXO27;FBXO17
prerank,aerobic respiration (GO:0009060),0.29051046846077694,0.6149341060493292,0.8772609819121447,1.0,1.0,1/20,2.45%,MTFR2
prerank,response to interferon-gamma (GO:0034341),-0.14473111596520946,-0.6143728057119493,1.0,0.971162343191838,1.0,13/67,20.22%,NUB1;TLR4;IFITM3;CX3CL1;GBP3;GBP4;GCH1;BST2;IFITM2;RPL13A;LGALS9;GAPDH;GBP6
prerank,phagolysosome assembly (GO:0001845),0.3109196679402271,0.6139578535233156,0.8753581661891118,1.0,1.0,1/12,4.45%,RAB7B
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.28801770752861294,0.6137878173218774,0.8869123252858958,1.0,1.0,1/21,2.15%,NAP1L1
prerank,regulation of cardiac conduction (GO:1903779),0.26046089627829544,0.6131800663506577,0.8971238938053098,1.0,1.0,9/54,16.00%,ATP2B4;ITPR1;ATP2A2;SLC8A1;AGT;ATP2B1;ITPR3;TMEM65;STIM1
prerank,positive regulation of filopodium assembly (GO:0051491),0.283845846719499,0.6129089272261032,0.879245283018868,1.0,1.0,5/24,12.82%,FMR1;RHOQ;RIPOR2;DOCK11;DPYSL3
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.25702535030384366,0.6128036839148516,0.9544534412955465,1.0,1.0,18/150,12.28%,HPSE;FGFR4;FGFR2;IAPP;KIT;FRS2;TCF7L2;IL18;PDGFRA;TXN;CD80;ANGPT1;OSBPL8;PIK3CB;TGFBR1;GAB1;RAC1;PDPK1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.2796215724323628,0.6117634273379629,0.8819951338199513,1.0,1.0,6/27,15.77%,IL18;AGT;ABCA1;ITGAV;NFKB1;LPL
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.28652139199114185,0.6116635505335442,0.8866498740554156,1.0,1.0,4/25,9.91%,KLHL15;CUL3;LONP1;FBXL17
prerank,synaptic vesicle membrane organization (GO:0048499),0.2985682048296336,0.6114892025310323,0.8768020969855832,1.0,1.0,4/17,15.68%,STX11;STX2;SYP;SNAP23
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.23774644026620126,-0.6109546005481659,0.9380804953560371,0.9723270849716575,1.0,4/12,33.80%,ESR1;ZC3H12A;ZC3H10;PPARG
prerank,negative regulation of cell motility (GO:2000146),0.25921103488047836,0.6106119318736388,0.9372427983539094,1.0,1.0,25/108,18.08%,ARID2;STK24;RAP2A;AFDN;SFRP2;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;SRGAP2;SRGAP3;NKX2-1;CLIC4;DPYSL3;MIA3;PTPRU;PIN1;NF2;SFRP1;PTEN;PTPRK;SLURP1;DPEP1
prerank,O-glycan processing (GO:0016266),0.2671035718420184,0.6104336557176597,0.8918032786885246,1.0,1.0,8/54,15.46%,GALNT1;B3GNT8;ST3GAL3;C1GALT1;POFUT1;ST3GAL4;ST3GAL1;ST3GAL2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.280898494087402,0.6104152567321649,0.8860435339308579,1.0,1.0,4/24,11.74%,MAP4K4;ROCK1;LIMS1;RAC1
prerank,calcineurin-mediated signaling (GO:0097720),0.318013570418499,0.6102689048235531,0.8765060240963856,1.0,1.0,4/10,24.17%,PPP3CA;PPP3R1;NFATC3;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.318013570418499,0.6102689048235531,0.8765060240963856,1.0,1.0,4/10,24.17%,PPP3CA;PPP3R1;NFATC3;PPP3CB
prerank,peptide catabolic process (GO:0043171),0.2842419225299044,0.6092620310557262,0.8900255754475703,1.0,1.0,6/23,18.08%,LVRN;CPQ;TRHDE;CTSH;NPEPPS;DPEP1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.25924584384777843,0.6092115128739523,0.9453441295546559,1.0,1.0,21/128,14.34%,TGFBR3L;BMPR1A;RHOA;NLK;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;TGFBR1;SMURF2;ARHGEF18;BMP2;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3
prerank,actin filament network formation (GO:0051639),-0.24779482865301317,-0.6086052030202692,0.9434523809523809,0.9728851417986074,1.0,1/11,0.95%,PLS3
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.31225630295073914,0.6085104622210572,0.8702064896755162,1.0,1.0,2/10,13.81%,ACTN4;RARB
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3101561706224168,0.6076566822811763,0.877521613832853,1.0,1.0,2/12,10.56%,HNRNPU;YTHDF2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.29701607954796244,0.606977676376797,0.8682795698924731,1.0,1.0,1/17,5.54%,RAET1E
prerank,regulation of Notch signaling pathway (GO:0008593),0.25863370317924583,0.6068273992043274,0.9234800838574424,1.0,1.0,17/76,16.35%,MMP14;DLK1;ARRB1;FBXW7;YAP1;LLGL2;YTHDF2;POFUT1;ARRDC1;CCN3;RBPJ;AAK1;TSPAN5;MAML1;PRKCI;SRC;METTL3
prerank,Golgi ribbon formation (GO:0090161),-0.22758103902641597,-0.6064844300394076,0.9421768707482994,0.9731944459159584,1.0,2/13,9.91%,STX6;MYO18A
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2591420488276905,0.6051730280382437,0.9332648870636551,1.0,1.0,19/87,17.83%,TGFBR3L;BMPR1A;RHOA;NLK;TGFBR3;SMAD6;SMURF1;TGFBR1;ARHGEF18;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3;SRC;PTPRK;ZFYVE9;SMAD2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.25889689814626005,0.6049408804246494,0.9271383315733897,1.0,1.0,17/80,19.36%,GBF1;RAB7B;SPAG9;SNX1;DENND2A;RAB29;ERC1;DENND5A;VTI1A;GOSR1;SNX32;TRAPPC10;VPS26A;RIC1;PIKFYVE;TBC1D10A;BET1L
prerank,secondary alcohol metabolic process (GO:1902652),0.26977468578221714,0.6043219037308412,0.8945005611672279,1.0,1.0,6/42,15.51%,IDH3A;SOAT1;SCAP;ABCA1;SOAT2;STARD3
prerank,inorganic cation transmembrane transport (GO:0098662),0.2517395140489907,0.6042007560552408,0.985985985985986,1.0,1.0,21/268,10.74%,RHD;RHAG;ATP2B4;CCDC51;KCNN4;KCNK2;SLC6A5;SLC6A2;TRPA1;SLC39A11;KCNH4;KCNH8;SLC9A5;ATP2A2;SLC24A3;SLC8A1;CACNA1C;KCNK12;TRPM2;TRPC7;SLC39A8
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.20642699653699487,-0.6039562510311697,0.9437751004016064,0.9737467098968309,1.0,4/17,24.73%,ADRA1A;ADRA2A;DRD2;ADRA1B
prerank,regulation of RNA metabolic process (GO:0051252),0.2645674909064676,0.6038159965807569,0.9056399132321041,1.0,1.0,12/59,13.96%,TRA2B;MBNL3;HNRNPH1;FUS;RC3H2;YTHDF2;HNRNPL;HNRNPH2;METTL4;PTBP2;MED1;RC3H1
prerank,blood vessel endothelial cell migration (GO:0043534),0.2878527398018955,0.603737185091075,0.8732572877059569,1.0,1.0,5/22,14.42%,SRF;ROBO1;NR4A1;EFNB2;MIA3
prerank,mitochondrial membrane organization (GO:0007006),0.2779179126101413,0.603505855081694,0.8623962040332147,1.0,1.0,11/32,22.00%,TMEM11;MFN2;CHCHD3;APOO;MAIP1;MFN1;MICOS10;BAD;SLC25A5;SPG7;IMMT
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2583744310398698,0.6034623077805754,0.9350104821802935,1.0,1.0,5/76,6.67%,SETD6;TRIM37;DAP;FAF1;ARRB1
prerank,histone H3-K4 trimethylation (GO:0080182),0.3095684478133213,0.6033390077217934,0.869753979739508,1.0,1.0,2/11,12.46%,KMT2A;KMT2D
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.26312577867596765,0.6031402947886608,0.8919514884233738,1.0,1.0,12/48,21.84%,ACAT1;PAPSS2;PPCDC;ADSL;GUCY2C;PANK4;PANK2;ADCY6;ADCY2;COASY;ADSS2;GUCY2D
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2597030061248743,0.6030763862926757,0.9092827004219409,1.0,1.0,22/70,24.97%,FADD;GSK3B;CASP8AP2;TNFRSF10B;BOK;PDPK1;CASP8;SMAD3;ITGAV;NGF;BAD;HIPK1;RIPK1;TRAF2;APPL1;DAXX;IL6R;DAB2IP;BID;BAX;TGFB1;MCL1
prerank,plasma membrane tubulation (GO:0097320),0.30303378458775465,0.6030256373667147,0.8660968660968661,1.0,1.0,6/13,24.31%,PACSIN2;SNX33;CHMP4A;WHAMM;SNX9;EHD2
prerank,positive regulation of defense response (GO:0031349),0.2554355762742204,0.6029025981168522,0.939203354297694,1.0,1.0,20/89,22.99%,DHX9;NMI;IL18;SERPINE1;RIOK3;AGT;POLR3D;AKIRIN2;SLC15A4;SETD4;LPL;CD47;RIPK1;IL16;SNCA;POLR3C;OPTN;GPRC5B;POLR3G;TLR7
prerank,regulation of autophagy (GO:0010506),0.25279726721661105,0.6028971232145232,0.982982982982983,1.0,1.0,43/216,16.84%,TRIML2;TICAM1;GSK3B;BMF;DEPDC5;DAP;ITPR1;EXOC4;NEDD4;EIF4E;MAPT;LEPR;TPCN1;FBXW7;SH3GLB1;FOXO3;HTRA2;LRRK2;KLHL22;ROCK1;MTMR9;HMGB1;CSNK2A2;PIK3CB;RB1CC1;BOK;DCAF12;TRIM6;SLC38A9;EXOC8;PRKD1;SNX32;PLK2;FOXK2;TRIM5;STK11;RPTOR;MTMR3;PRKAG1;CISD2;TPCN2;VPS26A;LAMTOR3
prerank,negative regulation of response to external stimulus (GO:0032102),0.2579487076666632,0.602820098727663,0.943031536113937,1.0,1.0,14/105,13.72%,RB1;RTN4R;CASK;NMI;PTPN2;EPHA4;ENPP3;SERPINE1;CCN3;PTPRS;ILRUN;ITCH;RORA;MVK
prerank,T-helper cell differentiation (GO:0042093),0.3048304979800436,0.6019371232693884,0.8763888888888889,1.0,1.0,4/14,19.41%,HMGB1;TMEM98;FOXP1;ZFPM1
prerank,modulation by host of viral genome replication (GO:0044827),0.3020058012225134,0.6018391638891484,0.8808823529411764,1.0,1.0,3/13,15.27%,FMR1;NUCKS1;VAPA
prerank,cellular iron ion homeostasis (GO:0006879),0.2640608251151487,0.6016842890231352,0.910577971646674,1.0,1.0,14/55,22.00%,FXN;ERFE;CYB561A3;BMP6;SMAD4;CCDC115;ACO1;ALAS2;CAND1;NUBP1;FRRS1;ATP6V0A2;SOD1;NEDD8
prerank,inositol phosphate catabolic process (GO:0071545),0.3037140175772283,0.6014878677700158,0.8828571428571429,1.0,1.0,4/12,20.91%,OCRL;INPP5B;PTEN;INPP5A
prerank,detection of mechanical stimulus (GO:0050982),0.2919646899270578,0.6012067703255127,0.8873812754409769,1.0,1.0,7/19,22.36%,PKD2L2;PIEZO1;LHFPL5;PKD2;CSRP3;PIEZO2;PKD1L2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.25120262024117085,0.6012028924453738,0.9521871820956256,1.0,1.0,21/121,16.57%,ANGPT4;KIT;PRNP;BMP6;IL18;EFNA1;ENPP2;EPHA4;CD80;ANGPT1;NOX4;AGT;PARP9;CNTF;IL31RA;ITGA5;CD44;UNC119;SRC;TP53;TNK2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2733618056864304,0.6000455680084897,0.8936959208899876,1.0,1.0,3/28,10.43%,ARHGAP28;ARHGAP18;ARHGAP35
prerank,regulation of endothelial cell migration (GO:0010594),0.25566982605740024,0.5986754314826714,0.946652719665272,1.0,1.0,16/85,15.59%,ATOH8;ANGPT4;ROCK2;GPI;ANXA3;ADAMTS9;ANGPT1;AGT;SVBP;PIK3CB;RAC1;RRAS;PRKCA;PRKD1;AAMP;PRKD2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.24791499622776195,0.5986007832043845,0.9396110542476971,1.0,1.0,13/117,13.65%,ALDH8A1;ECHDC3;PTGR1;CYP26B1;MTHFD1L;ALDH1A2;BTD;SCPEP1;AGXT;ABAT;HOGA1;ACOT2;PANK2
prerank,positive regulation of vascular permeability (GO:0043117),0.303391492272981,0.5983659710583243,0.8554744525547445,1.0,1.0,4/12,17.60%,BMP6;ANGPT1;TJP2;TRPV4
prerank,glycosaminoglycan metabolic process (GO:0030203),0.25631991303897494,0.5983326065247424,0.9031556039173014,1.0,1.0,7/54,10.90%,HPSE;GPC6;SLC35D2;B4GALT7;HAS1;SDC1;HS2ST1
prerank,ubiquinone metabolic process (GO:0006743),0.29797009752773485,0.5983055139361422,0.8940217391304348,1.0,1.0,2/15,7.08%,AIFM2;COQ10B
prerank,mononuclear cell differentiation (GO:1903131),0.27831275396186317,0.5979695781901752,0.8808933002481389,1.0,1.0,8/24,23.36%,IKZF1;TRPM2;IL31RA;AXL;RELB;THOC5;MYH9;IRF8
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2513657269900759,0.5976141666101084,0.9596774193548387,1.0,1.0,14/136,13.72%,SETD6;TRIM37;PAXIP1;RB1;DAP;TAF3;PRNP;TCF7L2;ARRB1;PIM1;PYDC1;HDAC2;ITCH;BTRC
prerank,positive regulation of calcium ion import (GO:0090280),-0.23184980156068752,-0.597512416812154,0.9288025889967637,0.9762956365176155,1.0,1/12,4.17%,PDGFRB
prerank,positive regulation of exocytosis (GO:0045921),0.26339311903067,0.5970704522918258,0.8751458576429405,1.0,1.0,10/35,21.88%,STXBP5;STAM;SDC1;SYTL4;SMPD3;CLASP1;RAB3A;SDC4;SNCA;PDCD6IP
prerank,gonad development (GO:0008406),0.26151962353951247,0.5967119357930519,0.9061085972850679,1.0,1.0,3/41,6.05%,KIT;WNT2B;MKKS
prerank,positive regulation of dendrite development (GO:1900006),0.3060893340522016,0.596526746267706,0.8801213960546282,1.0,1.0,4/10,23.13%,ZDHHC15;COBL;BMP5;DAB2IP
prerank,negative regulation of ATP metabolic process (GO:1903579),0.2872721501430517,0.5965075652598743,0.896,1.0,1.0,1/17,2.99%,PFKFB1
prerank,NAD biosynthetic process (GO:0009435),0.28225461220378095,0.5959536558517154,0.8913043478260869,1.0,1.0,8/20,25.15%,NADSYN1;PARP9;NAPRT;NMNAT1;PTGIS;NMNAT2;QPRT;NMNAT3
prerank,regulation of fatty acid oxidation (GO:0046320),0.2853542356037031,0.5959514997939316,0.8890410958904109,1.0,1.0,3/16,14.31%,APPL2;SOX9;ACADL
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2900572534242121,0.5952691093218709,0.8849315068493151,1.0,1.0,1/16,2.76%,MOV10
prerank,regulation of protein kinase B signaling (GO:0051896),0.24837269122162375,0.5947997405801005,0.9719157472417251,1.0,1.0,28/193,16.14%,HPSE;FGFR4;FGFR2;IAPP;KIT;PHLPP2;FRS2;XDH;TCF7L2;IL18;PDGFRA;TXN;CD80;ANGPT1;OSBPL8;PIK3CB;PPP2R5C;TGFBR1;GAB1;RAC1;RRAS;PDPK1;ITGB1;RAMP3;PLEKHA1;SRC;PPP2R5B;PTEN
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.2615544053586191,0.5945867762086217,0.9166666666666666,1.0,1.0,6/46,10.81%,PRKDC;TCF7L2;IL18;MFN2;ELN;RBPMS2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.22805643017868232,-0.5945716519762462,0.924924924924925,0.9769333662965018,1.0,1/12,8.02%,PRKCQ
prerank,homotypic cell-cell adhesion (GO:0034109),0.2665190131440514,0.5945653667638678,0.906392694063927,1.0,1.0,12/39,22.88%,PDGFRA;PIK3CB;TLN1;TJP2;CLIC1;STXBP1;FERMT3;METAP1;UBASH3B;FLNA;VCL;MYH9
prerank,regulation of interferon-alpha production (GO:0032647),0.27543004105823193,0.5944749628792726,0.8843710292249047,1.0,1.0,7/23,23.57%,DHX9;SETD2;PTPRS;MAVS;HAVCR2;TLR7;RIPK2
prerank,regulation of vasculogenesis (GO:2001212),0.293106351991684,0.5941661392055391,0.8819444444444444,1.0,1.0,3/14,13.44%,XDH;RRAS;HEY2
prerank,myeloid cell differentiation (GO:0030099),0.25935981107938944,0.5939161062314187,0.9052396878483835,1.0,1.0,11/47,19.41%,KIT;DYRK3;IKZF1;PTPN2;TAL1;ATP5IF1;KAT6A;ALAS2;RUNX1;SLC25A5;ZFPM1
prerank,response to glucose (GO:0009749),0.26336396943036317,0.593300763762028,0.9134831460674158,1.0,1.0,5/46,9.59%,GCK;TRA2B;TCF7L2;EIF2B1;ZBTB20
prerank,regulation of ATP biosynthetic process (GO:2001169),0.28932137808794756,0.5930540422444528,0.8798882681564246,1.0,1.0,1/16,2.84%,ATPSCKMT
prerank,regulation of lymphocyte activation (GO:0051249),0.30119271814187065,0.5930298061703108,0.8952513966480447,1.0,1.0,12/12,69.90%,KAT2A;SIT1;CD4;CD19;LCK;CRTAM;CCL5;THEMIS2;IKZF3;LAT;DCAF15;PAG1
prerank,positive regulation of neuron death (GO:1901216),0.26581260652865457,0.5926776780765092,0.9249146757679181,1.0,1.0,5/46,9.55%,GSK3B;PRNP;MAPT;FOXO3;PICALM
prerank,B cell differentiation (GO:0030183),0.26547607666990386,0.5925544260419735,0.9125560538116592,1.0,1.0,6/46,15.43%,FNIP1;KIT;PTPN2;ADAM17;ITGB1;DCAF1
prerank,receptor clustering (GO:0043113),0.273459403336724,0.5922981604674573,0.9076923076923077,1.0,1.0,3/27,7.48%,ITGB7;MUSK;SCRIB
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.29479536191706524,0.5912141781143564,0.9083333333333333,1.0,1.0,2/16,6.07%,PIGN;PIGA
prerank,regulation of protein modification process (GO:0031399),0.2608571592104051,0.5906785505331621,0.9139664804469274,1.0,1.0,9/50,16.09%,PHIP;FNIP1;PML;ATG7;PLXNB2;SPRED1;PIN1;SESN2;SPRED2
prerank,axon guidance (GO:0007411),0.24699804466634506,0.5905776988432534,0.975975975975976,1.0,1.0,35/201,15.48%,SPTA1;GLI2;ARTN;NCAM1;ALCAM;SPTB;NTN1;NFIB;FRS2;CXCR4;NTN3;EFNA1;EPHA4;DOK2;ROBO1;DSCAML1;PIK3CB;ARHGAP35;PLXNB2;GAB1;PLXNB1;EFNB1;DSCAM;EZR;RAC1;EMB;PRKCA;NOTCH2;PLXND1;EFNB2;PTPRA;SEMA3D;SRC;GDNF;NTN4
prerank,brain morphogenesis (GO:0048854),0.30153010293082294,0.5905390456921764,0.8797101449275362,1.0,1.0,3/12,16.14%,MKKS;FBXW11;PTEN
prerank,negative regulation of mitochondrion organization (GO:0010823),0.26946496342038295,0.5903816377365487,0.9088699878493317,1.0,1.0,3/33,5.53%,FXN;IAPP;MAPT
prerank,regulation of neurotransmitter secretion (GO:0046928),0.271738686345186,0.5901857013702402,0.9024676850763808,1.0,1.0,4/32,8.29%,GSK3B;FMR1;VPS18;LRRK2
prerank,nitric oxide biosynthetic process (GO:0006809),0.29367494772479963,0.590077316030481,0.8857545839210155,1.0,1.0,2/13,10.02%,NQO1;CYB5B
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2678037844356484,0.5893936944492804,0.9049382716049382,1.0,1.0,7/32,19.53%,EIF4E;FOXO3;ROCK1;PICALM;METAP1;TMED10;PRKCD
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.30554858147125286,0.5893934883134042,0.9028400597907325,1.0,1.0,10/10,69.46%,CEP250;TULP1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.30554858147125286,0.5893934883134042,0.9028400597907325,1.0,1.0,10/10,69.46%,CEP250;TULP1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4
prerank,establishment of protein localization to extracellular region (GO:0035592),0.26504474849614096,0.5893085946222693,0.9138533178114087,1.0,1.0,10/39,21.50%,STEAP3;RAB10;SVBP;ABCA1;MIA3;RAB13;TMEM167A;RAB3A;RAB8B;PPY
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.2573681764571019,0.5887432830313913,0.8990719257540604,1.0,1.0,10/38,19.80%,PRNP;EFNA1;EPHA4;NOX4;AGT;NCK2;UNC119;MVP;SH3BP5;PTPN1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.17534093788639138,-0.588442725565392,0.9836956521739131,0.9790480952577699,1.0,10/31,35.43%,TLR4;HSPD1;LGALS9;TIRAP;SYK;LAPTM5;PLCB1;CD40;CCL19;IRF5
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.26730595979147054,0.5883168254611457,0.8926417370325693,1.0,1.0,3/29,11.40%,FGFR2;TGFBR3;BMP2
prerank,negative regulation of ATPase activity (GO:0032780),0.2883355953322636,0.5883133580290307,0.8920056100981767,1.0,1.0,3/16,15.83%,PXK;ATP5IF1;TP53
prerank,cellular response to interleukin-1 (GO:0071347),0.2462281312324877,0.5877842666961162,0.9676113360323887,1.0,1.0,42/143,24.77%,HYAL1;PSMC2;PSMD5;MYLK3;TAB1;UBE2N;PSMB1;PSMD14;MAP3K3;PSMD1;IKBKG;PSMB9;FBXW11;SOX9;BTRC;RC3H1;PSMC6;NFKB1;SFRP1;SIRPA;CD47;PSMB2;MAP3K8;PTGIS;PSME4;PSMB7;PSMD11;TRAF6;PSME3;TANK;RBMX;IKBKB;PSMD13;PSMB8;PSMD4;DAB2IP;CCL14;RIPK2;PSMF1;PSMA5;RELA;PSMC3
prerank,regulation of response to external stimulus (GO:0032101),0.24798071529435387,0.587604812627942,0.963265306122449,1.0,1.0,24/121,18.46%,SETD6;USP18;ADGRA2;STK24;CXCR4;AKNA;PDGFRA;IRF1;NMT2;NLRP6;ANXA1;APPL2;DAGLB;CASP8;BRD4;XIAP;TRIM5;EFNB2;IL1RL2;FOXP1;LACC1;METAP1;USP14;FNTB
prerank,nitric oxide metabolic process (GO:0046209),0.2899641369854357,0.587543224506979,0.8966480446927374,1.0,1.0,2/14,10.02%,NQO1;CYB5B
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.2581847671009567,0.5875103303771432,0.9132882882882883,1.0,1.0,6/43,14.20%,BMPR1A;IL18;MFN2;RBPMS2;GJA1;ADAMTS1
prerank,pigment granule transport (GO:0051904),0.2799085334254553,0.5872472130196017,0.9055851063829787,1.0,1.0,3/18,13.82%,MKKS;MLPH;BLOC1S5
prerank,melanosome transport (GO:0032402),0.2799085334254553,0.5872472130196017,0.9055851063829787,1.0,1.0,3/18,13.82%,MKKS;MLPH;BLOC1S5
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.20906186269694324,-0.5865698360147302,0.9520295202952029,0.9790932002632158,1.0,7/16,41.00%,PTPN22;TNFRSF1B;FGF10;SOX11;TNFSF8;IL27;LST1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.19032575820799427,-0.5862292282039754,0.9539748953974896,0.9784412890521726,1.0,13/20,38.47%,HSP90AB1;HSPD1;CCT2;PSMG2;PSMG1;NDUFAF1;BBS12;HOPX;TMEM35A;PFDN6;HSPA1A;PTGES3L;PTGES3
prerank,response to peptide hormone (GO:0043434),0.2556456763785765,0.5860807775167758,0.9010356731875719,1.0,1.0,6/43,11.47%,ROCK2;EIF2B1;TGFBR3;ZBTB7B;ROCK1;ANXA1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.2719186924723821,0.5859451942757707,0.8904282115869018,1.0,1.0,6/26,15.09%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP
prerank,regulation of endocytosis (GO:0030100),0.25193703861803063,0.5858642738421599,0.9229934924078091,1.0,1.0,12/61,17.06%,STON1;PACSIN2;STON2;ZFYVE16;MTMR2;ROCK1;PICALM;SNX33;PRKD1;SMPD1;SRC;EPHA3
prerank,multivesicular body assembly (GO:0036258),0.26502498570417565,0.5858059975044596,0.9047044632086851,1.0,1.0,4/30,10.88%,VPS37B;VPS37A;STAM;VTA1
prerank,cAMP-mediated signaling (GO:0019933),0.27381915180380073,0.5857126053982469,0.896551724137931,1.0,1.0,6/24,18.32%,KSR1;AHR;PDE7B;SOX9;ADCY2;PDE7A
prerank,regulation of mast cell degranulation (GO:0043304),-0.20999270245806517,-0.5851089037124798,0.944078947368421,0.9781683909609163,1.0,7/14,31.58%,LYN;LGALS9;CD84;CD300A;SYK;FES;SPHK2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.2585186553299938,0.5847386616819543,0.9065628476084538,1.0,1.0,9/46,15.27%,RB1;ADAMTS5;ALDH1A1;NPR3;RBPJ;ADAM17;DOCK7;STK11;TLE3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.26668937676180754,0.5846277828382489,0.9068396226415094,1.0,1.0,6/33,13.17%,TCF7L2;SERPINE1;YAP1;ANGPT1;PDPK1;CAST
prerank,modulation by symbiont of entry into host (GO:0052372),0.2889170700672094,0.5845372407660714,0.9045643153526971,1.0,1.0,3/16,14.23%,TRIML2;TRIM6;TRIM5
prerank,steroid hormone biosynthetic process (GO:0120178),0.26320283709493875,0.5841165616940963,0.9216867469879518,1.0,1.0,5/29,15.93%,SRD5A3;MED1;FDXR;STARD3;DHCR7
prerank,chondroitin sulfate catabolic process (GO:0030207),0.2962313402713629,0.5835564386788786,0.8973607038123167,1.0,1.0,3/13,17.35%,HYAL1;BGN;ARSB
prerank,establishment of melanosome localization (GO:0032401),0.2761551588383212,0.5830061906551078,0.9053876478318003,1.0,1.0,4/19,17.50%,MKKS;MLPH;BLOC1S5;SHROOM2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.2782246296664429,0.5829728178943353,0.8992042440318302,1.0,1.0,2/20,7.87%,SULF2;SULF1
prerank,negative regulation of developmental growth (GO:0048640),0.26173833171069805,0.5824356776688322,0.9009546539379475,1.0,1.0,11/30,25.93%,RTN4R;PTPRS;ULK2;CDKN1B;NKD1;PTEN;DIP2B;WWC2;DUSP10;SLC6A4;RTN4
prerank,activation of phospholipase C activity (GO:0007202),0.2712064984743197,0.5821580967994539,0.9027946537059538,1.0,1.0,3/29,10.41%,LPAR1;GNAQ;ARHGAP6
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.24470476848329267,0.5821435669105206,0.9505664263645726,1.0,1.0,39/109,24.77%,PSMC2;PSMD5;TAB1;MAP3K1;VAV2;PPP3CA;PSMB1;PSMD14;PSMD1;IKBKG;PIK3CB;PSMB9;RAC1;FBXW11;PDPK1;BTK;BTRC;PSMC6;NFKB1;PPP3R1;PSMB2;PSME4;PSMB7;NFATC3;PSMD11;TRAF6;PSME3;FER;IKBKB;PSMD13;PSMB8;GAB2;PSMD4;BCL10;PSMF1;PPP3CB;PSMA5;RELA;PSMC3
prerank,protein targeting to membrane (GO:0006612),0.24841207420243894,0.5820171610413549,0.9416666666666667,1.0,1.0,25/83,22.93%,VPS37B;MYO1C;VPS37A;ARL6IP1;SRPRA;ZDHHC18;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;SLC25A17;PIKFYVE;CHMP4A;CHMP4B;TRAM1;PEX12;ZDHHC24;ICMT;RAB8B;PEX13;VPS37C;ZDHHC2;ZDHHC14
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.29720060256088365,0.5815000331850769,0.9059701492537313,1.0,1.0,10/10,70.30%,GNB1;GRK1;CNGA1;GNAT1;RHO;PDE6B;PDE6G;CNGB1;PDE6A;SAG
prerank,regulation of response to biotic stimulus (GO:0002831),0.26479005105283726,0.5812086021873607,0.9175891758917589,1.0,1.0,10/28,24.21%,IRF1;APPL2;CASP8;XIAP;TRIM5;FOXP1;APPL1;BIRC2;ELMOD2;FGR
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.24117985279683113,0.5810821350624865,0.9452479338842975,1.0,1.0,14/90,14.31%,MFAP2;LEPR;CXCR4;IL18;ZBTB7B;MFN2;ALMS1;APPL2;ACHE;GJA1;ADIPOR1;ADRB2;CPT2;ACADL
prerank,positive regulation of insulin secretion (GO:0032024),0.262371429746335,0.5810049150066311,0.9054373522458629,1.0,1.0,8/36,18.34%,GCK;TCF7L2;MCU;TRPM4;AACS;C2CD2L;NLGN2;BAD
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.19010191500462076,-0.5809062003288742,0.9683794466403162,0.9792847921885122,1.0,2/20,9.30%,AKR1B1;FDX1
prerank,circulatory system development (GO:0072359),0.24382015317876726,0.5805960154241019,0.960285132382892,1.0,1.0,26/118,19.41%,GLI2;FBN1;BCOR;SRF;PDLIM4;MKKS;WDR11;FBXW7;TGFBR1;CACNA1C;BMP2;PDLIM5;SOX9;CASP8;HEY2;FOXL1;CDKN1B;STK11;PKD2;PTEN;HSPG2;SALL1;SH3PXD2B;OSR1;ZFPM2;ZFPM1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.249246453559676,0.5802040947085353,0.9314917127071823,1.0,1.0,8/57,15.63%,KIT;PTPN2;IL18;PARP9;CNTF;IL31RA;CNOT7;NF2
prerank,protein insertion into ER membrane (GO:0045048),0.2574413033950064,0.5799418724953398,0.9228998849252014,1.0,1.0,11/37,21.74%,PRNP;EMC7;TRAM2;EMD;VAPA;CYB5A;EMC8;TRAM1;CCDC47;EMC4;VAMP2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.28202580061726445,0.5798102390286385,0.8937007874015748,1.0,1.0,7/18,20.21%,B4GALT7;EMD;MORC3;TP53;SFRP1;SKI;MED25
prerank,negative regulation of catabolic process (GO:0009895),0.25259307233767214,0.5794050317298073,0.925638179800222,1.0,1.0,10/47,22.09%,PFKFB1;MDM4;PDE3B;SF3B3;PIN1;AZIN1;FMN2;HDAC4;SIRT2;FLNA
prerank,oxoacid metabolic process (GO:0043436),0.2639035350245463,0.5793408433708195,0.9089775561097256,1.0,1.0,6/27,20.67%,PPA1;AGXT;ENPP1;THAP4;BPNT1;DDO
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.2917797563093044,0.5787170248816926,0.9084302325581395,1.0,1.0,3/11,20.46%,AHR;IL4I1;CEACAM1
prerank,regulation of neutrophil migration (GO:1902622),0.2985656561459852,0.5785979597247917,0.9081779053084649,1.0,1.0,2/10,22.90%,RAC1;RHOH
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2864563073001196,0.5776381871206563,0.901018922852984,1.0,1.0,5/14,24.82%,YBX3;ANGEL2;MAPK14;MAPKAPK2;HNRNPC
prerank,positive regulation of cell projection organization (GO:0031346),0.24283570267569177,0.5774002775974124,0.9633401221995926,1.0,1.0,28/115,19.67%,SETX;RHOA;OBSL1;CUX1;CAPRIN1;ROBO1;MARK2;CAMK1D;ARHGAP35;PLXNB2;PLXNB1;GRIP1;TWF1;P3H1;DPYSL3;ROR1;PLXND1;PRKD1;PRKCI;MAP6;STMN2;NGF;EPHA3;ARSB;PLXNA2;CAPRIN2;AMIGO1;PLXNB3
prerank,positive regulation of stem cell differentiation (GO:2000738),0.28558105608832596,0.5763577745293718,0.8929503916449086,1.0,1.0,2/16,12.56%,SOX6;SOX9
prerank,cellular amide metabolic process (GO:0043603),0.24129620438895683,0.5762869458607834,0.9516460905349794,1.0,1.0,21/102,21.53%,MTHFD1L;DNPEP;NLN;BTD;MTHFR;CPXM1;SLC19A1;PLPP1;DHFR;ACOT2;PANK2;SMPD1;ST3GAL1;ABHD4;SMPD3;SMPD2;MTHFS;MIPEP;ACOT8;ORMDL2;NAAA
prerank,protein polyglutamylation (GO:0018095),0.29058493772484806,0.5760858695440696,0.9151079136690647,1.0,1.0,2/11,12.26%,TTLL4;TTLL11
prerank,JNK cascade (GO:0007254),0.2517234874641038,0.5760270831958836,0.9219288174512055,1.0,1.0,6/40,11.25%,MAP4K2;SH2D3C;TAB1;UBE2N;IKBKG;CRKL
prerank,positive regulation of immune system process (GO:0002684),0.2804261549993428,0.5747647278062863,0.893387314439946,1.0,1.0,3/16,14.42%,PIK3CB;ANXA1;MIA3
prerank,sphingolipid catabolic process (GO:0030149),0.2776467686161631,0.5746713968131948,0.912621359223301,1.0,1.0,5/15,21.10%,ENPP2;SMPDL3A;SMPD1;SMPD2;PDXDC1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2720997182005315,0.5746027891072744,0.8979328165374677,1.0,1.0,4/22,12.85%,DDX39B;LEO1;SCAF8;BRD4
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2405661073476843,0.5733454354956914,0.9454926624737946,1.0,1.0,14/68,20.62%,HPRT1;ACAT1;EFL1;LRRK2;RHOQ;HINT1;ENPP1;GNAI3;ACOT2;MFN1;BPNT1;BAD;ADSS2;ACOT8
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.25594308422719675,0.5722590998832903,0.923699421965318,1.0,1.0,8/40,19.47%,BMF;FXN;FAM162A;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,manganese ion transport (GO:0006828),0.28513676883925665,0.5717806151366474,0.9085714285714286,1.0,1.0,5/14,23.20%,TRPC7;SLC39A8;SLC30A10;TMEM165;SLC11A2
prerank,response to lipid (GO:0033993),0.2383967983752802,0.5715644000084743,0.9660493827160493,1.0,1.0,12/105,13.08%,HMGB2;CDKN2D;FGFR4;ASXL1;FOXO3;SMAD6;ANXA1;ADAM17;TRIM6;SOX9;MAPKAPK3;CTSH
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.24496417374772078,0.5715419674441389,0.9368770764119602,1.0,1.0,11/54,16.94%,KCNN4;NEDD4;KCNMB2;KCNMB3;KCNIP3;DLG1;CAB39;KCNMB4;STK39;GABBR2;DPP6
prerank,mitochondrion morphogenesis (GO:0070584),-0.22614943951304955,-0.5714474751098036,0.9423076923076923,0.9824464223664634,1.0,7/11,42.60%,FIS1;SUPV3L1;SLIRP;MYH14;NUBPL;MFF;PID1
prerank,lymphocyte differentiation (GO:0030098),0.24809627043380156,0.5713413783168061,0.9314775160599572,1.0,1.0,12/68,19.35%,KIT;NFIL3;IKZF1;LEPR;PTPN2;LMBR1L;ADAM17;ITGB1;DCAF1;AXL;RELB;SLC25A5
prerank,metal ion export (GO:0070839),0.2577581281952671,0.5706474787719416,0.9105392156862745,1.0,1.0,1/31,2.10%,ATP2B4
prerank,regulation of hormone secretion (GO:0046883),-0.2023611010676516,-0.5703207474574299,0.9629629629629629,0.9820880772120211,1.0,6/15,33.27%,VAMP3;SCG5;EDN1;SOX11;EDN3;SNX6
prerank,regulation of transforming growth factor beta production (GO:0071634),0.2748149271948745,0.5700312617909191,0.9099590723055935,1.0,1.0,5/18,18.60%,SMAD4;SMAD3;ITGAV;ITGB8;LTBP1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.2769291174115329,0.5696094936227454,0.9151599443671766,1.0,1.0,2/15,9.50%,RAB10;SRPRA
prerank,transcription preinitiation complex assembly (GO:0070897),0.2836022980219509,0.5689786382459845,0.920114122681883,1.0,1.0,4/12,21.65%,TAF12;DR1;GTF2B;GTF2A2
prerank,positive regulation of interferon-beta production (GO:0032728),0.25695618881511023,0.568768090426895,0.9109026963657679,1.0,1.0,11/33,23.88%,DHX9;IRF1;RIOK3;POLR3D;MAVS;ISG15;POLR3C;POLR3G;TLR7;RIPK2;HSP90AA1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.27080551536743025,0.5684774234070382,0.9100126742712294,1.0,1.0,5/21,18.54%,CGNL1;MFN2;MAPKAP1;RASAL3;LZTR1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2579505768095998,0.5681319357941844,0.9289099526066351,1.0,1.0,5/32,13.15%,POLR1A;POLR1B;ERCC3;TAF1D;POLR1G
prerank,actin-myosin filament sliding (GO:0033275),0.2583290362095645,0.5679056988550084,0.911318553092182,1.0,1.0,4/38,16.49%,TPM4;MYH2;DES;TNNT3
prerank,muscle filament sliding (GO:0030049),0.2583290362095645,0.5679056988550084,0.911318553092182,1.0,1.0,4/38,16.49%,TPM4;MYH2;DES;TNNT3
prerank,regulation of macroautophagy (GO:0016241),0.2398322970712243,0.5675902348571297,0.9582909460834181,1.0,1.0,21/105,17.75%,EXOC4;NEDD4;TBC1D25;QSOX1;SH3GLB1;LARP1;LRRK2;IKBKG;SESN1;RB1CC1;GNAI3;SLC38A9;EXOC8;SNX32;RPTOR;PRKAG1;CLEC16A;SESN2;VPS26A;LAMTOR3;LAMTOR5
prerank,positive regulation of interleukin-8 production (GO:0032757),0.24446768832286148,0.5674975832819423,0.9370165745856354,1.0,1.0,8/49,18.73%,FADD;SERPINE1;HMGB1;RAB1A;PRKD2;MAVS;LAMTOR5;RIPK1
prerank,negative regulation of ion transport (GO:0043271),0.26775145970776876,0.5669560035740211,0.9161451814768461,1.0,1.0,3/24,10.04%,NEDD4;WNK1;PXK
prerank,oligodendrocyte development (GO:0014003),0.27528414502899884,0.5658893700181961,0.8968926553672316,1.0,1.0,3/15,15.18%,EIF2B1;TPPP;PRDM8
prerank,pyruvate metabolic process (GO:0006090),0.24002728836556902,0.5655047980315476,0.9221357063403782,1.0,1.0,5/52,11.77%,PFKFB1;GCK;GPI;PGM1;HOGA1
prerank,Rap protein signal transduction (GO:0032486),0.29242782024375796,0.5651194986782373,0.9039039039039038,1.0,1.0,2/10,13.86%,RAP2A;PLK2
prerank,carbohydrate homeostasis (GO:0033500),0.2458959184902549,0.5650758756965728,0.939297124600639,1.0,1.0,12/67,18.53%,FGFR4;GCK;LEPR;PTPN2;TCF7L2;MCU;APPL2;ADIPOR1;STK11;BAD;SLC2A4;HECTD4
prerank,multivesicular body organization (GO:0036257),0.2547380251745455,0.5646695104762145,0.9280575539568345,1.0,1.0,4/31,10.88%,VPS37B;VPS37A;STAM;VTA1
prerank,regulation of axon guidance (GO:1902667),0.29227712621556534,0.5646294935732058,0.9114331723027376,1.0,1.0,1/10,4.59%,MYCBP2
prerank,metanephric mesenchyme development (GO:0072075),0.2963339923550542,0.5639983013232001,0.9164086687306502,1.0,1.0,3/10,19.04%,PKD2;OSR1;WNT4
prerank,protein lipidation (GO:0006497),0.24208464111945038,0.5632868034231021,0.9358974358974359,1.0,1.0,18/59,22.93%,PIGN;PIGA;ATG7;PORCN;ZDHHC18;PIGU;ZDHHC15;HHAT;PIGM;ZDHHC3;ZDHHC21;UGCG;DPM3;PIGG;PIGH;ATG5;ZDHHC2;ZDHHC14
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.25445449823690713,0.5630361475780699,0.9274193548387096,1.0,1.0,6/39,18.34%,GCK;TCF7L2;MCU;AACS;NLGN2;BAD
prerank,regulation of actin filament polymerization (GO:0030833),0.24152066814010825,0.5630334371126116,0.939873417721519,1.0,1.0,17/69,22.50%,ARHGAP28;ARHGAP18;SSH2;CDC42EP2;NCK1;TWF1;NCK2;BAIAP2L1;PRKCE;DBN1;NCKAP1;PRKCD;FER;LATS1;VASP;LMOD1;SNX9
prerank,amino acid transmembrane transport (GO:0003333),0.24269805486769372,0.5629389527635664,0.9417040358744395,1.0,1.0,11/45,21.72%,SLC38A7;TSPO2;SLC38A4;SLC16A2;SLC38A9;SLC25A22;SLC36A4;SLC7A1;SLC38A2;SLC7A11;SLC6A13
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.260296912459121,0.562822042494386,0.9247448979591837,1.0,1.0,4/23,12.72%,NMI;UACA;CCN3;ADIPOR1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2558402488447309,0.5624511349940315,0.9304029304029304,1.0,1.0,6/28,17.29%,FGFR4;RAC1;ADIPOR1;MED1;SIRPA;CD47
prerank,cellular response to oxygen-containing compound (GO:1901701),0.23576046613004115,0.5623322139625723,0.996,1.0,1.0,51/291,18.35%,HMGB2;AQP1;ATP2B4;SETX;TICAM1;ROCK2;RHOA;ABCB4;MAPT;LCOR;PDGFRA;CDK2;SERPINE1;CD80;AGAP3;HTRA2;WNT6;HMGB1;P2RY1;IP6K2;AHR;EZR;AKAP9;WNT9A;SOX9;DMTN;SLC38A9;RORA;PRKD1;ADAM9;GLRA2;RUVBL2;RAMP3;RPTOR;ADCY6;PKD2;NFKB1;IPO5;LPL;SESN2;SFRP1;LARS1;LAMTOR3;AXL;PTPRK;EPHA3;SIRPA;LAMTOR5;DPEP1;MAPK14;PLAA
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.21617337899352282,-0.5620907390025454,0.93993993993994,0.9843826007053476,1.0,8/11,48.20%,BCL2;TAF9B;CD74;MIF;TAF9;TRIAP1;MUC1;SIRT1
prerank,regulation of neuron projection development (GO:0010975),0.2345982200079279,0.5619975948986344,0.9768844221105528,1.0,1.0,38/163,18.67%,ULK4;SETX;GSK3B;RTN4R;LPAR1;EPHA4;RAB29;LRRK2;MARK2;DENND5A;CAMK1D;ARHGAP35;LZTS3;PLXNB2;TWF1;PTPRS;BAG5;GAK;P3H1;PDLIM5;ZDHHC15;HDAC2;DPYSL3;ROR1;PRKD1;PRKCI;EFNB2;ADCY6;DBN1;PTEN;STMN2;SIPA1L1;EPHA3;ARSB;TRPV4;ABI2;MYLIP;TANC2
prerank,histone H3-K36 demethylation (GO:0070544),0.2951172705435573,0.5612145104581057,0.9158878504672897,1.0,1.0,3/10,21.63%,KDM2B;KDM4B;KDM2A
prerank,protein kinase B signaling (GO:0043491),0.26403120516393386,0.5610753693772301,0.9308578745198464,1.0,1.0,1/23,2.65%,SETX
prerank,regulation of urine volume (GO:0035809),0.2916700544476084,0.5609813736821486,0.9266467065868264,1.0,1.0,2/10,15.11%,NPR3;ADCY6
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.2410968985700488,0.5608562164655386,0.9338478500551268,1.0,1.0,9/54,15.59%,ATP2B4;ANGPT4;ANGPT1;HMGB1;PRKCA;PDPK1;ADAM17;PRKD1;PRKD2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.24867315715649402,0.5607135460196994,0.936,1.0,1.0,10/41,22.09%,KCNN4;PDZK1;KCNMB2;KCNMB3;KCNMB4;GABBR2;AMIGO1;ANK3;GNB1;FLNA
prerank,regulation of cell communication (GO:0010646),0.2511916079391605,0.5606918240366247,0.9130434782608695,1.0,1.0,12/35,23.74%,NCLN;GRK5;SLC8A1;ANXA1;TBX18;GRK3;VEPH1;PTPN1;UGCG;CDC42SE2;CXADR;CRK
prerank,AMP metabolic process (GO:0046033),0.2744991289016069,0.5604914196959933,0.9390581717451524,1.0,1.0,2/13,11.44%,XDH;ADSL
prerank,fatty acid metabolic process (GO:0006631),0.23337080644447394,0.5603957616832524,0.9726166328600405,1.0,1.0,11/115,15.77%,PON1;ECHDC3;LPIN2;NDUFAB1;ACACA;ADIPOR1;ACOT2;ELOVL4;CPT2;PON2;LPL
prerank,positive regulation of neurogenesis (GO:0050769),0.24077945623431488,0.560231096864421,0.9431578947368421,1.0,1.0,15/68,19.67%,NAP1L1;RHOA;OBSL1;CUX1;CAPRIN1;ROBO1;PLXNB2;PLXNB1;PLXND1;MAP6;NGF;PLXNA2;CAPRIN2;AMIGO1;PLXNB3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.25445845972132486,0.5598857000449806,0.8947368421052632,1.0,1.0,8/28,20.27%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP;LACC1;TRAF6
prerank,positive regulation of myelination (GO:0031643),-0.22796234797693354,-0.5592707189498939,0.9608433734939759,0.9846106574070375,1.0,3/11,15.09%,TNFRSF1B;TENM4;DICER1
prerank,positive regulation of lipid transport (GO:0032370),0.2829699132062411,0.5592612573129212,0.9046920821114369,1.0,1.0,1/12,4.57%,ABCB4
prerank,triglyceride metabolic process (GO:0006641),0.24237665674090442,0.5591463457040411,0.9322033898305084,1.0,1.0,6/48,17.79%,FABP12;LPIN2;AGMO;LPL;GK5;GK
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.24685242702333834,0.5584128258921135,0.9334098737083811,1.0,1.0,6/40,12.96%,MAPT;STOML2;PYCR1;LRRK2;STOX1;ATP5IF1
prerank,dendrite self-avoidance (GO:0070593),0.27458672651266325,0.5579805089289093,0.8949522510231923,1.0,1.0,3/16,11.81%,DSCAML1;DSCAM;EMB
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.26625510017007786,0.5579407173623202,0.9168975069252078,1.0,1.0,8/17,26.94%,BMP6;PRKCA;TRIM5;TRIB1;NFKBIL1;SASH1;CD55;LY96
prerank,organophosphate biosynthetic process (GO:0090407),0.2530436256192426,0.5578774002682461,0.9218009478672986,1.0,1.0,10/37,20.46%,LPCAT1;IPMK;PPIP5K1;TKT;IP6K2;AGPAT3;GK5;GK;GPHN;MOCOS
prerank,regulation of histone methylation (GO:0031060),0.27836715611955487,0.556568220090873,0.9170182841068917,1.0,1.0,1/13,5.67%,MTHFR
prerank,neutrophil degranulation (GO:0043312),0.23250054705794368,0.5554270204185361,1.0,1.0,1.0,69/425,17.98%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,cellular response to heat (GO:0034605),0.24249840375617232,0.5553721434539637,0.9371362048894063,1.0,1.0,4/35,8.22%,MAPT;RBBP7;TPR;HTRA2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.2231494452893889,-0.5553668711092287,0.9662921348314607,0.985130424475544,1.0,3/10,19.78%,GAP43;PICK1;DGKD
prerank,negative regulation of axonogenesis (GO:0050771),0.2586091297417435,0.5545430923672665,0.9314720812182741,1.0,1.0,4/27,12.24%,RHOA;RTN4R;PTPRS;ULK2
prerank,positive regulation of chemokine production (GO:0032722),0.24085828425123743,0.5542972759325343,0.9349046015712682,1.0,1.0,13/44,27.34%,IL18;HMGB1;ADAM17;TWIST1;LPL;MAVS;EIF2AK2;IL6R;TLR7;MBP;IL33;WNT5A;TLR3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.26141650921579157,0.5534127300528396,0.9143222506393862,1.0,1.0,3/22,14.37%,WNK1;FLOT2;CD44
prerank,neutrophil activation involved in immune response (GO:0002283),0.23165274301560343,0.5529608941268932,1.0,1.0,1.0,69/428,17.98%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2332827405024012,0.5526513027178902,0.9731682146542827,1.0,1.0,17/101,20.27%,HMGB2;TICAM1;RHOA;IL18;SERPINE1;CD80;HMGB1;PRKCE;ADAM9;NFKB1;AXL;SIRPA;MAPK14;PLAA;PDE4B;CD68;TRAF6
prerank,regulation of cellular pH (GO:0030641),0.2519746520728257,0.5524441038763581,0.9383313180169287,1.0,1.0,5/29,17.80%,SLC4A2;SLC9A5;CA2;TM9SF4;LACC1
prerank,negative regulation of macroautophagy (GO:0016242),0.25644337164052516,0.5520374854038922,0.9197452229299363,1.0,1.0,7/26,18.52%,QSOX1;LRRK2;TMEM39A;SCFD1;CLEC16A;CHMP4A;CHMP4B
prerank,adenine nucleotide transport (GO:0051503),0.26909334709944516,0.5519477357328635,0.9364238410596026,1.0,1.0,5/17,19.35%,SLC19A1;SLC25A42;LRRC8C;SLC25A17;SLC25A5
prerank,regulation of cholesterol storage (GO:0010885),0.2719060441706128,0.5517355413924306,0.9207232267037552,1.0,1.0,3/15,15.77%,ABCA1;EHD1;LPL
prerank,positive regulation of interferon-gamma production (GO:0032729),0.24188354493806968,0.5514654938619491,0.9453125,1.0,1.0,3/48,7.48%,FADD;IL18;SCRIB
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2619683410383885,0.5514043912376105,0.9258278145695364,1.0,1.0,2/19,7.49%,DHX9;SETD2
prerank,integrated stress response signaling (GO:0140467),0.2746781321723739,0.5513508031580387,0.930939226519337,1.0,1.0,2/14,11.33%,EIF2AK3;QRICH1
prerank,cell part morphogenesis (GO:0032990),0.27479630489474516,0.5511768958514903,0.9275766016713092,1.0,1.0,4/13,23.38%,PACSIN2;PNPT1;DNM1L;WASF1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.26056463621282666,0.5510765111107969,0.9420849420849421,1.0,1.0,5/22,17.02%,ACAP2;MAPT;EHD1;STMN2;NGF
prerank,positive regulation of phosphorylation (GO:0042327),0.23195354489050998,0.5507122776301211,0.992,1.0,1.0,39/240,15.71%,FNIP1;PFKFB1;ROCK2;FGFR4;FGFR2;KIT;MRE11;LEPR;MUSK;RAP2A;ARRB1;EFNA1;FMR1;PDGFRA;CCN1;EPHA4;LRRK2;AXIN2;ANGPT1;ZBTB20;DDR2;RB1CC1;P2RY1;CRKL;DSCAM;BMP2;RAC1;KCTD20;ADAM17;SOX9;PLAUR;ROR1;SLCO3A1;ARNT;BTBD10;WDFY2;PIN1;FXR1;LMO4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.26713793872997416,0.5505815044931975,0.9191780821917809,1.0,1.0,2/17,9.74%,SERPINE1;HMGB1
prerank,neutrophil mediated immunity (GO:0002446),0.2300431047018225,0.549240188688575,1.0,1.0,1.0,70/432,17.98%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;ADAM17;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.27941409304382664,0.5492376445610403,0.9239598278335724,1.0,1.0,4/12,16.05%,KLF9;CTSH;MED1;BRD8
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.2696240423438126,0.5490829443929883,0.9128630705394191,1.0,1.0,6/15,25.17%,SMPD3;SMPD2;PRKCD;ORMDL2;SIRT3;ORMDL3
prerank,positive regulation of sodium ion transport (GO:0010765),-0.21248527455766808,-0.5490259866128588,0.9840255591054313,0.9865152450171429,1.0,6/12,32.55%,SCN1B;NOS1;SCN4B;PKP2;GPD1L;SCN3B
prerank,regulation of cell differentiation (GO:0045595),0.23227611444787316,0.5475801604891224,0.9859013091641491,1.0,1.0,12/148,11.27%,CDK5RAP2;TCFL5;CBFB;SUZ12;FGFR2;ANP32B;SRF;VHL;ROCK1;TGFBR1;FLOT2;PRKCB
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.27159539283457695,0.5473296141648146,0.9290882778581766,1.0,1.0,5/13,19.67%,PLXNB2;PLXNB1;PLXND1;PLXNA2;PLXNB3
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.25870566017803187,0.5466924044973799,0.9405684754521964,1.0,1.0,4/22,17.80%,TRPM4;TRIM6;BTK;LACC1
prerank,regulation of response to interferon-gamma (GO:0060330),0.27107882942492956,0.546378367199408,0.9380281690140845,1.0,1.0,2/14,10.39%,PTPN2;PARP9
prerank,hexose metabolic process (GO:0019318),0.23992842101221779,0.5460353652714526,0.9444444444444444,1.0,1.0,3/39,8.44%,CHST15;SORD;PGM1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.24068929606530162,0.5453972117866129,0.9478357380688124,1.0,1.0,4/52,10.43%,DDX11;HDGF;SRPRA;TLN1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22957966201965746,0.5451538707665767,0.9691040164778579,1.0,1.0,30/94,24.77%,PSMC2;PSMD5;TAB1;UBE2N;PSMB1;PSMD14;MAP3K3;PSMD1;IKBKG;PSMB9;FBXW11;BTRC;PSMC6;NFKB1;PSMB2;MAP3K8;PSME4;PSMB7;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;PSMD4;RIPK2;PSMF1;PSMA5;RELA;PSMC3
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2223226544528834,-0.5445306339694359,0.9583333333333334,0.9871784396859971,1.0,2/10,23.08%,SREBF2;ABCA2
prerank,regulation of ion transmembrane transport (GO:0034765),0.24320319010624453,0.5442100093672615,0.9456264775413712,1.0,1.0,4/33,11.55%,NEDD4;WNK1;KCNJ13;AKAP9
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.25201561664370836,0.5439850971567508,0.9358353510895884,1.0,1.0,10/28,27.18%,ITPR1;TNFRSF10B;QRICH1;TMEM117;DNAJC10;TRAF2;DAB2IP;BAX;TRIB3;BAG6
prerank,lipid biosynthetic process (GO:0008610),0.23085608616323708,0.543925122495335,0.9598732840549102,1.0,1.0,10/77,15.77%,PAM;LPCAT1;NDUFAB1;AGPS;ACACA;AGPAT3;MVK;ELOVL4;FDXR;LPL
prerank,ovarian follicle development (GO:0001541),0.27574373026849597,0.5436026045860806,0.9365994236311239,1.0,1.0,1/13,4.54%,KIT
prerank,aminoglycan metabolic process (GO:0006022),-0.22484473659547113,-0.5430893126935027,0.9534883720930233,0.9868551210720597,1.0,7/10,36.32%,CHST9;B3GAT2;XYLT2;B3GAT1;CLN6;B3GAT3;B3GALT6
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.21260451454724166,-0.5423417411374198,0.9530791788856305,0.9862947442019396,1.0,2/12,9.30%,AKR1B1;FDX1
prerank,positive chemotaxis (GO:0050918),0.2595486629526107,0.5423031734248528,0.9192462987886945,1.0,1.0,4/17,20.02%,SCRIB;ANGPT1;PLXNB3;SEMA5A
prerank,acylglycerol homeostasis (GO:0055090),0.2600129251013442,0.5417735898677972,0.9292267365661862,1.0,1.0,3/20,15.77%,IL18;RORA;LPL
prerank,macroautophagy (GO:0016236),0.22632631565361935,0.5416897123777372,0.9807302231237323,1.0,1.0,36/118,23.32%,VPS37B;MTMR14;ATG7;VPS37A;STAM;MFN2;LIX1L;ZFYVE1;CSNK2A2;VIPAS39;RB1CC1;VTA1;ILRUN;ATG3;MTMR3;UVRAG;PRKAG1;SRC;MFN1;VPS16;PLAA;CHMP4A;CHMP4B;VPS39;PRKAB1;TOMM40;LIX1;PGAM5;AMBRA1;ATG13;ATG5;VPS37C;PRKAG3;TOMM20;ATG4B;PRKAA2
prerank,Golgi to plasma membrane transport (GO:0006893),0.23583934537676438,0.5411872732474563,0.9348066298342541,1.0,1.0,3/47,4.28%,MACF1;RAB10;EXOC4
prerank,cranial nerve development (GO:0021545),0.2766932395957568,0.5409095419863237,0.9320531757754801,1.0,1.0,11/11,72.35%,SALL1;PAX2;ATOH7;ISL1;TIFAB;POU4F1;TFAP2A;CHRNB2;TMEM126A;ERBB3;CHD7
prerank,cellular protein metabolic process (GO:0044267),0.22569239606921457,0.540879759277606,0.997,1.0,1.0,50/396,16.25%,MRPL36;TGM1;MATN3;F5;UBE2S;LOXL2;LOX;PABPC4;AGO2;GGCX;FBN1;CHEK2;LAMB1;PRKDC;SRBD1;ST8SIA2;SIAH2;MRPL18;STOML2;CCN1;PHKA2;QSOX1;B4GALT7;HTRA2;DARS1;DUSP12;RPN2;MRPL13;TTF1;MRPL55;APLP2;SEPHS1;NAGPA;ASMT;ADAM17;RPS17;ATG3;CTSH;MRPS33;MRPS18B;MIA3;ST3GAL1;UBL5;FDXR;CKAP4;LMCD1;PRSS23;ATP23;NOTUM;PLOD2
prerank,positive regulation of signaling (GO:0023056),0.24219855177600408,0.5404156193685294,0.9524361948955916,1.0,1.0,4/37,8.14%,ANXA2;SCRIB;RAB29;CD80
prerank,neuronal action potential (GO:0019228),0.2542404472090641,0.5399439006981114,0.9361430395913155,1.0,1.0,6/22,20.34%,KCNMB2;KCNMB3;KCNMB4;KCNA1;CACNA1G;ANK3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2261503495960192,0.5393134185237402,0.9828282828282828,1.0,1.0,24/132,18.12%,COIL;SETX;DHX9;PRKDC;SRSF10;EIF4H;DDX39B;RRS1;PRPF19;CELF2;SF3A2;SRPK1;PPAN;LUC7L3;LSM4;DDX1;MCTS1;DENR;PRPF18;GEMIN7;SRPK2;LUC7L2;ABT1;MRPL20
prerank,protein catabolic process (GO:0030163),0.22873855921316633,0.5390878698901657,0.9642470205850487,1.0,1.0,9/59,14.93%,CHEK2;SIAH2;PRPF19;ADAMTS9;HTRA2;CUL4B;STT3B;FBXO27;FBXO17
prerank,alcohol catabolic process (GO:0046164),0.2796853952671218,0.5389712933506678,0.9450381679389313,1.0,1.0,1/10,6.76%,SRD5A3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.24284385251683802,0.5388655623401202,0.952755905511811,1.0,1.0,11/38,23.13%,TRIM59;RIOK3;CASP8;RORA;PER1;OTUD7B;RIPK1;PPM1A;TANK;RHOH;DAB2IP
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.1692612224056917,-0.5385209595506997,0.9904306220095693,0.9866505172010801,1.0,2/23,8.44%,CALM1;NMT1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.23893025285304537,0.5374958333525509,0.9543429844097996,1.0,1.0,12/44,23.98%,CDC42EP2;NCK1;NCK2;BAIAP2L1;PRKCE;NCKAP1;WHAMM;FER;VASP;LMOD1;SNX9;CDC42EP1
prerank,vitamin transport (GO:0051180),0.24565672839000605,0.5370129253560161,0.9466824644549763,1.0,1.0,2/29,6.15%,PDPN;SLC19A1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.24950052159062042,0.5365119857328587,0.9263959390862944,1.0,1.0,7/23,22.04%,ATP2B4;LRRK2;ADCY6;PDE4B;SNCA;SIRT2;GNB1
prerank,T cell activation involved in immune response (GO:0002286),0.27187696170747006,0.5362724890476476,0.9298780487804879,1.0,1.0,12/12,72.83%,LCP1;TNFSF18;IFNK;F2RL1;ITGAL;ICAM1;LILRB1;MDK;EIF2AK4;SLC11A1;FCER1G;CD74
prerank,smooth muscle cell differentiation (GO:0051145),0.2778721584040922,0.5360481565280631,0.9166666666666666,1.0,1.0,3/12,13.44%,TBX18;MRTFA;HEY2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.27061199447204143,0.534828508393162,0.9362017804154302,1.0,1.0,4/14,21.08%,TNFRSF10B;ZFP91;TRAF6;TRAF2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.22396692306670984,0.5347073294141841,0.9648562300319489,1.0,1.0,20/69,24.94%,INTS7;PHAX;POLR2A;POU2F1;INTS8;GTF2A1;RPRD1A;POU2F2;ZC3H8;RPRD1B;POLR2B;INTS4;GTF2B;ELL2;INTS13;GTF2A2;SNAPC4;SP1;INTS6;SNAPC1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.26201067687202995,0.5344736870221711,0.9277929155313351,1.0,1.0,1/14,5.76%,NUDT5
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.23355895839365565,0.5343643266214778,0.9632432432432433,1.0,1.0,10/52,17.53%,ATP2B4;RANGRF;PDPK1;PRKCE;PRKCI;DLG1;ITGB1;RAMP3;EPHA3;WNK3
prerank,muscle organ development (GO:0007517),0.2286222025034158,0.5343179222079626,0.9595185995623632,1.0,1.0,6/54,11.32%,LARGE1;SOX6;SGCE;EMD;SMTN;CHD2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.27820668501853596,0.5337690484726774,0.9402777777777778,1.0,1.0,1/12,5.13%,B3GNT8
prerank,positive regulation of viral transcription (GO:0050434),0.24361250497192852,0.5334141794002039,0.9221938775510204,1.0,1.0,2/25,7.46%,DHX9;POLR2A
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.27879346710613817,0.533403728489851,0.9350850077279753,1.0,1.0,2/10,13.64%,NUMA1;MED1
prerank,GPI anchor biosynthetic process (GO:0006506),0.24422562064029538,0.5332910501653468,0.9377245508982036,1.0,1.0,9/30,22.29%,PIGN;PIGA;PIGU;PIGT;PIGM;DPM3;PIGG;GPAA1;PIGH
prerank,response to thyroid hormone (GO:0097066),0.27016553880036887,0.5331130597372208,0.9459459459459459,1.0,1.0,4/13,16.05%,KLF9;CTSH;MED1;BRD8
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.22399860200572014,0.532805885358376,0.9828109201213346,1.0,1.0,13/140,12.84%,LPAR3;LPAR1;IAPP;CXCR4;PDGFRA;SLC8A1;BDKRB2;HMGB1;P2RY1;CACNA1C;ITPR3;TRPM4;C1QTNF1
prerank,response to hexose (GO:0009746),0.24748720019418563,0.5323568691926334,0.9445129469790382,1.0,1.0,2/25,6.44%,TCF7L2;EIF2B1
prerank,cell junction organization (GO:0034330),0.23078162489360737,0.5317257011734965,0.9690831556503199,1.0,1.0,13/71,16.33%,SDK1;RHOA;MAPT;NLGN3;GRHL2;LIMS1;CAPZA1;TJP2;PPFIA4;PRKCI;SMAD3;PIN1;NLGN2
prerank,positive regulation of lipid storage (GO:0010884),0.2531312564669375,0.5314342460193819,0.9462227912932138,1.0,1.0,4/21,15.77%,PLIN2;EHD1;NFKB1;LPL
prerank,snRNA transcription (GO:0009301),0.22245245853751283,0.5310006547401277,0.9691489361702128,1.0,1.0,20/70,24.94%,INTS7;PHAX;POLR2A;POU2F1;INTS8;GTF2A1;RPRD1A;POU2F2;ZC3H8;RPRD1B;POLR2B;INTS4;GTF2B;ELL2;INTS13;GTF2A2;SNAPC4;SP1;INTS6;SNAPC1
prerank,osteoclast differentiation (GO:0030316),0.24897330142488353,0.5307030510885113,0.9309895833333334,1.0,1.0,4/22,18.34%,ANXA2;SRC;FOXP1;MAPK14
prerank,sphingolipid biosynthetic process (GO:0030148),0.22933074170695888,0.5292068746564244,0.966986155484558,1.0,1.0,13/71,15.59%,CERS6;CERS5;LARGE1;ST3GAL5;PLPP1;CSNK1G2;AGK;PRKD1;ELOVL4;SMPD1;SPTLC2;VAPA;PRKD2
prerank,cellular response to amino acid stimulus (GO:0071230),0.23940656384016593,0.5291563190716692,0.948905109489051,1.0,1.0,10/33,17.75%,KLHL22;SESN1;SLC38A9;GLRA2;RPTOR;IPO5;SESN2;LARS1;LAMTOR3;LAMTOR5
prerank,lysosome localization (GO:0032418),0.23125908500299744,0.5290044196558326,0.9556818181818182,1.0,1.0,7/37,19.55%,KIT;SPAG9;BORCS6;SYTL4;MAP6;KLC2;RAB3A
prerank,cellular response to glucagon stimulus (GO:0071377),0.25841702266489364,0.5289582413411684,0.9398084815321477,1.0,1.0,7/17,24.38%,ADCY6;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;PRKACA
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.24528122621481618,0.52862915588978,0.9432717678100264,1.0,1.0,5/25,21.08%,KIT;TRIM6;LACC1;TRAF6;TRAF2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.22083624806952912,0.5278254201973416,0.9754350051177073,1.0,1.0,13/110,16.32%,LPAR3;LPAR1;IAPP;ADGRL1;GNA13;GNAQ;S1PR2;ABCA1;ADGRG2;ADRB2;RAMP3;ADCY6;ADGRD1
prerank,integrin-mediated signaling pathway (GO:0007229),0.22515695476858522,0.5276347561016074,0.9663512092534174,1.0,1.0,21/73,21.49%,ITGB7;CUL3;DOCK1;PRKD1;ADAM9;ADAMTS1;ITGA5;ITGB1;PTPRA;ITGAV;SRC;RCC2;ITGB8;FERMT3;CD47;CEACAM1;FERMT2;FBLN1;ISG15;ITGBL1;ITGA11
prerank,regulation of ERBB signaling pathway (GO:1901184),0.25898168164357416,0.5272061065003767,0.9415670650730412,1.0,1.0,4/15,20.93%,WDR54;RBPJ;CEACAM1;FER
prerank,glial cell differentiation (GO:0010001),0.23717524497057468,0.5270022834688516,0.9454545454545454,1.0,1.0,4/28,12.56%,MMP24;NFIB;TPPP;SOX9
prerank,peptide hormone secretion (GO:0030072),0.24745343603446374,0.5266518780539243,0.95875,1.0,1.0,3/26,14.72%,RAB1A;ANXA1;SNX19
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2576154545810036,0.5265667127487531,0.9459084604715673,1.0,1.0,1/17,4.92%,PDE3B
prerank,protein K63-linked deubiquitination (GO:0070536),0.2427663372767609,0.5263596887349774,0.9467821782178217,1.0,1.0,11/31,24.52%,UIMC1;PSMD14;USP16;BRCC3;OTUD1;OTUD7B;USP20;ZRANB1;USP25;BABAM2;USP13
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.24810107351317706,0.5260878048523296,0.9454094292803971,1.0,1.0,4/23,15.38%,AGT;GJA1;SOX9;GDNF
prerank,positive regulation of secretion by cell (GO:1903532),0.22059755956944987,0.5258195082065633,0.9743589743589743,1.0,1.0,15/70,20.66%,FRMD4A;STXBP5;MYH10;BMP6;BMP2;EZR;SYTL4;ACHE;PPID;ADAM9;CLASP1;TMED10;DNM1L;RAB3A;SNCA
prerank,glutathione metabolic process (GO:0006749),0.23108594820597242,0.5258102244473768,0.9530892448512586,1.0,1.0,10/38,22.11%,GSS;HPGDS;GSTT1;DPEP1;GCLM;GSTM5;GCLC;HAGH;SOD1;GSTZ1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.23489308699817152,0.5256335380396326,0.9624724061810155,1.0,1.0,7/48,16.35%,USP18;PTPN2;ROBO1;YTHDF2;PYDC1;CNOT7;METTL3
prerank,macrophage differentiation (GO:0030225),0.27031131123891683,0.5255743424792265,0.9451476793248945,1.0,1.0,2/13,12.76%,CASP8;IL31RA
prerank,negative regulation of GTPase activity (GO:0034260),0.24438507485661326,0.5247618213447535,0.9317010309278351,1.0,1.0,3/22,9.13%,WNK1;LRRK2;CPEB2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2560367555048483,0.5245823948199478,0.9575342465753425,1.0,1.0,4/16,17.74%,PSIP1;WBP4;PRPF39;SFSWAP
prerank,camera-type eye morphogenesis (GO:0048593),0.2798069860492609,0.5243187679715141,0.9401459854014599,1.0,1.0,3/10,19.29%,KDM2B;SHROOM2;SKI
prerank,negative regulation of reproductive process (GO:2000242),0.2560708044586463,0.5241948994395211,0.9318181818181818,1.0,1.0,2/17,12.35%,SULF1;GJA1
prerank,glycoprotein biosynthetic process (GO:0009101),0.2231077329570282,0.5241298456605543,0.975991649269311,1.0,1.0,14/79,18.77%,LARGE1;FUT10;ST8SIA2;B3GNT8;ST3GAL3;B4GALT7;ST3GAL5;FOXL1;ST3GAL4;ST3GAL2;B3GALT2;CHST10;XYLT1;GCNT1
prerank,arachidonic acid metabolic process (GO:0019369),0.2333660314391398,0.5240996268615161,0.9553990610328639,1.0,1.0,4/35,12.45%,PTGES2;HPGDS;PTGS1;DAGLB
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.24512024144596095,0.5229156583819744,0.9563543003851092,1.0,1.0,3/20,13.34%,LYPD1;GNAQ;LY6H
prerank,membrane protein proteolysis (GO:0033619),0.23112383369295933,0.5220049808739573,0.9556592765460911,1.0,1.0,13/37,24.99%,SPPL2B;ADAM17;CTSH;ADAM9;ADAM19;NFKB1;TRAF6;RBMX;MYH9;NAPSA;RELA;TGFB1;SPPL3
prerank,regulation of interferon-gamma production (GO:0032649),0.22045850125649621,0.5218990152581865,0.9597457627118644,1.0,1.0,12/71,21.10%,FADD;PRNP;IL18;SCRIB;HMGB1;AXL;SIRPA;CD47;HAVCR2;ZFPM1;PDE4B;ISG15
prerank,amyloid fibril formation (GO:1990000),0.22780475984516343,0.521262804731193,0.967670011148272,1.0,1.0,7/51,13.52%,TSPAN33;IAPP;SIAH2;MAPT;CALB1;TSPAN5;USP9X
prerank,negative regulation of defense response (GO:0031348),0.22442397914348036,0.5210611967896753,0.9710144927536232,1.0,1.0,9/77,13.72%,RB1;NMI;PTPN2;ENPP3;CCN3;ILRUN;ITCH;RORA;MVK
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.267931067337369,0.520746040599592,0.9508196721311475,1.0,1.0,1/13,5.13%,B3GNT8
prerank,peptidyl-amino acid modification (GO:0018193),0.27205929161271136,0.5201509117022893,0.9115853658536586,1.0,1.0,2/10,18.00%,TTLL4;METAP1
prerank,glucose homeostasis (GO:0042593),0.22303186821388402,0.5199955145295814,0.9698544698544699,1.0,1.0,11/83,14.69%,FGFR4;GCK;LEPR;PTPN2;TCF7L2;NUCKS1;MCU;APPL2;ADIPOR1;FOXK2;STK11
prerank,male gonad development (GO:0008584),0.2327203196663912,0.5195804940261531,0.9601406799531067,1.0,1.0,2/34,5.16%,KIT;WNT2B
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.26969806811635494,0.5191946397358451,0.9544072948328267,1.0,1.0,2/10,14.30%,ZNHIT3;RUVBL2
prerank,regulation of type I interferon production (GO:0032479),0.22184874095051468,0.5190770966451269,0.9717277486910995,1.0,1.0,25/84,25.35%,POLA1;DHX9;PRKDC;MRE11;G3BP1;IRF1;POLR3D;ILRUN;ITCH;PIN1;NFKB1;MAVS;NLRP4;ISG15;TAX1BP1;POLR3C;RNF216;POLR3G;PCBP2;IRF8;CRCP;GPATCH3;RELA;DHX33;ACOD1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.2612244657242877,0.5183198232730918,0.9390787518573551,1.0,1.0,2/12,12.62%,TMEFF2;HDAC2
prerank,GPI anchor metabolic process (GO:0006505),0.2384733708722311,0.5181297992722793,0.9531442663378545,1.0,1.0,7/26,22.29%,PIGN;PIGA;PIGU;PIGM;DPM3;PIGG;PIGH
prerank,positive regulation of neuron projection development (GO:0010976),0.2189087227554381,0.5179180498341752,0.9854166666666667,1.0,1.0,18/85,17.35%,SETX;CAPRIN1;MARK2;CAMK1D;ARHGAP35;PLXNB2;TWF1;P3H1;ZDHHC15;DPYSL3;ROR1;PRKD1;PRKCI;DBN1;COBL;STMN2;EPHA3;ARSB
prerank,purine ribonucleotide transport (GO:0015868),0.25596686668943985,0.5170829521174789,0.9539918809201624,1.0,1.0,4/16,17.43%,SLC19A1;SLC25A42;LRRC8C;SLC25A17
prerank,regulation of defense response (GO:0031347),0.22054318666417008,0.5163143368100054,0.9714285714285714,1.0,1.0,14/76,17.80%,SETD6;USP18;AKNA;IRF1;NLRP6;ANXA1;APPL2;DAGLB;CASP8;BRD4;XIAP;IL1RL2;FOXP1;LACC1
prerank,melanosome localization (GO:0032400),0.23865907774953837,0.5162420896532847,0.9528061224489796,1.0,1.0,4/21,17.50%,MKKS;MLPH;BLOC1S5;SHROOM2
prerank,regulation of superoxide anion generation (GO:0032928),0.2619407952856212,0.5162252618867507,0.9373177842565598,1.0,1.0,4/14,24.86%,MAPT;PRKCD;SOD1;TGFB1
prerank,regulation of biosynthetic process (GO:0009889),0.2646513642521741,0.5157512011556067,0.9523076923076923,1.0,1.0,3/11,23.37%,PIKFYVE;SNCA;SLC25A33
prerank,regulation of defense response to virus by host (GO:0050691),0.23221056527911207,0.5149599259551236,0.9602409638554217,1.0,1.0,4/30,17.16%,DHX9;PARP9;TRIM6;MAVS
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.2280372403788725,0.5137039500279542,0.9539325842696629,1.0,1.0,11/41,23.77%,AFDN;PIEZO1;PLAUR;ADAM19;CD44;PTPRU;CD47;ANK3;DENND6A;GCNT2;PTPN23
prerank,cellular respiration (GO:0045333),0.22510184935525726,0.5135573372415522,0.9735327963176065,1.0,1.0,3/41,7.08%,MTFR2;COX10;COQ10B
prerank,acute inflammatory response (GO:0002526),0.24560130670671323,0.5127782469428742,0.9530456852791879,1.0,1.0,1/23,4.22%,MYLK3
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.2562154696132596,0.5120195390236995,0.9605839416058394,1.0,1.0,14/14,74.40%,TRAF6;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;CSF1;TYROBP;ATP6AP1
prerank,negative regulation of hormone secretion (GO:0046888),0.26666931713368824,0.5117186463966957,0.9419642857142857,1.0,1.0,1/10,12.35%,GJA1
prerank,cellular response to chemokine (GO:1990869),0.22433375594780658,0.5106766743099495,0.9622641509433962,1.0,1.0,3/46,8.79%,RHOA;WNK1;RIPOR2
prerank,maturation of LSU-rRNA (GO:0000470),0.23333296071914233,0.5094582867779227,0.9525,1.0,1.0,5/26,15.69%,ZNHIT3;DDX18;MRPL1;MAK16;WDR12
prerank,melanosome organization (GO:0032438),0.2375663811043401,0.5076383656712765,0.9559748427672956,1.0,1.0,6/26,17.76%,RAB29;AP3B1;BLOC1S5;AP1M1;SHROOM2;PIKFYVE
prerank,regulation of interleukin-8 production (GO:0032677),0.21737062408091384,0.5068902759127634,0.9691489361702128,1.0,1.0,11/69,18.73%,FADD;ARRB1;SERPINE1;HMGB1;RAB1A;ANXA1;OTUD7B;PRKD2;MAVS;LAMTOR5;RIPK1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.21059845051293227,0.5065984579055074,0.9929859719438878,1.0,1.0,32/198,16.60%,PFKFB1;GCK;GPI;LHPP;OCRL;NUDT5;PPP3CA;IPMK;ENPP3;INPP5B;LRRK2;AGPAT2;LIMD1;DUSP12;PPA1;PPIP5K1;PIK3CB;ACYP2;IP6K2;ENPP1;PLPP1;AGK;NUDT4;PANK2;AGPAT1;PLCB4;TAOK1;LPL;PTEN;GK5;TNK2;GDE1
prerank,central nervous system development (GO:0007417),0.21154537836366083,0.5063032412527483,0.997,1.0,1.0,39/250,17.89%,PBX4;CDK5RAP2;LOXL3;PBX3;NFIB;BTD;ADGRA2;CXCR4;SOX6;GRHL2;NIPBL;DSCAML1;UTP3;TPPP;ZIC5;NR4A2;PLXNB2;DHX37;NKX2-1;ATXN1;ZIC4;SOX9;SH3GL3;TMX2;NES;QARS1;CAPG;PKD2;PTEN;ANKLE2;NCKAP1;JRKL;HSPG2;ARNT2;WWP1;SLC6A17;GRIN2D;SHROOM2;MAST1
prerank,positive regulation of potassium ion transport (GO:0043268),0.2226757801389357,0.5062021310774306,0.9791907514450867,1.0,1.0,9/38,22.09%,KCNN4;KCNMB2;KCNMB3;DLG1;KCNMB4;GABBR2;AMIGO1;GNB1;FLNA
prerank,acylglycerol biosynthetic process (GO:0046463),0.2366274078271856,0.5057959643784826,0.9467005076142132,1.0,1.0,2/23,7.14%,LPIN2;AGMO
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.24298555610612468,0.5051290721340514,0.9538461538461539,1.0,1.0,5/20,15.99%,CARF;BMP2;RBPJ;SMAD4;SESN2
prerank,cytosolic transport (GO:0016482),0.21302736425661456,0.5047322285602076,0.9806122448979592,1.0,1.0,21/108,19.81%,AP4M1;GBF1;SPAG9;SNX1;DENND2A;RAB29;VPS13A;ANKRD27;ERC1;DENND5A;GAK;VTI1A;GOSR1;SNX32;VPS26A;EPS15;RIC1;PIKFYVE;TBC1D10A;BET1L;MON2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.21426155192460256,0.5031776086355846,0.9849246231155779,1.0,1.0,23/138,17.06%,STYK1;FGFR4;FGFR2;KIT;FRS2;MUSK;PDGFRA;EPHA4;ABI1;BDKRB2;DDR2;PIK3CB;CLNK;GUCY2C;IL31RA;POLR1G;ROR1;PTPRU;SRC;TNK2;AXL;NGF;EPHA3
prerank,ceramide metabolic process (GO:0006672),0.22078350302810096,0.5007640413294594,0.958980044345898,1.0,1.0,8/49,18.68%,CERS6;CERS5;PLPP1;AGK;SMPD1;SPTLC2;SMPD2;FA2H
prerank,negative regulation of protein localization to membrane (GO:1905476),0.23162404560580263,0.5002115118129384,0.9510050251256281,1.0,1.0,4/24,15.26%,RHOQ;PICALM;DMTN;LZTFL1
prerank,metanephros development (GO:0001656),0.2288432422952395,0.4995590556771577,0.9644171779141104,1.0,1.0,5/26,18.17%,NIPBL;CTSH;GDNF;PKD2;OSR1
prerank,autophagosome organization (GO:1905037),0.2130911381339537,0.4989530401277323,0.9691969196919692,1.0,1.0,13/50,22.41%,ATG7;ATP2A2;RAB1A;RB1CC1;ULK2;ATG3;ATG2A;STX12;UBXN2B;TP53INP2;AMBRA1;ATG13;ATG5
prerank,cellular response to starvation (GO:0009267),0.2085924054894546,0.4988968696168342,0.9909547738693467,1.0,1.0,28/147,18.09%,FNIP1;DEPDC5;DAP;HNRNPA1;STK24;ATG7;SH3GLB1;FOXO3;LRRK2;ZFYVE1;NPRL3;SESN1;EIF2AK3;SIK2;SLC38A9;PRKD1;ITFG2;RPTOR;MTMR3;PRKAG1;TP53;CLEC16A;SESN2;SFRP1;LARS1;LAMTOR3;LAMTOR5;SREBF1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.23865008555690548,0.49849743634215843,0.9589216944801027,1.0,1.0,3/20,15.00%,GSK3B;BOK;ITGAV
prerank,regulation of inflammatory response (GO:0050727),0.20857942216021402,0.4971652200801419,0.995995995995996,1.0,1.0,30/190,19.53%,SETD6;RB1;USP18;DHX9;NMI;PTPN2;IL18;AKNA;ENPP3;SERPINE1;AGT;NLRP6;CCN3;ANXA1;DAGLB;BRD4;RORA;MVK;XIAP;SETD4;IL1RL2;LPL;SIRPA;FOXP1;CD47;LACC1;PTGIS;RIPK1;DAGLA;PRKCD
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.23352079378474946,0.4969756912650516,0.9668874172185431,1.0,1.0,8/20,26.57%,SPPL2B;ADAM17;ADAM9;NFKB1;TRAF6;RELA;TGFB1;RHBDD1
prerank,regulation of B cell activation (GO:0050864),0.23139494046950687,0.4962774407822912,0.9603469640644362,1.0,1.0,3/25,13.21%,SAMSN1;AHR;IL4I1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.25277134964542547,0.4950637343258775,0.9551569506726457,1.0,1.0,1/11,9.77%,AGT
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2576649405943388,0.49423899945946803,0.9724770642201835,1.0,1.0,4/10,22.00%,TUT7;TUT4;ISG15;NEDD8
prerank,ion transport (GO:0006811),0.20778263934221106,0.4921571568826641,0.9897750511247444,1.0,1.0,11/111,12.03%,KCNN4;PLP2;SLC20A2;TRPA1;WNK1;SLC4A2;SLC9A5;SLC24A3;SLC8A1;PIEZO1;CHRNB1
prerank,second-messenger-mediated signaling (GO:0019932),0.2073273710128666,0.49215331469248247,0.9875130072840791,1.0,1.0,10/82,13.59%,CXCR4;LRRK2;MCU;AGT;SAMD14;EIF2AK3;PDPK1;TRPM4;BTK;NUDT4
prerank,negative regulation of complement activation (GO:0045916),0.2548958071805172,0.49191570142589097,0.9505582137161085,1.0,1.0,10/10,74.53%,SUSD4;CD55;C4BPB;C4BPA;CD46;VSIG4;A2M;SERPING1;CR2;CR1L
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2198325547895766,0.49188267284243103,0.9667063020214031,1.0,1.0,4/35,14.01%,PAM;ACAT1;ACACA;AACS
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.22003520298930263,0.4915898631664253,0.9809843400447428,1.0,1.0,10/49,19.47%,BMF;RTKN2;BCLAF1;BOK;EIF2AK3;PLAUR;SRC;TP53;BAD;DNM1L
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2058653225699103,0.49094445627241495,0.9959595959595959,1.0,1.0,19/151,15.59%,FGFR4;FGFR2;GAREM1;ARRB1;FBXW7;PDGFRA;NPNT;ANGPT1;HMGB1;P2RY1;CRKL;BMP2;PRKCA;NOTCH2;ROR1;RAMP3;CD44;SLC30A10;PRKD2
prerank,positive regulation of type I interferon production (GO:0032481),0.20879631531182233,0.4906614668642756,0.9810725552050473,1.0,1.0,8/73,10.54%,DHX9;PRKDC;MRE11;G3BP1;SETD2;IRF1;RIOK3;POLR3D
prerank,development of primary male sexual characteristics (GO:0046546),0.21944742580686666,0.49040967618511544,0.9719298245614035,1.0,1.0,2/34,5.16%,KIT;WNT2B
prerank,response to glucagon (GO:0033762),0.23545402631192108,0.48951956733734103,0.9745649263721553,1.0,1.0,7/19,24.38%,ADCY6;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;PRKACA
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.20340486826331944,0.4889246095325392,0.9959758551307847,1.0,1.0,17/152,15.11%,LPAR3;LPAR1;IAPP;ADGRL1;GNA13;GRK5;GNAQ;S1PR2;ABCA1;GLP2R;WASF2;GNAI3;ADGRG2;ADRB2;INSL3;RAMP3;ADCY6
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.22660770189579996,0.4889132043326202,0.9668711656441717,1.0,1.0,3/25,11.63%,DDX39B;SCAF8;HTATSF1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.23275784930797075,0.48753997960974516,0.9707446808510638,1.0,1.0,6/19,24.17%,PPP3CA;PPP3R1;NFATC3;INPP5A;HRH1;PPP3CB
prerank,female gonad development (GO:0008585),0.23191632524722305,0.4868662623232908,0.9735799207397622,1.0,1.0,1/19,4.54%,KIT
prerank,response to cytokine (GO:0034097),0.20247452222684315,0.48661381890100674,0.9929435483870968,1.0,1.0,30/141,21.36%,RHOA;ALDH1A2;SRF;AFF3;PTPN2;CXCR4;PML;SETD2;ANXA1;PRKCA;MAPKAPK3;CASP8;DPYSL3;ADAM9;SMPD1;SMAD3;PTPN13;SRC;IL1RL2;IFNAR2;RIPK1;SP100;RELB;PTPN5;TRAF6;SNCA;MAPKAPK2;ISG15;EIF2AK2;HDAC4
prerank,positive regulation of response to external stimulus (GO:0032103),0.20392806379803985,0.486233302285018,0.9939148073022313,1.0,1.0,25/128,22.99%,DHX9;NMI;BMP6;IL18;SERPINE1;RIOK3;PUM2;AGT;POLR3D;CNTF;PRKCA;AKIRIN2;SLC15A4;SETD4;LPL;CD47;ANKRD17;RIPK1;IL16;SNCA;POLR3C;OPTN;GPRC5B;POLR3G;TLR7
prerank,negative regulation of protein kinase activity (GO:0006469),0.20537633887868803,0.4859385216174318,0.9802904564315352,1.0,1.0,20/88,21.14%,RB1;CEP43;TAB1;WWTR1;GNAQ;SLC8A1;CEP85;PYDC1;PDPK1;LRP5;SPRED1;CDKN1B;QARS1;MVP;SH3BP5;PTPN1;TRIB1;CEACAM1;SNCA;UBASH3B
prerank,maturation of SSU-rRNA (GO:0030490),0.22081283371106508,0.485938461486668,0.9726516052318668,1.0,1.0,6/34,15.79%,RIOK3;UTP3;NOL11;DHX37;TSR1;HELB
prerank,mitochondrial transcription (GO:0006390),0.24409774657676042,0.48557215584926855,0.9630723781388478,1.0,1.0,2/10,14.97%,FOXO3;TFB1M
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.22850705942407523,0.48476427330281296,0.9613947696139477,1.0,1.0,7/22,22.93%,ZDHHC18;ZDHHC15;ZDHHC3;ZDHHC21;ZDHHC24;ZDHHC2;ZDHHC14
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.22850705942407523,0.48476427330281296,0.9613947696139477,1.0,1.0,7/22,22.93%,ZDHHC18;ZDHHC15;ZDHHC3;ZDHHC21;ZDHHC24;ZDHHC2;ZDHHC14
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.24268035008600541,0.4846544201407677,0.9551192145862553,1.0,1.0,1/14,4.05%,DDRGK1
prerank,carnitine shuttle (GO:0006853),0.24464395271937206,0.4837162686871894,0.9621542940320232,1.0,1.0,2/11,14.03%,ACACA;CPT2
prerank,negative regulation of bone remodeling (GO:0046851),0.2513966480446929,0.4833278274088443,0.9711399711399712,1.0,1.0,11/11,74.88%,SFRP1;UBASH3B;GPR137B;IL6;TMEM119;CARTPT;CALCA;GREM1;TNFAIP3;GPR137;P2RX7
prerank,positive regulation of leukocyte migration (GO:0002687),0.2271993167123627,0.4828926083586777,0.965865992414665,1.0,1.0,3/27,15.31%,ADAM17;MIA3;PLVAP
prerank,negative regulation of signaling receptor activity (GO:2000272),0.22494745575274208,0.48259987368369006,0.969811320754717,1.0,1.0,4/25,17.83%,GPRC5A;ERRFI1;RAMP3;SLC6A9
prerank,cellular response to UV-A (GO:0071492),-0.1835548553249217,-0.48198408549887184,0.9876543209876543,0.9980826828846481,1.0,6/11,44.83%,MMP2;CERS1;MMP1;OPN3;TIMP1;MMP3
prerank,protein targeting (GO:0006605),0.2030575641892448,0.4819148286356827,0.9938712972420838,1.0,1.0,30/118,23.87%,VPS37B;TRAK1;AP4M1;FUT10;MYO1C;VPS37A;MFN2;SRPRA;ZDHHC18;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;PIKFYVE;KIF13B;PEX12;ZDHHC24;TSPO;ICMT;TIMM23;TOMM40;SPCS3;VPS37C;ZDHHC2;ZDHHC14;TOMM20;PITRM1;TIMM10B
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.20755588914546427,0.48112030124336924,0.9815618221258134,1.0,1.0,8/62,12.61%,ERCC3;ELOF1;ELOC;POLR2A;SETD2;LEO1;ADRM1;SSRP1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.23366139589908047,0.48099991719288576,0.9631650750341064,0.9997948274679073,1.0,3/17,12.52%,SLC8A1;CACNA1C;TRPM4
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.22712557375306197,0.48097524877344155,0.9757033248081841,0.9993955513917833,1.0,7/22,24.49%,PSMB1;PSMB9;PSMB2;PSME4;PSMB7;PSMB8;PSMA5
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.22352871779343264,0.480769924780003,0.9699624530663329,0.9990686922299695,1.0,4/21,14.06%,SPPL2B;ADAM17;ADAM9;ADAM19
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.22683248490331814,0.48056105122719184,0.9723889555822329,0.9987420996743237,1.0,7/26,23.19%,NMI;ILRUN;ITCH;TRIB1;SIRT2;NFKBIL1;PCBP2
prerank,positive regulation of TORC1 signaling (GO:1904263),0.23431303522459135,0.478649401705833,0.9690026954177897,0.9990765770245529,1.0,6/16,25.20%,KLHL22;CLEC16A;LARS1;LAMTOR5;GPR137B;SEH1L
prerank,protein localization to mitochondrion (GO:0070585),0.24150969246739223,0.47770028157512834,0.9744744744744744,0.9990216952692091,1.0,5/11,26.97%,LRRK2;MAIP1;ISG15;RALA;COX18
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.20151334472025054,0.4773923417283127,0.9937952430196484,0.9987269460654351,1.0,15/95,20.27%,HMGB2;TICAM1;RHOA;SERPINE1;CD80;HMGB1;ADAM9;NFKB1;AXL;SIRPA;MAPK14;PLAA;PDE4B;CD68;TRAF6
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.18931642709183352,-0.4756909821205931,0.990909090909091,0.9981818118359802,1.0,11/11,81.09%,P3H2;P4HA1;EGLN2;P4HA3;P4HTM;P4HA2;CRTAP;P4HB;EGLN3;EGLN1;OGFOD1
prerank,superoxide metabolic process (GO:0006801),0.21392029125682085,0.47388985324257205,0.9752475247524752,0.999619349650855,1.0,5/29,17.52%,SOD3;NOX4;CYBB;CCS;SH3PXD2B
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.20591814937039427,0.47373712544848634,0.9808342728297632,0.9992729398302743,1.0,5/49,12.76%,KIT;IL18;PARP9;CNTF;IL31RA
prerank,histone H3-K9 demethylation (GO:0033169),-0.1846605953612425,-0.47348396194968234,0.9850299401197605,0.9976401463246912,1.0,5/11,32.71%,KDM4C;KDM4D;KDM4A;KDM3B;KDM7A
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.2347771500313874,0.47312977197462924,0.9611510791366906,0.9990915079858655,1.0,12/12,76.54%,CD44;GCNT2;FLOT1;FGG;IL10;IL1B;TNF;LCK;AGER;SKAP1;THY1;BMP7
prerank,regulation of interleukin-12 production (GO:0032655),0.20811426954421974,0.47272673840840407,0.9809630459126539,0.9988218367527636,1.0,6/47,20.32%,MAST2;HMGB1;FOXP1;CD47;MAPK14;IL16
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.20284072353593946,0.47212431163290125,0.9848975188781014,0.9986113978535087,1.0,8/64,12.61%,ERCC3;ELOF1;ELOC;POLR2A;SETD2;LEO1;ADRM1;SSRP1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.245205083112989,0.47205435945551266,0.9668587896253602,0.9982352863050552,1.0,1/12,4.71%,IDH3A
prerank,lytic vacuole organization (GO:0080171),0.2136773049565851,0.4710716379111929,0.9770253929866989,0.99818597874796,1.0,7/32,17.35%,VPS18;LRRK2;CLVS2;ABCA1;NAGPA;TPCN2;ARSB
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.24121842547857092,0.4697597316707295,0.9653092006033183,0.9982273122885305,1.0,3/11,20.34%,PRKCA;PLAUR;ANK3
prerank,ncRNA catabolic process (GO:0034661),0.21432321511379673,0.46963346227959546,0.972520908004779,0.9978646080153348,1.0,7/28,21.22%,POP1;EXOSC7;TUT4;ZCCHC8;EXOSC10;DIS3;TRIR
prerank,negative chemotaxis (GO:0050919),0.20957922122063571,0.4669595205878939,0.9847953216374269,0.9983728105512599,1.0,5/33,15.23%,RHOA;NTN1;ROBO1;ITGAV;SEMA3D
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.23155878978726913,0.4645194941227952,0.9826839826839827,0.9987662258818121,1.0,7/14,26.49%,AK7;NMNAT1;NMNAT2;PNP;NMNAT3;ME1;AK8
prerank,neutrophil chemotaxis (GO:0030593),0.19816883236040855,0.46363184094240734,0.99457111834962,0.99864618827188,1.0,2/53,4.98%,GBF1;CKLF
prerank,positive regulation of TOR signaling (GO:0032008),0.20537168611127743,0.4634128931834142,0.9830890642615558,0.9983265899466849,1.0,8/40,17.75%,FNIP1;KLHL22;SLC38A9;RPTOR;CLEC16A;LARS1;LAMTOR3;LAMTOR5
prerank,negative regulation of inclusion body assembly (GO:0090084),0.23710281909146552,0.4622899609474597,0.9635258358662614,0.9982861209032476,1.0,3/10,19.66%,DNAJB2;DNAJB6;SACS
prerank,negative regulation of immune response (GO:0050777),0.19456035960060214,0.46170020349891094,0.9969879518072289,0.998065667743234,1.0,31/154,23.19%,IAPP;NMI;ENPP3;SAMSN1;ILRUN;GLP2R;ADAM17;ITCH;ADRB2;PLK2;RC3H1;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;HAVCR2;YES1;FER;HTR7;SIRT2;GNB1;PRKAR1A;FYN;MYH9;PCBP2
prerank,regulation of peptide hormone secretion (GO:0090276),0.19887800108353382,0.46073123561710033,0.9947145877378436,0.9979796796075019,1.0,8/67,15.61%,GCK;ITPR1;CACNA1C;RAPGEF4;ITPR3;PRKCA;ENSA;PASK
prerank,positive regulation of integrin activation (GO:0033625),0.23903436754936674,0.4600693942188133,0.9780701754385965,0.9977843617423191,1.0,3/11,20.81%,PIEZO1;SRC;FERMT2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.22984191690619385,0.4599234866510516,0.9722607489597781,0.9974275173597369,1.0,3/13,17.19%,SPRED1;SPRED2;ATR
prerank,mammary gland epithelium development (GO:0061180),-0.17070742675679118,-0.45934393855273004,1.0,0.998468498095761,1.0,2/14,8.69%,AKT2;ERBB4
prerank,response to lipopolysaccharide (GO:0032496),0.19129476228549797,0.45924795448334077,0.9959636730575177,0.9972302334112986,1.0,24/138,20.93%,HMGB2;TICAM1;RHOA;SERPINE1;CD80;SMAD6;HMGB1;ADAM17;TRIM6;MAPKAPK3;ADAM9;NFKB1;AXL;SIRPA;FOXP1;MAPK14;PLAA;PDE4B;TRIB1;CD68;TRAF6;SNCA;MAPKAPK2;FER
prerank,B cell activation (GO:0042113),0.1965245516890017,0.45881440534341156,0.985200845665962,0.9969633927114192,1.0,9/68,15.43%,KIT;PTPN2;CTPS1;PRKCB;ADAM17;CASP8;BTK;ITGB1;DCAF1
prerank,response to fatty acid (GO:0070542),0.2185312880955162,0.45819301352050745,0.9751381215469613,0.9967513788351009,1.0,3/17,15.77%,FOXO3;SOX9;LPL
prerank,steroid metabolic process (GO:0008202),0.19323507721433664,0.456743151328175,0.9957671957671957,0.9967702845039191,1.0,2/72,3.24%,CYP39A1;CYP26B1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.1706181330114383,-0.45065873661271244,0.9967532467532467,0.9984755113962208,1.0,1/12,5.18%,PLEK
prerank,regulation of intracellular pH (GO:0051453),0.20030930033647365,0.44694870524929614,0.9883449883449883,0.9991271955213296,1.0,5/34,17.65%,SLC4A2;LRRK2;SLC9A5;CA2;TM9SF4
prerank,positive regulation of peptidase activity (GO:0010952),0.21037673487607128,0.4461315111053183,0.9854881266490765,0.9989205887593352,1.0,4/20,21.08%,DDRGK1;CTSH;PSME3;TANK
prerank,DNA catabolic process (GO:0006308),0.22955244491871202,0.44606200302247256,0.9703125,0.9985338541107395,1.0,11/11,77.06%,XRN2;DFFB;DNASE1L1;DNASE1L3;DNASE1;ISG20;FBH1;DNASE1L2;MUS81;SETMAR;REXO4
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.19464715164426155,0.4455411925751924,0.9911209766925638,0.9982664645646919,1.0,3/53,11.47%,LPAR3;AGT;ANXA1
prerank,regulation of T cell proliferation (GO:0042129),0.1929529511563777,0.44465713617608704,0.9870550161812298,0.9980895322075849,1.0,8/61,21.51%,CD80;NCK1;ANXA1;NCK2;IL4I1;SLC7A1;SDC4;PNP
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.20127413160897267,0.4442839899855193,0.9818840579710145,0.9977747615401891,1.0,5/30,17.01%,KIT;LMBR1L;TP53;SFRP1;MLLT3
prerank,negative regulation of type I interferon production (GO:0032480),0.200076195782199,0.4412114378419691,0.9909297052154195,0.9981622272003886,1.0,16/40,25.35%,PTPRS;ILRUN;ITCH;YY1;PIN1;MAVS;SIRPA;HAVCR2;RELB;ISG15;TAX1BP1;RNF216;PCBP2;REL;GPATCH3;ACOD1
prerank,innate immune response (GO:0045087),0.18358894374121038,0.437753730770443,1.0,0.9985907753318036,1.0,35/217,21.69%,STYK1;TRIML2;COLEC12;RNASE6;TRIM59;PML;TTC4;SETD2;TRIM28;SKP2;HMGB1;IKBKG;CYBB;SRPK1;CAPZA1;PYDC1;TRIM6;BTK;SMPD1;TRIM5;SRC;AKAP1;TNK2;MAVS;SRPK2;CFP;ANKRD17;SP100;RELB;YES1;SNCA;FER;ISG15;CLPB;IKBKB
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.1563040506102711,-0.43427289447028106,0.9963369963369964,0.9989550069400301,1.0,9/15,44.96%,TLR4;NLRC3;DDX3X;USP50;MYD88;TREM2;CPTP;CD36;TLR6
prerank,granulocyte chemotaxis (GO:0071621),0.18559937868459886,0.4342541074768028,0.9989212513484358,0.9989745978126358,1.0,8/55,23.23%,GBF1;CKLF;ANXA1;PIP5K1C;PIKFYVE;PDE4B;CXADR;CCL14
prerank,lymphocyte migration (GO:0072676),0.1991460630498076,0.4340516532184627,0.991556091676719,0.9986179493945081,1.0,1/32,4.98%,CKLF
prerank,regulation of chemokine production (GO:0032642),0.19025357559680328,0.43199746460765603,0.9907084785133565,0.99865069184212,1.0,10/36,27.34%,IL18;ADAM17;LPL;FOXP1;EIF2AK2;IL6R;TLR7;IL33;WNT5A;TLR3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.19756711588361478,0.42801134505242866,0.9949811794228356,0.9990890202532967,1.0,1/27,3.90%,LPAR1
prerank,regulation of phosphatase activity (GO:0010921),0.1995002082025024,0.42701132431639804,0.9897828863346104,0.9989033308306406,1.0,4/24,17.46%,MTMR9;BMP2;PTPA;PPP6R2
prerank,mesenchymal to epithelial transition (GO:0060231),0.21654531759979914,0.42246465253519244,0.981021897810219,0.9993535276700759,1.0,10/10,78.36%,SALL1;BMP4;FZD7;SIX2;PAX2;CITED1;WT1;GATA3;PAX8;BASP1
prerank,RNA methylation (GO:0001510),0.18214733921108134,0.42050284127016274,0.9935414424111948,0.9993100240566068,1.0,10/60,19.75%,RBM15;METTL5;RBM15B;METTL8;TFB1M;MRM2;METTL3;NSUN3;VIRMA;TGS1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.15158000394637366,-0.41476788628153644,1.0,0.9990653210929057,1.0,9/13,51.56%,TBX3;SRA1;SOX8;DLL1;EID2B;SOSTDC1;ANKRD2;PRICKLE1;NOTCH1
prerank,rRNA transcription (GO:0009303),0.19686832542539406,0.41159859925609243,0.9880159786950732,1.0,1.0,5/17,24.73%,GTF3C4;POLR1G;GTF3C5;BRF1;CAVIN1
prerank,rRNA modification (GO:0000154),0.19540285633385007,0.4115416961772264,0.9857142857142858,0.9999967966743174,1.0,4/21,17.46%,METTL5;TFB1M;MRM2;NSUN3
prerank,peptidyl-methionine modification (GO:0018206),0.2124204820014053,0.4108865167265969,0.9817671809256662,0.9996944125493269,1.0,3/12,18.00%,NAA20;NAA60;METAP1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.17326620548615307,0.41012470500259673,1.0,0.9994165325565617,1.0,8/68,17.16%,RAB7B;DHX9;HMGB1;TWIST1;POU2F2;SETD4;LPL;MAVS
prerank,negative regulation of dephosphorylation (GO:0035305),0.19908558861004066,0.4095099260835253,0.9890560875512996,0.9991079785973436,1.0,3/18,14.65%,PPP1R8;ENSA;PTPA
prerank,neutrophil migration (GO:1990266),0.17034575633160115,0.40044689843713394,1.0,0.9999961841626658,1.0,2/58,4.98%,GBF1;CKLF
prerank,N-terminal protein amino acid modification (GO:0031365),0.19788830991626175,0.39942097565178825,0.9873595505617978,0.9997374384345671,1.0,6/14,28.32%,NAA60;METAP1;NAA40;NAA50;NAA35;METAP2
prerank,rRNA catabolic process (GO:0016075),0.1889106931864564,0.3932504966071884,0.9933155080213903,1.0,1.0,5/16,24.54%,EXOSC7;EXOSC10;DIS3;TRIR;EXOSC8
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.17619356340738324,0.3927400658710561,0.9988938053097345,0.9997549194928544,1.0,8/47,19.53%,MAPT;XDH;AGT;TP53;MAPK14;RIPK1;DHRS4;PRKCD
prerank,potassium ion export across plasma membrane (GO:0097623),0.19398581204093152,0.3910161254791263,0.9927536231884058,0.9995483033201672,1.0,13/13,80.62%,KCNT2;KCNK5;KCND3;KCNA5;KCNK18;KCNE1;KCNE3;KCNE2;KCNE5;KCNH2;KCNE4;KCNIP2;KCNQ1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.18702234443337357,0.38602303907213215,0.9947575360419397,0.9996858708310871,1.0,6/18,23.60%,YAP1;SMAD4;SRC;FER;IL6R;IL6ST
prerank,negative regulation of hydrolase activity (GO:0051346),0.16769130560225237,0.380358521586995,0.9988851727982163,0.9998107393639536,1.0,8/49,20.27%,WNK1;LRRK2;CPEB2;TERF2;ATP5IF1;RCC2;PLXNB3;EGLN1
prerank,monosaccharide transmembrane transport (GO:0015749),0.1868014567374105,0.3770047077431706,0.9957924263674615,0.9997229035783383,1.0,16/16,81.34%,SLC50A1;SLC2A8;SLC2A7;SLC2A12;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC23A2;SLC23A1;SLC2A2;SLC5A3;SLC2A9;SLC45A3;SLC2A10
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.19539588372636557,0.3753015251123615,0.9970414201183432,0.9994745894575461,1.0,1/10,8.98%,RIOK3
prerank,positive regulation of T cell activation (GO:0050870),0.16227540319192346,0.3723703193098739,0.9978401727861771,0.9993105209312307,1.0,9/62,18.55%,CD80;NCK1;FLOT2;ANXA1;NCK2;SIRPA;CD47;SLC7A1;ZBTB1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.160350579529999,0.3512862274465774,0.9987357774968394,1.0,1.0,5/25,23.26%,DNAJB5;GAK;HSPA14;BAG1;HSPA8
prerank,cell-cell junction maintenance (GO:0045217),0.177429848825068,0.3351910506855164,0.9955423476968797,1.0,1.0,3/11,25.00%,NLGN2;FERMT2;MYADM
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.1363326248634543,0.32711504224505505,1.0,1.0,1.0,21/116,22.88%,IAPP;GLP2R;ADAM17;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;YES1;HTR7;GNB1;PRKAR1A;FYN;MYH9
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.13394297837560826,0.32115442160182694,1.0,0.9999532412771688,1.0,21/117,22.88%,IAPP;GLP2R;ADAM17;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;YES1;HTR7;GNB1;PRKAR1A;FYN;MYH9
prerank,insulin secretion (GO:0030073),0.15293132335910076,0.318411258708461,0.9986945169712794,0.999610650540532,1.0,2/19,14.72%,ANXA1;SNX19
